<SEC-DOCUMENT>0001683168-21-000402.txt : 20210205
<SEC-HEADER>0001683168-21-000402.hdr.sgml : 20210205
<ACCEPTANCE-DATETIME>20210205162029
ACCESSION NUMBER:		0001683168-21-000402
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		100
FILED AS OF DATE:		20210205
DATE AS OF CHANGE:		20210205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			urban-gro, Inc.
		CENTRAL INDEX KEY:			0001706524
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-MACHINERY, EQUIPMENT & SUPPLIES [5080]
		IRS NUMBER:				465158469
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-250120
		FILM NUMBER:		21595663

	BUSINESS ADDRESS:	
		STREET 1:		1751 PANORAMA PT
		STREET 2:		UNIT G
		CITY:			LAFAYETTE
		STATE:			CO
		ZIP:			80026
		BUSINESS PHONE:		720-390-3880

	MAIL ADDRESS:	
		STREET 1:		1751 PANORAMA PT
		STREET 2:		UNIT G
		CITY:			LAFAYETTE
		STATE:			CO
		ZIP:			80026
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>urbangro_s1a5.htm
<DESCRIPTION>AMENDMENT NO. 5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 7pt"><A HREF="#toc">Table
of Contents</A></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on February 5, 2021 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 8pt"><B>Registration
No. 333-250120</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 50%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-size: 8pt"><B>Amendment
No. 5</B></FONT> </P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>to</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>FORM S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">REGISTRATION
STATEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">UNDER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">THE SECURITIES
ACT OF 1933</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>urban-gro,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(Exact
name of registrant as specified in its charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>5083</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>46-5158469</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(State
        or other jurisdiction of</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>incorporation
        or organization)</I></FONT></P></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(Primary
        Standard Industrial</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>Classification
        Code Number)</I></FONT></P></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(I.R.S.
        Employer</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>Identification
        No.)</I></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>1751 Panorama
Point, Unit G</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Lafayette,
CO 80026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(720) 390-3880</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive office)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Bradley
J. Nattrass</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Chief Executive
Officer </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>1751 Panorama
Point, Unit G</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Lafayette,
CO 80026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(720) 390-3880</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><I>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Copies to:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="text-align: center; vertical-align: top; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>W.
                                         David Mannheim</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Michael
        K. Bradshaw, Jr.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Nelson
        Mullins Riley &amp; Scarborough LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>4140
        Parklake Avenue, Suite 200</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Raleigh,
        NC 27612</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(919)
        329-3800</B></FONT></P></TD>
    <TD STYLE="vertical-align: top; width: 50%; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Rob
                                         Condon</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Dentons
        US LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>1221
        Avenue of the Americas</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>New
        York, New York 10020</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(212)
        768-6700</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>
        </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 6pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt"><B>Approximate
date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration
statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">If any
of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box.&nbsp;&nbsp; <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">If this
Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">If this
Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">If this
Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;
<FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%"><FONT STYLE="font-size: 8pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Wingdings; font-size: 8pt">&uml;</FONT></TD>
    <TD STYLE="width: 22%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%"><FONT STYLE="font-size: 8pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Wingdings; font-size: 8pt">&uml;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#9746;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#9746;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">Emerging growth company</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#9746;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt">If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 62%; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Title
                                         of Each Class of</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Securities
        to be Registered(1)</B></FONT></P></TD>
    <TD STYLE="width: 1%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Proposed</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Maximum</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Aggregate</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Offering
        Price(2)</B></FONT></P></TD>
    <TD STYLE="width: 1%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Amount
    of<BR>
    Registration Fee</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">Common
    stock, par value $0.001 per share</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$51,750,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$5,645.93</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">Warrants
    to be issued to the representative of the underwriters(3)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">Common
    stock underlying warrants to be issued to the representative of the underwriters(4)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$3,234,375</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$352.87</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">Total</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$54,984,375</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">$5,998.80
    (5)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 8pt">Pursuant
                                         to Rule 416 under the Securities Act, there are also being registered such indeterminate
                                         number of additional securities as may be issued to prevent dilution resulting from share
                                         splits, share dividends or similar transactions.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 8pt">(2)</FONT></TD><TD><FONT STYLE="font-size: 8pt">Estimated
                                         solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under
                                         the Securities Act of 1933, as amended. Includes the offering price of any additional
                                         shares of common stock that the underwriters have the right to purchase to cover over-allotments.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">No
                                         registration fee required pursuant to Rule 457(g).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 8pt">(4)</FONT></TD><TD><FONT STYLE="font-size: 8pt">We
                                         have agreed to issue to the representative of the underwriters warrants to purchase shares
                                         of common stock representing up to 5% of the common stock issued in the offering. The
                                         representative&rsquo;s warrants are exercisable at a per share exercise price equal to
                                         125% of the public offering price per share of the common stock offered hereby. As estimated
                                         solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under
                                         the Securities Act, the proposed maximum aggregate offering price of the representative&rsquo;s
                                         warrants is $3,234,375, which is equal to 125% of $2,587,500 (5% of $51,750,000). </FONT></TD></TR>                                                                                                                 <TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">(5)</FONT></TD><TD> <FONT STYLE="font-size: 8pt">Previously
                                         paid in connection with the prior filing of this registration statement.</FONT> </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0pt; text-indent: 0.25in"><FONT STYLE="font-size: 8pt"><B>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until
the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become
effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the Registration Statement
shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section&nbsp;8(a), may determine.</B></FONT></P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><B>The information in this
preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed
with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek
an offer to buy these securities in any state or other jurisdiction where the offer or sale is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 32%"><FONT STYLE="color: red"><B>PRELIMINARY PROSPECTUS</B></FONT></TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="color: red"><B>SUBJECT TO COMPLETION</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 32%; text-align: right"><FONT STYLE="color: red"><B>DATED <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FEBRUARY
    5, 2021</FONT></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 14pt"><B>4,285,714
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 14pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><IMG SRC="logo.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><B>urban-gro, Inc.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 2.25pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This is a firm commitment public offering
of 4,285,714 shares of our common stock, $0.001 par value per share, at an assumed offering price of $10.50 per share (based upon
the last reported sale price of our common stock on the OTCQX Marketplace on January 20, 2021).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to this offering, shares of our
common stock were quoted on the OTC Markets Group, Inc. OTCQX Marketplace under the symbol &ldquo;UGRO&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 20, 2021, the last reported
sale price for our common stock as reported on the OTCQX Marketplace was $10.50 per share. The final public offering price will
be determined through negotiation between us and the representative of the underwriters in the offering and the assumed offering
price used throughout this prospectus may not be indicative of the final offering price. We have applied to list our common stock
on the Nasdaq Capital Market under the symbol &ldquo;UGRO,&rdquo; which listing is a condition to this offering. No assurance
can be given that our application will be approved. This offering will only occur if a national securities exchange approves the
listing of our common stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are an &ldquo;emerging growth company&rdquo;
under the federal securities laws and have elected to comply with certain reduced public company reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Investing in our common stock involves
a high degree of risk. See &ldquo;<A HREF="#a4">Risk Factors</A>&rdquo; beginning on page 8.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per Share</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt">Public offering price</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Underwriting discounts and commissions<SUP>(1)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Proceeds to us, before expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt; width: 0.5in">(1)</TD>
    <TD STYLE="text-align: left">The underwriters will receive compensation in addition to the discounts and commissions. The
    registration statement, of which this prospectus is a part, also registers for sale warrants to purchase shares of common
    stock to be issued to the representative of the underwriters. We have agreed to issue the warrants to the representative of
    the underwriters as a portion of the underwriting compensation payable to the underwriters in connection with this offering.
    See &ldquo;<A HREF="#a22">Underwriting</A>&rdquo; beginning on page 69 for a description of compensation payable to the underwriters.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have granted a 45-day option to the
representative of the underwriters to purchase up to 642,857 additional shares of common stock solely to cover over-allotments,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The underwriters expect to deliver the
shares to purchasers on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%"><P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ThinkEquity</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>a division of Fordham Financial
        Management, Inc.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">The date of this prospectus
is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_005.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="toc"></A>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="background-color: White; width: 100%">
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a1">PROSPECTUS
    SUMMARY</A></TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0in">1</TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a2">THE OFFERING</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in">5</TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a3">SUMMARY HISTORICAL CONSOLIDATED
    FINANCIAL AND OTHER DATA</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in">7</TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a4">RISK FACTORS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in">8</TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a5">CAUTIONARY NOTE REGARDING
    FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 22 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a6">USE OF PROCEEDS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 23 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a7">MARKET FOR OUR COMMON
    STOCK</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 24 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a8">DIVIDEND POLICY</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 25 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a9">CAPITALIZATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 26 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a10">DILUTION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 28 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a11">SELECTED HISTORICAL
    CONSOLIDATED FINANCIAL AND OTHER DATA</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 29 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a12">MANAGEMENT&rsquo;S DISCUSSION
    AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 30 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a13">BUSINESS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 39 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a14">MANAGEMENT</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 56 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a15">EXECUTIVE AND DIRECTOR
    COMPENSATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 62 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a16">CERTAIN RELATIONSHIPS
    AND RELATED PARTY TRANSACTIONS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 67 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a17">PRINCIPAL STOCKHOLDERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 68 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a18">DESCRIPTION OF CAPITAL
    STOCK</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 69 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a19">DESCRIPTION OF SECURITIES
    WE ARE OFFERING</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 72 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a20">SHARES ELIGIBLE FOR
    FUTURE SALE</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 73 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a21">MATERIAL U.S. FEDERAL
    INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 74 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a22">UNDERWRITING</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 77 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a23">LEGAL MATTERS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 83 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a24">EXPERTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 83 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#a25">WHERE YOU CAN FIND MORE
    INFORMATION</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in"> 83 </TD></TR>
<TR STYLE="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-top: 0in; padding-bottom: 0in; padding-left: 0in"><A HREF="#fsindex">INDEX TO FINANCIAL
    STATEMENTS</A></TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0in">F-1</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 2.25pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>You should rely only on the information
contained in this prospectus or in any free writing prospectus that we may provide to you in connection with this offering. Neither
we nor any of the underwriters has authorized anyone to provide you with information different from, or in addition to, that contained
in this prospectus or in any such free writing prospectus. If anyone provides you with different or inconsistent information,
you should not rely on it. We can provide no assurance as to the reliability of any other information that others may give you.
Neither we nor any of the underwriters is making an offer to sell or seeking offers to buy these securities in any jurisdiction
where or to any person to whom the offer or sale is not permitted. The information in this prospectus is accurate only as of the
date on the front cover of this prospectus, and the information in any free writing prospectus that we may provide you in connection
with this offering is accurate only as of the date of such free writing prospectus. Our business, financial condition, results
of operations and prospects may have changed since those dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a1"></A>PROSPECTUS SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>This summary highlights information
contained in greater detail elsewhere in this prospectus and does not contain all of the information that you should consider
before deciding to invest in our common stock. You should read the entire prospectus carefully, including the &ldquo;Risk Factors,&rdquo;
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and our consolidated
financial statements and the related notes included in this prospectus, before making an investment decision. Some of the statements
in this prospectus constitute forward-looking statements. See &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;
Unless otherwise indicated in this prospectus, &ldquo;urban-gro,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo;
refer to urban-gro, Inc. and, where appropriate, its subsidiaries.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">urban-gro, Inc. is a leading engineering
and design services company focused on the sustainable commercial indoor horticulture market. We engineer and design indoor controlled
environment agriculture (&ldquo;CEA&rdquo;) facilities and then integrate complex environmental equipment systems into those facilities.
CEA is a market segment that is defined by type of facility, and has no correlation to the industry; or more specifically the
crop being grown in the facility. The CEA segment is represented by any horticultural facility that is fully self-contained, and
has a fully-controlled environment. There are three facility types that meet these qualifications: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in; text-indent: 22.5pt; background-color: white"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> i. </TD><TD> Indoor Facilities - new building; or the retrofit of an
                                         existing building; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> ii. </TD><TD> Vertical Farms &ndash; a building with a smaller footprint
                                         that is built up vertically and we view this category as including modular container
                                         farms; and </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> iii. </TD><TD> Greenhouses &ndash; traditional and made out of a variety
                                         of translucent materials as to provide natural sunlight for the crop being grown. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> While historically we have been focused
on engineering, design, and equipment integration into indoor facilities, of which some are ultimately used for the cultivation
of plant-based medicines, we are planning to expand our reach within CEA across both facility type and crop type. The term &ldquo;plant-based
medicines&rdquo; includes (i) a wide array of herbal supplements including but not limited to curcumin, saffron extract and ginger,
(ii) CBD based therapeutics, (iii) cannabis based therapeutics and (iv) a host of medicines derived from plants such as caffeine,
menthol, foxglove and others. We are focusing on expanding to the vertical farming CEA sub-segment, which is ultimately and predominantly
used for the cultivation of a variety of crops including, but not limited to, leafy greens, herbs, cucumbers, peppers and strawberries.
As the global horticulture market has become more focused on the safety of the food supply chain, reducing emissions with current
transportation methods associated with these crops, and, growing local, we are confident that the vertical farming CEA sub-segment
will represent a significant and increasing share of our revenue and be a significant factor in our organic growth moving forward. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Demand for Our Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The world&rsquo;s population is expected
to grow from 8 billion in 2020 to almost 10 billion by 2050. It will become increasingly difficult to satisfy the demand for food
to serve this population growth in a sustainable manner. Governments, farmers and corporate enterprises are adopting new technologically
advanced farming techniques to meet demand and alleviate supply chain risk. CEA facilities including aquaponics, aeroponics, hydroponics,
new soil-based farming and hybrid methods are emerging in urban and suburban areas. This is driving demand for indoor farms across
the globe with the CEA market estimated to grow from $4 billion in 2020 to $12.8 billion in 2026. Consequently, businesses such
as urban-gro that know how to design, supply, and service those indoor farms will be in high demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Population growth and climate changes
have created a surge in sustainable farming from traditional outdoor operations to indoor settings. Climate change is being blamed
for lower production yields, including the loss of arable land. The efficient management of natural resources is further driving
the growth of CEA facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is strong demand for local and safe
foods. 55% of the world&rsquo;s population currently lives in urban areas and this is expected to increase to 68% by 2050. Producers
of fruits, vegetables, and other high-value crops are setting up production centers in urban areas to target this opportunity.
Further, a rise in emerging growing residential areas increases demand for CEA producers. The safe growing environment, conservation
of water and available nutrients are some of the many advantages of CEA facility derived products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As COVID-19 has recently shown in its
disruption of global supply chains, being able to efficiently and successfully grow food year-round in areas close to existing
populations and expected population growth will allow for security in food supply that was not possible before. Our deep bench
of experience enables the creation of facilities for cultivators within CEA to reach this efficiency and success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in; text-align: center"><B>Our Competitive Strengths</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our custom-tailored approach to engineering
design, equipment sourcing, and the integration of complex equipment systems provides a single point of accountability across all
aspects of indoor growing operations. We help our clients achieve operational efficiency and economic advantages through a full
spectrum of solutions focused on facility optimization and environmental health, which allows clients to manage their entire cultivation
lifecycle, establishing facilities that operate and perform at high levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our employees and the combination of
their educational frameworks with the practical application of their acquired industry knowledge is our most valuable asset as
an organization. Our team has designed over 300 indoor CEA projects with the highest value agriculture crop in the world and have
developed unparalleled know-how in creating an environment that is suited for the complexities of indoor agriculture.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Our Growth Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our growth is being fueled by increased
demand for sustainable CEA facilities. The introduction of new technologies, improved farming methods and a rise in entrepreneurship
combined with corporate emergence is driving organic growth. Acquisitions that complement our platform should also be a factor
contributing to growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As the demand for food produced from CEA
facilities continues to increase, we will market our services to these clients, hire additional sales and support employees, and
execute a focused targeting of our services to this industry to capture significant portions of this market. While we will continue
to provide our solutions to the plant-based medicine market that has been our strength, we believe that the CEA market will represent
a more significant and increasing share of our revenue and be a significant factor in our organic growth moving forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Complementary to the industry expansion
for our organic growth, and based on our initial success, we will continue to expand our presence and reach within Europe. We
plan on opening a headquarters office in Europe, a market where we are seeing increased demands for our expertise and solutions,
and have already signed several projects with European clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Another key area that will fuel sustained
and strong growth for us is in the introduction of new enhanced technology-focused equipment and system solutions. Our experienced
team of engineers and scientists are continually vetting emerging horticulture equipment solutions that may be of value to our
clients. Further, and focusing on our expanding service platform, we will continue to build out our facility commissioning and
staff training offerings. Revolving around our deep acquired knowledge base of CEA, we will grow through continued expansion of
this services program and further penetrate the market segments that we serve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have made investments in, and acquisitions
of, companies that are complementary to our offerings. We will look to continue to grow in this way to meet the increasing demand
for efficient and successful CEA facilities. We will continue to pursue accretive and synergetic acquisitions that utilize our
core strengths to further expand our reach into the horticulture and agriculture markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Preliminary Financial Results for the Three Months and
Year Ended December 31, 2020 (preliminary and unaudited)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These operating results reflect our preliminary
estimates with respect to the results for the three months and year ended December 31, 2020, which are based on currently available
information and are subject to change. Our financial closing procedures for the three months and year ended December 31, 2020
are not yet complete and, as a result, our final results upon completion of our closing procedures may vary from these preliminary
estimates. These preliminary estimates should not be viewed as a substitute for interim financial statements prepared in accordance
with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These preliminary operating results have
been prepared by, and are the responsibility of, our management. Our auditor, BF Borgers CPA PC, has not audited, reviewed, compiled
or applied agreed-upon procedures with respect to these preliminary results. Accordingly, BF Borgers CPA PC does not express an
opinion or any other form of assurance with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect our preliminary and unaudited
revenue for the three months ended December 31, 2020 to be between $9.0 million and $9.3 million, which would represent an increase
of at least 26% from revenue of $7.1 million reported for the three months ended December 31, 2019. Preliminary and unaudited
revenue for the year ended December 31, 2020 is expected to be between $25.6 million and $25.9 million, compared to $24.2 million
reported for the year ended December 31, 2019. This expected increase in revenue was driven by an increase in the shipment of
complex environmental equipment systems and sales of other cultivation equipment predominantly tied to design contracts signed.
We are entering 2021 with in excess of $14.0 million of contractually committed orders for environmental and cultivation equipment
systems for which revenue has not been recognized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect our preliminary and unaudited
net loss for the three months ended December 31, 2020 to be between negative ($1.7) million and negative ($1.4) million, which
would represent an improvement of at least $0.9 million from net loss of negative ($2.6) million reported for the three months
ended December 31, 2019. This expected improvement in net loss is driven by reductions in operating expenses and increased gross
profit. Preliminary and unaudited net loss for the year ended December 31, 2020 is expected to be between negative ($5.7) million
and negative ($5.4) million, which would represent an improvement of at least $2.7 million from net loss of negative ($8.4) million
reported for the year ended December 31, 2019. This expected improvement in net loss is driven by a reduction in operating expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, we expect to achieve positive
Adjusted EBITDA for the three months ended December 31, 2020, with Adjusted EBITDA for the year ended December 31, 2020 expected
to be between negative ($0.9) million and negative ($0.7) million, which would represent an improvement of at least $2.3 million
from Adjusted EBITDA of negative ($3.3) million reported for the year ended December 31, 2019. See &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations&mdash;Non-GAAP Financial Measures&rdquo; for a discussion of how
we calculate Adjusted EBITDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An investment in our common stock involves
a high degree of risk. You should carefully consider the risks summarized below. These risks are discussed more fully in the section
titled &ldquo;Risk Factors&rdquo; following this prospectus summary. These risks include, but are not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the effect
                                         of the COVID-19 pandemic on our business and operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to generate revenues sufficient to achieve
                                         profitability and positive cash flow;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>competition in our industry and our ability to compete
                                         effectively;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to attract, recruit, retain and develop
                                         key personnel and qualified employees;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>risks related to laws, regulations and industry
                                         standards;</TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD> risks related to the cannabis industry; </TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reliance on significant clients and third-party
                                         suppliers;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the ability of our principal stockholders to significantly
                                         influence or control matters requiring a stockholder vote;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability to successfully identify and complete
                                         acquisitions and effectively integrate those acquisitions into our operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our indebtedness and potential increases in our
                                         indebtedness; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the other
                                         factors described in &ldquo;Risk Factors.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We were originally formed on March 20,
2014, as a Colorado limited liability company. In March 2017, we converted to a Colorado corporation and exchanged shares of our
common stock for every member interest issued and outstanding on the date of conversion. On October 29, 2020, we reincorporated
as a Delaware corporation. In June 2018, we formed urban-gro Canada Technologies, Inc. as a wholly owned Canadian subsidiary,
which we utilize for all our Canadian sales operations. Effective March 7, 2019, we acquired 100% of the stock of Impact Engineering,
Inc., a provider of MEP engineering services. Our executive office is located at 1751 Panorama Point, Unit G, Lafayette, Colorado
80026, and our phone number is (720) 390-3880. Our principal website address is www.urban-gro.com. The information on any of our
websites is deemed not to be incorporated in this prospectus or to be part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1-for-6 Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 31, 2020, we effected a 1-for-6
reverse stock split with respect to our common stock. Unless we indicate otherwise or the context otherwise requires, all information
in this prospectus gives effect to this reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Implications of Being an Emerging Growth Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are an &ldquo;emerging growth company&rdquo;
as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act. An emerging growth company may take advantage of specified
reduced reporting requirements that are otherwise generally applicable to public companies. As a result:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are
                                         required to have only two years of audited financial statements and only two years of
                                         related selected financial data and management&rsquo;s discussion and analysis of financial
                                         condition and results of operation in this prospectus;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are not required to comply with any requirement
                                         that may be adopted by the Public Company Accounting Oversight Board, or the PCAOB, regarding
                                         mandatory audit firm rotation or a supplement to the auditor&rsquo;s report providing
                                         additional information about the audit and financial statements (<I>i.e.</I>, an auditor
                                         discussion and analysis) compliance with new or revised accounting standards until they
                                         are made applicable to private companies;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are not required to engage an auditor attestation
                                         to report on our internal control over financial reporting pursuant to Section 404(b)
                                         of the Sarbanes-Oxley Act of 2002;</TD></TR>

<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are
                                         not required to comply with certain disclosure requirements related to executive compensation,
                                         such as the requirement to disclose the correlation between executive compensation and
                                         performance and the requirement to present a comparison of our Chief Executive Officer&rsquo;s
                                         compensation to our median employee compensation; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are not required to submit certain executive
                                         compensation matters to stockholder advisory votes, such as &ldquo;say on pay,&rdquo;
                                         &ldquo;say on frequency&rdquo; and &ldquo;say on golden parachute arrangements.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may take advantage of these reduced
reporting and other requirements until December 31, 2023, or such earlier time that we are no longer an emerging growth company.
However, if certain events occur before the end of that five-year period, including if we have more than $1.07&nbsp;billion in
annual revenue, have more than $700 million in market value of our common stock held by non-affiliates, or issue more than $1.0&nbsp;billion
in non-convertible debt over a three-year period, we will cease to be an emerging growth company. We may choose to take advantage
of some but not all of these reduced reporting burdens. We have elected to adopt the reduced requirements with respect to our
financial statements and the related selected financial data and Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations disclosure. Accordingly, the information that we provide to stockholders may be different than the information
you receive from other public companies in which you hold stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a2"></A>THE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Common stock offered</TD>
    <TD STYLE="width: 50%">4,285,714 shares.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Common stock to be outstanding after this offering</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,997,761 shares (or 9,640,618 shares if the
    underwriters exercise their over-allotment option in full).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Over-allotment option</TD>
    <TD>We have granted the underwriters a 45-day option to purchase up to 642,857 additional shares of our common stock at the
    public offering price to cover over-allotments, if any.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Use of proceeds</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We estimate that the net proceeds to us from this offering
        will be approximately $41.8 million, or approximately $48.0 million if the underwriters exercise their over-allotment
        option in full, assuming a public offering price of $10.50 per share.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We intend to use the net proceeds of this offering
        to repay outstanding indebtedness under our Credit Agreement, to expand in the European CEA market and for general corporate
        purposes. See &ldquo;Use of Proceeds.&rdquo;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Risk factors</TD>
    <TD>You should read the &ldquo;<A HREF="#a4">Risk Factors</A>&rdquo; section of this prospectus beginning on page 8 for a
    discussion of factors to consider carefully before deciding to invest in shares of our common stock.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Proposed Nasdaq Capital Market symbol</TD>
    <TD>UGRO.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our shares of common stock outstanding after this offering
is based on 4,712,047 shares currently outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless we indicate otherwise or the context otherwise requires,
all information in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes no exercise
    by the underwriters of their over-allotment option;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes no exercise
    of the representative&rsquo;s warrants to be issued to the representative of the underwriters in this offering;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt">excludes 234,771 shares issuable upon conversion of Bridge Financing notes (see &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations&mdash;Recent Developments&mdash;Bridge Financing&rdquo;
    for a discussion of the Bridge Financing);</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gives effect to the
    1-for-6 reverse stock split with respect to our common stock, which took effect on December 31, 2020;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 638,277 shares
    of common stock issuable upon the exercise of outstanding exercisable options at a weighted exercise price of $6.30 per share;
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 202,752 shares
    of common stock issuable upon the exercise of outstanding warrants at a weighted exercise price of $13.28 per share; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 39,482 shares
    of common stock reserved for future issuance pursuant to our 2019 Equity Incentive Plan.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Trademarks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus includes our service marks
and trade names, including &ldquo;Soleil,&rdquo; &ldquo;Opti-Dura,&rdquo; and &ldquo;urban-gro,&rdquo; which are protected under
applicable intellectual property laws and are our property. This prospectus also contains trademarks, trade names and service
marks of other companies, which are the property of their respective owners. Solely for convenience, trademarks, trade names and
service marks referred to in this prospectus may appear without the &reg;, &trade; or SM symbols, but those references are not
intended to indicate, in any way, that we will not assert, to the fullest extent permitted under applicable law, our rights or
the right of the applicable licensor to these trademarks, trade names and service marks. We do not intend our use or display of
other parties&rsquo; trademarks, trade names or service marks to imply, and such use or display should not be construed to imply,
a relationship with, or endorsement or sponsorship of us by, these other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Market and Industry Data</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise indicated, information
contained in this prospectus concerning our industry, competitive position and the markets in which we operate is based on information
from independent industry and research organizations, other third-party sources and management estimates. Management estimates
are derived from publicly available information released by independent industry analysts and other third-party sources, as well
as data from our internal research, and are based on assumptions we made upon reviewing such data, and our experience in, and
knowledge of, such industry and markets, which we believe to be reasonable. In addition, projections, assumptions and estimates
of the future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty
and risk due to a variety of factors, including those described in &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Note Regarding
Forward-Looking Statements.&rdquo; These and other factors could cause results to differ materially from those expressed in the
estimates made by the independent parties and by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a3"></A>SUMMARY HISTORICAL
CONSOLIDATED FINANCIAL AND OTHER DATA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following tables set forth our summary
historical consolidated financial data as of, and for the periods ended on, the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The summary consolidated statements of
operations data for the years ended December 31, 2019 and 2018 are derived from our audited consolidated financial statements
and notes that are included elsewhere in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The summary consolidated statements of
operations data for the three and nine months ended September 30, 2020 and 2019 and the summary consolidated balance sheet data
as of September 30, 2020 are derived from our unaudited interim consolidated financial statements and notes that are included
elsewhere in this prospectus. We have prepared the unaudited consolidated financial statements in accordance with generally accepted
accounting principles (GAAP) and on the same basis as the audited consolidated financial statements. Our historical results are
not necessarily indicative of our results in any future period and results from our interim period may not necessarily be indicative
of the results of the entire year. Pro forma share and per share amounts presented herein reflect the implementation of the 1-for-6
reverse stock split as if it had occurred at the beginning of the earliest period presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Three
        Months Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Three
        Months Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Nine
        Months Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Nine
        Months Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Fiscal
        Year Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>For
                    the </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Fiscal
        Year Ended</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>December&nbsp;31,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>December&nbsp;31,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2020</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2020</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2018</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Audited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Audited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt"><B>Statement of operations data:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; width: 28%; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Revenues</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">8,359,422</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">5,583,064</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">16,625,688</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">17,056,737</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">24,189,803</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">20,050,776</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Cost of revenues</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">6,654,134</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">3,650,965</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">12,613,461</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">11,529,448</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">17,563,594</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">13,892,025</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Gross Profit</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,705,288</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,932,099</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">4,012,227</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,527,289</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">6,626,209</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">6,158,751</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Operating expenses</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">1,853,828</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">3,324,921</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">6,502,283</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">9,581,375</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">12,486,814</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">9,959,335</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Income (loss) from operations</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(148,540</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,392,822</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(2,490,056</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(4,054,086</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(5,860,605</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(3,800,584</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Other non-operating income (expense)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(545,741</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,416,708</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,469,826</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,665,318</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(2,489,968</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(95,289</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; padding-bottom: 2.5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Net income (loss)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(694,281</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(2,809,530</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(3,959,882</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(5,719,404</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(8,350,573</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(3,895,873</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; padding-bottom: 2.5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Income (loss) per share,
    basic and diluted</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.02</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.11</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.14</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.22</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.32</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.16</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; padding-bottom: 2.5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Weighted average shares
    outstanding, basic and diluted </FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">28,888,194</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">26,175,098</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">28,706,905</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">25,772,134</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">26,318,059</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">24,848,293</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Pro forma income (loss)
    per share, basic and diluted (unaudited)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.12</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.66</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.84</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(1.32</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(1.92</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.96</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Pro forma weighted average
    shares outstanding, basic and diluted (unaudited)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,814,699</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,362,516</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,784,484</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,295,356</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,386,343</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,141,382</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Historical</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Pro
                                         Forma</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>As
                                         Adjusted (1)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As of</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">September 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">September 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">2020</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">2020</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Unaudited)</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Unaudited)</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">Balance sheet data</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Current assets</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">4,586,195</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 8pt">46,266,195</FONT> </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Total assets</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">7,550,138</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 8pt">49,230,138</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Current liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">9,419,327</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">8,419,327</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Total liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">14,254,085</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">14,104,085</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Stockholders&rsquo; equity</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(6,703,947</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 8pt">35,126,053</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Total liabilities and stockholders&rsquo; equity</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">7,550,138</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 8pt">49,230,138</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Gives effect to Bridge Financing transactions subsequent to September
    30, 2020, the issuance and sale by us in this offering of 4,285,714 shares of our common stock at an assumed public offering
    price of $10.50 per share, after deducting the estimated underwriting discounts and commissions and estimated offering expenses
    that we expect to pay, and the application of $1.0 million of the net proceeds from this offering to repay outstanding indebtedness
    under our Credit Agreement as described under &ldquo;Use of Proceeds.&rdquo; An increase (decrease) of $1.00 in the assumed
    public offering price would increase (decrease) total assets by approximately $4.0 million, assuming the number of
    shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same. Similarly, an increase
    (decrease) of 100,000 shares offered would increase (decrease) our total assets by approximately $1.0 million, assuming the
    assumed public offering price remains the same.</FONT></TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a4"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>An investment in our common stock involves
a high degree of risk. You should carefully consider the following risks and all of the other information contained in this prospectus
before deciding whether to invest in our common stock. If any of the following risks are realized, our business, financial condition
and results of operations could be materially and adversely affected. In that event, the trading price of our common stock could
decline and you could lose all or part of your investment in our common stock. Additional risks of which we are not presently
aware or that we currently believe are immaterial may also harm our business and results of operations. Some statements in this
prospectus, including such statements in the following risk factors, constitute forward-looking statements. See the section entitled
&ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The COVID-19 pandemic could continue to materially adversely
affect our business, financial condition, results of operations, cash flows and day-to-day operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The outbreak of COVID-19, a novel strain
of coronavirus first identified in China, which has spread across the globe including the U.S., has had an adverse impact on our
operations and financial condition. Most recently, the response to this coronavirus by federal, state and local governments in
the U.S. has resulted in significant market and business disruptions across many industries and affecting businesses of all sizes.
This pandemic has also caused significant stock market volatility and further tightened capital access for most businesses. Given
that the COVID-19 pandemic and its disruptions are of an unknown duration, they could have an adverse effect on our liquidity
and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a result of these events, we assessed
our near-term operations, working capital, finances and capital formation opportunities, and implemented, in late March 2020,
a downsizing of our operations and workforce to preserve cash resources and focus our operations on client-centric sales and project
management activities. The duration and likelihood of success of this workforce reduction are uncertain; however, we have since
rehired several employees who were impacted by the downsizing effort. If this downsizing effort does not meet our expectations,
or additional capital is not available, we may not be able to continue our operations. The pandemic and its effects resulted in
temporary delays in our projects, however, work on all such projects has resumed. Other factors that will affect our ability to
continue operations include the market demand for our products and services, our ability to service the needs of our clients and
prospects with a reduced workforce, potential contract cancellations, project scope reductions and project delays, our ability
to fulfill our current backlog, management of our working capital, the availability of cash to fund our operations, and the continuation
of normal payment terms and conditions for purchase of our products. In light of these extenuating circumstances, there is no
assurance that we will be successful in growing and maintaining our business with our clients. If our clients or prospects are
unable to obtain project financing and we are unable to increase revenues, or otherwise generate cash flows from operations, we
will not be able to successfully execute on the various strategies and initiatives we have set forth in this prospectus to grow
our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The ultimate magnitude of COVID-19, including
the extent of its impact on our financial and operational results, which could be material, will depend on the length of time
that the pandemic continues, its effect on the demand for our products and our supply chain, the effect of governmental regulations
imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing. We cannot at this time predict the
full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on our business, financial condition,
results of operations and cash flows beyond what is discussed within this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have a relatively limited history of operations, a
history of losses, and our future earnings, if any, and cash flows may be volatile, resulting in uncertainty about our ability
to service and repay our debt when it comes due and uncertainty about our prospects generally.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We were initially organized as a limited
liability company in the State of Colorado on March 20, 2014. In March 2017, we converted into a corporation with the expectation
of becoming a public reporting, trading company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following is a summary of our recent historical
operating performance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>During
                                         the nine months ended September 30, 2020, we generated revenue of $16.6 million and incurred
                                         a net loss of $4.0 million.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>During
                                         the year ended December 31, 2019, we generated revenue of $24.2 million and incurred
                                         a net loss of $8.3 million.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>During
                                         the year ended December 31, 2018, we generated revenue of $20.1 million and incurred
                                         a net loss of $3.9 million.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>During
                                         the year ended December 31, 2017, we generated revenue of $12.3 million, and incurred
                                         a net loss of $2.6 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our lack of a significant history and
the evolving nature of the market in which we operate make it likely that there are risks inherent to our business that are yet
to be recognized by us or others, or not fully appreciated, and that could result in us suffering further losses. As a result
of the foregoing, and concerns regarding the economic impact from COVID-19, an investment in our securities necessarily involves
uncertainty about the stability of our operating results, cash flows and, ultimately, our ability to service and repay our debt
and our prospects generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We had negative cash flow for the fiscal year ended December
31, 2019 and for the nine months ended September 30, 2020.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We had negative operating cash flow of
($2.5) million for the fiscal year ended December 31, 2019 and ($3.0) million for the nine months ended September 30, 2020. To
the extent that we have negative operating cash flow in future periods, we may need to allocate a portion of our cash reserves
to fund such negative cash flow. We may also be required to raise additional funds through the issuance of equity or debt securities.
There can be no assurance that we will be able to generate positive cash flow from our operations, that additional capital or
other types of financing will be available when needed or that these financings will be on terms favorable to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our engineering and design services have been used and
may continue to be contracted for use in emerging industries that may be subject to quickly changing and inconsistent laws, regulations,
practices and perceptions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
the demand for our engineering and design services may be negatively impacted depending on how laws, regulations, administrative
practices, judicial interpretations, and consumer perceptions develop, we cannot reasonably predict the nature of such developments
or the effect, if any, that such developments could have on our business. We will continue to encounter risks and uncertainty
relating to our operations that may be difficult to overcome. To do so, we believe it will be important to:</FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Execute
                                         our business and marketing strategy successfully;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Increase
                                         and diversify our client base;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Extend our reach to include the global
                                         CEA marketplace;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Meet client
                                         demand with quality, timely services;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>When appropriate,
                                         partner with affiliate marketing companies to explore demand;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Leverage
                                         initial relationships with existing clients;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Enhance
                                         the solutions that we offer and focus on continually improving customer service levels;
                                         and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Attract,
                                         hire, motivate and retain qualified personnel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Our business is focused on providing engineering design,
and equipment integration into facilities prior to the facility becoming operational. We do not know for certain how much of our
revenues to date have been generated from clients in the legal cannabis industry; however, we believe the majority of our revenues
to date have been generated from clients that operate in the legal cannabis industry. </I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> We are broadening our market reach beyond
the legal cannabis industry and are placing a substantial sales effort on expansion into the rapidly growing non-cannabis CEA
vertical farming segment. However, on a historic basis, we believe our clients to whom we provide facility engineering design
and equipment integration prior to the facility becoming operational have primarily been in the legal cannabis industry. In addition
to selling to these clients, we also sell our equipment solutions to third parties, such as general contractors, and other intermediaries,
like equipment leasing companies. While we do not know for certain how much of these solutions are resold into the legal cannabis
industry, we believe that to date the majority of these solutions have been resold into the legal cannabis industry. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Now that the non-cannabis CEA
segment is gaining strong momentum, and since most all of the equipment systems that we sell originate in the general
horticulture industry and are agnostic to the crop grown in the facility, we believe that the proportion of non-cannabis
revenues will increase. However, we do not control to who such third parties resell
our solutions, and notwithstanding our expansion plans, a decrease in demand in the legal cannabis industry could have a material
adverse effect on our revenues and the success of our business. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>The cannabis industry is an emerging industry and
has only been legalized in some states and remains illegal in others and under U.S. federal law, making it difficult to accurately
forecast the demand for our solutions in this specific industry, and losing clients from this industry may have a material adverse
effect on our revenues and the success of our business.</I></B> <B><I> </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The cannabis industry is immature in the
United States and has only been legalized in some states and remains illegal in others and under U.S. federal law, making it difficult
to accurately predict and forecast the demand for our solutions. If the U.S. Department of Justice (&ldquo;DOJ&rdquo;) did
take action against the cannabis industry, those of our clients operating in the legal cannabis industry would be lost to
us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To analyze this risk, we are relying heavily
upon the various U.S. federal governmental memos issued in the past (including the memorandum issued by the DOJ on October 19,
2009, known as the &ldquo;Ogden Memorandum&rdquo;, the memorandum issued by the DOJ on August 29, 2013, known as the &ldquo;Cole
Memorandum&rdquo; and other guidance), to remain acceptable to those state and federal entities that regulate, enforce, or choose
to defer enforcement of certain current regulations regarding cannabis and that the U.S. federal government will not change its
attitude to those practitioners in the cannabis industry as long as they comply with their state and local jurisdictional rules
and authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The legal cannabis industry is
not yet well-developed, and many aspects of this industry&rsquo;s development and evolution cannot be accurately predicted, and
therefore losing any clients may have a material adverse effect on our business. While we have attempted to identify our business
risks in the legal cannabis industry, you should carefully consider that there are other risks that cannot be foreseen
or are not described in this prospectus, which could materially and adversely affect our business and financial performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>There is heightened scrutiny
by Canadian regulatory authorities related to the cannabis industry.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Our existing operations in the United
States, and any future operations or investments, may become the subject of heightened scrutiny by regulators and other authorities
in Canada. As a result, we may be subject to significant direct and indirect interaction with public officials. No assurance can
be provided that this heightened scrutiny will not in turn lead to the imposition of certain restrictions on our ability to operate
or invest in the United States, in addition to those described herein. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> It had been reported in Canada that
the Canadian Depository for Securities Limited considered a policy shift that would see its subsidiary, CDS, refuse to settle
trades for cannabis issuers or issuers with cannabis related activities that have investments in the United States. CDS is Canada&rsquo;s
central securities depository, clearing and settling trades in the Canadian equity, fixed income and money markets. The TMX Group,
the owner and operator of CDS, subsequently issued a statement on August 17, 2017 reaffirming that there is no CDS ban on the
clearing of securities of issuers with cannabis-related activities in the United States, despite media reports to the contrary
and that the TMX Group was working with regulators to arrive at a solution that will clarify this matter, which would be communicated
at a later time. On February 8, 2018, following discussions with the Canadian Securities Administrators and recognized Canadian
securities exchanges, the TMX Group announced the signing of the TMX Memorandum of Understanding (&ldquo;MOU&rdquo;) with Aequitas
NEO Exchange Inc., the Canadian Securities Exchange (&ldquo;CSE&rdquo;), the Toronto Stock Exchange, and the TSXV. The TMX MOU
outlines the parties&rsquo; understanding of Canada&rsquo;s regulatory framework applicable to the rules, procedures, and regulatory
oversight of the exchanges and CDS as it relates to issuers with cannabis-related activities in the United States. The MOU confirms,
with respect to the clearing of listed securities, that CDS relies on the exchanges to review the conduct of listed issuers. As
a result, there is no CDS ban on the clearing of securities of issuers with cannabis-related activities in the United States.
However, there can be no guarantee that this approach to regulation will continue in the future. If such a ban were to be implemented
at a time when our securities are listed on a stock exchange, it would have a material adverse effect on the ability of holders
of our securities to make and settle trades. In particular, our securities would become highly illiquid until an alternative was
implemented, and investors would have no ability to effect a trade of our securities through the facilities of the CSE. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may incur losses in the near future, which may impact
our ability to implement our business strategy and adversely affect our financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">While we have focused significantly on
decreasing our operating expenses by reducing variable expenses, employee count, and marketing activities in order to become cash
flow positive, such decreases may adversely affect our operating results if we are unable to support the business effectively.
In turn, this would have a negative impact on our financial condition and potentially our share price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We also cannot assure you that we will
be profitable or generate sufficient profits from operations in the future. If our revenues do not grow or our gross margins deteriorate
substantially, we are likely to continue to experience losses in future periods. Collectively, this may impact our ability to implement
our business strategy and adversely affect our financial condition. This potentially would have a negative impact on our share
price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may become subject to additional regulation of CEA
facilities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our engineering and design services are
focused on facilities that grow a wide variety of crops that are subject to regulation by the United States Food and Drug Administration
and other federal, state or foreign agencies. Changes to any regulations and laws that could complicate the engineering of these
CEA facilities, such as waste water treatment and electricity-related mandates, make it possible that potential related enforcement
could decrease the demand for our services, and in turn negatively impact our revenues and business opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Competition in our industry is intense.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are many competitors in the horticulture
industry, and in particular the cannabis industry, including many who offer somewhat categorically similar products and
services as those offered by us. There can be no guarantees that in the future other companies will not enter this arena by developing
products that are in direct competition with us. We anticipate the presence as well as entry of other companies in this market
space and acknowledge that we may not be able to establish, or if established to maintain, a competitive advantage. Some of these
companies may have longer operating histories, greater name recognition, larger client bases and significantly greater financial,
technical, sales and marketing resources. This may allow them to respond more quickly than us to market opportunities. It may
also allow them to devote greater resources to the marketing, promotion and sale of their products and/or services. These competitors
may also adopt more aggressive pricing policies and make more attractive offers to existing and potential clients, employees,
strategic partners, distribution channels and advertisers. Increased competition is likely to result in price reductions, reduced
gross margins and a potential loss of market share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>A drop in the retail price of cannabis products may
negatively impact our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The fluctuations in economic and market
conditions that impact the prices of commercially grown cannabis, such as increases in the supply of cannabis and decreases in
demand for cannabis, could have a negative impact on our clients that are cannabis producers, and therefore could negatively impact
our business. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our principal stockholders have the ability to significantly
influence or control matters requiring a stockholder vote and other stockholders may not have the ability to influence corporate
transactions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of January 20, 2021, our principal
stockholders own approximately 55% of our outstanding common stock, and following this offering, assuming the number of shares
of common stock offered by us, as set forth on the cover page of this prospectus, remains the same, will own approximately 29%
of our outstanding common stock. As a result, they have the ability to significantly influence the outcome of all matters requiring
approval of our stockholders, including the election of directors and approval of significant corporate transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are highly dependent on our management team, and the
loss of our senior executive officers or other key employees could harm our ability to implement our strategies, impair our relationships
with clients and adversely affect our business, results of operations and growth prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our success depends, in large degree,
on the skills of our management team and our ability to retain, recruit and motivate key officers and employees. Our active senior
executive leadership team, including Jonathan Nassar, Mark Doherty, Dan Droller, Brian Zimmerman, and particularly Bradley Nattrass
and Richard Akright, have significant experience, and their knowledge and relationships would be difficult to replace. Leadership
changes will occur from time to time, and we cannot predict whether significant resignations will occur or whether we will be
able to recruit additional qualified personnel. Competition for senior executives and skilled personnel in the horticulture industry
is intense, which means the cost of hiring, paying incentives and retaining skilled personnel may continue to increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B></B>We need to continue to attract and retain key
personnel and to recruit qualified individuals to succeed existing key personnel to ensure the continued growth and successful
operation of our business. In addition, as a provider of custom-tailored horticulture solutions, we must attract and retain qualified
personnel to continue to grow our business, and competition for such personnel can be intense. Our ability to effectively compete
for senior executives and other qualified personnel by offering competitive compensation and benefit arrangements may be restricted
by cash flow and other operational restraints. The loss of the services of any senior executive or other key personnel, or the
inability to recruit and retain qualified personnel in the future, could have a material adverse effect on our business, financial
condition or results of operations. In addition, to attract and retain personnel with appropriate skills and knowledge to support
our business, we may offer a variety of benefits, which could reduce our earnings or have a material adverse effect on our business,
financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our insurance may not adequately cover our operating
risk.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have insurance to protect our assets,
operations and employees. While we believe our insurance coverage addresses all material risks to which we are exposed and is
adequate and customary in our current state of operations, such insurance is subject to coverage limits and exclusions and may
not be available for the risks and hazards to which we are exposed. In addition, no assurance can be given that such insurance
will be adequate to cover our liabilities or will be generally available in the future or, if available, that premiums will be
commercially justifiable. If we were to incur substantial liability and such damages were not covered by insurance or were in
excess of policy limits, or if we were to incur such liability at a time when we are not able to obtain liability insurance, our
business, results of operations and financial condition could be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are dependent upon third-party suppliers of products
we sell.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are dependent on outside vendors for
the products we sell. For the year ended December 31, 2019, two vendors, Argus Control Systems Limited (&ldquo;Argus&rdquo;),
a provider of automated control systems, and Fluence Bioengineering, Inc. (&ldquo;Fluence&rdquo;), a provider of lighting systems,
were particularly important to our integrated sales solutions. Sales of Fluence&rsquo;s LED lighting systems accounted for 25%
of our consolidated revenue for the year ended December 31, 2019. We use Fluence LED systems in our designs and then sell them
to our clients as part of our overall package. While we believe that there are sufficient sources of supply available, if the
third-party suppliers, such as Argus or Fluence, were to cease production or otherwise fail to supply us with products in sufficient
quantities on a timely basis and we were unable to contract on acceptable terms for these products with alternative suppliers,
our ability to sell these products would be materially adversely affected. If a sole source supplier was to go out of business,
we may be unable to find a replacement for such source in a timely manner or at all. If a sole source supplier were to be acquired
by a competitor, that competitor may elect not to sell to us in the future. Any inability to secure required products or to do
so on appropriate terms could have a materially adverse impact on the business, financial condition, results of operations or
prospects of urban-gro.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As indicated above, we continue to monitor
the outbreak of the COVID-19 coronavirus. Should the outbreak continue to become more widespread, it could disrupt the businesses
of our industry partners and third-party suppliers, which, in turn, could impact our ability to procure equipment and raw materials
from them and thereby negatively impact the business, financial condition, results of operations or our prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have historically been dependent on a small number
of clients for a substantial portion of our  revenue. If we fail to retain or expand our client relationships, or if a significant
client were to terminate its relationship with us or reduce its purchases, our revenue could decline significantly.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> One client represented 26% of our
total revenue for the nine months ended September 30, 2020 and 51% of our total revenue for the three months ended September
30, 2020. A different client represented 15% of our total revenue for the nine months ended September 30, 2019 and 17% of our
total revenue for the three months ended September 30, 2019. A third client represented 21% of our total revenue for the year
ended December 31, 2019. A fourth client represented 14% of our total revenue for the year ended December 31, 2018.
Substantially all of the revenue derived from each of these separate clients were product sales. Although we have been able
to successfully generate substantial sales to different customers over time, there can be no assurances that we will be able
to continue to do this in the future. Our operating results for the foreseeable future could continue to depend on
substantial sales to a small number of clients. Our clients have no purchase commitments and may cancel, change or delay
purchases with little or no notice or penalty. As a result of this, our revenue could fluctuate materially and could be
materially and disproportionately impacted by purchasing decisions of any significant client. There can be no assurances that
clients who represented a substantial portion of our historical revenue will continue to purchase products from us in the
future, which could cause our revenue to decline materially and materially harm our financial condition and results of
operations. If we are unable to diversify our client base, we will continue to be susceptible to risks associated with client
concentration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our business is dependent on our clients obtaining appropriate
licenses from various licensing agencies.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our business is dependent on our clients
obtaining appropriate licenses from various licensing agencies. There can be no assurance that any or all licenses necessary for
our clients to operate their businesses will be obtained, retained or renewed. If a licensing body were to determine that one
of our clients had violated applicable rules and regulations, there is a risk the license granted to that client could be revoked,
which could adversely affect future sales to that client and our operations. There can be no assurance that our existing clients
will be able to retain their licenses going forward, or that new licenses will be granted to existing and new market entrants.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Our contracts may not be legally enforceable in the
United States.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Many of our historic contracts, and
those we may enter into in the future, relate to services that are ancillary to the cannabis industry and other activities that
are not legal under U.S. federal law and under some state laws. As a result, we may face difficulties in enforcing our contracts
in U.S. federal and certain state courts. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>System security risks, data protection breaches, cyber-attacks
and systems integration issues could disrupt our internal operations or services provided to clients.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Experienced computer programmers and hackers
may be able to penetrate our network security and misappropriate or compromise our confidential information or that of third parties,
create system disruptions or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses,
worms, and other malicious software programs that attack or otherwise exploit any security vulnerabilities of the products that
we may sell in the future. Such disruptions could adversely impact our ability to fulfill orders and interrupt other processes.
Delayed sales, lower profits, or lost clients resulting from these disruptions could adversely affect our financial results, stock
price and reputation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may be forced to litigate to defend our intellectual
property rights, or to defend against claims by third parties against urban-gro relating to intellectual property rights.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may be forced to litigate to enforce
or defend our intellectual property rights, to protect our trade secrets or to determine the validity and scope of other parties&rsquo;
proprietary rights. Any such litigation could be very costly and could distract our management from focusing on operating our
business. The existence and/or outcome of any such litigation could harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Changes in accounting standards and subjective assumptions,
estimates and judgments by management related to complex accounting matters could significantly affect our financial results.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">U.S. generally accepted accounting principles
(&ldquo;GAAP&rdquo;) and related pronouncements, implementation guidelines and interpretations with regard to a wide variety of
matters that are relevant to our business, such as, but not limited to, revenue recognition, stock-based compensation, trade promotions,
and income taxes are highly complex and involve many subjective assumptions, estimates and judgments by our management. Changes
to these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly
change our reported results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our ability to maintain our reputation is critical to
the success of our business, and the failure to do so may materially adversely affect our business and the value of our common
stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our reputation is a valuable component
of our business. Threats to our reputation can come from many sources, including adverse sentiment about our industry generally,
unethical practices, employee misconduct, failure to deliver minimum standards of service or quality, compliance deficiencies,
and questionable or fraudulent activities of our clients. Negative publicity regarding our business, employees, or clients, with
or without merit, may result in the loss of clients, investors and employees, costly litigation, a decline in revenues and increased
governmental regulation. If our reputation is negatively affected, by the actions of our employees or otherwise, our business
and, therefore, our operating results and the value of our common stock may be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may not be able to successfully identify, consummate
or integrate acquisitions or to successfully manage the impacts of such transactions on our operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Part of our business strategy includes
pursuing synergistic acquisitions. We have expanded, and plan to continue to expand, our business by making strategic acquisitions
and regularly seeking suitable acquisition targets to enhance our growth. Material acquisitions, dispositions and other strategic
transactions involve a number of risks, including: (i) the potential disruption of our ongoing business; (ii) the distraction
of management away from the ongoing oversight of our existing business activities; (iii) incurring additional indebtedness; (iv)
the anticipated benefits and cost savings of those transactions not being realized fully, or at all, or taking longer to realize
than anticipated; (v) an increase in the scope and complexity of our operations; and (vi) the loss or reduction of control over
certain of our assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The pursuit of acquisitions may pose certain
risks to us. We may not be able to identify acquisition candidates that fit our criteria for growth and profitability. Even if
we are able to identify such candidates, we may not be able to acquire them on terms or financing satisfactory to us. We will
incur expenses and dedicate attention and resources associated with the review of acquisition opportunities, whether or not we
consummate such acquisitions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Additionally, even if we are able to acquire
suitable targets on agreeable terms, we may not be able to successfully integrate their operations with ours. Achieving the anticipated
benefits of any acquisition will depend in significant part upon whether we integrate such acquired businesses in an efficient
and effective manner. We may not be able to achieve the anticipated operating and cost synergies or long-term strategic benefits
of our acquisitions within the anticipated timing or at all. The benefits from any acquisition will be offset by the costs incurred
in integrating the businesses and operations. We may also assume liabilities in connection with acquisitions to which we would
not otherwise be exposed. An inability to realize any or all of the anticipated synergies or other benefits of an acquisition
as well as any delays that may be encountered in the integration process, which may delay the timing of such synergies or other
benefits, could have an adverse effect on our business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our indebtedness could adversely affect our financial
condition and prevent us from fulfilling our debt service and other obligations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our indebtedness could have significant
effects on our business. For example, it could:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>make it
                                         more difficult for us to satisfy our financial obligations, including with respect to
                                         our indebtedness, and any failure to comply with the obligations of any of our debt agreements,
                                         including financial and other restrictive covenants, could result in an event of default
                                         under the agreements governing our indebtedness;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>increase
                                         our vulnerability to general adverse economic, industry and competitive conditions;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>limit
                                         our ability to borrow additional funds; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>limit
                                         our financial flexibility.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each of these factors may have a material
and adverse effect on our financial condition and viability. Our ability to make payments with respect to our indebtedness and
to satisfy any other debt obligations will depend on our future operating performance, which will be affected by prevailing economic
conditions and financial, business and other factors affecting us and our industry, many of which are beyond our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>Risks Related to the Cannabis Industry</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>As marijuana remains illegal under United States federal
law, it is possible that we may have to stop providing products and services to companies who are engaged in marijuana cultivation
and other marijuana-related activities.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Marijuana is currently classified as
a Schedule I controlled substance under the Controlled Substances Act and is illegal under United States federal law. It is illegal
under United States federal law to grow, cultivate, sell or possess marijuana for any purpose or to assist or conspire with those
who do so. Additionally, 21 U.S.C. 856 makes it illegal to &ldquo;knowingly open, lease, rent, use, or maintain any place, whether
permanently or temporarily, for the purpose of manufacturing, distributing, or using any controlled substance.&rdquo; Even in
those states in which the use of marijuana has been authorized under state law, its use remains a violation of federal law. Since
federal law criminalizing the use of marijuana is not preempted by state laws that legalize its use, strict enforcement of federal
law regarding marijuana would likely result in the inability of our clients that are involved in the cannabis industry to proceed
with their operations, which would adversely affect our operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Our solutions are used by cannabis growers. While
we are not aware of any threatened or current federal or state law enforcement actions against any supplier of equipment that
might be used for cannabis growing, law enforcement authorities, in their attempt to regulate the illegal use of marijuana, may
seek to bring an action or actions against us under the Controlled Substances Act for assisting or conspiring with persons engaged
in the cultivation of marijuana.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> There is also a risk that our activities
could be deemed to be facilitating the selling or distribution of cannabis in violation of the Controlled Substances Act. Although
federal authorities have not focused their resources on such tangential or secondary violations of the Controlled Substances Act,
nor have they threatened to do so, with respect to the sale of equipment that might be used by cannabis cultivators, or with respect
to any supplies marketed to participants in the medical and recreational cannabis industry, if the federal government were to
change its practices, or were to expend its resources investigating and prosecuting providers of equipment that could be usable
by participants in the medical or recreational cannabis industry, such actions could have a materially adverse effect on our operations,
our clients that operate in the cannabis industry, or the sales of our products and services. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>As a company with clients operating in the cannabis
industry, we face many particular and evolving risks associated with that industry, including uncertainty of United States federal
enforcement and the need to renew temporary safeguards.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> On January 4, 2018, former Attorney
General Sessions rescinded the previously issued memoranda (known as the Cole Memorandum) from the DOJ that had de-prioritized
the enforcement of federal law against marijuana users and businesses that comply with state marijuana laws, adding uncertainty
to the question of how the U.S. federal government will choose to enforce federal laws regarding marijuana. Former Attorney General
Sessions issued a memorandum to all United States Attorneys in which the DOJ affirmatively rescinded the previous guidance as
to marijuana enforcement, calling such guidance &ldquo;unnecessary.&rdquo; This one-page memorandum was vague in nature, stating
that federal prosecutors should use established principles in setting their law enforcement priorities. Under previous administrations,
the DOJ indicated that those users and suppliers of medical marijuana who complied with state laws, which required compliance
with certain criteria, would not be prosecuted. As a result, it is now unclear if the DOJ will seek to enforce the Controlled
Substances Act against those users and suppliers who comply with state marijuana laws. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Despite Attorney General Sessions&rsquo;
rescission of the Cole Memorandum, the Department of the Treasury, Financial Crimes Enforcement Network, has not rescinded the
&ldquo;FinCEN Memo&rdquo; dated February 14, 2014, which de-prioritizes enforcement of the Bank Secrecy Act against financial
institutions and marijuana related businesses which utilize them. This memo appears to be a standalone document and is presumptively
still in effect. At any time, however, the Department of the Treasury, Financial Crimes Enforcement Network, could elect to rescind
the FinCEN Memo. This would make it more difficult for our clients and potential clients to access the U.S. banking systems and
conduct financial transactions, which would adversely affect our operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> In 2014, Congress passed a spending
bill (&ldquo;2015 Appropriations Bill&rdquo;) containing a provision (&ldquo;Appropriations Rider&rdquo;) blocking federal funds
and resources allocated under the 2015 Appropriations Bill from being used to &ldquo;prevent such States from implementing their
own State medical marijuana law.&rdquo; The Appropriations Rider seemed to have prohibited the federal government from interfering
with the ability of states to administer their medical marijuana laws, although it did not codify federal protections for medical
marijuana patients and producers. Moreover, despite the Appropriations Rider, the Justice Department maintains that it can still
prosecute violations of the federal marijuana ban and continue cases already in the courts. Additionally, the Appropriations Rider
must be re-enacted every year. While it was continued in 2016, 2017, 2018, 2019 and 2020, and remains in effect, continued re-authorization
of the Appropriations Rider cannot be guaranteed. If the Appropriation Rider is no longer in effect, the risk of federal enforcement
and override of state marijuana laws would increase. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Further legislative development beneficial to our
operations is not guaranteed.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Among other things, the business of
our clients in the cannabis industry involves the cultivation, distribution, manufacture, storage, transportation and/or sale
of medical and adult use cannabis products in compliance with applicable state law. The success of our business with respect to
these clients depends on the continued development of the cannabis industry and the activity of commercial business and government
regulatory agencies within the industry. The continued development of the cannabis industry is dependent upon continued legislative
and regulatory authorization of cannabis at the state level and a continued laissez-faire approach by federal enforcement agencies.
Any number of factors could slow or halt progress in this area. Further regulatory progress beneficial to the industry cannot
be assured. While there may be ample public support for legislative action, numerous factors impact the legislative and regulatory
process, including election results, scientific findings or general public events. Any one of these factors could slow or halt
progressive legislation relating to cannabis and the current tolerance for the use of cannabis by consumers, which could adversely
affect our operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>The cannabis industry could face strong opposition
from other industries.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> We believe that established businesses
in other industries may have a strong economic interest in opposing the development of the cannabis industry. Cannabis may be
seen by companies in other industries as an attractive alternative to their products, including recreational marijuana as an alternative
to alcohol, and medical marijuana as an alternative to various commercial pharmaceuticals. Many industries that could view the
emerging cannabis industry as an economic threat are well established, with vast economic and United States federal and state
lobbying resources. It is possible that companies within these industries could use their resources to attempt to slow or reverse
legislation legalizing cannabis. Any inroads these companies make in halting or impeding legislative initiatives that would be
beneficial to the cannabis industry could have a detrimental impact on our clients and, in turn on our operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>The legality of marijuana could be reversed in one
or more states.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The voters or legislatures of states
in which marijuana has already been legalized could potentially repeal applicable laws which permit the operation of both medical
and retail marijuana businesses. These actions might force us to cease operations in one or more states entirely. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Changing legislation and evolving interpretations
of law, which could negatively impact our clients and, in turn, our operations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Laws and regulations affecting the
medical and adult-use marijuana industry are constantly changing, which could detrimentally affect our clients involved in
that industry and, in turn, our operations. Local, state and federal marijuana laws and regulations are often broad in scope
and subject to constant evolution and inconsistent interpretations, which could require our clients and ourselves to incur
substantial costs associated with modification of operations to ensure compliance. In addition, violations of these laws, or
allegations of such violations, could disrupt our clients&rsquo; business and result in a material adverse effect on our
operations. In addition, it is possible that regulations may be enacted in the future that will limit the amount of cannabis
growth or related products that our commercial clients are authorized to produce. We cannot predict the nature of any future
laws, regulations, interpretations or applications, nor can it determine what effect additional governmental regulations or
administrative policies and procedures, when and if promulgated, could have on our operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Regulatory scrutiny of the cannabis industry may negatively
impact our ability to raise additional capital.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The business activities of certain
of our clients rely on newly established and/or developing laws and regulations in multiple jurisdictions. These laws and regulations
are rapidly evolving and subject to change with minimal notice. Regulatory changes may adversely affect our profitability or cause
us to cease operations entirely. The cannabis industry may come under the scrutiny or further scrutiny by the United States Food
and Drug Administration, the SEC, the DOJ, the Financial Industry Regulatory Authority or other federal, state or nongovernmental
regulatory authorities or self-regulatory organizations that supervise or regulate the production, distribution, sale or use of
cannabis for medical or nonmedical purposes in the United States. It is impossible to determine the extent of the impact of any
new laws, regulations or initiatives that may be proposed, or whether any proposals will become law. The regulatory uncertainty
surrounding the industry that we service may adversely affect our business and operations, including without limitation, the costs
to remain compliant with applicable laws and the impairment of our ability to raise additional capital. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Banking regulations could limit access to banking
services.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Since the use of marijuana is illegal
under federal law, federally chartered banks will not accept deposit funds from businesses involved with marijuana. Consequently,
businesses involved in the cannabis industry often have trouble finding a bank willing to accept their business. The inability
to open bank accounts may make it difficult for our clients in the cannabis industry to operate and their reliance on cash can
result in a heightened risk of theft, which could harm their businesses and, in turn, harm our business. Additionally, some courts
have denied marijuana-related businesses bankruptcy protection, thus, making it very difficult for lenders to recoup their investments,
which may limit the willingness of banks to lend to our clients and to us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to this Offering and Ownership of Our Common
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>An active, liquid trading market for our common stock
does not currently exist and may not develop after this offering, and as a result, you may not be able to sell your common stock
at or above the public offering price, or at all.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to this offering, shares of our
common stock were quoted on the OTC Markets Group, Inc. OTCQX Marketplace under the symbol &ldquo;UGRO&rdquo;.
Trading on the OTCQX marketplace has been infrequent and in limited volume. Although we have applied to list our shares of common
stock on Nasdaq in connection with this offering, an active trading market for shares of our common stock may never develop or
be sustained following this offering. If an active trading market does not develop, you may have difficulty selling your shares
of common stock at an attractive price, or at all. The public offering price for our common stock will be determined by negotiations
between us and the representative of the underwriters and may not be indicative of prices that will prevail in the open market
following this offering. Consequently, you may not be able to sell your common stock at or above the public offering price or
at any other price or at the time that you would like to sell. An inactive market may also impair our ability to raise capital
by selling our common stock and may impair our ability to expand our business by using our common stock as consideration in an
acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>You may be diluted by future issuances of preferred stock
or additional common stock in connection with our incentive plans, acquisitions or otherwise; future sales of such shares in the
public market, or the expectations that such sales may occur, could lower our stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our certificate of incorporation authorizes
us to issue shares of our common stock and options, rights, warrants and appreciation rights relating to our common stock for
the consideration and on the terms and conditions established by our Board of Directors (the &ldquo;Board&rdquo;) in its sole
discretion. We could issue a significant number of shares of common stock in the future in connection with investments or acquisitions.
Any of these issuances could dilute our existing stockholders, and such dilution could be significant. Moreover, such dilution
could have a material adverse effect on the market price for the shares of our common stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The future issuance of shares of preferred
stock with voting rights may adversely affect the voting power of the holders of shares of our common stock, either by diluting
the voting power of our common stock if the preferred stock votes together with the common stock as a single class, or by giving
the holders of any such preferred stock the right to block an action on which they have a separate class vote, even if the action
were approved by the holders of our shares of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The future issuance of shares of preferred
stock with dividend or conversion rights, liquidation preferences or other economic terms favorable to the holders of preferred
stock could adversely affect the market price for our common stock by making an investment in the common stock less attractive.
For example, investors in the common stock may not wish to purchase common stock at a price above the conversion price of a series
of convertible preferred stock because the holders of the preferred stock would effectively be entitled to purchase common stock
at the lower conversion price, causing economic dilution to the holders of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A significant portion of our total outstanding shares
are restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of
our common stock to drop significantly, even if our business is doing well.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to certain exceptions, without
the prior written consent of ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the underwriters,
we, during the period ending 90 days after the date of this prospectus, and our officers and directors and our 5% or greater stockholders,
during the period ending 180 days after the date of this prospectus, have agreed not to or are otherwise restricted in their ability
to: (1) offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise transfer or dispose
of, directly or indirectly, any shares of common stock or any securities convertible into, exchangeable for or that represent
the right to receive shares of common stock; (2) file any registration statement with the SEC relating to the offering of any
shares of common stock or any securities convertible into or exercisable or exchangeable for common stock; or (3) enter into any
swap or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of common stock,
subject to certain exceptions. ThinkEquity, in its sole discretion, may release the common stock and other securities subject
to the lock-up provisions described above in whole or in part at any time with or without notice. See &ldquo;Underwriting.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The market price of our common stock may
decline significantly when the restrictions on resale by our existing stockholders lapse. A decline in the market price of our
common stock might impede our ability to raise capital through the issuance of additional shares of common stock or other equity
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>You will incur immediate dilution in the net tangible
book value of the shares you purchase in this offering.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The public offering price of our common
stock will be higher than the net tangible book value per share of outstanding common stock prior to completion of this offering.
Based on our pro forma net tangible book value as of September 30, 2020, giving effect to the 1-for-6 reverse stock split and
Bridge Financing transactions subsequent to September 30, 2020, and giving further effect to the issuance and sale of shares of
common stock by us at the assumed public offering price of $10.50 per share and the use of $1.0 million of the net offering proceeds
to repay outstanding indebtedness under our Credit Agreement, if you purchase our common stock in this offering, you will suffer
immediate dilution of approximately $6.70 per share in net tangible book value. Dilution is the amount by which the offering
price paid by purchasers of our common stock in this offering will exceed the pro forma as adjusted net tangible book value per
share of our common stock upon completion of this offering. If the underwriters exercise their option to purchase additional shares,
you will experience future dilution. A total of 39,482 shares of common stock have been reserved for future issuance under our
stock-based compensation plans, including our 2019 Equity Incentive Plan. You may experience additional dilution upon future equity
issuances or the exercise of stock options to purchase common stock granted to our directors, officers and employees under our
current and future stock-based compensation plans, including our 2019 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We do not anticipate paying any cash dividends on our
common stock in the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We currently intend to retain our future
earnings, if any, for the foreseeable future, to repay indebtedness and to fund the development and growth of our business. We
do not intend to pay any dividends to holders of our common stock in the foreseeable future. Any decision to declare and pay dividends
in the future will be made at the discretion of our Board taking into account various factors, including our business, operating
results and financial condition, current and anticipated cash needs, plans for expansion, any legal or contractual limitations
on our ability to pay dividends under our loan agreements or otherwise. As a result, if our Board does not declare and pay dividends,
the capital appreciation in the price of our common stock, if any, will be your only source of gain on an investment in our common
stock, and you may have to sell some or all of your common stock to generate cash flow from your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If securities or industry analysts do not publish research
or reports about our business, or if they downgrade their recommendations regarding our common stock, its trading price and volume
could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect the trading market for our common
stock to be influenced by the research and reports that industry or securities analysts publish about us, our business or our
industry. As a new public company, we do not currently have and may never obtain research coverage by securities and industry
analysts. If no securities or industry analysts commence coverage of our company, the trading price for our stock may be negatively
impacted. If we obtain securities or industry analyst coverage and if one or more of these analysts cease coverage of our company
or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock
price or trading volume to decline and our common stock to be less liquid. Moreover, if one or more of the analysts who cover
us downgrades our stock or publishes inaccurate or unfavorable research about our business, or if our results of operations do
not meet their expectations, our stock price could decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our stock price could be extremely volatile and may decline
substantially from the public offering price. As a result, you may not be able to resell your shares at or above the price you
paid for them.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Even if a trading market develops, the
market price of our common stock may be highly volatile and could be subject to wide fluctuations. Volatility in the market price
of our common stock, as well as general economic, market or political conditions, may prevent you from being able to sell your
shares at or above the price you paid for your shares and may otherwise negatively affect the liquidity of our common stock. You
may experience a decrease, which could be substantial, in the value of your stock, including decreases unrelated to our operating
performance or prospects, and you could lose part or all of your investment. The price of our common stock could be subject to
wide fluctuations in response to a number of factors, including those described elsewhere in this prospectus and others such as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the effect
                                         of the COVID-19 pandemic on our business and operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to generate revenues sufficient to achieve profitability and positive cash flow;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>competition
                                         in our industry and our ability to compete effectively;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to attract, recruit, retain and develop key personnel and qualified employees;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>risks
                                         related to laws, regulations and industry standards;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reliance
                                         on significant clients and third-party suppliers;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the ability
                                         of our principal stockholders to significantly influence or control matters requiring
                                         a stockholder vote;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to successfully identify and complete acquisitions and effectively integrate those acquisitions
                                         into our operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our indebtedness
                                         and potential increases in our indebtedness; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the other
                                         factors described in &ldquo;Risk Factors.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In response to any one or more of these
events, the market price of shares of our common stock could decrease significantly. In the past, securities class action litigation
has often been initiated against companies following periods of volatility in their stock price. This type of litigation could
result in substantial costs and divert our management&rsquo;s attention and resources and could also require us to make substantial
payments to satisfy judgments or to settle litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Taking advantage of the reduced disclosure requirements
applicable to &ldquo;emerging growth companies&rdquo; may make our common stock less attractive to investors.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We qualify as an &ldquo;emerging growth
company&rdquo; as defined in the JOBS Act. An emerging growth company may take advantage of certain reduced reporting and other
requirements that are otherwise generally applicable to public companies, as described above. We currently intend to take advantage
of each of these exemptions. We have elected not to opt out of such extended transition period, which means that when a standard
is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make a comparison
of our financial statements with the financial statements of a public company that is not an emerging growth company, or the financial
statements of an emerging growth company that has opted out of using the extended transition period, difficult or impossible because
of the potential differences in accounting standards used. We could be an emerging growth company until December 31, 2023. We
cannot predict if investors will find our common stock less attractive if we elect to rely on these exemptions, or if taking advantage
of these exemptions would result in less active trading or more volatility in the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Provisions of our certificate of incorporation and bylaws
may delay or prevent a take-over that may not be in the best interests of our stockholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Provisions of our certificate of incorporation
and bylaws may be deemed to have anti-takeover effects, which include when and by whom special meetings of our stockholders may
be called, and may delay, defer or prevent a takeover attempt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, our certificate of incorporation
authorizes the issuance of up to 10,000,000 shares of preferred stock with such rights and preferences determined from time to
time by our Board. As of September 30, 2020, none of our preferred shares were currently issued or outstanding. Our Board may,
without stockholder approval, issue additional preferred shares with dividends, liquidation, conversion, voting or other rights
that could adversely affect the voting power or other rights of the holders of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The requirements of being a public company may strain
our resources, divert management&rsquo;s attention and affect our ability to attract and retain executive management and qualified
board members.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a public company, we are subject to
the reporting requirements of the Exchange Act, as amended, the Sarbanes-Oxley Act, the Dodd-Frank Act, and other applicable securities
rules and regulations. Compliance with these rules and regulations involves significant legal and financial compliance costs,
may make some activities more difficult, time-consuming or costly and may increase demand on our systems and resources, particularly
after we are no longer an &ldquo;emerging growth company,&rdquo; as defined in the JOBS Act. The Exchange Act requires, among
other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley
Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial
reporting. In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial
reporting to meet this standard, significant resources and management oversight may be required. As a result, management&rsquo;s
attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may
need to hire more employees in the future or engage outside consultants, which will increase our costs and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, changing laws, regulations
and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing
legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are
subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice
may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty
regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend
to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general
and administrative expenses and a diversion of management&rsquo;s time and attention from revenue-generating activities to compliance
activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory
or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings
against us, and our business may be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">However, for as long as we remain an &ldquo;emerging
growth company,&rdquo; we may take advantage of certain exemptions from various reporting requirements that are applicable to
public companies that are not &ldquo;emerging growth companies&rdquo; including, but not limited to, not being required to comply
with the auditor attestation requirements of Section 404 of the Sarbanes Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may take
advantage of these reporting exemptions until we are no longer an &ldquo;emerging growth company.&rdquo; We would cease to be
an &ldquo;emerging growth company&rdquo; upon the earliest of: (i) the last day of the fiscal year following the fifth anniversary
of the first sale of our common stock under an effective Securities Act registration statement, which will occur on December 31,
2023; (ii) the first fiscal year after our annual gross revenues are $1.07 billion or more; (iii) the date on which we have, during
the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) as of the end of any
fiscal year in which the market value of the common stock held by non-affiliates exceeded $700 million as of the end of Q2 of
that fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a result of disclosure of information
in this prospectus and in filings required of a public company, our business and financial condition are highly visible, which
may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful,
our business and operating results could be adversely affected, and even if the claims do not result in litigation or are resolved
in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management
and adversely affect our business and operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may be subject to additional regulatory burdens resulting
from our public listing.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are working with our legal, accounting
and financial advisors to identify those areas in which changes should be made to our financial management control systems to
manage our obligations as a public company listed on Nasdaq. These areas include corporate governance, corporate controls, disclosure
controls and procedures and financial reporting and accounting systems. We have made, and will continue to make, changes in these
and other areas, including our internal controls over financial reporting. However, we cannot assure holders of our common stock
that these and other measures that we might take will be sufficient to allow us to satisfy our obligations as a public company
listed on Nasdaq on a timely basis. In addition, compliance with reporting and other requirements applicable to public companies
listed on Nasdaq will create additional costs for us and will require the time and attention of management. We cannot predict
the amount of the additional costs that we might incur, the timing of such costs or the impact that management&rsquo;s attention
to these matters will have on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may be exposed to currency fluctuations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although our revenues and expenses are
expected to be predominantly denominated in United States dollars, we may be exposed to currency exchange fluctuations. Recent
events in the global financial markets have been coupled with increased volatility in the currency markets. Fluctuations in the
exchange rate between the U.S. dollar, the Canadian dollar, the Euro, the Swiss franc, and the currency of other regions in which
we may operate may have a material adverse effect on our business, financial condition and operating results. We may, in the future,
establish a program to hedge a portion of our foreign currency exposure with the objective of minimizing the impact of adverse
foreign currency exchange movements. However, even if we develop a hedging program, there can be no assurance that it will effectively
mitigate currency risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a5"></A>CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus includes statements that
express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results
and therefore are, or may be deemed to be, &ldquo;forward-looking statements.&rdquo; All statements other than statements of historical
facts contained in this prospectus may be forward-looking statements. These forward-looking statements can generally be identified
by the use of forward-looking terminology, including the terms &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;continues,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;seeks,&rdquo; &ldquo;projects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; or &ldquo;should&rdquo; or, in each case, their negative or other variations
or comparable terminology. They appear in a number of places throughout this prospectus, and include statements regarding our
intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity,
prospects, growth, strategies, future acquisitions and the industry in which we operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">By their nature, forward-looking statements
involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.
We believe that these risks and uncertainties include, but are not limited to, those described in the &ldquo;Risk Factors&rdquo;
section of this prospectus, which include, but are not limited to, risks related to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the effect
                                         of the COVID-19 pandemic on our business and operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to generate revenues sufficient to achieve profitability and positive cash flow;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>competition
                                         in our industry and our ability to compete effectively;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to attract, recruit, retain and develop key personnel and qualified employees;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>risks
                                         related to laws, regulations and industry standards;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD> risks related to the cannabis industry; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reliance
                                         on significant clients and third-party suppliers;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the ability
                                         of our principal stockholders to significantly influence or control matters requiring
                                         a stockholder vote;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our ability
                                         to successfully identify and complete acquisitions and effectively integrate those acquisitions
                                         into our operations;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our indebtedness
                                         and potential increases in our indebtedness; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the other
                                         factors described in &ldquo;Risk Factors.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These factors should not be construed
as exhaustive and should be read with the other cautionary statements in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although we base these forward-looking
statements on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees
of future performance and that our actual results of operations, financial condition and liquidity, and industry developments
may differ materially from statements made in or suggested by the forward-looking statements contained in this prospectus. The
matters summarized under &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s Discussion and
Analysis of Financial Condition and Results of Operations,&rdquo; &ldquo;Business&rdquo; and elsewhere in this prospectus could
cause our actual results to differ significantly from those contained in our forward-looking statements. In addition, even if
our results of operations, financial condition and liquidity, and industry developments are consistent with the forward-looking
statements contained in this prospectus, those results or developments may not be indicative of results or developments in subsequent
periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In light of these risks and uncertainties,
we caution you not to place undue reliance on these forward-looking statements. Any forward-looking statement that we make in
this prospectus speaks only as of the date of such statement, and we undertake no obligation to update any forward-looking statement
or to publicly announce the results of any revision to any of those statements to reflect future events or developments, except
as required by applicable law. Comparisons of results for current and any prior periods are not intended to express any future
trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a6"></A>USE OF PROCEEDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Assuming a public offering price of $10.50
per share, we estimate that the net proceeds to us from the sale of our common stock in this offering will be approximately $41.8
million (or $48.0 million if the underwriters exercise their over-allotment option in full), after deducting underwriting
discounts and commissions and the estimated offering expenses payable by us. Each $1.00 increase (decrease) in the assumed public
offering price would increase (decrease) the net proceeds to us from this offering by approximately $4.0 million (or $4.6
million if the underwriters exercise their over-allotment option in full), assuming the number of shares we sell, as set forth
on the cover page of this prospectus, remains the same, after deducting underwriting discounts and commissions and the estimated
offering expenses payable by us. Similarly, an increase (decrease) of 100,000 shares offered would increase (decrease) the net
proceeds to us from this offering by approximately $1.0 million, assuming the assumed public offering price remains the same,
after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We intend to use approximately $1.0 million
of the net proceeds to repay outstanding indebtedness under our Credit Agreement. As of September 30, 2020, our Credit Agreement
bears interest at the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 12% per annum (14.5%
as of September 30, 2020), and matures on December 31, 2021. See the notes to our financial statements included in this prospectus
for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We intend to use the remaining net proceeds
(which will be approximately $40.8 million, or $47.0 million if the underwriters exercise their over-allotment option
in full) to support our organic growth, to expand in the European CEA market and for other general corporate purposes, including
to fund potential future investments and acquisitions of companies that we believe are complementary to our business and consistent
with our growth strategy. Although we may, from time to time, evaluate potential strategic investments and acquisitions, we do
not have any definitive agreements in place to make any such acquisitions at this current time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The expected use of net proceeds from
this offering represents our intentions based upon our current plans and business conditions, which could change in the future
as our plans and business conditions evolve and change. As a result, our management will have broad discretion over how these
proceeds are used. Proceeds held by us will be invested in short-term investments until needed for the uses described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a7"></A>MARKET FOR OUR COMMON
STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">Prior to this
offering, shares of our common stock were quoted on the OTC Markets Group,&nbsp;Inc. OTCQX Marketplace under the symbol &ldquo;UGRO&rdquo;. Although our shares have been quoted on the OTCQX Marketplace since October 7, 2019, because
trading on the OTCQX Marketplace has been infrequent and limited in volume, the prices at which such transactions occurred may
not necessarily reflect the price that would be paid for our common stock in a more liquid market. As of January 20, 2021, there
were approximately 156 record holders of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">We have applied
to list our common stock on the Nasdaq Capital Market under the symbol &ldquo;UGRO.&rdquo; However, we cannot assure you that
a liquid trading market for our common stock will develop or be sustained after this offering. You may not be able to sell your
shares quickly or at the market price if trading in our common stock is not active. See &ldquo;Underwriting&rdquo; for more information
regarding our arrangements with the underwriters and the factors considered in setting the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a8"></A>DIVIDEND POLICY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Since our inception, we have not paid
any dividends on our common stock, and we currently expect that, for the foreseeable future, all earnings, if any, will be retained
for use in the development and operation of our business. In the future, our Board may decide, at its discretion, whether dividends
may be declared and paid to holders of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a9"></A>CAPITALIZATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table sets forth our cash
and cash equivalents and capitalization as of September 30, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>on an
                                         actual basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">on a pro forma basis to give effect to the 1-for-6 reverse stock
    split and Bridge Financing transactions subsequent to September 30, 2020; and</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>on a pro
                                         forma as adjusted basis to give further effect to the issuance and sale by us in this
                                         offering of 4,285,714 shares of our common stock at an assumed public offering price
                                         of $10.50 per share, after deducting the estimated underwriting discounts and commissions
                                         and estimated offering expenses that we expect to pay, and the application of $1.0 million
                                         of the net proceeds from this offering to repay outstanding indebtedness under our Credit
                                         Agreement as described under &ldquo;Use of Proceeds.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This table should be read in conjunction
with, and is qualified in its entirety by reference to, &ldquo;Use of Proceeds,&rdquo; &ldquo;Selected Historical Consolidated
Financial and Other Data,&rdquo; &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;
and our consolidated financial statements and related notes appearing elsewhere in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Actual</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><B>Pro forma</B></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Pro forma as adjusted</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; width: 55%; text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Cash and cash
                                         equivalents</B></P></TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 11%; text-align: right">213,392</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%">$</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right; width: 11%">1,063,392&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; width: 1%">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 11%; text-align: right"> 41,893,392 </TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Capitalization:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current debt:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">60,000&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Revolving facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">600,000</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">600,000&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">600,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Term loan, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,596,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,596,280&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">596,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total current debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,256,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,256,280&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,256,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Long-term debt:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Related party note payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&ndash;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Revolving facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,676,493</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2,676,493</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,676,493</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Term loan, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,318</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">88,318&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,318</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Bridge Financing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,850,000&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,850,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,020,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,020,600&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,020,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total long-term debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,785,411</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,635,411&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,635,411</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Shareholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Preferred stock, $0.10 par value; 10,000,000 shares authorized,
    0 shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&ndash;&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Common stock, $0.001 par value, 100,000,000 shares authorized,
    28,272,285 shares issued and outstanding as of September 30, 2020, 4,712,047 shares on a pro forma basis, and 8,997,761 shares
    on a pro forma as adjusted basis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,272</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">4,712&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,118,289</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">14,141,849&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 55,967,563 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accumulated equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(20,850,508</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">(20,850,508</TD>
    <TD STYLE="padding-bottom: 1pt">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(20,850,508</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total shareholders&rsquo; equity (deficit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,703,947</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,703,947</TD>
    <TD STYLE="padding-bottom: 1pt">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 35,126,053 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>Total capitalization</B></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">337,744</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double">$</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,187,744&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"> 42,017,744 </TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A $1.00 increase (decrease) in the assumed
public offering price per share of common stock would increase (decrease) the amount of total assets by approximately $4.0
million and total capitalization by approximately $4.0 million, assuming the number of shares of common stock offered
by us, as set forth on the cover page of this prospectus, remains the same, after deducting the estimated underwriting discounts
and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares of common
stock we are offering. An increase (decrease) of 100,000 shares of common stock offered by us would increase (decrease) the amount
of total assets by approximately $1.0 million and total capitalization by approximately $1.0 million assuming the assumed public
offering price remains the same, after deducting estimated underwriting discounts and commissions and estimated offering expenses
payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless we indicate otherwise, all information
in this Capitalization section:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes no exercise
    by the underwriters of their over-allotment option;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 74.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes no exercise
    of the representative&rsquo;s warrants to be issued to the representative of the underwriters in this offering;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt">excludes 234,771 shares issuable upon conversion of Bridge Financing notes (see &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations&mdash;Recent Developments&mdash;Bridge Financing&rdquo;
    for a discussion of the Bridge Financing);</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 638,277 shares
    of common stock issuable upon the exercise of outstanding exercisable options at a weighted exercise price of $6.30 per share;
    </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 202,752 shares of common stock issuable
    upon the exercise of outstanding warrants at a weighted exercise price of $13.28 per share; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 39,482 shares of common stock reserved
    for future issuance pursuant to our 2019 Equity Incentive Plan.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a10"></A>DILUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you invest in our common stock in this
offering, your interest will be diluted to the extent of the difference between the public offering price per share of our common
stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after the closing of this
offering. Net tangible book value per share represents our total tangible assets less our total liabilities, divided by the number
of outstanding shares of common stock. Our net tangible book value of our common stock as of September 30, 2020 was ($7.6) million,
or ($0.27) per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our pro forma net tangible book value
of our common stock as of September 30, 2020 was ($7.6) million, or ($1.61) per share, after giving effect to the 1-for-6 reverse
stock split and Bridge Financing transactions subsequent to September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">After giving further effect to the receipt
of the net proceeds from our sale of 4,285,714 shares of common stock in this offering at an assumed public offering price of
$10.50 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro
forma as adjusted net tangible book value as of September 30, 2020, would have been $34.2 million, or $3.80 per
share. This represents an immediate increase in pro forma net tangible book value of $5.41 per share to our existing stockholders
and an immediate dilution of $6.70 per share to investors purchasing common stock in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We calculate dilution per share to new
investors by subtracting the pro forma net tangible book value per share from the public offering price paid by the new investor.
The following table illustrates the dilution to new investors on a per share basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 72%"><FONT STYLE="font-size: 10pt">Assumed public offering price per share</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right">10.5<FONT STYLE="font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: 9pt"><FONT STYLE="font-size: 10pt">Pro forma net tangible book value per share as of September 30,
    2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1.61</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="text-indent: 9pt"><FONT STYLE="font-size: 10pt">Increase in pro forma net tangible book value per share attributable
    to this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"> 5.41 </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Pro forma as adjusted net tangible book value per share after this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"> 3.80 </TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Dilution in pro forma net tangible book value per share in this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">6.70</FONT> </TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each $1.00 increase (decrease) in the
assumed public offering price of $10.50 would increase (decrease) our pro forma as adjusted net tangible book value per share
after this offering by $0.94 per share and the dilution to new investors by $0.94 per share, assuming the number
of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, an increase (decrease) of 100,000 shares offered
would increase (decrease) the pro forma as adjusted net tangible book value by $0.07 per share and the dilution to new investors
by $0.07 per share, assuming the assumed public offering price remains the same, after deducting estimated underwriting discounts
and commissions and estimated offering expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the underwriters&rsquo; option to purchase
additional shares to cover over-allotments is exercised in full, the pro forma as adjusted net tangible book value per share after
giving effect to this offering would be $4.21 per share, representing an immediate increase to existing stockholders of
$5.82 per share, and immediate dilution to new investors in this offering of $6.29 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The foregoing calculations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">assume no exercise by the underwriters of their over-allotment option;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">assume no exercise of the representative&rsquo;s warrants to be issued to the representative
    of the underwriters in this offering;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">exclude 234,771 shares issuable upon conversion of Bridge Financing notes (see &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations&mdash;Recent Developments&mdash;Bridge Financing&rdquo;
    for a discussion of the Bridge Financing);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">give effect to the 1-for-6 reverse stock split with respect to our common stock, which took
    effect December 31, 2020;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">exclude 638,277 shares of common stock issuable upon the exercise of outstanding exercisable
    options at a weighted exercise price of $6.30 per share;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">exclude 202,752 shares of common stock issuable upon the exercise of outstanding warrants
    at a weighted exercise price of $13.28 per share; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">exclude 39,482 shares of common stock reserved for future issuance pursuant to our 2019
    Equity Incentive Plan.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a11"></A>SELECTED HISTORICAL
CONSOLIDATED FINANCIAL AND OTHER DATA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following tables set forth our summary
historical consolidated financial data as of, and for the periods ended on, the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The summary consolidated statements of
operations data for the years ended December 31, 2019 and 2018 and the summary consolidated balance sheet data as of December
31, 2019 and 2018 are derived from our audited consolidated financial statements and notes that are included elsewhere in this
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The summary consolidated statements of
operations data for the three and nine months ended September 30, 2020 and 2019 and the summary consolidated balance sheet data
as of September 30, 2020 are derived from our unaudited interim consolidated financial statements and notes that are included
elsewhere in this prospectus. We have prepared the unaudited consolidated financial statements in accordance with generally accepted
accounting principles (GAAP) and on the same basis as the audited consolidated financial statements. Our historical results are
not necessarily indicative of our results in any future period and results from our interim period may not necessarily be indicative
of the results of the entire year. Pro forma share and per share amounts presented herein reflect the implementation of the 1-for-6
reverse stock split as if it had occurred at the beginning of the earliest period presented.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>For the</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Three Months Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Three Months Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Nine Months Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Nine Months Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Fiscal Year Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Fiscal Year Ended</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>September 30,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>December&nbsp;31,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>December&nbsp;31,</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2020</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2020</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2019</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>2018</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Unaudited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Audited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>(Audited)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt"><B>Statement of operations data:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; width: 28%; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Revenues</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">8,359,422</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">5,583,064</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">16,625,688</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">17,056,737</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">24,189,803</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 8pt">20,050,776</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Cost of revenues</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">6,654,134</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">3,650,965</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">12,613,461</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">11,529,448</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">17,563,594</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">13,892,025</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Gross Profit</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,705,288</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,932,099</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">4,012,227</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,527,289</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">6,626,209</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">6,158,751</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Operating expenses</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">1,853,828</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">3,324,921</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">6,502,283</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">9,581,375</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">12,486,814</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">9,959,335</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Income (loss) from operations</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(148,540</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,392,822</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(2,490,056</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(4,054,086</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(5,860,605</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(3,800,584</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Other non-operating income (expense)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(545,741</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,416,708</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,469,826</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(1,665,318</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(2,489,968</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(95,289</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Net income (loss)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(694,281</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(2,809,530</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(3,959,882</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(5,719,404</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(8,350,573</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(3,895,873</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Income (loss) per share, basic and diluted</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.02</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.11</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.14</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.22</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.32</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.16</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Weighted average shares outstanding, basic and
    diluted</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">28,888,194</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">26,175,098</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">28,706,905</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">25,772,134</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">26,318,059</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">28,848,293</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Pro forma income (loss) per share, basic and
    diluted (unaudited)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.12</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.66</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.84</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(1.32</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(1.92</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 8pt">(0.96</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 5pt; padding-bottom: 2.5pt; text-indent: -5pt"><FONT STYLE="font-size: 8pt">Pro forma weighted average
    shares outstanding, basic and diluted (unaudited)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,814,699</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,362,516</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,784,484</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,295,356</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,386,343</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4,141,382</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">As of</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">As of</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">As of</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Unaudited)</FONT></TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Audited)</FONT></TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">(Audited)</FONT></TD><TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; color: #333333; font-weight: bold; text-align: left">Balance sheet data</TD><TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: right">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: right">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: right">&nbsp;</TD><TD STYLE="font-size: 8pt; color: #333333; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 49%; font-size: 8pt; color: #333333; text-align: left">Current assets</TD><TD STYLE="width: 2%; font-size: 8pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 8pt; text-align: right">4,586,195</TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 8pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 8pt; text-align: right">3,998,205</TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 8pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 8pt; text-align: right">3,945,305</TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">Total assets</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">7,550,138</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">7,407,692</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">5,744,764</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">Current liabilities</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">9,419,327</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">12,317,185</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">9,571,315</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">Total liabilities</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">14,254,085</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">12,416,026</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">9,571,315</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">Total stockholders&rsquo; deficit</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(6,703,947</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(5,008,334</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(3,826,551</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; color: #333333; text-align: left">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">$</TD><TD STYLE="font-size: 8pt; text-align: right">7,550,138</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">$</TD><TD STYLE="font-size: 8pt; text-align: right">7,407,692</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">$</TD><TD STYLE="font-size: 8pt; text-align: right">5,744,764</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a12"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS<BR>
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>The following discussion and analysis
of our results of operations and financial condition should be read together with &ldquo;Selected Historical Consolidated Financial
and Other Data&rdquo; and the financial statements and related notes included elsewhere in this prospectus. Such discussion and
analysis reflects our historical results of operations and financial position and does not give effect to the completion of this
offering. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties.
Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors,
including those set forth under &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo;
and elsewhere in this prospectus. All share and per share amounts presented herein have been restated to reflect the implementation
of the 1-for-6 reverse stock split as if it had occurred at the beginning of the earliest period presented, except for amounts
presented in the financial statements and related notes included elsewhere in this prospectus. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview and History</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white">urban-gro, Inc.
(&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company,&rdquo; or &ldquo;urban-gro&rdquo;) is a leading engineering
and design services company focused on the sustainable commercial indoor horticulture market. We engineer and design indoor <FONT STYLE="color: #000712">controlled
environment agriculture (&ldquo;CEA&rdquo;) facilities a</FONT>nd then integrate complex environmental equipment systems into
those facilities. Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty
crops, including leafy greens, vegetables, herbs, and plant-based medicines. To date, a large number of our clients have been
cannabis producers, and we will continue to do substantial work for those clients, but we have added a focus on non-cannabis crops
as we seek to address a broader market. In particular, our focus going forward is on the vertical farming CEA sub-segment.
Our custom-tailored approach to design, procurement, and equipment integration provides a single point of accountability across
all aspects of indoor growing operations. We also help our clients achieve operational efficiency and economic advantages through
a full spectrum of professional services and programs focused on facility optimization and environmental health which establish
facilities that allow <FONT STYLE="color: #000712">clients to manage, operate and perform at the highest level throughout their
entire cultivation lifecycle once they are up and running.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We aim to work with our clients from inception
through design of their project in a way that provides value throughout the life of their facility. We are a trusted partner and
advisor to our clients and offer a complete set of engineering and managed services complemented by a vetted suite of select cultivation
equipment systems. Outlined below is an example of a complete project with estimated time frames for each phase that demonstrate
how we provide value to our clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our indoor commercial cultivation solution
offers an integrated suite of services and equipment systems that generally fall within the following categories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 94%">Service Solutions:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 90%">Engineering and Design Services &ndash; A comprehensive triad of services including:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">i.</TD>
    <TD STYLE="width: 83%">Cultivation Space Programming (&ldquo;CSP&rdquo;)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">ii.</TD>
    <TD STYLE="width: 83%">Integrated Cultivation Design (&ldquo;ICD&rdquo;)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">iii.</TD>
    <TD STYLE="width: 83%">Full-Facility Mechanical, Electrical, and Plumbing (&ldquo;MEP&rdquo;)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 90%">A service offering including:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">i.</TD>
    <TD STYLE="width: 83%">Training Services</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">ii.</TD>
    <TD STYLE="width: 83%">Facility and Equipment Commissioning Services</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 94%">Integrated Equipment Solutions:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 90%">Design, Source, and Integration of Complex Environmental Equipment Systems Including Purpose-Built
    Heating, Ventilation, and Air Conditioning (&ldquo;HVAC&rdquo;) solutions, Environmental Controls, Fertigation, and Irrigation
    Distribution.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 90%">Value-Added Reselling (&ldquo;VAR&rdquo;) of Cultivation Equipment including a Complete line of Lighting
    and Rolling Benching Systems</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 90%">Strategic Vendor Relationships with Premier Manufacturers</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; color: #000712">The majority of our clients
are commercial CEA cultivators. We believe one of the key points of our differentiation that our clients value is the depth of
experience of our employees and our Company. We currently employ 42 individuals. Approximately two-thirds of our employees are
considered experts in their areas of focus, and our team includes Engineers (Mechanical, Electrical, Plumbing, Controls, and Agricultural),
Professional Engineers, and individuals with Masters Degrees in Plant Science, Horticulture, and Business Administration. As a
company, we have worked on more than 300 indoor CEA facilities, and believe that the experience of our team and Company provide
clients with the confidence that we will proactively keep them from making common costly mistakes during the build out and operational
stages. Our expertise translates into clients saving time, money, and resources, and provides them ongoing access to expertise
that they can leverage without having to add headcount to their own operations. We provide this experience in addition to offering
a platform of the highest quality equipment systems that can be integrated holistically into our clients&rsquo; facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>COVID-19 Pandemic</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In December 2019, a novel strain of coronavirus,
COVID-19, was reported to have surfaced in Wuhan, China. In January 2020, this coronavirus spread to other countries, including
the United States, and efforts to contain the spread of this coronavirus intensified. In March 2020, the World Health Organization
declared the outbreak of the coronavirus a pandemic. We are a business that supplies other essential businesses with support and
supplies necessary to operate and we therefore believe we are an essential business allowed to continue operating under the Stay-At-Home
Orders that may be issued by many states and cities. However, as discussed below, we have seen a decrease in revenues for the
nine months ended September 30, 2020, a portion of which was the result of clients deferring spending due to the impacts of COVID-19.
The extent to which the COVID-19 pandemic impacts our results will depend on future developments, which are highly uncertain and
cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain
COVID-19 or treat its impact. The outbreak and any preventative or protective actions that governments or we may take in respect
of COVID-19 may result in a period of business disruption, reduced client business and reduced operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Due to the uncertainty and adverse impact
on our operations and financial condition resulting from the outbreak of COVID-19, we took the following actions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 96%">In March 2020, we began executing a substantial reduction in discretionary marketing and general &amp;
    administrative expenses.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 96%">On March 30, 2020, we reduced our headcount by 13 people (27%), from 48 to 35, by terminating ten employees
    and furloughing three other employees, including one member of our leadership team.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="width: 96%">Effective April 6, 2020, we reduced compensation for almost every remaining employee, including a 20%
    reduction for the senior members of our leadership team.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="width: 96%"><FONT STYLE="font-size: 10pt">Effective July 27, 2020, the reduced compensation for everyone other
    than the leadership team was reinstated. Effective September 7, 2020, the reduced compensation for the leadership team was
    reinstated.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="background-color: white">The
ultimate magnitude of COVID-19, including the extent of its impact on our financial and operational results, which could be material,
will depend on the length of time that the pandemic continues, its effect on the demand for our products and our supply chain,
the effect of governmental regulations imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing.
We cannot at this time predict the full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on
our business, financial condition, results of operations and cash flows beyond what is discussed within this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="background-color: white">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Coronavirus Aid, Relief, and Economic Security Act (&ldquo;CARES
Act&rdquo;)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">On March 27, 2020, the CARES Act was enacted.
The CARES Act is an approximate $2 trillion emergency economic stimulus package passed in response to the coronavirus outbreak.
The CARES Act, among other things, includes broad sweeping provisions such as direct financial assistance to Americans in the
form of one-time payments to individuals; aid to businesses in the form of loans and grants; and efforts to stabilize the U.S.
economy and keep Americans employed in general. On April 16, 2020, we received a loan in the amount of $1,020,600 under the Paycheck
Protection Program (&ldquo;PPP&rdquo;) of the CARES Act. The PPP provides for loans to qualifying businesses for amounts up to
2.5 times the average monthly payroll expenses of the qualifying business. On June 5, 2020, the Paycheck Protection Program Flexibility
Act of 2020 (the &ldquo;PPPFA&rdquo;) was enacted. The PPPFA extended the covered period of the loans under the PPP from eight
weeks to 24 weeks from the origination date of the loan, or December 31, 2020, whichever is earlier. Therefore, the PPP now provides
a mechanism for forgiveness of up to the full amount borrowed after 24 weeks as long as the borrower uses the loan proceeds during
the 24-week period after the loan origination for eligible purposes, including payroll costs, certain benefits costs, rent and
utilities costs or other permitted purposes, and maintains its payroll levels, subject to certain other requirements and limitations.
The amount of loan forgiveness is subject to reduction, among other reasons, if the borrower terminates employees or reduces salaries
during the 24-week period. The interest rate on the loan is 1.0% per annum. The PPPFA also extended the deferment period for principal
and interest payments on PPP loans from six months to ten months. Therefore, the payments of principal and interest under our
PPP loan are deferred for ten months from the final day of the loan forgiveness period (the &ldquo;Deferral Period&rdquo;). Although
the Company believes the PPP loan proceeds were used in accordance with the CARES Act guidance, the Company has not yet determined
if any of the PPP loan is subject to forgiveness and has therefore continued to show the entire PPP loan as an obligation on its
financial statements. Any unforgiven portion of the PPP loan is payable over the two-year term, with payments deferred during
the Deferral Period. The Company may elect to prepay the unforgiven loan at any time without payment of any premium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Bridge Financing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 15, 2020, we signed a $1,854,500
convertible note (the &ldquo;Notes&rdquo;) bridge financing (the &ldquo;Bridge Financing&rdquo;). The Bridge Financing is a combination
of $1,354,500 received on November 20, 2020, and an additional $500,000 received on December 15, 2020. The Bridge Financing was
raised by a combination of our Board of Directors, our current investors and two new institutional funds. In connection with the
Bridge Financing, an outstanding $1,000,000 promissory note and $4,500 interest accrued thereon was converted into a Note. The
Notes were issued in reliance upon the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;). The Notes carry interest at the rate of 12% and mature on December 31, 2021. The Notes will
be mandatorily converted upon the closing of a sale of the securities of the Company, whether in a private placement or pursuant
to an effective registration statement under the Securities Act, resulting in at least $2,500,000 of gross proceeds to the Company
(a &ldquo;Qualified Offering&rdquo;). In the event of a Qualified Offering, the outstanding principal and interest of the Notes
will be converted into the identical security issued at such Qualified Offering at 75% of the per security price paid by investors
in connection with the Qualified Offering. Further, at any time after the one hundred twentieth (120th) day following the Issuance
Date (as defined therein), and with five (5) business days advanced written notice to the Company, the Notes may be converted
into a number of shares of the Company&rsquo;s common stock, par value $0.001, equal to the number derived by dividing (a) the
principal amount of the Note plus any accrued and unpaid interest through the date of conversion by (b) the Alternative Conversion
Price (as defined therein). This offering would be deemed a Qualified Offering and the Notes, excluding accrued interest, would
convert into 234,771 shares of our common stock at an assumed offering price of $10.50 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Preliminary Financial Results for the Three Months and
Year Ended December 31, 2020 (preliminary and unaudited)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These operating results reflect our preliminary
estimates with respect to the results for the three months and year ended December 31, 2020, which are based on currently available
information and are subject to change. Our financial closing procedures for the three months and year ended December 31, 2020
are not yet complete and, as a result, our final results upon completion of our closing procedures may vary from these preliminary
estimates. These preliminary estimates should not be viewed as a substitute for interim financial statements prepared in accordance
with GAAP.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These preliminary operating results have
been prepared by, and are the responsibility of, our management. Our auditor, BF Borgers CPA PC, has not audited, reviewed, compiled
or applied agreed-upon procedures with respect to these preliminary results. Accordingly, BF Borgers CPA PC does not express an
opinion or any other form of assurance with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect our preliminary and unaudited
revenue for the three months ended December 31, 2020 to be between $9.0 million and $9.3 million, which would represent an increase
of at least 26% from revenue of $7.1 million reported for the three months ended December 31, 2019. Preliminary and unaudited
revenue for the year ended December 31, 2020 is expected to be between $25.6 million and $25.9 million, compared to $24.2 million
reported for the year ended December 31, 2019. This expected increase in revenue was driven by an increase in the shipment of
complex environmental equipment systems and sales of other cultivation equipment predominantly tied to design contracts signed.
We are entering 2021 with in excess of $14.0 million of contractually committed orders for environmental and cultivation equipment
systems for which revenue has not been recognized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect our preliminary and unaudited
net loss for the three months ended December 31, 2020 to be between negative ($1.7) million and negative ($1.4) million, which
would represent an improvement of at least $0.9 million from net loss of negative ($2.6) million reported for the three months
ended December 31, 2019. This expected improvement in net loss is driven by reductions in operating expenses and increased gross
profit. Preliminary and unaudited net loss for the year ended December 31, 2020 is expected to be between negative ($5.7) million
and negative ($5.4) million, which would represent an improvement of at least $2.7 million from net loss of negative ($8.4) million
reported for the year ended December 31, 2019. This expected improvement in net loss is driven by a reduction in operating expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, we expect to achieve positive
Adjusted EBITDA for the three months ended December 31, 2020, with Adjusted EBITDA for the year ended December 31, 2020 expected
to be between negative ($0.9) million and negative ($0.7) million, which would represent an improvement of at least $2.3 million
from Adjusted EBITDA of negative ($3.3) million reported for the year ended December 31, 2019. See &ldquo;&mdash;Non-GAAP Financial
Measures&rdquo; for a discussion of how we calculate Adjusted EBITDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>Results
of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">This section includes a summary of our
historical results of operations, followed by detailed comparisons of our results for (i) the nine months and the three months
ended September 30, 2020 and 2019 and (ii) the years ended December 31, 2019 and 2018. We have derived this data from our interim
and annual consolidated financial statements included elsewhere in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Nine Months Ended September 30, 2020 Compared to Nine
Months Ended September 30, 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> During the nine months ended September
30, 2020, we generated revenues of $16.6 million ($15.1 million of product revenues and $1.5 million of services revenues) compared
to revenues of $17.1 million ($14.5 million of product revenues and $2.6 million of services revenues) during the nine months
ended September 30, 2019, a decrease of $0.5 million, or 3%. This decrease in revenue consisted of a $1.2 million decrease in
complex equipment systems and a $1.1 million decrease in professional services, offset by an increase of $1.5 million in cultivation
equipment and a $0.3 million increase in other product revenues. A portion of this decrease in revenues was the result of
clients deferring spending due to the impacts of COVID-19 during the six months ended June 30, 2020. As a result of the deferred
spending, many of the completion dates in our client contracts were extended, but no contracts were lost. We began to see clients
start spending on these deferred contracts during the three months ended September 30, 2020. We signed 57 new engineering design
project contracts in the nine-month period ended September 30, 2020, including six new projects in Europe, and secured our first
horticulture commissioning project, an East Coast based lettuce facility. During the nine months ended September 30, 2020 one
client represented 26% of our total revenue. During the nine months ended September 30, 2019, another client represented 15% of
our total revenue. Substantially all of the revenue derived from each of these separate clients were product sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">During the nine months ended September
30, 2020, cost of revenues was $12.6 million compared to $11.5 million during the nine months ended September 30, 2019, an increase
of $1.1 million, or 9%. This increase is attributable to an increase in revenue from our lower margin product equipment sales
and a reduction in our higher margin services revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Gross profit was $4.0 million (24% of
revenue) during the nine months ended September 30, 2020 compared to $5.5 million (32% of revenue) during the nine months ended
September 30, 2019. Gross profit as a percentage of revenue decreased due to a revenue mix shift in the current period favoring
product versus services revenue as noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Operating expenses decreased by $3.1 million,
or 32%, to $6.5 million for the nine months ended September 30, 2020 compared to $9.6 million for the nine months ended September
30, 2019. The decrease in operating expenses was comprised of a $2.0 million reduction in general operating expenses, mainly due
to reduced salary and travel expenses, a $0.7 million reduction of marketing related expenses, and a $0.2 million reduction in
stock-based compensation expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Non-operating expenses decreased $0.2
million to $1.5 million for the nine months ended September 30, 2020, compared to $1.7 million for the nine months ended September
30, 2019. Interest expense, excluding $0.8 million related to the amortization of convertible debentures in the nine months ended
September 30, 2019, increased $0.7 million due to the increase in debt over the comparable periods. For the nine months ended
September 30, 2020 and 2019, the Company recognized an impairment loss of $0.3 million and $0.5 million, respectively, related
to the investment in Total Grow Holdings LLC (d/b/a Total Grow Control, LLC) (&ldquo;TGH&rdquo;). The Company also incurred a
$0.2 million expense for contingent consideration from the acquisition of Impact during the nine months ended September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As a result of the above, we incurred
a net loss of ($4.0) million for the nine months ended September 30, 2020, or a net loss per share of ($0.84), compared to a net
loss of ($5.7) million for the nine months ended September 30, or a net loss per share of ($1.32).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Three Months Ended September 30, 2020 Compared to Three
Months Ended September 30, 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> During the three months ended September
30, 2020, we generated revenues of $8.4 million ($7.9 million of product revenues and $0.5 million of services revenues) compared
to revenues of $5.6 million ($4.6 million of product revenues and $1.0 million of services revenues) during the three months ended
September 30, 2019, an increase of $2.8 million, or 50% . This increase in revenue primarily resulted from a $3.3 million increase
in cultivation equipment sales, offset by a $0.5 million decrease in professional services. This increase in revenues was in part
due to clients spending on contracts that had been deferred during the six months ended June 30, 2020. We signed 15 new engineering
design project contracts in the three-month period ended September 30, 2020. During the three months ended September 30, 2020
one client represented 51% of our total revenue. During the three months ended September 30, 2019 another client represented 17%
of our total revenue. Substantially all of the revenue derived from each of these separate clients were product sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">During the three months ended September
30, 2020, cost of revenues was $6.7 million compared to $3.7 million during the three months ended September 30, 2019, an increase
of $3.0 million, or 82%. This increase is attributable to an increase in revenue from our lower margin product equipment sales
and a reduction in our higher margin services revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Gross profit was $1.7 million (20% of
revenue) during the three months ended September 30, 2020 compared to $1.9 million (35% of revenue) during the three months ended
September 30, 2019. Gross profit as a percentage of revenue decreased due to a revenue mix shift in the current period favoring
product versus services revenue as noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Operating expenses decreased by $1.4 million,
or 42%, to $1.9 million for the three months ended September 30, 2020 compared to $3.3 million for the three months ended September
30, 2019. The decrease in operating expenses was comprised of a $1.0 million reduction in general operating expenses mainly due
to reduced salary and travel expenses, a $0.3 million reduction of marketing related expenses, and a $0.1 million reduction in
stock-based compensation expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Non-operating expenses decreased $0.9
million to $0.5 million for the three months ended September 30, 2020, compared to $1.4 million for the three months ended September
30, 2019. Interest expense, excluding $0.8 million related to the amortization of convertible debentures in the nine months ended
September 30, 2019, increased $0.3 million due to the increase in debt over the comparable period. In the three months ended September
30, 2019 the Company recorded a $0.5 million impairment loss related to TGH. The Company incurred a $0.2 million expense for contingent
consideration from the acquisition of Impact during the three months ended September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As a result of the above, we incurred
a net loss of ($0.7) million for the three months ended September 30, 2020, or a net loss per share of ($0.12), compared to a
net loss of ($2.8) million for the three months ended September 30, 2019, or a net loss per share of ($0.66).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Year Ended December 31, 2019 Compared to Year Ended December
31, 2018</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> During the year ended December 31,
2019, we generated revenues of $24.2 million ($21.0 million of product revenues and $3.2 million of services revenues) compared
to revenues of $20.1 million ($19.1 million of product revenues and $1.0 million of services revenues) during the year ended December
31, 2018, an increase of $4.1 million (21%). While this increase was partially attributable to the general growth of the cannabis
industry in North America, and a corresponding increase in the demand for our solutions, we believe that our increased marketing
efforts and industry demand for large, environmentally controlled, grow facilities primarily contributed to the increase in our
revenues. The increase in revenue primarily resulted from an increase of $4.3 million in sales of cultivation equipment, an
increase of $2.2 million in professional services, an increase of $0.8 million in environmental sciences revenues offset by a
decrease in sales of complex equipment systems and other revenue of $3.2 million. The overall increase in our revenues was primarily
driven by an increase in the number of sales that we generated. During the year ended December 31, 2019 one client represented
21% of our total revenue. During the year ended December 31, 2018 another client represented 14% of our total revenue. Substantially
all of the revenue derived from each of these separate clients were product sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In 2019, we implemented a strategic initiative
to more closely align with our clients and sell an all-encompassing enterprise platform solution. This solution is a full service
consultative integrated facility package for interior cultivation design. Supporting this directive, for the year ended December
31, 2019, the Company secured engineering design service contracts for 76 projects, totaling 1,914,030 square feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Cost of sales increased to $17.6 million
during the year ended December 31, 2019, compared to $13.9 million during the year ended December 31, 2018, an increase of $3.7
million (27%). This increase was directly related to an increase in revenue from our lower margin equipment sales, change in salary
allocation, and an increase in payables for contractors related to our design services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Gross profit increased to $6.6 million
(27% of revenue) during the year ended December 31, 2019, compared to $6.2 million (31% of revenue) during the year ended December
31, 2018. Gross profit as a percentage of revenue decreased due to increased sales of lower margin products, primarily lighting
systems, during 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Operating expenses increased to $12.5
million for the year ended December 31, 2019, compared to $10.0 million for the year ended December 31, 2018, an increase of $2.5
million (25%). General and administrative expense, excluding amortization of broker issuing costs and broker warrants associated
with our offering of convertible debentures of $0.4 million, increased by $1.5 million (19%), due primarily to our expanding work
force. Many of our new employees are members of management, hold advanced degrees, and are experts in their area of focus, which
increased compensation expense. Stock compensation expense increased by $0.6 million primarily as a result of the timing of vesting
of stock grants and stock options previously issued under our stock grant and stock option programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Interest expense, excluding amortization
related to the convertible debentures of $1.3 million in the year ended December 31, 2019, was $0.7 million compared to $0.1 million
incurred during the year ended December 31, 2018, as a result of increased debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As a result of the above, we incurred
a net loss of ($8.4) million for the year ended December 31, 2019, or a net loss per share of ($1.92), compared to a net loss
of ($3.9) million for the year ended December 31, 2018, or a net loss per share of ($0.96).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The Company uses the supplemental financial
measure of Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (&ldquo;Adjusted EBITDA&rdquo;) as a measure
of our operating performance. Adjusted EBITDA is not calculated in accordance with accounting principles generally accepted in
the United States of America (&ldquo;GAAP&rdquo;) and it is not a substitute for other measures prescribed by GAAP such as net
income (loss), income (loss) from operations, and cash flows from operating activities. We define Adjusted EBITDA as net income
(loss) attributable to urban-gro, Inc., determined in accordance with GAAP, excluding the effects of certain operating and non-operating
expenses including, but not limited to, interest expense, depreciation of tangible assets, amortization of intangible assets,
impairment of investments, foreign exchange gains/losses, and stock-based compensation that we do not believe reflect our core
operating performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our board of directors and management
team focus on Adjusted EBITDA as a key performance and compensation measure. We believe that Adjusted EBITDA assists us in comparing
our operating performance over various reporting periods because it removes from our operating results the impact of items that
our management believes do not reflect our core operating performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The following table reconciles net loss
attributable to the Company to Adjusted EBITDA for the periods presented:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Years
                                         Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>December
                                         31,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 28%; font-size: 10pt; font-weight: bold; text-align: left">Net Loss</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(694,281</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(2,809,530</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(3,959,882</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(5,719,404</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(8,350,573</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(3,895,873</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">393,158</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">125,733</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,057,501</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">374,850</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">704,230</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">119,961</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense &ndash; amortization of convertible debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">796,233</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">796,233</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,333,520</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">G&amp;A &ndash; amortization of convertible debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">167,834</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">167,834</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">432,578</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Impairment loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">506,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">310,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">506,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">505,766</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Stock-based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">399,258</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">509,219</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,391,807</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,606,355</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,830,426</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,245,826</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Contingent consideration &ndash; purchase price</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">155,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">155,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">61,339</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">73,928</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">181,750</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">193,956</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">266,476</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">154,136</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Adjusted EBITDA</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">314,474</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(630,583</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(863,824</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,074,176</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(3,277,577</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,375,950</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Adjusted EBITDA for the nine months ended
September 30, 2020 was a negative ($0.9) million, compared to a negative ($2.1) million for the nine months ended September 30,
2019, due to the offsetting effects of reduced operating expenses and reduced gross profit. Adjusted EBITDA for the three months
ended September 30, 2020 was $0.3 million compared to a negative $0.7 million for the three months ended September 30, 2019, due
primarily to reduced operating expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Adjusted EBITDA for the year ended December
31, 2019 was a negative ($3.3) million, compared to a negative ($2.4) million for the year ended December 31, 2018, due to an
increase in operating expenses primarily due to our expanding workforce when compared to the prior year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">There are limitations to using non-GAAP
measures such as Adjusted EBITDA. Although we believe that Adjusted EBITDA can make an evaluation of our operating performance
more consistent because it removes items that do not reflect our core operations, other companies in our industry may define Adjusted
EBITDA differently than we do. As a result, it may be difficult to use Adjusted EBITDA to compare the performance of those companies
to our performance. Adjusted EBITDA should not be considered as a measure of the income generated by our business or discretionary
cash available to us to invest in the growth of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>September 30, 2020 Compared to December 31, 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As of September 30, 2020, we had cash
of $213,392, which represented a decrease of $235,311 from December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Since inception, we have incurred significant
operating losses and have funded our operations primarily through issuances of equity securities, debt, and operating revenue.
As of September 30, 2020, we had an accumulated deficit of $20,850,508, a working capital deficit of $4,833,132, and negative
stockholders&rsquo; equity of $6,703,947. Our ability to generate sufficient revenues to pay our debt obligations and accounts
payable when due remains subject to risks and uncertainties. These risks and uncertainties raise substantial doubt about our ability
to continue as a going concern within one year after the date that the condensed consolidated financial statements in connection
with this prospectus were issued. The condensed consolidated financial statements included in this prospectus have been prepared
on a going concern basis and do not include any adjustments relating to the recoverability and classification of recorded asset
amounts or amounts of liabilities that might result from the outcome of this uncertainty. Our ability to continue as a going concern
is dependent upon, among other things, our ability to generate revenue, control costs and raise capital. Such capital, however,
may not be available, if at all, on terms that are acceptable to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As described in the notes to the condensed
consolidated financial statements included in this prospectus, on February 21, 2020, we entered into the letter agreement by and
among us, as borrower, urban-gro Canada Technologies Inc. and Impact Engineering, Inc., as guarantors, the lenders party thereto,
and Bridging Finance Inc., as administrative agent for the lenders (the &ldquo;Credit Agreement&rdquo;), providing for a senior
secured demand term loan facility in the amount of C$2.7 million ($2.0 million) and a demand revolving credit facility of up to
C$5.4 million ($4.0 million). Our failure to obtain additional debt or equity financing in the future could have a negative impact
on our ability to continue as a going concern or to grow and expand our operations, which will have a negative impact on our anticipated
results of operations. As of September 30, 2020, we had no availability under the revolving credit facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">If we do not raise enough funds from a
financing, or generate sufficient operating cash flow, or if additional expenditures and acquisitions are identified and we cannot
use our securities as compensation, we will need additional funding to continue to implement our business plan and to execute
our strategic initiatives. Other than the availability pursuant to the revolving credit facility described above, we do not currently
have an agreement with any third party to provide us with such financing and there can be no assurances that we will be able to
raise any capital on commercially reasonable terms, or at all. If we require additional capital and are unable to raise the same,
it could have a material negative impact on our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash used in operating activities
was $3.0 million during the nine months ended September 30, 2020, compared to $0.1 million used for the nine months ended September
30, 2019. Operating cash has been positively impacted from an increase in client deposits as demand for our services and equipment
solutions increased in the nine months ended September 30, 2020. At September 30, 2020, we had $4.1 million in client deposits
related to client orders, which compared favorably to client deposits of $2.9 million as of December 31, 2019. We require prepayments
from clients before any design work is commenced and before any material is ordered from the vendor. These prepayments are booked
to the client deposits liability account when received. Our standard policy is to collect the following before action is taken
on a client order: 50% deposit; and the remaining 50% payment made prior to shipping. We expect client deposits to be relieved
from the deposits account no longer than 12 months for each project. We do not have trade payable terms with most of our vendors
and as a result, we are required to prepay a portion or all of the total order. At September 30, 2020, we had $1.1 million in
accounts payable, compared to $3.8 million at December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash used in investing activities
was $0.1 million for the nine months September 30, 2020, compared to $0.9 million during the nine months ended September 30, 2019.
Historically, cash has been used to increase our investments in strategic partnerships and to acquire property and equipment.
We do not anticipate using significant cash in the future to invest in strategic partnerships. We will continue to have ongoing
needs to purchase property and equipment to maintain our operations. We had no material commitments for capital expenditures as
of September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash provided by financing activities
was $2.9 million for the nine months ended September 30, 2020, compared to $3.3 million during the nine months ended September
30, 2019. Cash provided from financing activities during the nine months ended September 30, 2020 primarily relates to $5.3 million
in proceeds received from the issuance of debt and a $1.0 million long-term loan, offset by $2.8 million used in the repayment
of notes payable and $0.6 million in financing fees related to the issuance of debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>December 31, 2019 Compared to December 31, 2018</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As of December 31, 2019, we had cash of
$448,703, which represented a decrease of $730,149 from December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Since inception, we have incurred significant
operating losses and have funded our operations primarily through issuances of equity securities, debt, and operating revenue.
As of December 31, 2019, we had an accumulated deficit of $16,890,626, a working capital deficit of $8,318,980, and negative stockholders&rsquo;
equity of $5,008,334.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Effective January 9, 2019, we executed
a letter agreement with 4Front Capital Partners, Inc., Toronto, Canada (&ldquo;4Front&rdquo;), whereby 4Front agreed to act as
our exclusive placement agent in connection with a private placement offering. Beginning in March 2019, 4Front initiated an offering
of up to $6.0 million from the sale of units, with each unit consisting of a $1,000 Convertible Debenture and Common Stock Purchase
Warrants to purchase 207.46 shares of our Common Stock at $3.00 per share for a period of two years from the purchase date. The
debentures were due May 31, 2021 and bore interest at 8%, compounded annually, with interest due at maturity. On October 16, 2019,
the $2.6 million in debentures plus $92,037 in accrued interest were converted into 1,102,513 shares of common stock at $2.41
per share pursuant to their terms as a result of our registration of the securities on a registration statement that was declared
effective on such date. The warrants contain a mandatory exercise provision if the weighted average share price of our common
stock exceeds $5.00 per share for a period of five consecutive days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash used in operating activities
was $2.5 million during the year ended December 31, 2019, compared to $2.3 million for the year ended December 31, 2018. Operating
cash was positively impacted from an increase in deposits as our business continued to grow. At December 31, 2019, we had $2.9
million in deposits related to client orders. At December 31, 2019, we had $1.3 million in prepayments and advances, primarily
comprised of prepayments to vendors to initiate orders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash used in investing activities
was $1.1 million for the year ended December 31, 2019, compared to $1.3 million during the year ended December 31, 2018. We had
no material commitments for capital expenditures as of December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Net cash provided by financing activities
was $2.9 million for the year ended December 31, 2019, compared to $3.1 million during the year ended December 31, 2018. Cash
provided from financing activities during the year ended December 31, 2019 primarily related to $2.6 million in proceeds we received
from our offering of units in addition to a short term note payable for $1.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In October 2018, we issued a $1.0 million
unsecured note payable to Cloud9 Support, Inc. (&ldquo;Cloud9&rdquo;), an entity owned by James Lowe, a director, which became
due April 30, 2019. The loan had a one-time origination fee of $12,500. Interest accrued at the rate of 12% per annum and was
paid monthly. As additional consideration for the loan we granted Mr. Lowe, as designee for Cloud9, an option to purchase 30,000
shares of our common stock at an exercise price of $1.20 per share, which option is exercisable for a period of five years. The
loan is guaranteed by Mr. Nattrass, our CEO, a director and one of our principal shareholders, and by Mr. Gutierrez, one of our
principal shareholders, and a former officer and director of the Company. The due date for the note payable was extended in May
2019 to December 31, 2019 and the interest rate was decreased to 9% per year. In consideration for Cloud9 extending the maturity
date of the note and reducing the interest rate, we agreed to issue 10,000 shares of our common stock to Mr. Lowe, as designee
for Cloud9. In December 2019, in connection with our entry into the facilities under the Credit Agreement, the due date for the
note payable was extended to December 31, 2021, and we agreed to issue Mr. Lowe, as designee for Cloud9, an additional 100,000
shares of common stock in exchange for this extension and his agreement to subordinate the loan to the obligations underlying
the facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Gross debt, excluding operating leases,
was $3.8 million and $3.5 million as of December 31, 2019 and December 31, 2018, respectively. This represents an increase in
gross debt of $0.3 million primarily due to a $0.7 million short term note payable offset by principal paydowns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Although our operations are influenced
by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the
nine months ended September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policies and Estimates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The discussion and analysis of our financial
condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting
principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates
and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets
and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions
that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the
carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions. For a detailed discussion about the Company&rsquo;s significant accounting
policies, refer to Note 2 &mdash; &ldquo;Summary of Significant Accounting Policies,&rdquo; in the Company&rsquo;s consolidated
financial statements included in this prospectus. During the nine months ended September 30, 2020, there were no material changes
made to the Company&rsquo;s significant accounting policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We have not entered into any off-balance
sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would
be considered material to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a13"></A>BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>History</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We were originally formed on March 20,
2014, as a Colorado limited liability company. In March 2017, we converted to a Colorado corporation and exchanged shares of our
common stock for every member interest issued and outstanding on the date of conversion. On October 29, 2020, we reincorporated
as a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our website is&nbsp;www.urban-gro.com,
which contains a description of our Company and products. In addition, we also maintain a branded technology product website at
www.soleiltech.ag. Such websites and the information contained on such websites are not part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white">urban-gro, Inc.
is a leading engineering and design services company focused on the sustainable commercial indoor horticulture market. We engineer
and design indoor <FONT STYLE="color: #000712">controlled environment agriculture (&ldquo;CEA&rdquo;) facilities a</FONT>nd then
integrate complex environmental equipment systems into those facilities. CEA is a market segment that is defined by type of
facility, and has no correlation to the industry; or more specifically the crop being grown in the facility. The CEA segment is
represented by any horticultural facility that is fully self-contained, and has a fully-controlled environment. There are three
facility types that meet these qualifications: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> i. </TD><TD> Indoor Facilities - new building; or the retrofit of an
                                         existing building; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> ii. </TD><TD> Vertical Farms &ndash; a building with a smaller footprint
                                         that is built up vertically and we view this category as including modular container
                                         farms; and </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> iii. </TD><TD> Greenhouses &ndash; traditional and made out of a variety
                                         of translucent materials as to provide natural sunlight for the crop being grown. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-indent: 0.4in"> While historically we have
been focused on engineering, design, and equipment integration into indoor facilities, of which some are ultimately used for the
cultivation of plant-based medicines, we are planning to expand our reach within CEA across both facility type and crop type.
The term &ldquo;plant-based medicines&rdquo; includes (i) a wide array of herbal supplements including but not limited to curcumin,
saffron extract and ginger, (ii) CBD based therapeutics, (iii) cannabis based therapeutics and (iv) a host of medicines derived
from plants such as caffeine, menthol, foxglove and others. We are focusing on expanding to the vertical farming CEA sub-segment,
which is ultimately and predominantly used for the cultivation of a variety of crops including, but not limited to, leafy greens,
herbs, cucumbers, peppers, and strawberries. As the global horticulture market has become more focused on the safety of the food
supply chain, reducing emissions with current transportation methods associated with these crops, and, growing local, we are confident
that the vertical farming CEA sub-segment will represent a significant and increasing share of our revenue and be a significant
factor in our organic growth moving forward. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white"> Through
this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including leafy
greens, vegetables, herbs, and cannabis. Historically, a large number of our clients were cannabis producers, and we still do
substantial work for those clients, but we have shifted our priorities to non-cannabis crops as we seek to address a broader
market. Our custom-tailored approach to design, procurement, and equipment integration provides a single point of
accountability across all aspects of indoor growing operations. We also help our clients achieve operational efficiency and
economic advantages through a full spectrum of professional services and programs focused on facility optimization and
environmental health which establish facilities that allow <FONT STYLE="color: #000712">clients to manage, operate and
perform at the highest level throughout their entire cultivation lifecycle once they are up and running.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white; color: #000712">Since
commencing business in March 2014, we have introduced new equipment solutions, products and services to the CEA market, expanded
our ongoing operations across North America, and most recently, we have entered into several engagements in Europe, and we plan
on opening a headquarters office in Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The majority of our clients are commercial
CEA cultivators. We believe one of the key points of our differentiation that clients value is the depth of experience of our
employees and our Company. We currently employ 42 individuals. Approximately two-thirds of our employees are considered experts
in their areas of focus, and our team includes Engineers (Mechanical, Electrical, Plumbing, Controls, and Agricultural), Professional
Engineers, and individuals with Masters Degrees in Plant Science, Horticulture, and Business Administration. As a company, we
have worked on more than 300 indoor CEA facilities, and believe that the experience of our team and Company provide clients with
the confidence that we will proactively keep them from making common costly mistakes during the build out that impact operational
stages. Our expertise translates into clients saving time, money, and resources through expertise that they can leverage without
having to add headcount to their own operations. We provide this experience in addition to offering a platform of the highest
quality equipment systems that can be integrated holistically into our clients&rsquo; facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Services and Integrated Equipment Solutions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We aim to work with
our clients from inception through design of their project in a way that provides value throughout for the life of their facility.
We are a trusted partner and advisor to our clients and offer a complete set of engineering and managed services complemented
by a vetted suite of select cultivation equipment systems. Outlined below is an example of a complete project with estimated time
frames for each phase that demonstrate how we provide value to our clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Our indoor commercial
cultivation solution offers an integrated suite of services and equipment systems that generally fall within the following categories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Service
                                         Solutions:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Engineering
                                         and Design Services &ndash; A comprehensive triad of services including:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">i.</TD><TD STYLE="text-align: justify">Cultivation Space Programming
                                         (&ldquo;CSP&rdquo;)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">ii.</TD><TD STYLE="text-align: justify">Integrated Cultivation Design
                                         (&ldquo;ICD&rdquo;)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">iii.</TD><TD STYLE="text-align: justify">Full-Facility Mechanical,
                                         Electrical, and Plumbing (&ldquo;MEP&rdquo;)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">A
                                         service offering including:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">i.</TD><TD STYLE="text-align: justify">Training Services</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">ii.</TD><TD STYLE="text-align: justify">Facility and Equipment Commissioning
                                         Services</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Integrated
                                         Equipment Solutions:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Design,
                                         Source, and Integration of Complex Environmental Equipment Systems</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Value-Added
                                         Reselling (&ldquo;VAR&rdquo;) of Cultivation Equipment Systems</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Strategic
                                         Vendor Relationships with Premier Manufacturers</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Service Solutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Engineering and Design Services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As a leader in indoor CEA facilities,
we provide our clients with service offerings that span from engineering design to the operational stages of the facility. Our
engineering and design services offering includes three engagements: CSP, ICD, and MEP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>CSP revolves
                                         around early-stage engagement with stakeholders and provides for a basis of design that
                                         optimizes for interactions between people, plants and processes, saving stakeholders
                                         money and time, immediately and in the future, through smart, informed decision-making.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>ICD revolves
                                         around professionally designed layouts for climate control, fertigation, benching, air
                                         flow and lighting, together ensuring optimal space utilization and product performance.
                                         These detailed plans are taken through the Construction Document stage and are leveraged
                                         by our clients to efficiently solicit contractor bids.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>MEP engineering
                                         design focuses on the gross square footage of the building, not just the cultivation
                                         space, which in turn eliminates the &ldquo;gap&rdquo; between cultivation systems and
                                         the building systems. We provide engineered construction contract documents for mechanical,
                                         heating, ventilation, and air conditioning (&ldquo;HVAC&rdquo;), plumbing and electrical
                                         systems required for the building permits necessary to obtain a Certificate of Occupancy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Our Service Offering</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We provide value for clients in the form
of facility commissioning and staff training. Combined, this solution focuses on the troubleshooting, tuning, and support of a
myriad of cultivation systems and equipment while further providing guidance for client interactions with tradespeople working
on HVAC, electrical, and plumbing in the facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Many of the current service options available
to clients are isolated to vendors providing post-sale service for a single piece of equipment &ndash; whereas our service has
a cultivation-level view of the complex system made up by each piece of equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>Training Services</I>. Complex cultivation
systems encompass a multitude of variables and environment readings such as temperature, relative humidity, vapor pressure differential
(VPD), electrical conductivity (EC), pH, network status, light status, photosynthetically active radiation, sunrise/sunset modules,
CO<SUB>2</SUB>, HVAC status, fan status, vents (including windward and leeward), shades, network status and flow rates. In our
CEA world there is a scarcity of skilled labor which impedes our clients&rsquo; ability to drive operating proficiency across
their teams. Our engineering team uses a series of tools and processes to ensure clients are proactive in preventing equipment
downtime, can operate all equipment and processes fluently, and have expert support in resolving potential issues. These services
range from equipment standard operating procedure (&ldquo;SOP&rdquo;) libraries to staff training sessions. With a unique knowledgebase
acquired from both our commissioning and training for a wide breadth of cultivation equipment, we provide our clients&rsquo; teams
with the skills to minimize equipment downtime and optimize processes in their facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>Facility and Equipment Commissioning
Services</I>. Today&rsquo;s cultivation systems are custom designed and extremely complex. Our team of project managers and engineers
supports the installation process by coordinating with a client&rsquo;s engineers and stakeholders to avoid project bottlenecks
while supporting construction trades. Our commissioning team ensures that the equipment is installed according to the design and
operates per the defined manufacturer specifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>Program Overview and Pricing</I>. We
estimate that, on average and depending on the crop, CEA facilities can lose up to $10,000 per 1,000 square feet of canopy per
day when offline &ndash; our training services are centered around proactively minimizing this potential loss for a fraction of
the cost. Our clients are best described as automation- and margin-focused and have an understanding of the importance of preventing
downtime in their facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><I>Related-Party Hardware and Software
Platforms</I>. Since initially collaborating with California-based Edyza Corporation (&ldquo;Edyza&rdquo;) in 2018, our multiple
investments have culminated into a 19.5% equity position in Edyza. Edyza&rsquo;s IoT platform employs a robust, high performance,
proprietary, tree-mesh wireless network topology and utilizes wireless hardware sensors to acquire data within the cultivation
environment. Our training services can help clients utilize the data garnered from these sensors to provide a high-resolution
understanding of what&rsquo;s happening within a client&rsquo;s facility through detailed multi-point information on temperature,
humidity, barometric pressure, soil moisture, and electrical conductivity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Integrated Equipment Solutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">While our engineers design most of the
complex equipment systems that are then integrated into a CEA facility, we also provide consultative reselling of more common
solutions that we integrate into the overall design. <FONT STYLE="color: #222222; background-color: white">For CEA, the environmental
goal is to maintain a stable and consistent VPD according to the client&rsquo;s priorities through environmental control of relative
humidity and temperature during all stages of growth. There are four main variables in CEA that affect plant growth (and can impact
VPD): (i) water and nutrients; (ii) environmental control; (iii) CO<SUB>2</SUB>; and (iv) lighting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Design, Source, and Integration of Complex Environmental
Equipment Systems </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Complex Environment Systems for CEA include
the integration of environmental controls, fertigation and irrigation distribution, a complete line of water treatment and wastewater
reclamation systems, and purpose-built HVAC equipment systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; color: #222222">The most significant variable
of interest in a CEA facility is the control of the environment, which is accomplished through the integration of both environmental
controls and the purpose-built HVAC system. Without proper design, the environmental control system is the most influential variable
in terms of temperature and relative humidity control within an indoor agriculture space. With properly designed equipment, the
environmental controls variable is less volatile, enabling efficient growing conditions.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; color: #222222">Purpose-built HVAC equipment
systems will provide a more stable environment, maximize plant health and yields, minimize crop loss, minimize utility costs,
save on capital equipment, and maximize sustainability. Additionally, private studies of a partner comparing purpose-built HVAC
environmental controls equipment to standard commercial HVAC and dehumidification, found increased crop yields with purpose-built
equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>VAR of Cultivation Equipment Systems </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We act as an experienced VAR to our clients
when selling vetted best-in-class commercial horticulture lighting solutions, rolling and automated container benching systems,
specialty fans, and microbial mitigation and odor reduction systems. The acquired knowledge of how each of these systems work
in combination with and in tangent to the overall ecosystem is a significant benefit that our engineers and product experts offer
to our clients. Not only are many competing products reviewed in each category with the intention of vetting the best solution,
we continually search out and review competing technologies to ensure that only the best-in-class equipment systems are integrated
into our projects. As such, we believe it will be imperative to maintain and to continue to develop close relationships with both
existing and new leading technology and manufacturing providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Today, we typically do not sell any cultivation
equipment systems individually as a one-time sale. Virtually all equipment sales are sold as part of a larger all-encompassing
project solution that spans over a 12 to 18 month period and includes engineering design and the sale of both custom complex and
more standard equipment systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #000712"><B><I>Strategic Vendor Relationships with Premier
Manufacturers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We work closely with leading technology
and manufacturing providers to deliver an integrated solution designed to achieve the stated objectives of our clients. While
we used to manufacture certain lighting products, we discontinued all manufacturing in 2019, although we continued to sell existing
inventory through 2020. Although we have numerous provider relationships, three vendors are particularly important to our
solution: Fluence, Argus, and Desert Aire, LLC (&ldquo;Desert Aire&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Fluence&rsquo;s
                                         LED-based lighting systems are designed to provide high levels of photosynthetically
                                         active radiation ideal for commercial cultivation and research applications. From sole-source
                                         indoor grow lighting to supplemental greenhouse lighting, Fluence custom tailors the
                                         light spectrum and form-factors to optimize plant growth and increase yields while consuming
                                         less energy and reducing operating costs as compared to legacy technologies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>After
                                         working closely together since early 2019, we have demonstrated our value to Fluence
                                         by engaging with clients, and introducing their product range, up to 18 months prior
                                         to facility start-up.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Building
                                         on this success, in the second quarter of 2020, we signed an exclusive two-year global
                                         System Integrator Agreement with Fluence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Argus
                                         provides automated control systems for the horticulture and aquaculture industries. Argus
                                         systems provide three essential functions: (i) fully integrated equipment control; (ii)
                                         advanced monitoring and alarms; and (iii) comprehensive crop and environmental data acquisition
                                         and management information. Argus capabilities include facilities automation and specialty
                                         monitoring and control applications to support the needs of cultivators. Argus&rsquo;
                                         systems are used in horticulture and biotechnology research facilities, universities,
                                         aquaculture and aquaponics, and many other custom control applications at sites throughout
                                         the world.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>In
                                         the fourth quarter of 2019, we renewed our multi-year strategic agreement with Argus
                                         to provide cultivators in North America with industry-leading, plant-centric solutions
                                         for environmental control, automation, and nutrient management.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>We
                                         have worked with Argus on over 50 projects and the extended agreement demonstrates both
                                         companies&rsquo; commitment to client success through early and ongoing collaboration
                                         with cultivators throughout their project lifecycles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Desert
                                         Aire manufactures commercial and industrial humidity and climate control systems, including
                                         their purpose-built GrowAire&trade; solution which has been designed specifically to
                                         meet the sensible and latent needs of indoor growing climates in the CEA space.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>In
                                         the first quarter of 2020, we signed an agreement with Desert Aire to be a Systems Integration
                                         National Account within the agriculture market.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We have not experienced
any material changes in the availability of equipment systems and products from Fluence, Argus, or Desert Aire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sales And Marketing Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Sales Overview</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our sales team is comprised of one Executive
Vice President, one Director of Enterprise Solutions, three Directors of Sales, one Sales Operations Manager, and one Sales Associate.
The Directors of Sales, serving as &ldquo;relationship ambassadors,&rdquo; are located across the United States and are tasked
with cultivating leads, generating and supporting sales, and managing client relationships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">With the experience garnered from providing
engineering and design services to over 300 CEA projects, and our continued research on finding best-in-class complex equipment
solutions, our clients choose to work with us because our team custom tailors a solution to address the client&rsquo;s unique
combination of process flow, complex environmental systems, cultivation equipment solutions, and any potential sensitivities of
the crop.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">When potential clients express an interest
in our solution, we provide them with a technical expert, referred to as a sales engineer, who can quickly and effectively explain
a proposed solution to resolve the client&rsquo;s specific challenges. We believe this technical sales process requires true segment
expertise, which we also believe has not been readily available to indoor cultivators. Our team includes talented and experienced
individuals including licensed Professional Engineers, as well as individuals with Masters Degrees in Business Administration,
Plant Science, Horticulture, and post-secondary degrees in Environmental Science, Horticulture, Agricultural Engineering, and
Electrical/Mechanical/Controls Engineering. We leverage these technical experts in their areas of expertise to continually find
and vet what we believe are the best-in-class solutions, and then educate and inform our clients on best solution use and techniques.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">In addition to leads generated from the
execution of our marketing strategy, for additional new business opportunities, we focus on referrals generated from our relationships
with industry partners and from contract referral agents. By offering a referral program to consultants whose primary business
model is to help their clients set up cultivation facilities from the design stage through cultivation, we ensure access to a
strong network of cultivators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Sales Cycle and Average Revenues and Gross Margins</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We generate revenue and profits based
on selling engineering design and managed services, as well as the sale of complex environmental and cultivation equipment systems,
and other service revenue products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Sales Cycle</B>. At the outset of a
client design project, we utilize a proprietary project estimation tool that accounts for multiple variables relating to the size
and complexity of the new or retrofitted facility. This tool optimizes the facility layout, taking into consideration the initial
costs of all custom cultivation equipment systems as well as the ongoing operational costs associated with labor and utilities
required to move the crop, in order to establish a facility that meets the objectives of the client. After the project estimate
is determined, a design fee and project deposit are determined. The design fee is dependent on the desired design services and
on the complexity of the overall project, including facility and canopy size, type and complexity of controls and irrigation distribution
system, which is dependent on number of irrigation zones, types of nutrients, and the number of individual plants that require
irrigation. We provide our solution pursuant to a contract that typically requires a project design deposit equal to 50% of the
project estimate, with the remaining balance due prior to delivery of the construction documents, which collectively takes, approximately
twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Following the design stage, we contract
with clients to procure and sell customized equipment systems and cultivation equipment. To begin the procurement process, we
charge a deposit ranging from 20% to 50% of total cost, which varies based on lead time, complexity, and the type of systems.
After the procurement window, which ranges from one week to five months to allow for the manufacturing and assembly of systems,
we charge a final shipment payment for the balance owed, which is due within two weeks of system readiness and prior to shipment.
Following installation of the systems, we dispatch an engineering team for commissioning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Revenues and Gross Profit Margins by
Category</B>. Service Revenues for engineering design services contracts can be hundreds of thousands of dollars, depending on
the spectrum of services desired by the client and the size of the facility. Product Revenues for customized equipment systems
can be millions of dollars, depending on the size of the cultivation facilities, the complexity and types of systems purchased
by the client, and the number of systems purchased by the client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our targeted gross profit margins on engineering
design services range from thirty to sixty percent. Our targeted gross profit margins on customized equipment systems range from
the mid-teens to mid-thirty percent depending on the type of system being sold. Gross profit margins on both revenue categories
are heavily dependent on the complexity and size of the project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Clients</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> We primarily market and sell our products
and services to CEA operators and facilitators in the United States and Canada. Our historical client base has been comprised
of indoor commercial cultivators seeking to grow high-quality cannabis crops. Since launching the engineering and design division
in 2018, we have designed and assisted in the build-out of 300+ projects for some of the largest independent and multi-state operators
in both the United States and Canada. Although the cannabis market has been our historical target market and an unknown but substantial
portion of all of our revenues to date have been generated from clients in the cannabis industry, we are seeking to diversify
our client base by expanding our reach within CEA. The term &ldquo;plant-based medicines&rdquo; includes (i) a wide array of herbal
supplements including but not limited to curcumin, saffron extract and ginger, (ii) CBD based therapeutics, (iii) cannabis based
therapeutics and (iv) a host of medicines derived from plans such as caffeine, menthol, foxglove and others. We are focusing on
expanding to the vertical farming CEA sub-segment, which is ultimately and predominantly used for the cultivation of a variety
of crops including, but not limited to, leafy greens, herbs, cucumbers, peppers, and strawberries. During 2020, we also continued
exploring the potential demand for our solutions in select countries, including those within Latin America and Europe. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Marketing Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We provide our clients with equipment
and service solutions for their facility that empowers their success for the life of their grow &mdash; from early stage facility
programming, engineering design, and the integration of complex equipment systems, through commissioning / facility start-up services.
Our team of engineers and experts understand the highly regulated market, challenges, and opportunities unique to cultivators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Marketing serves two general purposes
at urban-gro &ndash; brand image and lead generation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Brand Image</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our marketing strategy is to position
urban-gro as a leading engineering and design services company that integrates complex environmental equipment systems into high-performance
indoor CEA cultivation facilities for the global commercial horticulture market. Managing the clarity of our brand is a key component
of supporting our organization&rsquo;s growth initiatives and lead generation. We support our brand through (i) interviews, (ii)
website, (iii) e-commerce, (iv) events, and (v) corporate responsibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Interviews</B>. We retain a public
relations firm to amplify our business objectives through earned media to support of our corporate activities and marketing functions.
The focus of our publicity efforts is to engage and inform key audiences, build relationships, and provide vital feedback for
analysis and action. Our spokespeople have received media training and are briefed prior to each interview.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Website</B>. Our online experience
supports our brand by being both educational and transactional. By applying an established set of key metrics, user activity on
the website is used to generate Marketing Qualified Leads (&ldquo;MQL&rdquo;) to be passed to the sales team for engagement. With
the technology advancements and market expansion into CEA, our website offers educational content for investors, managers, and
cultivators to ensure they are considering key facility programming, design, and engineering aspects critical to high-performance
buildings. Given our team&rsquo;s early involvement with indoor cultivation, our experts are uniquely positioned to share knowledge,
thereby qualifying us for future projects. As a lead-generation tool, the urban-gro website produces qualified, trackable sales
leads. The leads move through the qualification and nurture process before being passed to sales and engaged by the appropriate
contact for advancement through the sales funnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Events</B>. In the era of COVID-19,
events and tradeshows have changed dramatically. Now virtual experiences, we participate in select events promoting thought leadership
through speaking and participation on panels. Event sponsorship is carefully evaluated with clear goals and objectives established
ahead of time. Participation in events must meet the following three-part qualification criteria: 1) engaging with potential clients
during and after the event, 2) building a network of collaborative design and construction firms across North America, and 3)
repurposing event content and delivering across our digital media platforms as curated content. According to Freeman, a top leader
in event logistics, in-person events are anticipated to resume in the second quarter 2021 at the earliest. This is subject to
change based upon the developments of COVID-19 in the fall and winter of 2020-2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Corporate Responsibility</B>. We leverage
our leadership position in the market as an opportunity to promote our corporate values of inclusion, innovation, and connection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><U>Inclusion</U></B>:
                                         Internally, we hire and promote underrepresented communities in STEM (science, technology,
                                         education, mathematics). Our project design and engineering teams reflect our commitment
                                         as demonstrated by leadership positions held by women across our project design, project
                                         management, and client engagement departments.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><U>Innovation</U></B>:
                                         CEA is an industry that is rapidly advancing, testing, and adopting new technologies.
                                         Our corporate development team works closely with our project design and engineering
                                         teams to vet new products and ensure they align with our corporate responsibility needs.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><U>Connection:
                                         </U></B>Through our outreach efforts across the United States and Canada, we represent
                                         a company committed to the development and nurturing of a deeper understanding across
                                         all disciplines of CEA, food production, and being on the leading edge of emerging industry-related
                                         innovations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>We
                                         have been a long-time supporter of HeroGrown, an organization that provides Veterans,
                                         First Responders, and their families with free access to benefit-rich CBD. Through &ldquo;Operation
                                         CBD Drop,&rdquo; HeroGrown provides an alternative to those struggling with addiction
                                         to deadly drugs prescribed for service-related injuries and psychological disorders.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Through
                                         our Client Appreciation Events at major tradeshows across North America, we raise awareness
                                         and funds for local charities. These events serve as opportunities for non-profits to
                                         bolster career opportunities, economic development, veteran health and housing, and other
                                         causes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Lead Generation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We generate interest in our services and
equipment solutions through a strategic approach to lead generation combining owned, earned, and paid marketing activities. These
lead generation campaigns include advertising, contributed articles and news stories, newsletters, referral agreements, social
media, and tradeshows / webinars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Advertising (Traditional and Digital)</B>:
We advertise with traditional print media outlets, as well as digitally through targeted pay-per-click campaigns. Ad components
include educational offerings as well as a clear call-to-action. Social media promotion is also leveraged as a part of the overall
advertising strategy but on a very targeted basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Contributed Articles and News Stories</B>:
Contributed articles and news stories support and further our reputation and showcase our expertise in key areas of facility programming,
engineering design, and facility operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Newsletters</B>: We provide a free
newsletter which provides insight into cultivation practices, product promotions, and client spotlights. These newsletters are
a great opportunity to educate the audience on our full extent of services and products, as well as demonstrate how we add value
through expert experience and oversight.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Referral Agreements</B>: Third-party
endorsements are powerful referral systems for lead generation. We have developed agreements with key influencers and affiliated
industry companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Social Media</B>: As a part of our
digital marketing efforts, we produce original and curated content across our social channels including Instagram, Facebook, LinkedIn,
and TikTok.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Trade Shows, Webinars and Panel Discussions</B>:
Tradeshows in the age of COVID-19 have been transformed into virtual events. We participate in select events as speakers and panel
participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Growth Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white">Our employees
and the application of their acquired knowledge is our most valuable asset as an organization. Our growth strategy involves leveraging
this considerable strength as a basis for growth across three pillars of focus and exploration. These three pillars allow us to
continue to provide value to our current and future clients:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #222222"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD>Expertise as a Service</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Expansion of Geographical Reach</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Expansion within the&nbsp;Commercial Horticulture Segment</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white"><B>1. Expertise
as a Service</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; background-color: white">We have always
aimed to provide the highest level of service and expertise to our clients from initial cultivation ideation to helping prior
to go-live to proactively solve for issues that may arise once operations begin and continue at their facilities. Our commissioning
and training services allow our clients to manage, operate and perform at the highest level throughout their entire cultivation
lifecycle once they are up and running.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt"><B>2. Expansion of Geographical Reach</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">While we will continue to establish our
end-to-end solution as the industry standard for CEA indoor cultivation, we intend to continue to focus on integrating our expertise
and service offerings with the best available technologies to allow our clients to achieve operational superiority and profitability.
While we believe that the U.S. market will experience continued strength, and this will represent significant growth opportunities
for us, we also intend to expand our reach within Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt"><B>European Expansion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"> Historically,
our business has found success with clients in Canada and states within the United States.&nbsp; While North America currently
presents the dominant opportunity for indoor new build and retrofit CEA facilities , the European CEA market, especially in the
vertical farming sub-segment, is rapidly expanding. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 22.3pt; background-color: white"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We first entered the European market
in early 2020, through key partners who have brought us into opportunities as a value-added component to their own sales cycle.
We have demonstrated the transferability of our expertise to the EU and have closed several deals to provide <STRIKE>value</STRIKE>
solution services to European clients.&nbsp;&nbsp;&nbsp;Further, in Switzerland, where the majority of our engineering and design
contracts were signed, the plant-based medicines market (hemp-derived CBD) has shown a strong, positive response for our solutions.&nbsp;&nbsp;Based
on our due diligence, we believe that the most common facilities in demand in this market will mirror that of our niche &ndash;
indoor, CEA, GMP-certified operations. We will look to capitalize on our current approach and expand our reach into Europe with
our services and products through a staged and cost-efficient approach by first entering the market through our strong partnerships
and leveraging our existing U.S.-based engineering expertise and overhead. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The term &ldquo;plant-based medicines&rdquo;
includes (i) a wide array of herbal supplements including but not limited to curcumin, saffron extract and ginger, (ii) CBD based
therapeutics, (iii) cannabis based therapeutics and (iv) a host of medicines derived from plans such as caffeine, menthol, foxglove
and others. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt; color: #222222"><B>Approach to Market
Expansion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Due to the rapid development of the European
market and the lack of established companies experienced in the design, construction, and operations of indoor cultivation facilities,
we will make a strategic and staged entry into the European market to ensure a sustainable use of resources and capital. The market
entry will be designed around a three-phased approach:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Phase
                                         One &ndash; Focus on establishing a client base and pipeline surrounding early license
                                         applicants and current license holders by providing facility and systems design for indoor
                                         projects.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Phase
                                         Two &ndash; Building on established vendor relationships, integrate purpose-built custom
                                         environmental equipment systems from U.S. manufacturers into our European offering.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Phase
                                         Three &ndash; Incorporate the development of the initial two phases combined with the
                                         partnerships, joint ventures, and domestic manufacturing of equipment to provide a turn-key
                                         project solution offering in Europe.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We believe the three-phased approach,
paired with the evolution of partnerships and domestic equipment manufacturing, will establish us as an experienced leader and
solution provider in the design, engineering, and turn-key systems for the European indoor CEA market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>3. <FONT STYLE="color: #222222">Expansion
within the&nbsp;Commercial Horticulture Segment</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Utilizing our in-house engineering capabilities
and synergies, we confidently believe that we can efficiently expand our diversification to include working on projects in the
CEA indoor vertical farming market segment in both the North American and European markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt"><B>Global CEA Vertical Farming Segment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">CEA vertical farm facilities for cultivation
are typically indoor warehouse farms and plant factories that are in purpose-built or retrofitted facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">According to Allied Market Research, the
global vertical farming market is estimated to reach $12.8 billion by 2026, with a compounded annual growth rate of 24.6% from
2019 to 2026. The market for non-container facilities&mdash;on which we already focus and have had success&mdash;is forecasted
to grow even faster. This rate of growth forecast is buttressed by the fact that more and more food will be needed closer to where
population resides, and CEA eliminates many of the risks of traditional agriculture, minimizing risk and allowing localities to
be closer and control their food supply more readily.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Market Entry</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our end-to-end approach, solutions, and
expertise are applicable for and valuable to clients creating high performance indoor vertical farms to cultivate high value crops
such as leafy greens, micro-greens, herbs, peppers, or even floriculture. After studying the opportunity over the last two quarters,
we see relatively few barriers to entry as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our engineers&rsquo;
                                         design expertise in indoor CEA seamlessly flows through to indoor vertical farming facilities;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our experts&rsquo;
                                         backgrounds are predominantly built on a commercial horticulture foundation; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our acquired
                                         expertise in engineering over 300 indoor CEA projects with the highest valued crop in
                                         the world will allow us to design high performance vertical farms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our approach to entering this market will
follow what we have done as we entered Europe &ndash; we will continue to reinforce our core strengths as we expand into new markets
through our partnerships. The first phase of entering this CEA market will be as a value-add to our partners who already successfully
sell to this market in North America. As we find success here, we will look to continue to partner to accelerate our reach and
begin to supply much of the equipment needed to build out a facility, and finally, after identifying and solving for any potential
gaps, we will look to offer turn-key, end-to-end design, engineer, and build services for indoor CEA facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><B>Acquisition Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">While entering any new market can be challenging,
we believe that our existing brand combined with the strength of our partnerships and expertise will allow us to capture a meaningful
amount of this market through targeting the most sophisticated, well-funded producers who are in need of a partner that has a
demonstrated history of success growing crops in this way.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">To speed up our expansion plan, and with
the intention of forming strategic relationships to assist in lead generation, we plan to place investments in; or acquire horticulture-related
positive cash flow entities at discounted prices based upon the synergistic upside available for both organizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">While we feel that our complex end-to-end
solution places us as a leader in the CEA segment, we do face competition from companies that offer some, but not all, portions
of an all-encompassing facility package. Further, these companies often outsource to third-parties for the integration and
sale of equipment systems and products, particularly within the cannabis industry. We also compete with other smaller and mid-sized
companies that focus primarily on either engineering design services or product sales. Within the services space, there are
several product- or services-specific competitors that offer similar services, such as MEP services or basic fertigation design.
Currently, we view our competition to be focused on equipment sales that are predominantly commodity &ldquo;off-the-shelf&rdquo;
items like lighting and other cultivation staple products, both pre- and post-startup. This competition comes from traditional
wholesale horticulture dealers, online retailers, and some manufacturers who sell direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Greenhouse manufacturers and European
systems integrators may increasingly seek to offer comprehensive product and service solutions to compete with our integrated
solution, but they are primarily focused on the greenhouse industry, and not on indoor CEA facilities. European systems integrators,
in particular, are experienced and have a strong operating history in traditional horticulture and provide specialized, intensive,
and large-scale solutions that revolve around greenhouse projects. Instead of competing with these integrators, we find ourselves
working with them, and combining synergies to work on projects together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Further, although we frequently partner
with direct manufacturers to deliver our customized solution, these manufacturers may seek to engage with clients directly to
deliver their products. In addition, we sometimes compete with electrical contractors with respect to specific components of facility
engineering and design.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> As the cannabis market continues to
mature and develop and legalization becomes more prevalent, we expect to see more competition from cannabis-focused agricultural
product and service providers. Going forward, our focus is non-cannabis crops. These companies may have longer operating histories,
greater name recognition, larger client bases and significantly greater financial, technical, sales and marketing resources. These
competitors may adopt more aggressive pricing policies and make more attractive offers to existing and potential clients, employees,
strategic partners, distribution channels and advertisers. Increased competition is likely to result in price reductions, reduced
gross margins and a potential loss of market share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>Regulation</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>U.S. Regulations</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> While we do not generate any revenue
from the direct sale of cannabis products, we have historically, and may continue to, offer our solutions to indoor cultivators
that are engaged in various aspects of the cannabis industry. Marijuana is a Schedule I controlled substance and is illegal under
federal law. Even in those states in which the use of marijuana has been legalized, its use remains a violation of federal laws. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> A Schedule I controlled substance is
defined as a substance that has no currently accepted medical use in the United States, a lack of safety for use under medical
supervision and a high potential for abuse. The Department of Justice defines Schedule I controlled substances as &ldquo;the most
dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.&rdquo; If the federal
government decides to enforce the Controlled Substances Act with respect to marijuana, persons that are charged with distributing,
possessing with intent to distribute, or growing marijuana could be subject to fines and terms of imprisonment, the maximum being
life imprisonment and a $50 million fine. Any such change in the federal government&rsquo;s enforcement of current federal laws
could cause significant financial damage to us. While we do not intend to harvest, distribute or sell cannabis, we may be irreparably
harmed by a change in enforcement by the federal or state governments. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Previously, the Obama administration
took the position that it was not an efficient use of resources to direct federal law enforcement agencies to prosecute those
lawfully abiding by state-designated laws allowing the use and distribution of medical marijuana. The Trump administration revised
this policy but made no major changes in enforcement. Specifically, Attorney General Sessions vacated the Cole Memorandum in favor
of deferral of any enforcement of federal regulation to the individual states&rsquo; Department of Justice or U.S. Attorney. However,
certain other protections remain in place via budgetary element embedment (the Rohrabacher-Farr amendment, now referred to as
the Rohrabacher-Blumenauer Amendment), which limits funding of any enforcement of anti-cannabis legislation. The Department of
Justice has stated that it will continue to enforce the Controlled Substances Act with respect to marijuana to prevent: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> the
                                         distribution of marijuana to minors; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> criminal
                                         enterprises, gangs and cartels receiving revenue from the sale of marijuana; </TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> the
                                         diversion of marijuana from states where it is legal under state law to other states; </TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> state-authorized marijuana activity from being used as a cover or pretext for the
                                                                                                                     trafficking of other illegal drugs or other illegal activity; </TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> violence
                                         and the use of firearms in the cultivation and distribution of marijuana; </TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> driving while impaired and the exacerbation of other adverse public health consequences
                                                                                                                     associated with marijuana use; </TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> the
                                         growing of marijuana on public lands; and </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> marijuana
                                         possession or use on federal property. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Since the use of marijuana is illegal
under federal law, most federally chartered banks will not accept deposit funds from businesses involved with marijuana. Consequently,
businesses involved in the marijuana industry generally bank with state-chartered banks and credit unions to provide banking to
the industry. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Although cultivation and distribution
of marijuana for medical use is permitted in many states, provided compliance with applicable state and local laws, rules, and
regulations, marijuana is illegal under federal law. Strict enforcement of federal law regarding marijuana would likely result
in a material adverse effects on our business and revenues. Though the cultivation and distribution of marijuana remains illegal
under federal law, H.R. 83, enacted by Congress on December 16, 2014, provides that none of the funds made available to the DOJ
pursuant to the 2015 Consolidated and Further Continuing Appropriations Act may be used to prevent states from implementing their
own laws that authorize the use, distribution, possession, or cultivation of medical marijuana. While it this appropriations measure
continued in 2016, 2017, 2018, 2019 and 2020, and remains in effect, continued re-authorization cannot be guaranteed. If this
appropriations rider is no longer in effect, the risk of federal enforcement and override of state marijuana laws would increase.
However, state laws do not supersede the prohibitions set forth in the federal drug laws. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> In order to participate in either the
medical or adult use sides of the marijuana industry in Colorado and elsewhere, all businesses and employees must obtain licenses
from the state and, for businesses, local jurisdictions. Colorado issues four types of business licenses including cultivation,
manufacturing, dispensing, and testing. In addition, all owners and employees must obtain an occupational license to be permitted
to own or work in a facility. All applicants for licenses undergo a background investigation, including a criminal record check
for all owners and employees. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Colorado has also enacted stringent
regulations governing the facilities and operations of marijuana businesses. All facilities are required to be licensed by the
state and local authorities and are subject to comprehensive security and surveillance requirements. In addition, each facility
is subject to extensive regulations that govern its businesses practices, which includes mandatory seed-to-sale tracking and reporting,
health and sanitary standards, packaging and labeling requirements, and product testing for potency and contaminants. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Laws and regulations affecting the
medical marijuana industry are constantly changing, which could detrimentally affect our proposed operations. Local, state and
federal medical marijuana laws and regulations are broad in scope and subject to evolving interpretations, which could require
us to incur substantial costs associated with compliance or alter our business plan. In addition, violations of these laws, or
allegations of such violations, could disrupt our business and result in a material adverse effect on our operations. It is also
possible that regulations may be enacted in the future that will be directly applicable to our business. We cannot predict the
nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental
regulations or administrative policies and procedures, when and if promulgated, could have on our business. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>Canadian Regulations</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Summary of the Cannabis Act</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> On October 17, 2018, the Cannabis Act
came into force as law with the effect of legalizing adult recreational use of cannabis across Canada. The Cannabis Act replaced
the Access to Cannabis for Medicinal Purposes Regulations (&ldquo;ACMPR&rdquo;) and the Industrial Hemp Regulations, both of which
came into force under the Controlled Drugs and Substances Act (Canada) (the &ldquo;CDSA&rdquo;), which previously permitted access
to cannabis for medical purposes for only those Canadians who had been authorized to use cannabis by their health care practitioner.
The ACMPR replaced the Marihuana for Medical Purposes Regulations (Canada) (the &ldquo;MMPR&rdquo;), which was implemented in
June 2013. The MMPR replaced the Marihuana Medical Access Regulations (Canada) (the &ldquo;MMAR&rdquo;) which was implemented
in 2001. The MMPR and MMAR were initial steps in the Government of Canada&rsquo;s legislative path towards the eventual legalization
and regulating recreational and medical cannabis. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> The Cannabis Act permits the recreational
adult use of cannabis and regulates the production, distribution and sale of cannabis and related oil extracts in Canada, for
both recreational and medical purposes. Under the Cannabis Act, Canadians who are authorized by their health care practitioner
to use medical cannabis have the option of purchasing cannabis from one of the producers licensed by Health Canada and are also
able to register with Health Canada to produce a limited amount of cannabis for their own medical purposes or to designate an
individual who is registered with Health Canada to produce cannabis on their behalf for personal medical purposes. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Pursuant to the Cannabis Act, subject
to provincial regulations, individuals over the age of 18 are be able to purchase fresh cannabis, dried cannabis, cannabis oil,
and cannabis plants or seeds and are able to legally possess up to 30 grams of dried cannabis, or the equivalent amount in fresh
cannabis or cannabis oil. The Cannabis Act also permits households to grow a maximum of four cannabis plants. This limit applies
regardless of the number of adults that reside in the household. In addition, the Cannabis Act provides provincial and municipal
governments the authority to prescribe regulations regarding retail and distribution, as well as the ability to alter some of
the existing baseline requirements of the Cannabis Act, such as increasing the minimum age for purchase and consumption. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Provincial and territorial governments
in Canada have made varying announcements on the proposed regulatory regimes for the distribution and sale of cannabis for adult-use
purposes. For example, Qu&eacute;bec, New Brunswick, Nova Scotia, Prince Edward Island, Yukon and the Northwest Territories have
chosen the government-regulated model for distribution, whereas Saskatchewan and Newfoundland &amp; Labrador have opted for a
private sector approach. Alberta, Ontario, Manitoba, Nunavut and British Columbia have announced plans to pursue a hybrid approach
of public and private sale and distribution. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> In connection with the new framework
for regulating cannabis in Canada, the federal government has introduced new penalties under the Criminal Code (Canada), including
penalties for the illegal sale of cannabis, possession of cannabis over the prescribed limit, production of cannabis beyond personal
cultivation limits, taking cannabis across the Canadian border, giving or selling cannabis to a youth and involving a youth to
commit a cannabis-related offence. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp;&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> On July 11, 2018, the Canadian federal
government published regulations in the Canada Gazette to support the Cannabis Act, including the Cannabis Regulations, the new
Industrial Hemp Regulations, along with proposed amendments to the Narcotic Control Regulations and certain regulations under
the Food and Drugs Act (Canada). The Industrial Hemp Regulations and the Cannabis Regulations, among other things, outline the
rules for the legal cultivation, processing, research, analytical testing, distribution, sale, importation and exportation of
cannabis and hemp in Canada, including the various classes of licenses that can be granted, and set standards for cannabis and
hemp products. The Industrial Hemp Regulations and the Cannabis Regulations include strict specifications for the plain packaging
and labelling and analytical testing of all cannabis products as well as stringent physical and personnel security requirements
for all federally licensed production sites. The Industrial Hemp Regulations and the Cannabis Regulations also maintain a distinct
system for access to cannabis. With the Cannabis Act now in force, cannabis has ceased to be regulated under the CDSA and is instead
regulated under the Cannabis Act, and both the ACMPR and the Industrial Hemp Regulations have been repealed effective October
17, 2018. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> On June 7, 2018, Bill-C45 passed the
third reading in the Senate with a number of amendments to the language of the Cannabis Act. More specifically, the Senate proposed: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> establishing
                                         a committee of the Senate and a committee of the House of Commons to undertake a comprehensive
                                         review of the administration and operation of the Cannabis Act; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> assisting
                                         provinces and territories to facilitate the development of workplace impairment policies; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> allowing
                                         provinces to place restrictions on the ability of individuals to engage in home cultivation; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> that
                                         law enforcement be provided with the appropriate tools and resources to address concerns
                                         about continued illicit production, diversion, and sale of cannabis to youth, including
                                         preventing the sharing of marihuana among young adults by rendering it a ticketable offense; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> that
                                         the prices set for cannabis products and the applicable taxes reflect the dual objective
                                         of minimizing the health dangers of cannabis consumption and undercutting the illicit
                                         market of cannabis; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> mandatory
                                         health warnings for cannabis products, including warnings about the danger of smoking
                                         cannabis, the danger of exposure to second-hand cannabis smoke, and the risks of combining
                                         cannabis and tobacco; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> testing
                                         procedures for THC content be standardized to ensure accurate measurement to better protect
                                         consumer health and safety; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> that
                                         forthcoming regulations for edible products and other forms of cannabis ensure that product
                                         packaging is child-resistant and does not appeal to young people, and that the type of
                                         available products should be strictly limited; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> adequate
                                         and ongoing funding for sustained, evidence-based cannabis education and prevention programs
                                         to provide Canadians, especially young Canadians, with knowledge about the health risks
                                         of cannabis use, including on-going research initiatives on the impact of cannabis use
                                         on the developing brain; and that the federal government commit to on-going educational
                                         initiatives to ensure youth are informed on the effects of cannabis use; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> to
                                         prohibit licensees under the Cannabis Act to distribute branded merchandise, such as
                                         t-shirts and baseball caps and imposing a moratorium on loosening the regulations on
                                         the branding, marketing, and promotion of cannabis for 10 years; </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> to
                                         set aggressive targets, comparable to the successful Federal Tobacco Control Strategy,
                                         to reduce the number of youth and adult cannabis users; and </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"> <FONT STYLE="font-family: Symbol">&middot;</FONT> </TD><TD STYLE="text-align: justify"> to
                                         ensure that the Cannabis Tracking System be operational upon the coming-into-force of
                                         the Cannabis Act. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Security Clearances</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> The Cannabis Regulations require that
certain people associated with cannabis licensees, including individuals occupying a &ldquo;key position&rdquo; directors, officers,
large shareholders and individuals identified by the Minister of Health, must hold a valid security clearance issued by the Minister
of Health. Officers and directors of a parent corporation must be security cleared. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Under the Cannabis Regulations, the
Minister of Health may refuse to grant security clearances to individuals with associations to organized crime or with past convictions
for, or an association with, drug trafficking, corruption or violent offences. Individuals who have histories of nonviolent, lower-risk
criminal activity (for example, simple possession of cannabis, or small-scale cultivation of cannabis plants) are not precluded
from participating in the legal cannabis industry, and the grant of security clearance to such individuals is at the discretion
of the Minister of Health and such applications will be reviewed on a case-by-case basis. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Cannabis Tracking System</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> Under the Cannabis Act, the Minister
of Health is authorized to establish and maintain a national cannabis tracking system. The Cannabis Regulations set out a national
cannabis tracking system to track cannabis throughout the supply chain to help prevent diversion of cannabis into, and out of,
the illicit market. The Cannabis Regulations also provides the Minister of Health with the authority to make a ministerial order
that would require certain persons named in such order to report specific information about their authorized activities with cannabis,
in the form and manner specified by the Minister of Health. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <I>Cannabis Products</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"> The Cannabis Regulations set out the
requirements for the sale of cannabis products at the retail level permit the sale of dried cannabis, cannabis oil, fresh cannabis,
cannabis plants, and cannabis seeds, including in such forms as &ldquo;pre-rolled&rdquo; and in capsules. The THC content and
serving size of cannabis products is limited by the Cannabis Regulations. The sale of edibles containing cannabis and cannabis
concentrates was not initially permitted, however the federal government anticipates that such products will be legalized within
one year following the coming into force of the Cannabis Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The success of our business depends, in
part, on our ability to maintain and protect our proprietary technologies, information, processes and know-how. We rely primarily
on patent, trademark, copyright and trade secret laws in the U.S. and similar laws in other countries, confidentiality agreements
and procedures and other contractual arrangements to protect our technology. Our patents are limited to certain sensors that
we obtain from third party manufacturers that do not contribute materially to our sales or profitability. Our trademarks are solely
for branding purposes, although we no longer sell any goods or services under the Soleil brand. As of the date of this prospectus,
the following summarizes the status of our registrations, pending applications, issued U.S. patents and one published U.S. patent
application:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Trademarks</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We have received the following trademark
registrations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 20%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trademark</U></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction</U></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
    Number</U></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
    Date</U></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Status</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4618322</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    7, 2014</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3266415</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    19, 2018</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European
    Union</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">017391806</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, 2018</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WIPO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1548013</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    08, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5209707</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    23, 2017</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3266410</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    09, 2018</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1083969</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    07, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European
    Union</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">017391781</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    11, 2018</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPTI-DURA</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5770091</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    4, 2019</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPTI-DURA</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TMA1070145</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    20, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">We have applied for and are awaiting receipt
of the following trademark registrations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 20%; border: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction</FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
    Number</FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    Date</FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1930075</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    13, 2018</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada
    (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0098111</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    08, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European
    Union (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0098111</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    08, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.&nbsp;&nbsp;Examination
    Completed.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0098111</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    08, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gro-care</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88898692</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    03, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gro-care</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WIPO</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0099548</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    24, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gro-care</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada
    (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0099548</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    24, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gro-care</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">European
    Union (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0099548</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    24, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gro-care</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom (Madrid)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A0099548</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    24, 2020</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL
    GIVES YOUR CROP A VOICE</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87671876</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    3, 2017</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowed
    &ndash; Intent to Use</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOLEIL
    GIVES YOUR PLANTS A VOICE</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87671878</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    3, 2017</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowed
    &ndash; Intent to Use</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Patents</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #D9D9D9">
    <TD STYLE="border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Title</U></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction</U></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Application
    Number</U></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Filing
    Date</U></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Patent
    Number and Issue Date</U></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Status</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sensor
    bus architecture for modular sensor systems</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/626,085</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2017</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,499,123</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December
                                         3, 2019)</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Issued</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Expire in 2037</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modular
    sensor architecture for soil and water analysis at various depths from the surface</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/626,079</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2017</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,405,069</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(September
                                         3, 2019)</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Issued</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Expire in 2037</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modular
    sensor architecture for soil and water analysis at various depths from the surface</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/519,800</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    23, 2019</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Published
    </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We rely on trade secret protection and
confidentiality agreements to safeguard our interests with respect to proprietary know-how that is not patentable and processes
for which patents are difficult to enforce. We believe that many elements of our design and engineering processes involve proprietary
know-how, technology or data that are not covered by patents or patent applications, including technical processes, test equipment
designs, algorithms and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our policy is for our research and development
employees to enter into confidentiality and proprietary information agreements with us to address intellectual property protection
issues and require our employees to assign to us all of the inventions, designs and technologies they develop during the course
of employment with us. However, we might not have entered into such agreements with all applicable personnel, and such agreements
might not be self-executing. Moreover, such individuals could breach the terms of such agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">We attempt to protect our intellectual
property via the deployment of non-disclosure agreements with both prospective clients and business partners as well as licensees.
There are no assurances that these non-disclosure agreements will prevent a third party from infringing upon our rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As of the date of this prospectus, we
employ 42 persons, of which 40 are full-time, and two are part-time. None of our employees are covered by collective bargaining
agreements. We also utilize the services of three electrical engineers, and a number of referral agents. We require all of our
employees and consultants to sign a confidentiality and non-disclosure agreement. We believe that our future success will depend,
in part, on our ability to hire and retain qualified personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Properties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our principal place of business is located
at 1751 Panorama Point, Unit G, Lafayette, Colorado 80026. This location consists of approximately 10,000 square feet, including
approximately 3,500 square feet of office space and 6,500 square feet of warehouse space. This lease will expire on August 31,
2021, unless we elect to exercise the one-year extension, which is exercisable at our discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">As of the date of this prospectus, we
are not involved in any legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --> 55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a14"></A>MANAGEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table sets forth certain
information as of <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date of this prospectus about
our executive officers and members of our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; width: 36%"><B><U>Name</U></B></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 6%; text-align: center"><B><U>Age</U></B></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="vertical-align: bottom; width: 35%"><B><U>Position</U></B></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom">Bradley J. Nattrass</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">48</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Chief Executive Officer and Chairman of the Board</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">Richard A. Akright</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">61</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Chief Financial Officer and Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom">Mark Doherty</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">41</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Executive Vice President &ndash; Operations</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">Daniel Droller</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">40</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Executive Vice President &ndash; Corporate Development</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: top">Jonathan Nassar</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">51</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Executive Vice President &ndash; Sales</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">Brian Zimmerman, PE</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">59</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Executive Vice President &ndash; Engineering</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom">James H. Dennedy</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">55</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Lance Galey</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">41</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: top">James R. Lowe</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">40</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">Lewis O. Wilks</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">67</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Executive Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Bradley J. Nattrass</I></B> is one
of our founders and has been our Chief Executive Officer and our Chairman since March 2017. Mr. Nattrass was our Managing Member
from March 2014 until March 2017 when we converted to a corporation. From October 2015 to August 2016, he was the Managing Member
of enviro-glo, LLC, a Colorado limited liability company engaged in the manufacturing and branding of commercial lighting products.
Previously, from January 2012 through August 2016, he was the Managing Member of Bravo Lighting, LLC, a Colorado limited liability
company engaged in the distribution of commercial lighting products. Mr. Nattrass received a Bachelor of Commerce degree from
the University of Calgary in marketing in 1995 and a Master of Business Administration from the University of Phoenix in 2001.
Mr. Nattrass brings executive leadership experience, organizational experience, and extensive experience in the industry to the
Board. Mr. Nattrass is familiar with the Company&rsquo;s day-to-day operations and performance and the horticulture industry in
general. Mr. Nattrass&rsquo; insight into the Company&rsquo;s operations and performance is critical to Board discussions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Richard (Dick) A. Akright</I></B>&nbsp;was
appointed as our Interim Chief Financial Officer in August 2019 and was appointed as our Chief Financial Officer in December 2019.
He was appointed as a director in February 2020. From August 2018 to present, Mr. Akright has been a director with Akright Group
International LLC, where he performs financial consulting services for small and mid-sized businesses. From May through July 2018,
he was unemployed. From July 2013 through May 2018, he served as Chief Financial Officer for LABS, Inc., a privately held company.
Mr. Akright was a director and chair of the Audit Committee for Koala Corporation (Nasdaq: KARE) in 2003. He has served as Chief
Financial Officer of companies owned by private equity investors and in the top financial position of corporate divisions of publicly
traded companies. He received a Bachelor of Business degree in Accounting from Western Illinois University in 1980 and a Master
of Science in Business Administration from Colorado State University in 1989. Mr. Akright is a former chief financial officer
who brings more than 20 years of executive leadership experience across a variety of industries. In addition, he brings prior
public company director experience to our Board. His prior experience and financial expertise provide the Board with important
insights into business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Mark Doherty</I></B>&nbsp;joined
urban-gro in March 2016 and was appointed as our Executive Vice President of Operations in December 2019. Prior to his appointment,
Mark served urban-gro in the roles of Director of Sales, Director of Project Management and Vice President of Cultivation Technologies.
From 2013 until joining the urban-gro team, Mark served as Managing Partner for MedCann Advisors, a consulting firm focused on
license acquisition in competitive markets. Mark began his career in controlled environment agriculture in 2010 when he founded
Aqua Vita Farms, a 14,000 square foot indoor aquaponic operation producing fish, lettuce, and basil. Mark earned his Bachelor
of Science degree in Business Administration from SUNY Polytechnic Institute and holds a Master of Business Administration from
the State University of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Daniel Droller</I></B> joined urban-gro
in February 2018 and was promoted to Executive Vice President of Corporate Development in August 2018. He has helped oversee our
strategic partnerships and investments. Prior to joining urban-gro, he held various Business Development roles at technology startups,
including MassRoots, Inc. from January 2017 to September 2017 and Chartboost from May 2013 to October 2016. Prior to that, he
led management consulting engagements for Deloitte Consulting. He holds a Bachelor of Arts in Neurobiology from Harvard College
and a Master of Business Administration from Yale School of Management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Jonathan Nassar</I></B>&nbsp;joined
urban-gro in September 2018 as Executive Vice President of Sales where he oversees urban-gro&rsquo;s global sales efforts and
&ldquo;Go to Market&rdquo; strategy.&nbsp;From October 2016 to present, Jonathan was a founder and has served as Chief Executive
Officer of Steelgenix, an advanced building systems company. From December 2014 to December 2016 Jonathan was Senior Vice President
of Sales for Documoto, a cloud-based solutions company. Jonathan has over 25 years of technology leadership and sales experience
and has also been a real estate developer.&nbsp;Jonathan received a Bachelor of Science degree in Business Management from Wesley
College, Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Brian L. Zimmerman, PE</I></B>&nbsp;was
appointed as our Executive Vice President of Engineering in December 2019. Mr. Zimmerman is also President of Impact Engineering,
Inc., where he has served since he formed the company in June 1997. The Company acquired Impact Engineering, Inc. in March of
2019. Mr. Zimmerman has over 30 years of experience as a designer, engineer and owner in the commercial HVAC, plumbing and electrical
engineering markets. Mr. Zimmerman received a Bachelor of Science degree in Mechanical Engineering Technology from Metropolitan
State University in 1989 and passed the Colorado Professional Engineering Exam in 1992. Mr. Zimmerman is a registered Professional
Engineer in Colorado and has Professional Engineering reciprocity in Arizona and California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the principal occupation and employment
experience of Mr. Nattrass and Mr. Akright during the last five years, see &ldquo;&mdash;Executive Officers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>James H. Dennedy</I></B>&nbsp;was
appointed as a director in August 2018. From March 2018 to August 2019, Mr. Dennedy served as Director and Chief Financial Officer
for Interurban Capital Group, a capital investment and management services company. From May 2011 through January 2017, he was
the President and Chief Executive Officer of Agilysys, Inc., a company offering software solutions to the hospitality industry.
Mr. Dennedy served as a director for Agilysys, Inc. (Nasdaq: AGYS) from June 2009 to January 2017. Mr. Dennedy received a Master&rsquo;s
degree in Economics from the University of Colorado, Boulder, a Master of Business Administration from The Ohio State University
and a Bachelor of Science degree in Economics from the U.S. Air Force Academy. Mr. Dennedy has extensive financial, executive
leadership, and organizational experience. Mr. Dennedy also has experience serving as a director of a public company, which brings
important insights into board oversight and corporate governance matters. Mr. Dennedy is chairman of the Company&rsquo;s Audit
Committee and an Audit Committee financial expert with experience in various accounting and financial roles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Lance Galey</I></B>&nbsp;was appointed
as a director in August 2018. Since 2020, Mr. Galey has served as the Chief Software Architect of Autodesk, Inc. From July 2017
to January 2020, Mr. Galey served as Vice President, SaaS Engineering, Oracle Cloud Infrastructure at Oracle. From June 2016 to
July 2017, Mr. Galey was Chief Technology Officer for MassRoots, Inc., a publicly traded company providing a technology platform.
From May 2016 through June 2017, Mr. Galey was the Principal Cloud Architect at Dynamics 365 at Microsoft, Inc. From February
2014 through April 2016, he was Chief Cloud Architect at Autodesk, Inc., where he helped transform their products into strategic
SaaS businesses. From June 2012 through February 2014, he was Vice President and Principal Architect at Salesforce.com, where
he led the architecture and development of numerous core infrastructure services underlying a large portfolio of Salesforce SaaS
applications and was selected as the executive MVP for the technology division of Salesforce.com. Prior to his time at Salesforce,
Mr. Galey served as Chief Architect and Head of OpenStack Engineering of Cloud Services for WebEx, a division of Cisco and as
the Director of Architecture for the Disney Connected and Advanced Technologies division of The Walt Disney Company. Mr. Galey
also served as Senior Program Manager at Microsoft Inc. and began his career at Amazon and Level 3 Communications. He received
a Bachelor of Science degree from Regis University in 2004. Mr. Galey is a seasoned executive with technical and management experience
in the industry in which the Company operates. Mr. Galey brings vital technological expertise to the Board and provides important
insights to our Board regarding the Company&rsquo;s equipment and product offering and the business development of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>James R. Lowe</I></B>&nbsp;was appointed
as a director in August 2018. Mr. Lowe cofounded MJardin Group in 2014 where he served as President of Cultivation, overseeing
all cultivation operations through 2017. Mr. Lowe left MJardin Group to become EVP of Operations of GrowForce, a spinout from
MJardin Group based in Canada focusing on international opportunities. Mr. Lowe is no longer an officer of GrowForce. Mr. Lowe
has served as a director of MJardin Group (CSE: MJAR) (OTCQX: MJARF) since March 2014. He has also been a cultivation advisor
for Lightshade Labs, LLC, where he has provided guidance on cultivation operations since 2012. Mr. Lowe is also the owner of Next1
Labs, a vertically integrated extraction and concentrate business with a multi-acre outdoor farm complex and the one of the largest
producers of live resin products in the state of Colorado. Lastly, Mr. Lowe entered the legal horticulture market in 2009 as the
owner of Cloud9 Support LLC, a retail horticulture supplies and design company that was responsible for over 50 design projects
and construction assists while laying the groundwork for future endeavors. Mr. Lowe brings to the Board significant experience
in the horticulture industry and prior public company director experience within the industry. Mr. Lowe&rsquo;s extensive knowledge
of the industry brings valuable insights to the Board regarding client demand and product offerings. These views add important
insights within discussions of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Lewis O. Wilks</I></B>&nbsp;was
appointed as a director in August 2018. Since 2004, Mr. Wilks has been the Senior Managing Partner at Bright Peaks Venture Capital
LLC, where he oversees the company&rsquo;s investments. In addition, since November 2015, he has been the Executive Chairman of
NCS Analytics, a Denver based company that is implementing its patent pending, predictive analytics engine to provide financial,
regulatory, and audit service to clients with real-time alerts for cash intensive businesses. Since June 2017, he has also been
Chairman of FuseIntel, a company doing intelligence sector analytics. From September 1997 to September 2001, he served as the
Chief Strategy Officer for Qwest Communications. Mr. Wilks received a Bachelor of Science degree in Computer Science from the
University of Central Missouri in 1979. Mr. Wilks brings valuable experience to the Board through his prior management and technical
experience. His business understanding and technological background provide the Board with important insights regarding the Company&rsquo;s
operations, product offering and business development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Governance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Composition of our Board of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our business and affairs are managed under
the direction of our Board. The number of directors will be fixed by our Board, subject to the terms of our certificate of incorporation
and bylaws, which will include a requirement that the number of directors be fixed exclusively by a resolution adopted by directors
constituting a majority of the total number of authorized directors, whether or not there exist any vacancies in previously authorized
directorships. Our Board currently consists of six directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">When considering whether directors and
nominees have the experience, qualifications, attributes or skills, taken as a whole, to enable our Board to satisfy its oversight
responsibilities effectively in light of our business and structure, the Board focuses primarily on each person&rsquo;s background
and experience as reflected in the information discussed in each of the directors&rsquo; individual biographies set forth above.
We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Corporate Governance Profile</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We intend to structure our corporate governance
in a manner we believe closely aligns our interests with those of our stockholders. Notable features of our corporate governance
structure will include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our Board
                                         will not be classified, with each of our directors subject to re-election annually;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we expect
                                         that a majority of our directors will satisfy the Nasdaq listing standards for independence;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>generally,
                                         all matters to be voted on by stockholders will be approved by a majority (or, in the
                                         case of election of directors, by a plurality) of the votes entitled to be cast by all
                                         stockholders present in person or represented by proxy, voting together as a single class;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we intend
                                         to comply with the requirements of the Nasdaq marketplace rules, including having committees
                                         comprised solely of independent directors; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we do
                                         not have a stockholder rights plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our directors will stay informed about
our business by attending meetings of our Board and its committees and through supplemental reports and communications. Our independent
directors will meet regularly in executive sessions without the presence of our corporate officers or non-independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Role of the Board in Risk Oversight</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board actively manages the Company&rsquo;s
risk oversight process and receives periodic reports from management on areas of material risk to the Company, including operational,
financial, legal, and regulatory risks. The Board committees assist the Board in fulfilling its oversight responsibilities in
certain areas of risk. The Audit Committee assists the Board with its oversight of the Company&rsquo;s major financial risk exposures.
The Compensation Committee assists the Board with its oversight of risks arising from the Company&rsquo;s compensation policies
and programs. The Corporate Governance and Nominating Committee assists the Board with its oversight of risks associated with
board organization, board independence, and corporate governance. While each committee is responsible for evaluating certain risks
and overseeing the management of those risks, the entire Board is regularly informed about the risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Director Independence</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Nasdaq marketplace rules require that,
subject to specified exceptions, each member of a listed company&rsquo;s audit, compensation and nominations committees be independent,
or, if a listed company has no nominations committee, that director nominees be selected or recommended for the board&rsquo;s
selection by independent directors constituting a majority of the board&rsquo;s independent directors. The Nasdaq marketplace
rules further require that audit committee members satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act
and that compensation committee members satisfy the independence criteria set forth in Rule 10C-1 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to the completion of this offering,
our Board undertook a review of the independence of our directors and considered whether any director has a material relationship
with us that could compromise that director&rsquo;s ability to exercise independent judgment in carrying out that director&rsquo;s
responsibilities. Our Board has affirmatively determined that each of Messrs. Dennedy, Galey, Lowe and Wilks qualify as an independent
director, as defined under the applicable corporate governance standards of Nasdaq. These rules require that our Audit Committee
be composed of at least three members, one of whom must be independent on the date of listing on Nasdaq, a majority of whom must
be independent within 90 days of the effective date of the registration statement containing this prospectus, and all of whom
must be independent within one year of the effective date of the registration statement containing this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Board Leadership</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The offices of the chairman of the Board
and chief executive officer are currently combined. Mr.&nbsp;Nattrass serves as the Company&rsquo;s chairman and chief executive
officer. The Board believes that this structure is the most appropriate structure at this time for several reasons. Mr.&nbsp;Nattrass
is responsible for the day-to-day operations of the Company and the execution of its strategies. Since these topics are an integral
part of Board discussions, Mr.&nbsp;Nattrass is the director best qualified to chair those discussions. In addition, Mr.&nbsp;Nattrass&rsquo;
experience and knowledge of the Company and the industry are critical to Board discussions and the Company&rsquo;s success. The
Board believes that Mr.&nbsp;Nattrass is well qualified to serve in the combined roles of chairman and chief executive officer
and that Mr.&nbsp;Nattrass&rsquo; interests are sufficiently aligned with the stockholders he represents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board does not have a lead independent
director. To help ensure the independence of the Company&rsquo;s Board, the independent directors of the Board generally meet
without members of management at various times during the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Board Committees and Meetings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board has established three standing
committees, the Audit Committee, the Compensation Committee, and the Corporate Governance and Nominating Committee, to assist
it with the performance of its responsibilities. The Board designates the members of these committees and the committee chairs
based on the recommendation of the Corporate Governance and Nominating Committee. The Board has adopted written charters for each
of these committees, which can be found at the investor relations section of our website at http://urban-gro.com. Copies are also
available in print to any stockholder upon written request to urban-gro, Inc., 1751 Panorama Point, Unit G, Lafayette, Colorado
80026, Attention: Corporate Secretary. The chair of each committee develops the agenda for that committee and determines the frequency
and length of committee meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board held five meetings during 2020.
Directors are expected to attend Board meetings, the Annual Meeting of Stockholders and meetings of the committees on which they
serve, with the understanding that on occasion a director may be unable to attend a meeting. During 2020, each director attended
75% or more of the aggregate of the total number of meetings of the Board. During 2020, each director attended 75% or more of
the aggregate of the total number of meetings held by all committees of the Board on which such director then served. Every director
then serving attended the 2020 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Audit Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Board has established an Audit Committee,
which as of the date of this prospectus consists of three independent directors, Mr. Dennedy (Chairperson), Mr. Wilks and Mr.
Galey. The Audit Committee held two meetings during 2020. The committee&rsquo;s primary duties are to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>review
                                         and discuss with management and our independent auditor our annual and quarterly financial
                                         statements and related disclosures, including disclosure under &ldquo;Management&rsquo;s
                                         Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; and
                                         the results of the independent auditor&rsquo;s audit or review, as the case may be;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>review
                                         our financial reporting processes and internal control over financial reporting systems
                                         and the performance, generally, of our internal audit function;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>oversee
                                         the audit and other services of our independent registered public accounting firm and
                                         be directly responsible for the appointment, independence, qualifications, compensation
                                         and oversight of the independent registered public accounting firm, which reports directly
                                         to the Audit Committee;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>provide
                                         an open means of communication among our independent registered public accounting firm,
                                         management, our internal auditing function and our Board;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>review
                                         any disagreements between our management and the independent registered public accounting
                                         firm regarding our financial reporting;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>prepare
                                         the Audit Committee report for inclusion in our proxy statement for our annual stockholder
                                         meetings;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>establish
                                         procedures for complaints received regarding our accounting, internal accounting control
                                         and auditing matters; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>approve
                                         all audit and permissible non-audit services conducted by our independent registered
                                         public accounting firm.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board has determined that each of
our Audit Committee members are independent of management and free of any relationships that, in the opinion of the Board, would
interfere with the exercise of independent judgment and are independent, as that term is defined under the enhanced independence
standards for audit committee members in the Exchange Act and the rules promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board has determined that Mr. Dennedy
is an &ldquo;audit committee financial expert,&rdquo; as that term is defined in the rules promulgated by the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) pursuant to the Sarbanes-Oxley Act of 2012. The Board has further determined that each of the
members of the Audit Committee shall be financially literate and that at least one member of the committee has accounting or related
financial management expertise, as such terms are interpreted by the Board in its business judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Compensation Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Board has established a Compensation
Committee, which as of the date of this prospectus consists of three independent directors (as defined under the general independence
standards of the Nasdaq listing standards and our Corporate Governance Guidelines): Mr. Wilks (Chairperson), Mr. Dennedy and Mr.
Galey. Messrs. Wilks, Dennedy and Galey are each a &ldquo;non-employee director&rdquo; (within the meaning of Rule 16b-3 of the
Exchange Act). The Compensation Committee held two meetings during 2020. The committee&rsquo;s primary duties are to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>approve
                                         corporate goals and objectives relevant to executive officer compensation and evaluate
                                         executive officer performance in light of those goals and objectives;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>determine
                                         and approve executive officer compensation, including base salary and incentive awards;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>make recommendations
                                         to the Board regarding compensation plans; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>administer
                                         our stock plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Compensation Committee determines
and approves all elements of executive officer compensation. It also provides recommendations to the Board with respect to non-employee
director compensation. The Compensation Committee may not delegate its authority to any other person, other than to a subcommittee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Corporate Governance and Nominating
Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Board has also established a Corporate
Governance and Nominating Committee, which consists of Mr. Lowe (Chairperson) and Messrs. Dennedy and Wilks. The Corporate Governance
and Nominating Committee held two meetings during 2020. The committee&rsquo;s primary duties are to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>recruit
                                         new directors, consider director nominees recommended by stockholders and others and
                                         recommend nominees for election as directors;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>review
                                         the size and composition of our Board and committees;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>oversee
                                         the evaluation of the Board;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>recommend
                                         actions to increase the Board&rsquo;s effectiveness; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>develop,
                                         recommend and oversee our corporate governance principles, including our Code of Business
                                         Conduct and Ethics and our Corporate Governance Guidelines.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Code of Business Conduct and Ethics</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have adopted a written code of business
ethics and conduct (the &ldquo;Code of Conduct&rdquo;) that applies to all of our directors, officers and employees, including
our Chief Executive Officer and Chief Financial Officer. The objective of the Code of Conduct is to provide guidelines for maintaining
our and our subsidiaries integrity, reputation, honesty, objectivity and impartiality. The Code of Conduct addresses conflicts
of interest, protection of our assets, confidentiality, fair dealing with stockholders, competitors and employees, insider trading,
compliance with laws and reporting any illegal or unethical behavior. As part of the Code of Conduct, any person subject to the
Code of Conduct is required to avoid or fully disclose interests or relationships that are harmful or detrimental to our best
interests or that may give rise to real, potential or the appearance of conflicts of interest. Our Board will have ultimate responsibility
for the stewardship of the Code of Conduct, and it will monitor compliance through our Corporate Governance and Nominating Committee.
Directors, officers and employees will be required to annually certify that they have not violated the Code of Conduct. Our Code
of Business Conduct and Ethics reflects the foregoing principles. The full text of our Code of Business Conduct and Ethics is
published on our website at https://ir.urban-gro.com/investors/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We intend to satisfy the disclosure requirement
under Item 5.05 of Form 8-K relating to amendments to or waivers from any provision of the Code of Business Conduct and Ethics
applicable to our Chief Executive Officer and Chief Financial Officer by posting such information on our website http://urban-gro.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Other than as set forth below, to our
knowledge, (i) no director or executive officer has been a director or executive officer of any business which has filed a bankruptcy
petition or had a bankruptcy petition filed against it during the past ten years; (ii) no director or executive officer has been
convicted of a criminal offense or is the subject of a pending criminal proceeding during the past ten years; (iii) no director
or executive officer has been the subject of any order, judgment or decree of any court permanently or temporarily enjoining,
barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities during the
past ten years; and (iv) no director or officer has been found by a court to have violated a federal or state securities or commodities
law during the past ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Bradley J. Nattrass was a managing member
of N.R.G. Exports, LLC (&ldquo;NRG&rdquo;) from 2004 to 2011. Due to a lack of financial resources incurred in the defense of
an infringement lawsuit, NRG defaulted on certain loans, and NRG&rsquo;s largest debtholder enforced such security, thus triggering
a bankruptcy proceeding which was subsequently discharged on September 27, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a15"></A>EXECUTIVE AND DIRECTOR
COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are an &ldquo;emerging growth company&rdquo;
under applicable SEC rules and are providing disclosure regarding our executive compensation arrangements pursuant to the rules
applicable to emerging growth companies, which means that we are not required to provide a compensation discussion and analysis
and certain other disclosures regarding our executive compensation. The following discussion relates to the compensation of our
named executive officers for 2020, consisting of Bradley J. Nattrass, our Chief Executive Officer and Chairman of the Board, and
our two other most highly compensated executive officers as of December 31, 2020, Richard Akright, Chief Financial Officer and
Director, and Jonathan Nassar, Executive Vice President &ndash; Sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have a Compensation Committee comprised
of Messrs. Wilks, Dennedy and Galey. Under our Compensation Committee charter, our Compensation Committee determines and approves
all elements of executive officer compensation. The Compensation Committee&rsquo;s primary objectives in determining executive
officer compensation are (i) developing an overall compensation package that is at market levels and thus fosters executive officer
retention and (ii) aligning the interests of our executive officers with our stockholders by linking a significant portion of
the compensation package to performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Year 2020 and 2019 Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following Fiscal Year 2020 and 2019
Summary Compensation Table contains information regarding compensation for 2020 and 2019 that we paid to Mr. Nattrass and our
two other most highly compensated executive officers as of December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="background-color: White; width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt"><B>Name and Principal Position</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Year</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Salary<BR>
    ($)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Bonus<BR>
    ($)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Stock<BR>
    awards<BR>
    ($)<SUP>(1)</SUP></B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>Option</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>awards</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>($)<SUP>(1)</SUP></B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>Non-equity<BR>
                                         incentive plan<BR>
                                         compensation</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>($)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>Nonqualified<BR>
                                         deferred<BR>
                                         compensation<BR>
                                         earnings</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>($)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>All&nbsp;other<BR>
    compensation<BR>
    ($)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 7pt"><B>Total<BR>
    ($)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 12%"><FONT STYLE="font-size: 8pt">Bradley J. Nattrass</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; text-align: center"><FONT STYLE="font-size: 8pt">2020</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">248,000</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">19,847</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-size: 8pt">267,847</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 8pt"><I>Chief Executive Officer and Chairman of the Board</I></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2019</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">240,962</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">19,950</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt"><SUP>(2)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">260,912</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 8pt">Richard Akright<SUP>(3)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2020</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">214,615</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">300,000</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">13,895</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">(2)&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">528,510</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 8pt"><I>Chief Financial Officer</I></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2019</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">8,654</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">4,456</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">155,097</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">168,207</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 8pt">Jonathan Nassar<SUP>(4)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2020</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">333,971</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">179,743</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">513,714</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 8pt"><I>Executive Vice President - Sales</I></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2019</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">212,000</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">6,000</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">218,000</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts shown in the
    columns captioned &ldquo;Stock awards&rdquo; and &ldquo;Option awards&rdquo; represent the aggregate grant date fair value
    of the awards computed in accordance with ASC 718. For a description of the assumptions used by the Company to value these
    awards, see Note 13 to our financial statements included in the Annual Report.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents amounts
    paid to Mr. Nattrass and Mr. Akright pursuant to a car allowance and health insurance premiums paid on their behalf.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Akright received
    a stock grant of 50,000 shares on January 1, 2020 and a stock option to purchase 833 shares of common stock at an exercise
    price of $6.60 per share on March 31, 2019.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Nassar received
    a stock option to purchase 40,000 shares of common stock at an exercise price of $6.60 per share on January 1, 2020.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Employment Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following discussion relates to compensation arrangements
on behalf of, and compensation paid by us to, Messrs. Nattrass and Akright. We do not have an employment agreement with Mr. Nassar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Bradley Nattrass</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are a party to an employment agreement
with Mr. Nattrass (the &ldquo;Nattrass Agreement&rdquo;), whereby he serves as our President and Chief Executive Officer. Pursuant
to the Nattrass Agreement, he receives compensation pursuant to our standard programs in effect from time to time, and is eligible
to receive stock options, restricted stock, stock units or other equity awards from time to time at the sole discretion of the
Board in accordance with our 2019 Incentive Stock Option Plan or other equity plans that we may adopt. He is also entitled to
participate in our group benefit plans. The term of the Nattrass Agreement is three years, however, if a change in control occurs
during the term, the term shall expire no earlier than the first anniversary of the change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under certain circumstances, the Nattrass
Agreement also provides for severance benefits following a termination without &ldquo;cause&rdquo; or related to a &ldquo;change
of control&rdquo; (as such terms are defined in the Nattrass Agreement). In the event of a termination without &ldquo;cause,&rdquo;
Mr. Nattrass is entitled to severance payments equal to 12 months of regular base salary and target annual incentive pay and a
lump sum payment for 12 months of COBRA premiums. In addition, in the event of a termination without &ldquo;cause,&rdquo; if Mr.
Nattrass&rsquo; personal guarantee of the Credit Facilities has not been released after 12 months, then he is entitled to $15,000
per month until the personal guarantee is released. In the event of termination in connection with a &ldquo;change in control,&rdquo;
Mr. Nattrass is entitled to a lump sum payment equal to twice the sum of his annual salary and his target annual incentive pay,
and a lump sum payment for 12 months of COBRA premiums. All other additional benefits and stock incentive rights (if any) would
cease and expire upon termination of employment, unless otherwise provided in the Nattrass Agreement or by the separate written
terms of such benefits or incentives. The Nattrass Agreement includes indemnification, confidentiality and non-compete provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Richard Akright</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are a party to an employment agreement
with Mr. Akright (the &ldquo;Akright Agreement&rdquo;), whereby he serves as our Chief Financial Officer. Pursuant to the Akright
Agreement, he receives compensation pursuant to our standard programs in effect from time to time, and is eligible to receive
stock options, restricted stock, stock units or other equity awards from time to time at the sole discretion of the Board in accordance
with our 2019 Incentive Stock Option Plan or other equity plans that we may adopt. He is also entitled to participate in our group
benefit plans. The term of the Akright Agreement is three years, however, if a change in control occurs during the term, the term
shall expire no earlier than the first anniversary of the change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under certain circumstances, the Akright
Agreement also provides for severance benefits following a termination without &ldquo;cause&rdquo; or related to a &ldquo;change
of control&rdquo; (as such terms are defined in the Akright Agreement). In the event of a termination without &ldquo;cause,&rdquo;
Mr. Akright is entitled to severance payments equal to six months of regular base salary and a lump sum payment for six months
of COBRA premiums. In the event of termination in connection with a &ldquo;change in control,&rdquo; Mr. Akright is entitled to
a lump sum payment equal to his annual salary and his target annual incentive pay, and a lump sum payment for 12 months of COBRA
premiums. All other additional benefits and stock incentive rights (if any) would cease and expire upon termination of employment,
unless otherwise provided in the Akright Agreement or by the separate written terms of such benefits or incentives. The Akright
Agreement includes confidentiality and non-compete provisions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Equity Incentive Awards</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Mr. Nattrass has not received any equity
incentive awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Mr. Akright received a restricted common
stock grant of 50,000 shares on January 1, 2020 that vests proportionately on each January 1 over a 3-year period beginning on
January 1, 2021. Mr. Akright received a stock option grant to purchase 833 shares of common stock at an exercise price of $6.60
per share on March 31, 2019 that vests proportionately over a 3 year period on each quarter-end beginning June 30, 2019 ending
March 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Mr. Nassar received a stock option grant
to purchase 40,000 shares of common stock at an exercise price of $6.00 per share on January 1, 2020 that vests proportionately
on each December 31 over a 3-year period beginning on December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Retirement Benefits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We provide all qualifying employees with
the opportunity to participate in our tax-qualified 401(k) plan. The plan allows employees to defer receipt of earned salary,
up to tax law limits, on a pre-tax basis. Accounts may be invested in a wide range of mutual funds. The Company has not provided
any employer contributions to the plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Year 2020 Outstanding Equity Awards at Fiscal Year-End
Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table lists all of the outstanding
equity awards held on December&nbsp;31, 2020 by each of the Company&rsquo;s named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="9" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Option Awards</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Stock Awards</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt"><B>Name</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Number
                                         of<BR>
                                         securities<BR>
                                         underlying<BR>
                                         unexercised<BR>
                                         options<BR>
                                         exercisable</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(#)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Number
                                         of<BR>
                                         securities<BR>
                                         underlying<BR>
                                         unexercised<BR>
                                         options<BR>
                                         unexercisable</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(#)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Equity<BR>
                                         incentive<BR>
                                         plan<BR>
                                         awards:<BR>
                                         Number of<BR>
                                         securities<BR>
                                         underlying<BR>
                                         unexercised<BR>
                                         unearned<BR>
                                         options</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(#)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Option<BR>
                                         exercise<BR>
                                         price</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Option<BR>
    expiration<BR>
    date</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Number<BR>
                                         of<BR>
                                         shares<BR>
                                         or units<BR>
                                         of stock<BR>
                                         that<BR>
                                         have not<BR>
                                         vested</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(#)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Market<BR>
    value of<BR>
    shares of<BR>
    units of<BR>
    stock that<BR>
    have not<BR>
    vested<BR>
    ($)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Equity</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>incentive</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>plan<BR>
        awards:<BR>
        Number<BR>
        of</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>unearned</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>shares,<BR>
        units or<BR>
        other<BR>
        rights<BR>
        that<BR>
        have not<BR>
        vested</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(#)</B></FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Equity<BR>
    incentive<BR>
    plan<BR>
    awards:<BR>
    Market<BR>
    or payout value of<BR>
    unearned<BR>
    shares,<BR>
    units or<BR>
    other<BR>
    rights<BR>
    that have<BR>
    not<BR>
    vested<BR>
    ($)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 8pt">Bradley J. Nattrass</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><P><FONT STYLE="font-size: 8pt">Richard Akright</FONT></P></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">730</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">105</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">$7.20</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">March 2029</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">50,000<SUP>(1)</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">300,000</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 28%"><FONT STYLE="font-size: 8pt">Jonathan Nassar</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: center"><FONT STYLE="font-size: 8pt">30,000<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 8pt">35,000<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-size: 8pt">$6.48</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 11%"><FONT STYLE="font-size: 8pt">August 18, 2028</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-size: 8pt">5,556</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-size: 8pt">33,336</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Akright received
    a stock grant of 50,000 shares on January 1, 2020.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Nassar received
    a stock option to purchase 40,000 shares of common stock at an exercise price of $6.00 per share on January 1, 2020.&nbsp;Such
    options vest proportionately over three years, commencing on December 31, 2020.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Equity Incentive Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table summarizes information
about our equity compensation plans as of December&nbsp;31, 2020. All outstanding awards relate to our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Plan category</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number
    of<BR> securities<BR> to be issued <BR> upon vesting<BR> of grants <BR> and exercise <BR> of outstanding<BR> options, warrants<BR>
    and rights</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Weighted-<BR>
    average<BR> exercise <BR> price of<BR> outstanding<BR> options, warrants<BR> and rights</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number
    of<BR> securities<BR> remaining<BR> available for<BR> future issuance<BR> under equity<BR> compensation<BR> plans</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 55%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plan approved by stockholders<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">518,500</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">6.07</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">39,482</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plan not approved by stockholders<SUP>(2)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">237,472</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6.88</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">958,724</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39,482</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">(1)</TD>
    <TD>The Company&rsquo;s 2019 Equity Incentive Plan was adopted in March 2019 and approved by stockholders in April 2019.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(2)</TD>
    <TD>The Company&rsquo;s 2018 Equity Incentive Plan was adopted in January 2018.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to January 2020, non-employee directors
were provided with a stock option to purchase 16,667 shares of common stock upon their appointment to the Board. All such stock
options are subject to vesting proportionately over a 3-year period, commencing on April 30th of each year following the year
of the grant. In addition, each director who serves as a member of a standing committee of the Board was entitled to receive an
additional stock option to purchase 1,667 shares of common stock for each committee on which he or she serves, which options vested
at the end of each year of service on the applicable committee. The exercise price for any stock options issued to our non-employee
directors will be at least equal to the fair market value on the applicable date of grant. Beginning in January 2020, non-employee
directors were granted restricted shares of common stock as an annual retainer and for serving as a member of a standing committee.
Each director will be required to attend a minimum of 75% of all Board meetings per year in person or telephonically. Directors
are reimbursed for travel and other expenses directly associated with Company business. Directors that are also employees of the
Company do not receive any additional compensation for their role as a director at this time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Year 2020 Director Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table provides information
regarding director compensation during 2020. Mr. Nattrass&rsquo; and Mr. Akright&rsquo;s compensation is reported in the Fiscal
Year 2020 and 2019 Summary Compensation Table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fees Earned
    or<BR> Paid in Cash<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock<BR>
    Awards<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Option<BR>
    Awards<BR> ($)<SUP>(1)(2)</SUP></B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-equity<BR>
    incentive<BR>
    plan<BR>
    compensation<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Change in<BR>
    pension <BR>
    value and<BR>
    nonqualified<BR>
    deferred<BR>
    compensation<BR>
    earnings</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>All
                                         other<BR>
                                         compensation</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 30%; font-size: 10pt; text-align: left">James H. Dennedy<SUP>(3)</SUP></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">133,333</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right">133,333</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Lance Galey<SUP>(4)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">James R. Lowe<SUP>(5)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Lewis O. Wilks<SUP>(6)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">126,667</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">126,667</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px">(1)</TD>
    <TD>The amounts in this column represent the aggregate grant date fair value of stock options computed in accordance with
    Accounting Standards Codification (&ldquo;ASC&rdquo;) 718,&nbsp;<I>Compensation&mdash;Stock Compensation</I>&nbsp;(&ldquo;ASC
    718&rdquo;). The fair value of stock options is calculated using the Black-Scholes option-pricing model.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px">(2)</TD>
    <TD>The chart below shows the aggregate number of outstanding stock options held by each non-employee director as of December
    31, 2020.&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 64%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Options</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennedy</FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Galey</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lowe</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,334</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilks</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,667</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Dennedy received
    a stock grant of 22,222 shares for being Chair of the Audit Committee and a member of the Compensation Committee and Corporate
    Governance and Nominating Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Galey received a
    stock grant of 18,889 shares for being a member of the Audit Committee and Compensation Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Lowe received a
    stock grant of 18,889 shares for being Chair of the Corporate Governance and Nominating Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Wilks received a
    stock grant of 21,111 shares for being Chair of the Compensation Committee and a member of the Audit Committee and Corporate
    Governance and Nominating Committee.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a16"></A>CERTAIN RELATIONSHIPS
AND RELATED PARTY TRANSACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following is a description of transactions
since January 1, 2017, including currently proposed transactions to which we have been or are to be a party in which the amount
involved exceeded or will exceed $120,000, and in which any of our directors (including nominees), executive officers or beneficial
holders of more than 5.0% of our capital stock, or their immediate family members or entities affiliated with them, had or will
have a direct or indirect material interest. We believe the terms and conditions set forth in such agreements are reasonable and
customary for transactions of this type. Our policy requires that any transactions with related parties requires a formal agreement
to be entered into and the approval of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We purchase certain cultivation products
from Bravo Lighting, LLC d/b/a Bravo Enterprises (&ldquo;Bravo&rdquo;), Bravo Aviation, and Enviro-Glo, LLC (&ldquo;Enviro-Glo&rdquo;),
distributors of commercial building lighting and other product solutions, which are each controlled by Bradley Nattrass, our Chief
Executive Officer, and Octavio Gutierrez. Purchases from Bravo, Bravo Aviation and Enviro-Glo for the year ended December 31,
2019 totaled $45,129. Purchases for the years ended December 31, 2018 and 2017 were $276,443 and $526,002, respectively. Outstanding
receivables from Bravo and Enviro-Glo as of December 31, 2019 totaled $0. Outstanding receivables as of December 31, 2018 and
2017 totaled $43,120 and $13,540, respectively. Net outstanding payables incurred for purchases of inventory and other services
to Bravo and Enviro-Glo as of December 31, 2019 totaled $8,570. Net outstanding payables as of December 31, 2018 and 2017 totaled
$5,562 and $93,394, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We entered into a lease agreement with
Bravo to sublease office space for 12 months commencing in September 2017, which was renewed in September 2018. We made lease
payments totaling $24,000 in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have worked with Cloud9 Support, LLC,
a company owned by James Lowe, a director of the Company. Cost of revenues provided by Cloud9 Support, LLC during 2019 totaled
$97,329. Cost of revenues during the years ended December 31, 2018 and 2017 were 84,746 and $58,196, respectively. Cloud9 Support,
LLC also purchases materials from us. Total purchases by Cloud9 Support, LLC from us during the year ended December 31, 2019 was
$392,963. Total purchases during the years ended December 31, 2018 and 2017 were $370,948 and $312,041, respectively. Outstanding
receivables from Cloud9 Support, LLC as of December 31, 2019 was $49,659. Outstanding receivables as of December 31, 2018 and
2017 totaled $79,235 and $42,237, respectively. Net outstanding payables incurred for purchases of inventory and other services
to Cloud9 Support, LLC as of December 31, 2019 totaled $16,402. Net outstanding payables incurred for purchases of inventory and
other services as of December 31, 2018 and 2017 totaled $13,240 and $7,168, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In October 2018, we issued a $1 million
unsecured note payable to Cloud9 Support Inc. (&ldquo;Cloud9 Support&rdquo;), an entity owned by James R. Lowe, a director of
the Company, which originally became due April 30, 2019 (the &ldquo;James Lowe Note&rdquo;). The James Lowe Note is personally
guaranteed by Bradley Nattrass, our Chief Executive Officer, and Octavio Gutierrez. The loan had a one-time origination fee of
$12,500. Interest accrued at the rate of 12% per annum and was paid monthly. As additional consideration for the James Lowe Note,
we granted Mr. Lowe (as designee of Cloud9 Support) an option to purchase 5,000 shares of our common stock at an exercise price
of $7.20 per share, which option is exercisable for a period of five years. The due date for the James Lowe Note was extended
in May 2019 to December 31, 2019 and the interest rate was decreased to 9% per year. In consideration for Cloud9 Support extending
the maturity date of the note and reducing the interest rate, we issued 1,667 shares of our common stock to Mr. Lowe (as designee
of Cloud9 Support).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 21, 2020, we entered into
an agreement to amend the James Lowe Note to extend the maturity date of therein from December 31, 2019 to the date which is the
earlier of 60 days following the date: (a) on which demand for repayment is made by the lenders under the Credit Agreement (which
is now only applicable in the case of an event of default under the Credit Agreement because of the removal of the demand feature
pursuant to the First Amendment to the Credit Agreement); or (b) which is the maturity date under the Credit Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, on February 25, 2020, the
Company entered into a subordination, postponement and standstill agreement with Cloud9 Support (the &ldquo;Subordination Agreement&rdquo;)
pursuant to which Cloud9 Support agreed to postpone and subordinate all payments due under the promissory note until the facilities
under the Credit Agreement have been fully and finally repaid. The term for the Subordination Agreement will continue in force
as long as the Company is indebted to the agent or lenders under the Credit Agreement. In consideration for Cloud9 Support&rsquo;s
agreement to extend the maturity date of the promissory note and to enter into the Subordination Agreement, we issued 16,667 shares
of common stock to Mr. Lowe (as designee of Cloud9 Support). The largest aggregate amount of principal outstanding during 2019
was $1,000,000. As of September 9, 2020, $1,000,000 was outstanding under the note. The amount of principal and interest paid
on the note during 2019 was $0 and $136,094, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 15, 2020, we signed a $1,854,500
convertible note bridge financing (the &ldquo;Bridge Financing&rdquo;). In connection with the Bridge Financing, the James Lowe
Note was converted into a Bridge Financing note (the &ldquo;New James Lowe Note&rdquo;). The New James Lowe Note carries interest
at the rate of 12% and matures on December 31, 2021. The New James Lowe Note will be mandatorily converted into shares of our
common stock upon the closing of this offering, at 75% of the per share price paid by investors in this offering, equivalent to
126,903 shares at an assumed offering price of $10.50 per share, excluding accrued interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a17"></A>PRINCIPAL STOCKHOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our only outstanding
class of voting securities is our common stock. The following table sets forth information known to us about the beneficial ownership
of our common stock on January 20, 2021 by (i) each current director; (ii) each named executive officer; and (iii) all of our
executive officers and directors as a group. Other than as set forth below, no person known to us beneficially owns 5% or more
of the outstanding common stock as of January 20, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise
indicated in the footnotes, each person listed in the following table has sole voting power and investment power over the common
stock listed as beneficially owned by that person. The percentages reflect beneficial ownership immediately prior to and immediately
after the completion of this offering and are based on 4,712,047 shares of our common stock outstanding as of January 20, 2021
and 8,997,761 shares of our common stock outstanding after the completion of this offering. Unless otherwise indicated in the
footnotes, the address for each listed person is urban-gro, Inc., 1751 Panorama Point, Unit G, Lafayette, Colorado 80026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="7" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>After this Offering</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Prior to this
    Offering</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>If Underwriters&rsquo;
    Option is Not Exercised</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>If Underwriters&rsquo;
    Option is Exercised in Full</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares&nbsp;Beneficially&nbsp;Owned<SUP>(1)</SUP></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares Beneficially
    Owned</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares Beneficially
    Owned</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Name of Beneficial&nbsp; Owner</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percent</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percent</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percent</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt"><B>5% Stockholders:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 26%"><FONT STYLE="font-size: 10pt">Octavio Gutierrez</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-size: 10pt">1,014,505</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-size: 10pt">21.5%</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">1,014,505</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">11.3%</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 10pt">1,014,505</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">10.5%</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt"><B>Named executive officers and directors:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Bradley J. Nattrass<SUP>(2)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,594,947</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">33.8%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,594,947</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17.7%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,594,947</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">16.5%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Richard (Dick) A. Akright</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17,395</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.4%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17,395</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17,395</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Jonathan Nassar</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">91,944</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2.0%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">91,944</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.0%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">91,944</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.0%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Mark Doherty</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">56,873</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.2%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">56,873</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.6%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">56,873</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.6%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">James H. Dennedy<SUP>(3)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">365,832</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7.8%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">365,832</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4.1%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">365,832</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3.8%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Lance Galey</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">19,166</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.4%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">19,166</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">19,166</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">James R. Lowe<SUP>(4)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">238,148</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5.1%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">238,148</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2.6%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">238,148</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2.5%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Lewis O. Wilks</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">21,388</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.5%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">21,388</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">21,388</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.2%</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">All executive officers and directors as a group (10 persons)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,585,692</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">54.9%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,585,692</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28.7%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,585,692</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26.8%</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>





<P STYLE="margin-top: 0; margin-bottom: 0">__________________________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Beneficial ownership as
                                         reported in the table has been determined in accordance with Rule 13d-3 under the Exchange
                                         Act and is not necessarily indicative of beneficial ownership for any other purpose.
                                         The number of shares of common stock shown as beneficially owned includes shares of common
                                         stock which may not be beneficially owned but over which a person would be deemed to
                                         exercise control or direction. The number of shares of common stock shown as beneficially
                                         owned includes shares of common stock subject to stock options exercisable and restricted
                                         stock units that were outstanding on January 20, 2021 and that will vest within 60 days
                                         of January 20, 2021. Shares of common stock subject to stock options exercisable and
                                         restricted stock units that will vest within 60 days after January 20, 2021 are deemed
                                         outstanding for computing the percentage of the person holding such securities but are
                                         not deemed outstanding for computing the percentage of any other person.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Mr. Nattrass pledged his
                                         1,594,947 shares of common stock to Bridging Finance Inc. as security for loans provided
                                         by Bridging Finance Inc. to the Company under a term loan facility and revolving credit
                                         facility as further described in Note 17 to the consolidated financial statements included
                                         in this prospectus.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Includes <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">345,833
                                         shares owned by HMG MRB Partners of which Mr. Dennedy is a partner and may be deemed
                                         to be the beneficial owner.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">Mr. Lowe is the sole equity
                                         holder of Cloud9 Support, LLC and as such may be deemed to beneficially own 107,462 shares
                                         held by Cloud9 Support, LLC.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a18"></A>DESCRIPTION OF CAPITAL
STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>The following descriptions are summaries
of the material terms of our certificate of incorporation and bylaws. Reference is made to the more detailed provisions of, and
the descriptions are qualified in their entirety by reference to, the certificate of incorporation and bylaws, forms of which
are filed with the SEC as exhibits to the registration statement of which this prospectus is a part, and applicable law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our authorized capital stock consists
of 100,000,000 shares of common stock, par value $0.001 per share, of which 4,712,047 shares are issued and outstanding, and 10,000,000
shares of preferred stock, $0.10 par value per share, of which no shares are issued or outstanding, as of January 20, 2021. Upon
completion of this offering, there will be 8,997,761 shares of common stock outstanding and no shares of preferred stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of January 20, 2021, there were 4,712,047
shares of our common stock outstanding held by approximately 156 stockholders of record. Holders of common stock will have voting
rights for the election of our directors and all other matters requiring stockholder action, except with respect to amendments
to our certificate of incorporation that alter or change the powers, preferences, rights or other terms of any outstanding preferred
stock if the holders of such affected series of preferred stock are entitled to vote on such an amendment. There is no cumulative
voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the
election of directors can elect all of the directors. Holders of common stock will be entitled to one vote per share on matters
to be voted on by stockholders and also will be entitled to receive such dividends, if any, as may be declared from time to time
by our Board in its discretion out of funds legally available therefor. The payment of dividends, if any, on the common stock
will be subject to the prior payment of dividends on any outstanding preferred stock, of which there is currently none. Upon our
liquidation or dissolution, the holders of common stock will be entitled to receive <I>pro rata </I>all assets remaining available
for distribution to stockholders after payment of all liabilities and provision for the liquidation of any shares of preferred
stock outstanding at that time. Our stockholders have no conversion, preemptive or other subscription rights and there are no
sinking fund or redemption provisions applicable to the common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preferred Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our certificate of incorporation provides
that shares of preferred stock may be issued from time to time in one or more series. Our Board will be authorized to fix the
voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights, if any,
and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our Board will be able
to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power
and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our Board to issue preferred
stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the
removal of existing management. We have no preferred stock outstanding at the date hereof. Although we do not currently intend
to issue any shares of preferred stock, we cannot assure you that we will not do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Certain Anti-takeover Provisions of Delaware Law, our Certificate
of Incorporation and Bylaws </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a Delaware corporation, we are governed
by the provisions of Section 203 of the Delaware General Corporation Law, which generally has an anti-takeover effect for transactions
not approved in advance by our Board. This may discourage takeover attempts that might result in payment of a premium over the
market price for the shares of common stock held by stockholders. In general, Section 203 prohibits a publicly held Delaware corporation
from engaging in a &ldquo;business combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a three-year period following
the time that such stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed
manner. A &ldquo;business combination&rdquo; includes, among other things, a merger, asset or stock sale or other transaction
resulting in a financial benefit to the interested stockholder. An &ldquo;interested stockholder&rdquo; is a person who, together
with affiliates and associates, owns, or did own within three years prior to the determination of interested stockholder status,
15% or more of the corporation&rsquo;s voting stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under Section 203, a business combination
between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">before the stockholder became interested, the board of directors approved either the business
    combination or the transaction which resulted in the stockholder becoming an interested stockholder; or</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">upon consummation of the transaction which resulted in the stockholder becoming an interested
    outstanding, shares owned by:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">persons who are directors and also officers, and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">employee stock plans, in some instances; or</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">at or after the time the stockholder became interested, the business combination was approved
    by the board of directors of the corporation and authorized at an annual or special meeting of the stockholders by the affirmative
    vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Special meeting of stockholders </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our bylaws further provide that special
meetings of our stockholders may be only called by our Board with a majority vote of our Board, by our chief executive officer
or our chairman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Requirements for Advance Notification of Director Nominations
and Stockholder Proposals </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our bylaws provide that stockholders seeking
to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual
meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&rsquo;s notice needs
to be delivered to the secretary at our principal executive offices not later than the close of business on the 45th day nor earlier
than the close of business on the 75th day prior to the first anniversary of the date on which we first mailed its proxy materials
for the preceding year&rsquo;s annual meeting of stockholders; provided, however, if no proxy materials were mailed by us in connection
with the preceding year&rsquo;s annual meeting, or if the date of the annual meeting is advanced more than 30 days prior to or
delayed by more than 30 days after the anniversary of the preceding year&rsquo;s annual meeting, a stockholder&rsquo;s notice
shall be timely if delivered to our principal executive offices not later than the 90th day prior to the scheduled date of the
annual meeting of stockholders or the 10th day following the day on which public announcement of the date of our annual meeting
of stockholders is first made or sent by us. Our bylaws also specify certain requirements as to the form and content of a stockholders&rsquo;
meeting. These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from
making nominations for directors at our annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Authorized but unissued shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.5pt">Our authorized but unissued shares of
common stock and preferred stock are available for future issuances without stockholder approval and could be utilized for a variety
of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence
of authorized but unissued and unreserved common stock and preferred stock could render more difficult or discourage an attempt
to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Removal of directors </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our certificate of incorporation provides
that a member of our Board may be removed from service as a director, with or without cause, only by the affirmative vote of the
holders of a majority of the shares of voting stock then outstanding and entitled to vote in an election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Limitation of Liability and Indemnification of Directors
and Officers </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our certificate of incorporation and bylaws
provide that our directors and officers will be indemnified by us to the fullest extent authorized by Delaware law as it now exists
or may in the future be amended, against all expenses and liabilities reasonably incurred in connection with their service for
or on our behalf. In addition, our certificate of incorporation provides that our directors will not be personally liable for
monetary damages to us for breaches of their fiduciary duty as directors, except for liability (i) for any appropriation by a
director, in violation of his or her duties, of any business opportunity of the Corporation, (ii) for acts or omissions which
involve intentional misconduct or a knowing violation of the law, (iii) with respect to illegal dividends or redemptions, or (iv)
for any transaction from which the director received an improper personal benefit. Our bylaws also permit us to secure insurance
on behalf of any officer, director or employee for any liability arising out of his or her actions, regardless of whether Delaware
law would permit indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These provisions may discourage stockholders
from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of
reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might
otherwise benefit us and our stockholders. Furthermore, a stockholder&rsquo;s investment may be adversely affected to the extent
we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.
We believe that these provisions, insurance and the indemnity agreements are necessary to attract and retain talented and experienced
directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is no pending litigation or proceeding
involving any of our directors or officers where indemnification by us would be required or permitted. We are not aware of any
threatened litigation or proceeding that might result in a claim for such indemnification. Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing
provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Listing </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have applied to list our common stock
on the Nasdaq Capital Market under the symbol &ldquo;UGRO.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transfer agent and registrar for our
common stock is Equiniti Trust Company (f/k/a Corporate Stock Transfer), 3200 Cherry Creek Drive South, Suite 430, Denver, Colorado
80209, phone (303) 282-4800.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a19"></A>DESCRIPTION OF SECURITIES
WE ARE OFFERING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are offering 4,285,714 shares of our
common stock, assuming no exercise of the over-allotment option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The material terms and provisions of our
common stock and each other class of our securities which qualifies or limits our common stock are described under the caption
&ldquo;Description of Capital Stock&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Representative&rsquo;s Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Please see &ldquo;Underwriting &mdash;
Representative&rsquo;s Warrants&rdquo; in this prospectus for a description of the warrants we have agreed to issue to the representative
of the underwriters in this offering, subject to the completion of the offering. We expect to enter into a warrant agreement in
respect of the representative&rsquo;s warrants in connection with the closing of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a20"></A>SHARES ELIGIBLE
FOR FUTURE SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to this offering, shares of our
common stock were quoted on the OTC Markets Group, Inc. OTCQX Marketplace under the symbol &ldquo;UGRO&rdquo;.
Future sales of substantial amounts of our common stock in the public market, or the perception that such sales may occur, could
adversely affect market prices prevailing from time to time. Further, because only a limited number of shares will be available
for sale shortly after this offering due to existing contractual and legal restrictions on resale as described below, there may
be sales of substantial amounts of our common stock in the public market after the restrictions lapse. This may adversely affect
the prevailing market price and our ability to raise equity capital in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon completion of this offering, 8,997,761
shares of common stock will be outstanding. Of these shares, 4,285,714 shares of our common stock (or 4,928,571 shares if the
underwriters exercise in full their option to purchase additional shares) sold in this offering will be freely transferable without
restriction or further registration under the Securities Act, except for any shares purchased by our &ldquo;affiliates,&rdquo;
as that term is defined in Rule 144 under the Securities Act. Of the remaining shares of common stock that will be outstanding,
234,856 shares are &ldquo;restricted shares&rdquo; as defined in Rule 144. Restricted shares may be sold in the public market
only if registered under the Securities Act or if they qualify for an exemption from registration under Rule 144. As a result
of the 180-day lock-up period described below, the shares subject to lock-up arrangements will be available for sale in the public
market only after 180 days from the date of this prospectus (generally subject to resale limitations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Rule 144</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In general, a person who has beneficially
owned restricted shares of our common stock for at least six months would be entitled to sell such securities, provided that (i)
such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, the
sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. Persons
who have beneficially owned restricted shares of our common stock for at least six months but who are our affiliates at the time
of, or any time during the 90 days preceding, the sale, would be subject to additional restrictions, by which such person would
be entitled to sell within any three-month period only a number of securities that does not exceed the greater of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>1% of
                                         the number of shares of our common stock then outstanding, which will equal approximately
                                         89,977 shares immediately after this offering; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the average
                                         weekly trading volume of our common stock on the Nasdaq Capital Market during the four
                                         calendar weeks preceding the filing of a notice on Form 144 with respect to the sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">provided, in each case, that we are subject to the Exchange
Act periodic reporting requirements for at least 90 days before the sale. Such sales both by affiliates and by non-affiliates
must also comply with the manner of sale and notice provisions of Rule 144 to the extent applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Lock-up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company, each of our directors and
executive officers, and our 5% and greater stockholders, have agreed not to or are otherwise restricted in their ability to, subject
to certain limited exceptions, offer, pledge, sell, contract to sell, grant any option to purchase, or otherwise dispose of our
common stock or any securities convertible into or exchangeable or exercisable for common stock, or to enter into any hedge or
other arrangement or any transaction that transfers, directly or indirectly, the economic consequence of ownership of the shares
of our common stock, in the case of the Company for a period of 90 days after the date of this prospectus, and in the case of
our directors and executive officers and our 5% and greater stockholders for a period of 180 days after the date of this prospectus,
without the prior written consent of ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the underwriters.
See &ldquo;Underwriting&mdash;Lock-up Agreements.&rdquo; The underwriters do not have any present intention or arrangement to
release any shares of our common stock subject to lock-up arrangements prior to the expiration of the 90- or 180-day lock-up period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a21"></A>MATERIAL U.S. FEDERAL
INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of the material
U.S. federal income tax consequences relating to the acquisition, ownership, and disposition of common stock acquired pursuant
to this offering by non-U.S. holders (as defined below). This summary deals only with common stock held as a capital asset (within
the meaning of Section 1221 of the Code) and does not discuss the U.S. federal income tax consequences applicable to a non-U.S.
holder that is subject to special treatment under U.S. federal income tax laws, including, but not limited to: a dealer in securities
or currencies; a broker-dealer; a financial institution; a qualified retirement plan, individual retirement plan, or other&nbsp;tax-deferred&nbsp;account;
a regulated investment company; a real estate investment trust; a tax-exempt organization; an insurance company; a person holding
common stock as part of a hedging, integrated, conversion, or straddle transaction or a person deemed to sell common stock under
the constructive sale provisions of the Code; a trader in securities that has elected the mark-to-market method of tax accounting;
an accrual method taxpayer subject to special tax accounting rules under Section 451(b) of the Code; an entity that is treated
as a partnership for U.S. federal income tax purposes; a person that received such common stock in connection with services provided;
a corporation that accumulates earnings to avoid U.S. federal income tax; a corporation organized outside the United States, any
state thereof or the District of Columbia that is nonetheless treated as a U.S. taxpayer for U.S. federal income tax purposes;
a person that is not a non-U.S. holder; a &ldquo;controlled foreign corporation;&rdquo; a &ldquo;passive foreign investment company;&rdquo;
or a U.S. expatriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This summary is based upon provisions
of the Code, its legislative history, applicable U.S. Treasury regulations promulgated thereunder, published rulings, and judicial
decisions, all as in effect as of the date hereof. We have not sought, and will not seek, any ruling from the Internal Revenue
Service, or IRS, with respect to the tax consequences discussed herein, and there can be no assurance that the IRS will not take
a position contrary to the tax consequences discussed below or that any position taken by the IRS would not be sustained. Those
authorities may be repealed, revoked, or modified, perhaps retroactively, or may be subject to differing interpretations, which
could result in U.S. federal income tax consequences different from those discussed below. This summary does not address all aspects
of U.S. federal income tax, does not deal with all tax considerations that may be relevant to stockholders in light of their personal
circumstances, and does not address any state, local, foreign, gift, estate (except to the limited extent set forth herein), or
alternative minimum tax considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For purposes of this discussion, a &ldquo;U.S.
holder&rdquo; is a beneficial holder of common stock that is for U.S. federal income tax purposes: an individual citizen or resident
of the United States; a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created
or organized in or under the laws of the United States, any state thereof or the District of Columbia; an estate the income of
which is subject to U.S. federal income taxation regardless of its source; or a trust if it (1) is subject to the primary supervision
of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the
trust, or (2) was in existence on August 20, 1996 and has a valid election in effect under applicable U.S. Treasury regulations
to be treated as a U.S. person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For purposes of this discussion, a&nbsp;&rdquo;non-U.S.&nbsp;holder&rdquo;
is a beneficial owner of common stock that is neither a U.S. holder nor a partnership (or any other entity or arrangement that
is treated as a partnership) for U.S. federal income tax purposes regardless of its place of organization or formation. If a partnership
(or an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes) holds common stock, the tax
treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. A partner of
a partnership holding common stock is urged to consult its own tax advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>PROSPECTIVE INVESTORS ARE URGED TO
CONSULT THEIR OWN TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME, ESTATE, AND OTHER TAX CONSEQUENCES OF ACQUIRING, OWNING, AND
DISPOSING OF OUR COMMON STOCK IN LIGHT OF THEIR SPECIFIC SITUATIONS, AS WELL AS THE TAX CONSEQUENCES ARISING UNDER ANY STATE,
LOCAL, OR NON-U.S. TAX LAWS AND ANY OTHER U.S. FEDERAL TAX LAWS (INCLUDING THE U.S. FEDERAL ESTATE AND GIFT TAX LAWS).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Distributions on Our Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Distributions with respect to common stock,
if any, generally will constitute dividends for U.S. federal income tax purposes to the extent paid out of current or accumulated
earnings and profits, as determined for U.S. federal income tax purposes. Any portion of a distribution in excess of current or
accumulated earnings and profits will be treated as a return of capital and will first be applied to reduce the holder&rsquo;s
tax basis in its common stock, but not below zero. Any remaining amount will then be treated as gain from the sale or exchange
of the common stock and will be treated as described under &ldquo;&mdash;Disposition of Our Common Stock&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Distributions treated as dividends that
are paid to a non-U.S. holder, if any, with respect to shares of our common stock will be subject to U.S. federal withholding
tax at a rate of 30% (or such lower rate as may be specified in an applicable income tax treaty) of the gross amount of the dividends
unless the dividends are effectively connected with the non-U.S. holder&rsquo;s conduct of a trade or business in the United States
subject to the discussion below regarding foreign accounts. If a non-U.S. holder is engaged in a trade or business in the United
States and dividends with respect to the common stock are effectively connected with the conduct of that trade or business and,
if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment, then although the non-U.S.
holder will generally be exempt from the 30% U.S. federal withholding tax, provided certain certification requirements are satisfied,
the non-U.S. holder will be subject to U.S. federal income tax on those dividends on a net income basis at regular graduated U.S.
federal income tax rates in the same manner as if such holder were a resident of the United States. Any such effectively connected
income received by a foreign corporation may, under certain circumstances, be subject to an additional branch profits tax equal
to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and profits for the taxable year, as
adjusted under the Code. To claim the exemption from withholding with respect to any such effectively connected income, the non-U.S.
holder must generally furnish to us or our paying agent a properly executed IRS Form W-8ECI (or applicable successor form). In
the case of a non-U.S. holder that is an entity, Treasury regulations and the relevant tax treaty provide rules to determine whether,
for purposes of determining the applicability of a tax treaty, dividends will be treated as paid to the entity or to those holding
an interest in that entity. If a non-U.S. holder holds stock through a financial institution or other agent acting on the holder&rsquo;s
behalf, the holder will be required to provide appropriate documentation to such agent. Such holder&rsquo;s agent will then be
required to provide certification to us or our paying agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A non-U.S. holder of shares of common
stock who wishes to claim the benefit of a reduced rate of withholding tax under an applicable treaty must furnish to us or our
paying agent a valid IRS Form W-8BEN or IRS Form W-8BEN-E (or applicable successor form) certifying such holder&rsquo;s qualification
for the exemption or reduced rate. If a non-U.S. holder is eligible for a reduced rate of U.S. withholding tax pursuant to an
income tax treaty and does not timely file the required certification, it may obtain a refund of any excess amounts withheld by
timely filing an appropriate claim for refund with the IRS. Non-U.S. holders are urged to consult their tax advisors regarding
their entitlement to benefits under a relevant income tax treaty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Disposition of Our Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the discussion below regarding
backup withholding, a non-U.S. holder generally will not be subject to U.S. federal income tax on any gain from a sale, exchange
or other disposition of our stock unless: (a) that gain is effectively connected with the non-U.S. holder&rsquo;s conduct of a
trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent
establishment maintained by the non-U.S. holder); (b) the non-U.S. holder is a nonresident alien individual who is present in
the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or (c) we
are or have been a &ldquo;United States real property holding corporation&rdquo; within the meaning of Code Section 897(c)(2)
for U.S. federal income tax purposes at any time during the shorter of the five-year period preceding the date of disposition
or the holder&rsquo;s holding period for our common stock, and certain other requirements are met. Although there can be no assurance,
we believe that we are not, and we do not anticipate becoming, a United States real property holding corporation for U.S. federal
income tax purposes. Even if we are treated as a United States real property holding corporation, gain realized by a non-U.S.
holder on a disposition of our common stock will not be subject to U.S. federal income tax so long as (1) the non-U.S. holder
owned, directly, indirectly and constructively, no more than five percent of our common stock at all times within the shorter
of (x) the five-year period preceding the disposition, or (y) the holder&rsquo;s holding period, and (2) our common stock is regularly
traded on an established securities market. There can be no assurance that our common stock will continue to qualify as regularly
traded on an established securities market. If any gain on your disposition is taxable because we are a United States real property
holding corporation and your ownership of our common stock exceeds five percent, you will be taxed on such disposition generally
in the manner applicable to U.S. persons and in addition, a purchaser of your common stock may be required to withhold tax with
respect to that obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If a non-U.S. holder is described in clause
(a) of the preceding paragraph, the non-U.S. holder will generally be subject to tax on the net gain derived from the disposition
at the regular graduated U.S. federal income tax rates in the same manner as if such non-U.S. holder were a U.S. person, unless
an applicable income tax treaty provides otherwise. In addition, a non-U.S. holder that is a corporation may be subject to the
branch profits tax at a rate equal to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and
profits. If the non-U.S. holder is an individual described in clause (b) of the preceding paragraph, the non-U.S. holder will
generally be subject to a flat 30% tax on the gain derived from the disposition, which may be offset by U.S.-source capital losses
even though the non-U.S. holder is not considered a resident of the United States, provided that the non-U.S. holder has timely
filed U.S. federal income tax returns with respect to such losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>U.S. Federal Estate Tax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The estate of a nonresident alien individual
is generally subject to U.S. federal estate tax on property it is treated as the owner of, or has made certain life transfers
of, having a U.S. situs. Because we are a U.S. corporation, our common stock will be U.S. situs property and therefore will be
included in the taxable estate of a nonresident alien decedent for U.S. federal estate tax purposes, unless an applicable estate
tax treaty between the United States and the decedent&rsquo;s country of residence provides otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information Reporting and Backup Withholding Tax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We report to our non-U.S. holders and
the IRS certain information with respect to any dividends we pay on our common stock, including the amount of dividends paid during
each fiscal year, the name and address of the recipient, and the amount, if any, of tax withheld. All distributions to holders
of common stock are subject to any applicable withholding. Information reporting requirements apply even if no withholding was
required because the distributions were effectively connected with the non-U.S. holder&rsquo;s conduct of a U.S. trade or business
or withholding was reduced by an applicable income tax treaty. This information also may be made available under a specific treaty
or agreement with the tax authorities in the country in which the non-U.S. holder resides or is established. Under U.S. federal
income tax law, interest, dividends, and other reportable payments may, under certain circumstances, be subject to &ldquo;backup
withholding&rdquo; at the then applicable rate (currently, 24%). Backup withholding, however, generally will not apply to distributions
on our common stock to a non-U.S. holder, provided the non-U.S. holder furnishes to us or our paying agent the required certification
as to its non-U.S. status, such as by providing a valid IRS Form W-8BEN, IRS Form W-8BEN-E or IRS Form W-8ECI, or certain other
requirements are met. Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has actual
knowledge, or reason to know, that the holder is a U.S. person that is not an exempt recipient. Backup withholding is not an additional
tax but merely an advance payment, which may be credited against the tax liability of persons subject to backup withholding or
refunded to the extent it results in an overpayment of tax and the appropriate information is timely supplied to the IRS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Information reporting and backup withholding
will generally apply to the proceeds of a disposition of our common stock by a non-U.S. holder effected by or through the U.S.
office of any broker, U.S. or foreign, unless the holder certifies its status as a non-U.S. holder and satisfies certain other
requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to
a payment of disposition proceeds to a non-U.S. holder where the transaction is effected outside the United States through a non-U.S.
office of a broker. However, information reporting but not backup withholding will apply in a manner similar to dispositions effected
through a U.S. office of a broker, if a non-U.S. holder sells our common stock through a non-U.S. office of a broker that has
certain connections with the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Foreign Accounts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain withholding taxes may apply to
certain types of payments made to &ldquo;foreign financial institutions&rdquo; (as specially defined under these rules) and certain
other non-U.S. entities if certification, information reporting and other specified requirements are not met. A 30% withholding
tax may apply to &ldquo;withholdable payments&rdquo; if they are paid to a foreign financial institution or to a non-financial
foreign entity, unless (a) the foreign financial institution undertakes certain diligence and reporting obligations and other
specified requirements are satisfied, or (b) the non-financial foreign entity either certifies it does not have any substantial
U.S. owners or furnishes identifying information regarding each substantial U.S. owner and other specified requirements are satisfied.
&ldquo;Withholdable payment&rdquo; generally means any payment of interest, dividends, rents, and certain other types of generally
passive income if such payment is from sources within the United States. U.S. Treasury Regulations proposed in December 2018 (and
upon which taxpayers and withholding agents are entitled to rely) eliminate possible withholding under these rules on the gross
proceeds from any sale or other disposition of our common stock, previously scheduled to apply beginning January 1, 2019. If the
payee is a foreign financial institution, it must enter into an agreement with the U.S. Treasury requiring, among other things,
that it undertake to identify accounts held by certain U.S. persons or U.S.-owned foreign entities, annually report certain information
about such accounts and withhold 30% on payments to account holders whose actions prevent it from complying with these reporting
and other requirements, or comply with comparable requirements under an applicable inter-governmental agreement between the United
States and the foreign financial institution&rsquo;s home jurisdiction. If an investor does not provide us with the information
necessary to comply with these rules, it is possible that distributions to such investor that are attributable to withholdable
payments, such as dividends, will be subject to the 30% withholding tax. Holders should consult their own tax advisers regarding
the implications of these rules for their investment in our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a22"></A>UNDERWRITING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have entered into an underwriting agreement,
dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021, with ThinkEquity, a division
of Fordham Financial Management, Inc., acting as the sole book-running manager (sometimes referred to as the &ldquo;Representative&rdquo;).
Subject to the terms and conditions of the underwriting agreement, each of the underwriters named below have agreed to purchase,
and we have agreed to sell to it, the number of shares of common stock listed next to its name at the public offering price, less
the underwriting discounts and commissions, as set forth on the cover page of this prospectus and as indicated below:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 84%; border-bottom: black 1pt solid"><B>Underwriters</B></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 13%; border-bottom: black 1pt solid"><B>Number of Shares</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>ThinkEquity, a division of Fordham Financial Management, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt double">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The underwriting agreement provides that
the obligations of the underwriters to pay for and accept delivery of the shares of common stock offered by this prospectus are
subject to various conditions and representations and warranties, including the approval of certain legal matters by its counsel
and other conditions specified in the underwriting agreement. The shares of common stock are offered by the underwriters, subject
to prior sale, when, as and if issued to and accepted by the underwriters. The underwriters reserve the right to withdraw, cancel
or modify the offer to the public and to reject orders in whole or in part. The underwriters are obligated to take and pay for
all of the shares of common stock offered by this prospectus if any such shares are taken.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have agreed to indemnify the underwriters
and certain of their affiliates and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act), among others, against specified liabilities, including liabilities under the Securities Act, and to contribute
to payments the underwriters may be required to make in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Discounts and Commissions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The underwriters propose to offer the
shares of common stock directly to the public at the public offering price set forth on the cover page of this prospectus. After
the offering to the public, the offering price and other selling terms may be changed by the underwriters without changing the
proceeds we will receive from the underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The following table summarizes the
public offering price, underwriting commissions and proceeds before expenses to us. The underwriting commissions are 6.4% of the
public offering price. We have paid a $35,000 advance to the Representative, which shall be applied against actual out-of-pocket-accountable
expenses, and which will be returned to us to the extent such out-of-pocket accountable expenses are not actually incurred in
accordance with FINRA Rule 5110(g)(4)(A). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><SUP>&nbsp;</SUP></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per Share</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total Without<BR> Over-Allotment<BR>
    Option</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total With Full<BR> Over-Allotment<BR>
    Option</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 55%">Public offering price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Underwriting discount (6.4%) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Proceeds, before expenses, to us</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> Our total estimated expenses of the
offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding underwriting
discounts and commissions, are approximately $290,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Over-Allotment Option</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have granted a 45-day option to the
Representative to purchase up to 642,857 additional shares of common stock from us solely to cover over-allotments, if any, at
the public offering price less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Representative&rsquo;s Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon closing of this offering, we have
agreed to issue to the Representative, or its designees, as compensation warrants to purchase a number of shares of common stock
equal to 5% of the aggregate number of shares of common stock sold in this offering (the &ldquo;Representative&rsquo;s Warrants&rdquo;).
The Representative&rsquo;s Warrants will be exercisable at a per share exercise price equal to 125% of the public offering price
per share in this offering. The Representative&rsquo;s Warrants are exercisable at any time and from time to time, in whole or
in part, during the four and one-half year period commencing 180 days from the effective date of the registration statement of
which this prospectus is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Representative&rsquo;s Warrants have
been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative
(or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities
underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result
in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective
date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases.
The one-time demand registration right provided will not be greater than five years from the effective date of the registration
statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater
than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear
all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions
incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted
in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation.
However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price
below the warrant exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Discretionary Accounts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The underwriters do not intend to confirm
sales of the securities offered hereby to any accounts over which they have discretionary authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Lock-Up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We, our executive officers and directors,
and our 5% and greater stockholders, have agreed pursuant to &ldquo;lock-up&rdquo; agreements not to, or are subject to other
restrictions so that they may not, without the prior written consent of the Representative, directly or indirectly, offer to sell,
sell, pledge or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to,
or could be expected to, result in the transfer or disposition by any person at any time in the future of) our common stock, enter
into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or
risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration
statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible
into or exercisable or exchangeable for shares of common stock or any other of our securities or publicly disclose the intention
to do any of the foregoing, subject to customary exceptions, for, with respect to the Company, a period of 90 days from the date
of this prospectus, and with respect to our executive officers and directors and our 5% and greater stockholders, a period of
180 days from the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Right of First Refusal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have granted the Representative a right
of first refusal, for a period of twelve (12) months from the closing of the offering, to act as sole and exclusive investment
banker, book-runner, financial advisor, underwriter and/or placement agent, at the Representative&rsquo;s sole and exclusive discretion,
for each and every future public and private equity and debt offering, including all of our equity linked financings (each, a
&ldquo;Subject Transaction&rdquo;), or any successor (or any of our subsidiaries), on terms and conditions customary to the Representative
for such Subject Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nasdaq Capital Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have applied to have our shares of
common stock listed on the Nasdaq Capital Market under the symbol &ldquo;UGRO&rdquo;. Our application might not be approved and
the consummation of this offering is contingent upon such approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Price Stabilization, Short Positions and Penalty Bids</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In order to facilitate the offering of
our securities, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of our securities.
In connection with the offering, the underwriters may purchase and sell our securities in the open market. These transactions
may include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions.
Short sales involve the sale by the underwriters of a greater number of shares of securities than they are required to purchase
in the offering. &ldquo;Covered&rdquo; short sales are sales made in an amount not greater than the underwriters&rsquo; option
to purchase additional shares of securities in the offering. The underwriters may close out any covered short position by either
exercising the over-allotment option to purchase shares or purchasing shares in the open market. In determining the source of
shares of securities to close out the covered short position, the underwriters will consider, among other things, the price of
shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment
option to purchase shares. &ldquo;Naked&rdquo; short sales are sales in excess of the over-allotment option to purchase shares.
The underwriters must close out any naked short position by purchasing securities in the open market. A naked short position is
more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our securities
in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions
consist of various bids for or purchases of shares of securities made by the underwriters in the open market before the completion
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Similar to other purchase transactions,
the underwriters&rsquo; purchases to cover the syndicate short sales may have the effect of raising or maintaining the market
price of our securities or preventing or retarding a decline in the market price of our securities. As result, the price of our
securities may be higher than the price that might otherwise exist in the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The underwriters make no representation
or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our
securities. In addition, neither we nor the underwriters make any representation that the underwriters will engage in these transactions
or that these transactions, once commenced, will not be discontinued without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Electronic Offer, Sale and Distribution of Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A prospectus in electronic format may
be made available on the websites maintained by the underwriters or selling group members, if any, participating in the offering.
The underwriters may agree to allocate a number of shares of securities to underwriters and selling group members for sale to
their online brokerage account holders. Internet distributions will be allocated by the underwriter and selling group members
that may make internet distributions on the same basis as other allocations. Other than the prospectus in electronic format, the
information on any underwriter&rsquo;s website and any information contained in any other website maintained by an underwriter
is not part of this prospectus or the registration statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Other Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">From time to time, the underwriters and/or
their affiliates may provide in the future, various advisory, investment and commercial banking and other services to us in the
ordinary course of business, for which they will receive customary fees and commissions. However, except as disclosed in this
prospectus, we have no present arrangements with the underwriters or any of their affiliates for any further services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pricing of the Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The public offering price was determined
by negotiations between us and the Representative. Among the factors considered in determining the public offering price were
our future prospects and those of our industry in general, our sales, earnings and certain other financial and operating information
in recent periods, and the price-earnings ratios, price-sales ratios, market prices of securities, and certain financial and operating
information of companies engaged in activities similar to ours. Neither we nor the underwriters can assure investors that an active
trading market for the shares will develop or that, after the offering, the shares will trade in the public market at or above
the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Offer Restrictions Outside the United States</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Other than in the United States, no action
has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any
jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold,
directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer
and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in
compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes
are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus
in any jurisdiction in which such an offer or a solicitation is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Canada</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The securities may be sold in Canada only
to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument
45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National
Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must
be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities
laws. Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission
or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission
or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s
province or territory for particulars of these rights or consult with a legal advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>China</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information in this document does
not constitute a public offer of the securities, whether by way of sale or subscription, in the People&rsquo;s Republic of China
(excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan).
The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to
&ldquo;qualified domestic institutional investors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>European Economic Area&thinsp;&mdash;&thinsp;Belgium,
Germany, Luxembourg and Netherlands</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">The information in this document has been
prepared on the basis that all offers of securities will be made pursuant to an exemption under the Directive 2003/71/EC (&ldquo;Prospectus
Directive&rdquo;), as implemented in Member States of the European Economic Area (each, a &ldquo;Relevant Member State&rdquo;),
from the requirement to produce a prospectus for offers of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">An offer to the public of securities has
not been made, and may not be made, in a Relevant Member State except pursuant to one of the following exemptions under the Prospectus
Directive as implemented in that Relevant Member State:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to legal
                                         entities that are authorized or regulated to operate in the financial markets or, if
                                         not so authorized or regulated, whose corporate purpose is solely to invest in securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to any
                                         legal entity that has two or more of (i) an average of at least 250 employees during
                                         its last fiscal year; (ii) a total balance sheet of more than &euro;43,000,000 (as shown
                                         on its last annual unconsolidated or consolidated financial statements) and (iii) an
                                         annual net turnover of more than &euro;50,000,000 (as shown on its last annual unconsolidated
                                         or consolidated financial statements);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to fewer
                                         than 100 natural or legal persons (other than qualified investors within the meaning
                                         of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent
                                         of the Company or any underwriter for any such offer; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>in any
                                         other circumstances falling within Article 3(2) of the Prospectus Directive, provided
                                         that no such offer of securities shall result in a requirement for the publication by
                                         the Company of a prospectus pursuant to Article 3 of the Prospectus Directive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Hong Kong</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Neither the information in this document
nor any other document relating to the offer has been delivered for registration to the Registrar of Companies in Hong Kong, and
its contents have not been reviewed or approved by any regulatory authority in Hong Kong, nor have we been authorized by the Securities
and Futures Commission in Hong Kong. This document does not constitute an offer or invitation to the public in Hong Kong to acquire
shares. Accordingly, unless permitted by the securities laws of Hong Kong, no person may issue or have in its possession for the
purpose of issue, this document or any advertisement, invitation or document relating to the shares, whether in Hong Kong or elsewhere,
which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong other than in relation
to shares which are intended to be disposed of only to persons outside Hong Kong or only to &ldquo;professional investors&rdquo;
(as such term is defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (&ldquo;SFO&rdquo;) and the
subsidiary legislation made thereunder) or in circumstances which do not result in this document being a &ldquo;prospectus&rdquo;
as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance of Hong Kong (Cap. 32 of the Laws of Hong Kong)
(the &ldquo;CO&rdquo;) or which do not constitute an offer or an invitation to the public for the purposes of the SFO or the&nbsp;CO.
The offer of the shares is personal to the person to whom this document has been delivered by or on behalf of our company, and
a subscription for shares will only be accepted from such person. No person to whom a copy of this document is issued may issue,
circulate or distribute this document in Hong Kong or make or give a copy of this document to any other person. You are advised
to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this document, you should obtain
independent professional advice. No document may be distributed, published or reproduced (in whole or in part), disclosed by or
to any other person in Hong Kong or to any person to whom the offer of sale of the shares would be a breach of the CO or SFO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Israel</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The securities offered by this prospectus
have not been approved or disapproved by the Israeli Securities Authority (the &ldquo;ISA&rdquo;), nor have such securities been
registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent
the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with the offering or publishing
the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered
an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the
securities offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with
the Israeli securities laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>United Kingdom</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Neither the information in this document
nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United
Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as amended (&ldquo;FSMA&rdquo;))
has been published or is intended to be published in respect of the securities. This document is issued on a confidential basis
to &ldquo;qualified investors&rdquo; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and the securities may
not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document, except
in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not
be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person
in the United Kingdom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any invitation or inducement to engage
in investment activity (within the meaning of section 21 of FSMA) received in connection with the issue or sale of the securities
has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United
Kingdom in circumstances in which section 21(1) of FSMA does not apply to our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the United Kingdom, this document is
being distributed only to, and is directed at, persons (i) who have professional experience in matters relating to investments
falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions)
Order 2005 (&ldquo;FPO&rdquo;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high net
worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together
&ldquo;relevant persons&rdquo;). The investments to which this document relates are available only to, and any invitation, offer
or agreement to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act
or rely on this document or any of its contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a23"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The validity of the shares of common stock
offered hereby will be passed upon for us by Nelson Mullins Riley &amp; Scarborough LLP, Raleigh, North Carolina. Dentons US LLP,
New York, New York, is acting as counsel for the underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a24"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The consolidated financial statements
of urban-gro, Inc. as of December 31, 2019 and 2018 and for the years then ended included in this prospectus have been so included
in reliance on the reports of BF Borgers CPA PC, an independent registered public accounting firm, which are included herein,
given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a25"></A>WHERE YOU CAN FIND
MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have filed with the SEC a registration
statement on Form S-1 under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This
prospectus, which constitutes part of the registration statement, does not contain all of the information set forth in the registration
statement or the exhibits and schedules filed therewith. Statements contained in this prospectus regarding the contents of any
contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and each
such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit
to the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are subject to the information and
periodic requirements of the Exchange Act and, in accordance therewith, file annual, quarterly and current reports, proxy statements
and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other
information regarding registrants that file electronically with the SEC. The address is www.sec.gov. We also maintain a website
at www.urban-gro.com. You may access our annual reports on Form 10-K, quarterly reports on Form10-Q, current reports on Form 8-K,
and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of
charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The reference to
our website does not constitute incorporation by reference of the information contained on or accessible through our website,
and you should not consider the contents of our website in making an investment decision with respect to our common stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fsindex"></A>INDEX TO FINANCIAL
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Page</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%"><B>Unaudited Interim Financial Statements:</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#sept01">Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#sept02">Consolidated Statements of Operations for the Three and Nine Months ended September 30, 2020 and 2019</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#sept03">Consolidated Statement of Changes in Stockholders&rsquo; Equity (Deficit) for the Three and Nine Months
    ended September 30, 2020 and 2019</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#sept04">Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2020 and 2019</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-6</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#sept05">Notes to the Consolidated Financial Statements</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-7</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><B>Audited Annual Financial Statements:</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec01">Report of Independent Registered Accounting Firm</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-18</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec02">Consolidated Balance Sheets as of December 31, 2019 and 2018</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-19</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec03">Consolidated Statements of Operations for the Years ended December 31, 2019 and 2018</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-20</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec04">Consolidated Statement of Changes in Stockholders&rsquo; Equity (Deficit) for the years ended December
    31, 2019 and 2018</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-21</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec05">Consolidated Statements of Cash Flows for the years ended December 31, 2019 and 2018</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-22</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="#dec06">Notes to the Consolidated Financial Statements</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">F-23</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 89; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="sept01"></A><B>CONDENSED CONSOLIDATED
BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-indent: -10pt; padding-left: 20pt">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">213,392</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">448,703</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">853,585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,564,969</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">775,064</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Related party receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,772</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,658</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Prepayments and other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,734,382</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,278,728</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,586,195</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,018,233</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">152,577</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,035</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Operating lease right of use assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">114,017</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,848</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,710,358</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,020,358</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">902,067</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">902,067</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Intangible assets, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">84,924</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">86,151</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,963,943</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,389,459</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,550,138</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,407,692</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,132,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,753,862</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,863,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,686,841</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Related party payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,972</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,087,592</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,915,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Related party note payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,812,709</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Revolving Facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">600,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Term Loan, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,596,280</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">80,339</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">123,395</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,419,327</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,317,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Non-current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Revolving Facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,676,493</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Term Loan, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,318</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Related Party note payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,020,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,347</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">98,841</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,834,758</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">98,841</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14,254,085</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,416,026</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Shareholders&rsquo; deficit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Preferred stock, $0.10 par value; 10,000,000 shares authorized;
    0 shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Common stock, $0.001 par value; 100,000,000 shares authorized; 28,272,285
    and 28,209,312 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,272</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,209</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,118,289</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,854,083</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(20,850,508</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(16,890,626</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,703,947</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,008,334</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,550,138</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,407,692</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="sept02"></A><B>CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; text-align: left; text-indent: -10pt; padding-left: 20pt">Product sales</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">7,910,540</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">4,633,974</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">15,135,472</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">14,469,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Services</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">448,882</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">949,090</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,490,216</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,587,121</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total Revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,359,422</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,583,064</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">16,625,688</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,056,737</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cost of Revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,654,134</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,650,965</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,613,461</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,529,448</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Gross profit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,705,288</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,932,099</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,012,227</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,527,289</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Marketing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,749</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">263,948</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">236,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">914,563</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,411,821</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,874,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,892,623</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">General and administrative - amortization of broker issuing
    costs and broker warrants associated with convertible debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Stock-based compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">399,258</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">509,219</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,391,807</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,606,355</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,853,828</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,324,921</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,502,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,581,375</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(148,540</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,392,822</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,490,056</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,054,086</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-operating income (expenses):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(393,158</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(125,733</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,057,501</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(374,850</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense &ndash; amortization of convertible
    debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(796,233</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(796,233</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(155,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(155,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Impairment of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(506,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(310,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(506,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,417</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,258</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52,675</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,765</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-operating income (expenses), net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(545,741</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,416,708</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,469,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,665,318</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Income (loss) before income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(694,281</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,809,530</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,959,882</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,719,404</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense (benefit)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(649,281</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,809,530</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,959,882</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,719,404</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(694,281</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,809,530</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,959,882</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,719,404</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Earnings (loss) per share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Net loss per share - basic and
    diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.22</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average shares used in computation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,888,194</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,175,098</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,706,905</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,772,134</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">See accompanying
notes to condensed consolidated financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="sept03"></A><B>CONDENSED CONSOLIDATED
STATEMENTS OF SHAREHOLDERS' DEFICIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>Additional</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>Paid
                                         in</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Total<BR>
    Shareholders'</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-weight: bold"><FONT STYLE="font-size: 9pt">Balance, June 30, 2020</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,830,978</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,830</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">13,522,833</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(20,156,227</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(6,604,564</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">399,258</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">399,258</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant to satisfy accounts
    payable</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,630</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant program vesting</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">131,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">132</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(132</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issuance related to
    acquisition</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">154,750</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">155,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Clawback of stock granted</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issued for lease revision</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">30,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">31,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Net income (loss) for
    period ended September 30, 2020</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(694,281</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(694,281</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Balance, September 30, 2020</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,272,285</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,272</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">14,118,289</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(20,850,508</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(6,703,947</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>Additional</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>Paid
                                         in</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Total Shareholders'</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-weight: bold"><FONT STYLE="font-size: 9pt">Balance, June 30, 2019</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,820,633</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,821</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">8,438,943</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(11,449,927</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(2,985,163</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">509,219</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">509,219</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock options issued for
    loan term revisions</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">20,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">20,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant program vesting</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,160,833</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,160</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,160</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Net income (loss) for
    period ended September 30, 2019</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(2,809,530</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(2,809,530</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Balance, September 30, 2019</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">26,981,466</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">26,981</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">8,967,004</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(14,259,457</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(5,265,472</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
SHAREHOLDERS' DEFICIT (Continued)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Additional<BR>
    Paid in</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Total<BR>
    Shareholders'</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-weight: bold"><FONT STYLE="font-size: 9pt">Balance, December 31, 2019</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,209,312</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,209</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">11,854,083</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(16,890,626</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(5,008,334</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,391,807</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,391,807</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant to satisfy accounts
    payable</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,630</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">9,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issuance related to
    loan term revisions</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">99,900</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant program vesting</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">253,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">253</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(253</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Clawback of stock granted</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issuance related to
    debt</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">499,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issuance related to
    acquisition</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">154,750</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">155,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Warrant issuance related
    to debt</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">76,822</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">76,822</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issued for lease revision</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">30,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">31,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Net
    income (loss) for period ended September 30, 2020</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(3,959,882</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(3,959,882</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Balance, September 30, 2020</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,272,285</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">28,272</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">14,118,289</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(20,850,508</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(6,703,947</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Additional<BR>
    Paid in</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Total<BR>
    Shareholders'</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-weight: bold"><FONT STYLE="font-size: 9pt">Balance, December 31, 2018</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,229,833</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,230</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">4,688,272</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(8,540,053</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 9%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(3,826,551</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,606,355</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,606,355</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock options issued for
    loan term revisions</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">37,830</TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">37,830</TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grants issued for
    loan term revisions</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">10,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">24,090</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">24,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock grant program vesting</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">1,241<FONT STYLE="font-size: 9pt">,633</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,241</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(1,241</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock issuance related to
    acquisition</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">999,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Warrant issuance related
    to convertible debentures</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">614,041</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">614,041</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Equity value of exercise
    price associated with convertible debentures</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">719,479</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">719,479</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Broker warrants associated
    with issuance of convertible debentures</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">278,678</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">278,678</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Net
    income (loss) for period ended September 30, 2019</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(5,719,404</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(5,719,404</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Balance, September 30, 2019</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">26,981,466</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">26,981</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">8,967,004</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(14,259,547</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(5,265,472</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="sept04"></A>CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine
                                         Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Operating Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Net income (loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(3,959,882</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(5,719,404</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Adjustments to reconcile net income (loss) from operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">193,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">368,661</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of convertible debenture components</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">810,166</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,391,807</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,606,355</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Contingent consideration expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Impairment of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">310,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">506,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on disposal of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,468</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,572</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Inventory write-offs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,258</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,352</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Bad debt expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,849</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,252</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Changes in operating assets and liabilities (excluding
    effects of acquisitions):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">658,706</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(899,859</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(171,147</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,745</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Prepayments and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(784,210</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">123,376</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts payable and accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,470,559</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,164,412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,172,186</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">925,922</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Used In Operating Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,028,113</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(86,299</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Investing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(572,250</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,817</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(387,160</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Cash acquired in acquisition</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,742</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Used In Investing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(122,817</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(894,168</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Financing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of Revolving Facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,207,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of Term Loan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from Revolving Facility advances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,069,061</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Issuance of convertible debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,565,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,020,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">970,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Debt financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(638,046</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Repayment of notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,743,428</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(227,749</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Provided by Financing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,915,619</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,307,251</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Net Increase (Decrease) in Cash</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(235,311</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,326,784</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Cash at Beginning of Period</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">448,703</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,178,852</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Cash at End of Period</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">213,392</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,505,636</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental Cash Flow Information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">670,165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">291,441</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Income Taxes Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Operating lease right of use asset set-up effective January
    1, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">326,095</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Debt financing costs booked in equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">676,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock issued for acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">155,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,020,003</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Note 1 regarding the acquisition of Impact Engineering,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="sept05"></A>NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1 &ndash; ORGANIZATION AND ACQUISITIONS,
LIQUIDITY AND GOING CONCERN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Organization and Acquisitions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">urban-gro, Inc. (&ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our,&rdquo; the &ldquo;Company,&rdquo; or &ldquo;urban-gro&rdquo;) is a leading engineering and design services company
focused on the commercial indoor horticulture market. We engineer and design indoor <FONT STYLE="color: #000712">controlled environment
agriculture (&ldquo;CEA&rdquo;) facilities a</FONT>nd then integrate complex environmental equipment systems into those facilities.
Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including
leafy greens, vegetables, herbs, and plant-based medicines like cannabis and hemp. Our custom-tailored approach to design, procurement,
and equipment integration provides a single point of accountability across all aspects of indoor growing operations. We also help
our clients achieve operational efficiency and economic advantages through a full spectrum of professional services and programs
focused on facility optimization and environmental health which allows <FONT STYLE="color: #000712">clients to manage their entire
cultivation lifecycle, establishing facilities that operate and perform at the highest level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #000712">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our indoor commercial cultivation solution
offers an integrated suite of services and equipment systems that generally fall within the following categories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Service
                                         Solutions:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Engineering
                                         Design Services &ndash; A comprehensive triad of services including:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="text-align: left; width: 3%">i.</TD><TD STYLE="text-align: justify; width: 81%">Cultivation
                                         Space Programming (&ldquo;CSP&rdquo;)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="text-align: left; width: 3%">ii.</TD><TD STYLE="text-align: justify; width: 81%">Integrated
                                         Cultivation Design (&ldquo;ICD&rdquo;)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="text-align: left; width: 3%">iii.</TD><TD STYLE="text-align: justify; width: 81%">Full-Facility
                                         Mechanical, Electrical, and Plumbing (&ldquo;MEP&rdquo;)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">gro-care&reg;
                                         - A recurring revenue subscription-based managed service offering including:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="width: 3%">i.</TD><TD STYLE="text-align: justify; width: 81%">Remote Monitoring,
                                         Reporting, Support, and Training Services</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="width: 3%">ii.</TD><TD STYLE="text-align: justify; width: 81%">Facility and Equipment
                                         Commissioning &amp; Audit Services</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 16%"></TD><TD STYLE="width: 3%">iii.</TD><TD STYLE="text-align: justify; width: 81%">Environmental Sciences
                                         Groups&rsquo; (&ldquo;ESG&rdquo;) Compliance and Program Services</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Integrated
                                         Equipment Solutions:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Design,
                                         Source, and Integration of Complex Environmental Equipment Systems Including Purpose-Built
                                         Heating, Ventilation, and Air Conditioning (&ldquo;HVAC&rdquo;) solutions, Environmental
                                         Controls, Fertigation, and Irrigation Distribution.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value-Added
                                         Reselling (&ldquo;VAR&rdquo;) of Cultivation Equipment including a Complete line of Lighting
                                         and Rolling Benching Systems</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8%"></TD><TD STYLE="width: 4%"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Strategic
                                         Vendor Relationships with Premier Manufacturers</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="color: #000712">Since
commencing business in March 2014, we have introduced new equipment solutions, products and services to the CEA market, expanded
our ongoing operations across North America, and most recently, we have entered into several engagements in Europe. </FONT>In
June 2018, the Company formed urban-gro Canada Technologies, Inc. as a wholly owned Canadian subsidiary, which it utilizes for
its Canadian sales operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective March 7, 2019, the Company acquired
100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&ldquo;Impact&rdquo;), a provider of mechanical electrical and
plumbing (&ldquo;MEP&rdquo;) engineering services predominantly focused on the indoor commercial horticulture industry. The Company
believes the acquisition of Impact will improve the Company&rsquo;s ability to better serve its current and future client base
by expanding on the fully integrated products and services offered by the Company. The Company initially issued 500,000 shares
of Common Stock valued at $2.00 per share to effect the acquisition of Impact. The Company accounted for the initial acquisition
of Impact as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%">Purchase Price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Allocation of Purchase Price:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">49,742</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">93,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">902,067</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">45,620</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the agreement to acquire
Impact, the Company was required to issue additional shares of Common Stock to the former Impact owner if the average closing
price per share of the Company&rsquo;s Common Stock was less than or equal to $2.00 per share for the 30-day period beginning
on the date that was 150 days after the initial date of the listing of the Company&rsquo;s Common Stock on a national securities
exchange or quotation on the OTCQB or OTCQX (the &ldquo;Valuation Period&rdquo;). The Company&rsquo;s Common Stock price was lower
than $2.00 per share during the Valuation Period and the Company was required to issue additional shares of the Company&rsquo;s
Common Stock to the former Impact owner. In September 2020, however, the Company and the former Impact owner agreed to satisfy
this provision of the agreement by the Company issuing 250,000 additional shares of Common Stock to the former Impact owner. The
Company valued the issuance of these additional 250,000 shares at $0.62 per share of Common Stock based on the market price of
our shares on the date of the agreement and recorded the additional issuance of shares as contingent consideration in the statements
of operations and comprehensive income (loss).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Liquidity and Going Concern</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since inception, the Company has incurred
significant operating losses and has funded its operations primarily through the issuance of equity securities, debt, and operating
revenue. As of September 30, 2020, the Company had an accumulated deficit of $20,850,508, a working capital deficit of $4,833,132,
and negative stockholders&rsquo; equity of $6,703,947. These facts and conditions raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern, within one year after the date that these financial statements are issued. The Company
continually evaluates opportunities to raise equity and debt financing and has also sought to implement cost reduction and revenue
enhancing measures to help achieve profitability and continue operations. There can, however, be no assurances that the Company
will be able to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can
there be any assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable
the Company to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going
concern basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Accounting Standards Codification
(&ldquo;ASC&rdquo;) 205-40, <I>Disclosure of Uncertainties about an Entity&rsquo;s Ability to Continue as a Going Concern, </I>we
assess going concern uncertainty for our condensed consolidated financial statements to determine if we have sufficient cash and
cash equivalents on hand and working capital to operate for a period of at least one year from the date the condensed consolidated
financial statements are issued or are available to be issued. As part of this assessment, based on conditions that are known
and reasonably knowable to us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key
assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those
expenditures or programs, among other factors, if necessary. We believe it is probable that management&rsquo;s plans, when implemented,
will mitigate the relevant conditions or events that raise substantial doubt about the Company&rsquo;s ability to continue as
a going concern within one year after the date that the financial statements are issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 2 &ndash; SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Unaudited Condensed Consolidated Financial
Statements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has prepared the accompanying
condensed consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting.
The condensed consolidated financial statements are unaudited and, in the Company&rsquo;s opinion, include all adjustments, consisting
of normal recurring adjustments and accruals necessary for a fair presentation of the Company&rsquo;s condensed consolidated balance
sheets, condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of
shareholders&rsquo; deficit and condensed consolidated statements of cash flows for the periods presented. The results reported
in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected
for the entire year. Certain information and footnote disclosures normally included in financial statements prepared in accordance
with accounting principles generally accepted in the United States (&ldquo;GAAP&rdquo;) have been omitted in accordance with regulations
of the SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and
notes thereto included in the Company&rsquo;s consolidated financial statements in the Company&rsquo;s Annual Report on Form 10-K
for the year ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Significant Accounting Policies</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a detailed discussion about the Company&rsquo;s
significant accounting policies, refer to Note 2 &mdash; &ldquo;Summary of Significant Accounting Policies,&rdquo; in the Company&rsquo;s
consolidated financial statements included in the Company&rsquo;s 2019 Form 10-K. During the nine months ended September 30, 2020,
there were no material changes made to the Company&rsquo;s significant accounting policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Use of Estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing condensed consolidated financial
statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements
and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates
include estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for
deferred tax assets, and allowance for bad debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Reclassification</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified
for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recently Issued Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &ldquo;FASB&rdquo;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&quot;ASU&quot;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&rsquo;s financial statements upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; RELATED PARTY TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company previously purchased certain
cultivation products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&ldquo;Bravo&rdquo;) and Enviro-Glo, LLC (&ldquo;Enviro-Glo&rdquo;),
manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&rsquo;s
two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $0 and $43,912 for
the nine months ended September 30, 2020 and 2019, respectively, and $0 and $7,442 for the three months ended September 30, 2020
and 2019, respectively. There were no outstanding receivables from Bravo and Enviro-Glo as of September 30, 2020 and December
31, 2019. Net outstanding payables incurred for purchases of inventory and other services to Bravo and Enviro-Glo as of September
30, 2020 and December 31, 2019 were $0 and $8,570, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has made payments to Cloud
9 Support, LLC (&ldquo;Cloud 9&rdquo;), a company owned by James Lowe, a director, shareholder, and debt holder. Payments to Cloud
9 were $0 and $75,617 during the nine months ended September 30, 2020 and 2019, respectively, and $0 and $24,368 during the three
months ended September 30, 2020 and 2019, respectively. Cloud 9 also purchases materials from the Company. Total sales to Cloud
9 from the Company were $359,562 and $229,688 during the nine months ended September 30, 2020 and 2019, respectively, and $112,405
and $103,088 during the three months ended September 30, 2020 and 2019, respectively. Outstanding receivables from Cloud 9 as
of September 30, 2020 and December 31, 2019 totaled $9,772 and $49,659, respectively. Net outstanding payables to Cloud 9 as of
September 30, 2020 and December 31, 2019 were $0 and $16,402, respectively.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2018, the Company received
a $1,000,000, unsecured, interest only, promissory note (the &ldquo;Promissory Note&rdquo;) from Cloud 9. The Promissory Note
was originally due April 30, 2019. The Promissory Note is personally guaranteed by the Company&rsquo;s largest shareholders, Bradley
Nattrass, who is the Company&rsquo;s Chairman and Chief Executive Officer, and Octavio Gutierrez, a former officer and director
of the Company. The Promissory Note includes additional consideration of 30,000 options at an exercise price of $1.20 per share.
Under the initial terms of the Promissory Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019,
the due date of the Promissory Note was extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable
monthly. In connection with the execution of the Credit Agreement (see Note 9 &ndash; Debt) on February 21, 2020, the Company
entered into an agreement to amend the Promissory Note (the &ldquo;Amending Agreement&rdquo;). Pursuant to the Amending Agreement,
Cloud 9 agreed to extend the maturity date of the Promissory Note from December 31, 2019 to the date which is the earlier of 60
days following the date: (a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the
maturity date of the Credit Agreement. As part of the Amending Agreement, the Company issued 100,000 shares of Common Stock to
James Lowe as designee of Cloud 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash; PREPAYMENTS AND OTHER
ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Prepayments and other assets are
comprised of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Vendor prepayments</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,828,531</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,070,788</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Prepaid services and fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">268,655</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">187,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Deferred financing asset (See Note 9 - Debt)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">630,805</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,391</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20,028</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Prepayments and other assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,734,382</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,278,728</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 5 &ndash; INVESTMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of investments are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September
                                         30,</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2020</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <BR> 2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Investment in Edyza</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,710,358</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,710,358</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Investment in TGH</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">310,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,710,358</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,020,358</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">On January 24, 2020, the Company
entered into a Membership Interest Redemption Agreement (the &ldquo;Redemption Agreement&rdquo;) with Total Grow Holdings LLC
(d/b/a Total Grow Control, LLC) (&ldquo;TGH&rdquo;), whereby the Company agreed to sell the Company&rsquo;s 24.4% membership interests
in TGH back to TGH for total consideration of $370,000. As a result of TGH&rsquo;s failure to perform its obligations under the
Redemption Agreement, the Company initiated a lawsuit against TGH seeking damages (the &ldquo;Lawsuit&rdquo;), and subsequently
fully impaired the remaining investment in TGH during the three months ended June 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">On September 24, 2020, the Company
and TGH entered into a Settlement Agreement (the &ldquo;Settlement Agreement&rdquo;), pursuant to which the parties agreed to
settle all claims brought in the Lawsuit. Pursuant to the Settlement Agreement, TGH agreed to pay the Company a total of $61,919
in six equal installments. TGH&rsquo;s first payment was due by October 4, 2020. TGH also agreed to reimburse the Company for
up to $25,000 of its attorney&rsquo;s fees related to the Lawsuit and the Settlement Agreement. In consideration of the foregoing
and subject to TGH satisfying its payment obligations, the Company agreed to release any and all claims related to the Lawsuit.
The Settlement Agreement also provides for a mutual release between the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">On September 24, 2020, in connection
with the Settlement Agreement, the Company also entered into an agreement (the &ldquo;Pullar Agreement&rdquo;) by and between
the Company and George R. Pullar, a former director of the Company and the Company&rsquo;s former chief financial officer and
the current chief financial officer of TGH. Pursuant to the Pullar Agreement, in exchange for Mr. Pullar relinquishing all right,
title and interest in and to 1,000,000 shares of the Company&rsquo;s common stock, the Company agreed to (i) execute the Settlement
Agreement, (ii) transfer, sell and assign to Mr. Pullar the Company&rsquo;s 24.4% membership interest in TGH pursuant to the Settlement
Agreement and (iii) issue Mr. Pullar a fully vested warrant, to purchase 400,000 shares of Common Stock at an exercise price of
$1.00 per share which expires five years from the date of issuance. The Pullar Agreement also provides for a mutual release between
the Company and Mr. Pullar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 6 &ndash; GOODWILL </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded goodwill in conjunction
with the initial acquisition of Impact on March 7, 2019. The goodwill balance as of September 30, 2020 and December 31, 2019 was
$902,067. Goodwill is not amortized. There is no goodwill for income tax purposes. The Company did not record any impairment charges
related to goodwill for the periods ended September 30, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 7 &ndash; ACCRUED EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Accrued operating expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">798,752</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">854,056</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued wages and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">402,710</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">487,327</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Accrued interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,635</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accrued sales tax payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">616,999</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">345,458</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,863,096</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,686,841</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued sales tax payable is comprised
of amounts due to various states and Canadian provinces for 2015 through 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 8 &ndash; NOTES PAYABLE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of notes payable
excluding related party notes payable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Unsecured, interest only, note payable with Chris Parkes originally due December
    31, 2018. Initial interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending
    the maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest
    rate was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest
    rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly principal
    payments in the amount of $10,000.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">20,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">80,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018. Initial
    interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date
    to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased
    to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest rate, the Company
    issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly principal payments
    in the amount of $10,000.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Note payable with Hydrofarm Holdings Group, Inc. (&ldquo;Hydrofarm&rdquo;), secured by all currently
    existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a)
    90 days&rsquo; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December
    2023. The note was repaid in full on February 27, 2020.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing
    fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matured on May 7, 2020 but is
    repayable prior to maturity for less than the $1,350,000 in total payments. The note was repaid in full on February 27, 2020.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">632,709</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Paycheck Protection Program (&ldquo;PPP&rdquo;) loan entered into on April
    16, 2020. Interest rate of 1.0% per annum. Payments of principal and interest are deferred until August 1, 2021 (the &ldquo;Deferral
    Period&rdquo;). The PPP loan may be forgiven in part or fully depending on the Company meeting certain PPP loan forgiveness
    guidelines. The Company has not yet determined if any of the PPP loan is subject to forgiveness and has therefore continued
    to present the entire PPP loan as an obligation on its financial statements. Any unforgiven portion of the PPP loan is payable
    over a two-year term, with payments deferred during the Deferral Period. The Company may prepay the unforgiven loan balance
    at any time without payment of any premium.</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,020,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,080,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,812,709</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less current maturities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(60,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,812,709</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Long Term</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,020,600</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 9 &ndash; DEBT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company's borrowings as of September
30, 2020 and December 31, 2019 consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Revolving Facility</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">3,276,493</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Term Loan, net of $315,402 unamortized debt issuance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,684,598</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,961,091</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;Less current debt due within one year</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,196,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total long-term debt</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,764,811</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 21, 2020, we entered into
a letter agreement (the &ldquo;Credit Agreement&rdquo;) by and among the Company, as borrower, urban-gro Canada Technologies Inc.
and Impact., as guarantors, the lenders party thereto (the &ldquo;Lenders&rdquo;), and Bridging Finance Inc., as administrative
agent for the Lenders (the &ldquo;Agent&rdquo;). The Credit Agreement, which is denominated in Canadian dollars (C$), is comprised
of (i) a 12-month senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which was funded in
its entirety on the closing date (the &ldquo;Term Loan&rdquo;); and (ii) a 12-month demand revolving credit facility of up to
C$5.4 million ($4.0 million), which may be drawn from time to time, subject to the terms and conditions set forth in the Credit
Agreement and described further below (the &ldquo;Revolving Facility,&rdquo; and together with the Term Loan, the &ldquo;Facilities&rdquo;).
The Credit Agreement is personally guaranteed by the Company&rsquo;s CEO and Chairman, Brad Nattrass, and was to be in place for
the original term of the Credit Agreement (1 year) plus a 1-year extension period at the discretion of the Lender as provided
in the Credit Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final maturity date of the Facilities
was initially stipulated in the Credit Agreement as the earlier of (i) demand, and (ii) the date that is 12 months after the closing
date, with a potential extension to the date that is 24 months after the closing date (the &ldquo;Initial Maturity Date&rdquo;).
The Facilities bore interest at the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus
11% per annum. Accrued interest on the outstanding principal amount of the Facilities is due and payable monthly in arrears, on
the last business day of each month, and on the Initial Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Facility could initially
be borrowed and re-borrowed on a revolving basis by the Company during the term of the Facilities, provided that borrowings under
the Revolving Facility were limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable,
(ii) 85% of investment grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the
lesser of C$4.05 million ($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems
contracts and (B) 85% of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving
Facility may be prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan
may be prepaid in full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 4, 2020, the Company executed
an amendment to the Credit Agreement (the &ldquo;First Amendment&rdquo;) whereas the Facilities described above are now due on
December 31, 2021 (the &ldquo;Revised Maturity Date&rdquo;). The First Amendment also increased the rate at which the Facilities
will bear interest to the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 12% per annum
(14.5% as of September 30, 2020).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the First Amendment, the
Company is required to prepay, on or before January 31, 2021, $1,000,000 of the balance of the Term Loan and begin making monthly
payments of $100,000 on the balance on the Term Loan starting on March 1, 2021. Additionally, the Company is required to make
monthly payments of $50,000 on the balance under the Revolving Facility beginning October 1, 2020 and can make no more draws under
the Revolving Facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurred $1,314,868 of debt
issuance costs in connection with these Facilities, of which $676,822 was non-cash in the form of Common Stock and warrant issuances.
The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing
based on the market value of the underlying Common Stock at the valuation measurement date of $1.00, the remaining contractual
terms of the warrants of 5 years, risk free interest rate of 1.14% an expected volatility of the price of the underlying Common
Stock of 100%. The Company recorded the debt issuance costs as either a deferred financing asset or a direct reduction of the
loan obligation based on the pro-rata value of the Revolving Facility and Term Loan, respectively, on the closing date. The debt
issuance costs are amortized as interest expense over the life of the Facilities, until the Revised Maturity Date. As of September
30, 2020, there were $630,805 and $315,402 of unamortized debt issuance costs remaining related to the Revolving Facility and
Term Loan, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded interest expense
of $1,057,501 in the nine months ended September 30, 2020, of which $368,661 related to the amortization of debt issuance costs
on the Credit Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company
recorded interest expense of $374,850 in the nine months ended September 30, 2019. The Company recorded interest expense of $393,158
in the three months ended September 30, 2020, of which $164,941 related to the amortization of debt issuance costs on the Credit
Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company recorded
interest expense of $125,733 in the three months ended September 30, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 10 &ndash; UNIT OFFERING </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 9, 2019, the Company
executed a letter agreement with an exclusive placement agent in connection with a private placement offering. Beginning in March
2019, the placement agent initiated an offering (the &ldquo;Offering&rdquo;) of up to $6,000,000 from the sale of Units, with
each Unit consisting of a $1,000 Convertible Debenture (the &ldquo;Debentures&rdquo; or a &ldquo;Debenture&rdquo;) and Common
Stock Purchase Warrants (the &ldquo;Warrants&rdquo;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share
for a period of two years from the purchase date. The Debentures were due May 31, 2021 and bore interest at 8%, compounded annually,
with interest due at maturity. The Debentures, plus any accrued but unpaid interest, were to automatically convert for no additional
consideration into Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity
event was defined as: (a) the date on which the Company&rsquo;s Common Stock is listed for trading on a recognized stock exchange
in either Canada or the United States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying
both the conversion right included in the Debentures and underlying the Warrants, have been duly qualified by a registration statement
in the United States, allowing the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in
Canada. The Company filed a registration statement with the SEC on September 17, 2019, to register the securities in connection
with the Offering. That registration statement was declared effective October 16, 2019, triggering the liquidity event indicated
above and the $2,565,000 in Debentures plus $92,037 in accrued interest were converted into 1,102,513 Common Shares at $2.41 per
share. The Warrants contain a mandatory exercise provision if the weighted average share price of the Company&rsquo;s Common Stock
exceeds $5.00 per share for a period of five consecutive days. As of September 30, 2020, no Warrants had been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><B>NOTE 11 &ndash; RISKS AND UNCERTAINTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><U>Concentration Risk</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September
30, 2020 and 2019, one client represented 26% and 15% of total revenue, respectively. During the three months ended September
30, 2020 and 2019, one client represented 51% and 17% of total revenue, respectively. At September 30, 2020 one client represented
26% of total outstanding receivables. At December 31, 2019, one client represented 15% and another represented 11% of total outstanding
accounts receivables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September
30, 2020, 27% of the Company&rsquo;s total purchases were from one vendor. During the nine months ended September 30, 2019, 15%
of the Company&rsquo;s total purchases were from one vendor. During the three months ended September 30, 2020, 48% of the Company&rsquo;s
total purchases were from one vendor. During the three months ended September 30, 2019, 20% of the Company&rsquo;s total purchases
were from one vendor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Coronavirus Pandemic</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outbreak of COVID-19, a novel strain
of coronavirus first identified in China, which has spread across the globe including the U.S., has had an adverse impact on our
operations and financial condition. The response to this coronavirus by federal, state and local governments in the U.S. has resulted
in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has
also caused significant stock market volatility and further tightened capital access for most businesses. Given that the COVID-19
pandemic and its disruptions are of an unknown duration, they could have an adverse effect on our liquidity and profitability.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of these events, we assessed
our near-term operations, working capital, finances and capital formation opportunities, and implemented, in late March 2020,
a downsizing of our operations and workforce to preserve cash resources and focus our operations on client-centric sales and project
management activities. The duration and likelihood of success of this workforce reduction are uncertain; however, we have since
rehired several employees who were impacted by the downsizing effort. If this downsizing effort does not meet our expectations,
or additional capital is not available, we may not be able to continue our operations. The pandemic and its effects resulted in
temporary delays in our projects, however, work on all such projects has resumed. Other factors that will affect our ability to
continue operations include the market demand for our products and services, our ability to service the needs of our clients and
prospects with a reduced workforce, potential contract cancellations, project scope reductions and project delays, our ability
to fulfill our current backlog, management of our working capital, the availability of cash to fund our operations, and the continuation
of normal payment terms and conditions for purchase of our products. In light of these extenuating circumstances, there is no
assurance that we will be successful in growing and maintaining our business with our clients. If our clients or prospects are
unable to obtain project financing and we are unable to increase revenues, or otherwise generate cash flows from operations, we
will not be able to successfully execute on the various strategies and initiatives we have set forth in this Report to grow our
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ultimate magnitude of COVID-19, including
the extent of its impact on our financial and operational results, which could be material, will depend on the length of time
that the pandemic continues, its effect on the demand for our products and our supply chain, the effect of governmental regulations
imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing. We cannot at this time predict the
full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on our business, financial condition,
results of operations and cash flows beyond what is discussed within this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 12 &ndash; STOCK-BASED COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock-based compensation expense for the
nine months ended September 30, 2020 and 2019 was $1,391,807 and $1,606,355, respectively, based on the vesting schedule of the
stock grants and options. Stock based compensation expense for the three months ended September 30, 2020 and 2019 was $399,258
and $509,219, respectively, based on the vesting schedule of the stock grants and options. No cash flow effects are anticipated
for stock grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2017, the Company began granting
Common Stock to attract, retain, and reward employees. In January 2018, the Company implemented an equity incentive plan to reward
and attract employees and directors and compensate vendors for services when applicable. In May 2019, the Company adopted a new
equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. This equity incentive
plan was approved by the Company&rsquo;s shareholders on May 23, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock grants under the equity incentive
plans are valued at the price of the stock on the date of grant. The fair value of stock options granted under the equity incentive
plans is calculated using the Black-Scholes pricing model based on the estimated market value of the underlying stock at the valuation
measurement date, the remaining contractual term of the stock options, risk-free interest rate, and expected volatility of the
underlying Common Stock. There is a moderate degree of subjectivity involved when estimating the value of stock options with the
Black-Scholes option pricing model as the assumptions used are moderately judgmental. Stock grants and stock options are sometimes
offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. Stock grants and
stock options typically require a 1 to 3 year period of continued employment or service performance before the stock grant or
stock option vests.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stock Grants:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows stock grant
activity for the nine months ended September 30, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; font-size: 10pt; font-weight: bold">Grants outstanding as of December 31, 2019</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">412,501</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Grants awarded</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">794,166</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Forfeiture/Cancelled</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(200,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Grants vested</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(253,333</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of September 30, 2020</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">753,334</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2020, the Company
has $393,215 in unrecognized share-based compensation expense related to these stock grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stock Options:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">The following table shows stock
option activity for the nine months ended September 30, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of <BR> Shares</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<BR> Average<BR>
    Remaining <BR> Life (Years)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<BR> Average <BR>
    Exercise <BR> Price</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-weight: bold">Stock options outstanding as of December 31, 2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,702,167</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">9.21</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1.21</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,425,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.49</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt">Expired</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(297,501</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">9.19</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; text-align: right">1.21</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options outstanding at September 30, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,829,666</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">9.35</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">1.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options exercisable at September 30, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,437,578</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">8.88</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">1.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2020, the Company
has $1,919,523 in unrecognized share-based compensation expense related to these stock options. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 13 &ndash; SHAREHOLDERS&rsquo;
EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2020, an executive left the Company
and returned 100,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its
issued and outstanding stock by 100,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2020, a former executive
who had the right to receive 1,000,000 shares of Common Stock per the terms of his separation agreement that was reached in September
2019, entered into an agreement with the Company to exchange the right to receive those 1,000,000 shares of Common Stock for the
Company&rsquo;s ownership interest in TGH (see Note 5 &ndash; Investments) and a warrant to purchase 400,000 shares of the Company&rsquo;s
Common Stock at $1.00 per share. The Company retired the shares and reduced its issued and outstanding stock by 1,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>NOTE 14 &ndash; WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">Warrants are immediately exercisable
upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of shares</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<BR> Average<BR>
    Exercise Price</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 55%; font-weight: bold">Warrants outstanding as of December 31, 2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">692,034</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">2.88</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issued in conjunction with debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,481</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.41</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Issued in conjunction with agreement
    with former executive (see Note 13 &ndash; Shareholders&rsquo; Equity)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">400,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1.00</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Warrants outstanding as of September 30, 2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,216,515</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.21</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Warrants exercisable as of September 30, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,216,515</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The weighted-average life of
the warrants is 2.5 years. The aggregate intrinsic value of the warrants outstanding and exercisable at September 30, 2020 is
$0.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>NOTE 15 &ndash; SUBSEQUENT
EVENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has assessed and determined
that no significant subsequent events are to be disclosed according to ASC 855.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="dec01"></A><B>Report of Independent
Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the shareholders and the board of directors
of urban-gro, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Opinion on the Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying consolidated balance sheets
of urban-gro, Inc. (the &quot;Company&quot;) as of December 31, 2019 and 2018, the related consolidated statements of operations
and comprehensive income, shareholders&rsquo; deficit and cash flows for each of the two years in the period ended December 31,
2019, and the related notes (collectively referred to as the &quot;financial statements&quot;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and
the results of its operations and its cash flows each of the two years in the period ended December 31, 2019, in conformity with
accounting principles generally accepted in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Going Concern Uncertainty</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered
recurring losses from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as
a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Basis for Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (&quot;PCAOB&quot;) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audits in accordance with the standards of
the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain
an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness
of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our audits included performing procedures to assess the risks
of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis
for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ BF Borgers CPA PC&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company's auditor since 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lakewood, CO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 18, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="dec02"></A><B>CONSOLIDATED BALANCE
SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; padding-left: 10pt">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">448,703</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,178,852</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,564,969</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">501,191</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Inventories, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,214,224</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Related party receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,658</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepayments and advances</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,258,700</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">928,682</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,998,205</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,945,305</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Property, plant, and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,035</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">441,141</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease right of use assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,020,358</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,261,649</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">902,067</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">106,179</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">96,669</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,409,487</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,799,459</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,407,692</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,744,764</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,753,862</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,630,893</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,686,841</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,144,142</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Related party payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,972</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,802</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Customer deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,915,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,298,609</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Related party note payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,812,709</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478,869</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">123,395</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,317,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,571,315</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Non-current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">98,841</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">98,841</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,416,026</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,571,315</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Commitments and contingencies, Note 11</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Preferred stock, $0.10 par value; 10,000,000 shares authorized; 0 shares
    issued and outstanding as of December 31, 2019 and December 31, 2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Common stock, $0.001 par value; 100,000,000 shares authorized; 28,209,312
    and 25,229,833 shares issued and outstanding as of December 31, 2019, and December 31, 2018 respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,209</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,230</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional Paid in Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,854,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,688,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(16,890,626</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,540,053</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,008,334</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,826,551</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,407,692</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,744,764</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="dec03"></A><B>CONSOLIDATED STATEMENTS
OF OPERATIONS AND COMPREHENSIVE INCOME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEARS ENDED December 31, 2019
and 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">24,189,803</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">20,050,776</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Cost of revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,563,594</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,892,025</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Gross profit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,626,209</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,158,751</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Marketing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,016,073</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">992,288</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,207,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,721,221</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">General and administrative &ndash; amortization of broker
    issuing costs and broker warrants associated with convertible debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">432,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Stock-based compensation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,830,426</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,245,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,486,814</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,959,335</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,860,605</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,800,584</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Non-operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(704,230</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(119,961</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense &ndash; amortization of warrants and
    conversion price associated with convertible debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,333,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Write-down of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(505,766</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other income, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">53,548</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24,672</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,489,968</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(95,289</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Loss before income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,350,573</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,895,873</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income Tax benefit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8,350,573</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,895,873</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8,350,573</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,895,873</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Earnings (loss) per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Net loss per share - basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.32</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.16</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Weighted average outstanding shares for the years ended December 31, 2019
    and December 31, 2018 - basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,318,059</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,848,239</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="dec04"></A>CONSOLIDATED STATEMENTS
OF SHAREHOLDERS' DEFICIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE YEARS ENDED December 31, 2019
and 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Additional</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Retained</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Total</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Common
    Stock</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Paid in</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Earnings</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shareholders'</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(<FONT STYLE="font-size: 9pt">deficits)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 35%"><FONT STYLE="font-size: 9pt">Balance, December 31, 2017</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right; width: 10%"><FONT STYLE="font-size: 9pt">25,046,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right; width: 10%"><FONT STYLE="font-size: 9pt">25,036</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right; width: 10%"><FONT STYLE="font-size: 9pt">3,258,116</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right; width: 10%"><FONT STYLE="font-size: 9pt">(4,644,180</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt; width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right; width: 10%"><FONT STYLE="font-size: 9pt">(1,361,028</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Clawback of stock granted</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(375,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(375</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">375</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Payment of outstanding balance
    for PPM</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">80,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">80,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock based compensation</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,345,825</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">1,345,825</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Stock Grant Program Vesting</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">558,833</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">568</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">(568</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Warrants</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4,525</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">4,525</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><FONT STYLE="font-size: 9pt">Net loss for year ended
    December 31, 2018</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(3,895,873</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 9pt">(3,895,873</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Balance, December 31, 2018</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,229,833</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">25,230</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">4,688,272</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(8,540,053</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 9pt">(3,826,551</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
</TABLE>





<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">Additional</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">Retained</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">Total</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid in</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">Earnings</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">Shareholders'</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">(<FONT STYLE="font-size: 9pt">deficits)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 35%; font-weight: bold; padding-bottom: 2.5pt">Balance, December 31, 2018</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 10%; font-weight: bold; text-align: right">25,229,833</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 10%; font-weight: bold; text-align: right">25,230</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 10%; font-weight: bold; text-align: right">4,688,272</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 10%; font-weight: bold; text-align: right">(8,540,053</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 10%; font-weight: bold; text-align: right">(3,826,551</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,830,426</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,830,426</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock options issued for loan term revisions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,829</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,829</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock grants issued for loan term revisions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,284</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,300</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock Grant Program Vesting</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,360,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,360</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,360</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock issuance related to conversion
    of convertible debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,102,513</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,655,934</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,657,037</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock issuance related to acquisition</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">999,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Warrants issued related to convertible
    debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">614,041</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">614,041</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Equity value of exercise price associated with convertible
    debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">719,479</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">719,479</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Broker warrants associated with issuance
    of convertible debentures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">278,678</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">278,678</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Net loss for year ended December 31, 2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,350,573</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,350,573</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Balance, December 31, 2019</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">28,209,312</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">28,209</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,854,083</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(16,890,626</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(5,008,334</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="dec05"></A>CONSOLIDATED STATEMENTS
OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Operating Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Net Loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(8,350,573</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(3,895,873</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Adjustment to reconcile net loss from operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,476</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,136</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of convertible debenture
    components</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,612,197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,830,426</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,245,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Impairment of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">505,766</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Warrant Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,394</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Inventory write-offs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,531</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Bad debt expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,464</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on disposal of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(72,416</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Changes in Operating Assets and Liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(849,355</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(73,917</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">443,322</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(167,040</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Prepayments and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(324,273</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(88,684</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable and accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,671,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,667</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Customer deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(383,203</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">147,360</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Provided by (Used in) Operating Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(2,487,435</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(2,285,136</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Investing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Purchases of investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,085,975</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(861,649</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(192,954</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(369,480</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash acquired in acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,742</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Purchases of intangible assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(40,255</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(33,674</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Used Provided By (Used In) Investing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,147,942</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,264,803</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Financing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Issuance of convertible debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,565,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Issuance of capital stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">970,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,992,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Repayment of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(629,772</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from related party loan</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,000,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Cash Provided by (Used In) Financing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,905,228</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,072,000</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net Increase (Decrease) in Cash</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(730,149</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(477,939</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Cash at Beginning of Period</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,178,852</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,656,791</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Cash at End of Period</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">448,703</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,178,852</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental Cash Flow Information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Interest Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">612,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Income Tax Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Convertible debentures and accrued interest
    converted into common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,657,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock issuance related to acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Common stock retired</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Operating lease right of use asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">326,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>urban-gro, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="dec06"></A><B>Notes to Consolidated
Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the years ended December 31, 2019
and 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1&nbsp;&ndash; ORGANIZATION AND
ACQUISITIONS, BUSINESS PLAN, AND LIQUIDITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Organization and Acquisitions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">urban-gro, Inc. (&ldquo;we,&rdquo; &ldquo;us,&rdquo;
our&rdquo; or the &ldquo;Company&rdquo;) is a leading&nbsp;engineering design services company that integrates complex environmental
equipment systems to create high performance indoor cultivation facilities for the global commercial horticulture market. Our
custom tailored, plant-centric approach to design, procurement, and integration provides a single point of accountability across
all aspects of indoor cultivation operations. Our solution offers functionality that helps customers manage the entire cultivation
lifecycle, from facility engineering and design to operation and day-to-day management. We offer a full range of custom services
that are integrated with select cultivation equipment and product solutions, which we primarily source from third party technology
and manufacturing partners but also develop in-house.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our service offerings include full facility
programming, engineering and design services, start-up commissioning services, facility optimization services and IPM planning
and strategy services. Complementing these services, we work with customers to source an integrated suite of select cultivation
equipment systems and crop management products, which include: (1)&nbsp;environmental controls, fertigation, and irrigation distribution
systems; (2)&nbsp;freshwater, wastewater, and condensation treatment systems; (3)&nbsp;light emitting diode (&ldquo;LED&rdquo;),
high-pressure sodium (&ldquo;HPS&rdquo;) and ceramic metal halide (&ldquo;CMH&rdquo;) lighting systems; (4)&nbsp;rolltop, multi-tier,
and automated container benching systems; (5)&nbsp;odor mitigation &amp; microbial reduction systems; (6)&nbsp;air flow systems;
(7)&nbsp;industrial spray applicators; (8)&nbsp;pesticides and bio-controls; (9)&nbsp;plant nutrition products; (10)&nbsp;substrate
and coco bag solutions; and (11)&nbsp;our Soleil&reg; technology data analytics platform that includes wireless environmental
&amp; substrate sensing and remote monitoring and support.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2018, the Company formed urban-gro
Canada Technologies, Inc. as a wholly owned Canadian subsidiary which it currently utilizes for its Canadian sales operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective March 7, 2019, the Company acquired
100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&ldquo;Impact&rdquo;), a provider of mechanical electrical and
plumbing (&ldquo;MEP&rdquo;) engineering services predominantly focused on the cannabis industry. Management believes the acquisition
of Impact will improve the Company&rsquo;s ability to better serve its current and future customer base by expanding on the fully
integrated products and services offered by the Company. The Company issued 500,000 shares of Common Stock (&ldquo;Common Stock&rdquo;)
valued at $2.00 per share to effect the acquisition of Impact. The Company has initially accounted for the acquisition of Impact
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 85%">Purchase Price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Allocation of Purchase Price:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">49,742</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">93,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">902,067</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">45,620</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Basis of Presentation </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles
(&ldquo;GAAP&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Liquidity and Going Concern</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since inception, the Company has incurred
significant operating losses and has funded its operations primarily through issuance of equity securities, debt, and operating
revenue. As of December 31, 2019, the Company had an accumulated deficit of $16,890,626, a working capital deficit of $7,318,980,
and negative stockholders&rsquo; equity of $5,008,334. These facts and conditions raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern, within one year after the date that the financial statements are issued. The Company continually
evaluates opportunities to raise equity and debt financing as well as implementing cost reduction and revenue enhancing measures
that will allow it to increase profitability and continue operations. There can, however, be no assurances that the Company will
be able to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can there
be any assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable the
Company to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going concern
basis.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Accounting Standards Codification
(&ldquo;ASC&rdquo;) 205-40, <I>Disclosure of Uncertainties about an Entity&rsquo;s Ability to Continue as a Going Concern, </I>we
assess going concern uncertainty for our consolidated financial statements to determine if we have sufficient cash and cash equivalents
on hand and working capital to operate for a period of at least one year from the date the consolidated financial statements are
issued or are available to be issued. As part of this assessment, based on conditions that are known and reasonably knowable to
us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key assumptions, including the
timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those expenditures or programs,
among other factors, if necessary. It is probable that management&rsquo;s plans, when implemented, will mitigate the relevant
conditions or events that raise substantial doubt about the entity&rsquo;s ability to continue as a going concern within one year
after the date that the financial statements are issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 2&nbsp;&ndash; SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Use of Estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing consolidated financial statements
in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of assets and liabilities at the date of the consolidated financial statements and revenues and
expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated
useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for deferred tax assets,
and allowance for bad debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Basis of Presentation and Principles
of Consolidation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are presented in United States dollars and they include the accounts of urban-gro, Inc. and its wholly-owned subsidiaries. The
financial results of Impact have been included in the Company&rsquo;s consolidated financial statements from the date of acquisition
on March 7, 2019 and all intercompany transactions have been eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recently Issued Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &ldquo;FASB&rdquo;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&quot;ASU&quot;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&rsquo;s financial statements upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Functional and reporting currency and
foreign currency translation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency
of the Company and its subsidiaries is US dollars. All transactions in currencies other than US dollars are translated into US
dollars on the date of the transaction. Any exchange gains and losses related to these transactions are recognized in the current
period&rsquo;s earnings as other income (expense).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fair Value of Financial Instruments</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s financial instruments
consist principally of cash and cash equivalents, accounts receivable, accounts payable, notes payable and other current assets
and liabilities. We value our financial assets and liabilities using fair value measurements. Fair value is based on the price
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable
in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation
hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized
into three levels (with Level 3 being the lowest) defined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1:&nbsp;Quoted prices in active
markets for identical assets or liabilities that the entity has the ability to access.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2:&nbsp;Observable inputs other
than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for
identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated
with observable market data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3:&nbsp;Unobservable inputs that
are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes
certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amount of our cash and cash
equivalents, accounts receivable, accounts payable, and other current assets and liabilities in our consolidated financial statements
approximates fair value because of the short-term nature of the instruments. Investments in non-marketable equity securities are
carried at cost less other-than-temporary impairments. The carrying amount of our notes payable and convertible debt at December
31, 2019 and December 31, 2018 approximates their fair values based on our incremental borrowing rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no changes in Level 1,
Level 2, and Level 3 categorizations and no changes in valuation techniques for these assets or liabilities for the years ended
December 31, 2019 and 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cash and Cash Equivalents</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid
short-term cash investments with an original maturity of three months or less to be cash equivalents. As of December 31, 2019
and 2018, the Company did not maintain any cash equivalents. The Company maintains cash with financial institutions that may from
time to time exceed federally-insured limits. The Company has not experienced any losses related to these balances and believes
the risk to be minimal. There are no restricted or compensating cash balances as of December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Accounts Receivable, Net</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivables are carried
at the original invoiced amounts less an allowance for doubtful accounts. As of December 31, 2019 and 2018, the balance of allowance
for doubtful accounts was $18,920. The allowances for doubtful accounts are calculated based on a detailed review of certain individual
customer accounts and an estimation of the overall economic conditions affecting the Company's customer base. The Company reviews
a customer's credit history before extending credit to the customer. If the financial condition of its customers were to deteriorate,
resulting in an impairment of their ability to make payments, additions to the allowance would be required. A provision is made
against accounts receivable to the extent they are considered unlikely to be collected. Occasionally the Company will write off
bad debt directly to the bad debt expense account when the balance is determined to be uncollectable. Bad debt expense for the
years ended December 31, 2019 and 2018 was $67,633 and $106,464, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Inventories</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, consisting entirely of finished
goods, are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost method. The
Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based on its
assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold at the realization of change in
value. Once written down, inventories are carried at this lower basis until sold or scrapped.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Property and Equipment </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Property and equipment is stated
at cost less accumulated depreciation and impairment. Expenditures for major additions and improvements are capitalized and minor
replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise
disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated)
for tax purposes where appropriate. No impairment charges were recorded for the years ended December 31, 2019 and 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives for significant property and equipment
categories are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 77%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and Technology Equipment</FONT></TD>
    <TD STYLE="width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Equipment</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease term</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Equipment</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 or 5 years</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Operating Lease Right of Use Assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease right of use assets are
stated at cost less accumulated depreciation, amortization and impairment. The Company has two operating leases with an imputed
annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on August 31,
2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021. Operating lease
right of use asset costs incurred in 2019 were $123,563.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Convertible Notes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its convertible
notes at issuance by allocating the proceeds received from a convertible note among freestanding instruments according to ASC
470, Debt, based upon their relative fair values. The fair value of debt and common stock is determined based on the closing price
of the common stock on the date of the transaction, and the fair value of warrants, if any, is determined using the Black-Scholes
option-pricing model. Convertible notes are subsequently carried at amortized cost. The fair value of the warrants is recorded
as additional paid-in capital, with a corresponding as a debt discount from the face amount of the convertible note. Each convertible
note is analyzed for the existence of a beneficial conversion feature (&ldquo;BCF&rdquo;), defined as the fair value of the common
stock at the commitment date for the convertible note, less the effective conversion price. Beneficial conversion features are
recognized at their intrinsic value, and recorded as an increase to additional paid-in capital, with a corresponding reduction
in the carrying amount of the convertible note (as a debt discount from the face amount of the convertible note). The discounts
on the convertible notes, consisting of amounts ascribed to warrants and beneficial conversion features, are amortized to interest
expense, using the effective interest method, over the terms of the related convertible notes. Beneficial conversion features
that are contingent upon the occurrence of a future event are recorded when the contingency is resolved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Intangible Assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s intangible assets,
consisting of legal fees for application of patents and trademarks and license fees paid for inspection services, are recorded
at cost. Patents and trademarks, once approved, will be amortized using the straight-line method over an estimated life, generally
5 years for patents and 10 to 20 years for trademarks. License fees are amortized over 10 years. Intangible assets are included
in &ldquo;other assets&rdquo; on the balance sheets. The net balance of intangible assets for December 31, 2019 and 2018 was $86,151
and $63,755, respectively. Amortization expense totaled $1,879 and $974 for the years ended December 31, 2019 and 2018, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Goodwill</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the
purchase price over the fair value of net assets acquired in a business combination. Goodwill is not amortized, but is tested
for impairment annually as of December 31st and at any time when events or circumstances suggest impairment may have occurred.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The testing for impairment consists of
a comparison of the fair value of with its carrying amount. If the carrying amount of the reporting unit, including goodwill,
exceeds the fair value, an impairment will be recognized equal to the difference between the carrying value of the reporting unit
goodwill and the implied fair value of the goodwill. In testing goodwill for impairment, we determine the estimated fair value
of our reporting units based upon a discounted future cash flow analysis. Goodwill is our only indefinite-lived intangible asset.
Definite-lived intangible assets are amortized using the straight line method over the shorter of their contractual term or estimated
useful lives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Impairment of Long-lived Assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates potential impairment
of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to
result from the use and eventual disposition of the asset. An impairment will be recognized as the amount by which the carrying
amount of a long-lived asset exceeds its fair value.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Investments</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments without readily determinable
fair values and for which the Company does not have the ability to exercise significant influence are accounted for at cost with
adjustments for observable changes in prices or impairments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Revenue Recognition</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with ASC 606, <I>Revenue from Contracts with Customers,</I> which requires that five basic steps be followed to recognize revenue:
(1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance
obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration
given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the
performance obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration
given to whether that control happens&nbsp;over time&nbsp;or not. Determination of criteria (3) and (4) are based on our management's
judgments regarding the fixed nature of the selling prices of the services and products delivered and the collectability of those
amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our service and product revenues arise
from contracts with customers. Service revenues include full facility programming, engineering and design services, start-up commissioning
services, facility optimization services and IPM planning and strategy services. Product revenues include an integrated suite
of select cultivation equipment systems and crop management products. We enter into separate contracts for the service and product
revenues we provide to our customers so to clarify our obligations under the terms of the contracts. New contracts are entered
into if the services to be performed or products to be delivered need to be modified. Service revenues are satisfied when services
are rendered or completed in accordance with the terms of the contract. Product revenues are satisfied when control of the products
is transferred to the customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues for services and products for
the year ended December 31, 2019 were $3,167,237 and 21,022,566, respectively. Revenues for services and products for the year
ended December 31, 2018 were $928,063 and $19,122,713, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Customer Deposits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s policy is to collect
deposits from customers at the beginning of the contract. The customer payments received are recorded as a customer deposit liability
on the balance sheet. When the contract is complete and meets all the criteria for revenue recognition, the customer is billed
for the entire contract amount and the deposit is recorded against the customer&rsquo;s receivable balance. In certain situations
when the customer has paid the deposit and services have been performed but the customer chooses not to proceed with the contract,
the Company may keep the deposit and recognize revenue.&nbsp;Of the outstanding customer deposit balance of $3,298,609 at December
31, 2018, $2,678,565 was recognized as revenue in the year ended December 31, 2019. At December 31, 2017, the entire customer
deposit balance of $3,151,250 was recognized as revenue in the year ended December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cost of Revenue</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s policy is to recognize
cost of revenues in the same manner as, and in conjunction with, revenue recognition. The Company&rsquo;s cost of revenues includes
the costs directly attributable to revenue recognized and includes expenses related to the purchasing of products and providing
services, fees for third-party commissions and shipping costs. Total shipping costs included in the cost of goods sold for the
years ended December 31, 2019 and 2018 was $679,911 and $490,526, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Advertising Costs</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertisings costs
in the periods the costs are incurred. Prepayments made under contracts are included in prepaid expenses and expensed when the
advertisement is run. Total advertising expense incurred for the years ended December 31, 2019 and 2018 was $159,728 and $153,878,
respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Warrants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The Company accounts for its
warrants issued in accordance with the GAAP accounting guidance under ASC 480, &ldquo;Distinguishing Liabilities from Equity&rdquo;.
The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing
based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual
term, risk-free interest rate, and expected volatility of the price of the underlying common stock. There is a moderate degree
of subjectivity involved when using option pricing models to estimate the warrants and the assumptions used in the Black-Scholes
option-pricing model are moderately judgmental.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Stock-Based Compensation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically issue shares
of its common stock to employees and consultants in non-capital raising transactions for fees and services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock issued
to non-employees with the value of the stock compensation based upon the measurement date as determined at the grant date of the
award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock grants
issued and vesting to employees with the award being measured at its fair value at the date of grant and amortized ratably over
the vesting period. The Company also estimates forfeitures at the time of grant and revises those estimates in subsequent periods
if actual forfeitures differ from its estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Income Taxes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company files
income federal tax returns in the United States and Canada and state and local tax return in applicable jurisdictions. Provisions
for current income tax liabilities, if any, would be calculated and accrued on income and expense amounts expected to be included
in the income tax returns for the current year. Income taxes reported in earnings, if any, would also include deferred income
tax provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred income
tax assets and liabilities, if any, would be computed on differences between the financial statement bases of assets and liabilities
at the enacted tax rates. Changes in deferred income tax assets and liabilities would be included as a component of income tax
expense. The effect on deferred income tax assets and liabilities attributable to changes in enacted tax rates would be charged
or credited to income tax expense in the period of enactment. Valuation allowances would be established for certain deferred tax
assets when realization is not likely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Assets and liabilities
would be established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions,
in the judgment of the Company, do not meet a more-likely-than-not threshold based on the technical merits of the positions. Valuation
allowances would be established for certain deferred tax assets when realization is not likely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Loss Per Share</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes net loss per share
by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period.
Diluted earnings per share would be computed by dividing net loss by the weighted-average of all potentially dilutive shares of
common stock that were outstanding during the periods presented. The diluted earnings per share calculation is not presented as
it results in an anti-dilutive calculation of net loss per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treasury stock method would be used
to calculate diluted earnings per share for potentially dilutive stock options and share purchase warrants. This method assumes
that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase
common shares at the average market price for the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recently Adopted Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued an Accounting
Standards Update (&ldquo;ASU&rdquo;) amending the accounting for leases. The new guidance requires the recognition of lease assets
and liabilities for operating leases with terms of more than 12 months, in addition to those currently recorded, on the Company&rsquo;s
consolidated balance sheets. Presentation of leases within the consolidated statements of operations and comprehensive loss and
consolidated cash flows will be generally consistent with the prior lease accounting guidance. The ASU was effective for reporting
periods beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU effective January 1, 2019
under the modified retrospective method with respect to lease contracts in effect as of the adoption date. The adoption of the
ASU increased our assets and liabilities by $326,095 in 2019 due to the recognition of right of use assets and lease liabilities
with respect to operating leases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3&nbsp;&ndash; RELATED PARTY TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2018, the Company received
a $1,000,000, unsecured, interest only, promissory note (the &ldquo;Promissory Note&rdquo;) from Cloud9 Support Inc. (&ldquo;Cloud9&rdquo;),
an entity owned 100% by James Lowe, a director of the Company. The Promissory Note was originally due April 30, 2019. The Promissory
Note is personally guaranteed by the Company&rsquo;s two majority shareholders, Bradley Nattrass, who is the Company&rsquo;s Chairman
and Chief Executive Officer, and Octavio Gutierrez, a director and former officer of the Company. The Promissory Note includes
additional consideration of 30,000 options at an exercise price of $1.20 per share. Under the initial terms of the Promissory
Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019, the due date of the Promissory Note was
extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable monthly. In connection with the execution
of the Credit Agreement (see Note 17), on February 21, 2020, the Company entered into an agreement to amend the Promissory Note
(the &ldquo;Amending Agreement&rdquo;). Pursuant to the Amending Agreement, Cloud9 agreed to extend the maturity date of the Promissory
Note from December 31, 2019 to the date which is the earlier of 60 days following the date: (a) on which demand for repayment
is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company purchases some cultivation
products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&ldquo;Bravo&rdquo;) and Enviro-Glo, LLC (&ldquo;Enviro-Glo&rdquo;),
manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&rsquo;s
two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $45,129 and $276,443
for the years ended 2019 and 2018, respectively. Outstanding receivables from Bravo and Enviro-Glo for the years ended 2019 and
2018 totaled $0 and $43,120, respectively. Net outstanding payables incurred for purchases of inventory and other services to
Bravo and Enviro-Glo as of December 31, 2019 and 2018, was $8,570 and $5,562, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has purchased goods from Cloud
9 Support, LLC (&ldquo;Cloud 9&rdquo;), a company owned by James Lowe, a director, shareholder, and debt holder. Purchases from
Cloud 9 were $97,329 and $84,746 during the years ended 2019 and 2018, respectively. Cloud 9 also purchases materials from the
Company for use with their customers. Total sales to Cloud 9 from the Company were $392,963 and $273,760 during the years ended
2019 and 2018, respectively. Outstanding receivables from Cloud 9 as of December 31, 2019 and 2018 totaled $49,659 and $79,235,
respectively. Net outstanding payables for purchases of inventory and other services to Cloud 9 as of December 31, 2019 and 2018,
totaled $16,402 and $13,240, respectively.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash; PREPAYMENTS &amp; ADVANCES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Prepayments and advances are comprised
of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Vendor Prepayments</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,070,788</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">776,478</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid Services and Fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">187,912</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">152,204</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Prepayments and Advances</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,258,700</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">928,682</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 5 - PROPERTY PLANT &amp; EQUIPMENT,
NET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property Plant and Equipment balances
are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Computers &amp; Technology Equip</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">87,300</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">61,910</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Furniture and Fixtures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,518</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,162</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Leasehold Improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,072</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">143,215</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,414</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132,875</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,721</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">R&amp;D Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,031</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Other Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated depreciation</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(370,376</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(309,975</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Property plant and equipment, net</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">165,035</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">441,141</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense for the years ended
December 31, 2019 and 2018 totaled $264,597 and $153,162, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 6 &ndash; INVESTMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The changes in the components of the Investments for the years
ended December 31, 2019 and 2018 are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="11" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Year Ended December
    31, 2019</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Edyza</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>TGH</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 58%"><FONT STYLE="font-size: 10pt">Beginning Balances as of 1/1/2019</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">812,883</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">448,766</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">1,261,649</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Purchase of additional shares under SPOA</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">897,475</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">897,475</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Initial purchase of Membership interest</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">367,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">367,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Additional Membership interest purchased with first option</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Impairment of investment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(505,766</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(505,766</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Legal fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Ending Balances as of 12/31/2019</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">1,710,358</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">310,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">2,020,358</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="11" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Year Ended December
    31, 2018</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Edyza</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>TGH</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD STYLE="width: 58%"><FONT STYLE="font-size: 10pt">Beginning Balances as of 1/1/2018</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">400,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">400,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-size: 10pt">Purchase of additional shares under SPOA,
    including $75,000 reflected in Accrued Expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">400,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">400,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Initial purchase of Membership Interest</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">125,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">125,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Additional Membership interest purchased with first option</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">150,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">150,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Additional Membership interest purchased with second option</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">158,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">158,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Legal fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">12,883</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">15,766</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">28,649</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #EEEEEE">
    <TD><FONT STYLE="font-size: 10pt">Ending Balances as of 12/31/2018</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">812,883</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">448,766</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-size: 10pt">1,261,649</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Edyza</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2017, the Company entered into
a Simple Agreement for Future Equity (&ldquo;SAFE&rdquo;) with Edyza, Inc. (&ldquo;Edyza&rdquo;), a developer of wireless sensor
technology, to provide the Company with the right to obtain an ownership interest in Edyza to be issued when Edyza engaged in
a priced round of investment. The Company paid Edyza $400,000 for the SAFE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the Company and Edyza
entered into a Stock Purchase and Option Agreement (&ldquo;SPOA&rdquo;) whereby the Company and Edyza agreed to terminate the
SAFE in exchange for Edyza issuing the Company 442,685 shares of Edyza Common Stock at $0.903577 per share, or $400,000 in the
aggregate. In connection with the SPOA, the Company agreed to pay Edyza an additional $400,000 in six monthly installments ($50,000
a month in August and September 2018 and $75,000 a month from October 2018 thru January 2019) in exchange for Edyza issuing the
Company an additional 442,685 shares of Edyza Common Stock at $0.903577 per share. As of December 31, 2018, the Company had paid
$325,000 of the additional $400,000 to Edyza under this installment payment plan. The remaining installment payment of $75,000
is included in Accrued Expenses on the Company&rsquo;s Balance Sheet as of December 31, 2018 and was paid to Edyza in January
2019. During 2019, the Company acquired an additional 827,018 shares for $897,475. The Company has capitalized an additional $12,883
in legal fees associated with the purchases of the Edyza Common Stock. The Company measures this investment at cost, less any
impairment changes resulting from observable price changes in orderly transactions for an identical or similar investment of the
same issuer.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>TGH</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2018, the Company entered
into a Membership Interest and Purchase Agreement (&ldquo;MIPA&rdquo;) with Total Grow Holdings, LLC (d/b/a/ Total Grow Control,
LLC) (&ldquo;TGH&rdquo;), a developer of environmental controls and fertigation/irrigation distribution products, to purchase
5% of TGH&rsquo;s membership interests on a fully diluted basis for $125,000. The MIPA also contained two separate options for
the Company to purchase additional membership interests in TGH and a purchase right for the Company to acquire all of the outstanding
membership interests in TGH. The first option was exercisable from July 1, 2018 thru August 31, 2018 and allowed the Company to
acquire an additional 5% of TGH&rsquo;s membership interests on a fully diluted basis for $150,000. The second option was initially
exercisable from February 15, 2019 thru May 15, 2019 and allowed the Company to acquire an additional 15% of TGH&rsquo;s membership
interests on a fully diluted basis for $600,000. The purchase right is exercisable from May 15, 2019 thru February 15, 2020 and
allows the Company to acquire all of the outstanding membership interests in TGH based on a total valuation of TGH of $7,500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2018, the Company exercised its
initial option and purchased an additional 5% of TGH&rsquo;s fully diluted membership interests for $150,000. As of December 31,
2018, the Company owned 10% of the membership interests in TGH.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2019, the Company and TGH renegotiated
the terms of the second option, accelerating the beginning of the exercise period to January 2019 from February 15, 2019, and
reducing the purchase price for the additional 15% of TGH&rsquo;s membership interests on a fully diluted basis from $600,000
to $525,000. In January 2019, the Company elected to exercise this renegotiated second option and purchased an additional 15%
of TGH&rsquo;s fully diluted membership interests for $525,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to December 31, 2018, the Company
had advanced TGH $158,000 for equipment orders the Company had placed with TGH. TGH agreed to apply this $158,000 in equipment
advances toward the second option membership interest purchase price of $525,000, and the Company has reflected this $158,000
as an investment in TGH as of December 31, 2018. The remaining balance of $367,000 for the second option membership interest was
due in installments of $35,000 every two weeks through May 2019. As of March 31, 2019, the Company had made total payments of
$336,000. The Company capitalized an additional $15,766 in legal fees associated with the purchases of the TGH membership interests.
As of December 31, 2018, the Company&rsquo;s fully diluted ownership interest in TGH was less than 20% and, the Company measured
these investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions
for an identical or similar investment of the same issuer. As of December 31, 2018, the Company determined that no impairment
of its investment in TGH was necessary given the recent valuations and no change in qualitative factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also made the remaining $367,000
in additional payments to TGH under the renegotiated agreement reached in January 2019 to acquire additional Membership Interests
in TGH. When the payment plan was completed in May 2019, the Company was issued the additional ownership interest in TGH resulting
in the Company owning 24% of TGH&rsquo;s membership interest. The Company believed that this ownership interest in TGH resulted
in the Company being able to exercise significant influence over TGH and that the Company should begin to account for its investment
in TGH under the equity method beginning in July 2019 since the operations of TGH were insignificant in June 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2019, the Company decided
that it should remain independent with regard to any investments in environmental controls and fertigation/irrigation distribution
entities and decided it should divest itself of the ownership interest in TGH. The Company entered into preliminary negotiations
with TGH to sell its ownership interest in TGH back to TGH. In connection with those negotiations, the Company determined it should
not record any equity interests in TGH and the Company recorded a $505,766 write-down of its investment in TGH to an amount the
Company anticipates receiving in proceeds from the sale of the TGH investment back to TGH.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2020, the Company and TGH entered
into an agreement whereby TGH agreed to purchase the Company&rsquo;s remaining investment in TGH in consideration for a short-term
note due April 24, 2020 in the amount of $200,000 and a long-term note due in a lump sum on January 27, 2025 in the amount of
$110,000 with interest of 4.0% payable annually in arrears. Per the terms of the agreement, the Company retains its ownership
interest in TGH until the $200,000 short-term note is repaid. As of the date of this report, TGH has not made any payments on
the $200,000 short-term note and the Company has retained its ownership interest in TGH. The Company does not have the ability
to exert significant influence on TGH and therefore has recorded the investment at its adjusted cost basis.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 7 &ndash; OTHER ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included in other assets are the following
intangible assets:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 27px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents, consisting
    of legal costs paid to third parties to establish a patent, which are capitalized until such time that the patents are approved
    and issued or rejected. If approved, capitalized costs are amortized using the straight-line method over the estimated lives
    of the patents, generally five years. The Company has two issued patents as of December 31, 2019 and had no issued patents
    at December 31, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 27px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License fees, which
    consist of fees paid to have the Company&rsquo;s products certified by a nationally recognized organization. License fees
    are amortized over ten years.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net balance of intangible assets as
of December 31, 2019 and December 31, 2018 was $86,151 and $63,755, respectively. Amortization expense totaled $1,879 and $974
for the years ended December 31, 2019 and 2018, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 8 &ndash; ACCRUED EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Accrued operating expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">854,056</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">240,941</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued wages and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">487,327</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">490,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Accrued interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,958</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accrued sales tax payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">345,458</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">401,282</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,686,841</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,144,142</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued sales tax payable is comprised
of prior period sales tax payable to various states for 2015 through 2019. The Company has set up payment plans with the various
taxing agencies to relieve the obligation. The payment plans require monthly payments in various amounts over a period of 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 9 &ndash; NOTES PAYABLE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes payable balances totaled $2,812,709
and $2,478,869 at December 31, 2019 and December 31, 2018, respectively. Interest expense incurred on the notes payable was $596,075
and $119,961 for the years ended December 31, 2019 and 2018, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of notes payable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Unsecured, interest only, note payable with Chris Parkes originally due December
    31, 2018. Interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending the maturity
    date to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased
    to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company
    issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the
    amount of $10,000.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">80,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">80,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018. Interest
    payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date to March
    31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased to an annual
    rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company issued the
    Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Unsecured, interest only, note payable with Michael S. Bank originally due April 30, 2019. Interest
    at 19.8% per year is paid twice per month. The note contains a demand re-payment provision that can be executed by Mr. Bank
    at any time by providing a one-time notice. The Company may re-pay any part or the entire principal sum at any time with penalty
    and abatement of interest expense from date of early payment. The note includes six thousand warrants, each exercisable to
    purchase one share of the Company's Common Stock at a price of $1.00 per share. In March 2019, the Company repaid $35,000
    of the principal and extended the maturity date to April 30, 2019. The note was repaid in full on April 30, 2019.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">298,869</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Note payable with Hydrofarm Holdings Group, Inc. (&ldquo;Hydrofarm&rdquo;), secured by all currently
    existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a)
    90 days&rsquo; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December
    2023.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Secured agreement to sell future receivables to GCF Resources, LLC, net
    of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matures
    on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments.</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">632,709</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,812,709</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,478,869</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less current maturities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,812,709</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,478,869</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Long term</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective November 20, 2018, the Company
entered into a letter of intent (&ldquo;LOI&rdquo;) with Hydrofarm Holdings Group, Inc. (&ldquo;Hydrofarm&rdquo;) whereby Hydrofarm
agreed to acquire all of the Company&rsquo;s issued and outstanding common stock (the &ldquo;Merger&rdquo;). Pursuant to the terms
of the LOI, Hydrofarm extended to the Company a secured, interest only note in the principal amount of $2 million. The note was
secured by all of our currently existing and future assets. In connection with the execution of the Credit Agreement (see Note
17), the Company repaid the note and the Merger was abandoned.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 10 &ndash; UNIT OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 9, 2019, the Company
executed a letter agreement with 4Front Capital Partners, Inc., Toronto, Canada (&ldquo;4Front&rdquo;), whereby 4Front agreed
to act as the Company&rsquo;s exclusive placement agent in connection with a private placement offering. Beginning in March 2019,
4Front initiated an offering (the &ldquo;Offering&rdquo;) of up to $6,000,000 from the sale of Units, with each Unit consisting
of a $1,000 Convertible Debenture (the &ldquo;Debentures&rdquo; or a &ldquo;Debenture&rdquo;) and Common Stock Purchase Warrants
(the &ldquo;Warrants&rdquo;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share for a period of two years
from the purchase date. The Debentures are due May 31, 2021 and bear interest at 8%, compounded annually, with interest due at
maturity. The Debentures, plus any accrued but unpaid interest, will automatically convert for no additional consideration into
Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity event means: (a)
the date on which the Company&rsquo;s Common Stock is listed for trading on a recognized stock exchange in either Canada or the
United States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying both the conversion right
included in the Debentures and underlying the Warrants, have been duly qualified by a registration statement in the United States,
allowing the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in Canada. The Company filed
a registration statement with the SEC on September 17, 2019, to register the securities in connection with the Offering. That
registration statement was declared effective October 16, 2019, triggering the liquidity event indicated above and the $2,565,000
in Debentures plus $92,037 in accrued interest were converted into 1,102,513 Common Shares at $2.41 per share. The Warrants contain
a mandatory exercise provision if the weighted average share price of the Company&rsquo;s Common Stock exceeds $5.00 per share
for a period of five consecutive days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 11 &ndash; OPERATING LEASE LIABILITIES &amp; COMMITMENTS
AND CONTINGENCIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two operating leases with
an imputed annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on
August 31, 2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of operating
lease liabilities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<BR> 2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<BR> 2018</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Operating lease liabilities related to right of use assets.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">222,236</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(123,395</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Long term</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">98,841</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a schedule showing future
minimum lease payments:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year ending</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Minimum</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
    31,</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lease
    Payments</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">177,688</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,688</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company is involved
in routine litigation that arises in the ordinary course of business. There are no legal proceedings for which management believes
the ultimate outcome would have a material adverse effect on the Company&rsquo;s results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><B>NOTE 12 &ndash; RISKS AND UNCERTAINTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><U>Concentration Risk</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2019,
one vendor composed 24% of total purchases. During the year ended December 31, 2018, two unrelated vendors composed 18% and 11%
of total purchases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s primary suppliers
of automated environmental controls and fertigation represented 3% and 46% of total accounts payable outstanding as of December
31, 2019 and 2018, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2019,
one customer represented 21% of total revenue. During the year ended December 31, 2018, one customer represented 14% of total
revenue. At December 31, 2019, one customer represented 15% and another represented 11% of total outstanding accounts receivables.
At December 31, 2018, one customer represented 19% and another represented 13% of total outstanding receivables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Coronavirus Pandemic</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #000712">In December 2019, a novel
strain of coronavirus (COVID-19) was reported to have surfaced in Wuhan, China. In January 2020, this coronavirus spread to other
countries, including the United States, and efforts to contain the spread of this coronavirus intensified. In March 2020, the
World Health Organization declared the outbreak of the coronavirus a pandemic. We are a business that supplies other Essential
Businesses with support and supplies necessary to operate and we therefore are an Essential Business and allowed to continue operating
under Stay-At-Home Orders issued by many states and cities. However, the extent to which the coronavirus impacts our results will
depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge
concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact. The outbreak and any
preventative or protective actions that governments or we may take in respect of this coronavirus may result in a period of business
disruption, reduced customer business and reduced operations. Any resulting financial impact cannot be reasonably estimated at
this time but may materially affect our business, financial condition, results of operations, and cash flows. Effects from the
COVID-19 pandemic began in the latter portion of the first quarter of 2020; therefore, there was no impact to our 2019 results
of operations, financial condition and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 13 &ndash; STOCK-BASED COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock-based compensation expense for the
years ended December 31, 2019 and 2018 was $1,830,426 and $1,245,826, respectively based on the vesting schedule of the stock
grants and options. During the year ended December 31, 2019, 1,361,966 shares vested and were issued to employees. No cash flow
affects are anticipated for stock grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2017, the Company began granting
stock to attract, retain, and reward employees with Common Stock. Stock grants are offered as part of the employment offer package,
to ensure continuity of employment or as a reward for performance. Each of these grants requires a specific tenure of employment
before the grant vests with typical vesting periods of 1 to 3 years of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2018, the Company implemented
an equity incentive plan to reward and attract employees and compensate vendors for services when applicable. Stock options are
offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. The stock option
plan authorizes 3,000,000 shares of common stock. 1,995,499 options have been awarded under the Plan as of December 31, 2019 and
1,259,000 options were awarded as of December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2019, the Company adopted a new
equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. Stock grants under
the equity incentive programs are valued at the price of the stock on the date of grant. The fair value of the options is calculated
using the Black-Scholes pricing model based on the estimated market value of the underlying common stock at the valuation measurement
date $0.90, the remaining contractual term of the options of 10 years, risk-free interest rate of 2.75% and expected volatility
of the price of the underlying common stock of 100%. There is a moderate degree of subjectivity involved when using option pricing
models to estimate the options and the assumptions used in the Black Scholes option-pricing model are moderately judgmental. Stock
options and stock grants are sometimes offered as part of an employment offer package, to ensure continuity of service or as a
reward for performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following schedule shows stock grant
activity for the year ended December 31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 67%; font-size: 10pt; font-weight: bold">Grants outstanding as of December 31, 2018</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">1,802,667</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Grants awarded</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">41,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Forfeiture/Cancelled</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(70,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Grants vested</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,361,966</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">412,501</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock grant
vesting periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 47%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Unrecognized stock compensation</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">Year Ending</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">expense</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">264,167</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">142,552</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 13%; font-size: 10pt; text-align: center">2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">148,334</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">34,775</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1pt">2021</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">412,501</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">177,327</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">The following schedule shows
stock option activity for the year ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of <BR> Shares</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining <BR>
    Life (Years)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average <BR> Exercise
    <BR> Price</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 55%; font-weight: bold">Stock options outstanding as of December 31, 2018</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,184,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">9.68</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1.15</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">736,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.20</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.38</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt">Expired</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">218,332</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">9.12</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; text-align: right">1.33</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options outstanding at December 31, 2019</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,702,167</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">9.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">1.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options exercisable at December 31, 2019</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">703,538</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">8.89</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">1.17</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock option
vesting periods under the two stock options plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">Unrecognized stock compensation</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">Year Ending</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">expense</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">540,998</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">359,521</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">408,964</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,015</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2021</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">48,667</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">2022</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">998,629</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">489,936</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: right; padding-bottom: 1pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 14 &ndash; SHAREHOLDERS&rsquo;
EQUITY </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, an executive left the Company
and returned 375,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its
issued and outstanding stock by 375,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 15 - INCOME TAXES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes
in accordance with the asset and liability method prescribed in ASC 740, &ldquo;Accounting for Income Taxes&rdquo;. The Company
has adopted the provisions of ASC 740-10-25, which provides recognition criteria and a related measurement model for uncertain
tax positions taken or expected to be taken in income tax returns. ASC 740-10-25 requires that a position taken or expected to
be taken in a tax return be recognized in the financial statements when it is more likely than not that the position would be
sustained upon examination by tax authorities. Tax positions that meet the more likely than not threshold are then measured using
a probability weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized
upon ultimate settlement. The Company had no tax positions relating to open income tax returns that were considered to be uncertain.
The Company determined the valuation allowances are established when management determines is more likely than not that some portion
or all of the deferred tax asset will not be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company files income federal tax returns
in the United States and Canada and state and local tax return in applicable jurisdictions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has experienced substantial
losses for both book and tax purposes since inception and has no tax provision for the years ended December 31, 2019 and 2018.
The potential future recovery of any tax assets that the Company may be entitled to due to these accumulated losses is uncertain
and these tax assets are fully reserved based on management&rsquo;s current estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s estimated operating
loss carryforwards and expiration dates for tax purposes are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2016 - $1,618,386
expiring in 2036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2017 - $2,182,354
expiring in 2037</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2018 - $3,060,443
no expiration</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2019 - $6,819,954
no expiration</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Realization of operating loss carryforwards
to offset future operating income for tax purposes are subject to various limitations including change of ownership and current
year taxable income percentage limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has no credit carryforwards
for tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s tax returns since
inception are subject to examination by taxing jurisdictions in the United States and Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 16 &ndash; WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The following table shows warrant
activity for the years ended December 31, 2019 and 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center">December 31,</TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of shares</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-weight: bold">Warrants outstanding as of December 31, 2018</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">6,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">1.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Warrants issued in connection with convertible debenture
    offering (see Note 10):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to convertible debenture holders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">532,134</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.00</TD><TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to 4Front as part of compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">153,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.41</TD><TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Warrants outstanding as of December 31, 2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">692,034</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.88</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Warrants exercisable as of December 31, 2019</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">692,034</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2.88</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The warrants issued to convertible
debenture holders expire June 24, 2021. The warrants issued to 4Front as part of compensation expire May 31, 2021. Warrants issued
to Mr. Lowe in 2018 expire March 31, 2023. The aggregate intrinsic value of the warrants outstanding and exercisable at December
31, 2019 is $0.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>NOTE 17 &ndash; SUBSEQUENT
EVENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><B>Credit Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 21, 2020, we entered into
a letter agreement (the &ldquo;Credit Agreement&rdquo;) by and among the Company, as borrower, urban-gro Canada Technologies Inc.
and Impact Engineering, Inc., as guarantors, the lenders party thereto (the &ldquo;Lenders&rdquo;), and Bridging Finance Inc.,
as administrative agent for the Lenders (the &ldquo;Agent&rdquo;). The Credit Agreement, which is denominated in Canadian dollars
(C$), is comprised of (i) a 12-month senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which
was funded in its entirety on the closing date (the &ldquo;Term Loan&rdquo;); and (ii) a 12-month demand revolving credit facility
of up to C$5.4 million ($4.0 million), which may be drawn from time to time, subject to the terms and conditions set forth in
the Credit Agreement and described further below (the &ldquo;Revolving Facility,&rdquo; and together with the Term Loan, &ldquo;the
Facilities&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final maturity date of the Facilities
will be the earlier of (i) demand, and (ii) the date that is 12 months after the closing date, with a potential extension to the
date that is 24 months after the closing date (the &ldquo;Maturity Date&rdquo;). The Facilities will bear interest at the annual
rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11% per annum. Accrued interest on the outstanding
principal amount of the Facilities will be due and payable monthly in arrears, on the last business day of each month, and on
the Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Facility may be borrowed
and re-borrowed on a revolving basis by us during the term of the Facilities, provided that borrowings under the Revolving Facility
will be limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable, (ii) 85% of investment
grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser of C$4.05 million
($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts and (B)
85% of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility may
be prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan may be prepaid
in full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions. As of
April 30, 2020, C$0.4 million ($0.3 million) of the Revolving Facility was available for future borrowings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company utilized a portion of the
proceeds from the Term Loan to refinance existing indebtedness, including a $2.0 million loan with Hydrofarm. The Company terminated
the Hydrofarm loan concurrently with the closing of the transactions contemplated by the Credit Agreement. Remaining proceeds
from the Facilities are expected to be used (i) to pay down existing debt obligations and (ii) for general working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The obligations of the Company under the
Facilities will be secured on a first lien basis (subject to certain permitted liens as set forth in the Credit Agreement) by
substantially all of the assets of the Company and certain wholly-owned subsidiaries of the Company, as well as a limited recourse
personal guarantee of Bradley Nattrass, the Chief Executive Officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Credit Agreement also contains customary
provisions, representations, warranties and events of default for facilities of this nature and affirmative and negative covenants,
including without limitation, covenants relating to maintenance of collateral, reorganization and change of control transactions,
creation of liens and incurrence of indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Amendment of Promissory Note and Subordination
Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the execution of the
Credit Agreement, the Company entered into an agreement to amend the promissory note (the &ldquo;Promissory Note&rdquo;) dated
October 18, 2018, as amended on May 20, 2019, between the Company and Cloud9 Support Inc., an entity owned 100% by James Lowe,
a director of the Company (the &ldquo;Amending Agreement&rdquo;). Pursuant to the Amending Agreement, Mr. Lowe agreed to extend
the maturity date of the promissory note from December 31, 2019 to the date which is the earlier of 60 days following the date:
(a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0.35pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>4,285,714
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;<IMG SRC="logo.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>urban-gro,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>ThinkEquity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>a division of Fordham Financial Management,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;13.</B></TD><TD><B><I>Other Expenses of Issuance and Distribution</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> The following table sets forth all
costs and expenses, other than underwriting discounts and commissions, paid or payable by us in connection with the sale of the
common stock being registered. All amounts shown are estimates except for the SEC registration fee, the FINRA filing fee and
the listing fee for the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount
                                         Paid</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>or to be Paid</B></P></TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right">5,999</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA filing
    fee</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,748</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq listing
    fee</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing and
    engraving expenses</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal fees and
    expenses</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"> 1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">00,000</FONT> </TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting fees
    and expenses</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT> </TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer agent
    and registrar fees and expenses</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Relations</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,000</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous
    expenses</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,253</FONT> </TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,000</FONT> </TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;14.</B></TD><TD><B><I>Indemnification of Directors and Officers</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are incorporated under the laws of
the State of Delaware. Section 145 of the Delaware General Corporation Law (&ldquo;DGCL&rdquo;) provides that a Delaware corporation
may indemnify any persons who are, or are threatened to be made, parties to any threatened, pending, or completed action, suit,
or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of such corporation),
by reason of the fact that such person was an officer, director, employee, or agent of such corporation, or is or was serving
at the request of such person as an officer, director, employee, or agent of another corporation or enterprise. The indemnity
may include expenses (including attorneys&rsquo; fees), judgments, fines, and amounts paid in settlement actually and reasonably
incurred by such person in connection with such action, suit, or proceeding, provided that such person acted in good faith and
in a manner he or she reasonably believed to be in or not opposed to the corporation&rsquo;s best interests and, with respect
to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. Our bylaws includes
such provisions related to our authority to indemnify a director, officer, employee, fiduciary, or agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section 145 of the DGCL also provides
that Delaware corporation may indemnify any person who is, or is threatened to be made, a party to any threatened, pending, or
completed action or suit by or in the right of the corporation by reason of the fact that such person was a director, officer,
employee, or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee,
or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo; fees) actually and
reasonably incurred by such person in connection with the defense or settlement of such action or suit provided such person acted
in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&rsquo;s best interests,
except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the
corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 130; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the DGCL, where an officer or director
is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or
her against the expenses which such officer or director has actually and reasonably incurred. Article VI, Section 6.1 of our bylaws
contains a mandatory indemnification provision, which requires us to indemnify a person in the defense of any proceeding to which
the person was a party because the person is or was a director or officer, against reasonable expenses incurred by him or her
in connection with the proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section 102(b)(7) of the DGCL permits
a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable
to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability
for any:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>breach
                                         of a director&rsquo;s duty of loyalty to the corporation or its stockholders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>act
                                         or omission not in good faith or that involves intentional misconduct or a knowing violation
                                         of law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>unlawful
                                         payment of dividends, stock purchase or redemption of shares; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>transaction
                                         from which the director derives an improper personal benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our amended certificate of incorporation
does not include such a provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to Article VI, Section 6.2 of
our bylaws, expenses incurred by any officer or director in defending any proceeding in advance of its final disposition shall
be paid by us upon delivery to us of an undertaking by or on behalf of such director or officer, to repay all amounts advanced
if it should ultimately be determined that such director or officer is not entitled to be indemnified by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Section 174 of the DGCL provides, among
other things, that a director, who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock
purchase or redemption, may be held liable for such actions. A director who was either absent when the unlawful actions were approved,
or dissented at the time, may avoid liability by causing his or her dissent to such actions to be entered on the books containing
minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives
notice of the unlawful acts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have an insurance policy covering our
officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;15.</B>&#9;<B><I>Recent</I></B></TD><TD><B><I>Sales of Unregistered
                                         Securities</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the three years preceding the filing
of this registration statement, we have issued the following securities that were not registered under the Securities Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In December 2017, we issued a $300,000
unsecured, interest-only note payable to Michael S. Bank. Interest accrued at the rate of 1.65% per month and interest payments
were tendered twice a month. In March 2018, the holder agreed to extend the loan through March 23, 2019. In consideration for
the holder&rsquo;s agreement to extend this note, we issued 6,000 warrants, each exercisable to purchase one share of our common
stock at a price of $1.00 per share for a term of five years. None of these warrants have been exercised. We relied upon the exemption
from registration provided by Section 4(a)(2) of the Securities Act for transactions by an issuer not involving a public offering
to issue these warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In 2017, we granted 245,000 shares of
restricted stock to employees. In 2018, we granted 498,166 shares of restricted stock to employees. In 2019, we granted 25,800
shares of restricted stock to employees. The issuances of these shares of common stock were made in reliance on the exemptions
from registration provided by Section 4(a)(2) of the Securities Act for transactions by an issuer not involving a public offering
and by Rule 701 under the Securities Act for issuances of securities pursuant to a compensatory benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In October 2018, we issued a $1,000,000
unsecured, interest-only promissory note (the &ldquo;Promissory Note&rdquo;) to Cloud 9 Support, LLC (&ldquo;Cloud 9&rdquo;).
The Promissory Note is personally guaranteed by our largest shareholders, Bradley Nattrass, our Chairman and Chief Executive Officer,
and Octavio Gutierrez, a former officer and director. As additional consideration for the loan, we granted options for 30,000
shares of common stock at an exercise price of $1.20 per share to Cloud 9. In connection with the execution of the Credit Agreement
described below on February 21, 2020, we entered into an agreement to amend the Promissory Note (the &ldquo;Amending Agreement&rdquo;).
Pursuant to the Amending Agreement, Cloud 9 agreed to extend the maturity date of the Promissory Note in exchange for 100,000
shares of common stock issued to James Lowe as designee of Cloud 9. We relied upon the exemption from registration provided by
Section 4(a)(2) of the Securities Act to issue the note, the options, and the shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In December 2018, we issued a $2,000,000
note payable to Hydrofarm Holdings Group, Inc. (&ldquo;Hydrofarm&rdquo;), secured by all currently existing and future assets.
Interest accrued at 8.0% per year and was paid quarterly. The note matured on the earlier of: (a) 90 days&rsquo; notice from Hydrofarm;
(b) acceleration of the note payable due to us being in default; or (c) December 2023. We relied upon the exemption from registration
provided by Section 4(a)(2) of the Securities Act to issue the note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2019, we issued 3,000 shares
of common stock to each of Chris Parkes and David Parkes, the holders of two unsecured, interest-only notes payable, in consideration
for extending the maturity dates of the notes and reducing the interest rates to 9% per annum. We relied upon the exemption from
registration provided by Section 4(a)(2) of the Securities Act to issue the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">From March 2019 to June 2019, we received
gross proceeds of $2,565,000 from a private placement of units (the &ldquo;Unit Placement&rdquo;), with each unit consisting of
a $1,000 Convertible Debenture (the &ldquo;Debentures&rdquo; or a &ldquo;Debenture&rdquo;) and Common Stock Purchase Warrants
(the &ldquo;Warrants&rdquo;) exercisable to purchase 207.46 shares of common stock at $3.00 per share for a period of two years
from the purchase date. The Debentures were due May 31, 2021 and bore interest at 8%, compounded annually, with interest due at
maturity. The Debentures, plus any accrued but unpaid interest, were to automatically convert for no additional consideration
into shares of common stock at a conversion price of $2.41 per share upon the occurrence of a liquidity event. We filed a registration
statement with the SEC on September 17, 2019, to register the securities in connection with the Unit Placement. That registration
statement was declared effective October 16, 2019, triggering the liquidity event indicated above and the <A NAME="ElPgBr2"></A>$2,565,000
in Debentures plus $92,037 in accrued interest were converted into 1,102,513 shares of common stock at $2.41 per share. The Warrants
contain a mandatory exercise provision if the weighted average share price of our common stock exceeds $5.00 per share for a period
of five consecutive days. As of September 30, 2020, no Warrants had been exercised. These sales of securities were made in reliance
upon the exemption from registration provided by Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder
for transactions by an issuer not involving a public offering, or in reliance upon the exemption from registration provided by
Regulation S under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In March 2019, we acquired 100% of the
stock of Impact Engineering, Inc. As consideration for the acquisition, we issued 500,000 shares of common stock valued at $2.00
per share. Under the terms of the acquisition agreement, we were required to issue additional shares of common stock to the seller
if the average closing price per share of our common stock was less than or equal to $2.00 per share for the 30-day period beginning
on the date that was 150 days after the initial date of the listing of our common stock on a national securities exchange or quotation
on the OTCQB or OTCQX (the &ldquo;Valuation Period&rdquo;). Our common stock price was lower than $2.00 per share during the Valuation
Period and we were required to issue additional shares of common stock to the seller. In September 2020, we agreed with the seller
to satisfy this provision of the agreement by issuing 250,000 additional shares of common stock to the seller. We valued the issuance
of these additional 250,000 shares at $0.62 per share. These sales of securities were made in reliance upon the exemption from
registration provided by Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder for transactions by an issuer
not involving a public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2019, we terminated our then
Chief Financial Officer without cause. Pursuant to the terms of our agreement with him, all of the shares of our common stock
that we had conditionally issued to him and which were to vest over a three year period, immediately vested and we issued an aggregate
of 1,000,000 shares of common stock to him. We relied upon the exemption from registration provided by Section 4(a)(2) of the
Securities Act to issue the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 21, 2020, we entered into
a letter agreement (the &ldquo;Credit Agreement&rdquo;) by and among us, as borrower, urban-gro Canada Technologies Inc. and Impact
Engineering, Inc., as guarantors, the lenders party thereto, and Bridging Finance Inc., as administrative agent for the lenders
(the &ldquo;Agent&rdquo;). As additional consideration for the entering into the Credit Agreement, we issued 500,000 shares of
our common stock and warrants to purchase 124,481 shares of common stock with an exercise price of $2.41 per share to the Agent.
We relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act to issue the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 15, 2020, we signed a $1,854,500
convertible note (the &ldquo;Notes&rdquo;) bridge financing (the &ldquo;Bridge Financing&rdquo;). The Bridge Financing is a combination
of $1,354,500 received on November 20, 2020, and an additional $500,000 received on December 15, 2020. The Bridge Financing was
raised by a combination of our Board of Directors, our current investors and two new institutional funds. In connection with the
Bridge Financing, an outstanding $1,000,000 promissory note and $4,500 interest accrued thereon was converted into a Note. The
Notes were issued in reliance upon the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;). The Notes carry interest at the rate of 12% and mature on December 31, 2021. The Notes will
be mandatorily converted upon the closing of a sale of the securities of the Company, whether in a private placement or pursuant
to an effective registration statement under the Securities Act, resulting in at least $2,500,000 of gross proceeds to the Company
(a &ldquo;Qualified Offering&rdquo;). In the event of a Qualified Offering, the outstanding principal and interest of the Notes
will be converted into the identical security issued at such Qualified Offering at 75% of the per security price paid by investors
in connection with the Qualified Offering. Further, at any time after the one hundred twentieth (120th) day following the Issuance
Date (as defined therein), and with five (5) business days advanced written notice to the Company, the Notes may be converted
into a number of shares of the Company&rsquo;s common stock, par value $0.001, equal to the number derived by dividing (a) the
principal amount of the Note plus any accrued and unpaid interest through the date of conversion by (b) the Alternative Conversion
Price (as defined therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;16.</B></TD><TD><B><I>Exhibits and Financial Statement Schedules
                                         </I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT>Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following documents are filed as exhibits
to this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 11%; text-align: center"><B><U>Exhibit No.</U></B></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 88%"><B><U>Description</U></B></TD></TR>
<TR>
    <TD STYLE="text-align: center">1.1</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000141/urbangro_ex0101.htm" STYLE="-sec-extract: exhibit">Form
    of Underwriting Agreement.</A> (incorporated by reference to Exhibit 1.1 to Form S-1/A filed January 14, 2021).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">3.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820003602/urbangro-ex0303.htm">Certificate
    of Incorporation</A> (incorporated by reference to Exhibit 3.3 to Form 8-K filed October 30, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">3.2</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000028/urban_ex0301.htm" STYLE="-sec-extract: exhibit">Certificate
    of Amendment to Certificate of Incorporation</A> (incorporated by reference to Exhibit 3.1 to Form 8-K filed January 5, 2021)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">3.3</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820003602/urbangro-ex0304.htm">Bylaws</A>
    (incorporated by reference to Exhibit 3.4 to Form 8-K filed October 30, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">3.4</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="margin: 0pt 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000117/urbangro_ex0301.htm" STYLE="-sec-extract: exhibit">Amendment
                                    No. 1 to Bylaws</A> (incorporated by reference to Exhibit 3.1 to Form 8-K filed January 12,
                                    2021).</P>


</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">4.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000141/urbangro_ex0101.htm" STYLE="-sec-extract: exhibit">Form
    of Representative&rsquo;s Warrant</A> (included in Exhibit 1.1).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">5.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000240/urbangro_ex0501.htm" STYLE="-sec-extract: exhibit">Opinion of Nelson Mullins Riley &amp; Scarborough LLP</A>. (incorporated
    by reference to Exhibit 5.1 to Form S-1/A filed January 25, 2021). </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316818001391/urban_s1-ex1001.htm">Letter
    Agreement between Edyza, Inc. and Registrant</A>&nbsp;(incorporated by reference to Exhibit 10.1 to Form S-1 Registration
    Statement filed on May 15, 2018).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.2</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316818001391/urban_s1-ex1002.htm">Intellectual
    Property Purchase and Assignment Agreement between Edyza, Inc. and Registrant</A> (incorporated by reference to Exhibit 10.2
    to Form S-1 Registration Statement filed on May 15, 2018).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.3</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316818001391/urban_s1-ex1004.htm">Business
    Lease between JW Properties, LLC and Registrant dated July 22, 2015</A> (incorporated by reference to Exhibit 10.4 to Form
    S-1 Registration Statement filed on May 15, 2018).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.4</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316818001391/urban_s1-ex1005.htm">Commercial
    Lease Agreement between Bravo Lighting, LLC and Registrant</A> (incorporated by reference to Exhibit 10.5 to Form S-1 Registration
    Statement filed on May 15, 2018).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.5</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316818001931/urbangro_ex1008.htm">Form
    of Common Stock Purchase Warrant issued to Michael Sandy Bank dated April 19, 2018</A> (incorporated by reference to Exhibit
    10.8 to Form S-1/A Registration Statement filed on July 11, 2018).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.6</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820000293/urbangro_ex1009.htm">Redemption
    Agreement with Total Grow Holdings LLC dated January 24, 2020</A>&nbsp;(incorporated by referenced to Exhibit 10.9 to Form
    8-K filed on January 30, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.7#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820000908/urbangro_8k-ex1001.htm">Separation
    Agreement, dated as of March 20, 2020, by and between urban-gro, Inc. and Larry Dodson</A> (incorporated by reference to Exhibit
    10.1 to Form 8-K filed on March 23, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.8#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820000908/urbangro_8k-ex1002.htm">Form
    of Stock Option Agreement to be entered into on the Effective Date by and between urban-gro, Inc. and Larry Dodson</A>&nbsp;(incorporated
    by reference to Exhibit 10.2 to Form 8-K filed on March 23, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.9#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316819002757/urbangro_ex0401.htm">urban-gro,
    Inc. 2019 Equity Incentive Plan</A> (incorporated by reference to Exhibit 4.1 to Form S-8 filed on August 27, 2019).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.10#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1010.htm">Form
    of Deferred Shares Award Agreement</A> (incorporated by reference to Exhibit 10.10 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.11</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1011.htm">Letter
    Agreement, dated February 21, 2020, by and among urban-gro, Inc., urban-gro Canada Technologies Inc., Impact Engineering,
    Inc., the lenders party thereto, and Bridging Finance Inc., as administrative agent for the lenders.</A> (incorporated by
    reference to Exhibit 10.11 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.12</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1012.htm">Promissory
    Note, dated October 18, 2018, between urban-gro, Inc. and Cloud9 Support Inc.</A> (incorporated by reference to Exhibit 10.12
    to Form 10-K filed on May 18, 2020).</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 133 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; text-align: center; width: 11%">10.13</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 88%"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1013.htm">Amendment
    to Promissory Note, dated May 20, 2019, between urban-gro, Inc. and Cloud9 Support Inc.</A>&nbsp;(incorporated by reference
    to Exhibit 10.13 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.14</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1014.htm">Subordination
    Agreement, dated February 25, 2020, between urban-gro, Inc. and Cloud9 Support Inc.</A>&nbsp;(incorporated by reference to
    Exhibit 10.14 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.15</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex1015.htm">Promissory
    Note, dated February 21, 2020, between urban-gro, Inc. and Cloud9 Support Inc.</A>&nbsp;(incorporated by reference to Exhibit
    10.15 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.16</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820003648/urban_ex1001.htm">First
    Amendment to Loan Agreement, dated as of September 4, 2020, by and among urban-gro, Inc., urban-gro Canada Technologies Inc.,
    Impact Engineering, Inc. and Bridging Finance Inc.</A> (incorporated by reference to Exhibit 10.1 to Form 10-Q filed on November
    3, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.17</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820003648/urban_ex1002.htm">Agreement,
    dated as of September 18, 2020, by and between urban-gro, Inc. and George (Bob) Pullar</A> (incorporated by reference to Exhibit
    10.2 to Form 10-Q filed on November 3, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.18#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820003956/urbangro_ex1018.htm">Employment
    Agreement, dated as of July 1, 2020, by and between urban-gro, Inc. and Bradley Nattrass</A> (incorporated by reference to
    Exhibit 10.18 to Form S-1 filed on November 16, 2020)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.19#</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820003956/urbangro_ex1019.htm">Employment
    Agreement, dated as of July 1, 2020, by and between urban-gro, Inc. and Richard Akright </A>(incorporated by reference to
    Exhibit 10.19 to Form S-1 filed on November 16, 2020)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.20</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820004100/urban_ex1001.htm" STYLE="-sec-extract: exhibit">Form
    of Amended and Restated Promissory Note</A> (incorporated by reference to Exhibit 10.1 to Form 8-K filed on November 25, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.21</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820004100/urban_ex1002.htm" STYLE="-sec-extract: exhibit">Form
    of Amended and Restated Promissory Note</A> (incorporated by reference to Exhibit 10.2 to Form 8-K filed on November 25, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.22</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820004100/urban_ex1003.htm" STYLE="-sec-extract: exhibit">Form
    of Convertible Promissory Note</A> (incorporated by reference to Exhibit 10.3 to Form 8-K filed on November 25, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.23</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820004375/urban_ex1001.htm" STYLE="-sec-extract: exhibit">Form
    of Convertible Promissory Note</A> (incorporated by reference to Exhibit 10.1 to Form 8-K filed on December 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">21.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1706524/000168316820001656/urbangro_10k-ex2101.htm">List
    of subsidiaries of the Registrant</A> (incorporated by reference to Exhibit 21.1 to Form 10-K filed on May 18, 2020).</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">23.1*</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="urbangro_ex2301.htm">Consent of BF Borgers CPA PC.</A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">23.2</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316821000240/urbangro_ex0501.htm" STYLE="-sec-extract: exhibit">Consent of Nelson Mullins Riley &amp; Scarborough LLP</A> (incorporated
    by reference to Exhibit 5.1 to Form S-1/A filed January 25, 2021, in which it is included). </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">24.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1706524/000168316820003956/urbangro_s1.htm">Power
    of Attorney</A> (included on signature page of Form S-1 filed on November 16, 2020).</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instances Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</FONT>*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Schema Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</FONT>*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Calculation Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</FONT>*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Definition Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</FONT>*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Label Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</FONT>*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension
    Presentation Linkbase Document </FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">__________________________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">#</TD>
    <TD>Denotes a management contract or compensatory plan or arrangement.</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>*</TD>
    <TD>Filed herewith.</TD></TR>

</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b) Financial Statement Schedules</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All schedules have been omitted because
the information required to be set forth in the schedules is either not applicable or is shown in the financial statements or
notes thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;17.</B></TD><TD><B><I>Undertakings</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) The undersigned registrant hereby
undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during
any period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(i) To include any
prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(ii) To reflect in
the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission
(the &ldquo;Commission&rdquo;) pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in
the effective registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(iii) To include
any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Provided, however, that Paragraphs (a)(1)(i),
(ii), and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those
paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section
15(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), that are incorporated by reference
in the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the
purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial&nbsp;<I>bona fide</I>&nbsp;offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from
registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) That, for the
purpose of determining liability under the Securities Act to any purchaser: If the registrant is subject to Rule 430C (&sect;230.430C
of this chapter), each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other
than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A (&sect;230.430A of
this chapter), shall be deemed to be part of and included in the registration statement as of the date it is first used after
effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede
or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for the
purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the
securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller
to the purchaser and will be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Any preliminary
prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (&sect;230.424
of this chapter);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) Any free writing
prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) The portion of
any other free writing prospectus relating to the offering containing material information about the undersigned registrant or
its securities provided by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby
undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual
report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan&rsquo;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid
by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e) For purposes of determining any liability
under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in
reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(f) For the purpose of determining any
liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of Lafayette, State of Colorado, on the 5th day of February, 2021. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><B>URBAN-GRO, INC.</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Bradley J. Nattrass</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Bradley J. Nattrass</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
</TABLE><BR STYLE="clear: both">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 42%; text-align: center"><B>SIGNATURE</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 39%; text-align: center"><B>TITLE</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: center"><B>DATE</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Bradley J. Nattrass</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Executive Officer
                    and Director</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal executive officer)</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">Bradley J. Nattrass</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Richard A. Akright *</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Financial Officer
                    and Director</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal financial officer)</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">Richard A. Akright</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ James H. Dennedy *</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">James H. Dennedy</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Lance Galey *</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">Lance Galey</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ James R. Lowe *</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">James R. Lowe</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Lewis O. Wilks *</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center">Director</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"> February 5, 2021 </TD></TR>
<TR>
    <TD STYLE="vertical-align: top">Lewis O. Wilks</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Indicates that such individual signed their name pursuant
to the power of attorney previously filed as Exhibit 24 to this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 137; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>urbangro_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 23.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the
incorporation in this Amendment No. 4 to the Registration Statement on Form S-1 of our report dated May 18, 2020, relating to
the consolidated financial statements of urban-gro, Inc. as of December 31, 2019 and 2018, and for each of the two years in
the period ended December 31, 2019, to all references to our firm included in this Registration Statement filed with the U.S.
Securities and Exchange Commission on February 3, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>/S/ B F Borgers CPA PC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lakewood, Colorado</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 5, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %. A8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/&GC/3=,T;1/'UKK(!_5917\E6F?\%4_VS-#\#^*_ ?ACXO_ /#7OB;XO?\
M!1+XA?LE_L]_M6_L\?LJ:-\4/"UU\"/@Q^QWX9^-7Q#^(_P6^!_@?Q;H>F_&
M'XI6GCBT\:>$-8U:^^)NN?!^R\7:5XP\5:+IE_X)\ ZE\.[K]H?^"9'QY_:J
M^-?PV^+5G^U;\./B+X;UOX:?%=?"/PR^)GQ,_9_U+]E[Q1\=/AI?>!O!WB>V
M\::Y\%-0\7^-[?PMXE\/>+-8\5> ]=O/#FNMX2\1R>&[+Q%H6FZ&=4O- TP
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MX8\'VL'PVAOO&T?B/7_B)KA\4QZ;X3\,:+>_%WBC_@JE^WO\7/A_^W#^TO\
M KQ[\$O@Q\*/V-OV)/V$/^"@F@_![QU\#+SXJ^*OB7!^TO\ LK:K\=_%?[/7
MC#XC6WQ0\"1>&_!5M-X3U6UC\5>&_"+?$$:]XCL;VP\3:?H&@2^%]: /ZQ:*
M_)?]EGXV_M:^%_V_?C-^Q3^T_P#%;X7?'B)OV3OA1^V5X,\=?#WX-W7P0/P]
MN/B)\7_BK\(?$_P6M="E^('Q$D\6> M%G^&^F>(/ OBCQ'JG_"?VR:GK6E>+
MM6\3E=,O;'PSQ5^Q9^RM^V%_P5D_;GLOVE_@+\/?BW<^#/V*?^"=G_"O?$OB
M+3#;^._AQ<>*/B5^W^FO:]\+_'VC7>F>.?AMXHN9_#7AVYB\8^!=>\.^*=+O
M_#.@7NF:K9WNF:==( ?NW17\;GP=_P""H?[;/B7X7?LE_LQ?";Q[\=_'NMV'
MP'_:!^+?BW]K;X=_L@-^VU\;/C%\+?AW^W+\</V3OV6;V;P;=>//AOX7T^P\
M9?"WX-?\+'^+?QIU[_A*M:^(&J:UX'N/#EMI5SXHUWQ(_P!>:I^W[_P4MT[3
M?V/?C=^U9H=G_P $Z?V<O$/PW2;]H7Q_?_LB>*_C=X:TK]H?2OVB/&_PTF\)
M_M :3>?&*T^)7[)7P!^*7PFT3X<_$'X:^/M1TK5M+\$^(?BE<Z)\4OC6EIX3
MLE\0@'])UGK^CZCJFL:/IVK:5?ZEX>GM+3Q!IUEJ-I=:CH=WJ%A!JMA;:Q8P
M327.F3WNEW5MJ-I%?1V\MU97-M=V\<EK,LPV:_EL^*_[8?[0W[+?Q4_X*?VV
MDZ_\ ?#&KWW_  4T_8B_9Y\4_MH^)O@/X1\(:=^S?^SY^T]\!OA[XET/XP_'
MX^&;[28_C%<_LU^'?&_A/X#_  W\;_&+Q9IWA6*^G\&>)/B/>:;X"@\0^'Z?
M\(?VY/V^OBCHOPY\%>!?VM?@W\0+SXV_\%9?C1^Q5\._VN+;]G#P_K_P:\;?
MLZ?"W]AGQ1\1W^)OP7\&>&?&?A>P\4:['\6OAQXPMK[Q9/\ $GQM\/Y?C'IO
MBVQT;^W?A+HMK\.X0#^I"N$M/BA\.+_Q]JGPKL/B#X&O?B;H>EV^NZW\.;3Q
M;H%SX]T;0[M+1[;6M4\'PZB_B'3]*N5O[!K?4+O3H;25+VU>.9A<0>9\!?\
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M  C\2](^'GPO'@"VO]8A\0Z9K?C;Q9J>IZ3)8>$K?COV3_A[XP_:&_X+,_M
M_M1>._'?A'Q3X<\"_L5_L#^/_A1\/_&G[/'PWU/QK\)_!O[1UG^UYK&E?#[X
M>_&'4)[KQIX#F\+:_H&I^(_'?B3PY:Z/J?Q<O=:TO0?%5C::-X!\-*P!_1(K
M;AGC.2#C.,@].<?C[TZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D9@H+,<*.I[ >I] .K,>%&68@ D+3)/N-P"<< YP3G@'&>"< CH1D'
MC- 'R)^U!^Q5\$?VMM:^$_B?XG7/Q?T'QA\#[SQEJ'PP\;?!'X^?&;]GGQQX
M8G^(&C6?AWQC':>,?@KXU\#>(YK77=$T^VTV]M+C4I;9[)KF$QB&[N5F\>\1
M?\$M/V5O&&E?#RR\7WG[3WBG7_AC#X^TCP[\3M9_;2_:UG^->H^"/BA=Z#?_
M ! ^%/C'XTQ_&>W^)OCCX0^*+KPMX>GN_AAXM\5ZOX,MI-+A?3M+LGN;[[1^
M2_[,OBCQ9^TC^W7^UAX#^(_[2_\ P5YT77O!7_!1#XY^!?AK;_!/P[\0;3]A
MCPS\+OA59>&_%GA[P)XU^+5M\$O$/PO\.)<O::]X?UKP[K?Q$T[5[\ZKHNA1
MQVUWK^CO=_7'A'_@KC\9]:\2Z+XJ\1?L@>#_  ]^S%??\%+?%G_!,74?B99_
MM*S:S\8;7XG6GQP\5? 7P-\5[+X)R_ [2?"]Q\)_$7CNR\&Z'XCBU+XVZ-\1
M?#.I:YXBN-+\"^+/#?A[1?$7C  _03X*?L&_LR_L[W_P7O?A#\/;WPI#^SUX
M1^/_ ( ^#>EKXP\6:KHO@+P-^TM\1/!?Q3^*7A+1]*UK6+^ >'Y/%G@#PJO@
M_29TFM? N@:6OAGPDFCZ"1IP^?/VE?V$%@^#?[;GA']C[X6?#J'QY_P4:?5_
M#_[1=I\8/C!\5-&^!FAWOC[X9^(OAGXV_:'T/X0:5HWQ \+WGQ,ETB[T&?QO
MX4\#Z+\(KSX[WFCZ+=^._BEI^I^'-.U>OGWX:?\ !67XW_%GXP?L>'0OV6?A
MWX<_9(_;._:D_:,_9T^%_P <-:_:#U?5_B\J_LXZ!\=)M1UCQ=^SYIWP8T^S
M\(7'Q*\0_ _Q%'X*^P?%KQQ;>'](T^X7XDIX/U/5]%@>QX!_X+,Z';_M/W_[
M-7QRT7]E.'6#\*/VA?BBI_9 _;4L/VP?'/PWN_V;-%TGQAXX^''[0OPUA^"7
MP>U7X5^-=2\%W>MZAX8DTO4_'&A:MXC\(>(O"*ZC'>6]M>7 !^J?[-_P&\'_
M ++_ .S]\$OV<_AW#*G@GX&?"WP-\*_#,UQ%#%>WNF^!O#ECH$.L:DL ,4FM
M:X]G)JFM78W/>:E?7UQ,\LEP9'\*\ ?\$[OV:/A[\=K']HZVT[XO^./BCX:U
M;XB:U\.+CXR_M%_'WXW^#_@UJWQ9EO#\1]5^"'PZ^+'Q)\8> ?A'J7BZRO[W
M1+_4? WA[1;^#PS=WOABQN+/P_J6HZ;>?FCH_P#P6V^)G@__ (0OXH_M0?LM
M> ?@K^S+\0O^"<GQ=_X*2^!?%O@']H>[^./Q6\4_#;P5??!N/PA\,-0\"2_"
M'X6>&O!7Q;US3/C!X9N[ZVN?''B7X:W%_P"(])T?1/BA<WFC>)!;\]H__!P!
MH,?ASXYS:WX$_9)^(GC;X<_L2_&_]M;P3X:_9 _X*#^!?VL-%N-/^ %AX>U/
MQ]\$/CMXD\,?"'PE>_!+XHI8>+M"O/#>KZ+X:^+'PT\96NG>.W\,^,[^X\%3
M6FJ@'Z1:C_P2T_8^U'1_C)X4E\*_%:#P-\;O&\'Q2UWX=:7^T9\?-)^'?P_^
M+%O\3(_C/'\6?@)X-T[XCVNA?L]?$H_%E'^($GC+X*67@?6Y/$%U?R/<-97D
M]E/XM\6O^"6/P?\ "7P%_:&\,?LT_";6O&OQ)_:#N/@1??%.#XL_MP_M8_#/
M6/B_JOP1^)8\;Z9XY\4?M+:!=_%_XR:)\88K&^U2RM/B);6&J7_B./3/!/A7
MQI+?^!?#5AHEEY;XJ_X*??MO:!\0_BO\';3_ ()\_".X^*/PX_9%TS]O6STO
M4OVX+JS\,:I^SOJ>J^/O#D'@/5O$NE?LM:_<Z1^U1-XE\#S:9;> M&T'Q;\
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MT:S^H?"GP,^&O@[XS?$_X]>'M"FT_P")GQD\%_"/X?\ Q UC^U-3GL-4\*_
MZX^)%U\-;"PT*XO9-%T3^Q)?BSXW6XN-'LK2XU0:I:#4WF_L^Q6/\C?V8O\
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M^*OQD^%O[4?Q\_:^^-GQ!\:^&?#MO>_M!_%WX]_LLZY^RCJ"6^C>')M'\/\
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MP!IDEUI]M<II=Y<6'@SP]H/AFUNKJRFN8]%T;2[(2[;"V:, ]HHHHH ****
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MTBR\*P6^H6OC>WU?PE]S:3^SQ\%-!\6>'?'&A_"SP)H_BKPGI>DZ-X;UC2]
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MFKP3J^DW=UI&M_VE\(M<^$?A35?%5C<ZAX/LGT7X]?#_ $(>)/\ 0?$&I:>
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M_0!_P_2SNQ^RW*=F[=CXVPG&,9W;?A.WHV,;BVT[=V#M7_A^FH&\_LMN(R2
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MW'B&_EB:>&R\9:)>:EI-IXMB?[)8ZY<:K;:YH$1CDU6QT3];\#T'Y"OY6_\
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M*4"1\*BABI^1 #]E<#T'Y"C ]!^0I:* $P/0?D**6B@ HHHH **** "BBB@
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MXLG??'+,O"96,2$;%\TD32NWR^5"$4HKW+ //*L<,CS.UND4F-OEJH*A$3S
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MM7\5Y)* AB&)&Z4C(.0S;2F=JGH, !@%()+LV7$Y<  A=N&B).226&XL3O7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?$?Q1XH\+_M(Z_\ "#PC\0?V9OVTOB%JGBSXB^"/ ^H_'7Q#\2M7B^*-W?\
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MF\4/X,\6>,O%>O\ @7Q1I/PN\-^,_!U_XE\1'0/$5C#X@UR'40#S'P9\3_\
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M&6M^&KSQGX"LO$_AOQ'??#GQSK/P\>SUG2-'\9:+XBTW2M86ZL]7FO-/$%T
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MK?VD3^I67[6'C,W>AV?B+P#\*OA];:9X7^'_ (_^,/B;XG_&[QW\*_#7P_\
M!_Q9^)?BCX=_#:VT$?$[]G'P;XU\1?$'Q')X"\97$_@GQUX'^$%G9:Q#X7\.
M6_BC47\4V^I:: ?=]%?F/X!_X*$W'C;X>_&/Q?8_"OP]XFU_X;Z+X03PWX3^
M$/QBA^)=QXC^)GQ \9:[X%\$? ?QKK6H_#SP-8_"_P",NHZY;^%;C6_"EY!X
MFB\+>'O'&D>(]6O3I?V*34O1/%/[6WC^PUKP?JO@GX5?#KQ=\'?'7[-OC_\
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M@;XW\::KX)U'6/!-IHL"Z1X;TSQ;XIU#44N8^D^ O[8^F?'/QMX+\ IX%O\
MP=XHU_P)\7_''BC1=6\1K=:EX9T[X<^-OA?X;\&ZUI-O#HEO!XQ\"?%S2?B3
M-XA\+^/+*\TRTTV[\+:WX(U+3?\ A.=$\8Z)X0 /N&BOR[O_ -OKQ_HOPR^%
MWC;7O@-X9'B+XX^$?AY\0_A3X2\,?%;XF^/AJ'@OQ;XT^&?@_P 1-XK_ .$.
M_9BU;QUH_B[P=)\7?!=\/"WA+X9?$*R\2&76+>U\06=KH,]XW4^(OVV/'?@J
M7QK!XV^#7A'PC<>$OV>O%WQRTJQ\2_%+XF>%]1^*EWX6^'NK?$2]\-?"6U\:
M?LT>%H/$]GX>L+;2=%^)C:Y=>%_BO\*M4NM0N/$_P5/AVV\-:UXQ /T;HK\]
M/%_[;&L^%=%\8^+H/AQX&U3PU8ZW\0/"7PJ\+3_'>RT+X\?&SQ?\*/B;HOPD
M\?V?A+X6:Q\/+?0K?P_I/BV3Q/!#XAN?B9<O%::7X5U3Q/H_A;3O&$M]X;^A
M_@3\>] ^/<OQ/O?"MG)!H'P]^(6E^ [+4;B>_M]4UFXNOA-\,_B-K$?B+PQJ
MVBZ+K'@+Q5X3USX@:GX \7> ]?CG\1>&_$?A'4;3Q NDZRUYX=T< ^A****
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M$8!!! (?10 U5V@98L1W/7IC'TSSUSGJ3W=110 4444 %%%% !1110 4444
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M@M]>"?4+BZNI^SHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#YPN/V3?@C<:?XHTD:5X\L]*\5>)K
M3QE+IFE?&SXW:+I_A3Q59^)+OQ<NO?"NRTCXB65M\&-2NM>U#4;K5;CX1Q>"
M6UJVU+4M*UC[=I.H7EC-)I'[)?[/6B)IZ6?PYM9AI=_IFJV3ZMX@\6Z_+'JN
ME?#_ ,5_#&WU22?7=?U*:YU.Y\)>.O&2:QJ%U)->>(/$GB?7/'6O3:EXZU&Y
M\1R?1=% 'RYX?_8N_9H\+^'O"OAK1OAJ(K'P3I]UI7AG4+SQAX^U?Q5IUC>?
M&/0?V@;F%O&^L>*;_P 9W[R?&/POH/CL7&I:_>7,>J:;#;Q3)I;SV$MFU_9!
M^!E@L::?IWQ)T^.ST=M#T*'3_C[\?K"#P;:R6^GV=S>_#R"T^)T,/PW\0W]A
MIRZ=J?BOP&GASQ/JFF:CXBTW4=7NK'Q5XFM]6^FJ* /FN;]D3X!2Z6=+B\):
M]ISFQ\*6@U_1/B;\5= \<1W7@WQ5\0_&VE^)8/B%HGC;3_'=OX[U'Q3\6OB;
MK'C+XB0>(X_'GQ#G\=^*(O'_ (C\36NL7D$NOIO[+GP"TK38-(L_AMI!TVU\
M2?"?QC96MY>ZWJ26'BSX'S:-<?"_Q)IS:EJEW)IVM^&KC0=-N'U*R>WN]>G6
M\F\2RZQ)JNJM>^^T4 ?/FB?LK? #P]H4?AK3?AQIS:-!\1/ OQ8LK75-5\1:
M])IGQ$^&FF^%M'\%>*M(O==UC4K_ $?4-&TGP9H&F-'I=U:6>J:?#J5GK%MJ
M%OX@\01ZIK_"7]G?X2_ Z[UN]^&F@ZUH\NNZ-X:\,RPZMX]^(7C.PT;PEX+N
M_$E[X/\ !?@S2_&_BGQ'IO@#P-X5E\7>((_#G@GP-:>'?"FBV=\FGZ;H]M86
6&G6UI[910 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /@ OT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#YGHHHKT "
MBFLP4$D]!G&1D_AUYZ9QC\CAH61R,#9M)R6 ))R!QCGC)Y.0,[3\I(H 5B.!
MU). !@D@D9&/3U]L]L@J8F?AV"J<_+T;@X7Y@>[;2<?09S4RQI'EN^ -S,S$
M!0<<NS'JS'J.#MZ 4I8=!@GG&"., L2>P "D\\9&.M  BJBA5X ]3D\_-DGO
MP<^W?&,4@<L^U"&(*_*!]X'.XAL@ KQQR21COD310*Z[W8R(P&T*7C&WG=N5
M& 8EL<'<" ?I5S 'S;1NY/  .>_0#K[<>G% %:.(A@[Y#88*%+ J"=ISC@G!
M!SU!SC.,U)';QQLK*IR !DMG&%VXZ#M@=QQGCI4Q. 2>WI]<9Y]>M+0 4F1Q
MR.>1R.1ZCUI3T..O:F;<D'G''''\))7)QG*YQ@$ Y.=W8 5\X(!P3[X[CO[Y
MQQR,YZ D,C4ID8P#R!G=CU.3ZC  ]5)[U)P,>YXX '3V  X]!S^9HS['Z_YY
M_3'ZT +11368*,_D.Y]A0 ZD) !Y [<GC)Z _4D?G49+ME1&V<$<XQGU/J ,
M\=#^%2+"P(\Q@X7!55!49'*YP0-H*Y"G(!/O0 T."0H.YCD\#L/4\#..WU[4
MXHYZ90=3QR<G! P<AFR>?3G'7,X"J>% /L #@_EQQW]/6E_#].G;_P"M]/;F
M@"*.&.,[E!STR6+?B,CC/ZCGV$U%% !1110 44W<._'&>>./7Z?RZ'!XHW+_
M 'A^?T_7D<=>1ZT?UT_S 7@=P/3/YX SZ#H/3VI<YJ+9))S&I(#;6P5 )'WL
M'G/!"@^G<XJ1;>9@27"'/3:#D #DGDG)'(QW.!R<YNK23:<[-:Z1DUO;=*W=
MZ7_4;VWN_P"O(:SJ#C< 1V]^,9]NN?TYQ32ZM@(0S,0  >N>Y&0#QZ]>E6TM
MXUPQ5BRG(/F2G)QR=I?;ECDX VX.!WJ5(D0?*I SNPWS$'IU;) X& "  H
M&0<Y8A)248W?V6VDM]'9Q?F][WMU"ZV7]?U_3Z%%8IRPRI7)Y8A> <<X#$]
M!TZCMVG^S/S^\'."?EZD @?H2/R]JN45FZU7^>UK;*-_G[O^7R!N_P#P"I';
M%7#.V[:69=ORX8D\D9Y.TD9Z@Y(/-2QQ1QEBH/(7JQ88.0,9.!DDYYSSEL9J
M:BL[MZO5MMM[7;;=[*W<0#^?/Y]_QHHHH **** "BBB@ HHHH **** "BBB@
M HHHH ***.O2@ HHHH **** "BBB@ HHHH ****/( HHHH **** (I(4D W
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MB@ _S^H/\P#^'IFJC6P'*$AB69B?FW9_^OR!WP!D#I;HH SF4Q'#$%3@*XR
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MXX)'RXXY&&R:H#@?,^(__/EX6_\ !JO_ ,I:/,^)'_/EX6_\&J?_ "EKO<1
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MWQ8'&#T]C^?X#K[$THJ=Y\VU_=LUMRK>WG??7Y!^!P6[XC_\^?A?_P &8_\
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MX! QGZ<8I=_Q)_Y\O"WL?[47_P"4O/Z5WK8.-P'<],]]I'UXW9Z8&.M.#*
M".P& < <#/<X[XS[#M5^QAS-M:-)<MW96O=IJ5]=M=OL@>?F3XD#_ER\+?\
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MQWS%;2RW3K!Y_G)+-<W F-VJH%6W.TR12JZ/,^\NKK(D>.HWR8Z1Y_X%_/\
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MR7_Y34;_ (F_\^OA?_P9+_\ *:O0MZ^OZ'_"C>OK^A_PH \]\SXFC_EV\+C
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MU8]"V2,9 [UK&O)7YO?O:U[1M;32T?F!YUN^(_\ SY^%_P#P9C_Y2T;OB/\
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MH6?A3;# ML-/@\6^)K>&&6&69IIB\/A9M\]RS"/@8W1!LA6)&-EV^Z_Y+7\
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M9]OP/\P?KG/MCO1MY)&/R'X=N,?CGOBKCAVFKU$TM6N2U];M7YW:^WS#3O\
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M,4?DO"T\DK10XMTG!^ZXSL[+FG))Z.+N]-5?2SL!YF?%-LMPML?$GCWS,HK
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M_0>U_P#\"+7_ .1*[\.IS@@X],\?7MCWSWZ8!-.HO_7X=@_KL>>GX?6H!/\
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MA&U*4I/W;Z_S:V2M?1VNOE?31 ?AKX1U"YN-8T3392;RSEU;2C<(X67R0MV
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MXA.1QE-Q=P7)(;.T "0X_47PG_P3T^#5G^WUXH_8-^(O[8OCO4-7DT#P_=>
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M'"#;)C;N(./-P4S^[P#DUREY&K>-?#I)*YT;4E(P>&$\#9*=1D*K -C<,,H
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MJ8WH,=%?&1G'H<''< ]N.GO5<J\7+-O7[IX&5 )"L<=<]\#^6*M]:3'4]_\
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M77QVB2.."+_A0>AND,$2Q1!I/%UHS':@5 6R68A<LV2237U+^V#_ ,&_6O\
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MG>(_ X\7W&OGQIJ7A:^6]L[A=9TLZ=#IHT%[>>+RY_M#W*MNC"8?^=3]M_\
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M3BVFM4UWU7GW=[K8#^3?3)XI[$;9%DS&'5D=2", QD%3W(&T\A@N>>_[S?\
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MF0X!).*_.[_@J1"R?\%,/VL/.A='/CSPT_[R,HWDR_#CP5)"^' )CDB9)(W
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MOHN^TO;/5M(GMM1TN]18YFM[NPN+::!PS0S1NHKW?QW:V\>K#Y0I_L'3F"E
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M-!<"0,CAF$9V\_2UWX%\/QQ72J=;_P!3= ?\5%K+9*122JI#7C6\I9ANE5H
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MAYH[E;O4+V"30+;4H='>WO[Z[O+Z_@DL6@O+^[O+VXCDNKJXED\)L=&O=/\
M%5A'IT5LUV?$J20?;&FCMRH\$6#;LVW[Y6C10T6/FWE<@C%?4'CX ^!_&.0,
M?\(KKIP0"!FP?ITP<\YY/)'<8\A10/&^CD+AO^$DC!.P<_\ %!6 PIQ\H/\
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M/DE9%>6"/C %=)+XF\%&WF1-&C5FMYHH\>&L-YDB.L2@",L#YC(VYB-NTLV
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M]*UF2Y6UBNHVN+B4BS:$Q1(SR8CD,@VD&)LJ*^E+KQSX4:"]6&_GDDDMKN)
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M>&/TYHWC/PW::/I5I+?7D4UKIMO;R1/HVN2%'@3:\4C"P8&53N"*K;&8Y8E
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MIH'_  0IH!'7'I^6>3[G/-.I"<>GXG _SQ^9 [UJ QV4 @D#@GG@84@$DG@
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M A@PQ@B/6\@_@>?3H<'./::\^TI5C^(?BB-45%7PQX,PBC8BJ5UK.U0,!>N
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MZE+-(6XPL4<COR0N S#7\/7$4/AOPSO)!?PQX: !*KRFA:>&ZG'&0><<X[Y
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ML1O,VF:&=6U"WGF^R/&MW+!;S4/@1\/_ !UX]T+Q1)X%\#>+O&D7@RTNM?\
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M;*WM;9BJF9=JDQ;E(4 DDC"D ]/);3)@RZ<%WMC>;S<2S-A=Y6X.T$\+NV@
M?>P*Q?!=MYOAVT(BAD8W%\6W6T,S@ Q<LSH6.1G)Q\H"J2, #II;)T6,B"%
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M1&%YJZ/X%U[1O$T6I7UWOA:0-<2+?SW#:FLKB.-+JQE!2UAB1B84\QPH14'
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MT_3/@7\2_'=Y=_9M>_9KUC4KE+3X&^.M6A@OO@M+<V_P;\3WTOP[LOAWJ&@
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M^]PH)ZXV@]J^=-/^%?Q!'C(7,MQ+$GV[SV\2^=E)%!B</Y899-P3%NUN]O\
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MG5)@"K0H?WB!5;J#H67A%--MH["QDBM+:'S EO&NS:2<29R ^YGW!U8D*00
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M[.ZA9X9X)7ZF+P]YRQR)=(!@.A!/SHZ H6Y(99%PZG^+&1D$[OT0_P"#DO\
M9>NO"'[4GP._:2\$Z<BZ=^T%X+U7P+\1(+1DMS/\4?A!%HJ^&_%-Z'E$=WJ?
MBGX7ZQ:^&+F<K']GTSX2^';>-7$TS+^77@6PUC1_!.GVE_K,EU/;F)A$8H9$
M@5YHD$)N60W<_DEX]J2R/&K&1$XVYUBG44ERQG))+FE)II;1\M$N5676[;5P
M.SNO#;M:W#"Z&U+>X8^66YQ$^5///0#!X&XXQR:_:J_T!=5_;1_X(:S2SW$!
MT+X%?"[4XDC8"*YDCLOBG"8IBRL'4+() JL'R%8GH:_&N W"74]M-=O>1/;R
MR?/'%&N'CPR^7"D<9!RP(9#D$@Y/-;FA?$?XD/K6C>(9/B9\2I/$7P_T:RTK
MX>>(9?B'XSD\0?#O2+?[=;V^C_#W7)-<;5? ND007%U;P:9X4N](L8(;N[2&
M"-;B;=$U+F][65E>VM]%;9=E_F!^N7PU\$?$GQ1X#_X*I_"C]E7XBR>$OVN/
M'/[:7Q2\7WYTG5+7PW\5/%OP#L?BQXS;6?!_PP\3W:)<:7<VUU->+//IUQ!-
M##=7=FMQI]UK-I?Q\UXW^"/[6?P__P""3_QZ^&_[4/Q'\:7U^_QK^$>L_#OP
MM\0/&5OXR^)/@'PQ<ZLZ:B-7U">?5M;T[0/$VL6DMWX=TK6K^]:V:RU>ZLDM
MX;QE;X/^#_CWX%17WBV\_:E^''Q5^,NI>.M9'B'0?B3X)^)W_",_%+P-XLMY
M]1U;5]?M-0UN3[)XGU;Q;J=])J&O>(?$M[>:PM_;6FHP^=?"6X/M/Q9^/OPB
M_P"%':S^SU^S%\,_B!X$\(>//'FG?$;XM?$#XR>+=)\=_$[X@ZWHBR1^'[!K
MBP>XTNVTJP#B9[BX)OKERXE@-Q/=7DZDG%\KM>R>CTU2>CV>CL^VV@'2_MY>
M-OCQX7^ ?_!-#PA\.?C]\5_A;I/@G_@GK^S]XVTF#X=>+]8\'0:A\0;'P+X<
ML;?Q9XD_L26VE\0SV-KHMI;V5CJ33:?;V]SJ436CC4)C7Z(7^OCP]_P6Q_9J
M\17NO7'AN;XO_LG? [4/&T6GWUUHVG_$7X@ZWX:^/NBVEQXBLK2:UM/$.IO8
M>%/#=A9Q:G!>/:6OAS21;)$+&'9_/OXLUSQMKUAH-OXN\=>,/&5EX=TC3O"'
MABR\7:Y?^);;POX3LAY=AX6\-0ZK=WBZ#X7TZ,>7I_AK2A9Z)9)\EM8Q 5Y1
M\>+'XP?$_5_#'BS4_'WCSX@ZWX:TC0_#^CW_ (E\8>(-8\3:!IWAO4KO7O"U
MGH.O:GJ4NHZ/I?A/5-7U'4/"MEINH6,'AO4KZ^U#14LKNZGGE;<>6*2]Z\N9
MN^JTY;;WZ[6MUO=(#]TOV*OAS\;O!G_!3_09?CEI7Q8TK5M4\-?M-S^"9OBM
M<^(=2N[_ ,$6D7CJ.V3PIJ.OZAJ@/A;3-3UB[FMM,T^ZBL]-N-:%\+&WB\06
MMS?_ #I\%O&/C_X/?\$;OVI-8^&'Q \6?#_7?&G[;'P<\)7WBWPOJ]QH?B6Q
M\-?$/QQ\)/#'BW2?#>O6?DWFBR:MHEY>:0+FRE^VP6^HW,=O-'/,LB?G'-X\
M_:R&G1^-M?\ VL?VCI_B7H>BZEINB>*]1^,GQ(UGQMH&BZC<?:-0T#1_B?J?
MB>Z\?Z!I>IQRL-6T[0M=M;*]8>5<1W$<:;?/;;QKX[L/!G@3P/#\1?&%OX#\
M0:M\-O$NO_#T^*/$1\#Z_P"(HM0M9K;Q'KO@_P#M ^&-<\3VMQI>FS:?XHU?
M2[O7K&[L;.[M]0@FM8I(R2^U:,5)NR3O:UD[WNU=ZZO5MOJ!^R.NWD?Q*_X)
M?_LX:E\>_$WC/XGZ9\(O^"CMKX:E\3^+];NO$7CF3X1'1?$FK^)_!5WXDO$D
MUB^T5_#ES=Z+#8M<FXNM/TO18Y)IKO3K2:/Z5_:;^"O_  4.^('[<GPN^._[
M.'Q:\;1_LSCQ+\/?$7PM\=>!?BAI?AG]G3X;?!'2M(1O$]EXH\(QW=EX>ETX
MZ?8ZAIWB+3]:T36I=;M[][*S^Q3"U6Q_%O4O$_BT^#9O!,?B_P 6KX)CUN;Q
M3!X(;Q1KG_"$V_BJ2VGL9/%5OX/>_;PU;^*WLIY;'_A)DTO^V/LL\L+W4EN\
MD+?4]Y\6?^":UGKGPI\6:Q^R5^TM_;VC>-/!_BG3/A/H7Q^TV3X!:I\1?#&A
M:L^B^(O%&EW]Y:Z[?V3:I91:OJ8%H9Y-2N/W-E<:8MYI]S52GR6UYDV^ENUO
MSM]UNH%?_@I5X/6/_@H-^U)K4.I7$C:[XC\)7'D^86MK>.#P+X>B#0+C"F50
M?,979)%V, NWYOBDZ!*,9NWYZ<GMUKT7XZ>._B=^T)\8?B'\:_%?CF71-=^(
MWB&;79M T/PYX>N-&\.V*6]M8:1H&FW.IVTVH7EOI6EVMK;-?7K"XOKE;B]>
M. 7(@B\<U#PYXJAM)7/Q(UF4J4PG_"+^$5#;G"X)6QW?@.&(VL"#QTTXN,$G
MNKW=T]VVM=K)/\/F!?N=,:T)EN+T06,2DW%[/-'#;P$LJ(TDDA$:H6=(\LPS
M(0I(R:HZ-X/T2W:ZU;1)( VK$27%]:E9UNCDN<3@LK@&4D["!ANF"*X3Q]X#
M\::WH4"6GBO4?$9A>&7^R;G3M)TQ)044#:^E1VPN=H<%ENW,916?_6*AJ_\
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MW9SUZNS,>I)JDDE9*R6R73[[@>03?!>:ZV+?>)M2FB1Q*H1UB9'6.6(.A6S
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MDN(U1-/FT;0;"&9[?4X9I4.H:;:0ZE"S10R21>1-$LTP2SNF>PGN8WY;X4^
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M04Z' ]NPX K!4$IO[4'?1Z<KNK15G=I):-NZV8_/S.?2X6TNKN=@9S#.\KD
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MX*_:;T_2_ ?PPTBP\%>$/#G@SP[=-JOB;^P/"^D:AXT\2>)O&%UK>O:A[O\
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M"T#Q1H7QSO\ Q!+::-I>HV:VD]_J7A#PI'-J=R)_(6V6VB:$7LH?HM(^$O\
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M8T#5-=\-:_IVL>&]7UC2KW^7+X5VGQ(^,O[$/PH^">D_M6?$R^_:S^+=E>_
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M8GDL8K:TD>,LD;%':!F0LB,5*Y4$XKZ,^%WQ@/\ PL/X./>_"[]G/2('\?\
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M5:VUJQLW\IU[Q%>6G[/_ (?\):7KUU8Z=<?M*?M$>([[P]I6H2Z:TL"_#O\
M9JTWPOJ5U!I\L%R-.#VNN6^C+*3IYO;*]FMHC=V;-">T;G**A>S7*WS1BU:\
MKMK1KHM>9Z770/"U&NZAJ0\.67AS6K[Q'<WK:3#X9L]%UFZ\3RZHA83:7'X<
M@LGUM]2@"R-<6(L!<VT<<TL\<<44CKU>J>$=?\*^#+;7?$.G:IH&LKXXUCP-
M?>$/$.AZEH6N:;+I>B6&O#4KVWU6&UN4ANDU%;>WB^R+&PA^T1W$Z."OTGJF
MKC74\=6'A_Q):VOQ:^)'P!^!5GH?B277(-,U#7SH^MPWGQE^'5OXIEO+?^RO
M&WQ#\,V7A.:*6YN+1O$>C_#OQ/\ #JYU*&_^(EA8:URWCF'Q#HW[.OPO\'^,
M_$NF:CXA\/\ Q/\ B#<0>"SK%KK_ (F\":'?:#HGV>QUZ]M[K4!:1:G?I>7N
MG:(]Y*^FH\DSQ6YO5C:?;>]91?+>U^6?-V3MHM7TOLNX'D>G>!/%OB7PEX7U
MWPAH.N>,M8\6>)?&WAJ+PEX4\-ZSK^KV,/@^PT"ZFUJ<:1;7K"PO6U]+=&FM
M[:&": A[J1Y8XQ\NR1ZC!9W4L^F7%I%9_';QII&H/J^BWD3Z9K"WWBR2;1+R
M#4;:&;2O$<(@N-VF7<5IJ<,5I>Q2P*8)U'VSJGBK4;7]G#P9X/T[7[FRL=0^
M+WQ3USQ!HFFZE-82WC0>%O!MEHMUJ\-E-#<SV46;U=.BNRUFMRUS/!&+DRN8
M9=03XB^)_!GPC?7],NM5_:(\"?#3PK::]JMXMU%9_M.>$];^+>E_!?Q!XOU<
MW!FL7F@T+1?A1XYUJ^^TZG9>"?$UAJ6H&6V\-15G7YN=75DK\KOJ[23U71I[
M=[I]0/+_ (4^"]3U_P"$\?B.W6\6+P_X+\&3Z596FA7]XWBZ_P!2U+P_X9N-
M)\.16:>;<W.G7&N6#20V$-\WGS1:8(DNRT2>??%'PUXO\*Z7>^#O$O@_Q3X<
M\37$ND7$'AWQ'X=UO0]=O8;O48H[6XT_2M3L;2[O[>=T>*&YLHKJ!KB&XMQ+
MYT,\<7W'\*O%<$GAKXC>$OAC\1](\.Z/X'_9L^'WP,^$/B?6-1M/#ESX_P!(
M\+^-H=2\6Z_IU^CK9:-XW^/'CC6_B'\4KV^M+F&"TE\9Q>%;#59M&TC0II.8
MT@ZU\-_#/P@\.?$W6K6R\5Z;^U9\)_''@CP]J_B*SUK5_AIX.TG3O%,/Q%\2
M:W=_;-6LM \.^-M?O?AS9V7A&_N[4Z]JWABX\:"R,'AEI=1:JU%"[2DE9<S;
MYI-M]+:J]KM:+1 > 6FCZKI^@7UUX@TWQ!X8N[+PMX<\0>&[#6O"'B:S'BK3
M=5\0IX96^2^N;2S@T;1Q-'>-8:]J"/I6LWMH^EZ=+<74L.=OP9X&\9>-]2\$
M1GPUXDTGP?XV\<>'_ ]O\19?"GB&;P;9ZEKU]!IT4JZ\UE'HMYY33A4C344B
MN;@?8H;@W@,([C2O$=[KOA']IC5O$GB"\UO7O%/A[P3-/>ZQJLU_JWB.X;X[
M^%=6OA%/=3M+>N;*.YOF@@9888%DG5884)'TOX,D\3R?M.^#/B[HGQ"\/^'O
M@U/XP\/6NC>+-5\4V'_"&:5\/FM8(;#X5S^$9+R22QUBTL2N@KX/.AE]*U?&
MM,_D6[:M6D:KDTE%Q;BVV^;1J+=HZ:WZ-N_9 ?G-::A)91R6J1QNL%U>PEW+
M*7:*[FB9PI/RJYCW!<MC.TDXJ9]6DD!5H(NGRE7*E3_>4Y//3J#T&,<YNZ>U
MLL,RN(QG4-3,2L5=O+;4;DIALG<"",,&.[(()!!-\M:*1D1#/0E1@C&<C..W
M/?&,'/-53<G3@Y?$TKWM>^OIV XV&8D7$>%4S7GF'YP-A,@) ##G&!@L3G.,
M9/$&N866SS\RK]GR5.,@%\D$@]N1Q_A6G\H2[QC_ )",I&,9YF@P>.<$ CTQ
MD=#5'68T\VS!!<"&W?;QEVRJ[,8 (.\@#J3U.,"G*2BDW?648Z:ZR=E\K[OI
MU VX[-;HK=7)\PR8D6(X:)4<[E7:1PZJ=I8$G<"<D<5;>TMF7:T$;+\HVE01
MA>%&&R.P'MG(QCB.TF40B-MH:$")E7JK("I##^'!4CKCCC(Y-LL"N>,=>O;'
M_P!<KG\1Q5 C&NX_L"O<VZ9C"$/""=H 7"^6H_U9R%9B@PP9@1EG)Q%:YDNT
MG,R9D6WG $2 J'BBDVC!V%@&4!=A52&PI^4CH;^:-H_L^X,TSA, \E NYCQR
M,A@%))#."N  H..+1/[0%MOD:.,0HI)0[!Y-N $(7&U2"(P%'[DIG&[ 4G)+
MW4I.Z7O-I6>[TZKHNH'00.9(T<XRZ@G&1W(^Z>AZ9QZ^PJ:H518-L0X"X$>0
M%&-N['  X.\8 Q@=#@&H)KZ"!_+<L7VJY5020K9"L0.@8JX'J4;TI@<+,-IU
M)(F6'#S 3.N]8P Y!*D.9  2.A)4$$@\G-^%\ZOX7DCA?[3<-K6H^=.8DMXR
M5M=-4N/D7Y/E7RSY9.X2*8U*U?GP5U)0TD,8\\%R@9@JB0#8 X!R,MR0<8!
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MX8\/:AJ>AZ0+#4M'M=:\5^(-$TR/6HKV6*UMM(>Y74+I[FSDAMFMYXISZ/\
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MA,<T:2+\-_![P/XO_9T_:JT+]HC]G_\ X)'_ !5^&/AV+X)>-/A1XK\(Z?\
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M]G>'/$/A+1_&D=WJ[P:>-/T+5M'M]<6YU:6XDCM[);+3K@2W\DLJQVXBE9F
M6@#^5_\ X.H/C@^E^!?V/_V;](U%CJ?C7XC>-?CAX@T^T!DN;;0/A9X=M/"/
MA^ZN0CY@BO\ Q'\3)Q8F2-OM<FE7P@(^QW#Q_P _OPEL]2D\%6EWK%L8KU?L
MH$C32^=/#)<1PQRRPQOY*MAWSL0 CRW^\'W>M?M^?M.ZE^W+^W5\6?C7HVHW
M=Q\-]*N-,^%'P7MKI+9FL/A?\.9-0M+.\B>%$#IXS\9:AXS^(P\V2:>*+Q?:
M::UU-:Z79&.GI5A?V>B@S3(85-MO @C1G;SXDC *.6R)&5\'AARS*4S6E)Q4
ME*3DE%IZ1<EK=:M;6N[-VN[;[ =?;006=U=K&K(HLKAY"SRR-@1 LQW,QX4D
M#;TV]#6AI_PY\2Z=<>+3J/AVWA;P]X>\*>+M<:34?#\K6?A[Q?<:5'X;U-%A
MU1WU ZF^MZ8QT_35OM4L(KIY]6L+&"VOI;?.ACN!<7OVI@\AT^[&0@C W6_.
M<<' P/7 R0"1GZ0\7Z98WE]^T%JD^CV5_JWA?]EC]G?6O"TUY;H\^DZW<^)?
M@5H<NH:?*P9K.>\TK5=0TB>XB^9]/O;JW*,CE'GG?/S22GKJI7=U9V5TETMY
M?<2XWE%_RMOUNK?@?*\FE:8TNF&6"-Y;BXO_ #C)(YDV0!V1E'F!HPH!W[-J
MA2RD8(QV$W@9(/#VE^)[K25B\.ZEK&K>'=,U)]0MVAFUK1++3=2U:P2S6_:_
MM6M+/5M,G\^YL[:UN!=(EG/<21W"P_7_ (?T66Q_:D^&GP!TKX2^%/'OPJO?
MBCX)T?0]-O/#*VNN?%'X>W_]DWJ_&R7X@J\NKZ$WCGPO=7/Q,CNQJ:^%O!-I
M>GP[K5A):^'M4M3P#>*]6\&?!#0SH^C^%K_7)OVD?CK%8^(]=\.:?KD&DZ/;
M:#X*MCIFC^'-62;2+=[K;;/+>SP3W<%M#%80K"I9S52HZEKI+ENE9MJSMW]/
M,(QMJWS2>CD]VE>R?3W4[+2]M[GS)<:99:0EM>Z1')975A>66J1W=F\ZM9-9
MW4$T&IL072+[-<K:RQWC[%@F%OB6-B@KRCXY:=X_T?P]H?B[2[:\B\'>(=9U
M;0I_$L>HVM_>ZAXQTZVLM?U/3KBR-U=:S D6DZQI>H'5)-/M["ZENC:PW]S=
M0W4,?Z2:9XCUGP#J/Q1UCPII?A;1X?'_ .QAX6^*NL:')X4T76M#L/%/B0^&
M+[Q#%H.GZM;7?]F^%KK4K:]UH>'8P^E6D=V;5%73M.L(K;AOAUX?M=>C^!6K
M:KH^C76H>+?VPM,\,^*)TTBSLO[8\*7=I\/[NZ\+7"6\*-#HXN]0U1(K"*-X
MK.29T@@4!0(3LT^52[IW2?DVM?3N4?G7I]YX^O/A[>ZA<Z7833);SF/4KB[N
M8]4EMTNC"K+IR@6!:%08U-Q$@==LCEG&ZG-%;VUO\,&CN!#-/#\.V>,QB25V
M:Z8L-S*S+&Y+?=94BVL\>P!_,^[-?\0W?CCPO\=_#NH>%/!.C:1X7^'7Q3\8
M^!H_#OA2TM=7\'ZKX*FEU?2H+75[>7^W?$ME>VUH-%UNRUZ^NWU"SNGFMY8]
M12!Q!):2>&OCY\#_ -G_ ,+?"WPS\1/AE?\ B[X%:=X:TFX\&+J.N?&GP5JC
MVE[8_%9OB3;RC6],/CC3);SQG#=Z+J%IH'A.VBCTUM/6ST.]M%7]?UZ;?(#R
MK6(DGMI4EB66%X)T='19$9&D0,&# HP*;LDX_O;@0#7COC"6_P##MY\/=9\%
MEK/Q%;>+=*O--FLKJ:"0ZDFE:ZL4AND=GM&0;F%Q$5FB 41NN2*^NIV\'Z%\
M9M4/B;0+WQ!X#T7XG>*H]7\.Z+8)JEW<>&].UO5HH_L.B_VGH5OKMOH\<5MK
M4_AU]<T*S\0Z=I-UH5QKNA6E^VKV.F_A"?QUXK^#GB+7=4^#/QD\*:7+\=KS
MPG;?"SPEXL^&UY\2/BK\(_V9?B'\6_ _P1\8>'O$W@/X=>*M'FU_4=*\-:I)
M966B^([/6]*'B#P!X;\77_B37M+U&'1R_=07*G=S]YW]VTUHO-K>Z:ML!\B.
MOBJUM)9SX<\-QVEE:R32O'K.ONL5O:P--(=L:L[%(HF.P!G;&T!B<'4\8>#_
M (B^!/$'BGPCXA\$^&-$\4>"O$>N>$?$E@OB"\OSI7B'P]K%QH>OZ9]LTVXO
MM+O19ZO8W5D][IUY>:?=/!]HL[NYB,,[?0OB+4-6^(OP,^+WBG7])\)Z?JG@
M>U\,P>$_&OACPGI_A*SU&Y\3G6],U3X>W^EZ5#;6.KR?V-;2^+=*F$3ZCH$>
MA7D-W-)::FOE^J_M:Z1*?$7[2/B&.UMW?3_^"A7[2.BZ]JZ6@,^G:#JM[-=>
M$]+U6]0,UG87VN6NO3Z6)5VW=[:7\<!:6*98HB[2B^:4;/XHZM:=GO?:P'YJ
M?$*Y^(-AH4$ECHUM86TL<DUY>:)=7VI72006;W5V\MO=+((K6&-7N;J[AB"6
MR*\DDD<2LQZOX1Z7XL\0^ =;\7^(-/FN?#.G:S8^%[37KB_L8[FYUB_TJ[U:
MWTM]*%Y'J<UE%IMA<W,>J#37L5+I:W=Z+FYL8[C](OAT_BKX87/PKFTO1],T
M;6/&7[ '[0?BS5X=<\)Z;J%]K<^JZC^U1JOA+69;;5+6Y>0:S\/M-\(#9&B#
M6/"=M8P7,4MDSK7F?P\\+Z;\3M)N+_QW)I=E-XM_:D^!'A/5?$&B6&F>&;^T
M\(^,_ _QMU+Q#X5\.ZBML+'PI9>+-4T/P[86-W';2:5HNI+I6MR65S!IGDR4
MIM2C-Q3FN;FD[WG=)*]MN5:1LO75@?,EM;6RRZ0R!3*]QJ4<JF1W8I']I"Y1
MI&"%P<N=H+L6(VG.99+V9]5M]*:[E;3K35;K6=/TUILVMMJ_B'0?!.E>(-4M
MK;.Q+[6--\%>$M.U"X53+<6GAG1K=V\NQB5?H+3M5U#Q_<>.O!GC#X>>#?!N
MA^%/!'Q:\16__"->#9O!^M_ K4_ VEZQ>Z9/>:Q<B77+ZP&N65IX/USP]XTN
MM3U/Q)-JJPIJ::U"E]-Z3J^K:!;?M.>'OA#I_P -? .G> _$FH_!;PEXMTJ7
MP_:ZAKNMZEXU\!> (?$GBB/Q5<Q?VUHFLQZKK-UJ?AJQT-[73/#ZP6-BD6IJ
MMW=W.T:TY.RBMF[7DMD[O7RZ?Y@?$]]8:=*;VZN(86NA<E8Y'9E9@K@ ;=^U
MB@^Z50.N[Y6%=5H/@R?Q3K.B>'=!TN\U;Q!X@U&PT31M+L[J1+B_O[V816=L
MCSW,4$49FD+27%W/;V5E +B]O;BVM+>YN(_=/!3:4=(L/ WA76OA7X?\=R>,
M_'7AGQ'I'QP^'/BG6K/XQ,?&2Z?X&F\#_$W0_!WC70M$NK:RC/AK5O!_BZV^
M%.EZ5J4-UKUAX^\2QZ])8:!+^RO?^*_"/[1G@BW5-)CO&U+Q9X>U73]7T#1-
M<BM/L_A/Q4UY:6RWG]H6T-S;WEBML+RU\QGL_M-LL[6UU('J59QYX\M^5I+X
MK-.S;;5U%ZW2O=I>=@/GSQ)X2M-!N;O3KZ;PWJ!B@A=;KPQXV\*>/O#=Y'>1
MK<02Z9XI\#>(_$_A'6H7ADAD$VF:U?QHWRNRS*4'DOQ!CU#0_!<]YX9MFBN5
M9!>7%NQ>>#3U%[+>/%;2!H3O\F/S98HVNE( @42N&'UW/XNUWPO\*?A=X\T_
MP_X"O=<^)^@ZUJ?C7Q;JOP[T#5-&.K:'?0Z'%\-O#^@>1_PCWA.TT#1H-.U?
M6+'3;%==\17?B4:R]U#IQTBWA]4US3]*^&W@[XA^(]%\ >%=,\8ZCJW[/>H6
M.A>)--/B'_A1&N>,O!/B7Q?XV\+:5IVJM)!?R7\NG:+J^CV/B-;BX\%Z+XA7
M0IX]2U*R2]@B5:34E'FB[KEDHMW7VKIII/M:]_4#\L?AWJ7CS4-.U>0Z?'JM
MG8VUP\%_JT]W:/'>1QRS+%&EK&DMQ(%"3 W):%U(C!../1?AW\1/$G@_PFS:
M*GA2PUC6_BIXQLY_$5]X'\(>(_&GABXUBS\4Z1XBA\!^-=7T34/$7@34]0L)
M[O2M2U;POJ&F:A)9FXDAN;:>9Y:^HO@MX4C\0^(?$IUF^\/W+>$/AIXQ\;>'
MM'\6Z)XOUKP]K>N^&X["=$UW1?AUX<\;^.==TC0M*GU7Q9J.B^'_  QJCZA%
MH3+JT<>A1ZE)6;I'BOX7:^/##_$3Q3\+M5N_%WQR\>_"G6O&/PK^%?Q@\'Z+
MH_AGQGI7B&#1/&'B27XE?!/X)^'X/'OPJ^(%KX7URTE\&0ZA<ZSX6'BO1_$.
MHQ:7J$.K#.<ES1NY5+)Z5(N.[_E5F]V].J \?\"0P?\ "#>#(]J%5\)>'TCC
M9$151='ME $6U44;!L\L( B@KM   XCQW:VL'PZ\0WMI&BSIY#(T4@$32"YB
M9=\0+0LV551OC)^506P *^Z?@?\ ##3]%\)_#[P'\2-%TQ?BOJ?@[QM\0]0T
M'Q+;^)=3MK;0OA'H-YX5\':/J^F> ]'\9^,]0@^)'Q,T/XF^))=&\*Z%J.NZ
MWX'^%GA_5K;3]0\'_$73=3N.6O[CP?\ $'2O J^)-7^%_BWQ WQY^#>A6TOP
MG^&'QF\$Z/XC\#ZUKEY!XT\#>/;CXB? WX0^#X9K6VMM.U_P1>Z'_;/C0'3_
M !!HFHV$V@7+7^G:3DIT[037+*-ERM6L^:Z5FW%6=W>R>[=] ^1]-'BR?3]/
ME;P]H4SO9VDN]M5UM79GMHFWM%$5BC9UDRZ1J$4G"J(RM6'LO%!9I5\*^&!(
M=K2.^JZTLI&V2(L3M+%F0O&&)RR;XR2%Q7U]I=Y;_$CQMXW\ Q>%O!'A>/Q7
MHVN>%?@MINA:39Z18^"O&?AWQ)>^*/ &CSZQ,ESJFI6OBD)J_@#7M6U);W5+
MP^)-/OYP1H]I;Q<#\3],N/".D>"O!%I8VT?BWPIX9U3Q'\1)[BQC36-0^(/Q
M#73=?E\'W\BS".RL?AMX6T?P5X.T[3H_M7D^))O'FKRW45UK,MH2#<K7JU>9
MIRLTN6R3;:;7O)+16^T[=@/EGQ!-X\M_#%]=V.BZ(+M8D,<^G:CJ$M[''_:$
M-O<20VM\J6SK':O,DQ>-CY(EEM\3HAKD_@WJ/B?Q!J-[;ZS]HO=%B@=Q<7+-
M;26M_(\#"& *L,[HT#SL%!:*,J=RJRJ#^A_B6]OOAYJFA_#OP7X/\$^)_!^J
M>"O".I65_K/@7_A(=9^+LGB;PS#JU]XYL]:69O$%DLNKW^HP:#9^%+NPMO#J
M:';V\J->6-[(_8PZ5H/B+Q?^RW\';S1O#_AWPQXT\'? ;4OB7XHTRWL[+QGX
M_P!9\0BYU-+:/Q9J(G3P9<^)672_ %G=:=&VG6VJZY_PF>M17_E3Z>&JS3LX
MR<4G:;4N:3Z75N5=;ZZ6N]+L#XN%M:@7)0DM;7[Q+B9BR+'-$4$B[QN()).]
M06(PV5R :PZ>?8H64,UO!L7<-SE7C^ZN2201U P"/4$5[]HNN:E\3?#_ ,9-
M(\9^ O!?A&Q\ _"GXA>/++4_"W@R/P5=?"#QMX)B@E\'>$]1NI&?4_$&D?$S
MQK<Z1^SZWA/Q3<ZAXGNO$/C_ $'QI9ZB-2\$ZDM[V'QI\0ZMX&\?>#_A_P""
M/V?/!7BNV\4_#'X!7FG_  \N/".J7GB+X^ZQXV^$'@BXO(=%\66QG\3Z)JWC
M'Q-J.H>&M"U;X=76F)X5\1)_:\$']OVFHO+#JRJ1:LE.,HS2=^5J*YFKO>3:
MM;KT\@^9]0>U>[FCCVM<Q.S.(Y(8Q 0S!GN%,B!DS@8P63 4G 8', U#*B2]
MB96",(O,LSO1@"!&=N]LG"J0S*V,X; W='XL^$7P[\'^-?B'X3\)>(;CXB>%
M?#WC;QQX1\.?$"[O]/U&?X@>%/#OBS5M'\/>-)]0T>.+1KZ7Q=I.FV/B"74M
M%1-(OY;][S2DCT^YMD3";P)X=#VDL>GIYME'#';$L515MF#Q(X56)1<''!(4
M '/%:1G5DDU3A9ZZU&N_3E\@(H(+%[DR/,8WW%V@FEBW+E$&Y6CFD4!2JYB:
M0\$.8T!-*9K==8)6> 1@0GB:';C9#M)(; !39\P.-NT 8XK)O_!7AY=/FA73
M@,7$MV%&-_VF2-82=S%24>--H55;."PP2$7$7POX<,K>;I?S3:?!93 HN[Y8
M[>-@ 'X^: G?\KE0I8*Q"B[U.5^Y#F3T7.[./=NVC6FEK6 ].-Q:R;09H6#-
M^['FQ'<PP2J#=RWS_,%R?G48'&>8U.2);UI(KJ!B]O"CJ9"S+Y<D[ GR58#)
ME8 $Y 4<9R62V\%Z L=B18(#9OYL*L3A)"5W,1]YD811+M)^ZB9^X ,6^\-:
M%IUTZV]IM,J+)*D4*3'<7D;S&,DB%1(78*%ROR$9R"*5ZW6G#_P9_P#:@(VY
MGU)T?RHV,Q5Q&250B8%C" 68C!)0+N/INYK-^&$L]QX9,<7G.HU?4%>\E3R3
M+B#326B1Q$%^5U52P;YPX;E0HTY0D@U$C>L1$S?)C<3^]V[.=H!!;H>3QW(K
M*^%)-SX6D,4DBP+K6H@M.JQR2'[-IA>.,(S*J! JE\JP82;0#R27\2E_V]^0
M65W*RN[7=M7;17]%L>BH-C-#:QK*ZJAEE;+HNW?YCEV(4R;Y!D*V<-DJ0K;<
MN=8X[(0*Z-,;RXDDVLS+@>86+LN1%)D$A&V%L[ER 2NP&$B&.U;RXQQ-.V0/
MF)PH(!8R -\Q;*A7;Y]PP<*81PV:Q1JTLJ7DWG2LIV_.[[=SC.=I8$ 9''S'
MGC2RO>WO)-1=KM7WMV;LN_R$TI*S5UV[^O<J:4IENK6#@)_I;@Y!W&2'9@@Y
M!VCJ/[Q)!QR/Z#O^"-'_  42L/ ^JZ;^Q'\<]?:RTG5M4:S_ &:O&6KNZZ5!
MJUYNE_X49K.IN&@TBXU27[1>_"V\U%K;2]3OUNO +ZC'XJU?P%HOB;^?/1&_
MXF-L V52.7KMX!C.#QR3QCC@8.>JT[7[&&]TW4XY"RO]LMFP)6BGW)<PM%+;
MF)TN(Y+>58YHYXMKP/&LBR(Z97'E=2E%OWII;MZVYG=7]%M;HD"222C;E6R5
MK:O6UM-S^L_]H[_@B#\,/VC/^"E/PL_X*4ZQ\=/B/X;\;?"SQG\!_&EA\+])
MT;PO<^#M8O/@-J5O?Z197VJ7MLVM6]OKSP^1J;6\HE@#,UH0>G[C5_*1^P-_
MP6MU;X1V^A?!C]M.[U;Q/X&M(;/2_"W[0=G;W.M^*/#5E$HM[>R^+.CV2W6J
M>(]+MT$>SQOHMM<ZQ:012OX@TV[@#ZG;?U!?#_XC^ /BMX4TKQU\,_&OA3XA
M>"]<BDFTCQ;X)U_3/%'AO4DA<Q3_ &/6M&N+S3YGMYDD@N(A<>=;SQR03QQR
MHZ+RC.UHHHH */I_G^=%-9@N,YY.,!68G\%!('<GH.YQ0!^)/P[_ .")_P -
M/AS_ ,%4_%7_  51LOCA\0M2\>^*_%GCWQ9/\)+W1?#,/@JTN_'OPAC^$5W;
MP:O!"==>+3M,C_M6U9I=TMW^ZF!CR3]#?\%./^"DGPQ_X)Y_!677;^\TOQ)\
M=?B!::MI/P%^$JW7F:KXO\060BMM3\3ZO9VJ3WFF_#OP%)?6.H^,?$=Q'!8+
M+<:5X9MKP:_XBTBUN/FO_@H5_P %Q_V</V1]-\0^ /@SJ7A[]H[]I*W%YIMM
MX+\):W!J?P^\!:O#++9S3?%KQOHTES8Z7<:1=1RF]\#:+<W?C2>:W-E=VV@Q
M2OJ=M_%QXR^)OQF_:[^*GB']H#X^^+IO&WQ*\;O;+J&IO']BTK0]&T[>FD>$
MO"&BAVM?#7A+1XI'&GZ18[1+=27.K:G)>ZM>W5[*=?N_%V_KH!QUMJWB_P")
M_P 5]4^)7Q'UW4_%GCSQYKVL>+/&/B?4K><W>N^(M8FO[W4;LQ;"MM;B5A;V
M-I'^XL+*"&SB^6%"?KSPU/:Z9IT43B\63=(2!8WK(<A0,%("IR%)Z_+QQDD#
MQNXBC\'^)_";Q6?]HK<PSP/;VS1M=*S1:GEXE:6* % NV0W$L87S$!#EP*[N
M\^(TND>&]0O[?PSKIDL;6>6+[6]BEF)?-BB)N1::B]V$5)78&&*23S-G[MD+
M"MH2C3<N=>\FHJ27-9/=<R=E=]/)VV=@^R/A^?"^N_ ;XQZ7KWC%? \-[\8?
MV>DT_5M?T'Q??^![G6(/"WQ]N+;3_'8\'>'O%?B[2O#PMOMFH0^)-$\%^-FT
M76+'3S?>&Y;.XDU/2Y?#WC3X>>"=)T_X?0>-['Q='HWPR_;*M[_QIX>\-^.[
M'P%_PF7QH_9C^)GPW\'>!_!3>,_!_A#QIJ>FW_B_4M L)_%6K>"?"^C7^KZX
MFI165MX=M+K7C\.?"WXR>+O$6IW/@K4YS_8NKS1^(+F*&>2.S&H^'+#58M)F
MNXF*PRW%M;:OJMK:33#?'%J%ZD?,QQZO:F-;?40[H%-[:EDW!026A&2H(XVY
M!(!*CN,XING&4U44URR=_LQDG=6BHMWUY7J[-=+W3 ^O_@=JWP)\(_%#]ECX
MC>(_&/PC\,:9X'\>>!?$'Q>@\<>"OC)XN^+QU_1_B3J.KWNK> K7PWX$U?X:
MW?P[3P4/"\)O'\>Z'K6B3V_B-=3\'>(]9ETR'Q#\Y76N::OP/^"'@B\N5O->
M\):CX_O_ !3X?FAOIH])?7]!^%EA97]P\]F-)NY+]O#NLVQ>UN+B]CBLY!<P
MP17$/G<%K@VRZ2.0?*)/7C!C[<<@=!P3T%:ERZB]N,L!FWC'S8&0493]X\@L
M0, \G\:VY(WFVN?F:DXRM:Z3LM-=.C?EVNP^C=-\=>']>N--L$\9?"G2M-NO
MV:/V+/!?B?2/CIX2^+FH> ?%_CGX1_LT?"3P1XQT_4/$'PS^&_Q%\1>%?%_P
M_P#&7AO6M)LO$MSH TK6UMKNVTKQ'/ UH9_(_B3?> H_%%Y'\-;/[;X7CTOP
MV[Q65OXGL-%N/%,>E6=QXRA\(P?$/2]$\8IX,/B,7MOX5E\::5H^ORZ:D<NJ
M:=8[X[=>9TZ2%+:U9F!VHXVJR;<^=-QUP,@CH?N[<#%:!N[8 X&S_:\TD#)S
MR-V,<GCH,GBLW4Y6J<5HER.[=TVTM+:-).ZULWIL3)-JRDXZJ[6[5U=?/9_@
M>\^*?%G@"7QK^T/J&C_$GPC-HG[3VE>./[(\2:-X1^+]SJ/P@N=1^)'PU^*7
MAW1?C=X<O/AGH=[)8>*;CP7/X)^)&B_!R_\ C!>V6@W%UJ^FS>((HK'0]?\
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MXQ^(7A3P?>ZGJU[<6>I6/A#QE)I.M^'=+NM6TS[#/<7^D_+=A)$)-0+2H/\
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MU7PCH$NDQ60TE=/B2Q5Y/HW_ (9W_9A_Z5Y?VK__  <?\$X__IE5>J?L1_\
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MY9W6E:W-=:Q>WFJ"34M/N#::I=SZAIWV.Z83+YL/$'C-0%_X1*WX"CG4) 2
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MZ:^H'T9XG^*WQ,\=:0GAWQAXZ\:>)M&M]3AO+/3M<U>XO;**_M(9[.QO[_\
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MPQLK:?<2O"5EPS(3&@8*XDVCY6XX+<TG.=TI2YFDKMW2:Y8O5PTLY)Z:7:W
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MR]&KS'28D%QX(2.\CBC^V^) KVDB%% ?Q*VV&1UF5I)2#EG+@NS!0J81?3/
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MWG2SU!D MH"CI'%%);7#1%"3)*-I"LDI))>]=M/12;6KEZV5WV R-(O87O\
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M>DMIMO*XMPB1-#&Z1(BQ!0JO&1&=H#!54)'R$.3Q8=)I%9&T2U <$%HX8HI
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MB2VTN=Q\T\5^'O".C:KX9@T"VT^U^PW^A(TT$-HM_="6_19[K4+VVA@%[<'
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MMXB&(7&X*(A&<C[QV<DX&5)I;RZMUM[Z!YXTF^VR_NG8!S^]4;@#CY>&)/.
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M6(YX)ZUY=H]K;RW?@B(EIEFN?$KF,L87^0^)$6,A'#*A95C4J,9/.7.!Z?\
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M;]Z4N9&W$MO+,<G!()P%OCP[ !PTHX(_X^+C'!(!_P!</09'/(/-4K=?QO\
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M9]_VFW"L\TS9WLP(*EB.HSG!( X]*2^@T/2[9K_4;Q;*SBVF2>6YN%@1I0N
MSJY?#LP4%4.&SE0O- &!\2H!'IVA%94MB?$]B!F _P"DAK#5\6<;)$P1B )
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MN29/,%XZ9\V8+@R<8B#^2< N,M&S $!64@,+T>B0NBLID (&5:6<$''((\X
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M 8U&=I4AJP=2E@2YD,7WC,A4#&2KHO8X5E&>!U&03SQ75:K&KVD@&%?&$8Y
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M&"KM^:,G(P!_<[XY'USQBL_5-9M[VU:%(IT)>$ M&^!MN(9L<)R2("BKD9+
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M*$G'MG/OSVKR'X@0ZA=> ?$-JOD_9)Y+:$L\<1*-+>P(C')5I @(;:&3/(+
MY:O8+#/V*VXP/LD !((R0ASP>F,C(R<9 ->3^-+]$\&ZM:E9@9+JQ(_=L58#
M4;= P(0@J&5LG<!@$Y[#26JQ#NFG4AMJMY;6O?K?6U^P$.G> M6_LW3POB'Q
M08UL;-$,/B*ZAB""W14\J%9G$48 ^2++^6@5-QP";'_"%:DI)/B3Q6-O+_\
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MKHDV6 *E=1T?=D.6'2Z&6& <$KSR"<U%-VC"+34N2_PM)*^S?26MTGJUK:R
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M<^F:?XH@M)]-U^26.-R-.O,.5.Y'1%*E2,$.&S@CGC [8\X\$1>,I_"FB/\
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M@S"@D_Z2O  '5OL7 SR?ZX%9LD'B='A%MX=\+0%KN*'SH)WC2<E7(MG9+?\
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M5Y!\0+%1\/O$$]O AOE-L()T4B<3F[@VLCL3M!D(P I(S@<&G'6G4MMS4_\
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MGJ,XW>AR>" #^6>: /.O$=O;.VK7;6UO;%[2%M[PP?+ I0[MH7(W'D*@#J2
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MM'%-J376O17/FSR1Q(UO!#JL-EB,-@--:LZJK[&&0*]&TD!9[; .[S;U9-W
MV+ !N7!'&YAG@'  ]S/?2[+;4(?+D99)[9OM"JOE*(KB)\-E@^7.%3 ;D@=^
M,?9PJ.4OWB;>MXJ*T5E:Z;:27?\ ,2?,KV:3Z-6\MF[K;SW/-Q\$-""VYCNK
MB/RBSRJ)KN0WH8AHTNC/+.N(%PD8B" JH+AF)-=CX=\-OX>T[5+:TN$F65[I
MYVNT43#S NZ.)845%A4IMBR ,;E9VY%=<FJLBA187K@ '.(0,$#H#(" ,'J
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MO%MZ<JDO=:;LY7=FY1M>-KINU]4@*NIIJ/\ PFGA\[[4.-/N]B1F41&+%X2
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M6;R%4;PMR60+YJ(9,E?O$*!Y;I_Q>UO5K;6;.\\'7[*=*U%Q+:27/F68>"2
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M%8W(&>@7R_-4@YSO&,8(;A?!\&H-J/C>.'4)8GC\1KO<'/F?Z#8X+?+DC(R
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M@G5[Q;>*>Z66]:ZN[G%_X*@?\$W_  ]^V?X 7QOX#BM/#/[2OPVTS4KKX?\
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MBJ*$JD4ER2<K<NMO=Y4E[UG'5][+KT _)Z\UZWT31O$&HAXKBXM&O-0@M1*
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MIKN&' >15<C<BGDL >=B_*6.,\ CIZ<U0\A[[Y[AF0+S%&&V[58X+,,AM[;
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M*[H79)]LJ%L;5>9TU-WU=W*5NCTZVMTTUV ^DYY%1) S#[IR> H #'!R1\Q
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MA:%;K!KNL/:W>I6VHZ'!/<7J6D5O<W-O:6UO$;G\P/#/Q*T?Q==2VFB$27,
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MK?@;PW\-O$7B/P9\9]!U72/$&I^ OB'%XM\,:/XR\*ZW:V;S3IJ(;\-_BIX
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MOAI,^IZU%<Z]XATSX2Z7JOAJ?QS_ $8Z9IGA_P#X+G_\$EO@3\?)_"<'PO\
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M)L=&NO&T%]KGAS7M8TG2898-(L==NO#VJ::NM)I4$C6^G3:E%<7-I;+#:Q7
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M&*^LKJWC]Z^$Z?#31_#6ISI\1?!.NZ+>_LG^)-"T?Q/XM_:=\!IXR\1:[/\
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M+^+]9UB*_P!#\1P7_ASPYH=_=:IK>GMI$Z75E$ZW%QI]HMQJ-I[#^S)+'/\
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M8?\ !.#]E#Q1??$'X<?%1M?^'M]JECX]^$?P?F^ ?PZUW0[KQCXFD\.#PO\
M"*?PSX.;P9::5H!T[1KFTA\-:59:CJ6G7NMV$,UEJD%S. ?GG_P<H?"'1?&O
M['WP?^)EW%<C5?A'^T7X66.]MA.[V_AWXC>'?$7A+7+<)%#-&IO-5'A79)<F
M*%7@V+)]HEA5_P"9?P'=:/9>&8=-TJ*2*WA%JH7[-,HD9+J*0F1_*RTK%'9M
MQ+8544-E5K^M3_@X/D$?_!.7Q 2VW=\:?@@H.<'_ )'2 G!]0JDX[XQU(K^2
M'P/<&3P]L\T,6%CF,%"Q NHL$("6&64$L!CN6&7K6EISR]WFBH\KG91BV[7O
MNK[:-+74#V"VO89[NXFB+,D=G.2&CDC.Y(E+ &5%.2%^[UXR0<BO5/\ A5_@
M3PU(UCXB^/%AH/BG4O"GA/Q-<:1J'P/^(MYX2T-/$ND0:_ID.M>/_"NO^*=6
M-A!87D)U?5_#OPN\1W]DPF^R>&-3,84^:-)NN+I%/F-]ANDPIW8)M44*,9RY
M8[=HRV[Y<9Z>\^,?&7P:O?$-B\O@(?$'4+/X9?"33M7US1_C+-'X7U;4-.\%
M:18ZCHUU9>%]/O7TV72YXY=&UW3[/6XM4LKVWN[6Y;3[Y)(X.B3:E26OO.5T
MK/:%[VZI/^D!Y'>> /'ECXAO?#3>#/$^HZEX&U#64\33^&M&U'Q9HMA:6.G6
M.K'7+?Q'H-I=Z-?^&;O0=5T;Q-H_B2"Y72M8\,ZWHNN64LECJEG)+ROP^\/^
M+&^'6I>.+;P!XUD\#P^*_&KS>,],\'^)=0\&K$GB:\@FO)/$T%C<:2JI< V^
MI3&\%MIU_')8W<EM=Q2P)[-XZ^(OB;QG\$HM/N?&-C;>)?&WQP\9^+-<\,Z+
MJUKI,,+VGPQT3PMX&OF\)6FH2:E9>#O"6GVR>%_!$E_!<6&EZ=I8TZWOKS48
M+Z>Y]8\*^(],U#XZ^&?C7H_QH^%FA?"71_B)H.MVVBW?Q;^'>F>._!OP<\%Z
MGI.G^)/@#'^S7?\ B.U^)>NW47A?2_$'PP30O#W@#6?AOXU@U]/$^H^,AIFO
M^)=;L(<JJ<4U"\G**?O?92;;6VM[*R=^NBT#YGT[PGXW\=P1IX,\ ?$#Q:50
M:EN\->"?$NMQ?V?8:C)I]U>"73=-N8BD6HP7&F[0YFDO;>YM88Y9[>>./SW5
M?AE!\8]5LO#VE>&?&FO^+8(;J&WTWPGX8UK5O$B06.Y-2@DTFUL)[F*"QN5D
M^VO<P1):7+>5.\4I5*^M/&>DZMXJ_9]_9UTG2?'OP\\.:/IU_P#&O4K;X<_$
M7X\?#WX+6VC/J7QKUM;76-.UWXL^,? GA'Q7<FPMHO#MQ%H>O:GXXL/[$%S%
MX<ET[4&O#Z%>^,/!'B:'XF>'KKQ/X8\0^+]2TO\ 9RM_$OCO7/C/IGP.\,?&
MS6_A?\%/#O@7XN>)(_B+X]D\+>&(E\2?$ZPO/&-B/'6H^$#\16L)/&-T@\5:
MU)I!3FW%ING*]DVFW&&J_B6V3VB_YK ?FWXG^%SV6F6_P\TCP+XY?Q%I/B6"
MTU[0T\%:X_BW3Y(TNDN4U[23I;:OIZK?SZ?#,DEM!B2ZL0A$=S%N[[2/AKK6
MG>#_ (<ZR^G>*8O%-MXB\;?#CQ/X(O/#M[!?>%S\(/ ?A#QOXEU/4;=X#J=O
M=Z=;^)M1CUZSN;>%-(L= NK^<JD=T8OI_P =_$X>'M.\8Q:?XT\)>%=<TO\
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MQDD2Y)B'U-?0^"?#OA3XE66A>.?#GV[Q;^SUJ6FQ^&K3XU?#_P"+NFZ+KO\
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MFK:MIGA@W%K<Z>MMK%S+JMXO:W:C[.HKVLW&RU=K[NR3Z]QGQK%H]H]U>PF
MFV@BMI!A!Y2-(&+N<*8\-CG.0"I;DU5+^$+;6;71KF^TVWU">ZB@6WG:)'\Y
MI_+6 H4YGRI5K?!?=\F,Y%?1%O8:+%\/?@3X9OM"^''AT^.O&'C6S^)?Q@U#
MP!X0USXIIX7T[QIX.T6U&G_$7Q1H6K^(?"G_  C&CW>JR#7/#UYIFO30W%Y8
M:KK=YX=DGTF?@KGX'WWC+XW_ !A^'OB3X._!#P'X!TRR^+DOF^&_@!\-_!?Q
MB^$MOX"TWQ%<_#[5M4_:6T?P;IWQV^(&HW6L6?AO3-?U#XJ?$[QSHGCV?Q/-
M?V6EP+)H*Z7$I+WO<@VIR?-**46ET6SE-[V=KQU>H'BME\,?$W]H^';:[TPK
M)I7PPF^-^J6LVI6LMTOP\\2Z9=ZKHNJ0C/[^Z>PUS2<Z>BF[MII'MY$#Q-C6
M^'=LT&DW0^SW$*1W;JXN,N866]U0[99 JH&#%B0P5D8J#@$5ZO'H6IZ=J?B3
M6+6XNGO7_P""6GPRLXH;DW4S136GPU\"S)<>4I)99&MR2R"-KB6;<K;I0:^@
MK7PU\'? OCZ3X?RZ%X5UOX>C2/#?V!H/V:=,\5_%WQSX,UGP_+KMI\8/"?[2
MS:?=_%I=2\63W=YXUT1/!OCG2O@_X9L9)O 2?#ZWM--\7P:EG"IRNZYKN6L5
M\-FUK%)_'T5]+60'R1?6,=Y<6?FPM+%#'.SXC9U4O$[#<0"J@FU@)S@@!F7
MW5A67@:\\.>.?BQX*\0V4<6M^$_&\ND:M86\D5]':7T&FZ:SHLT :*9!',H2
M6/Y#OSRRDCZ2\2I<^%XO@IIG@OX9?#'QO9>-O ^G:Z?$'CCX)>"/B;XB^)WB
M'Q!=/I_B73-#\8^+/#7B;Q9\,1X7N;(>$TTCX)Z_\.=:TC4%?6_$.I:OJMQH
M]_8^+?M ^!/[3_:W_:QDN%FTI[+XW>)M,_LHWTUY_9ZVUOI#"SDNVWRW4MF?
M]#:ZD=GN5A,TA9V9FV]ISS2Y4DK2M47+*][)QUT>_+IW 7_A&K/)/V"0<#I;
MGIV _==L].W-47T*W6_MX!92^7)&Q:/R#EGR%#C,9.4XY&.2,GUXO_A6<'_/
MX_\ W^G_ *J/Y"JS?#FU6[BB%U.9'3@K<W B*CYOGC#*CMG(W,A<#A9%'!V
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MK,/E/[2OPS\1>/?@3^RSKLWAOPY\/-2U#7OVBM7%EX?\.VG@[PAXST^[T_\
M9STG2_B-HOP]T&QTWPQ\/_\ A)-/T&TMKG0/!^CZ!X'U>ZT:]^(O@CPUH'A7
MQ_I&EVJ;E)VA""4KIJ46FK*]ZB35DW=PO>]KO=@>'>/-.AA\'>"?&EK!<?\
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M.ZOK_@30O&WAO4[S3=&TK2K_ ,/^*O!NJ7OAK5='FTN6&\TN]OK'4C=6E\T
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M1ZK\&_ .N?$GXI?#_P 3>']-U:_^-NG?M#:AX7N_BYX-;Q>MWK'C+3+'X?\
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M/$>N^%OA/X4USX<_$_\ 9^M]+\3?!CX%_"?X"27.A?&/3_VB-,\=:#XR\/?
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M/8D9 /N.,CU ()&<$'!"!E;.#G'!QTZ ]>G0U\C?M)_MY_LA_LC:#=:[\?\
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M?$/2O%'@2'X3>!;OXM^ E^)_@W1-3\+ZIX9;Q9XGT2S\*^./"L/CGQ;#XO\
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M0=3TK2_"'B7P[X5\*"[76-&UB37--OQJ<-[]@M-&NX=:O+BWTZ2*Y?\ (?\
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MK6^CQ7+:A#I@W1Z7;ZB+%M-745LEE6VBNX].D>Q6Z6(21V3O;JPB=E/UQ/\
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MW,MJLN S9N0L91&5V.Y0>AU6.^B\;:#&^H%Y)-.F*R-:1C:8S>;$*))M(9F
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M-:ZY-*TK"9VVO*6);<2 Y^4_Q=I\.XE@TN\C+"3;.S*\3,8R?MNK'Y&."4P
MH9ER<#&1BBE3?-)N6D6XM1>[35]U\.VF^V@'5S11SWEA'*BRH$GR&R?]9#-N
M;&>O^CQ,#D!3'GG<^?(-!TOQ+/XG\='1)=&@T^'5XX%@U:&]D!N1;6;-+$;-
MU;!B=8_W@8X3*\$UZO?6\MS?V5JEP]LYCG;SHU#E?+M9)" NY,[PVTDL, G@
M\@\1X/TV6;4_&L27]Q&\?B7#.J<28T^R!8CS!U4YP7.TJ""2,C6IO2?_ $\7
MIL_^&_X(&G_8OCK@_:O!O/3_ $/7.W'_ #UJDVD>.%OH4:[\'J'C89^R:X5
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MW_V), =C-<0 NJ[MJLL19@.H.#D(/F'XDUG--NE9/2I=V[<LEJ^BUW^74/\
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MI'.<Z*C&<KNRY>7YM)W226\EM;I>_4/KZS^*.M:4?#\\FA>%=8T[PY\)]?\
M@Q>:!K4'B+^R?%_P^\3:WXCU_7=+\1W7A_Q)X=\3Z=J%[>>(KC[+KW@GQ)X0
MUK2#IVDW&EW]O=QWTM]P'C/XSZ_HNJ?LWW?P_P#AY\-/!L?PF^).M>)? GA_
M3D\?ZEI3:CXRTC6AJ</C#Q'XP\<>+?'GBXJ]JDT&J:OXGN-3W*ENLT&FPV]G
M;9VHNZV%R%QEHF^;O\S/C Y!/' . V2,Y%>4^);.1=2^'9-Y-(MSXFTX!&7
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M74EO9[9%;$962203'(4XU5.,DYN[E>22;<8VLFE?9-[6O?7YA]#6P_T6  8
MA0=  !L!R.@! Z=.<KQG(\H\?VHE^'FOO! &O'$4=O*F!()VNH1&RLQV!]Y4
M G RJDY(.?4;%PUC:[C\S6\).<\L8QTSDYSMQST/.<C'E?C"UFD\&ZE=?;)0
MJW.G'[. HC_X_;9MIRXP%W$$^6<L,D@G%9M--IW33LUV:W3 GTW0O'+:;ISO
M?^%2SZ?9,3<VFMO<EC;1EOM#P3I \V?]:T*+$9-YC&PK5MM#\;("QOO!Y !)
MQ9Z^IP.N"9W&1D=5;W&,UT%IH\\MI:R+JTL:RVUO(J+'\L8:)2$7_2UP!G
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MIHT5F4JH=$.TD-GIC(!)H@*-')C2]2G;[7>'=#';A$1KF8I"6:0,7A7".-N
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M,9M3%Y[RB,(J((][HJ/T"Y*EERV1QVA\8R71\'RI]E'EFVM=T@N8AY;K*HC
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M,:?%C8N,:C >-HQR(R/R)KA]=O;(#0GD:[ /Q?\ AE<I]E#QL8XO%EDQ>[R
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MY[XN[9AGURKXSC'3MP>15'49]0DM7#V B7S+?]X+JW8J1=6S*"@<LY\SRT'
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M$+1PYYDB(!8N"BY!^;)N,5"*BMEHKZOJ]2S4G&L".0O;QJHB<N%NHG&TY#$
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M92%5A)@%F QD8VKP_4@C"X_BYT \YU-%\WXR*#"@-AX?8-. 85SHI!EEX<E
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M_P#8=GC)FNL$!@0X;@C)S@<;3G\/I45QHUK#-:QK/.Z23#<0XRHVOD@@8)&
MP!XR,'KD4!9DQ]@\19Y'V[4\[<#@16G P0,8].O7DGFO8C_B3S #<#/$,-@Y
M4I%C/')Q@%>>N",<T1A(M*UZ&-F*P7%_"A8_.5CMK-%)]\+SC@?3%%F VBW"
ML,JTD*L/4&.'/7I0#O;W;7Z<VJOYI:V*&M BUU7)D4MHEPI># FX2TVF%\K\
MX)88#KD%R3P<;WAZ-/['TX.TA*V4/,Y F(+.-\YW-^])&UAD_=5LG?D\AKFG
M6QL=1CQ<N@TB>7RXG43/*4@9A'E64DM,Q *G" @YQ6QHF@6DVDZ:V^ZA_P!
MARCLAD7][<#:Y"+\R[2#@ #ITJ7RR?*^636MFD[7TO9KKM<->N_6VU^MK]+W
MMY&I?*BZQI&W@">16(/;[%?$JQ]-VUB#@;@A'S 5?N=)T>]EBGO=/TZ[F@&(
M);NTM;F2#.=WDO-&[1$@X)C*D-\P.[YCSUSI%M!J&G6H>9DN)71W+#<H:VN)
M05PO*[H$RIXYW @C!TAX:M,<3W('IN _3';I3Y4[W2U7*[I:I;)Z:I=$]%V
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M@E-UJ E\HL$,ABM/,V%L';OSMR,XZ]Q4=D93HUU'&V'^TJD;$#Y=HC"]1A@
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M9_X3W3S_ ,QJT((Z?V=K9&/_  5]\U3NO'6E.UH9-7MB8KN-HBFG:SF-_+D
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MS)()&V-ME#%EC(/E@"/+#)*<4W%MOW;V2=D[JSYEU\K[?,HZ#4EU;[.INGM
M/M-N%6,R%V?S,1<L@PH;EN>3S@@8K@_'WQ)N_ K6%F\<%YJ-[;?:X;9'D6..
MUWF#S996158;D*HN2RRDA@0I9N[U/5H;J!52&Z#K/;2?/%M4JDFXC()^;)'
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ML;MI2V]BKQK@#.Y%.4I1<53G=V=VHVT:[-N]K[=UKH!T@\;Z>  -8BP ,?\
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MV$\:M(Y*QS6L4J*P6'&Y595;!*D@_>!S5F8:^$;?)9B,C#*3(QQAV8C,0.2
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M5 '<5PW@5A]@UQFEMY<>,_&F7@5E1"/$5\#&^X &:/A9V YD.5X)KM3(H_B
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M3:M<3)N5F1[6V3=M*LHW"5BN&&XG)+9P1@"FY2>G,]=_>>JV?5/O\V!D:O\
M--8$\$VC$GW,MMD\#^5;;HC7[AEW9MD&&+8QY;MTR!S@9SDD <<\8VMJ$NK-
M<;T6WESC@[?-BX4=%P=H49QMR"0!FI1<RW#)=>>;<2(JO-;I;SQQ' 41O&T@
MDC8;C\N5QN( "J<:TM&YMI)-QMK=RE&Z2Z7=NK S=1L[4>,-!VV@W)8W>R59
M0%0+YI:-HCAW4#E2!M7=QMPV>R%O;X0E.6&>&<YXZ8#9P"0/7. 3R<\-J-O.
MOB?1+F2[9H8M.O&DU*2../[.@6ZD"+"LI\S<N6# L2/E&6 6DBN=3\2'R]'U
M::'11)-!?ZNUG;Q7DDB2",6^F6US'.R12;7+S7,-NLC*CP2R(:TISUG=2NZB
M]S[<5RJ_NN2LH[NW?J]PUM0U."&XDT?0[%-0UUU9Q;[REKI^1('NM1N6W0+Y
M*V[21Z>TEM<Z@\7V>":&0@U>TOPU!;W$VIZ@WV[5[F 6\D[%EM[2W+Q3-9:9
M!@&VL?M,9N=DK3SM<22L+@1%$6/3= _LFWBMK"]>**)$4DPI-/*(V+J9[B:=
MY'P2< G8K$[$3>:UA!>M_P Q63.,X^SV^0,[1GYS@9X'/<=JU:UYKN]FK7]U
MW=[VM:ZMH[JR]0)I=.M@LACB12R.6'S'S&"87=\Q'&.2>.20,X%0Z4 D+ D*
MQD '(&<J,+W'\7'! /)!QBAK:\Z-JK@'J/(MP2I..,/W(('7J..Q<D*VZ1IY
M@9B?FDRJ2/(2JKY<88!G (3:A^7>,9R,L!%BCDO;@.H; CQG( S*#QC !^8]
M.>GH,5;ZU@BDTI8X52-M4@65>=C1N#Y@<$_=*\,3R<$@@$8LFVDDE:2&]F@+
M* ^((V#KTW!VD)!Y'0$G@CYA5&^@N4FTU)-0DD,NHP0J6MH!Y?F(R>8-LA$C
MJK-M5E52<,2"  ";LOA<KM)V2=D]+N[7NKK^3V-:.PLFC3-M$247)* DY'WC
MD=3R3D=>V*>UC: LPMXMQY! _CPW.,X'4 >O / %55MKYE#?VI)RH/\ Q[6_
M<#_;XZTOV6^_Z"LG_@/;_P#Q5 62V27HDOR2);VWLOL,K)!$CJ ,$;2""%;C
M=P,Y"X_,J:E6SLO(W&&+=L09W-G:$SU+<[2[8  (RQ YQ69=6MV()=^HR.I
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M4X (!W Y'$=G:7GV<&/4Y(T+.-AMH7P4;:=K-("=_)(  4G/0 4"(8%VV'B
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MV]PTUSLU":-P^"?(B8/AI!DAG"J.#@*#\Q'4#)N?9;[_ *"DG_@/;_\ Q?\
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MR9C:6V22Q@0Y;DL=HZ]L\Y.>,Y'-96F6MO+;L9(E<B1QG+<ALYSAN2V<>I&
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MNT@N[M44L6> ,!+L#%9)2 Q".0=@^1CM "G.=ZT[4WO6AA-W',B&:0HTLZ3
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M!JSMRJ2UOIN^BW7<90:]UB2%V"RM"RLCNEI  !DHPW!\J=RL,CD$$].3Y?\
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ME%N3:5FU+1I7VZZN^X?UJ7TUV]DD\M)_,?=Y91+2(NLN-RH1T&8P68E@%&T
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M>,N9<D;Z)-2=U9W^S);/6WWZBNDTKI-[+J[;V+Z^([F0J$U N63>@6VA^:,
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MK6L<,3RSGQ'J>8YW2%W@"?V$ R0S*T8;<'=%,AC4@HM@=2EW=#4IG%E)O>"
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M1!(P$;)2;O>,HV_F25_2S;TZW2&=-97-S%'-LM)6#W%P6R5#KF>4D[2ZGC)
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M.$G2_"OVFWU*V5(8_$NILK61T[44FNI7.@AHVCG>"'RMI4^<7,BE=I>_B#Q
M-2:4Z9X9\B"SO%M7/B'5"\UT(X_LUM,O]A!88)2&2:X0RF%49UAE(VUK2<I2
M5Z<>2S?,J<$M-5KUN]+6U8GS-+EM>ZW5U;KLUTV_X<ZFVFN3/=E+*4L\SEU(
M7Y&\I0,$/C&-N&8_>;DX%<5#++_PD\C_ &($RZ3K;2SK(?-C>;68)&@DC>4!
M%C=C$2T892@$A#AC4]OXB\1K.K?V5X4"WMS&+LR>)=34V_G-]F=K91H3&YCC
MB(F4R&(E\Q<+\YP[:]UP>()+Z?2O#T-K(-9M$DCUN_DNF@O-1:_@N'@;2%AW
M%41&C\[^)@&RH#%23Y;.E.*3CRN2CRI<UTM+V4MG&ZWU'_7XW_X/J>AS7,[V
M,$,EG+''NMA',67:< !!N+$$LKL<*O.,C&&H>XN?M-FWV;#9Q&&>.)7V*Y4@
MM(N,[B3DKP,DCJ?*?%?CF_?P=J4<K+X:U+3=2L+&6>SNI;D&V,C1O<6TI6U>
M0,Z2E-Z1 1B*3.962/S7P?XGN?%/B?2=+UOQ3JCZ7)+<075O%J=X5GMX+::9
M))G;<RI/.#%);F-XVB#;V_>$ C7BHQ35WHM.11NWNKMZ6:;5M5?JP/?I_&,=
MMK5U9V&EWVMZNPA1]-TP0-LW1Q'<U[=7%O8#.4^47;2 !PL;%'V9D1\>:C'?
M\V7AZT>[NY9&L ]UJL#OL5TE%\MSIC/"@^01E@2[!MZ@$=3I,GA[1Y)H-.;3
M]-TO$)A@L8C:VWF,%+NMO;11QB1V60S%442S;W?<[$E]OJFG"VU-#=Q!IM0N
M98EPY+I)'&JD80@;L[AG!"^Q($R3<H<S4DXMQ]BN56C*]]=TFKN2M97W XR7
MPA%<VGF:I>>(=7#%"\D]W'I^\^:#DII+6JHI. /+1?FP-V?FKC_%OPYCBL-)
M3PSX;GU.=-5DN;FPU'5[QXKFWN8KMIBPEO@%D$KH=ZNDCL=TKD,V[V)]2L#I
MQ@%U"9RR_N_G\S'VA7/6,+\J?,WSYP"0.<5-+J6GF:Q'VJ K#(6E8ER(P4D7
M)'ED]3L^7.<X&1DC?DA*'*FW%V?,I>\[7LW*VK=WJUY= /#?#7PZ2#6E:_\
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M@@\D2+(2$@=6[&Q>"^N);BQ:"^M9 OEW.FO'?VCX2+F"YM3/"Z*QD1C'(5#
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MZ^)S$-)<HF=KWK( &^7)!; X))R)GKS2<G&\G=.4N6#M_#DEISRW25UJD[6
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ML5RR3:YFKJS5M%KO==-AGJUSI4MT^HS,DL+17,LBAHGBC#+(3EB57:@;E@2
MN1D#FEM-*EBLGOPLS--&8VVI(R+BY0@IP0&0QL R]4D(S@C/D9L/A:8M1(U;
MQ'F-YA'CQ%\0VW)N'S$FZYR<<,>>=QXI$L?A6=/23^U?$8=E)V_\)%\0E  ?
MRPNP7?EC@8("DLP\SKS5>UI=9P\M5=?@[?*P'N%Y!,KZ&/(D&[4;0,# PR&M
MSO4_)SP"6'\(^_BIS;RG54W6\@ 2(?Z@XW>7-N!!CQGF/..F5Z<@^'7%A\+1
M+9^7JWB-@]TBS ^(_B&2(RKEWR;OAURV-F"6) !!P/TN_P""=G_!,VP_;?\
M%MWXMU"?QGH?[./@W66T?QEXM@\7>.=+U3Q?XALH+6YN_ O@.:ZU&"9[F"WO
M+;_A(O%=NCV.@K,]A9S3:ZI@M!U:=KJ479-V3U=K:)66NO5H#X\^%G[$/[2W
M[8/Q3\4:1\"/ ":_::?J>G)K_C?6KTZ)X$\([A8QRVOB/Q!-;O!-J:VGF747
MA32#?>)'M9(;R;3[2RN(+M_Z3/V7O^"%'PB^'OAC18_VC?'&N?%O7X9KB^U+
MPOX/GN_ 7PZ66]FN9Y]-EGL9O^$YU>TMVDM?LMU;>(/#<A,$Z7$%Q!<&%/VM
M^&/PM^'OP8\#^&_AM\+O">C>"O!'A+38]+T#P]H=JMM9V=LFTRS2N2]Q?ZE?
M3 WFK:OJ$]UJFKZA+<:CJ5W=7US<3R=_7)=ZV;2;;23:M=M]'OK]X'S3X'_8
MT_9-^'%G:V?@W]G#X+Z,+2-HX[T?#OPQJ&L2[X&M9IKW7M5TZ_UO4;NYMWDB
MO+V_U"YO+Q9)3=3RF60MZT?A;\,6M(;$_#GP(;*W6)8+-O"'A\VL"P1&&!8K
M<Z?Y,2PPDQ1*B*(XR8TPIQ7>44@/C'XA_P#!/+]B7XG?:)/$_P"S+\(X+^[E
MFN+C7?!_A6U^'GBF6YG<RRSR>*? +^&M=D=YB9I!/?2QRR,QE1][[OR6_:%_
MX(7/86&I:U^RQ\3]0N[HO<7:?#OXP7%K>0SB3YDT_1/'.E:99W%JL;;8;2+7
MM+OBD")]KU:XG#3M_1O133:V;7HVOR: _P ][XI_#_XC?!GQ5J7PK^,/@;7?
MAW\0=%%E-<>']<M/+.H:5+.CVNO>&=6MQ)I7BWPU=O+Y4?B'P[>ZCIT=ZEQH
M^H2V&NZ?J.E66?<0E[VS_P!&;!=L@P,%9A+%N8#9@@G()Y4G*D[N*_N!_; _
M8Q^!_P"VW\++SX8?&;0993"9[WP9XZT&=M)\>_#KQ!)"L<6O>#O$<&V[T^5B
MD::II;M+HVOV:?8=:L;RW*JG\,_[5/[#'Q:_8R^,TOP>^)^MWNIV.H6DVL?#
MSXD6>M>,[/0?B7X7B>R$^JZ;$VJ7#6&M:'=7MOIOBOP\]S+<:3J)BNX&N=$U
M32;^YZ(5KV3C*4F_LVUTZIMOH[VW[ :C6[?VC=HML_\ Q[6[QH+=MOW7RRQ^
M7@GLS8SRN3P*CMH"O]J%[1V_?;%/V<G;^YEQDE/E'RGG()..N<UX'#\*KZ:Y
M:)?$%V08H',H\4^,3G<'95)^W;P5*' (VC+8'.3,OPEU!_M@.O7N^%RI_P"*
MH\8C>OEL^6(O\G&54<8QD')X-\\O^?53_P EZ_\ ;WY@>M7]O-)9JABD$<5N
M]T46%MTFR:&-2^Q,D@R@L.C(C=%#D>4^'/B'X<O=2U.*[G_LJ+1Q]HAN-0D@
M@74(8Q(9E@CGEC=[H+&##8KYEQ,Q5(HR^VLV;X67\4$LDNMW$@%L;E4/B3Q>
M58K+#$$8/>LC M*I8/E6"L2,\C!T_P"#YN[BY2:XT[8\T8B1Y]5+)O8@EF1%
M+/N^8L2W QEL\Q.3?+RTYQG=\MU%1;23?-%.TE9Z73M=OS)NN=KFO)I>ZW?1
M)VLO-7VWL>RE/$WB#4WECFD\*Z6UF)(&CMVA\07-NTI\N\BDN$>"S68M'+#Y
M]E)YML5E#NC ND/P]T)[F[-Y<:QJ,V]&>ZO;J!KF8F,L9'\BSMDD=B,-MC5&
M VB-06-7] \/-H]K::)<W4M[-9Z8X>[DEFDDE#:@3$K23%IG2.)XHXPY)1(D
M5<*N*VXM.B^TW@,DS;'4C+D@ PD$8 V@X4<D9)))-;65^;=M*_6.G:+6E];V
MLVK7V*_K^O(^6C\*/&,>CW,JV%FTS:;); O?0%3$;?:;I8643BZ!7<C$E0^0
MZODBOJ:1&2#356,J5@L@P1.<"VM!R54 J!O12 !M3'4&J+64::1+,))&9+-I
M K,S#_5JVUN>0N_A<#(ZYR:EELX0EJ=\G[[R6<*QRK21POPQS@$N!VQP!DIF
ME&"A>U]>CDVNNRV6_0"^Z ZO:X0$&POCP@.Z,7$ 0D 9* ;]C<C[X!SFA%1K
MNZ!!8&.#(=<CY99\8SUPN-N1]W:1US6<]F@U"TAWO^\L[UF)D?(,%S @'+$J
M")#DC&<@C!+"IXM/5[NX3S&^6*)L;V.!NE!^Z0?F 4C)X.['O0')VPW>+M1_
M=719/A>6,I4&P4?\)KJ>%"B$,-0!)<.]PZBW4>7;K_K:ZT1JVG6+%00(X"V0
MI8C[(^T\#)P<8+9X(/0YKCXK2-?&%]*6N6D7X8^9_K,6B[/&FHG9''YID69@
MJF5A&D;J5 >1PPCZ5K./['92!Y59DB<;9&&TM:2-QSNZ_*1G@$@8(5E+)6TT
M5[62LKZZ=M-^^M^@&G<K$NI:8552#!>;@H!W +$<-@'@$<]@3ZTQ5)U"3]V"
MOV6W)4)F,$S@,1E=N<D MUR15"6T1;ZPC+,1-!=DDM)P52)E(^?/.3A@01@X
MZD%Z6,8OY8RT@/DPON+, 6:4*?E!Z;<CT&>!QB@"_9(IAE+(IQ<7H!*9.Y;J
M=%&2O8 KCU!!&:H0HATBP.U"IL;0;\*P;,# 9DY#9(7DL=S<DEB32VMBCQR'
M?(,3W8/S,01'<2QC&,#H 3QR1R0#BJD=HK:59R$_O);6WE*!V54:2%F9=P(^
M50-HZG /4L32E*,?BDHO5J[2Z:VW[J]NG?0"]?0QO':K(%4.&4OA8VRMDI&&
M(&2K@CJ &+="37/_ &%?M-G;&1G2>=(P8R"P4N5P6!) +J-N0,A67!VD5L7%
MBH^S;9)7WD\EV7!^QJZA>>/GQNZ@\\\5EK;A=0MH6+,)+BW4[CN*9\U6 8DD
MA><'UR>]85$G34^92::2E!VC*\K-6:N[=.J:\T!T=BN7N@075+JX*;DW ?O5
M^4'!QB/<,'D*.P%4+=,:,K>6.#.ROL&,^?=X._!&[ CP0V0I7LW);6,4K7$?
MG3+Y<TF "1N7S51<X8_-@'J3SST.*IQVJ?V6LXDDW;95VJS+C;/=(IP#CY5@
M1AP>=X'&W$SC!MR56FDWHM5HDETC;=/[[ZA_7]>IK7L:B#3&\M0#=V^6V#)!
ML[MCEBN60%8=V<H'\G=\QCRK@#5+;*;E$=R1B,'!*)M8#;C@E@K<_,3UP:S[
MFP1([)A)(1-<P KYC[_GM;B5@I/& T<63V,K+T90'262"_MX3-( T$K,X9LC
M"*<)R,L <,,[=N1@'%;TXI0@[\UHRLTVDTW*^EE>WII\S)PO[3EFKN47:\KQ
MLDVFEKJEI:ZU[EVUC!N;X[ 6$Y,?R!L$QIY816!()E 8 ?Q'&"3FJ=LJMIFJ
M9QA=4U4(548V+>RA I5=OE[-@C .T(4"?*03%!8(;F\57D A<,N695)B4OR
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M)8\'[QSSU-VC_+'KM&*>OFHW(<%)--RUDY:2::;[-=/+8?#;E;*4+IVGE?\
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M-J6BMHUYGXRZ3X@LM=EEU'2;FQOK?R)(//M[J-X%\NZ*L/-5=CLKJ40;F!=
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M/#<J7FOZW=:=K6N^)-1TG3M+GFM8);^QT33[W79V,T+KI=J\K.T0P=6^EO\
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MC'0M=TF")=!URWUJ%GNI8S:Z%97]I'J3M5(4^9.-2[WYI*Z>O>]KWN[+L]]
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M+?VI?!?P4^(WPSU'X'WWCN.75=)U*PDCTBX\%'6?$VD);:QJOA_3=;O=-O\
MQ5IVB7=A%XVLM+O-'OK@1ZM=3GRKXGZIX=_:'_8K\0?M.:I\&OV>?AK\=/V=
MOV@OA]X8-U\&?AEKG@WX?_$3P-XD%K+8^&O%/@R\\7:FTACUAK6>_F.OZLEU
MIME=Z/8PZ.=;DN[.E7GI?E:UT24>CVMIN[O374:23D^LK-_)65NWFNI^=WB;
MP-\2/ $V@_\ "=>"M=\&-X]\/P^+_!?_  D<4%B/&'@^Z,,4'BCPX$GN&O\
M2)GN(4CNW%NTC3P@PX<,W&1M?#3[T+'$(FO]1DF?S%7YS>RM+M7ILYS&Q(78
M58#YJ_;'_@II^T#XIUWX;?LL> I?AQ^S58V_QE_90\,>-]>\06OPNU*W\<>!
MK]?%&AW?]A_!G7D\9SIX'\$M+'Y T&[L/$<[1'RAJH)=S^(HT:]=IHF:TA50
MQ!ECFVNYW8"".X#(2NT!220#M>8%2S'M'+64J,6G9.4-6K+6]GJOOZZV0]?Z
M21QV@ZW:7.O^,+6R>"6:'54CN(5NGF$DD=_=HQ6-@5@"-YFY5 1%.%R  .ZF
MN;_SK<K! LB-,J,)U(XB)&"$4\%LASN;<QZ;B:\Q\)>'M:7Q1X]DO=%T_2X+
MK6[YK:\5)G>X1=4O'25I%OF%TTT;*PGMXD57VN$D7Y3Z,/#5V,@7MKP"!^[O
M "2,-C]T.HP#D@' P:UI\R2C\<6GRS5[))O27,^9MMW3MLG?9 (E]?C4)E6%
M/M$D44CAI_DV@*/D8J0Q;(QN4X4@9)W&DAGU"..] A@*27%TTY\\##G ;8/+
M/R(1\O."HQD 8-=M#G6[AM#<P%Y8))UD2&=PJPR1H8VWO"P+&4L&P0NT]=WR
MVAX:N>/],M.,XW1W6<$D\@1LN#Z!FXP"35^\Y;6BKIIZN5UI*+3T2U336NO3
M<$-Q?FT\MHXO()4AC(H+-]H!!9-I!4MA<C@$*>2.2>[U!9K0FWAW^=L0B;<%
MQ#*<*I7 ) RS9R<[20 N$?PW<*N6O+0@'@%+LDGDX ,:@L1G'*Y]152?1)HY
M+9'N(V-U<B)6\M]JGR9)-[CS6++MB*X&&RP(;:"A;T6BOLK*RW>KZ)):M@6O
M/U%KTNT"[S"S!3*K)D#!&"GWB!\Q W!21]WBL6]>5KB9I$2.0W22MM+/L<K&
M"I)QN  #9] %' !K8_X1ZZP=MQ!R"IS#)R,Y QY_KCC(ZYXY!RA ;>ZEAD(<
MQ7,<;LBLB9/DDD!G<X"N ,Y/7!7: 8FIRE&*M&#M*<K=8R6EUK[T5;9II6>F
M@'5::ZR332*<J(+2,\='2"-64' !P5/J?7%7[Z$W%G<0 X\V,Q\\@AB 5(XR
M&!*D'@@D'BEME!@A. "8HR<#KA!R,$#.<'.,@YZY!$^]3[^Q'7N",]<X^7U-
M: >>:[]LBUKP*A-D[C5M1B3SH('N 4T"];=8D*&60#>CL#DPB=,'<Y;IBVJ
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M0,6A>2TGMKF-) '>WN()U!BFC=OW4KE7K<!K.J]3C_'J /4D GCT.:R6\0Z
MMP+-M<T=;MB%6U;4[(7#,<X40&<2DG!P N>#Z5\^_MI> /&?Q8_8]_:M^%7P
MZUR^\+_$'XF?LV_';X?>!/$^EW$EGJ?AOQCXR^%7BOP_X8U[3KR+4-(EM+[2
M=;U"RO;2ZBU;3'@N(8W34+-E^T1_S/\ _!*C_@C=_P $V?V[?V _V8OVLO%N
MG_M$ZE\8?B-\/H+KXA>--+_:\_:!L]<T[XE:1J%]HWBG[&^G^/X=-TJ>SU.T
MG$%E9Z?:VMM RPOI\4C31E@?U\*X8 KR" 0PY4@@$$,.&!!X()!YP>*^1O\
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MZ9\1+[Q/X2\!:]HE]\3_ !3+IJ>&1=_$N>#Q2]WJMLNFS!XX-/GLY5U&TCU
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M6_!FEP^(G-CXNN;?6)[RYU#4)K_3KJ^@M7GTDPQR0S?*8U:S<L@2;Y0HSE,
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M+FCBQ'XSU*#_ (0OQRJR30M%X&\<IY\4(EEA9?"&M@S1QK(I>2,'S8T#H6=
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MB2ZU"9.,&16BM"K)AB"A(9>OWE;YN#6/=,\OA'7HT5I)'L-2"I&A8O(+"0[
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M(#11IC'(8JR@M@]2Y51C/)"_3HE!R<'TBVVFGJG;I;RZ^O0#Z?D_:N^,=_\
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M:2T246[)-/5WW5]@/KKXT?M,^(/C'\/+[X76?P-_9B^#/A/6M?\ ^$H\3?\
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MZUGPQ=Z5-J3ZT-)6>")[-SK,EW 0PNY-0BEDA?YC_MZR/=N1D?-$./4?O/\
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M4?#%P\^G1Z;JMMJECK6G6ZVT-W%J$\2^Z:3\3?!_A0_ .T\(KXIU_P />!O
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MP4NFCD0'EO@K_@K/^V=XC\'^%O$'BKXE_#WX:^)]:T#2M2\1?#W6_P#@A_\
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MFL/$_P $OVI)I/BQH6LZ?J/BV[:SUNYCA\/>)_#MYHNI:)OVW@7\LOVGM?\
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M*:6^N-%L+W4+N2>2:]DO+J[GD9>&TS7[N'X7>)/!://_ &AK_CCPGXNL[[;
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MR":"X3_@G_\ !\O;3V]S&)M5^(]S TEM.EQ&L]M/XWDM[J!GC59[6YBFM;N
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M8[6:RU%=-\1M>2Q?8[4R_0NK>*/ ?C_Q'XL^&OB#XCZ%HO@SXD>#_@YKD/Q
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MFBZN3JFIZ?\ 8])U;5+S3].U/5Y;W1]7M[;0K&YGUF[;2[O[/8N$1GZ?P/\
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MS[C7Z+75MX,U#]I#0_@59?"+X/:?X \81_!CP3XDGN/AOX>U/XC-??$;X1>
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MM;0J;J*TLVMEDG7:P<RK"KNK/(,D99L!JLC1;PKD:UJ'S%7!^U7?7C& ;@@
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MV, MGCAM['XP^&+35KG6$%TR7<[>-?!?BC5;HHUJFO64<B21?#ESIUQ'J5A
M^HW3-.\W[UI97:/_ $>Z<;'>1I%R(]I".G4'CDF:?PL]RN)=2O'(P1FYN^7
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M525U\'O1_P# >]@/F_18].FM8XY(["6Y?[1,J/':2W$EN)G F"NCRM OW1(
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MN;>RET^WOVAM;PI<VI^TSV\LC%H)$W1E@L)&P**T?\9:?\NGK_V_?Y6Z_+U
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MT<,-E'J$TM_# ES<SS2<09]5;4+J5[1!=FSM5E13'M2#=<^60/-(+$AR6##
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MI-\K)*%9_LQ=-_VC#E" #C=@D_,=P"[G]I6<>H2W32@PM920@!7^=_+B4+D
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M-%TG7-5TW2]1DNH(XY&U+3+&\BLKV6:!((9I)X7=UC1'9E1<>3^,M6\2WK^
M8K^XOKJ&]^+'A[5IQ<7]S<+J6MQ>$/'-K!JM^DEQ+]LU7[%J&HPKJ%R#=K#>
M7<8F5)Y8I?M:'X6_#./6Y)=9'BJQ\(']FCXC?&*\\!Z%X[\*>)O&OA#QO\/M
M9A\.VOP^U#QK8VUU97>A:]<06>O:=XJU+PTE\G@SQAI]Z=+UW7O#U]9W?AOC
M;P%X9^,WA;X*)\*]/O\ X7>)-?\ VL?A;\#=4M]:\7WGQ"T*WNOB!\-_B+XE
M\.^-].O]2TS1=:M9M.M_"_BFR\0>'K@W%C</;Z!+I%_ ^KWR:5TS?+&<H+WG
MR7]U-*VBT:TTWMI>S>M@,#3O%_Q*TC2KK0](UO7])T._,KWVC:7XBU33M(O&
MN /M#76FVFHP6<[7&/W[2P,TW_+4L37.W$VO);IOMHK9(9+>6&6)E1[>:WEC
MEM9+=H9%>&6":.-X98L/ ZK)&59%(]"E\1_!.'4=)BF\-?$]/#>D>,M!?5M>
MMOBAI4GB?QO\.K#Q%#%XT2^\)W'PR;1O"WC+5/!L>H:CX8@\'ZS';:%XK6QT
M[6#J^E"\5L_Q-\(_%/P^T;XO0^/O']IXAU#P=XBTGX8?#[6O#MC9Z+H7CSQK
MJ$^F^+O^%C:=8S6%UJDW@5/A#%;^,;;1;N&%TN_B5X*L;W59+K1-7MI3VKBF
MY0Y):6C=7EK:35E;31Z]/D!5'C_XGQ:O)XM_X2KQ-%X@DLK>UN/%;>*]:CUZ
M2PB5$BM[G76U0:G):J[@);S7311LXV(K/SYSX[UKQ#J.AZOK.HW7VJZU.9+J
MZUN\N9-3O+^Y<8:>>\EENYKN9U14$TK2.%6-5D6--E>=>/-*\:W^@>19^(TU
M?RY+5IM*M;-;&YG58T4+%);6D7G['*R-#-)'"!&27#A<87A.R\0Z'X*\0Q>(
M+F6TM[F6TCTO3IXYKF]M2FYKBZ*2Q+$+>XCDBB@V7!*-#/NAAR-T3K6O'DY)
M:7<G%V5T]5:STO97LKW5KH#Z M]1UFXF\/27UU=R'3+9+/1[QKN=Y[6VTZWE
M:QMK25IGFL[;2D8)I=O;F"+3U54M8XU5<0)?ZA'K-Q/%?WZ7&H2QPZA/'>7*
M7&HPWJ2/>P7\RRB2\BOG8O>17#RI=R$O<+(W-+:SQ2?V-$C[GBDU%I 2=P\V
M&499>Q+J>.BA@%) )JM&1_;$([_:[#_T6_\ A_G-3%J6(;33C[UM%9^YTNK-
M)J^D8ZZV; Z.3QAX[M]*FT&U\4>*4\,6FHWD]AI,?B?6H='L)I?M$#"QTR/4
M%LK19(;J>"5(;50\-Q<1\QS.IKQ:MXMC2S6&6XC2QTN]T:Q$6HS1+9:-JD&I
MV^J:/9A+I/LFE:E;ZWK5OJ.FP".ROH=8U:&Z@ECU*\6?.N;R!(;RV+ 3?:VD
M*8.2H;(QQ\W /3@#/.>*TTU:R5<%E/3T'&U><<]3GC.0.O-=6G9?^ Q_^1 K
MM?\ B..ROK/RS'8W_P!BDU"TCNBEK>-I;7,FG27UI'<>1>/ILE[>/I[W$<K6
M3WMVUMY;7<Q;2@\6_$%H?#3+KFO2#PDB?\(B\GB+4_,\+B-W*+X<,FH[]""?
M,JKIGV0",F/'EY6J,VKV,D4R+(@8QLH R3NQG'RKCGT/S9Z#');:ZM916\4;
MR)O",Q&5!'SN=IW'AL8P"1DD= <T679:^2_R \_^)WQ0^-5KK^D:C:ZMXIOY
M[8RZT-:;6-=U/58=7$8M[B=]3_M66XL8I]/MXK:\N('M+VXM0T;:C#$J+'P/
M@3Q3XC3PIXEO#I<FHZ;-XKU/6I;&POFBM-*O?$6IW6J:O-I6GWFI2Q6%JU](
MD6R*&2\N+:"V%S<S20;Z]\N-8L)+:XB#$+<VUQ;S*CE T=S"\$JED*_?25E+
M!MVTX4!L8\-\'SZ?9:/\5;.V=X(K;QIXGL[(PDSW/V"P\5ZM;6"(CE48I9V\
M4*%W)*?,67BN>4)*K>,DG-2:O%M+EBE):/5O^96M=-I]0^A=/U*75=.TK4'F
MNIE.A:+!8B\GEGFM-+T_3;:RT?3(3*\OV>RTG3+6ST[3;*%DMM/L;2VLK2*&
MV@CC3S;Q[XS\=:;\-X_#$7B3Q%_PAD>JV(C\-KXDUE?#@']I"=8CH2WRZ:8A
M,\D_DFS\II )%&^/)[3PISX8\/L2S!M"TH@N )"/L,1)=0S ,=WS8."2<#KC
MS7QU-:3^&(+.4B4G7K%VC^8$ 7 48(R 58JQZ_ZQ<@<UK3BU"*:U2V:3:U;\
M[;@>AKJ7B"\ALY)H)+WR[#1[6WGNIVGD2QTC2[#2]&MXII[AIH[72M)T_3M,
MTJ!&1-/TVQLK*T2"WLX(8][5O&?Q"UR;19_$>J:WXF7P_?V-[I5OXC\0:IJ\
M%H;.XAN/L]E_:.H78T];E8C:R26L8=(9) J.I9'R;/5].MK6VMR_,$,<7"DC
M]VBK@,!SMQC\.*=-KNG2IA9\%22,JV,D,@#<#:,MR3T( (YR+W^YK9;-6?3L
M!U?B;XH>/_&E[XON1<ZQIOACQEXK\0>*;CP+!XKU;4O"NGW&NZM<ZE/I\5E,
M^FV&H06LLS01W$VB69G1-S6L6YDKC#?ZZ V+2$%06P/*).T9((63//&>A/'.
M<8I6.JV<-C!!)*?,6::20(' ^:63 W #G!#X&<9"D_Q5;&MZ>, ,QP.24;=V
M/=1R>O)'('U"244HK9*RWV^=W][ PR]].ERIA54>\WW#,R*(Y/.5G"@.W  P
MBC.YB/G .*9(3]MNE))87T6<9X&VUZ^WH#QZ59BO8&CNXE<,TU[OCQR&5I8P
MIZ=R<<\<8SGBJLY_XF5\!@ WT2L3_$#';$*BC.".^[& >,D\34ASQY=M8N^^
MSO\ B!VEK_Q[0?\ 7)/_ $$5/52"1!;PJS!3Y,9Y!(Q@<<>OOQ[U%]MB.,,B
M8)W99&R,]%P3C/4G@8QC=@5?F!:,\?(^\<XVC')SC /3D]^W7%1*K9+N<L1C
MC( 'IC)&>V1C( XSDFNMQ;J.'3J23\O5FW$CGCDG [  =_E?]J@Z^:GYCCZG
M..>V* +%)D>H_.J_VJ$@[)$8^F]0.N,DY/ Z^OI2":(Y+%2Q/.V12...,LIZ
M#TZ_D(J5%36J;EHU%-)M-VO=JVGWC]?NZG*6[PK+=;KFX4&52$\U_,^Z?D*#
M@R!AM )R#D@\<ZD>GRR/)(9KB+=&BQ^9)()0F<G>Y D#8.PHV<;<!=N,Y]M)
MJ+27+Q::LI,H8J7M6:,C)(+RS0 L"<80-R,$@\&[)=ZTD4S-IK+MC)&Z6U(#
M*?EXCNIGR,DC$9YZE1R.64^9R:2496T:3:LDM[+M?1+YB(# R7UPK32DI82R
M!UD^?Y&B!3>5#,K%T;##';/&6GU!LZ6"X,C;E0,.,9@1C(W Z $[@,@Y.">O
MS8OB3Q'>">\MO%6MVM[9/=)J,5ZEJ8)C_:,L4>D65J8(KE0D'DNUTV8L+Y0$
MLP;R/H<RS-X=TZ67F6>*T\TE2"7DLD+D@A<$E]Q&,X*YP<BH IZ4Q_M.+IS;
MY) ( PMQTSG@Y)R<DXR!S@Z6H9%GJQ (/VVS ;@[?]+ASEADJ#D=_F/KSC.T
MH#^THCC_ )=AW/39<G%6=1MH3'JEU@F6.[MT4[CMVRW$43@+G&=K,1CHP4XX
MR-HUYIKF]Y=DHQ>W=)[;_E8"O:#'C2[PL !TF+(4H;@LL5F<^6,L(N 22,;M
MI'3%=5>"-;2Z^0K^X?)9-H]LD@#.0. 2<D8!Y(X>WTRT?QG?HT4?EG2;=E+,
MQF!"698!0QS&V,G X8 9YP>DGTFTCMYY5B562&1E*L2P8+D' [=N03U!7D8T
MI2]R,4FVD^=](MMM)MW;YEM9R:MK9: :EN T2DJ2"QYV$Y7"C*D#'!!P0>#G
MOR+0.%8%"0RL,B+ 7*G.["@8X!!&,9.??$BTFTDA0M'N8$AF+8!8[2<9([D8
MP/<8SBGC1[(')A QSP_(QDC&TEOQ'8$G@9%<T[7]C+371QU5GJ]F[:75KV7W
MG]>9D:XQ/@?Q059@PT#5R)(5,DD96SN<,H4$EQG*KT/WCWK.0'_A)_!>26SX
M=LCELAR?L2JQ8'D,2&)'\))QBC7["V;P=XCGD261UT'5W7R6*R@?9IU"P_?(
M<8RK>6XS]Y3EC2* OB?P3PR9\.VF%<C>/]#V@,< %P,;C@98'@9 #IRE*'-)
M=VGHE):ZI):6M;SWZ@-T-<:_XM+?92?)LB K)]IVK$$=64G=MW?+M.3D,W.\
M$]]IR V\)*\[$ (3@-D[@S $+_"2&8'G..:\UTBUBF\2>+I"L0E$%HX;+>9D
M!T ;#$#;@(<#"@C!(!QW%GI-I/##(58-M1CEB0V3DXYP#\H! &,?,2=W%IWB
MG&S3LTUZW_3LM]40TN>+<K-1DE'75-J[[:6_'2Q@>"2/L.O#&?\ B>7C$!=P
M$8@^;+XVA22F,-@X/0#GLM,<?9@3&TB^9*,+&'WG=P0RAMHP<%2 21D+CFO/
MO!NG6TUGKF\N7&MW>T%MS*JHIXP5^4-A6)[L,9R<=79Z5;7$.Z0Y=6=#EB<A
M2<8.<8P0#CC\S4N:4XPM\2D[Z67+WV?7?_ARSJE,1'^K\H@C =-HVYRQ)V !
M=H).2,X.1CD\U %-MJ#LH*F^M?FV_*09(CA6P,@#D =@#CG;4W]B68YX/'3<
M<D#TY_\ U&LNWM8I5O9""7@O+5(R68;4D>$X."0652%)/()^7 Y"?-[2+M[J
MA/7S=M'JNFSL_D!<U5C]IT<<?/%\^1R0IB?&>V=N,C!Y-:5P1]JO01TMXW!Q
MG "L/3 P<9)('K@&L74Y&^U:2[@;5A8X YX,9  QC&P,I^8_,00,#%7;Z*WN
M;N<R8)2V1E4,V?,"DA?E R%/)SG(],&E!^]6ZVJ=.ON1T5^O3L!@^*%W^';$
M 0<7^FG=<,L<98:S&2%9MNZ3:5/EDAF!7@ UZ-(8SO.TLQ+9 C8Y))+*,*0>
M2<#)!P "!S7E'BC3[-]!LIC'$T[:CIK$3.5#+_;,"C;\ZJ&VC: 1@A>V0:[R
M30;(NSF-0K2E@%WB0%G)Z[L=6R>"#VSP322LY<LDW[SBW=\R5M-6E>RVLM?4
M"72V0+? JW_'_.=Q0D,@CM^/NL<C'0\ C!QD&M8!,[E4X))8^6<G!Z_=]1SQ
MG'&*Y6QTJVN6O%95^2\FC4-N8>7'%;8##<"23*0#UP&R3G T!H%J#TB'7(!D
M'/KP_7\.W/>J3ND[6;2NG9M-[K;OY[@>:6PD7XPZJ-L6!HEN<N%,R;GTO885
MYD9 /]:JJ63T!R*Z_P !%C8ZWN,YSXJUP9N%*R$%K4]"1A"58KG'RALXSD>?
MVUK:_P#"V]6MW90JZ);!8-K-)*-VEKN60O\ (JX(=6W _+MY&*[WX?E?L&N!
M%F4+XIUSY;A@\@^>W(RVQ/E/ 08)50^6)R1E3;YZJM>]1MRTLFHQTMOJ^NVO
M=L$;EV-T6OD G&DZL6.,%1]@N2"21\O ^5C@#L:P_ASM'A'0@.#_ &?#\H )
M(\I,=!G *@<<#IP*OZK;0SKK;S+O$.E:J_#;"2NG3]""!][;NR&  &X8X.#X
M#TRTN/"&@M,K,ZZ=:J 7*@!+>-%).X<E5R2<;W+-U)IO^-'37V4M-K^]=*[T
MW272R>X'I)P 3A\<Y&QNGX*??@ YZ8[G,M<'4M5.TD?:(02 #@C3[,'."0#Y
MBR  9RX<YZFH/[$L3QY0YXXFR>?0;^OI56WTVSFNM0C>,L(9+=8B'*KM:PLY
MC@;LG,DL@4L 0, X 6G&=1WYJ;B[-J\HN[OMIT>RO==] .D50, 94<X)B7C)
MS@D(3CMS[=JR"0-4O22%Q86&-P5>2]V5W(0,%@K]1R#U^<$L_L2R.#Y''//F
MGJ#V^?USS],53&FV@OKJ!8R%2RM91ASG?(UPK$L 2P&U1@EOE4;0>*7/4NKT
M9)-I?%'1=[+L E\Q.DP)@G-P5R3Q@3.<X/S<X'!'0@@]16BKJ5TIR/E L@P)
M53PL@(W'Y0=V&!)QM0Y(. <R^4+I4 7)VW#;0.K8D;@$]SVR"3TP215MHHY[
M?38Y =C&S#C/JLV>F,CU!Z\C/>AZ56UJU3;LOM>\EOMY:V Q_$@W>"_B4&6#
M,GA+Q_$?/9$M@K^%-;4>?,Q\N&V)QY\S,$CCW,3Q796(C^P:>#M8C3M-!,:#
MRQC3[483&0R @;&#89 I'4&O._$VF6K^#OB&=@+0>$O'J6ZS%O)'E>$]:$:7
M !!\AY,>>P(;RR1D$ATZJVT6Q:TLF$:MNT_3B=LIV!O[/MMRQ_-@QJV5C(+#
M:!R1@EN4U:U.3;2;LXIJ^KB^NCMM*V^X%VVV#5]0&"%*0C&.<J@ZJ0#DC!SM
MY'.<')U\19!"L3T^[SCT!VGK_P#7P<8KDH=+M6O[VW9/W4<5LZ+O)(>0'=\V
MX'KP.2,$\X%7?[%LL F$<_\ 38XS]=PXZ\\?X2JDG=QIN23M+WHZ33?-&SM=
MJVKU6VK \Z\>L#XV\%A3%D)&&$F%('VO4",*1D2%=@'0D,!R2,]=9LY^(?B$
M9E"'2]'(CV8BXTG3P2Q ^5A)YH5<@$^8",X+>?\ C:RMH/%_A"%08XY"A/R&
M0N_VJ]0H-Q#1_*K_ +PX.T 8R2J]MI<,-KX\UZW@BN$":9I060OFU(DTVRD8
MA6C+,Q=C$3YB_O;>4[2"H7!/]XDXVE[6[=U9*[]VVUT];KTMJ'7Y_J=G,/\
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MF%&8_>Q@D@C'([>M<KXXTVULO#E](L<Q8",,UN3N+!B S!A+^[!W!P$W =&
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M!QEPBLOREL=!@$@9QQ5^VFT[V;TL^6*LM;JUM;I[WTW \PUC5?%\GAG7(_\
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M '4+F?R+P.]M:Q!#:R!PJ_:3O,;9(5_E"MGD[\<1L*:2226R27W*W]-ZOKJ
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MC,JH#A"*^DG75FDL3,Z174@5W@PI:VE:,L\$K+&%9H6+1G8S[BI*,RX-/_M
M&7[3_9UVMP%V+,ME.DPC8?.A89PK'[R8P?NDD=(IM1+SV\C6MXI25< V[JQ
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M%EJ)QD\V,Z^G?)R![YP352ZOVF>RW6M\OEWJ$![2:/S'\J=?+C+G#N1DX'.
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MYC]XY&3C#_/\0/)_&WC7Q_H>AI=6^BW6E12-;QO?RBPNUMPT.(T2VCN)[AF
MV8982JL?G(!!K!\.^*_%OBGP=X@_MRXGDM].>Q2UU&.(0RWC2O()+;9@!DA1
M5D,P $^\DLYCPOO:Z@%A6$V.I.K0Q*YCMIO+E544]5X= RAADLN5!Z@8YOQ;
M=M+X8O+6UTK4E2-(T1(K69%BC0,?EX8)&H!+8 !4 %NE9U?X<O\ MV_3[4=G
MI;U V[7[0G]D-<29C;[=Y8/!&([DMOP,,64@]3EFQ@<FHXR1JD8XYN;!1SPV
MZ.5<CC) VDGCN .0<+#.'_LBW\NXC,+7?S3(RB3=!<;F1R,/L< $J< A@>00
M%0@ZG$.,B[T[(!SC_CY'\P1^%17DX.$HNWQ:M)JUTFK/3737IZH"2Z%T4O3$
MZ+#Y\@._YL2;\]-AX.1WQR<]*N+%J^U"+G<-JXP/E/'48C''<$<$'/.<FE=W
M02.]B\FX;-U(YD2)FB!#@%2Y.,C()YX8J.IQ5H:H J@66I,%55#+:2A6"@#(
M^7D''!'!'3UK?M]_W_UIV 66/4_+<R3C:$(;/!"\GLFXCJ=O);#8[TRWBU)K
M> QRJ$,9V  DJ-[\'Y,YSGKV(QQBB35 T,JFSU)!L8;I+>14&X8P25QDXR,D
M A3G@4VWU62*"!%LKQD"$[A9SL'!=R2K#*D?PY!P2I- !=VFIS6MW"TJA;BT
MN[9B0 =EQ:RPR8)48(C=L'(P0.17BW@NUN+72?BG8P3 6VG>,_$VFK"I"W)3
M3_%6JV,9#@+LW+;*R@2(@&57&W;7MDFKR,CI]BO40HX+-9S$J"&R[G"K\OWF
M.0."3CFO%/"\PFT_XO1&UN9C=?$+QI)MMXI-P+>--;E^SF5<A9HW!C8E=@*O
MU5@:B4H1E%RE9J,K:NUFTGHD[Z]]N@'MGAEE3PSX>3+;AHFE'#9=OEM(2=[J
M'&[*-R3DG)YSD^<>/XY[GPO"LDJ"TDUFP58_N2$_:6<X.,,40.&(;NA(.!GT
M'PL/^*:T %2 -#TG().Y0+*(;3G;DJ01T&#SCBO/O'$F[PW:0F*< :SI^V1H
M7,.6N3G]Z/E)VMD+PP,;8 RIJN:/*I77*WH[/5MJ/:^_=>865T^J32=WUM?3
MK>RW^1W\$>HFVMS"X$?DQ",,,D1A H#8C/S !<X)'N:>T6KD$&6,#J25X !'
M7]V">H^4')Z@?*2(H=09((42UOY$6*-0Z6TQ1P$&'0A2K*W)5E8@@Y!YJ7^T
M6((-GJ 4C#$VTP '4DDJ%P,9.3@8SVJK/L_N IV,6HO:1M%*OE%I  WJ)7#'
M'EG"[@>">GL:M"+4R1^]B[<;E.<^GR'\L<=#R#5:QO3#:Q1BVO)0IEW/#;RO
M&2TKMA60%6^4J&YZ^V#5LZC)S_H6H#GD?9+C\L;!TY_E64ZL8.UN9KLTK/L[
MQ>O4>FN]^AG6Z7H2Y9F41I>R&4-@_.Q"R2?*,[",D*"<=%&X@52F/^GWH(#;
MKZ'+8Q@*EL&R#@D=/EQ_"0?0V8[H>7=Q>5<AIK]G#F-Q&C-(@>)V)!5T!)=.
M JYSTXJW&#J$Y/.;^+KP3\ML<<Y/KZ\=>N*S]O>ZY4DXS35XW;:?*^;E3T\M
M7U9G4DXQ35OBBG=)Z.23]-.IV4+1""'?@$Q1\DC^X,#)/4#MUQSC!JIJ#QB!
M3"%9UGA8*&4;CYG )W<9)./3/H#22V/VN&U;S&0B-"=K ;OD P000QP"<GGC
MT%86I:<+*%7::=PTB\"3D_O%SS@8P>AQD9SR,U@KMI7>K2U<FM6EMS:[[&EW
M:U_E?0U5O[P *MI-M4 #'E]  .F\$X [ DY..<4O]HWHW'[)-A1D\Q# SC<<
MR@@$\?-C!%<V+F-@I+RNRH 9$<;1]YU3=M)+KD YZ%BV>3C26PAF@B=[LQ-*
MJ2[27W*)(PS(VU<%D9F1CG&]6/N:G&,91@GLK5)6>DN:STO_ "V=D[>=Q&H+
MZ_8*RV5PRG!W+Y9&.>A\SGZ@D>AZU$VI7X)"V%PP!(S\HY!P>-W0'('KC\:O
MVLUK;PK"9U?9G:<$D*3D<E00<CJ "<#GK4WVJRR3F/).2=@Y/OQS^-0[)V3N
MKM)[771V>NO9[=P.?M=)M9I+G]VNV*;;&'(RNW=SOYW$\$]#^N;K:-:J,LD?
M7&=V>3[@'\^G7GK7"VOB/4#<QQ#1]75KM@Q+6]MM7]V[EI2925P<A1D<87/%
M/?Q1J,MA//#HNM#>&MU46UN) YVDL$\P\#+ M@'/3I6KC3<KQJ)1=M.6;>UG
M9Z7N]=MG;LP--[CP[]NN+8ZOI/[NRD=8EU&T!6X#$+&5$X/F,SR#:NUU8,KC
M) K2ON-+M^F/-AP5P%V?9XRA&./ND$G)SG/>OFF+1=1O)YM%OO"URFKZ?;S:
MI MM8V,4LD%UJ3&/6M2U%0EU)(KSK;I:B22.-(DE;>[8B^DI5$6@V,4I<7$%
MM;*2OS(\XMT#*QR"2" "P^;)W*54X.-U_7]+^MK@0:/_ ,?Z=/\ 42=<8Z7G
M7((^F1UJ]>RQ?8]2B$J+,UQ8A8RX5OEGMF;:K'D!>202H R3\M4-(/\ I\:G
MC;!*5 '/S"Y[GJ/D7:"3CD\[JO7T$)M-1G,4;2QSV>R0HI91++"DISC'S*YW
M$]\'CNP,VSU")O&=ZDM_$8%TBW)@>0;%D,=J0Q))7@X4#+8+9 SFNKNKJQ:U
MN56XM2S0R* KQACD8P,$'DG'KT[YKD;&TLY/%]["\5JZOI<,AA-I#YB$0VG[
MPSF'>5(&-A?DX;& M=1?Z;8P6=S+%:PK(D+%6\I!C(VE@0G7 ('<XXX I-I;
MZ>?SL!9M+BS%NF^6WW<[@SQ;ER<J&!/!VD8'/'L*L&YLL'$MON(.#YD(.2#W
MW<9]3^->;^,/$6E^"]"359M+COKFYN4MK:$AEA>031JXGF2*1H@8&8QG:09%
M1>%X/)^$?BMX:UVVF.LZ7!HEW$R[8[>*YOK>2-@PC83K:JZ/NXPRCYAE0%!-
M7:/O6E>S2C[K7-W>MN6WGOT ]!\0202>"/$L'F0/,_A_584B::)6WFWN3LRS
M':3N!SCD_G4"!E\2^"@X8,OARSW!CN((M 3EAD-CNPX)!-<GK/C+P7-X5UV"
M*YAN;N;1M6AB1[.]C$LKV\T2H9C;@1*[&,"3<-@^?<, U9TCQ/I.L>,_"=II
MC/(NG^'(([J1HI8UBN8HA;FW3SU1WV*0WF!&W;@=Y9JBZO;K_7?<#9TBY1=>
M\70R7\>W; 4L2"GE;EQYA8X5VFV A068G.<$5W.FW-L+>W)F@!$:@!Y$4HP=
M]PPS*RDJT9^Z,I@YZ"N"TF&WE\0>+]R(\@2V<EK:/@A.&6Y*&1RJD!E$@ Q@
MJ.".YL;"TD@AE>VA:0QK)D1J,MN=<8P2,!!@#&0>1DFFK6=Y6:E%):^]UOIH
MN5K9N[U]&')^#+BU%KKO[^WW?VO=M@O'N*[ "5R0><C;CDY/'!KK;*>W6TB!
MEM@0THQ(\88#<.Q8D<YZ@ C!&:\>\+^*O"^G'Q'8:LHM+F#7;ID+VTUPLB^6
MA3#P13(I#DDH=A C+'D UKW7Q!\$:?I%S>%Q?SVL,DJ6L=C="2<^:JJJ226P
M12"Q/S-@8]MIZ(U&TFZL5*^L?9MVOTT26FE^BOK8+^GW(]46YMRRCS[3 ()/
MF0@#!/<G@\DC'0YR1GG$CFMQ!?\ [Z-M][8M&-REI$3[."57[Q48_ D\5Y?\
M/?B18>--9;0[SPW;:;=R13W%B]K-+>V\L5I'+/<BX:>VA:%VC3$2HTH<DC,8
M7GT^&W@-M=OY4>Y;RT"ML!*"1XW95R, 9)^5<  DCI3=1QG:4U))24DH<K4M
MXK2^^B[+5L+W_P"&L.U,-YVG*<9$+[LDD@X4D9'<#/&3@D9QQB_<RQ1WLPD=
M%_<@D.0F5P0OWOO!CC@9SD<9'&=JDH6;3,@D^0YR2.2VQ>_7[V3[ UH7,<,]
M[+YD:L1"F ZABH*L05XX'.&"G!8#CFG"<)*2B[2FG*47S:-1M>[LM%9^Z]P.
M2\3W5O'X?L%-W;P,-3L,[L,0/[:B<+A02I*L'&XA<-N/)%=ZUQ:9DW36I<O)
MR)86.=Y*DD-U!(QUP#C&<8\_\26ULN@V+K':ASJ>GJ7EMHK@,%UF%2I1XY!E
MMI&?O @@$!>.]>PL"7;[+;9+R_=BB7.'<87:@].@[9!V\5I!+DA9W7*DI._O
M;J^NNOZ:: 9^F36J)>>8\ 9M0N&4,T8W*8K<*^6P67  # D=N0!C3%Y:CCSK
M9U(88+P@@Y'.0W)'/)Y)Y.>:Y::XT[2=)UG5+RUCD@T^>^G*);B:18X;:.41
MJ"#\K%7P,H <DG&XGRCPS\9-#U?4VL]:\/6NC6LL<C6-U;>;?EI%(=5O(3:*
M\"/ )&#0F;;.%B<8?S%)3A#24K-JZ5F[K;HF!TMI<!?B[JK"\589-#LPT>X/
M%<.K:4%._E59".I<#!W<GKV'@/9'8:X=JH#XIUS&UE<<M;DG='N!Z8Z\8((!
M(!\O\-:IIFO_ !3U*YL0S69TOR(D:VQ')Y4VEQ.Y1T#QJ=HVG",%^88KTSP&
MABL-;'D"V'_"5:V1$K[E(9K=E8')!9_O$ _* 0JC-84W>M*VJDIV=NGNM.VE
MM5L"Z=_O_P C=U2:(6^L S(K'2]74 NJ,"=.F4#YMK G)YZ#&,Y)!P?AW/:I
MX.T%9)H ?[.LV_>N@8^9:PS#*O\ ,-HD$6>F(R%X"UJZA;Q2PZXTD,<I&EZN
M4W+N+%;"XVA<],'A<8&3SVKRWP+XU\)0>$M)CU21(;NW1[*6.2SN+@J;$+:@
MB1(949&6 E"&R1\Q^]BMG4@FTY:KREOUZ=_/4#W4W6G $F>TQ@Y^>+IW[^E9
MMI/;K=:F9+B !IH-N^2,@M]@M4=@23DB1)5;&06!R3N!/#_\)Y\/SQ]J@YX_
MY!=T/P)^R' /0^V<8ZU67QSX&CFU&:6[CDA61'AC73;MG"1V,$LJJ#;%$8SF
M=%W*@W  X1<E>UI_S?A+_(#U,W5@?^7BT_[[B]N,9'H/R&<XK)^T6O\ :&I,
M)X"C6>F)&X="K.C:GYBK@XW(3'D 97<I))(SX7H'QATK6/$,6E7'AJVL]/O+
MG[/8WB.T]Z22/*:ZMC9B*-6^991'([(0H0*%;/MJVUG_ &A=)]FAV"ULGB3R
MTPC2&ZW.5 Y8G8QV@?*BD@%>;C)25XNZO:^MK_- 1:DV=*1HPA0S.A;CA?/4
MX4<8.Y1SCID=\&Z2JC2I)"JQ 6>7=E5,_9YSR6('RL5Y/UZ"LZ]V_P!DQ[04
MVS$*"W3,XSP,#C&<@=SC'.;;;)H=-1U#1L+)'1P&5ALF4Y!&/8'KSUZ88'.^
M(;J./P7\2";N*WE/A+X@/;SNPD\MAX2UPPW*(I+RK"5$@2(,TBIL0,6"GLK"
M\LGL;!I+JUD<Z=IQ9VDCW.?L%J=_)R-Q)8J>5R ><UQ7B6*#_A#OB+(T4$<D
M/A3X@^7,]O'(MLD?A36@C^4\<BLL7#%"C#U!^\O6V5EISV%B[VUN7.FZ:S%;
M>-%)>PMFR$\OY023QP!P%%&EK^O^>G7_ (/J@(X+F :I?MY\'DR?95R7CV%4
MA;('('RL, <@9./0:QN=/[3VG_?<7^/X_ABL**WM&U"_A\F'RXEAVKY*;50P
M22$[2I'+KN.  3G/.XUX<GQLT-]<-J/#=NNA-.\46H?O/[1*;R(I6L/LP5&,
M81G43DB1W95*!(U4I1@KR:2O:[OO9Z:)@==X[N(?^$Q\)20W,<:B.-&>(JP_
MX_K\[79,A,J<]N"<G' Z^Q2*7Q]KDZ>7*O\ 96D()EE5EVC3;)=L: Y5"%"/
MM& \99L"10WE7B#7M!UWQOX8M]*/FV5ND)F>*S>+?,]Q<MY;++'"Q4(Z%Y%0
M'(=%;&5'J>G101>/=;2&TBC6/3-*"S1NZD>;IEG*RB!'$0 ,@^;R]WRGGYUS
ME2E'E=[6G6ERMK=RLUTT757ZW6X'43O'%J-KN=8E' +R! "T%PK99V'+<*>>
M>_05Q/@"XBBCUTR3P1!M8N C2/&0RX1@0&;!ZY#=#V)(KM;I(Y-2MTEB216P
MVV10W*PSG*@YPP*J21C.T D@8KQCPIXI\,Z;<>(M/UIEMY8=6=H ]K-<I)"1
M& 4,,,RIM#C*D#YD)R/E%55:7LV[)*HKM[I<K;U[+?M^('NWVZW_ .?VT_\
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MGY'^BQ$>\<?'7J"G?I[YQ]2Z_J_^3N!AK(A@OEWH9)-1D>,>8C,Z[P^5RQW
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M   /4(M-\,$JHNM7(\I7X,0)R@X($1/.TY(RN0<#*@&]%H7A9MN;G6LD\D-
M8QZ CRU?U+88=>".IX&*^\1ML AU-1A =VL"%E# $AEA8*YZC:I,8C"XPY:I
M1XL\4)KNEZ1"FF"&[MM4>=IK*6:=FLX(&M_(D6X@C4*SM]H62VDEG 7;/"H
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MN[-)XIX[+3)66>:QNX%ABGNVNG@B6X$;M,/.),J>8J+&T;$DJ*[JZT1UTFW
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M5^M/#G@;X2:AJ?A$R_$>VU"2,W:E8K%_#\@ TQU1&@U6XU&2(L=J2D,KD$R
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MDBO!==_:Q\4KJ<Z:?KEB8@]H8['3_#XU&WN(0\ANH%+Z?.)C<Q^7&([>[20
M[1N$@QS2^KV:BZJ=]&U&4?)_9DT^V^JWW&<VTLRBTC\NU+6TLI4)<%R=[$.D
MJB,A"J<!E8@X*LN3QGK?,VJ7CR7%NK?9E%N!(QMQ(70!=S DO@$D$ \!>]<1
MXR^/6F&+2M9U_P +>)KA[Z^2W>YLM,TK3DDNI5N0B2P6]U9?8G%Q97!PL4KO
M)&L0WHV^J&F^-O%GB&>35-"\!WLUK(B+(-3:P3;&,&/:OG-))/&NUV9I"3(Q
M *J%QB!Z!J-U ]HP>YLU*W,/F1I(WF(A;",78'@!ANS&C%N6D )%8>J^)K;1
MXG>YN;%V6/B&&>:2>0%=JE5"JLH" 9\L_+C/+55MM3\<:W:7$B>&].M&BO((
MV_>SM(L;%L>:I'F,",9W! "0%! +##\7> /&7B,Z:H6VTVX:0VZ2M:32Q-%M
MN)_*6/Y)045<%B6#XWXP5H O7/BJRETZ:[\V"2![221C$S+(?W14QYG"6JRA
MB(PDL\0W!E9XV3%<#IVJJW@V2"**-MUT)+?[1?+&T\C>7YL<L2I=-;Q)"RL)
M@[H3O$<3 !VN7/PKOM*TR:VO[V WTD4DB3 I:W$DG11:)L6=_+R5;8'16(8.
MS,S'D;'P;J:>#Y+B1;N60ZD^1<W)V-Y4<)$QVF.14E((4A2"[$2D'R\@'IMS
MJU^ML3(FF)'':1@D&X9HML8+'S/-CB:(*PQF"-G)8G&T!N0U_P 40F+P\TMS
MIPB@\06#2&"X$K*(]*UB-)'W(A2(/*B2?O"5=T +@,#JR>%YUM#N6<JULK'>
M\[1X2)2PV'?*^ YPJ1GY5+MG"5S/B'P?'-8^'[=X'2&YU[3;>5HXP#Y;Z;JW
M##<=H8JG# L<D':Q.T ZP^,[2.2&(:K8+$VTEFO#D+R7(PH&1@G<5^4CD-P!
MF7?Q#C$+VQN(+E%\I2UA<SSWCD/%M3[&T<:NZD](Y]TC91%)89;_ ,*XT@@,
M-)M=P08^60(V0,DLC!BQZJG4X<!2<&H[CX>:5$L<RZ9#$6N;98Y,%]JRW$,3
M9P[*Q*R8.26(.X84%@ :3?$N33[*"Y-C)+;JH5@Y^S7+LBD+;&RU.:QN5N,K
MB5C&44;WC,R*F_/U#XC7.I:!=SVNCV\C6SQN]O<ZK%#+\N&C>,0+=21NXW-M
M"/&"HPVTYK4U7P!833?V/IVA,U[%!:3Q369#RRO<0>9YEQ&3(88HPX5W8!9#
MG8QR0)])\'?8[*^TK^R+E[V_MOWIN0Z[&B\S[,R6[H)BY=Y-TB Q[5"[W8.(
MP#SWQ;\<=;\,:-X<OX_#%M?K=75IIA1/$+V%Y!<:I/<PHY5M!OEDAC3$NT&-
MI2VQ9(OOU9^'/Q7\5^/K._O4T*PL#IGB'4=#BG2\NKF.:;3!;&1_,F2U,97[
M4L;P>=*T)1W!"EHJO?%7P6=7T#PKIL6EWEO%IGB;1[O5+N( -:V=C)<7ES&=
MHC^_$R6RSS";R!+]H,,TT;1GF_ =EXU^->OZ_P"%? 5IX:TGP;H,W]G7VMZG
M86=QH>DZX\7FR:?I&E:8$FO=0N;.]M[J[>2*RBE1!]INVD1D5JG>,I.2C&^]
MKMMZ:6U\KV?EL-M65HZJ]]WS=M/0]Z_X23Q/+%<)J$VC6D=Q/,YC51(\\,5Q
M(NIF*.[N8AY%L(3"SM-LE,I<&,0NK^&_MC^//">M^$]!_LOPU9:'J%CJ&F:;
M 7N;MHM0O4E%W=S33KIFFP$QZ;#?0JEK:3Q1VL]M$VI3O<M!9_3&O?LW_%#Q
M1I[13^+OA^LEK8PZ=9AO"^KV:O();R65YGMA="V6WDO)!%'%;R-<I+ 9)0()
M ?//VL/V>_C5X[\-?#JQ\)?##5K_ $_PS=ZH-2ULZMX&T;2=4U1M&TZRMY=*
M.J>*+>^N[9V%ZR/<V.G!<$.0S?-YN+A5>8Y2J;D\,ZSGBZBI1YJ,L/&=7#VK
M.$YT(592=.=I0C-*,9\R]U_3Y+7P-')>(O;UJ=/'+#4H8"C.O5B\5]:<,-B8
M_5HU80Q+H0I0J47.E5^JNI.JN3FE-P_L1^)_%/@_X;ZOK7@0^%YI/%%Y<:?X
MAAN8I+\I=Z64:TD,$,RS6=U';-&8E)2*X@V-+$Z2+M^N9OB%\;=7LKG2=5UO
M09=&OK:6&\TNX\-:+=6<UO)O1H[BRO+*XM9XRLD@"7$<YW,DJD,@!^1/V<O%
MEC^S)I6I?#GXB?#[Q$+K5[QO$?B&]#VEIXETG5)$T;2([==$OC::;J6C):PL
M;*ZT_6)9;J6VGF@NKR)V>']/?AMXJ^$WQ1LD;P+XET77;Z&"%[[0I4ET?Q1I
MOG9V'4?#6K):ZJD;-\B:A:0WFBW)21[34KA8I)4]9UJG-[E27)]E)M*SY;[^
MLKMZWO:UU;Y;_@_<K_Y+78_(7]HGX3?"[P9)<ZMI#:EHNI>(;"^UPZ;8V<\G
MAGPWIMQ:_96TR34KVX(LI+/7+B6V$T-HEM!836$<0NYO,"<Q^S5X!UZZ\$>+
M(9&U#27$NEV^I:9]JU+2H8KJWDO(KAD6)HC+'+)$\UI.T:N;>9#N8G>WZJ_M
M)W/P\M_ GB+P!=:AHLFN>(KCPYX9U^S@O_#[WOA'PSKGB'1%\3:OXB6YO);W
MPY;0>%Y[Z_M;F[L5AW^1?"15MUE'7:=X&L+,_$&T@LU,%CJU_960GF:Y=[;3
MM<U'3K)WO)'9[R1[.VB9[V65Y;MV^TO)(TPD;:JFXVBFY*2>F]D^]U;II>^W
M:XHOFBGW_KR_0^#]$\ ZSH5E:M:6469[>":2ZGN99[BYP%R9KAH//E!R>'E*
MH6+!2SDGP7XB:!8ZS+);S:7;KJ&C75M!J=Y<2S);W$5W#]JL($M_+\J=E,I<
M3,RR6\D,T>'5\+^L4GA5!I5CMMMA&EVZ# C94#1HQP&=@W((!7(V[1GO7S_X
M\\(Q'17<V\$B/>C(*8#*;C4%VR+M!X&T@ ,1A5 R#CDE"4=TXN6O36UKZ)OJ
M]>OKU:DKM+7E>N_KOK?\3XB@\/Z:MO:P1Z9H$4ZQ1 I*P5_W:8_=EK?8YW$Y
M18\@X8DA@%YW6VM](#PM:Z/!^[9I)B$2..-G95\QU@.V223"Q*8VPJ2R%LJL
M=?4_B'X8%8C-I"Q)N42+:2,QB9R#A;67RUFM3D%P)7,:,P0.J[ GSCXXTV5(
MKQ;NS26?3+8VWE6EU''*191N#E&:W6[GDEB#2&3>\[IO4-M,A=-7DU/91D^O
MO-)OIM:W-;9[6M<II-QL]VKKJKNUKM6=UKHMFEJT>/:=J2ZKIMU/<6&I74,B
MW4&E:?"]Q;6<$!-S&)YYXU@%S?W<J1RO*GG64"&."W+&.2>3JO#VK6FGZ/!;
M-X4;[?=:?I2_:]1E1KFUO+'S&U2WEA=I)8UO5*K%. F6Z2%I,+Z3\,M>\-:I
M9:=H]WH=A;1V4$*&[O((H_W-U<RBS;=([*\F5D:5 R.CQAURNXFK>^-(I-9U
M"WL?!.G36]M>R6*W$TEJB3O9%[=I8-BR&:WF\OSHW9]^6R$.%-*524ERMIVU
MMRQ6JU6O*K=+]U:]S1Q@JDXMVBE)*[;L[+E;LKMW>OY'/^%=1\+ZIK4FEZ[I
M)A.LA=,L[I;JXTZZLM0OIO+BNHI5CE&H0VQ 26VO $N87<>9#(%)G\5:5K&D
MW6H/XT@M=.U$ZIJ:W&HC4H9;#4+6VAM0'AL3#%'IUA#;21"Q:2]N9)[9Q;E5
MDM6=TUHZOXGTR[T]]"_LP1ZK'>V5SIE]]CO[>_M$N197<=S'&8YX[:2X9I=-
MO(9;&\RHNH76,%)(O NG?%738?AO\5K;4+/QQ_:3ZKX%^(EYKTSQ2ZJJV,%A
MH-U+HR10IITCV=HDMM<6<=K;&5KN*&YEPTJG*<TY.W,HZ+E6O]VT>5)OHV[:
M=M"/<BXZ^TC9\UKP:>MK-VOLO_ O(L:!I5S817$6F:<ODJFDSI"D$Z6R17%J
M99)4E D+M))(&<#Y6=BS$DY?M(]+UJ93OTCS$60,9$^T[5(90L9)A/S DC(!
M'(;('RTQ)OB$]T^EV,=K9ZGI-G;V6M:5//!)?6.IV8-O?23A;:)#%-/%(]J%
M556)T92Z,DAP_%/BKXB^#M,^W:MKUK80++!$LJ6<5RS3LP2*'9#:REBS#:95
M3R>-Q;9S41E4Y8\\8J7+'GY6W%2:3DHMJ+DD[I-J+ERIV5[)\JE*2INZYGRI
MJS<-;2;<K+9.UW\7D>M6G@C5X-C:CIL]M9SKGSQ<,RH[!5CM2?,#"78S-OD@
M1&5,!F9L#E++PY-_PM'2M/DB+ :)KAMT%TY$P,=NNXY0JB 6Y82 .Q/R@[1S
MZ%\'O$VGZS\*_$7C3Q#)?:F;6TGGO+C2K6YU"]F9O%%YX7B:UT73K.YN1+;:
MA L MK:WEO9HFCOH(7MY)'BT7\.V\/QH^'4A>_A?5/#>OQ20N+F2<QFSM[NQ
MF98[421!UN\S0RJGV:*.620AXY8QI9I)])*ZVVNUW?;J0TTVFM4[/5:/KLW^
M!W.F^$+D("L"$H"!F\G <G:=F3&Y!55"GC'4J,!J[>T\&70C %C%)A5!Q>3,
M5.6)W%8T4YSQ@'IU->GZ=X00!9//N#L "@DL .-S!60;CD[,$$XY "@N.WL_
M")9"ADNLI@_+((\!BQ'S @N.#@$ ISQ\U DU*Z6MG9^I\S)XATL2SN+J-VFN
MO+4DNF6#DD E",9 #=CP00#S/-JT 9RS*W&U%6=%4 A"P#!N<,7R<?*^X$9&
M6Z75/ V@WSJUOX7O-.V3$2XEDA=F8$F-QL&".I+!2#C[K#;766/@_P (VMK;
MPR>%)9YX8RCSR>=EVWDR'<AC8+(V9!\V26.1VH&>+G4;3SKB0NA=K:2)E\P9
M7)7!))7 (R HW?PDD[@:R=3\2::(8[>))IHXA;YG00F(L8PK1DM(LC/&ZF-L
M1 #;P63YZ]IU7P-X9N8+Q+7PF87E@A$3AKH$/'.DC#*2"9BR*RY;<H$A0$ X
MKD=0\ Z!'*+== -G(=DTMO-<W<4L"OAD=$:X#1K,G[XY53N*R$!=I(!\M?'7
M2SJ/@+58[8J96TW4%C2)UW,SP6Y"E6=?DVI)YBM\SAOD "%FU_A%X5,'@/1)
M+W5KFWU&QM]/_P!%1+1@DTMK# 6(D1BX\F1U;:[9 X.2!7T+\7_!^AZ=\,?%
MM_;Z>(KBRT&>2"5I[QU5@D;.S++(\<H+",;#%)NPQ*[0375_#OP-I+^ = ;^
MR@8_[&TAYW6^OT<-+:VLAP3,N5:23.5SP JC@ '2_2]K^=F_T?W >31^"9HY
MY+BRU=TE,:D-)(B.\C88B86\+OY3-\P14QG&Y@!FM'3_  S]GNI+^:\>_P 6
MLXFF23.'F0HHQ*JNEN'(95V+@ @D@BOI$^ ]->V8#2B5V%ALU*_\_'(^4+-O
M"Y W%0S*0"!R36B/!&GB%V&CVXC:&1S_ ,3.^8$*K_Q&? #*"2@(=P/E!W<@
M'P7>Z?;R?M ^&]\\ZRCP5JL3H&'EJ/-MID52TFTEP-ZJ6SO8KD97/T;>>!8-
M:EBO5U"6,1PMO#2;@B1QL1Y2I#(5?:G[Q7 XQEN!7/\ B/P_##^T;\,]*CL(
M8[67P+XGNY$^T7<DHDBD 27=().(T=R$# D9X) KV70;/40DA M61HL.T<V5
MRPD#E-P0EG9MN  P)4D  9N7P0?E+[E+;Y?J!Y[:^"85\*[I-0U8_9-.=WC$
MJ,)?(M@DD+ ($D0-"T>TD<X9F;&&Z\6BIJOA\!&+'2X "1N90T*I\RJ,9( P
MO!.>!QSJ0VMZOA-!A#$WANVDE'S"5&DTJW=@@"#/S22'()5CW)%7+_2C>7%A
M9M'&HN]":W>.X\QHG,]D(6BG-K)',(2&=)TAG@GDA9ECE3>L@BZ=DEJMW>][
M[>[:R\M?,A*7-?G]W^7E7Y[G!S:+.\GB*7[-J*,L2R@+%(;<!#@+M,8RRD,2
MX;_6!L],MXCX9^!=E+XZTKXY_P#"2^(CK=UH:^ E\+B6TDT.V\.0M<3O"EB+
M-=02^N-<N)O$#7SWC"*6Y:T2!8 P;-M_V8KFQE\1R1Z;\.]3B>:[D%WK%S\6
MKZZV73I,$@EE^(X=$M615M  GE;Y!.)F8D>E:3\*M2?]G_P?X0,NG:J]A';Z
M-:6VN76OS>'Y%C\6ZSXBFDN19:K:>(YGBU#5KV.WG;6?,\J&UCG,Z+ODPJT(
M5I4G-U$Z-3VD53GR*3LDZ=5<D_:4I6BYT[T^;EBG44='O3J.GSI1B^>+BW)<
MSBG_ "7M&,DTG&6KB[]S(USPK%K?]G>';F2]B36M2UC2_,CD-I(D=WX<OT9X
MIFRJ31(\LBW .860;89BY O_  G^%T'PO\&:1X LI]8U?3?"-K#H\&L3R"X>
M[19!(]Q<O IC$S2W#1F*!0BX0*(]PKAO OP7UK1/BA\,=>5O!VBIHFOZO'>V
M_@P>+=.;7S<>'=0%G+K$&LZ[JUK>/I]W:HL,L,:*ZZE?RW&U_(FBZ3QQ^S[=
M^)?&.N7MBGA$VW]G6&@I<ZY+XWN=<C2TTX6 NDN=#\46.G&X@1EFM7DLLM<Q
M)+=,ZJ32^KQ>)^M.=7G]@J')SVHN,6VI.GRZU4ISC[1S7NNRCHFCVDU2=&T>
M5S52[BN924>6RE>Z35KJS3LK6/<8]#23;F[N%*[R,':P'!)8.0P7< """>"5
MP,UB2:(OE7162<M#<1*%(95D594$?0-N+$]1GD9QV-[X;>"]0\&>$M-\.VPT
MFX33FFC>2PFO6MF+2EC\^ISW-Y(\GWIIYIY'DF9B %( Z;['>;;C]U$56YB\
M[#?,L@9<M"I R"QPNTGIC!P1709[?=?^N_78\F\::!/?V]K!#$97W;U53A]P
MV'DL$&[YMS')R!RN*XFU\!74BL+^XGL#:RJ]K#&;1W",H*3R-Y9&YP 2JX4M
MN^4  #Z#UK3MTMJL:LQ(<9"E=N/+!VLP4\!3@!2QS]WD9IWVGS"[F$,:N'$8
ME#DAB&+.VQ0A;8&.3N"G<P(["@2:DDT[I[/[U^AXG/\ #R>ZDM[M-8N3<,C.
M\DABBD5@SQ(D)@AW!,P#> 6+<D*=U4O^$(U'[5:375V=0GLKAFD,+,3"A4X2
M RK$0)!N:08!#EG)/0^]0Z9>I:H@MH2JH[(^XB0(6902=OEE04<K\^XEB6"M
M@&G%IEXR%8X[;;&6\Q&D97#DYRY"A'!P7X+#.!GY!N!_UY_UU/SR^+.D:B_Q
M!U&."[U2V232M%C4Q%1!]H:WD613^\,BS!73SFV!!T,GF)Y=<#=>!O$6J6RV
M\>MZBC0R>:@FDAD2545E*SGRSL&YP$&"691EE"X/UK\1/#UU<^,M5E2VMPKV
M>F"4[VWB=;8*P"",Y9@R@,' D^Z5R@%6]$\-7:QA533F$;8D<2KYCL#"71R%
M9E">=;LT;",LGW22L@5&OM96BE9*,4G[L6Y6=[W:NM-&OGU/BO3O!OC"+6+B
MP36;](_L 5YD6!8XE'E7#*H$>?W<T$2*-V[8JMG!Q6S8Z-X\ET6>P75M>L;4
M:E?K)<Z<8-/O)B!"9/-N5MVD96#*BC*GAG#%N!]LZ1X:;_A);E8[. O);IYH
M!S#AH2 SLBD,74'Y6)8<$J%8%NWT#PA&]G>F>U4@W]_PT>1F18T(&Y0<NA51
MO4(-A(;#@T6;LMVW^.R7STW_  !56TE-<]I*2LU"S6RLDT]==;WV]/R6O_V>
M+"_EU2]FM_$4^IS6LTTMY<:G)?W5P9(I)MLTES;OYP)4,4=2F[D)DUS6@_LZ
M6L^EVLEP-:<NH3#V^F;<^6&!=!:$R*"2<-D?*!B/[P_:!O ,!M[MK>SLHX_[
M*E>59(PNU?L1#-N1&#;=N0 _<@<-BJVA> #)HMB8[.P"NF TSKO"JJ,25QD
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MV^AM=1IJTK)0C:5FULK.V_FDUK]S?=$6DMU;(LJR81FQ:.I)Q#,X!F9A%B5
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M=@#AC"A7"@C&=V"5#!D) (X8^<:UX.CB_P"$>=7E<R:_9(4P' WV%^Y*?=7
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MX+J42.*[OO%-I%$B H(K?PK9P$I\[&-(U@20;BV595+94N7_ +(/A_[1\/\
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M>V075Q$'+RQQP6\LR 2N9&WR*K-C>9, 'C*J,(,5]#VFF1);3J[,P.CE5&<
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M@G6I+]Y7>>0/,0+XK, 5W$";R0!U+@K&H4A1L*C''TU:Z)&;ZX8A'!6*-3N
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MLPW+VIEDDL9_-@=MJK6C>?LTS74-Q%JGCKQC?PQ:C>0-')KER8RGE^0PE*2
MONA9H95=69UR,D%<?-OC;]F:S^&4?Q?^)D7B+Q/XU32/"%[XA\/^#=1U#Q3J
MFFZ8+25'M-&MM+M=5D%SI=A"S?9K:SL[;[!;>:L*QV=L(D.QIIKK9VT5F[ZJ
MZO\ 9TUN]-+=3ZLEN/LBF2_\4:180J'9Y;V\ACC102"\RY8X^6-3CE@PVKM
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M&(+<NFV5'>PNV2[=06$4D)4KE *[.3]JCXJZA$LUE^SUJ"3SDR,=6O[PLKR
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MW2:M?@N!@F=5RHR5.549&&Z= <XQDUV>EVRF,@A-I9#D*%1LB(L@4'W4EO\
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M0Q>'KB8Q2>:L7 4_> *EN!\JEL?*=H!YRK#*UF?MQZEX2_8F_9*\<?$/X*?
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M-;I6NU?][?BQH::?J]M,-)N_.@N+6X1%ME3;LNX"&P1_J\,=Y7*1G"J5R*]
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M$DB9V V")RS[(W!(KDO$OPYTW0_ 'A[P5HW_  4Y_:2D^''@N34KK3+3P)X
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M)8V6-!&#\MZQX0T/0-3FU72X)))HY$4QW5L'CVNDA41 Q9\M<21.S[QO9=C
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M\Q^ZJ'/ _O$8 QP.3U8D[JXRP\R$.?+F6)F54:8>4@W! C*T@4,[2?*B;@S
MD*"P"GK+6*Y*,!;N<,3EDD3.<C &#R"IR,Y (SUK36VW;6S7Z=?T]3GC5E&R
MW25DNWW)O2W^9M7>IV6GW(MKVXAM;J]<K;0SLH:1A,4VQJN5?YR!N# *BM*^
M(E9Q@WOCCP]:B</JMDL]L)/.'E7)FBV%4=W5;9YO*!*Q_:0C6V[]WY_FJT:_
MFKK_ .UI^UQ$X<^'?V=4MUGVI-'J&E[Y7=W14_Y*!<OM=HG&R%96< 2K'Y8W
MURH_:S_:^U2VM[O3=+_9TN+&Y0S6T^GWOA*]M)UMG>UN'M+P?$*1+MH;JVGM
MKORIF^RZA!=Z>YAGM)X(?4A-RLG"<6[V7)4:2OIJH-:JW0U=.5I-34V^6^L$
MI6VUNK65W96UZW/T6U/Q_H]PVZQO8[J2],UI% D-_ UP\)_>D+<VEOB-3E3+
M*4@.2$E+;L2? [3?%\7Q(\8^(]9OM(7X;1^#]-TO1KBY\47]SXJF\>:AJU]J
M'B'2[KPH=!73++PII&A1: ^@^(+;Q%<:A>ZC?ZSIUSI<-KI]M<S_ )%>,OVB
M_P#@J;J^KZ-+\,OV<_AO\3_"5Y>76E^)/$7A#P7#XHL/"UY:K#,L6M:GI/Q$
M:.UFELYC)';LLTOF?.D)A;<WZ3?L6>(_CUXI^&WCJY_:$\(:?X+\91_$:6UT
M#1]+\.W7AI&\+1>%-#;[9=V]U?Z@]U<RZZVJ6ZW<<R1"*V2V"-+#)(27+%QG
M)-.#O%N,DT]U[K47O_-&WJ='M)1A4C"49*I&$9Q3A)-1G&:UY9.+4HIWC*+?
MO1;<6XGZ!6&LZ*MW&IU.T4E)#@L_*E&QG$1(Q_WT<<@X.+DVI:$T5RS:C;><
M)8]I/G [=RC _=L#QMWJ .,D]#7FENJVTJLV8OE8EB6/.T+GDG^-@.G(Y ')
MJ:3+&0-<D2O(N(QE59,)O9<G("H&)/&W SUJZ>(JS3;T3?NOW7?>^EDU9KLK
M^9@Z:G[\XI-WYE>^VB>EM$E>UNMSU)+K0) I^UVC$J",2.JL,#!Y"@8X&T@/
M\S< @922?0O*DV7=J?W3/D^80R*WS<%2%XY /4C"D[@*\^'DH0)+MT:/!!8,
M?F&?F;G:I(!Z@C!&"."7%XMC*EXTA6,E802JOC<P#."=F<%2<\ <CCG7VM1:
M\S^Y?K$S]E%RY5.[[6O;3KT_STM?4ZS4M5T?3=.CN089Y9)'C@""612P"R*9
M=@^1""5&XIDX&1NYIZ7XETN>*Y>[LY3<VMO/=1Q6MAJ-S',;>WEN%MV,$-QY
M?FF+8KW+Q1EV&YA&K,F9';6ES:^5=3,\,C-^[=,8'\6S/. ,$D8P0N#DC-ZT
ML[33;>=8[EH0UI<K,4_UKH]O-&VUBP\PB.0X#':6')V@TG6J+5RV_NI[:ZZ;
M-)I^3\S1TH\J7+>6EWS.-]]=':ZW\]CX5\#_ !1\):Q\,]&\46LUS=>(OB0D
M_B76]8:PU$O=77B/5KB72[.2_P#L6Q;#2K*2TMXX6G^S+.EQ,ZI-,T:_=]A=
MQ7FK:>EJ)L6MI''^_M[BT'FF+:R(MY';R,I8%A(JM'_!OW BOY7/AYJ^O^&?
M&GAGP5:>,]=U'0?!/Q6O/!5HDUW/:6VK:+X+^(M_X=MI+W1XKBXM+9=1M=.2
M\O;& 2Q6LLTD,,L@57;^KH.C:IILP,;%;.,R%64@8C!95/7:/E 4'.T*>12J
MXI8F;J6Y962:OI9)**BFTTDE9+HM.B*IT^2^M[VZ6V(K&W5[O4?E4[1">1EQ
MD9&YF*KN4' V$C: !ELXW[:SA>.,^4JEOFD8\DY^52%S@_+@G!(XP0&*FL6V
M1?M&H,)1L)@"JN[]XQ10$) /+?>&TX"X)!&:V(FB"Q@WHC8#'EY)V-QE>6R<
M'D@COG Q2C)Q=TVM&M+/??1W6J>NET*=*,G?X7>[\]5YJWY_@<[8W-C:_;8[
MN&Y6=+B41-%8W]\C(R@KAK&WN8XOG'$<QC< EMH7&[R?Q!\%/@%KESJ'B/6_
MA-X>UG7=1U635]3U&]T#7(Y[[49XRDE]+=SBVLTNG)4ER\?3"C+@'VZP:U4W
M"1WX5I;AVD!R"2JC))!!PJ@X)S\N[MNI[W5H\2QR7\,D,CO&R.^47"R NP8L
M#P/FWX"A@QQ@"AMM*+VBK).]TM^U_P /PL0Y155MVC:]W=N[:2NU?2W;2V_<
MX7X>Z-X;\.64'A+PWX6TWP_HL1OKNRT[25>"PMY;AS<WJF.>XE<23R$2$!MH
M.\#8"!7?1V$7D71,8#K<0*N"#MS,A902PYR2F<H#][(!!JM9QZ+9R,]C?6\<
MA*$N) 60$D*J[LX4DX8@G=\H([4JZA:8R;Z%78HR1"0_OF+ KWY;."."6.58
MXQ5QJ3C#E5]+6=MDNEK==>M_TB;IRDN5Q;DU>2:?5+9R:::?9:1OL3WT;^99
M-@,-NX@LHP1L) RWS!<L.I/;%,NH%DF(9!(Z0C<IX#,B*#G. QS@ KN'.<X.
M:CGN_,=&4J(QD1DL2I)"NP5L9'R[<$95N<'@$OFGAF7S&F6-WAC,A!RXD*#<
MH YX?"M@8Z\$YJ'.5I)N_,TWLKM*U]KO3LTNMC=4U[G51C9='NVGH[+>UDG_
M )>1?&FTTW_A6.LOJ=G97&GLL(O8;VWM[NS$&Z[D=I;>82H_[I@=R1N\;M^Z
M82(I'QM\++!5^'/A 76Z61-*D"/)O$GV<7US]AC97^=@MJZ<@, $ SD<_1?[
M6%_!:? W6#+KUCHL>H:_X7T>[U#4+J"RLK*VU36!!<W-S>W4L5M;P_9Y&#SS
MS10Q!&,DB*":^?Y=4T#PCI.CMJ6NZ;::7=6RV>A_V9=)XCDGAL(+94>&U\,#
M6IX;6.([3>W<4%NTDBQ"=YV\H4Z<IT9*$'*7/"5DM;QA)PDDG9N\VG=I*RWO
M98^[[67/HN:5KW6JLUK;H_/7Y.W/^(HHX-3N;B2 N8[6,E00A6&)-L:+N^\I
M  $AQC/S%<YK\P/VM/$'Q*\*?M!_ 7XJ>'-"N/$_@C28M=\*^(=,TGPSIVL7
MO@=KWP#XW;4_&-M<WFKZ==/J'BJ74/"7AVSL81Y$5KHNJ2O=VXU+47L_OCQK
M\9?A%H>LV!\2?$/2]!&M&TT[2QK%CK]C-J=W-=_9H[:QLKC1Q=W+R331PDQ6
M[Q++,()'23>H^+_VUO"_BSXA>&-$TKX,QW^MZB=4N_[8$":EX>AM;5-*CM5,
MVH:SI]E# HNW599$E!AB>XD?9 #(^/L*SBG["I.HDJ<THM.TM9/2T=$T[JVF
MB:>IT<\-&YQ2E9IMV5GUOM8_'BV_X*K?M076JW+[?A9831(I$<7@2[CBCO(M
M/?3[F$I>^(+@3Z?]L<WZ1W"W#B^LK2='2VC>"7MX/VK/VS_B=\+/$'BB;PU!
MJGA36]/\4VND>(/!^C>!;"ZN==L3':3+I^C37DVM;;*<W/VJ06QD)C7[+&03
M,G%>$?V>]5\->+_%7AWXB^!Q;ZGX(UJ73?%,8BL=7M89U=%%W;WED\HUC3IU
MNH9K35M-:XT[4;61;VTN9;<&0?9'@&XTNZ\*:5:>%BEUH6DW-WI&GV.D:+J4
M%GHUPEV89-.O(TL%A:]2:5)+Z>%I4B$]N]S,&8A?<S#)89=E6"S"&98#%O$U
ME2G@:$JJQF%@L.JWM:\)^[&',Y48I2E.51/11NWA3Q*J5JE#V=2+IJ_M&K4Y
M*[^"5DVVO?\ A2491=[NR_++QO=:%H&KQ^))].O=5A7^W]*U>61;S4-&EOTO
MI[O2KO1-3N-)TV^F@NM)GB>!-1TO3]3DFAG$UC"Q,0^T;3QI\<?#7[,O@[X<
M_#GP_P#$/P7X\A\=^-OBE9CX;^)M.DT>/1_$>F>!K?0M'UG3M#V3Z5K$GF75
M[J0\036^AZ-;6UR-4OK6>&:!.3_:E\.WWACX6:KJGAV.71I+;Q=\.WMI[>V!
MF74-3N-:T>':CK+&#?2W6G6RR-&0LZ6^UXYIX_,_27P-\-=3BNFEO;&3^T1H
MNO6[S7$3-))-?Z'=:2JMNR&D%]?K<C<5'G0J92B%F7S:V;XF6!CEZ5)X64U7
M:C2IJI*HHSI\SJM.JE*-27-"+4+N_*F="24X5+)RIRC*#=[<T)PJ1NNW/3@V
MK:I(K?LV?%/4-,^(DWC;XL_LK^-M5^%^G> O!^C>&]$\7>)8O#7BG1OC)X9%
MDGBCQQX6T*V>&%OAWJI@DM],O[BSDAOS M[8W.LAWOKG])A^UIX9O_'UW\2-
M _99>7XH2^'1X>3Q1K?CK$T.DVEFL>G6ES9P:9*L$"21QK=L=/:>XM$95D+L
M&KY+TSX:>-9+=8K6_9K9%14*2L(H(Q_JA%Y:C=MA;@\ A6*N3ACZ=\.?AUXB
MLKJ[O-6U-#',H41QM(3)&P)>0,Q!D7[JL#N7>CB-0I!/@4J5+"4*.'H4X4Z&
M'IQHT:<8I*G2CS<L%O91YFH]8J_+:[.W,,?B<TQV+S'&5)5<9CJ\\3BZTI.4
MJV(J*"J59.6KE+V<.9OWI<J<FWJ>&_L[_%G]J#X#WWQ4T_XFZ#\)/C%X2^*'
MB6;Q-+H^J7$V@P6<UU:36UYHJP6.D[=3T::WEMH'@U"*#4OM&G,S&XM[E!']
M(WG[9FM>*?#\7P[N?V=_A#X0\*MIJ>&K&>\\1>(4T7P39:I'=:5+K7AK1?#>
ME2ZW'-I=E<7%S:KI,<6HJ8UA@1A-,RY/CGX/MK/ESV=^8I(6*D $ <L^X*N"
M5>1F(QAN,@G %>+:C\ ]?M9WO+K6(XML43E62Y8L[^=L#>:VU>>0P(;<P(R"
M<*JZDZ=2%.HZ4IPG&-1*$G3G*$XQJJ,XN,I4W-5(QFG!RIP4XRCS)XP=%<O-
M"SBU?6;4MF[VU2=K635NCOJ?)/A>UMM,\96GPI^$/@CQ?J/P9T[Q9:V]K\7_
M (@_$^T_X67KAN=7-IXL^).L>&[RXO[_ ,)>'];5C+X"^'/A/_B::AJRZ9K/
MQ$U;2E2ZMZ_.3Q9^S1\=O#OB[5[72M>\*>&;#4_&5[>VS>'_ !'XDTK0Q>6=
MQ>VMOJ'V!-"9(9C9.95MIHY9K2"^FMBY1)0?UZO_ (=ZM:7ZK#/%!+"_FFYM
M]WFETG#I(H0#:T>!-N8A<K@G.,>2_'^XA\--IOB'6[:;4T\6^)+VS:]O-7TW
M18='U'^QK_6UNM;OYHI8H%UT:?<VMG]AL95EU22VMI#&KAZ\[*,NEE6*FL/5
MK5L/BL+3^N3Q=6>(Q6*S6&):EF5?$U'S3KXK!U%3K1A"C3C+#T84J5.C3I0A
MW8_,IXZCA*-51E' T987"J$?91I86=2KB%144]>7$UJE1NT5.4W.45-U)U/@
M_P"(_P"U5^U\OQ&\<P>#/B!\3_#?AB+5(=+LM \&WU[>^#[>".PL2]YHMQ=:
M4HLK+4-6:YU"*WD^R?8S,UIY7V2")YO8O >G?MI?$+P+)XT\8?%+5=1TO6K+
M6X=-T+QKJUQ::[;ZA8M-J&B^-+"YTJRDV/)=V(BM(A9WEGJ&DRWB7D!^T1([
M/AQJFAQV'BF=O$OAN*--3U#4GAM?%.F:A'(TO^D)I=K>M%8VNH:K:K&@G@18
M(&!#V\LB@E?I'X=W%]J]SHD<%OJ<=C)JMLDEQ&;58DTZ6]14NH[6Z,9O+:YL
MV=F%JKH(I/+1G9P!^GYMDV69?D63YK@\VGC<;C[O%X%X2="G@K8:5:T*\\+2
MA6DJB]D^2MBN9OVDFK)+Y^CBZE;$XBA.A&G&A9PJ*:;J7E97AS-P]WWTW&SV
M3OH?F8WPN^-NC^.'TQM*T:YC\6+<:C>>,-#9M0T2RAN#/=7>JZC9RO:3Z->/
M=7DZ6.DWG^DW1W1V"S0V\_E^X>%_#GQL\._&VU^*7A?PQ\/8+)M'\!>&]3\.
M7]UXCT^QUJYTGX>:'X;U>_U6.WT*XN%O+Y[4:K>I$=MSJ-S=VT-Y:QPLZ^Q:
MW^SYKMO^U3^SS<W#?VE8Z=X#^(#WFLO;&1+-=&TT6-U!]J$.^"&]?5D2!\1F
MXABE!C+YS^A.D? LW;'4A<RB\E N;@0QIY,1<N^$61''KD%1E=I"QC./D\RS
M#%9EA(X'&UGB<)&#@J%5*4$G&FIQ;:O)2C2I*5V^;EC>VM_4P.)K9=BZ>.P<
MY4,71EST:\)24Z52TTJD;-:I5*D;*UU-JYM_#/X_?M&>$O!/PT^%]D?@?XNL
M? /@W1=%N/$7B/X8S6UWJ]UH>Z2TU6\T^>[EBN=67]SY.J7$+SB1/M=Q?/>2
M22'CY?B-^TU%^TGXF^/"?%[PA_;MYX;\->#9/A[<>%S#X"M=,\/VB&W?3-*M
ME:\^T7%RT]_J5Y/<R0:O+J%T@MXK3RX;;VZS^'=OHB*J3RO)):E)9IER^"6W
MC(11Y:L,F-50$JC+QG-:Y^#FFS:U>WQO+E5GM[67>LP5V;,S2. T99BK,,X/
M.0OS=%\]SDW=R;;[W>_K?_+R,IN+?NJ^K;DV[MMROILM7S:);M=SS_\ : _:
MI_:2\:_#CQ1\,KCQG\(!HGCWP=K7A+4K?1_@Y;:C%I]IK5G+;2-:VMUJD$4<
MUJC^9:3QV\,EG<1"YC4NB)7*?\$[M?\ "'[,WP)\2^&?BE\0K"YUB\^+,%Y9
M:P/!7B+4XDA\1V_AG15TFZDABNHX9IKJ"2SM+N_U"W:/[9"ZP2&W:!NNUSX.
M0W=VL=F9TCDD;S+AG<DR&-\;"$^288Q(,$,A&T8Z^U_!'X,>$])T;5AK>F3:
MHLFJQWCB66^F;RY/L:K)_9]LKQW?E7]O;72,]I<36\UNMRJHT0QM3J4;I8B%
M2=+WFXTIQA4<N1Q@XRG&<5[UN:\9>Y=)<S3252<(25-J,Y*W,V^625G&$XK>
M"DE+3E>EKI'UK?\ Q-^#;W=CITGB?0&U"YN!:Q0K9ZE'//=K]E1K>.(:6I><
MO<VD(@B$C1W%U:0ELW5OYWY9_L-Q:)#^TW_P4?AE@+?9_P!HN.6-3I>IL84N
M;&ZN(2J"Q+^6X9MI9$60N),E&5S^E^F^ ?!^C7JZI:V"74X@6W@DU6_NKI],
MM6N;:ZN#IT%S;Q/93W=S9:<TTJ0PW3BRM8V<+"J5^;?[%4L%E^UO_P %*;3[
M<%;_ (7UH<TCRC:5,VA32!RH)4[V>1S\QV,%')QG!PYJ4U*UVHJ]M$^9.ZOO
MM;5/1]S6C*HW>LXN7+?W6^6TG;3G;:NF_=O9=%<_0_4_$-MIDWVC2]-M6^PW
M$-Q%*]@L,OFQ31M%+'#<"%_DD"E5FC0G;N"D8K\-_&O[*/@3X9ZE8Z+X"\.Z
MSIO@CQ1\"OCY?:S(4U#7Y+?7XM%:\L-,.J.)OLBSVVHF6"*=([."RTQO+F>:
M0JW[DZY;:?<9EE+M.-LB'@;0A5@S,O7H#F0$@!2V"3CX;^/OA_1]2\'^++:_
M2.[@TKP'X_NK!89[FUN=-N!X/U=8Y89;*>W<+&R1?NPS02HJI-%(BD#&E3=.
M5U)-2TDN6W6*B[WO=>6^^YT2:<7S:QM9[_"[=M;>C/YT_#OPP\6ZC:>'?$,N
MB^-/#]SHVJ?#L:?XS:WU[7K'5Q"='A\&IX3M4T?3Y-,AT2QTFV>QADO+BYTR
MPT=EM[41Z7+'%[K\ _A-X7\??LP_MN_$_P 2OJ]UXF^%UYHS^'98=1O([:34
M-=L_%&IZA?:G;17"0:M(][:*[)<VT^UFDG54$\B#]>/V3_"&E^-?@_\ !?1M
M5TZPNK:7X8?"/5XVFLHE@^US_#[0+F#48VV+Y-T6OYYDGES<SW$EU<,7>1I7
M_.+]E+5Y/#O[(G_!3*\A:W8Z9XFT)+:.0S!)&:+XAZ3(F82C&,Q[0A0@EP3D
MKQ7HMRFJBEKRJ\;Z6M*SVM>\7RZZ+=7:N<#W?:[MZ7=OPM^1^D/A#X:^&=:^
M%G_!./Q?K6E7NM'X/?L5Z1XQT'25O-06.^U?P_IO@_6+*+5;>TEB.KV5G++-
M=_V=<B2.7[+$[1R1*_F?7EM^TCH?C2PN'\0ZI-<2:Y87NGZE.UXT5PUIJT4T
M$WDRHVV%U$TCO&5,,D86%T\MW6O#?V;+X?\ "G?V!I[B1@K?L?:?#*K()8'B
MN/#'@IEMXT99I)T= 8V4(SR1.=R;F"GV;QQ^SO\ #CP5G5]6\%ZEIMQJ&DW^
MO'2-/U6]@AMK:.V-Q:P:A#;S7/\ PC"7-Q#!=@S$26]I>--);VPE /+*:C&3
MFFXQ4G*RN^51ES)66[BI)-;/:^PU>ZLKNZLKI7=UI=V2OM=M);O1'YR7WQP\
M+^)O&T6F?&G4O"VJR^$-6:P?6_$?A[4;.&YFFU#4IY]($OAC2X#%8VKL";56
MN])MKS50UE=PRW<$-S^/_P 5SK.N:W^TCXI\&7>E6_PTTKXCRWU]IECJTFDZ
M?JIU/7],AT]]%T34(TN=6M;"[GT2XGMIS!<A([*Z423VB(^_\3-9UZUUJ5;E
M-0T:VNM=\8:E9K/)=6U^8=4U?18Y(S;7%P]U+I^G-!9Q:/?W$2?;8WGNX)KR
M$-(OS=XDTJ[M0FH:G<RKIVOW$^H6BK=?:4NS:71@>2ZA60[;I&(7;(&D:+8Q
M+;$(\+AK 4\)B,5BH5)*.,HP5.A*K.I"*5>==."E+D4VIQYE",'=N]EH>[F]
M;VM.A148WH7YVE&+O[*$-;:2T6K3>M]._K_ACQ3I-O8_![4?$TWA"#P[X9\6
M3M&=/TKP]J7CNVACO1K6HC5;*.TN=6O=*U&UMIM):3Q3%!I;:7<WU@EO=6MP
MYN?8[']I_4O 7QB^-?BRST'4=8TSQMX0U7PYX7TS7M92"P\,)JEK9Z;9>)].
MTJRLM/TVU;6=*6\NH%\/Z59W>@3W\4ZM/+:W9E\#^$WP<G^-0U?P]X)UW6M3
M^(6D:'K?BNV\$6MC86]O?^'?#PMOM=[;^)->U_0] TV9)+ZU6ZAF+7,%D;B\
M.ZTM;PQ\3_P@?B6?7/%^BV.E7M_J/PRT?Q!X@^(D&FZAX;\06OA;P_H=QI^F
M^(-<DU;0KZ70]6TG3M0U33K:XU#PSJ&N07#WD+6CW*),\/U%*%!2K1ASV<WS
MJ49J-YS<G*#M>:<]Y1O&ZM;2QYF(IU(PPTZKP]JU-.G[/$4:DHQ3A",*T*=2
M<L/4U@^6KRS:?,^57M]6^$/CQ!XHT;X(?"[[)XFCU#P]\:=<\07/B*Z\3&_7
M6- U_P .JH\/:ZKVZZAK[V.IV<^HZ?)<K9:99K,K6\*7K215]ERM!;ZFZ21G
MRWME=E2*:9@X\P9V0+))MQ@>9&NP <E$R:_/;PU\+%\,>*?AAXZT/QIX=^(W
MA&]^)EKX7?7_  ;I'C6#1=)\01Z<UZVDZMJ'B;PWHEO%J#Q7=NJVMI-<21O.
M@FCC#Q&3] XS&=19A,K+Y"E)49@9"3)EHB6#%9%;<!D$@@L0>*K"U,/6C*>'
M?,N9PG935I1E:4)1J1C*$HR:O&48R7-"ZUC?DS#"U\'5C0Q$%3JQCS<L:M&J
MG";YH257#UL12FGRM7C6FM&G9IQ7F_[,O[1OP/\ V<_VCOBMXL^,NJ^*=!\/
MWGB[XOZ/;7WA[X>>+O&+MJ.JZ7\.)K2T\K2[18=S&QO)KT&62\L86M)9(UM;
MRVFD^_--_P""I/[(]E=1B#XZVNIZ8)V73_"LO[)_QS\*:FXNIRD,,GB33K[Q
M5:W%S#$Y@NG700E_(\<D(:0O"OR#<>$_!-_<RW6H:!H-]>W'FS7ES=:/8SW,
M\K@>;+<7+PF:=S&D08NQ9PH^8YYY5/ 7PTO;O5M,G^'^@6UYHU]8VEY:7>C:
M/,98=5T73?$&GW\ LKFY4V>H:)K5A?6ZRF"ZC$CPW5M!/;RH?:PN?XS QI8"
MAB*=.+G5KTZ+NI56XIU6WS6G"$)IM0LX\\)2;=F?,8SAK(\VQ.)QN/P4\14J
MTL-2Q$G.4H*%%2I4/9QYH^QJ.+E%U*;4Y7W239XQ^S;K]K-HGQ3FL(&,5S\6
M]:OX8WAN+)8+?4K"VN8M]O?K;W44LEOM_<SQK/ $2.=(G+*?I:ZEBN]+N)40
M -;F)X@L@4[P%DV$;D8L%)+ LI+ *64.13T[PIX2T*":VT33-+T*VFE$TUOI
M-G%9PS7"HL*3SI"$665;=(X8V.=D*B-0%)J>^2-;2X6*4_9]DJR*/EX.V,[B
M.$RI=X_XB"P)5<FO+FZ:<N>UZB][=\VO-TTT<M?.V^Y[ZA>2E!M1V5TKQ48J
M"W^)I1BKVN]7IK?SYO#^A265@\6DP1XTN"0_QC!M45V8QC:'D/RH'SASA\#-
M>=>*8](T72K+49+2U6TTCQW\)M6U"!E=+:?3-*^*7A"_U-+QX@LBP/86MQ!-
MY;)*8I':!S)L)[+X2:JUU964U_<)J,=[=7NG$W8#$ W3160@."%6WFB@'[M5
M!@CF0 ER#Z\^G:<R307>FV,]K+M6[MKNVMY+9T256,4L<D;@L& &2 4<"5<%
M0PQ]N^D%OW>RT72^VFANDTM9.3[O?Y[[6MN?I'#^T1^SAXDU)S%\-O!S1R7U
MU)*1JWBN%+J%9VD5)(3J5W&R8D#N L<RMM0A)00OEGQ]^(?P'NO">DMX7^'&
MAQ:C9:_/>3-8>)O$LD=QI\GAGQ#:36$\;WZA+6>[NK1&$;Q22A/LF]H;B3?\
M4>"/V0OBC?:'HVO^'?%_@IM(U 7$NGC5-?U2#4+6TANI[<0ZG%'I<L27T:6X
M6[6*4^8[">-R9"M6_B'^SW\3_ FDVNK>)O$W@B'2);Y;*6\7Q7]GMK4_9;J^
MDU/4+F[TZ&*UTZPL+6YOKJZ=MUO!%A8YW=%;!63NU=:MIMJ^^ETK[OY@]CX-
M^#/_  CV@7>DF8:)87,<FFDQ316^G[[4Z3?"ZO9TD2&!+==2$$D[S[8A+( ^
MUL"OWB^#MS^S]HWPH^%F@>&?!'ALWNC^&-"6^NK@PZM>>(=3EM(KCQ!K.K:B
M\0FN-5UC6I+Z]NPUPR;W1(8HXD1:_F=^(7B32_$^NZ;XEL;G4;C3[K3+>W6;
M4--NK$33VEY+%=)!]I1$NTMYI%@N)86D$$Z&"Z\NY62,?2GPX_:Y@\*VUIIV
MLZ9?K8V6R"*XL[@2_+$-JN2H6:+S!N)6,.0I ^X,G:4)2C"T$K*6BDFDFU;5
MM.[^>_<N<N>3=K7TLO))?I<_IP;]H?X.>#)WT&/X,WVM16EKX?&L>(?#7C/]
MD/PGHND:AXCCNY;;3M5TOXS_ +1OPD\=+J=CIMK%JRR6OA"_L-:M+UXO#=]J
MU_I^I6\'U[HL_P (Y/#@E34M)N"TY\LGPQ>*FQX+=XT#-*MM* I \V&5K=CN
M>*>= DDG\R_A#]L;X.>//$&A>"9]+O/$'B#Q)JT.C:7!-X>\S2=1U&__ +-M
M[,W-Y=M;)N+6-G%%<ZA;G[)#$/+$$<C^=^D6CZ[\3[71VBN-%F41N4\IM<T)
MH8A;E46)'BU$[_+3&SY/GB0N=V,U-65)1IPC1=*K&+]K+VCFJC:3C)0=U#35
MI/7T3ODHVE*5WJHJW:R:_'T^9^QND>+/A[ITDZ0Z?:1+&(T6_M+6 22N0H$T
M=G.\8C.S(9%F)0A6:0!@R]Q=_$SP/8_V#<PWN3;Z]822@PQPJZ?8[]AC9<RO
MO9U223;'(V(=F0SBOQP7QKXZM;0S3Z5,X2,[/LFI:?>2HPV1D):K-%,S,620
MB-I2R L-@ +>:>.?VE_#?@"31(_'?C*W\+RWM]YUO;Z[;SV<DHM[.]DEF@B;
M9,\4,5O<3&7RWAF2&8VTDOEOLQ]HX-.+U7^5^SN664^(^@-\1?B%>VSRQL_Q
M1\87MM)<6U];HT,OBR_OO.$<UO'(R -B8.&CAB.6D+!0WH^M^-+&;3H1'I=[
M$7D5$N3INL+%*%.%@$QLAC!P)')/[X*I(;*GY1\(.FK75]K,.M22V^J:YJ%_
M;20LK&6'5;M[RVN5=3M:*2"=94W-(/+7/W037B?[1?[2/CCX->+[GP]H>D>!
MK[1X?#FC>)?[;\3Z9\1KZZN=0O6O/M6F&;P;J\%I%#;M;0)%YME/<9N_-E<Q
M1,U?%QP]3%XFK3I<CFY59^_+ENE)RD[J+2UFNFG31.W#"$JDG""N[2:NTE:-
M]6WHO*^I^DMEXEM?M5LZ6%Y,B1V]K)#=V^J6P,;P"7S)6,,6XNS%Y8[=W",S
M$'))KL?'.HQ3^&HIVT&>VDL8]S&2/5I(E-T$\N*))G99(E"^9%<0M)YBR OL
M8**_"O1?^"F_Q'M]&N]6G^'/PC:_M%=8])NK#XK7MEM0)#&P\06'CJ.TTLS3
MI<1!M6AA5(XT$9F\P.GZW>$OB?JGQ@_9L^#OQ'UA-%T'4/B!X.B\3ZAHGAJ#
MQ')I=AJ-]<.GV73[G5KG4+RYL8XK>%+*1[J[:8K)/'-)#/!G>O@JV!A)XB,9
M1G.$$HU$U*23FE)Q49+W5S)W<=+-IZ"]E*$>9IVNE?3=IM=>R?S[G ZEJ-RM
MHHC6.%YG>5YC [L5<SH(UR#LWQH O#OM(7(88'+VE^Z&-E-N!',KN\EE;M*N
MU7RRS7:!DB#$ PI]ULG<N0#!J[W,44CO=SLR"0-&\)B'DSB18@X.X@X+*H(3
MRRNT@.A5:6FN["!@J2I*FSS(XUX:$.^(7D*Y<!BV&4Y,?SX"L5\X1X7XONG>
M[U.X></(T[RYQ$BN?.9WE#1+M')QNSB1F*_,PP?(KG4HX)W<RE5EC;!#G!D8
MDG<W0X<+@$G)Q@  5UOC:XN9+B_7S"$>ZN"GD^2N5#G]W(4N9E1D3+Q*GRN5
M7/4FO#]:E>,,@GN51/F.(U3!*%@=P&T.P&W!VDC()R #T49U)5%&4FUKI:.V
MGDMFV]6]NNP'=Z;XWT?0M?\ "VLZ]J3Z;I>DS+J%_J"V.JZR;2W@%Q%YKZ7H
MMGJ>K79+R1(D-GIUW,S$-Y+HLNRG%\1?!_Q!/B+4/#6OQ:XEHH@O96T?Q/I$
MJ74NTK$(=?T/1YG5H\D&.#:&"@E'.T_*7Q%O'D\.:[%)-/*'\/WI==Z,N3(<
M[PV[YHP X'(&<;<C)S_V:;HKHOCB*.61A+J&D%0$6,[?L]SAO(5F$<7RG(4L
M 5&#M)KZ*AAX?5:U5RDY491C%+E46I1NW):N_O65GI:[NW9;."5+F;O)\MO[
MJYFK>=]]N_8_2+X5:O/INB_8;:V B;5=0NUD=R^9/L\!$SQM*A1D$:')50J#
MY@"2:^M/ %U]MTZ^D)47$DD\JP"50J0SW4K,&F9Q;D6Z(IC::9&"H%#@FOAO
MP%<3W-O9?999X2K217*S+L5_,B(GE$B'#?(3\APR@ $$$ _97PW:9=/NK==Z
M%$"# =XW =CY;,(V5HB6(:,2-)C:0KG:*^=Q;3KS223O%M[W<HQU:>UEI9:=
M=&8]6?7G@;1VN887\V%8H((=GFV=]=-*DD;&=X(;*Z RR%9HQ*08V4QRSI@%
M^'\;W5Q&EPT1-LUH1]HFNK&]MY!-YDTZW"PQG5+F8/9J/(8.%4^5 6#[B)D^
M,FE?"3X6^,OB/K6G:CJFG> /#IU>_P!*TBYLX]<O["S>UM&ATXZE?:78"XQ<
M(T:WUW:H\<4DEQ)$ K'\\?'_ /P4N^%UOI]W=S>"_%&I)J1CA-KI/CWX8Z_<
M0S+).T0OK'1?%E_J"/Y<(666&T?3UN$$<M]OF@$G51R^M63GATY>S<H3DK:M
MIW5I2T;C=>ZWW33U*C"4DW%-V:6F^NNWY]CZ^T^]?^TB4>XB:2)+FWEDEF4Q
MI,JO( 7Q(D.YD2-O+7Y55.H)'H6F6U_=36*6\@F?S_-A\PS"%%8AR2[Q_,PD
MWX:+S7&\E$;#8_*#Q!^WU\/M*LK;6++1SKYO4L"-'TCQIH<^O6(O;);]AJ5D
MEE-+9R6:D6FHHZJ+6^$EO&9U7?7ZD_#O43KJ>$M5M(;JW34-'L=7%JUU%)=P
M1:G:072(4MV8326RDC*0;7"S,"9'PN&+P=;"M.K2]G"<FJ=Y)\W*HMV2E)KX
MOM6>OS"4)0MS*UW9:IZVOT\CNM=T;6X-+N[V_M;>&)+>XS-;7FG,XE\TB.XD
M;SHYR9(C%%'E'F#,T4T=J(917S1K&IVEO=6#R&-5D?[.98Y5=&\P;M[A#QY$
MWS.'4*S%7C+)OQ]5^+=3N)M$OIY+F>9!%-;M$K0"*,VQ#!W01"0%IC$))'=G
M>0X^1G /PS?V%[<3V]O/=$%@%++N\PB$B50L> J8*,@&=TA<DD@&N0D]FMKZ
M&*TMF,K+LG(>-6C#@C:'&YW6+R\L907;Y5 "ECRO=3:M$FFZC(KM.HN;&4J&
MC='0E(T+ ,<L%<#EP-N%50SH#XXEM/Y:2M*P"-$IW1GRI" .FTLY<[=C$ XY
M)Q@D== LB^'-1FVO%NFTY & PDSW,$)!W%"5029:7.%QD#<<4X\NO->W+*V_
MQ6?+MY_+[A/_ #_+0ADO[B2]%PJ;$DW2D[TXRA8*%1WRH5L-M##^)?E(KP7Q
MY\)?$7Q,TU]4TOXE^+_ EEI5K>17VE>&=4>VM==>=X)EEO8@7_TB !XHI@AQ
M&[K\Z,IKJ_[>U*:Y#6,T; 331LL2P8Q#F-"HEP6#1 MM4I(RX<)SQUVC7TB^
M%]?59%*F.XF8+G<US<.3,H##CYBI3YLA <XR,]F5RE'&Q?\ <JOHM'"S^])+
M[PP\[5+M_$FMMW)KLM-?D=_^PC\.M7D_9;_:6^%>G>-/$NF:K?ZYK"6/C2*[
M(\3Z.WB!].O;;4;:\7YDN@MK.B2O'"YMXHFE179,WX_V&?&EU"D6L_M0_M"7
MK'(<#Q[>0Q ;1E8C#/"JQR'=EY")1D_< 4GI/V#M7C@\/_'R&>[B0-JOA^8-
MG@G[!)$220-X!B.WTQ*",E"WV[!,[Q[UF>7;'Y@;[J\L?GSG 7:5V< $$X'4
M#WW6J.5XR<?>C:*E%65TTK\J;3TUE;=W:L>CIV5^]E?Y/=+NKV?R/A.V_8-U
M/S89+/\ :,^/D-X)P?-F^(NL:@@MC$T<VZWOIKG3DF>)BD$Q62>TGV74:02Q
MK-'KP?L"^(55A!^TY^T'&FXX$GQ,\09(R<',CW19O[[AE5R=P7!X^Y;2_FWH
MRRPJ"N\!RR%SP@?#8 *@$@8(;!8]JZBVU&9@R^?;E%*A3(<#)7+[?D8D ]SQ
MT()SQUSG6E!6;YM'*+ES);WLY73=VE>S]5U#\0O$OQ!\.R(?#_C'Q'HCV]U!
M'=2:+KL&E,DUK"S>5(;=-/54M]XPJ!XDF )=73#5!H_Q&T'3=*L=%\+>(_#V
MF:+!)-I>C:%H>BZ'IVE64UK/LN;"QTZPT**RM7M[F9OM,#)$8[R6=I]MR;@U
MQ/B#1O"^L02PW6E:=<7$[_:4U);2W-\MU$ZLK^?*H9O-*E)8F;RYHBT+*(W
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M+%V3!8DD8("@!B%&_(&=7P?J?CCQ=X\L=+N-5UBWT^YGA:9XYYHA"2R8& S
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M"I2;2LGJM'*%[IKIS.7>VFKTM<V]K)*Z;3LH\O2*C9\][;NS33TLV[Z'<_\
M!+37O'.I_&[5?#?B34?"MWI_@GX%_#R!-)L-2N[K6=*L]1T?P!JOA0W\<]C%
M;7,MWX?U+3[ZY%E>W2Z5<:A+874=I<)<6D7SM^S49+C]E#_@J-;1LF!XA\'
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MD_\ "X]7GN;N(_V:FBQZ=IFJ6TD+&>6;2SX2TBQU2Z$BB19G:5K2)97N+AD
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MCI,;V[VLBB6"X@E<PO#*B.65HRJ  5_HZWHO(]1<I+#NB$Q0^5E3Y6\*"OF
MMYDB'D\!F!&">>BM%*2:7Q*[\WIJ_N_"YG_7Y7-RSDQ+>LIPTB1[>Q^?<"%;
MDDC#%!MY4;CC(%6)=,CN;!8O-FDE$?F1[[IX@'7<0K,H8JI! (7GC(XSG(TW
M#L\TCR"1;>WRH!\M6VDD*"2&'F9RQ+'C;G K<MUA?:6\T$XDQ')P?E&<AEX
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MU.Z^)UW9:9K=MXLOK36UL+W^SK33XO#U]HO]FLJ6R7S""\8QW4?Z ?\ !/\
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MNLW^N:GJNJWC7VO:[JGB'4-7U?Q#?RI$QN=3O[U?M%U=E@'^US22W$A;)<L
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M,4NV623<VX;741@#[A.RL]+?KY'\?'@?BU%M[6X3RXQ-;RN\I 0M)%)AG =
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M&JEXX%E<M+AW=964R$^8#O569@I616& 0FTLW@XVT<1.VGPR22ZR7O=^JO\
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MMT^\Z-9]NE.J[<JDF&+!@7+%"0A8$D#:<YRO!^;D5F7%[N\#^+S('#+IT#(
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MQ'>1^)O#6M7<#7-ZYN-9TK3]9LM-AU%%:/[9+:0SVK>6L<$EU,;G4;GZ<L&
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M[%16R5]N8TO]OSX2ZFHT[6+SQAX(U!66"\MO%?AO5K>.W/EF7R9)-*GN6M9
M4CA0NRQ^8QDS- K3'X^MOC;X L_VG/C=\0]4\5Z>_AWQ)X7\')H.I1I+/::M
MJ=A-]GDA\Z9K*.)A+-8VSRW]UIUK ]S^]O(41U;QGPIXBMOC_P#M)6-Y\8]N
ME7FLZ-)9WB67A_1M"LY-2T&UBM]+,&G:Y9:O9B V\"[KEK/[3.UUYJ2RLR@O
M_8ZM_!D7QW2\\8ZWX+TS2_"EOXFN].TGXAK*WA;QI=7&F>+?"VFZ%>P66I:/
M/=2:3?:MI'CO3HHKNWC_ +8\)Z5NB9':.NIRA1IS<DYR<.;DBFG)/E:AS?"F
MWHI2LD]9.,4V<5*$:E2-.4U34I)<_)4J**:D[N%)2J322O:G&4VVE&+>AYCH
M?Q=NO"%S\6)1I>C:JOQ(\.:_X5N)=6:2U@M[77&N[?4=1NUMKQY;NYGM+FXO
M52&]^RMK:VM[(T]I;B(_1=S\2?VB_'_@'Q=<ZW\(-2\4>"K7P1#)XJ\0>$_"
MWQ \/S^'?"][8+IY\1:QK^MV?C'0[BRU.%EN6U6719-.=I5F:62"397FW[*?
MAC1_$/[0UO9>*/#=EJWAG6F\=:,MGJMOX4NM.^V75^D$%M967CS2?$OAK4]2
M@MA<6WAG2]7M&6_U.32X+C4;6W>ZO5^[OVT_VQ_CYX4\/0_ &:\UB[T[_A#=
M"T&R\4>(?!/PJ\)^*?!VD>$WTNP3X>>#]1^%NOZUI(\.VFFV.FZ/XAT,R:;X
M>N;-K;38=!%A;;VQKSJ>VI4Z&'Y[J$IN4X4X1IN.D>=IIRC>\E#WW&,G'FO&
M_;A:.$E2K5L9BJ=/EAR8>DE5J8B515$FY4(.%2G25/F<)U&Z<ZEJ4E3E&<X_
MGIX*^*GQ=B\#:SX M?B*LGPT\6^+='U+Q+X3U/7=$U>;6)[?Q'H*-?#^T4'B
M.>]7^QM-B=K2\M;B>VTN.W@B@M4>"L+XY1?9OBA\0[:,)&(_$4,G[M&1.=+T
MR58RCL[DJDBQR.TF]WC+'YF<#E+/Q9J=L=<OBWAW61JFBSZ);S7N@7$)T>.]
MDT[55U'PVC:991Z5KNDW5DMC;WQ*H'BNDLOMFG7$-]-SNN:OJ.N2WFJZO?W6
MJZG>2QR:CJ%\Y>\O)HX8H%,SD RN(8H8F.!M$8)X/+>$J+,J&+C."H4\%B<-
M.DE*\JM7%X*O"HM.7D4,+4BVW[6]2"2M[2W/&M%82KA^6TIUZ=:,[+54Z52#
MA)+5-RJQ=[RBO9MKXE?Z+^(/Q6TCQ-\)OV0/"<7A3QYH6H?!GPCXNT'7O$OB
M.PTJ#PEXYMM5URRU"SO_ (:7>G7,VHWMA81P/!K":]':30ZH\\=I&UL/M$OH
M'["&MOIW[19A@DL#;:_X3\4Z9ON9%M]QEN++5+**W1G/F74DEH8%MP[22B:4
M1DM$JGXWU?7;.[TGPEIME+XP(T73+Q=5LM=UF#4] AUNZO9=U_X+T>*W@;P[
MIUSH\>EVFHV=S<7DUSJ-C+>*]O%)%"]KP-J^DV'B;1[G51XAM2FO^$WM=8\/
M7]IIFLZ#Y'B739=1U&RN[Q9([>X33!=FRN3'BWO%\V;,*@-M.C%0J-N[E3=.
M6]G%S4FK+S<K]7S/5)6,E.W)[J:A)S6Z=Y635[WM9*VFEK[WO]7>$[S2K#X.
M^*X/$.GRZMHVE_M?64FIZ9 \L!N;.[^'GQ3<P0-%-:D3[=+:=0]Q&0('EA8;
M?)G\B^*4EO\ \))?2Z6D-EITFLW4NG6TR-%+;6/E0SVUK(@>15=8-J_ZR1C*
M,%F.YJZ6YL]1M/ 'Q1U6]U_6;N&R_:(T7PW%I0BTRRTG6"G@OXM:M;>/-6L+
M6S@:Y\2KI^D16-KK%F8;5M,\2ZVE_!<7-[;R6OG/Q+$DVN2LRD9FM'0J Q1)
M+6'+C'4J0'4C:6^]R#MK%[O1;]&^R]%VZ:W\E;HISO!SF]I2N[;:I)*V]DUT
MN_O/T5_8SDF'P;UJ!ISAOB1KOEB%I%8DV^E(%4,<,3N=L!<$CDD 5]8ZK-G3
M-3@9D03Z%J]J5BC:1BLVE7=LRLQ8IM9G)4;3A#P.-U?F!\ _VA?!WP@^'&HZ
M!X@T3QSK6HWGC34M0LU\/Z3I[::8KNUB6('6=5U;3[1;U9[=%ELRCS1VS>:G
MF;"C?6,GC?\ :*\:^&]'\4>$OV>],\*>"_%VAR:AH?C+XF_$W3+6QO-+O-.O
MMVH6]GH%M<Z@BVZ0?:(H;BQ,\MOB-HW642IS5L1AJ-6C&MB<-1EB:ZH8:%?$
M4*,\164(U)4,/"I5A.O65*+J.C1C4JJG'VCI<MFX^K8F<:U6&'K5*=&G[>M4
MITJE2%*C*?(JM64*<HTZ?.U!SJ.,.9VYVT^7YO\ V3/#EKX^_9<^('@2[G-L
M/$6KSV<5W]JU&R:UO;GP;HD5C=S2Z7-'>3VT$D9FN;)5FAN #!/;W$3-"_L7
MB2QU23X]_%2_2R$R:I^RY_9&ER@22R33V%Y<6K6B;BUP\\=O-90;I6+R121,
MS,S,:\T_8;_Y)5XCA@CD2WB\9:<UM"R.MV$F\-V2Q9R%;<XB175<$2*R]>!V
M>NZSJ]O\?OB4A*E-&_9S;5+:U-E;17,MRVHW)F!DMX;:]GA-Q: >5<7+-;11
M$VC6TCO*>F6E2IUBYM679N-Y)ZK6-UIHT^C9A=V2OHKV7F]^GDO^ >7^ K/5
MA^Q%\3=)%L6U"W\1_%2!K%K66XN4GMD\&27%JMG&1)'+"$9W*,/+42,_".6U
M_P!M*6Z_X5=X(FE:,F+QWILG^K54\]? >JX#LI^3>W41;T"-T&!63\*M>NX/
MV/?BKXJ$4DEZFO?%F_> RS6]NTNI:5X,=;=;@-<W422S7=Q'')*\\C1@1-*[
M,9*T?VP&$OP,^&>HJ))+6]\3>'I[9F"&1DU#X=:NT,F%/S;V$AE8DLK!0Q 5
M!5Q2]K=/3VLE9;6Y;QMK?31:7VWOHD4_V==9U/X8>,;OX2Z[=I)I?C[0/#WC
M_P "WTD,D*SWNJ:)'=WEM;*9941KR#[9I]XBF0/J_AUF!B%Q HZ#]M>XGF^$
M.A([(T0^)FDNP16R^?"/C- 68CY@A)"@ \8+'<!FE\6OA[J6I_L\_"+XL>%V
MNT\9?"?PQX6\26AB2/[2WAJ>"PEUFW 2%FG_ +/NTM]<A9WC\FUCU<%G-P O
M.?M->*M.\;_LZ> /%NGL#;Z_XZT"[DB3;(ME=IX2\:Q:G8!Q]YK*_66-E!9H
MPJE699,DIN]2%OYGTWTEIJM/GVT ^L?"FKAO"'A EF#'P?X9$2[G(1AHMF A
M(X,;D!0<_/C&T'YA\P>+)U^.WQHTOX=2'[3\.OAFG]M^-3#(PCUG52Q6;2WG
M4X19,6VA1!"=L+Z[*I9YBT79>,/B%!\-/@MX<UNV>#_A(+_P9X8TCPM8R21[
MY]:O=,L(FOS 8Y99K;0+-KG6Y5$#K-):6MFQB%V9X;7P%^'Q\!^";:.^1G\3
M^*#%XA\42W9'VU[J]V26UG<3LYG8VEL4,B2O(1=37#Y!8E<?A;<H_%S))Q<6
MFFUS)M+9Z]4W=;:#T:T2?*W>2DM;]+7MIM97?5V5F?3(U1ID3 @02JH1%588
MXE10(;>*&)1#';Q1^7#'%$D<<42^7&B(BX16N'#KYT39R0S[_E.2&V\*>X([
M*J)U.".?:-%A3 E6.,,P; )=%&YL X(91@H1R<!1DM5^Q6XE!98)968E74#=
MO(VKG*D \+NRO 7*$%P<9KK?5Z6?GWWM_P /Z VF[I<JT[OROKKK_P ,?"W[
M8AF;Q[X%\R5<R>"[L!D9L$C79MF0?NE?,5#DJ&4 @C:6KU[]FVZT;Q%J/@70
M(=4EM]3\/>&-5T_7KS0[F;2==T:_U;QGJ6K:+=6VL*I>.ZDT*ZL9Q+" YM7D
M@+QM*43Q3]KZ=_\ A/? 2RQ2Y;PCJ/\ RSB:5"FM.P#Q.=C@K]S<>^0.@'J_
M[.D%G%J/PUU"VL;>*:_TWQ>=3GBMUMY=3FTWX@ZK8VUW?R [KBXM;)8-.MVE
M+[+.VAAB4(HQTR^"G?6W/9::*Z5EY?/<$G)I+5O;5+I?=Z;)L^P/VH;6">ST
M5F@TZ1XM,NHY&ALK6$RA()1NE>**,R2,[;]Y4LOVB49)!KS_ . 4\UI\)O"M
MM$P2!9M6"  ED,FL7C[5*E=J!A,Y;&)"Y/R[@!K?M,7DL>GZ( [J[07BE %9
M5B$=R<*X=Y7$DD:RR%XX]H3RQNXQR?P%NIYOA;X<4H/EOM6B4A3M94U6[#Y)
M8<L)F; ! (&U1SG)M--I::>5]>RUT[_@#3BVGNO^!UV>ZV/J+2]88QR@JOF(
MY;<$#*S ( I7?\OS*I.6&TC(3$C$Z-QK<C1VS2"-"MS;.CC<[1D128",VT!1
MNQ-E0S@L-RKD'B;!U5+E0"A><&,;6$F%5"^2QPA?82A/4QL!S@5+JEWYEK#"
M#*I,L.Z1@,9*-Y;R'AE&?F8+N.  <+C&0C-\)7=Y]NU1-UNX:>[FVSQ%@CQW
M4LB-$X(&P;M[Q,"JE1B0$*1Z[<-J4NA';<6Y26X\H!4F&R$0*ZMF:4QE1(H2
M,Q+&0V"<XW5X'X2EBEU#5(#-)&ZW$Z*!$OEB*25A)(2S8C0-)YSDC<XC9<DN
M,^SVRDV**WVE HPV541H2S!2L:-F167) 8N\;>6R;45A7PV(?[^K_C??OY_U
ML^QY\FYMN6MVW9I.RO[J]Z,HOE2M\+ZM-:->FZ#?2+&CO,72Q5-C798X26,/
M%!(Q68R+"':-<.6E58RS1X.WUGQ;=L_A+391=012.7EG6.2]-Q#;QQ0RQ@6L
M#-;1(S-'&[B%P=K@ #+'Y_T19I+M+%XYI8;R$?=$+,TEO'O0F-3)<;A&-XV1
MA(HU=I6+ )7JVJVD]KX>=I=,*O++LBE>XDMB$S$9U%H8I&5W)19IL6WR>4 )
M &%8WO\ Y:_E=I/S2U)Y8K6RNNO+!.S>NL:<7;RNUY=3Q*2XD>>266[M\3BX
MB=%+Q@$^:T>YG^9Y!(WSXCB\N4^4J,J;W@@*12L[-"R0F%O*\J65E$2RD1':
MP^126*D8R';+J5^:G<SL%CA\B9FMGG,ORK(SFW$B1.,.@.]U#RD-]X-PP&3=
MCD$FGAE0O)*-H5M@DW2[@Q(F>+]SO_=,JR##I)'M;YB5=Z>6WD4?-'C^=GNK
MZ.":-X8[AI?LXA\O*R?/CY54,P4!HW9<^:K2-N8$U\X>,Y[D."LJ Q[95*HV
MX^9&P(&<9 7@L/0#@CGZ"\6NYGNRZA"7:WAPJJBO:2.NU)!V<A\-EF4@#(Y#
M?-/C"Z;SRK1R,Q>1!(%VC"JQ9%))W!>2K-P[_=R"2.O#.]9*]^SMW23[>:\^
M@DK=6_4\EU^]-HB:C):17T6G227\FFM/?V/V\VBB?[$EYIMU;:E:&[:(6XN;
M*XBNX3LEM3',(Y%_K!^"_C?X%6GP9\)?L^_&/]DSX*:1\.+SPEHMOJ-H/ DG
M]II>ZQX?MTU;5_%?]MF\\97_ (BU-KZX^W>+-&\0Z9XAM[Z87D#P36]LL/\
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M4;P[(X1BK%5.%X4 D ?*1DG^#2CUF!8HQ-&LA.6'FDL 6P6V?+( I&TCH2,
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MJUDK/U\PDE-).*MWN_>:::;V2?3MUZ,FLKA%^T1$LJB&W(W+D2R!-A;C",[
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M=N%*MU)S7/S.!O><O& X'F!HRQ7>JL&V$A7.6(/R\G&<"A23U6MGM]SM\_\
M/R,Y4YPE)+FJ7UBK+;SY=E?=N[6]K&I=W.55D1,IB/!/S%E=%!8':S +C=M
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MDEK[]1;W:3;ULD>G:5&]Y:V7E3AY)X+>2,(Q>4M+$P)V L_S,,J2%9G3 7.
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M^-_#/_@DIX/\!6N@ZM_PIOQ;\1/$^@6EN+'XA_'7XGV7P1N8[EM3>[NKC3?
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M$/BG1[_PE?Z)!XD:.+Q?;V4,6C>(-1O]+M?#<%CZW\*A&WPU\$E5(">&=.1
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M !$^&:'[%J^J:OX(T_2_%#:_X9T[6K>W\2Z??6=C>V,US#I]]IWTK\=OA?\
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MCMC[1XB_9Y\->-?CKHOQ=T/]CKXM^/OB?)X%^'_A*PO?BE\:]3\-_#[0M&\
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M/PS\;]-U;2XY+"_C$L02.:VN@4O8!$$W03I)S%*CALS1EH2P4PLQ8.WYEFN
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M*4L5F5##K,*\JD9259O&48U/M127*]'EN&JR53$*KB)<_M8QKXFO6HTIZO\
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M49)98AE&VNLBQLRJF_'E^7U).Y5^4#SV%F60*H4 EW)*2*6 W$ _, VTO@$
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M ) 1<$(>5K6:P)0;@YC^2/R-QVJ%<K(P&"'+EUV D (,@COSMEJ(D9E/EQ2
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MLX!7<N\\^85 7!H&"=MXC)@^5OF4R+(\3$JH< ,V]G.-F#("I4+GBDB%W8R
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MXE\"_&7X:V_@GXE>&;^"P\3VVGSV6BZYHUV]M#=QBZ_X1FZFT6ZF:RN8)Q)
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M'3TN8O*N%6*UGMIY?Z5O@?\ \%:_^"AGP/\ &.G:_P#$GQV_[1?P\24-XM\
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M7'W<RJ6!P%-5K4AF$, 5FW_9RWWBJCY,JS$;]V2%&/E"[1SFM@[S@1JHV!R
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M<LC_ " $(QC5%8*%/EO+%)Y>T8W>4Y*L44AG.?*OQB\&^&?"6OV'B=;&XM?
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M43T[)VM\V]"S+;K/',KP ':05>,J6; *[?EW.6QR2 $49Y*G'[Q? J.'7_\
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M-2DH4'.:U_B[_P $]]2_8[^,W['Y\3_%#3/B.GQ8^.5[HEII]EX0N]"&G/\
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M77<GR=+C5<>5:<L59I=5??Y=EH9UO@?NJ5VM+/=M^\E'JMUTOOH<A?F6-]@
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M+1+5/WM4TSQ_]F[_ ()\?M>?M.3>!6\"?"_7M!^%GQ$\0ZC8R?&/Q?;R:/\
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M^3$5G%<KC2G9)M)J,D^5V:?2Z5[ZNUKZ]W^US\4_'_Q6^#=]<?$GQ _BG4?
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M47/-RJ2C).T;1^CABISDZ,H12Y&X33L_=4%44HO:5WH[WE?5.RO^%^A_$/\
M:3_X)U?M&:C=?!_XOGP)\4/"PT&2Q\7>";R6^\+^,O"^NZ+IGC?04O\ 1M3C
MLY-7\+^)O#VN6%UKOA+6+2SGFL[N:SU&WAE03+_6O_P3+_X*A_L\_M@>.O"_
MA:>2Y_8T_:@US65M;WP)8ZY.GP ^*GB^[T;4[W5K[]GC5-9W:5X-\?\ B&^@
M;Q+)\$-?O%M_&MK!K4T&A^(M7LTUY/YOO@!XY\#?M/\ Q2_:2\3?$[P!\*O
MFD:I^RIXTU7XQV.@>%M6^+7Q;^*]SHWQ'T2[T#Q1^SWI'Q'\6BP^'7Q?\!:;
MJ7AF\\8:KX$U?PW:7'P@^%FMW]GHSZ[J.H"?])/^"2/PE^%NE7G_  4\^ OC
M7P-IO[0OP!L/C3\ OA]KNC^/K6'0-<UW2].O_B6W@/XA:?<:1);:EX!^(>C7
M$$NLZ/XH\(7UGJ_A'79K-+6\MK.6[UC2_%K*'*^:'OI)W2LDV]4FGK9ZM-:W
MO=LUA*2E%)M)R5UM?IJOZT/UA_X*-?!SP-\'?AMXV'@KX4^#_AUXR_:B\;VF
MM_&R]\"MJGAOPGXT\9?LZZGX2\0:#\2;7X8V]ZOA7P]X[\76OQ2\4Z+\5M=B
MTRV\1>)Y/#_@U]8U/5I]%%Y<_@_%;2IJ,#6HNTU#1K^WO+.XL9Y].U.PU"W:
M26UU30[ZV=);'4;)W6>VN4:1K6Z$,@Y50?T>_P""AVN_$7]FKX6? &/QW\8_
M$7[2GP(U+X^>(?A]\&]0^(>G"R_:<^'O@.[^#?B36O$/P_\ BUXJD%OI'QBU
M/PCXCT+PY%X&\827,&OZOX9O[VSUV^N=5M[&YNO@5]2T/7K[2_$G@C5;?5="
MNUBO)M1L;UI;);BU=UN[2ZLY<S6=]M=+:2T\NROHWCN6N1.D,>[ADTDWT2OH
MNB6EDNMO37[PJ1Y9O6]US=-+ZVT?3SU^],^:O$%I#HWB6'5;7Q'/K,USJFI:
MS=VNH7-U<:SH6L:7?PZE=2:CJ$L<33G6KB=-5MC'.IMYQ<$/"DFU?ZI?AE\6
M-4-S-IZ23-]HUK4%1%+*]M"-0G!0H@C,:K$-L419?* $;KE6"_S,_$Z5)-5U
M2\C5H)'U76[J"9=JE(CI]L8X5^<HEQ#MS%AC"LY5E\LJC'^@K]FD1:PRZK*(
MW@EV/;MAC$[796=7C^7<D4:LRK]S.U"=N_+9SE=TG&3LY<KU6J:ND^MTD].F
ME^@E"33=K)+F=[K3NM-3],H?BKX@O+&+3SJU\L20J%"75S"QC< 1H1'(@+(A
M ROWBBE@P)2N%U:]UN_@<PZGJB2.SB259W=PF-HC+%6*J@!10?E4'"C85"PC
M3[-96G"MYDB*VZ,[6BV$'R\94+D\,$8@+F/) KT70-1TNP'EMPQQYK,YX*!E
M&<$XW?,,*"& RY; :NI)6V6VK[Z::;:=S*;E%7BD[:M-O;R26K^X^?X_@OKO
MB2Y.H:A<3V]M,[_O9W\ZYFCCSODS<%A%+]U</O;<78[G96/LO@WX?^%O 8GD
MAB6:^AF2<3SF-I$#00.IWF,"0F598U55"H%#-\S$GL?%'C:W:".VL7S'M9L%
M$:,,2':-21E2JXWA%>,'_5E5 SY+>Z[+*[2RS9R$W_,&8^;N 4AP,ILC&#C
M+-@9+4IJ":MS)<L?_ K>]\K[>3\G<A)RC=JSNU;7]?4^D;OQY);1I-'.(DN8
M%=XE)7YDDC DR&X7:=I1 "=^_>H#*WF6N?$&^O&D_?J>ZDEW$8!<G8H9582;
M GSARV4 ;H:\K?5VN%9#(Q5"TGE!5W%%Q$O)',?[S#+\R_*K'#&.JSRF3>0J
MD*@^4HLF<[=JQX7;P0FP*,ARV0*PE4C3:NWKT2N[=VM-/3_,VITG*+<;+>W2
M\KZWT_'5F3X]OO[7T'4K>1O.=K*[E5W#;1)'!)*"<8 56C4G;\N!@JV37\P7
M[4U_]I^*]W*\?DS"RTB]+LQRJFYOUBV&14+% S.[LC)(&.=YP*_IO\1KNT;4
M =F7L;U49HU+-F"90LA.'S)N,?7&#@X)!K^6/]I:4/\ %^ZVHBRR:%IHD20*
MA<IJKA5(4,&9U\HB)MT<4G\9)!'/&I*=>+Z6G9:VV2OY-K>S]%H;1I>ZO:2L
MDV^71Q5^MW;=;^=K'[6?\$\M5^U?LT^ +3&];!/$,$;"1RW[CQ/JT#"-79L;
MA&&,6"@8.R;0<#[X^&OQS\6?LU>/G\=>']/E\3>%-<MK>S\?^"TG:"75M-AF
M>>VU?19FE2SM/$NBM)*UI)=(\-_93W>G3/#YT4L7YL?\$Y+@)^SKX3(D0%-4
M\81!V:8J)1XGU+<02Q;:=Q;:$CC7!94#%B_WO>>1<0!'*$2*BM"-PC!2/<R[
M4X#YS\Q&%X4]ZCVDX5%.,FI1;2DW=V3:Y7T<;:-6M:[6NIE!*4G%QTD^7F2;
MY+-M./3HEKI9_,^N/'7Q>_X)9?M(W-SXW^(_B?3_ (:?$6ZL(],UO7+N3Q-\
M+?'\L%LEQ#;VVO7ND11Z3XMBTPF:/3IM877(+:((MHR6L_ER_F#J'Q7_ .#>
MS]@[Q!JGQ@\(-)^UM\?K2]DUS0;"ZU/Q5\;=8T_Q3:65K%8WVGVGBF*Q^$O@
M35;B6TAEMO$=OH]IJNEW!N+C39K<3-'-%\7O#7PRTCP]K'B?QK=V&DZ98V-[
M)+=W1B9FCALS/*D$;/NFE8,JQV\8>1Y65Y BD/7\AO@+Q#;_ !'\0?$C59M/
MALH1K$\]A:+$$%OILAO+>P@N&B;S/M$-K;HL[JK!I6;]XX)8>A3Q'M.:?L*:
MJ:.53V>EKN*]YW7-N_)?<3+FC>'-==4G>/?H[7VOIN?W1_"__@KI\-?&7[.O
M[0^M?M.:[J'P[\6_%/5O'Z?#/P78Z-K'B#P_X-^'>O\ PS\.>'?!/AJ'Q);6
M,=OJ6IS:W8ZWJOB&[8+/=:_JVHWL=I8Z9<:?96O\]_@;]MW3_AUX;\"^%O"%
MG]H?3-8\$'Q#XKO;5IH-,TK1=7TB?7Y-)TT,'U&<Z=!J+H2JN9(K<6YW,8KC
M\S-$O]0U;2TMM0O[^[1%14^UWLUT@16$48Q*\BH@4(J*%(5(LX).!U$5FJH\
M8"E> (RJ*%XVX 4?ZMB=_P I!8J-RMOKT%@Y5Z=.=1PG:TH-^ZXR4FU)IV3?
M=)I1>O4D_2+_ (+[?M__ +,O[=7QQ_8D7]G'Q9X@\4/\,8?BM;^,5UGP=K_A
M7[$/%:^&3H36SZY:6HU W;Z#J"S+;QO]FCC'F%&G79^4-DPB\3WNS8!]FC=8
MR&;&^$I&",X$A("G*@L<C/\ >\=^(%HD7Q^^%C)&K>?:*2GS[RZ'4XRVX[6!
M;@@*>, XW$BO:HD4^+=2"[RLD-M$2A$21R1K\LDF&5B^>&8.S#M@$$725L9!
M.Z:I2MHEJ[K7KK9M>7K<F?*HMS5XKXE:_56NO6W56[G] _PM_P""D_P!^$W_
M  1L^*?[)6G?$WQ[X+_:SU'P/\7Y?AE/X1\->*K.Z\/_ !&U77+OQ'\-M6TC
MQWIUN=/T;5;+5XM*U&SU5KE8]+OH%>X4^08Y?1OAQ_P5W_X)O_MZ>$?A]\$/
M^"POP)\):7\<_!^G27GAKXUZ=X.U[_A$K]I9);:[\5^ _&W@Z\;XH_!'5-;A
MM86\4>$['67T:]NHYD34+_2/LUG%_/G;Z;%> /-'OV!2OR1G+[D4?,"6.=V]
M<?/N&=H)4K\]^/M/MT_:&^']NT47D3^ YXW"F4KN:^U5'8DL'4C*2/ALJ!@?
M,</T5Z2A"<XK2*DVFTE:SM%;WO=W6]MF90JN4U&R2=UI>]UMOHDTG?[C^N+P
MC^SM_P &T?P_UK4_%^I?M(:7\0M-DOI-0_X0OQI\?_B;XD\.6[1^=YUC+H.@
MQ:5KGB6QGG'G7&F^+;[Q'!<R1I;RI)92RVTW _ME_P#!?/X9^#OA%%^S#_P2
MK^'L/@70X- 'A'2OC&G@FS\ >#/A9X<E#175I\&OAQ':Z:\WB1(Y9_[*U[5-
M/L-#T6[?^V1I^N78MP_\OV@>%-+GOM6$L$2A=4OP-B2#81<2(RDJ"P^<G8HP
MFPH,J!@>LZ5X<L[*.,Q0Q%<+M9MY/#!026W#=M4>:!DEAL^88JZ5%2IT9RNU
MR*2AS2Y(W6R2=FENEWUW0IU7"<ERQZ)MWO=)6>^J6RTUOMH?0O[%/@\IJ'Q%
MN+V2ZO+YSX;O;Z]O9GN[Z]O-0N_$E[?:G>74V^XOKZ]N\W5W>7,LDT]W<7MQ
M,TCW99?V2_9:_;"^*G[$7C?5M<\)Z7%XZ^%GC6XL)OB5\+;^Y%FU_=:?;+:V
M?C+P3JVUE\/>-+"SVV5XD\,^B>+-,CMM.UFVM[ZRT+7-%_+_ /98*QZK\1DM
MVD ^Q^%)#$H("M%<:PK2L 0BL5F6#&<&/*L,A5'V&@:>,-)L$;DI\RJQ 8*P
M5@H" $9:,J7)8DNP!8M\#FU>>'S:=2B^2I246G?2TJ<4J;M=2IV2O%[WUV4E
M]#A:5.KA(<\5+F4U>]I:MR333W2:>UDU:VY^T7BWXZ_\$8?VQKVY^(/Q5O\
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M$8SJOW5^ZEJEJ[WYN;5VZ=&_1)':?MMK!'\,_@_&%$INOACK!@1&R(W;Q$"
M4(RL\42F1]SR/M)PJL?,C^ZOV0KB,? KP.TA!A_LFURRR!@TC+G<6PC9 !3*
MM& X+'<%"'X/_;A4Q_#WX'89DW?#;6"(RH7:(M?;8[D');=MD=1\A$>5?;DG
M[F_8^5S\"? Q:)5C.CVN5EP6 DR LNT%D!=@53:54,%.2"]:54EAZ#V3<_O:
M;OZ6Z^B./%7^IX5VYG>:\D[RO;772WH^9;69]"ZB[+NR$0,&*QRE7C..=Q 1
M2X; *G=$,D.H .%_2W]@>]TJW^$FNV]Q<ZBFIK\9=41UMKN>T>U@N?"O@^;2
M;BV43>6]RE[:W@2[LHK>]@:=(Y[VY@G@MH/S-U8Q1JP\M@"7!WE R%=V3M^[
MR&&Q%+,,;>$YKZ'_ &9/V@_ GPXU6R^"GQ$GT?P]!\0-5N/B%\/?B'9ZS:3W
M&B:[)<1^";SPOX^M1>Q1^';'56\)B^\++J$,5S?M<7%S.T6G7^BZC#C2O[3W
M79M.*:WUVW35KI<VGPW#*&EB[.]G2JQ=D[OFY+)I/:\5=O;YGUW^V3>_&F?5
M/$>N?#?]G7PC\8_B!\'O"'C*Z^&^@R^(M9T=_CS\'/VC_A3JWPR^./PED=]!
M\1Z=:^-/!^I>';+XCZ+ILUE?:7XHN/#.E:%,L$NM70D_+?\ 9H_X)X?M!_M&
M_P#!(/\ :<^$OCNQN?@5\9_VA/VOKW]HGX>>&/B%X&L_A_ILS?#/0/ OA_0-
M/USPKH.DZ%8?#;PU\1M=T;Q)IVE:CI/AZVT[2M.TS1]4M]!31Y+?S?WMCB:Z
MUJ'5KW7+#3M?71])T2:"&.2]BBFL;K5[^.]OF&HV5]):ZU]HM(4MI=*T\V2Z
M;<W$%[JEW_HUC]*6D<\]K'#J+0WKW<"&Z$DS7;22>1#%/&MR;6U%Q&S )%,M
MK PB&]((T411^^\UKTLI>6^SHR4\30KRQ#<W5A]5E6G2IQ?/R64JLFVX)I2E
M"UFCZ58.G.NIW<7=P45&+C'G4;M?:N_BU=S_ "X_BU\)_B5\"/B/X@^%/QC\
M%ZY\.OB=X*NDCUKPYK"-;7UM',LHL-9TC4(&^SZOX?U>)GGTCQ!H]Q/INJV;
MOY%RV98A_4=_P;:M>?$ZP_X*.W/C/5M7U/6O'6J?L^3^(/$%A+;:7KMS<W%E
M\1KB35K*\L;2"VL]9M[JVL+JV:&S-LQAE,UG,LLY;ZZ_;1_9O_9X_:B\-77P
MW^/OA_6_"6LV.DZ]KGPC^+FCZ>NH>,_@KK(U'6]/OM T&TA@^WZMH=Y/8-XP
M\2?#;Q9K.H>%O%>E3:CJOPKU&TU3P[XCM++SC_@@9^S7\4/V4O'O[=_PW^)V
MG6-Y+=S?L_ZUX*\>Z!)/<>!/B=X0@A^(<-IXL\'WA+S?8[E;F"34-*N\:OX>
MN;C[!J40/E37'%2S"&-P]2+_ '-:$E%Q;2O[SO4IWU<5YV<;QUE'6/36P-3#
MU8M>_3;4HSM;2_PR25HR\K[6>CT*7_!>KX:Z?X;_ &9_V2M(O&;4YM3_ &F/
M&MKKVHP3:A:'5KV'X ^*8-,U2.TNKZ]BTN:*TM2=1AL9/[.O)HU8VIM0L _F
M*\(^,O$/PI\5:G=:'XEN(%L_L,&J3M:RZCX7U)]5AN5MK?Q_X=8PRM9,OER1
MZOI&K6E_ITXL]:TB^LI[-4/]67_!PVMQ-\%/V1Y4 FTVU_:0\=Q7LH5&"W6I
M? KQ<FFVY,PCPDL5AJ979N;,2 QN I7^/+X?>.+=M772-0M+?[1J9A\/YEE_
M<SVD-TZ6\%E+/"\1AC9YFNM O3$LT+>9HM_]L1-'N-:4'4HNZ4XI2<F^J<I-
M6BE[VB25M;*[['%55IO5MM)MMW:;NK;):62^1^BLOC7_ (6)X'/BO^RFT267
M4_$NEW-FE]'JD"7FFZ18&34K'4HXX5NK&Y2ZMYK5Y EPG^INH(7B$=?T<?LF
MWHB\)Z=< $.+*$I&5)*QR")T1XV421+EF9=Y8E,<$*-O\R_P^L+6R^%<UA:Q
MQV=G;>.O&4,443._V=)O#NB7,WRN&$<:22,\: \\*N%CWU_1G^Q]??:/!?AQ
M/F5I-+TMG9R-RO/9Q2,5*DQJRR$JP=\("> K UR5TH<O+:#YY.RTLW%)-)O5
MVND]TW?6Z-H)U::3DXV]U\KT:22M[R>FMVEIHNS/T5FUR\ )62%0RLP$H+(7
M;(8(@>(D?,1&6=F9L;N#BN>EUZ],A8.\3L"5Y4)M898(60LK%<JW+'!P.@:J
M<IBE1R 0$8KE5^;,7S,1EF5,L"NX.2-JXSD 8<\QF9L*RHB%51U DV@L%DZM
ME0,AF)#Y! 7 5JJG7;:C)VV2EW>B7,V[*ZU;[G.XR3:M+>2LTV]&UTT=DMUI
M;RWZY-6FNBC37!V_,JHS9V[MS,,<'#@ G8PY=1'L3"5)>7A2$;07)\H&3*LP
M$FY6QA5 51&A1"'*,[LS$287 L#&8H5 &(D1&=M@5C'^[\Q-NXC.W*F3;OW8
M.TU/?3J(%4;M[1H!C+ $R2%610=I944;F;8KX*!F*5%6K*3M&3275:-[KS5D
MU=/[RXQCR*;4I/FDE%)M-QZ2LKI/7;>VAIVD\ID^?(5$.Q<@@_/$N6*[=TCJ
M78(25&QBROA16L9@ZGEP@EC'WU5DW%0NX%1M4*3MSEC-@$E&*UR6F7!"R(LB
M,5?)VDR<'=GYF1,MN:-6Y)&\ $X.-!KGRBX>9"ZX=@5/!C59,9P20^<D_>4Y
MPNWY:PDW)WD^9]WO9?);7_$WH\RALU>4E;7:ZMH]4NU]=PUR3?IEXL7F.DMC
M=HF=DC>8T#A5"2Q%""S .K[E< [-A"X_EH_::F\GXNRQN4>=-'DB81QC?YB:
MO*B>> 3&DBMB$K L:)M8JFY5V?TT>,?&?A_PAH=]J?B'4;#2=/M[6Z=[O4+B
M.)4=+65A'''-)"TUQO*M!#$&:60QY*AF8?QK:I\9=6^*G[0_Q"O+IB-$2XU]
M-#LI$C1ETG3]:F^R/,B*_EWM[;HEW<[7F5)IG7<2C/+>'4YU.=1]R$97;33U
MT[--76NVC3N]4*K)-<B>LK6>EDTU=2U?*F^K7ZG] _\ P3Y\>^%_#?[/6GCQ
M%XCT_2TTSQ%XU"K=7MG%);P'57N'01O&K2!XYRS ^;+O+!<(52K7QI_X*&>&
M/#<5_I'PJTP>)-6AFN;6/Q'J7F1:1"T$DEN'M+**1)M10%%96GFMDG\QG=G"
ME*_$'P?JMU!J>K6 F+6@NG=%5Y/+A9BIRL<9:,-*-C,57G R6QD[^I73EF\X
M[V<;65 J*K9)7:5 5XQC(8 $J00N&('J8;+XR7MIQYX\K?LW=)WE*[5E>>EG
M%=-6[W.:,YQTC)JVMD]%=]O.WH['3_%[XV_$/XMZM=ZQX]U^]U.1[":."QC(
MM].L[:,7'E06EG"WV:"..26Y=A%$"6G(((7+?GU^S3,K:MX[3!8R1VKA5.T;
M#-=JY<D.S.JGY@1C!Z;B17U)J3LOG!0=JV[AF &!)LDRWS!7*D $[AC:<!<-
MN'RO^S:1%X@\=,"!MAM7 P-X+7TZ]3C8 6.T("&R?,9%"M756IQIT9\L'&ZC
M_,HM)WT32CS1NK6U=VWKJ3_5_P"O4^AO":YM54S*,7%Y'$(0(VD1+R>%3EQ-
MA4>*0\KQG(&W:H[N*-OFP-OE@RC+EEVY' W#.78'>2,DX4%5R#P?A&(O#.5W
M#;>7@#&,E2XNKEP%7.0Z M%OQAMC?W2S^EJB@@LF^'AB< RH1R!L!V;65F)V
MR.5;'RAF(7UJ$5"C3;N^:*EJK:M1;71Z.UM;VW,Y74I1YK;)W<4HK=.F_M-[
M.[:UTU/ECXE_NOC[\)I"!L6TM@AY!):^NT<LN3R(Y)2H C"E S;P,GV0,X\6
MWNY(B-EL[*=WDD%%"N%5@-KMD$M(P;:<8/7R#XLA4^.?PE< DO:6X7<=^ =1
MGA(;&"H".Q4#)#E"22./6MV/&=W&WF*OV:([=JLA1MY100VX,I!R,,,D!<9Y
MY-'CD]-*/>^KNK+5]_NOV85&N2?I9=KW6SUZW/7-&#&)&9F"%AF-0 J9 )"R
M<-N.$&W!)4DE@PW5\T?$F5%_:&^&TFR,)+X-GC,B"0@%]0O@6DVL5$40*;3\
MI0ES(S[E"_1UL[11C"/N1'+A,.,85255BBABV&=BZD#."7W8^:/B@6'QY^%C
M AA+X>O(>K, R7=RS.P91N6)) [LI)) .UL$UT8NSHUVDDN5NVJ2:MMJ]%W\
M_,YJ+:FKK=M>E[VU]-/--W/6-$&-6UO!4@:C=,0JLCE))BR$-N*EXT 7<HVN
MX9N P [Q;E<P?*>=A 3'EAD;&T@J!N.!O4$#>=RJO.?/]*D*:MK0)#&2\$@R
M'8JEQ"DL:KNCP)$29(V4@*A! ? !/5QDC VJI58BP.&"%57.Y258GYLN 2!]
M_>6) JC*^'HK3^'!NWIMVZ:;V>^PZU_:.[;U3^32]W;:/3KW/L']F*Y>/6/B
M /,=P^G^'Y)20I:1UOKHD 8&U$$@",@$:%BJ;)C-)<?8*7(+NWFN&.0BL56(
MK&<F-@B*0&0J6VR)P,HZ LC?%W[-<CQ^(?'9 #(= T.55E P2-3,#L'W$@#S
M(V:$1DR>4K"6&2..*Y^OHI?,&YF8J [J[=!L8NY8$H3Y2_ZM!&2R+S.0WE+^
M9YU)RS3%-KD;</<W24:<$F]$[NW=^I]7EL>;#T(.3:2DE+3F=KOMRW>_FGHM
MCH89EW,PD B*JRQE2ZQX8IRQ).=[$#+8^=0P?@K,@974AFV(T;'8H.03MVQ,
M%*\%T0@JQ"DC(;;(F&)1$\:RLZ1RL%+CEO,D>9@7R%0ABA!P<C"D@<"MV/Y6
M5,L3L;:@0 * RR,9-IPP"IF-LC+$!E R1Y=U;WK/R76W]:_>=<XJ,FD[I;/\
M;::;Z%W?(@&U1$""6G8DA'4D)_$X9E89<! 9ERH3<0*;$2Q7.\ ,1N!R%* D
MI)O+AR?+R5"QD=002#4<;+&(\J%1&P0^]059^6,B*[$J"6#^5T! "G#5-;@2
MR,I4C</FX9&.YD7<ZG'+ J75/F) &X \9=+6]'K?_(32TM>SV;5KOKZV?]7-
M.%F8?.D9;S"5#%DDW%B BA<99U0* VY58E@K*%4[:QP@22*,LKMORQ$0PSK'
M&O+L@9,A"6D.U5#%B"U8:Y0.H8,,IM8Y)P8_D=LJ0I51\Q3<TC;FRNY<Z43N
MYE+97>I1%D58SDL[LR1AG!"C"ID@K@@'! *-Z,;)R=N9WY==;I/F_2_WEA'<
M*X15";I 6 VA97<ALJ"W( V#/S!D!(Z 0M:P3!S.Y$KHFY83*D,CN\@CD2-V
MDC(#1MYBR(^U69%=?,#*\[%4%P[.[E@H 4HP.)/,558,'EWN%Z[2,E02!)+"
M/,CVNYVK$^SY [[3* 0@.-\A8C 8KM0[Q$S 4N6/+RV2CIIT[V[;_BD53E*<
MF^5*]N9W=]%9:-Z[6O;T*T5G-#Y";U9HPZ[A"D*E.3$I*DQQQJX"QY0D+\C,
M6RYUQ'.ZJZM)^^7R-K%1L!SDJ[1DKC!()#APNTA  5@A+<+(JR(2$ 4;,."2
MZGR]RCRQN5<MF3S'X'E1B35A^>2,1.Z[GV R;<;'$AD;"B0$I@%6;#*6;&,\
MRH.+<J;LVT^1NT+JRO[JYKJW,M;II6UU6W]?U\OD<8^C^*-!UB'Q;X!\2ZOX
M-\66";(M:T&=8;BXA=E=K2\M9XI]-U?3;LC_ $C2M6LK[3KJ(O'<6LH("^BV
MO[8W[2GAJ!;'7_ 7PL\=3QJ4&K6MGXB\!ZC>MDM]JU'3=!U'4?"RW<BC]\N@
MZ%X=TPO\UMI=DJ>6;D!AC4+),)$?#*%0+N &Q7);YB5.X"(X5=I*.3UMR6MK
M.Y$MO$[K$&W(B[ "7"!U!^^1GYP,D Y7@FOAN+/#?P_X[J4ZO&G!>0\1XG#P
MA2PV.QF"J1S&A1@GRTJ6;8/%8''NE#F?+3JXK$QI6Y,-]5@G2ERU,)2J25TT
MM6W%I-:;+1\R:WYKM?9:=CS/Q5^US^UAXUC;3/#EGX+^$=G<;XGU3PCHM_KW
MC-4/*K9>+/&%[JD6@,J\&^\->'](UY)0)K+6]/8>77"_#_X)?9-0G\0:[<7F
MK:O?3/J%_J.HSRZAJ-]>3L9IKF^OKQY+N[FED+M+<W4L\\AY>5FRS?1UMI=@
MJILA&]6"@"-%D!08!W!G)1AD,<;E)W!6(V'H5A&4PH#XQ&H#(0B<9=@&.,MP
M07?!.1\V!W\*\'<&\ X2K@^".%<BX8PV,Y98M93@84,5C)0ES0>-Q]6IC,QQ
M2C)*4*=?'2HQE>HJ'M;5HYTL%145)J5W9V;T2\EHM;7NVFMGH.TRR2RB$=M"
M!$@*NP!4%%Q@!F<C@8!95&%7"C."=!7+!U+J6$;1G:?EQDB+>6&9(QG>AC,<
MB@KO=P<4#80&"*SHS[B5*KYD+L@9 0V5VD;02%R/O;<T\AG>,,550 )(\DG=
MN<;<[3D%ERIWJ3@Y!&T#WW)\SE'W6^BZ:)=?)+_AK([5:RM:W2VUG?;5Z:F2
MT$88Y0%U.W>#(. 6#!59PJJ6#$.P)(<H&&,U&]K"Z+&0$*DD$+T+1DHF<\@N
MK$1L1DYVG.[.H82TDBE1DR[MRL, ,%  \S#N2&9I J.JRL%4M@$T1AF+#;Y6
M6PT99X_D)526(C_>*PQM*_+NR3R,)MR;;U;:=WW6SV\@<8RMS14K;75[?C_3
M,E[&XR764RR(Z@;,)$JLRDEPWWI%*JT2^8"2'+;E!40@;23(?WI5A]TF-RP5
MBR#EL!E!(=V &Y<$,NWI4VL>(QB0.W!4LO  (XSG=U  ;+(4P5?%A[>.4D/E
M/O%2RJ"&(4AF8$_+D+\K<%]C C'RZJO)))I-I;MN[\WY_P"1E[%-R;=E=<JC
M;:W6][6?K?<R5"B,*C$LS-AOOX^?<">" "P7DC:,[1@8Q.\(F0,R[@S#A0P
M^8 DMM)#*<M@$9('RXX$:0%':,$R8W#<#EC)T8J.FTC<H#;=Q !*[E-6)9'V
M_>^8JNUE4 %G8;7"\!6(8D?, ,;R"7P"55NUMG&2DKNUY:)^=E>WJ^FTQI\D
MY-WE%IP5K.47*WO-*UM+J5]%&SMN4VN(%#KEEEXC#;LQDN^X.R$$(Q!XPQCV
M@'CDF)7MMS>:KO\ -*NP&5EDD$H42[@Y@+,WS.R0QL7.!M4*@M+';L[*^1L<
M,2Z_/(%.Y"-HRBN"&VM]WD$'(%$MN@:)T7<%20I("0FQG9PSJ".59C&Q'?:R
MCJHB,Y*RYFH[.UM%Y:;JYK&"C:S=DK/1>]VE)=ULK6LG;8:SHHY<C:A+,&4A
MLHNS:=AV@E>!MX.-P.>6*0@1!)*%=]QSL.5D" AGV,, EC@*-WS$DD-4$C*0
M(P8V0QA7(&2QVEG;)4X5L*<G+LX(P0=PEM-K* 9"C-AP<J%*E0 <@,Q7#$!2
MB#[RARP!;=\LJ?,US.UHRM>6S:<K;2O[SLK+T,ZM.4I73NK/XGHM=$M-NO?4
MLO&AVEC)C!=E#XR4B\L!AMR54?.^""=PQC<"MM8X\*0"KE$#K&YCXV@H^TJY
MVMN8*<\LKGKG%%9D1UC8C+'^^N4!3<"Y 4@$J=RA>1UW;<&\CH5SF8\GBW4$
M#H06."#N!^4C&0,[0<Y7,U22DW3:Y5^[Y93M;3FC*_+=ZM6NM-C*2DHVLHJ+
M2:3?O2WYK/>_=:'PU+<0M#/*D@:5)D$]JL322E'+'<KAB3'$"B.53=O3*G:,
M5F3S[0RQ[GC/'FD+M?@*%'./,\M$1E)PT@+O\S,QP5NOE4#=E(AYLDA8*[.J
M;=K8,@1EP02%/&!DG)E261D .UOF(V;B?O.TA4!E. 8W#?-\Q&WHQ*CWSG;;
MBJD6]+VC;25Y*.J5WI9M6=^_=;D;AMA?Y@5<JI;8JRG8650F3N &XJQSO!(
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MR9!3YN4)&YE VH200#N 5<[AN&*^$OCMXTT?POXST6#Q(R6OAS6O#9>^U*9
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M:"2>W1O1-;V/4<HU6DE&,7+6HN5:-O5RE+EV:YF]+OJM_P ^O^"L_A^S\/\
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MO::I/UL$\;JRJQ V[PV"Q=XV/+)M;<#_  MG+%QC;N+52E4EMJ,SX1. #\@
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0*%VURIN]W>-W??[2OYG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -R J@# 2(  A$! Q$!_\0
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MG&-6<4DVDM%*"L[)*\+72U;LU\HI\%/&*@X\?^( 4QC<K%EX4]8FW,,KEB
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M,[:MKF;>O+'1RE9V2;?-LXM-N'U3P\[ZC;>5+?1W27EI(H9(YT2$W$.ULKL
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M=7UPF([R:2Q1T60?/:VHCMSM+H#^Q<)#10E6^4H&X)( (&PC> V.GWL,!D,
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M)]=U&T:)PQ(!8YVAB^QHQC E!7?YH4')!^90"K8%9W.2 #N VLN?E^8' /4
M '((.YP7^Z,D=-#&U8147)NFM%)-MP6K3NU)R3=M.:RO]J[1BJD%5DUS1CHO
M=?-S23=W*TEH[W5KZ;[:^!:W+X1^)5M+X&^+'AZ/P]XB$)M[6YG7_1;TNI E
MT>_*?,@ECW- )Y"0ZJI8*ZCX7^(O[/WCCX,7\VI:/YWB?P4TKNP$#23Z:HSM
M28*[@X"OY<H14<(2%9N:_4K7_#>B^+[*32M;L5N[>2-Q#,[;;FW=@3YUM*A$
MMO)P&++*?F/.2N*\O(\6_#J.:+5C<^.O CJT222QFYUO18.@MYH2UQ]MM!&?
M*;:$YB0*JA%W[U:=+%7;FE4E=JK%1<X^\TW9I.46UK&25VM;:'K8/'U:#M3<
M73Y4N1R4HVM9)._N2Y79)Q;C9.SU/RE?0]+\16USJ>EN;6\02+<VDBDMND)#
M"5,("S%"01C;E5;(Q7E6AZWXH^&WB&/5]!N;G3+V%GE:-'D6*YAA(Y;:ZK(I
M^8JCY.PN ,Y%?I_X_P#V?O#WC72;OQ?\(;RVLM1N'^TSZ=!&8[9I$(:2,I&_
MF03%T*-')""23^[.03\):OILXN&\.>.M*;0];C/E(]S"(Q,2Y'G0R'9\KLIV
M^6X_AWC.0?'KX:=)MR3B_LSO[DK)N^E]=.9IV:OMO;Z;"8NEBZ<XNTG%6G&I
M[K:FFMG:+BM4I1:=[/1V9]]_!;]H+0/B1!:Z=KWDZ%XEVI$\4\JI;7TAR&EM
MV*@Q2*1AHW=N'&T+C+?0?B#0GB4.2JPN%B<J#NW, Q&W?@_)D_,S  D8.<K^
M)7C'P_J6AOHQMY)T\F5[BWO[3<)H%18VCW.!E%&TD,TFTY8CDDG[2^#?[5-[
M#H>D:!\4;E[N&YF\FP\0!M[1JA5(OM88@2*H9B"9=@5F53\Q)SC4E&48U%K%
MVYK):)[ZN*MKK*[L_D<&*RJTI5<(I<L8W5)/G<6EO%S5Y+36^K;;6FB^K!IA
M8[R%^1\?,A0?*0!D*Q^5L@D'&TD-N(P*TETJ.0L @#(H<"55'0$L1@';C&.@
MW,1ORHKH+*WM=0M+?4=/GBNK.Y026MS;D7$,F[^[(-P!&[#K\X#%@0S,*T+?
M3V,PX4Y*C=Y07!PQ)94 R >"6(V?,4W%SCK48^SD^9Q;DG'16LVF[MM]=+)M
MVM>S>GD0JRC*TW>+[K5;I:*R>KLUIRI/EUT*7@;Q5XG^&/C"V\7>#M0GTK4H
M;>*UN8U8M9ZIIQD$TNEZK;1M&MYI\GS?N6=98&D:6VEAF E;]-/ GQ37XOZ+
M<:QX8UG7-!\1Z?!;R^(_!3ZU>S7.F^<\Z_VAI,_VA'U#17:WE59/)6>V.(YM
MK$L?S6O--S,2$\PX4%,A&Y'WAR6);'"G."3R3S6EHE[K7AF]TW7/#U]+I>M:
M?<B>ROK1PDT!VA "P'ER0R!0L]M(&@GC&R2-AS732KJ"]Z4G;X7%:*-GI=6;
MUYKVOIJG=GN9?F53!2NG*IAWRMTDT[^\OX<I7Y.:[;:34W&*FVTI1_1GPU<_
M$'5/$FH*GC#Q8EC;R0I(KZWJ+0B0QEI%,;3,-[$IO4GC;T(P5^B);'6-0TF6
MRN-6O?-,3*9&E,J7"M&4DBO0X(G23E,-C826W!5VU\]_"CX[P>-]/GTZQT;P
M]HWC]-USJ.FSQ7AM?%#K"WF:GH4R7-JWVA, 7&D.9)8Q)N@FDCWLOHNE?&%9
M=8M= U#1;H:I.?\ 2KBU\,WTNF0LH E$MRFKW=Q NX, S09CW;9%./,7U<'B
M:=&?/&HW4BXR7VDEJXVE%.]^BT:LEKK;]!P6+PF,PZ5"]53O[ZBG:<97E3;;
M4N9-M24EMS.%U9GW'^RM^T]J?@_Q%8_#7XL:W=R65PT&F^&_$&MWFJZ@\:[I
M$B\.7 6_MK:UOI6>%=%UF07OVE"VF369FCM;BX_8:VN8KR""Y6-VCE"7<(G@
M"D,LC.I>-BXBD1U5D()9"-Z$':*_G%\1W&F7$>DZAK^B1/#'*8IDD\RVNHD<
M,D9DMVGN4U""%LF:V$JO$I1U5B"H^[?V:?VD#I-U8^ _%ESFTOI;6'0-?>^@
M5=6FG+P06/B&^GA\PW-N$MAI.H/<?\3*-C9ZA+;S6]O->>!Q5EE'&IYGED.7
M$M7Q>%BU!5+*_MZ%."LI<L9.K2C9RDY2A&3<U*_J$*[G3A4A2JTX\T$XOV4[
M7DX<R^&I-N3BY.,9R7(W#XCU;]H3]F'0/&>EVNDVGGV6H1"YN?"OB#RIM4O+
M771'>:EXGU'6&2*22+0=2D_LZVU"T$L:2-'#/&OVJUM2/QD\0^&-5\&^)K[2
M?$FFO9ZOI4PM=6LRRRG#AWAO;*5"4NK"ZC'VBQN4S%=1*N'21953^H4VEGK&
MFW-G<RC4;+4+*:TN9(RUNMS:S*\,RHT)5K;S%!5Q&RLKJ,'*$U^?W[57[.EG
MXLT]=1MKJ*R\0QRW(\*:M+9^79K+<O=7<O@V^CLS),V@0Z9912)J5UG^R[IQ
M=V\96:[M9%PCQ15H\N5YA-U,-7=2-&H^:;HRGS6^RI^SOK4@FW?GJQC'DJ0E
MK1KT\2_W];V>)H0BX5:EXK$>SNG[24W%1J\CC&":CS*-DE4]P_)5--C,,4T,
MOG0S()8O+)Q(K\-*K9(0LVXJ&!(QAL<[>.U(K'YF6;., AL,I4.O4Y"\+$W
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MZL(3_2?$_B"WL;F"TWB8F"T,45]<,DUO!"V'E3YA\&^*I?B'H%]K,GC7P_\
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M!# X R2P/!S7W+X@^'^^4!X9UW.S$LC!6VDD<E"RA3R1U*@ ;2,'E3\.9+N
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M$-Q%++>:>6,XFM-/ NKF1HQ$ZD;T_2C_ ((WZ%J?ASQQ^UUI&J6=S8W5E;?
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M?#UU')IA\GS=/U'3EN"L,J3R!K.^LR\[!VDWQH8_J?P3\;/A9_P5J^"7CO\
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MK,R^:ZG:HX8*QX^9449*GIMW="9?^&A/VG?M$L*?$_Q5]DBVE(W2!QNX)(8
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MP_\ %/\ 9\\"M<O)':MXN\+_ !"\0Z!HIN\)&7OO#NL>$?$]WHUO+))^[?\
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M'XH6\MU\/;Z2/3O#GBV\C5KWP3=%PEOINLRN)3=^%[EW6**XE82:*X)8O:8
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M2N[6YDW&2NFES*Q]\W/Q-T #Y6TZ.-582M)X@TQ@B<,C'R<D$#)09W$D!<G
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M@OJ6IONGE0 @M"%#X,@SN&& W)N<-A7[BTNCI=JIGOI=4F5F,FHWKI%;*RD
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MH&D_'G0/B!X?\$6/ASQE?Z_8_#JTT'Q!XLL_'7]F;?"UO#9ZCJ7]G3:=<W9
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M%&VMH)/HE=\T7;1N^FO,[MGV3;?%,)YB_)$3&I#%1'@;VST(7#9'RA0. >P
MT;+XBK?7IMAY:@6^^24(00<E0HX#*1@$D9+\*0#R/CI=:=U'[Z.-L@ EROS
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M_G?Q,^$OA[Q5H"Z59^+;>U$NHV4AN(+2*]EB6U,I_P!3'>VV%D\UE9@V0 N
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MAL/&I"5I/DP]2-FTHU*<ME--34;I*#O9-.W\OGB[P[Y:W2W6GV\<R(RB01H
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M*?9ZLRQ?-+N$94@,Q#AW))3("A2F,JK!58[B,?/7BNK>)0LQCRI0.2Q)4MP
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MV<6H67A?P02+/5]5NK*<FWN;BZCE?3-#T^\)MM0U>YBAF$EE%?;/Z@+7XO\
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MND0489?A(2Q,\*N6I%3@KRFTZNFD=+7YULY-6W;/ACXH?ME_MU_&KPE#\/\
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M3\)VTB/?>#+V:-E5?%.BLES=>"KNXW.M_)>>'+L):ZM%/IORG_P0=\07M[X
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M(1YG=.3G+-1GSJ,%3O%RNJG,H*R?\J;Z-[=C^EO_ ()G_P#!0OQ-^V2GBWX
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M>Y!SA5;3<FI?'*+BT[MQYFU=)/1']*/[1/Q6_P""3FH_ [QUIW[,VC^$-/\
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M+.&^1 @8(R@*#G<3EBW&[A-JLP '\TL/PSTSP]\1/$>G^5#&=/\ $^NV&TJ
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MPI;_  K;7=*D\3?!GQ[9RZG<_#_Q3HS7*PCPIXSTO4)M0-AJ&@7+?V'?^(-
MN+6YL3=:-JNIZ5J-G?Q2Q_TKA?'?@RIE&2<0U(YKA>&L\J1C2XAJY?4EE>64
M:U:OA<-BLZIQG]>R;+<5B:+H+,<1AJ^%PU>KAWF#P5&O#$4_S:MP7F*H+%0Q
M6&Q+E%25*U?#UY3O*UIUJ3IW]QQ4:D:;YN3ED[Z_C]\&W%W\3? J);W*_P#$
M\M90SJ-GE1I(2^2J%4'"':3]UL9R=O\ 07\';>"PT^RF'EB>XN7D;<3E<7<R
M# P>PP020"23@9S^6_P0^!OB7Q?^TKX0^%&B:9/8?$:77WT74-)FM3)'X7NK
M:&XFU;4M;BMUE1=*TFQ2XU26\$PMM2L(DEL9Y$NK>1OZB_CS\'O@C\"OV7O%
M^MVOAK2M,'@/POHJGQJ+"P?Q6[KK6C65UJTVJ7:;1J.JR7$[7<[D1H;N55B$
M*I%7WV><183 QHT).5:>-49OV$H.-/"\LE#$-MR52G5E44J3@_WL(N2E9J4O
MOO#'%0RO!YI+$TZSE7QL*%[QO"G3IPE)U.:/-)QDW&4(VDFK-)M1/R+^.4TE
MU\1==D9B,6VGQAF).T1V[A>N#E2#D#D\\@UXE(Z^4X;!"L1AG"D8.T')&=I)
MR.Y4GYNI'[(?L=>"?@%\=+'QWXIO?AYH_C!E/A-6U;Q:H\1K)),/$49BTK[8
MTEMIPA6!EO390P_;)&M3<,[6L83Q/XK_ +6W_!)WX/\ Q/\ &7PD\;_"JPC\
M:>!->D\-^(;?2_@U-J5C!JD<<<SQVM_ R0W$065 9HPJ$@@C %?(YKXF\.9#
M1HSS*I'!89\F'HXK%8G#X:G7K1HJ?)352,W%JG"4G%\\E&+F^9.R^EQ=6G/%
M5ZD6E"KB)RI7]U\KDW!)-Z3Y5=I/1W6NR_,R;RV8;)$C(X!VJ8R"1R I $A(
M#!2<  <\<W-+T#6M?N)+#P]I=]JUW#:7-[-;6$/GR)9VR-)-,40\E$1F$2'S
M96+*B2,"*^H/C[^U;_P3X^('P5\;Z'^S=\-%L/B[?6VECPA=CX62^'+A+B'7
M=/>_2WU>>14LYGTN*_123\Z,8P"9%-?4W_!*[PG\-/BG\%?%_B+Q!X4\'>+M
M;T/XGW6F+XC:T_M&99+;1-(N/LEO>7$%O<(NGSW$R((T^RN\C3VL]Q!/&X\V
MGXJ\.9YE<Z_#&89)FF8_VA3P-/!/-856H4_JN)S#$588""QD/89?5JRPZ="-
M*KBIX93KQPRQ$X<=2-.]*+24ZW,Z;35YQI^]4DFI2O:Z7-9^\U>U[GY(%2S;
MD&8I5,H(QM:'> &P&P 02 I'R@8(X-0N.A!8*A8\E>NW*$Y.W'WPV PZ CK7
MU%^WY\![_P#9;^*VE^(=+BN)/@W\5=4U'_A&-019)(/"?BM0=0O/!.IS;I#'
M]JMVNM1\,R3[!?V,%[:PN]QIUPJ_4_\ P37^%WPH^,%C\99?'_@CPCX^31K[
MX?+I$GB'2+/5WTL:EIGB9M0CLY9TD:!+N6RMC<QQNHD>VC:4&2)2/M:V9X"G
ME+S:DJE>A^ZO156U12J5%2=.4JB;;IN5IIQY7RN25I19#H.^DDU;:2=U]RL^
MO9:VMU/RR)SUW$\@G!+$?,J$Y (XW<=01GCJUS3M&O\ 7;Q;+2H/M%V;6YOK
MAS+;VMI9Z?9(EQJ6IZE?W,EO9:9I5A!B6^U*_N+>RLH5W33J656^J_A'\5_V
M//AW^V9^VKX#_:)\.^%+7P+X7\7'1_AII6I>#KO7]"\/1^&-6\37'BC[%%8V
M5W;^'K2UTNZ\.JS7 MQ>M);VMF99D,!_1G]FSQ/_ ,$U/VRK7XI>#O@9\-/
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MDOYN_@E^QWX1\+W2BST&TC,07=<WJK+=L"^4?<ZL ,L2X. 6900<#/R#\4/
MSP>(I;6QC>XCL?',D4EK&%,:1QNL:SG _=1C<P4J )?D^4F-=O\ 6FG[:?\
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M3_CS\1[5<(L/C[7\_-\@62_61 K$$$'<2 #@DY.2HK^C;X%Z7JOC[]M&_P!
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M,>6!!SMX&/FQ\IJ-'38H9D?B/)Z#<LA*J5W YR<$]2<$X+$C^O\ _;!^'?\
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M0WT77;7P1IB[+"UOK6YNYKG4/$.M7EO!I6F?:DM9VCBTJQ@M84GD5N8_;_\
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MC"E"<4HQMHGR<R6K3<VM-3^9G]OCPTNM?\%,OVVH)H_+AN?COJ)9Q(LLGR>
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M %OQ->V5WHGAWQ59^+H[K6]2U"^TJ/5'\/OH4=XME82A--MWD^SM6\8_"_\
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MT3QAKN@^&M0.IVD4-E?OJ&D:797J7.GM]EU-KDW5L(H (Y?,++XF>./A7?\
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MG)13<2VJSA5< 3!0T/F-LPP*_.%^:0*,#:D^$-EH\!2:%XHXG$4:P>3-:QM
M1Y@6[0A+@0EXPRK&S0J4#,WG''U6(Q,*-*EF$\MS"G%*K36,5"4\*XVA?WH.
M<7.G%*?-RTURSDY*2VT>3YCRTZU3"\G*TXRISBX*G+6,90OST^3ELY.\I7;2
M=SY'C@=CYEK->V<((4 37$'G(A):18 /+;:P!4%6Y #8XRU[O5+-[>W35KE8
M@TIB20# !VC='%SE)."YR"0%8[L #Z*U/P7I^7CBU*U^VSR"*TM;262:Y"%F
M#S7EQY M8%4C(@MD=@"29I6X3S./PMI4'B&32%NX;S4C="VCB$BW$TX98FC6
M/S69A#*S>7YK)&H:-@!NRHO#9MA,6I2C%R48NHU[&52?)3:3DG*E>+BVEI*+
M=G%7T".#J.<*=2,.:4I)+E<DI+^]**4>:22YEUM[ST)]#UDR6LENRWJ2RA)9
M)?MTD4;QHS'[-+;PQ*CJY W%I&(+  8#!O8/A_K+6.H1RV]L\'F*AEC5Y_-;
M"C<GFALO%D_NE3"9,GR@N0#PA\)=0ECOUO$@MKJVGD,@FF*I &BADBCPL1EF
MGQ(LDWE1RA2<&0%&QT7BSQAX)^!_ANWUC5VM]7\17-N3X=\-VDS&^GN%4^5>
M74RP2-8Z=$Z_OKJXAC^U*#%9K+= 0KYV(P,\SG*@J$X8:NTI3K.2C.*_=5%2
MIM*=6[YHQ_=I1DI-N$(R9]/A<LH8>#J8F,(4N6_OQ:G+F?*HRLY-MR3:2BY-
MN*NES,Z7]MAOA_XO_9ZM;SQ?%;:7\2?"UUIR_"K5+2W1]:N3?ZAIS>)?!=T#
M+ VJ^%M4MHWU.:"X\Z'PKJENVLZ<8[C4;^'4/SW_ &7?VC/%'[-/Q'LO'N@>
M&O"/B34K#%G/IWBK2TDCO=+E=_M=A!K-H\&K:2+N%6C2YL;F$F4+)-#,$"#Q
M;XE?$;QQ\5?$5YXF\2W5P^_=!86R/<1V.F6*%5BT_3;9YO*LK<,/-E2,@2SR
M32RR2S2.[>8:=-J%I/YUS%<2VC$QO*\I:2)AA24ZJ6 )5DW*HR"I^85]WPMD
M%3A?+(X+#9CB:E/#8JIB\#2Q&)A6J9;3JI3C@\'523]A"?M*\:;E.*JXC$1H
MJ%!QI-57[62KPY:7L73^KKFM72IW5*3J1M&57E6JBI<D$J5IQBV_ZG?@S_P5
M]\*>%=5L++7IY](\ Z^YNM)U*#5]7U'5/!=T /M/@[5[&'0-%FO[G2I'06NL
MQ:KI6E:GI4D&H06=]=/>V=M]>?%;0OV2?VT--3QKK^DZW9^-=/$4D'Q?^&D]
MAJ7B;3IX(U9=2OM.TBYT=_$+Z6%@E%S-=VNMVT$=J!>V\;A[;^..)8)MT@0F
M=H\ KA79 %&%*N&=P05*DXAW$QJ%D8GWCX5:G\9/!EZVN?!'QAJVFW,<,$]_
MHL'B"XT>*>& O)"8KO[9:V22QL\BQ6L_D.Y.5F*0LJ_=T.+J].C+#9S0P^;8
M9WY7B%##XB$DKP:KJ,J<94]%1G)472C'W:R48\G?A\ZQ-.C]4QL*.882;E^Z
MQ,6IWC+VEZ=5RERU8OWHKF@FU)JI"RM_6/X5L/B!JO@JZ\'^,_$6D?''X=R[
MH=%^)FBIJ5G?V=Y9*9K;_A+/#H75;[2(YKY83J&MZ7<Z]IMJ\$MPR:L+-1<_
MD1\5_#/Q+_8]\8^-/!NF07<?PG^/5Q>>(_@GXRTG4]+UG2=/OYI(5\?>';WQ
M!I,-O90>,M'@O8HIM$M8H[5H;G3=>TY'T^X+I\F:+_P4<^-&FV]AI<WBZ_TE
M;%[C3-<AA,ESJTDCZ@]SJ+HFKD6VEWUW=^9)?30+).;Y8V\EU??'L^._VV?B
MU\;=$U3X;>/_ !#I/C/0);ZS\3Z%K6M>$M#_ .$HT>YT><S:5JFA>*&A/B+3
MY!93W&F7=BNIW%G'9ZCK5C&)K;4)S<>#Q[B\@XOR=X+,LMQN*J898/$TI5Z%
M"KAI5:%7"UHPJRG4YJE.$J,)0JRC.I*U2+]K2Q%3FC-\VR_%86E!T<QPV*P;
MG4PN(:C5Y6_<K4*TG+VL\-4I2<'"4W*E*U6,V])>8_%/Q9<Z1HC>'+,-IDC2
MHQMLR1MQ%Y'ES)*L;*K(1))$RA3N4*J]6^63KMWY[WCW$RW#OD2+<2":-CG"
M(8V1]V<X*E%&   #D=7\0-6OM9UZ?4[R5G>Y9%VX/E@H%*R+N.#(>0Y/SL3\
MY P!RD.EB6-G0;B&.YXQ/,0V3DL4B#[L@E&(R2#D#!*^%A*-&GAXRJWJN3<(
MSJ4X*?LUS.E3<**C22C#648-TE-R<7;E1\E.5/E]JVZD+I*]XJ,4KJW*FW96
M3O%-N5K:)'VU^S-^UMXG\"7:>'E^&OA?Q=>&Q33]&UN&>[\+ZCITL#216-WJ
ML>B@:9XDF@2XDA,FI6*:C- ICN-0E0!A8_:=^*.L^/O&5U97<%A80:6+"&^G
MANETK1#?365I-)=I!,3"USJ]M;6EW?1>?)Y5[+>7"H#>%1\B>!FURP\0QW.E
MW%K$MG(#=RD+<*KDG8SQRHX:0LKO!%*CQ/@[E<(^>2^-=YK*?$J_L;AY+N6_
M.F7.F/>7$UUF&]T^V=WB,[8 ^UQ7INI<B.62&4R#]T&;RZN4T,;Q!A)IX:*P
MF"Q%;#TG9\E>;I>UK0HJ*A&<:,Y>]S*4E4:FW3C&,>F@\3C54P3K.&$=%5%&
MZ<8U(2:][W(RE)QORJ51M0CK?E1^L'[!=C$GQ&/B#4K W-IX7U/06DM;N:VD
MT^!%.H:O=:C=WA>WB&G:>UA87-[-F-H+8^8D9D(1OU6US]KK]E#2+A--^(/Q
M(\,ZCKS075KJ-YX;\.:KXAT*\;3=2;4M/NK>ZCM+2.UN["YOKFWAYOY;P7-S
MYFGXE9X/RK_X)=^+++2[BTE&H0Q:A9_$/3K6_@OA)<V?]A>,M+7PO:RZM$T%
MR;[17NC-#J-J\<@4-%&D1:Y7/ZY^&/V6/V*H->U:Z_:,U3X(>.?'VK:I_:>D
M^!=%NC!J<&G%8$L([+1K#5-(:5[J(12WU_>-!#<6QW2BYCM)74X8PV:5<RXC
MIX26%YO[;I82K]=5&%&%*ADN#^K5U'$33E&O4KXEI.-6]2,E!2]^_P!WP?A\
M11RK%4\%/ QF\?5CB)XZ-1TH1C2IJFU&FXRG*KRS44^?2.MHVYG_  H\3_L;
M_&2+3O"</Q;T&*+2_$27-GH/CO2?$?A?4TFU&[GO+.VTMH)+K2[W1HKG[0;.
M"X6U,*RM!&MOYJR0?J-X5\%:W;VT%I!XZ^#>H>"=)A"6_A=OAM=^+WELO*^S
M6L>K:QKGAS4#I:QJHCDGM+?6+MU0M+=/EA'^0GB[]KS]BS]F7XBVNFZ;^PC\
M/?"?B/0+<3:'K'B?X9>'!XCL(HRT%OK6AW&JIJ>DZAIK7<:V\^N^&=6AU**1
M4:::]+6\D7T)X4_X*">#/VAK*WCL/$7Q ^#>O6MO-=V'B#P?XA;5OAA;W$2!
M9-'U'7M>E\*:3INH20OYUM8//IR72Q(Z*+FTCBK] R;"\/X6K6AF]3(:N/C3
MC2DL-1JTW4I4E)2P]1YIAI8:,$]8TZ3I4:BYIU;*3B?;83&8*+EA\3BL \2I
M<EL-1JX=.,(M*G+V\G/FB]8^\HVM=J]W^A'B3X'>"-.O[;Q!I]G\0? 5]':R
M2W]_\$+X:7X:@FN9?.DN_P"QY;Z77=/2"$A5EL] T^SGC!DGMX5VK%\J?$[X
M!?'"QN+3Q7\.?B#/\?/"YCG^VZ%K$]U9^,K*TNPRW=FNEW.LZMHOBW2KZTFF
M@U&32KS1;R=7GM;KPS<PR&Z/A'_#QGX/_">.6R\5?M 17UW#<E9[+P#H&J_$
ME89D"M<C2=4TO7],\):(EW.SLEAIDR6@N))9#I$1,D2>(^._^"U7POT1YI?"
M'ACXF^/]5:&4VMSXJNM"\.V$-P-XM5O+31KL:I):PS"&=[>YOIH&1W,*&526
M_-N,?#/P"S^EC+Y%@L!FN.G4G+'<&Y=BL-CUC'&+^LUZ6 IT>'IU(SA3DIXI
M4'[2"G3Q%&?-46.8X_AU4W3Q>8T<+.$I*+I8B4:L9M2O:%*%:%1-)\U.?/3F
MG:<;-V_''Q_\-9_@;XLU3P)XLTWQCX49+V]AT7PYXIDU#27N?#-OJ$L&D75C
M++'I_P#;-JEC!%9W,@L"T3(!<1B5QO\ 6?!^J(KJGA?5O"MG%:H/M.C:0\%W
M<S^:4E2=)8DDN[.Y41@?9Y4$XE95=MT&U?LOXA?\%LI_&GAL:=?_  )\(>+9
M[HV+R^%?B1IO@CQOX(TE$MO+U>2"RUSPM?22WMW/A-'D".L.G&4ZG(;@16S:
MJ_\ !:GQ7J?A'6O!/PL^$_A+X*W,GA"ZTW3(/"=U;V%CH!GCO+;4M7T?2M$T
MSPQH>C7KSWNG6VEW-GI=KK$UPQN)(;>VL(YI_G<VR"AB,+757-,?5IX>*IJK
MBN'Y5:^/E)4J5.M+"T\U6&I/F5*5>K*4H4Y5:]>E.L[*7Y%B,JX7ABJKI\4U
M/8J-1T*=/*<14KJ4N:3I2JT_9T'RM656;IJ[C[2/*G?C?#7QZU#X)6FL?#7X
M?01ZIXWO] N;KQ?J&H.\NA^%-?OH':S:>U6.2+5-<AT=9K:RM=0G_<W4%PD,
M"P3WMR?$8_'_ (=LO"VO:4?#UGKGQ UK4[W47\=ZXD6L:_K$^M)9V.D7"75X
MK_8I-+GOHS96U@L5M:M)#((I'@0I^==W^T?X@\,Z'=:1X?-C=Z18^(KK5;J[
MO;3_ $^?Q!-;O#<R2WB.DMS:W%L&@3S2&985,C%B$#_#?QBOO&LVDW^J+;V;
MZ;HDDMQ!IL4J!KFTU8)IT9"-DR,+1)6EE93O6)EW8W+X>(X-S;%99@<%F52I
M/*LJQ/US"T*.-KT%/&1Y:SKXC#8>>'YZ>)Q4Y16#J5*U%TX0E4<Y3M3\BOF.
M:U%25/FHX&C1>$HX91@H4J=51G-U(V=\0X1YOK,O>=6K*$5&+5^D^,NAWGAR
M^NO$&AZ[?67A;4M0LO#ER?M<VGZ9<>(X[22^N=-TQC=.FKVZ6]FVKAA'$VGR
M710Q11Q6\TO->#_V@/BWX!F>7P]XPU2VDD2>VGBEN#=1R6<J!;JRG$BD2VUP
MBB*XAD\U6PK?*T8KRKXN^-?B+\7O&W@7P8HDN;VUN)=+\ ^ K.<6VAZ#JGC:
M73;:9(;5)9;:SNM471]-NO%OB*5KK5+RSL([K5;BYAL;2*/ZML? ?P#U_P &
M2^%(_$XT/XE_#2X\3>%O%-Y*RVNI>(-3T+4;B"UU^TTVYU*5-<T[6;>."46,
MG]GZGI#SR6D.H7L$JBV^YP-*>797@O[1HK&XZCAGBJ]/+HJOBL+EL,5]5HXN
M4:?U7$8[DE*%+%_4HMN4JT\-A<3A,)7G)+"XUJ5?+Z]13IT9XGV4:GLJOL5)
M1FZ"E/FJ\G/)2IN;KSI.=54YKVD8Z]C^V7XNG\0:;K6K6-K?:G9.C&YU!OM*
M:A8S0/%JGAZ^B81S/I6H+<72B$76R,W ,<:;B5_2?]D7]M'5/#VK6/@;4]<O
M(_#L&F7!T?5;^1;F Z?)<_:-)N7DF6/RE2*YN-"U5Y'58;G3DFEF8O;S)_/G
M-?V*ZYJ>@^<(=8T6Z,%]9.#&9(?+26RU&QD9]M[IM]:R0WUC/;L[K!<(MPL$
MRR*OL/A+XTZSX3LO[+BO;B#3Y=+U+2;V-9))+*[@O+BSO;=;_2F+6.IQV%]:
MPWMNM]#.4FAW1%&<R)[N$Q><9)B\-C\GQ&*FXSC+$8>IB*E6GB,'.-.JTO:3
M?MX5X^RY;2DK6J1_>1Y)>IE?$698+$0=:MB)17).I&45S3O%26L^6,E.R:DN
M:RO/5II?V=>&_C5H.OZ?;I>7T>E>(H;LPNVN-!);7TEZJ6]JU]?P$Q65MKGF
M-9VNL'[7!,\Z6.JP7$+1W,?SO^U%X"\(?M+^"M9^$7B[68?"FJQZC)J_P6^(
M>MP2P:A\)?BA%9M#>^#?&EQ83RZE=>%O$EA:Z=]LN[4Z@NI>$!;7T<6JZAX%
MT^WN?YM-)_:D\1^$K?2[O2;Z?3I(&A&IZ:M[)<Z5/'$US:7EC' RR6MWI.I6
M=U?V6HZ;J-I<:?>6.H2Z==6DMD^P>T^%_P!O.\U7?H7CV\UF9K&TN[?PSXCA
M2TN-234[60/X1EU47S12W$/A[R$ALYH[Q=6M=)O=0T6#4?[,.G6UK^D/CK*L
MPP-; YGDU:IA\3"4,13E&,\-4T7M=:<9U:?OQ]IAJU.//2KPP]6T7!L^\7&F
M68S#RPN,HWIUX2ISA-)4&FG>%1\LI:3OR35I0FH3CR346O/OAOKGQ/\ AU\7
MM-AA_M?P;\:/A?XMGTX:/=?8UN%\5:+?3V=_X9U"^AD-G>6US<0206]W%Y]A
M=PS0:A;R26]RDS?U >(]9\'_ !U\&_"#]HS1=2U+PWKOA^6R\0?V,'M8H6O9
M+69-?\&>*-@+QOH>H6,\VDVUY"7TB^6ZS#/(D5W7\D7QK^-[^)OBG-XNTZV\
M/W!U'3?"VJKJEGH<>@:[]NM]*M[8/-KNGQVGB&>5(+2"$#Q#=>()K)X!%;7$
MD$9>;]_?^">7Q>\(?&;X?>+H?#>I:MI/B2_LS?>*O ^OQ:=-HT?CBWTNYO;_
M ,9>&[S3XK:P1O&*PW;:IICZ!I,UYJ7V_5 VH7,]REO^393;*<SQ,<-*,\FS
M>:PT(XB4:$E6HSQ6(RG&*FE2HK%4:U/ZK.C&=*56.*J*@Y1H2I3Z.$L92AB*
MN!I595:>)O4HJJW%RY+RA6A"3?/5Y5"G7:G:<53J))\R7YW_ +>LT&@>)OB5
MXCGL]9N=,\>_$NT\?>$5:.1-4/\ PE6G-JU_;36D%I'-+JRWE[<:7J$<5C;S
M:M=)$\<2/<,BVO &KS_"_2[7PC>?V?9>(-(TZ*[UC0?#_DPZ-X=UF[*2GPU8
M/'<317#V:I'+KUS"PC@\52ZW;PVSVXB(^K?VJ?A[<:I\2?V?=-74QIGBC4M>
MNO$.AZM-_P 3F[T;4/#VFW U3QUJ-C(UL\K>$8]2CU'0(99HK&?QO:Z"BS@V
M]R+?XW_:A\">'O@IKOPFB\.V]ZFG:I:>+M(U_6+BYEO[_7O$$%QH6M:;J>JW
MC^5;_:]7L[_7!IME$(+2UBTB\MK..-(B9/QK/\;EN*SN/ >,IUWF6<8_/\ZI
M4?9WINC0E+%T)34ZD8T:5:G'&4J-.'ML17Q3KU)1H87#^VK_  ?%N%K99CLU
MQ.#480PV(PDZ]24E^Z>)J.O3HTH1E&]7VV+G6JU)/V="BZ<$G6K)4_0]6\?:
M0;\:KJ-]]IU5U&;2SAF%TEK$B%X_.D/V5UV(JQ6P4LBJV^48"O\ E-\1_! T
MWQ'JWB*Y1+S3!JT]JEXTC+*MM<3RC3[VT>.1IHH2B;X=C*UO#/'N$J.47W?5
MOB>D]O-;6%Q/:7<>3)!<10EY^@+P7:%VC<H7$J/Y#'Y3$KEGV9'P8TV7XN?%
MGPAX#O9Q:Z1JKW5]K=U-:_:ID\,Z#:7.JZM;6,22*;6_GM;8Z=I=TN#87%W!
M<(I^S)$?J>$\AJ\*TL?C(.5##NA%8J+<8<F'PKG5C[&,(PC2M&2ITU^^4W./
M,]8H^(HYIB\WQ^&PR4ZV(Q%6.'HN#<>>KB)PI\U1_%.+G&#O[O)RR47+0^EO
MV$?V,!\9M?;XD?$6Y:R^$/A*_P#[*BL+>YFT[5?BSK>)#)X:TN\M;8B'0/#*
M/YGB[7(WMKN[DGL?#.ED7<FJWFF_U;^%/ D5OX1@\+WD&EZ'X0L-'@L/#7AW
MPA)#IB:-I\EHT*/H%A%;PV-F8[>2,JDD:7#7968RO.[Q7/YP_"'P?JGB*SM-
M \%Z%I6GZ3X:M(;3PQX4\+.FF6_AK3K0--8Z7HNG/)%87EC+C9/83B._>ZN[
MS5H]7GOYY;6[]B\0_M9>*]2L+W[#X,N/"VHZ'9#0]'?QE9FZ\1R^(/LV)M1:
MRNH8F3PGX8M(X;MFOKTZ5--&K"TEMM2>4?HF39YD&2X#,>*.(Y_V?AZ&7>VI
M5ZL)UW4H4IU5B,'AN6G&E+$3G7HTJ=&%6&(Q>+QE.%-22:I?T=D&49;POE5I
M0C[:NG5QN/\ >E4Q,X0NXPO%RIX:C&\,-0E.$7S>TDIU:LY+Q#]J>XTWX&:Q
M?O:_$WQ)/X?T;PS#K'B=KW6[VYBTC2BJS0+XZM8=+M_[=U35M]O'X5\/Z;)<
MW9CA+7T&EV\MI!JWX!>/OVK/BAXT\>>(]7\(V-YX>\(:TEM8:7X?DT6WU+4&
ML;26Y>/Q+J@"WCQ^)]16X^T:G!9WTUG!:6^G:-&]Q%IRSR<9^U/^TSXA\?>.
M-:T3P_XS\2>(_!NG:Q=W$&H:YK5_J%AK^O"15U'QC-827,EIK^IW]XLLFD:Y
MK?VM]-TW9'H\<$%W-(?FKPLNHZU>I+>ZA<&-?+*S-)*75B<;K:.)XHU8#'RQ
M J ,JN24;Y"ADU?B#$8CBCB3!8:$<91<LDX:Q4:^)PG#>68FGAJL:5:CB93A
MB,]Q/L\/4S'&J$%0G;+L#&CAZ=:IB/S/B'-L1G=2HZCEA,OISFZ=%3YZDI7E
M255.#C&*DHN,5S7DVI64%"$MW0=7U#Q[\8M+\*?%'4=3UZUM_%5Y?>.=/$SV
MVFPZ;X<6>[O;NYML'3K72+MK:"!YDMXBUIJ*K;YN+N.OWA_8IU#7/!.D?$+X
MA>*X]:7X??&'Q5>>+O#]KIC:O'X)^&VE26L.F:=KFK6]MINK2ZOJ^HQ6(W"V
ML=.L?#3/!I<NJ1I(_D_B/^T7X?OO#/@;PC\0M"1+&YUB^M_!_BN736:*[U72
MK*Q:?P9/JTT39G?3OL.I::>&+12Z5#+(396T<7O_ .RW\??BQ\!=-M?$&I7&
MH^)O $<,SZCX=T;Q/93W?A^YDA4_VCKWAZ_GDNXXTBFCNBMWIJZ9J\&V"ZOF
M$82/ZO)Y87$8[),^4X4*&%>(RZG@\/3@Z&'QN#JM5L1'#QIT:*A'$2A><8QQ
M3P2PT'7;56E6Y.'8X? XREC5"<:3I55"4)PE5A.45"I*M&5E*G*$E3E&,N;E
M<9IO5GVY^T%X]_:)^'/B._U7PK?^);KPAJ-A-?CQ9I'A^"ZT/4] =(S<1>)M
M#UF,V5_ICVCL)$$R:8EI*;B%+LSW$ _)?64UOQ/X@DB\/:3%HK>-/*(\/:-'
M-;V&KQ1-+/:ZC!H5M<W4%O;0 RWEL#&OE[+NXT]886&?N#]K_P")'BK4? ?P
MY\5ZM=2>'?#WQHM-4\6> O@[:WVMKIVH^$O#\L-H_P 4?'%AJVMS6GA2S\7Z
MEJ=LW@'X:>'I_$A.AV.N:SX@U72M)NO#EMK'Q#X<MC=:;J7C;Q193WUM>2_8
M["YFT]KR,ZD<AG,%B7OM/2(""TTVYT^UECBGD-N5M5=928[&<V)Q&(C4J5:2
MDZ>&6*J1K2=6O\*I0E.G4ITYN5*HX5W"K"GRQG#VLJDEU9IA9XG,N1.LL/:-
M=^UJ-S4:T%**I1A)U:5*I"I3J+GM4E&=*\>9N1]3^$+'POX1TO3Y;/1=(DUZ
M_P!:@CNO$=];&]UBXLMJZ?->R7FI?:[G3TN':X1TLS$#'MA87)4*OS]^T6EQ
MX3^(I\/ZE9MH_B8^!OAAX@U)8U\C?<>(/ NBZG:M?V[$"YN)]$.CW5U<N$N/
M[0EN'F N%DKI=1U Z/J/@C2[S6"8);S1=1O9M5EU51<6FF75M)J#"/QA%9:K
M>Z9%,\\=Q:7-KY1D;:C&!D:7Y9^/GC+7_%WQ?\7>*]2D\2ZR?$&JM/IVH>($
MUS5=0U.UOY_M>GPQZC-#=MJK16]];Z98FWN+EI+>"TM87=8HE/@\,Y9#^T,3
MB<15E7JUZ=>I/FG-R:CB(4DIJ4I<L5!1C3I7C"-.-Z<'RQY>)Y?"I.OAXTIT
MI4W0C34:<H*-*$)57[2U)N]24XQY[*_O7E/FC;G-6UR;7'AN+AR9(U:$^:<M
M'Y;M+& RX^5,-M;:K!F8  A0?=_V7/@)\9OVD/%]QI7PD\.Q7\6BZKIUGXA\
M3:Q?R:/X2\//.'NBFKZT;6[/]I+!9M*-+TVTU/6$BDC/V%!+$T_Z1_L>_P#!
M*N35;32_BA^UA#?V^FW,MC>Z%\ ?#NJ)8>(+V-Y(?*N?BSXL_M#3K/PE%>3/
M%#!X*T;4CK<5L&D\1ZOI%Q.NBVWZL>-/&_BCX4^$%\(_ OX=_!#P%X9T*SEL
M=(\&>"_&WA[PC'8?+B&"UT'P[X,T[PO8>4[F:ZF'B;;<R.DUW=+<3SS/^J4\
MAQ%7!^TJVP>#Y$VO9.MB)46G*U##J5.$'4A%JG/$SBE)I_5YN*4OI,+PU*&%
M]KF"JX;"\O-]7C3G/%5:4^=Z*\845-*23G>HOC]EJHGBOA[]CSX,? #2+76/
MC1<^,OC#JEN'O9_#>B>#M=T/P?JESI\EQ=06UQ86BZQK.K:=I1N66!-1N8+*
MY=_MUQ8Q/)#9Q?(?[7G[?6KV_@"\^%GP36R^%G@_4YM0TFZ\"VO@]? ^O6.F
MV<_D7KW5UH-]_9D=OJ<Z36=I8S:+;7NK:?\ :+W55M1+#;3_ #E\;_VM_C'H
MJ:SI7B37/%OAK6_,8WT]OK+V.D6TT?FR$6VN:?J4_P!JDA=5E$UIJ(L$CQB2
M<$,,S]GG_@F?^T#^T]=VWQ)^)]UJ'P;^$.JO:ZVVO^)+6XO?B5X_LM05+N.;
MP/X3GS<1VUY8E+B;QEXTGT^RA@FM[K2=)\5(UY]@\"C@LMYIX;),KE@J+M'&
M8JLH8C-<34YU.I3^NSG7Q%&A)I*O"F\-1]G>+]U-+SW.KB)3RKAO UL+&=Z>
M(J1IQC6=.3]FW7QG-[>+J>ZYRJU**Y9-03G='YH^,/%-SK-COC^U3.NEVEO>
M/(28K:ZM+2.TDE158HYNKB'S8VE)**[;H%*[C\J^$X6::WFDR#((Y'.?O.%!
M)+_*7W,-P)4,N&?#5]:_M,^&M(^%_P 8?'O@KPLNN?\ "&:=K=[-X.;7KBQD
MUH^'X[MHK:#5K[3IY=+U._M)8WM;B[LI6COE$%R(XGN&A3YY\%:+>:G=W%MI
MUI+<&&0;1%$66%<ML,A"L(PP_=C#%CC]V&(->_E4J%+*JU:E%+#5J=&I1FM(
MRI2C-1:>BZ7::C).-K73BHP5!8'!XJG9*+GRRJW7+[LJE*I)..DW[6_9OE4O
M><G)^Z>';'0-1TZ[AN-T%W+&L<FZ%3&'9@UM>0MYD3 (ZF.\A*999A/&Y:%X
MF\0\>:+?>'KS3M2MI7MIK6Z=H[F+*R1R*\8ADC9L[T=USL8.CK(4;<'<UZI<
M^&-=T^R@O)"ABC*QL(O,)@E^5S%,@10KDC#;B0V/W3.59JI^);8>)?!>LJ^)
MK[3[0W\1_>.Y^Q?O9 &8LZ@Q;SL+L04169E&Y>/ XET,33FJJK8;$5(T:T)S
M3C'VK5*VEXN#YU>,E9W47=24C"A4]ABX3C4=6C.HJ-2/NS485;4FTK<JBY33
ME"2LHRMS:Z];\./B$-<LX[:["K>11HEY;*JF)9F!3S[=?,#-;W)5E6,Y>,DQ
M%V #2>H-;:9=3$SVVS?'(5EMV,3+MV[7$8_<R$,I*QN4!.!OXWCY#^$GAF_U
MW7+'5I]0AT70K":.2^NO."WU[;*7:6QT^V".&:=4V-<W!2&U!$Z"61$C;Z^T
MNV@:XFLTU-;F&WE+07-R/(,]I_RRE>-RQB<(P+I%*X6;?Y>Y) 3Y^=X;#X7&
M5%AJM[)5*L:::]E*<_AYU'EO9I\J<N6+BI.Z:?CYO@*.$Q=2G0G>+CSRIQ2<
M:+FY^Y%I*+MI:"<E"%N9QMRGZO\ Q:UP:UX _9@\,2W-QI'A_P ,?LZ>!Y_M
MMO:27$T<GBFWM);W4;F&*0SRH8/#^DP7"K.7CMK)5@5D_=5W/A7]G77?^$3_
M .$ITKQ;HOB758(/MD?ARR\0)9:OK22'S8Y=/M[Z6PN[D:@L*3P^7-))NC)E
M5Y+8)+X:OBW5;?1OA9KGAVY@TW4-!^#?@(V5Y=ZI8:?.8])L;[2WM+.+5)Q#
MJUJVHVES]DCM[::9IDO;9HI!+<K;^#>*/BEJVM:I_:5]HNAZ3-;BXN)VT&VM
M]&T274I2C7$^G:/96T=AIMU<ND3S)ID$:MY+,1%&723Y7('@*&*QN)QJG4QD
M\96ITZ\HRBG3I1A1BG.$N6K['V48ZTHJ^G---L^VHU*%*K/$54Y5:D817+)1
M<81PE"$)-:^[&*]UN*4G=N3NW)GCF_\ &7@S6_B/X.\9>';.PDU2]2;7?!?B
M2&'43?1O-+*4MY5>X-E>VB7'GVNJ:.]M=Z?=JT,;>=+.R9_PC^._Q$\'7,GA
M+3[NR\2^"=3N++4!X/N]+LT@:\TQ%_L_4M%C00R:9XML%6.*RU+29[+4Y6MU
MCCD9Y'AG\9E\67,EK?Z??Z5IU]:S7"W#*T9M+EIYYY9&N3/;".5KB.-(XK6Y
MD:::P@\Q;(P":99.7B(DEB2.2-)\N8FD9$BW;MT2R2OM"LIP$G,8^95EW1N,
M+[%?'5,1JX^STJ1FE)OVBG4E-.6S^'EC).R;3ERWN7#%)34Z-2<7+VCYI.UX
MN3O'FC*TXN3<6EORIV4MO<_VK_!^I0^&?%OQ9^"&NZNGP@^)%SH^N?'7X:HL
M6DR>'_'#ZAMTCXLVGAJUN;VQF\+^*M1N(](\375FUIK'@WQP+C2M:@N]!\3>
M'[O3OR0U?5;JWFG@=@C^6TH52S@[Q(H9' QB0%ERR[E8$;2PX_9GX9?$?5+*
M]FT3Q#)%J%O>37$<\7BRR3Q+I2OJEH^G:UI/BS1]5:XC\6>!_%EF\VD>,?#%
M]*(-3TF>Y1=URMM(/D3]JW]D.7P_H]_\7?@=9ZEJ_P .](D:Z\>?#L76H:]X
MY^!<EXCRL-0O[E&O?B#\*;U+9[WPM\0[/[9JVFV%K/;>/=.TFY:UU36/>X=Q
M>$A6>&Q%.A1K8F:E&KRTZ?UNK*,*49591C!SQ*A2I475J2E4K0IT5*<G2BXU
M#!T:N(GB*=*%.4VEB*3BE:2O:M2B[-PFM*D(R<HRE[2RCS<N'\&?%)L;.V:[
MU$VD:VMNPN8I%=&/E>9&C+M=2ZXW!A"< J!\O7Z!U'XIM);A'EDU6)@[ "Y@
MM(XI&VAYX[A8_-EEF;!D06EL5("F1@-U?%/PO+GP[ISR#>ESI\4L;C]Y$T,B
M+/ RR@F%@("JQE'=<$*LQ1B3]7^"?@]?ZZJ7MW#/#!Y,MRL1FV+]DAC\V:XN
MYY'CABBBC!:=II4@BC.Z24'IX&=T,LPN*KXG%S5*$9S4K.,.=J=1)1BN67,W
MRV5[-M12YIJ_Y_F&%5/%UH1<TI59.%.,4U)\]12E%)MJ[2Y8ZOTYCC-=\7W>
MJR$:;!(9I6*RF<&\E5,9C07;C,4*C>[+&HWLO!8KD^$^)=0-YI]E<^?)*-4D
MOGAD*^7'/8VC"UM[BWB68LUM>S"\:*9FS<0I'*0FUT/L?C_7_#6E>&(/^$6L
M!-_PE6IZUHFG:E#!!:B]T/1%@@\0ZC#=6P&H3VNJ75VFE:3=NZ32VL-_=J$C
MO(HT^=M1N]3U.\DO;J-I;F18(;>&W7$-E;6Z-%!96<"%(K6SMX"(K6VM46.%
M%8+%$!@>QE%*FZ7/&A.A3C4Y8JLTJC=-N#<U[SM&H^2$>9.\9N;E)-&^ PJ@
MI59Q:DWRQ<^7FLG=MV5X^][L=5>*:NTVEGNJ6JEMKG[X7RD4C(^;*KD@-A,G
M 8@C[N6(6C->+/@01S[OF)$[8C55  V * NTD%6._)+!0I) LW"7!;,[16Y1
M0_DAY6E+-T3RD0E9 1]\[1AF#%2Q%5'+*"41R!@AGD  Q@;4AB+H"&!VDL 2
M2"!\V??BUJK*4I)QNVTDFKV::U:>M[OI[UFD>I&-VDGS2;2B[M**>G*TU9O2
M[E>R5TKV;4<[.C;L;MQ8."1&"54C&7)4Y.6>1MH.",9YJ>+5$@C9(I/WC*0W
MEN6A 8 *ICV@NT8/\#)O#99XSUL^%_"/B7XC:]!X9\!^&_$?CSQ/<7<5HGA[
MPGI5_P")-8^U3#;#%/8Z+%=O!YC%FQ=) BA7=2(T=U_1KP3_ ,$=/V_O&5E;
MZG)\(O#O@BPN@&27XA_$_P $^&;Q0 "2^@65]KOBF/RXVW/'+H"NN> -V#UT
M<-4KQ<:-*KB%3E[WL83J\LFE*TE3C**DUK%2:;MH=U' 5L3%NC2Q%6*L[PI2
M<>;1VYFXQUDE9J;;7O*/+J?(7PX^RL$>_?Y"<E[C-PK2J62-%B( )!))"_(2
M5!5."?9M56S&J^$Y-/1!'-XET]K@3VZ*/L<<I>[=X$*F3RX0SQAF)RD:;T0@
MC[6LO^"+G[9FE&*.;QE^R]I]V?+B%A/\7/B +H22!61/.C^",FF"X=2)$$=\
MY8;V#E!)MZ;0/^"17[:%GJL%_KU_\ ;?3K5)BE[-\8]3EM_.E@S;;_(^'UQ<
MPK,KGR9YK5(I<C<R(-X\+&9'FM6I4KQP6-=HS7L5A:S3O3J13M%+D?)-/FDX
MI=;K?Y_'<.9I+%/%T\'7?)%\M""IVE:G4A%2<:L>6#<]92Y4FDY-,^"/BI\;
M]:MH9=#T&]N['3YC,MS:12LUG+O"K*L%NET\1:>3<TQ6SA:<[!*K^7&Y^+-3
MEO)I+H39-U<13!$D*AHVD$C,)@I<!ER&$9&XM\K1QGYJ_;_Q!_P23_:4EM)[
M_3O%W[-T^HRB4S:E=?$_Q.;2"?#%+2QFLOA5JEA$Y41M]H:]C++O\V1/*6,_
M&7CG_@F3^V9X0:X:V\$^#/&%V<Q0OX$^*O@W7"UQ(CR1LUGJ=]X>U3YDWM&T
MU@AD578*R;BNF5X'^S\-1HU,+7PM."2_VB$HWG[JLGS3<=>:7/)Q4KO=)I=>
M58*I@X05>BZ3BK3JU)4VY2=N>S56:C"+3M+22DI1[2/SXMKQY5MV4C;((\L
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M#J6B7EY<W7E1)KFCZ]HFC:CX?U32($F@MM4L@+RVM88K;6-.G>Q7R_I\NR[
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M"D[:A?6(O+Z%5-L()O$;?]K?PYXE\8)X&DT_Q#\,?B'I]E<2R:1XQ\%Z]=^
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MCEW $E,;"S*2"N%XRH *ZGQYX&M-*4^,/!%Q=WGA.ZDB.IZ=-/+<ZEX6N)6
MC\YY'DGU/097E,%IJDS&[L&VV6J^:&MKRX*[Z,Z&,IJM2J58J\H3@KTJE.I!
MM3IUJ2^"I'W5O)2@X3A.<)*1A#"TVG[.\DI-/EOI)6NFE%M/RE[R5MU9OL?^
M$;OOA]H6@I86L4#>1?6\F8VDEE6\-H)S,^V/S)F-N[2S;1]XH@1(O+/K7PS\
M /JTD.O:1// J2LVHV[@R2M&%E6VBN'A 662XNHY)D*1[4C;[1$[/E1_<-J'
M_!&7]@35+:.TO?A;X@DAB:1XU7XB^-(S&TK!GV;-54*"1G:!M&2 H!-)I_\
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MO[H+W_@B'_P3RU#3K'2[GX6^*VLM.5TM(H?BGX]MA&DC*S)_H^M1*4#*"J8
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MQ#J'B#4H88;Z:_\ B3XWO;2YC@M8K.))=.NM7FL7"P0HO,!&[<_+,Q,^K?\
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MV#1Y0[E8[<D$$UG:_P#\$//^"=GB:[GO-8^%'BJ>>YACAE>/XI>/H 8XY_/
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MO0O!7B*'Q!?7?A[PQJ\^AZ]J<]O9@-8KH^KP/9WMCJ4FGZ@H,<@MQ!<0S/\
M,O[&O[?.EW'['?P/^-'[;7[3O[&^I>*_C+\4->^%WA3XI?L[>(?&EO\ L^>-
M_%!N_$E[X>\.^&-<^)6@>&]:@U5-"\,ZS/JDNLZ;I>GVBZ7.);J22&:XF /U
M=HKY3_9S_;E_9 _:[N_$]A^S+^T7\*/C=?\ @V*VN/$VG_#_ ,56.MZAI-G=
MRM!;ZC-8Q.MU-I4\VR&+5+6&?3VEF@C%SNN;<2<[K7_!1/\ 86\._'%/V:M<
M_:P^!>E?'=M6A\/M\,KSX@:%%XCA\17#^5#X=N4:Y^QVOB%Y\VHT*ZNX=5^U
M!K5K07*F( 'V=17RQ^T=^V]^R-^R%'HC_M.?M#?"SX(OXE6YET"T\?>*++1]
M1U>VLY!%=7MCI;-)J,^GVTF8[C44M38Q2QS1O<!H90G0^*?VL_V:O!?@+X:_
M%/Q+\;?AUI?PU^,7BK0?!/PQ\?2>)+&X\'^,_%/B>+4IM#TG2?$-F]SIC27L
M>CZH3<7%Q!:6W]GW:W=Q T$BJ ?0WZ?7WH'('3IVZ?A[5^47C3]N^W^)7QM_
M8'/[(G[2W[&?BG]G_P".WQ0^._@3XG)XO\1>--0^(WQ1F^%6FZ#;3Z#^S+-X
M2T#5/">M>(/!VM7>KCQVOBG6O#]G9B7PW+IMSJ]I)J\$'K_C?_@JA_P3I^&>
MI:AHOQ _;%^!G@[6=)^(_C#X2:EHWB'QA;:9J]E\0_ ,NC0>,O#<^F7,:7T<
MOAVX\0Z-;:AJ!M_[(CN;Z*V2_>=)4C /OZBO%?BI^T=\!O@A\*V^.7Q<^+_P
M[^'WP>%EIFI0_$GQ+XJTFQ\'ZA8ZU:F^T6?2-::Y-IK/]L6(-_I<>DR7LE_8
MJ]W:+-;HT@\J^"O[?O[&'[1OBSP[X%^!'[27PK^*_B_Q9X.U?Q_H&@>"?$<6
MN7]YX2T#7K[POK6JRQVL;+IYTO7].O-.O=/U%[34X'B29K,6\\$T@!]?T5X%
M^T#^U-^SG^RGX7L_&G[27QK^&_P4\,:G>R:;I&J?$+Q3IGAU=:U&&-9YK#0[
M6]G2]UJ\@@DADFM=*MKN>%9HC(BB6+=S'A;]MG]DWQS\!?%O[4/@OX__  T\
M6?L_> ]+U;6?&GQ3\.^(8-9\,^%M/T&T2_UF37)+!;B[TZ;3[*2*ZN+.YM8[
MU8)4D%N59"X!]245\4>"/^"C_P"P;\2?BWIOP'\!?M:? KQ9\8-9@M)])^'^
MB^/M&O-?U(WNGV^JVUE90I,(;G5Y=/NH)QHD4[:NCR>1)9).CQKT'[0G[>?[
M&?[*&N>'/#'[2/[2_P (/@MXB\611W&@Z)X]\8Z9HNJ7ME-,]M%J4EI+*TVG
MZ2\\<L::OJ26FFEK>Y NL6\YC /K8=_8_P! ?Z^U+7YG?\$S_P!M'Q_^VIX;
M_:JU_P >:)X'TB/X)_ME?&_]GWP5=> GU*33O$/@#X<ZAI\/A;Q+J-U?ZIJD
M-]JNLV%^MW<7NE31Z3=QR03V5O'"RD_0/[1/[<_['G[)FI^&=#_:5_:0^$OP
M5UGQD"_AO2/'OB_3M%U/5+42O U^EA)(UU;Z7YL4\0U:\BMM-WV]T/M1-K<"
M, ^KP<Y_#]0#S^=+7Y:_L(_M_7?[1WA']MCXC?%_4_A3X(^'/[,O[77QF^"W
MAKQYHVLM8>#M1^$OP_M-"O\ P[X[\2>)-9UB[TAKG5;#6$O+C5K"[M-$NH)+
M5K&!/-3?]/\ [.'[<?[(/[7MQXEL_P!F3]HOX5?&R_\ !X@D\3:;X#\56.K:
MGHUO<^6+>]NM,WQ7_P#9TS2PHFI16\E@TL\$?VC?-&K 'U717PYX+_X*7?L
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M"XG;Q+;O:W5I.T^CQWD445U;-.T7GQ;@#Z@HKYTL?VN_V7M3^!<G[3EA\?\
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M&!G/K@=>I[DTAC4Y..>QP#M//S $=<G.3GH* /Y[O^"JECJ?_!/SXU_LP_\
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M7XF?M0W/A.'X=_MFZE\4/$W[1.B_M2Z-X8_:7G^ ;^ ?$GQFT?4]-\)+\/\
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M\61>)T\4:KX7T35_%&K6>F7VJ:IK4/A33;E]-T^XL;/3T2T^W/CS?6<'P/\
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MJ3PK9>)/BU\3/!'@G4=)T;4=+CTV#2K#QU=?'CPKX)\%:OXGOM+>7PO)X_\
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M-4\<>)_"?B?0Y/B OAG6?^"D/C@:7<:O8^)]'AU?P1'\ =<%AJ$%A?F.?_A
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M<D!<[27*YR!T+!023@XP<G'.3^,'PY^&D_Q<^/7[.WA+XAM\7_%/[/$?P?\
M^"A6I^!?"WQ0U3QQ+;>._AE9?&S]A"U^$VG?&:U\5L==\=:1;6^H>,K[X<V7
MQ5FOO$^N^";32]1\0KJK_P!N+-U.I> 9[VZ\%? N*;XAZ;\*/"G_  4!U;P?
MH^@Z1XC\:Z?'!\(+G]GCQ)XQG^';ZY;7PU1OA&/$&N7VA6OAK^T(_#FF>&OL
M?P_TP6?AG3['1+< _7,M&RE61F&U=RM&[9';(*DD9SRW<$YX)#VV\@@Y(Y*J
M2PSQG*@D'C@]>..E?E5H?[)GPGU;XP_M1_#[4_#WBL?"?X=>"OAGJ_P.^'NG
M^*/&'AGP+\$_%7COP]XSU#QKXM^ EOX;U+1S\._&[ZKX>\/W^A>)?"%Y::_\
M+;[^T9?AC>^"/^$Q\61Z_P#,OBSQ3XP\67OPHU;]I^X\)7OACQ'^R=^SIXH^
M%.L?%W7/C/X!\/0_$[4?#&LS?&7Q?X1U7X1>'X9O"_[6EAXIO/#\NE^($N-$
M\=>!_"UQX'O?@!=:-KNJ?%T, ?O:)(R=H&2#@A5+ '()Z#ME6).,!D8XW"LB
M\\0:%I^J:+H^H:I866L>(I;^W\/Z=<W$4.H:O-IMBVJ:G#IML[":[DLM/BDO
MKN.!7,5K&TT@V*Q'Y/\ P<^"LWQ=_:1\5>%?VGKN[^.^D^$?V%/V%=4<>*M&
M\1V'PV\?>--;^+G_  4"M[CQ?XB\!^(=/TK1M8\=Z+X=T7PU)<2:GX=TN^L-
M1UD>(-2\.Z;?OX.3P]Y[K7@_X62:O^QG\1OVD?"NF^+_  _\+OC7^U=\%E^)
MWQBT"]\?>)M,\,>$]:^*.C_ 31O%7C?Q/9ZWXN\0:G&OAS2K?PSXO\5:AJOB
M/Q7XEM[/7]6\0Z]X]\0R:SK(!^WA56!5E4J>JD @\YY!&#SSSWYZTN!QP.!@
M<=!Z#VKF_#?C#PWXN/B!?#FJ1:F?"WB34_"&OB.&YA_L[Q)HZ6TFI:7)]I@A
M\V6T2\MF>:V\ZU?SE$4\A5PO2T (54@@@$,"&! (8$8((/!!'!!ZCCI2%5ZD
M9]NQQ@CCH2,#!QD8P#BG44 -VC@<8!SZY^7;S^?;^II2JDAB 67(!(&0#C(!
MZC.!G'7 STI:* &A5#%@ "2"2."Q (RV/O8& ,YZ#T& JI&UE5EXX(!'RG(X
M.1P0"/0\TZB@!"JL"K ,K A@0""",$$'@@C@@]J"JG@@$ @C(!P5.5/U4\@]
MCR.:6B@!" 000"&!!! ((/!!'0@C@YZT!5'0 < #CH!D #T !.,>I]:6B@!N
MT9!(YSG(R.<$<XQD8) SGK3J** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $P._/3]#G^>/R
M'I2!$7<%15W,7;:H7+M]YS@<N>I8\D]33J* &A%7)"J"S;F(4 L^ NYL#EMJ
MJ,G)P ,X I0JJ,*H RS8  &YF+,>.[,2S'J6))Y.:6B@!  !@#CG]>W^?2FB
M-%+,$4,X4.VT;GV#"[VQEMHX&XG':GT4 -"("S!5#/C>P4 OM&!N(&6P.!G.
M!P.*7:O' XQCC@8SC Z C/!'-+10!Q&M_#WPUXA\9>"/'>J6]U-X@^'T/BF#
MPU*E[<16L$?C+3K32]=%Y9(XMM0\^SL;:.W^U1O]E8221$-(:[557"[0 H V
M@#   PH _A '0#&/Q-.HH :$0,SA%#,068* S%5V@L<9)"_*"2<+P.*7:,8P
M,9SCWSG^=+10 W8NXOM&\@*6  8JNXJI88)4%F(!) +$C!-8U]X;T'4[W0=1
MU#2;&[O?"]Y<:CX>N)[='?1K^[T^ZTFXO-/R-MO<2Z;?7ED944.+>ZGC4@2-
MG;HH :R(V-R*V&5AN4'#(=R,,@_,C ,IZJ1D$&D9$;[RJ<%6&Y0V'4Y5P#P&
M4\AAR#WX%/HH XKP-X"\/?#OP\?"GAJVGBT1]=\8>(G@O;N?496U3QSXMUSQ
MQXBE>>[>21HKKQ%XBU6X@M\^3:6\T-G;HEO!$B]D=H).<';G)!(& 1N]SC@]
MR  >,4^B@#B/A_\ #WPS\,?#%KX0\)6MQ:Z)9:CXDU2WBN[NXU"Y6[\6>)M5
M\7:T6O;MY;EXI];UK4)HH2_E6\#Q6T2K%!&!VVT8Q@8^@^G\N/IQ2T4 (5!.
M2.<8ZGIG/TY[^HX.1Q31&@+,%4.X =U 5GVC"[F7#':#A<G*CH:?10 @   Q
MP.@].<C'ICMZ#I6)KOAK0/$]I%8>(=(L-8LH-3T;6HK6_MTN(%U7P]J=MK.A
MW_EN"K7&E:M96FHV+L&^SW=M#.@#QJ1N44 -9$<$.JN#M)5@&7*-N4X((RK
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MR]\3/VS/BEX>_:+USQKH5U8/^QQ\$?BMX _9X^-,@T:SNKS4?'WCNSU--?\
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ML&]UKX4_#_3F^'/Q DA\&_'F;PWJ.MZ1H/QZ\/W6D:1K/P?TC18+%]0UN_\
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MCF[U#Q-:V4F@Z)-8)KNFBVM-5OK:YU)I_+LHII!M(!]#T?Y_S^8K\-/V7_\
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M/#OAUH/[7UGX1^+_ (C^"?#'AOXD64%O<1ZA;MX7U'4&O]+$FJV$=SIZ_:0
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M-:98VWA#Q!JUQ"\7AOQS&K:E8I8LT6H(D]W;!@D\BO\ T2X[_P">_P#CUHH
M_GSU3]D'XP^-OVI_^#@#P[X>^&NN>$?"_P"V)^Q[\%/AO\&?'NKZ4^D^ ?B'
M\1M=_9M^,/@#Q/<:;K4KQ:=J.H:%XL\1:;#XKG+QRV'VR"2ZD2.X#GXMUCX2
M?M>_M8_\$L/V;O@#X4_9!_:<^#?QW_X)K>-/V/OB%K?@SXT:1X#^'-O^T=>?
M"2T\5:9XKTK]FOQ7XAO?'O@WQ'XF\(#0[7Q3X;U/XC^#AX,&LW_A.%],\2B>
M2PD_K>QR#SQ[G'/J.A_'IVI JCHH&<YP ,YZ]/7 S0!_+I\#OV:?&W[<'Q\L
M_$/Q7\-_\%B_AYJ'PS_9Q_:7\ ^%OCU^VAHG[*/PLMO ^J_M*^!$^%.O>"_"
M^@_![PYX:\?_ !-_XE<K>/M/U :G?>%/"7BOP1X>EM;6RD\3WU]+\P>._$_[
M9_[.?_!&;XT?L->.?V%OAY/X"^$GP$\?>'-4_;7\$_&_X/3_ +(WB+X<:;J5
MR[?$GP/IDNK?\+/UKXL:M-+%9>!_!,O@RRU%_'$FG7.M:KH4EA>V2?V58 !"
MX7.<8 &">^,8SDYY')ZU^0VE_P#!"'_@E;H^NZ?JEG^RKHCZ)I.N6_B/3_AG
MJ'CGXF:M\%X=3M)S<VXE^#>I^,+KX;W>G?:/WDVC7GANXTBX16M;FRFLYI[>
M4 ^*O@[\"/B/XL_;1_X(7_%AOA!XI\0_";X6?\$P;_3/%WQ#G\)RZAX+^'_C
M[4O@_P""H_"6GZSK%Q ]MH'BRZD:Y70T<0Z@K&86[1,S S_MF7'[<=S^V_\
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M-!\6_%CXI>.O$DY^'&H16-Y9VGBNW\9^"[Y],?3(-EDPB=XO<1_PT%_P3O\
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MTOK70?BM\%K[5I?AAXS^"?PU<2^$="=O^$6\&>%HK/PYXZ\&>#_$GBS7)-5
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M/M6\/^'-)UBR\+^$/'-YJ'Q?L?#=O\5]>B\<I\M0S:!K7C/]A_3_ -I+Q?\
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MYO-5\2^%](^/_B7QII/[)][\=/VWH?B7JTOB_P ;^'M-O?B=IGQ*\%0_L\^
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M\-?$NJ>/O%%EXJ\3]5\*;#XFZW\3_"^J>(/C%X.\$?M81_'!;7X@:+XEU_\
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M#N;S1([>V\8MK,,$>CW=UI44:+'IUQ+9K#(P![!1110 4444 %%%% !1110
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M0?"%[:ZYJWA;5M:T31M%TSP1IGAGQ'JD=IT/B'XD>//VC/!6N_$[XC>++O\
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MY_ OA3QOXC\.Z&NN3^)7TRVU?Q1X4M[?PP ?M0\,!DBD,,32VZN('\M6DAW
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MD:18/]C@F%K'/]EN"][=B*TA"$RSH74-U_D1+*UPL4:SNJH\WEKYKHIRL;R
M;RBY.U-Q4,<@9Z_CE8ZCH=SX^T+2?@SXD\4>-/V7M&_:8_9'_P"%;:UJFM^(
MO&WAC3_B7-_PN*W^+_AWX7^-_$MYJNJZ_P##;2M L?@_JMN;#5]8\&:+XN\0
M^+],\-:I$L6H:)HO.-XGL%\/6FLR?$+XA7'_  4B/QATK1[SX<Q>,?B&MT;R
M7XJ60O\ P2WPJ?4X?!4G[+4'PX>Z:[\6Q>'KGPFOA@7'C;3_ !//\2HK?4G
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M4\*1Z3?27%EXBMK[2CKMO#HVK^2NCZAJ9T97U.71+:_DUFWLXI9;BPB$4@4
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MFUS%T[3/V@OA)\5/B7\68_@%#\8]1_: \+_#!]8TWX>?$;P3;:O\(/&_P_\
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MDCH3[]?S- #4.5ST!9B,@@X+$\@@$'V(R._-/I  .G_Z_<GJ3[GFEH ****
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M+?W%_P",/B18:1I/A73F\-^*?%WZ?X'IUZTA .<\@C!!Y&.>WOGF@#\KM/\
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M 8'.0Q *Y&.F#DGTYI#(!M'(+D!<C'+9)'/4J 20.@'ID@ DHJ,OL7+$$\
M?Q'Y1@#L2QP!GN!G)IQ; )QP.OJ.N20<< 8/&2<\#U '44@(8 CH1D4%@HR3
M@9 S[DX'YD@?6@!:*0$G.01@D?4>OT.?TI 1DJ""5 W#.2,_=S]<&@!U%%%
M!1110 44']<'C_.3^AJ/?@@<@M\W(.=I8#CCC'&X'!4,._! )***3(Y'4CJ!
MUYY'YT +13-Z@E<G=@,%Q\VTX&['7 .<\9!X(Y7*+(K!64EE<;@1RNWINW=
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MN8H9(_TP^!_[)WP+_9XU#7]?^&_A"6W\7>*8(K7Q+X\\3:]KWC3QWKEG#/\
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MJ1O%FH:K>>#(?#5M%KOQ3^W'_P %B?VA/$?_  3K^+OQ?_9I^&GBC]F#X\_
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MO"ESXU>ZT75G6W\%?#&T\<?%&\O-,U"&P\!W44FE7&IZ/BW]JOP=I%UX?L?
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MN]_:&T+P1JGQJ;Q;K>M>)CX2^*W@SX<>$/!?ACX?70\3W7B?QE\//!WB30O
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M:4-"TQD-]IIT'4SJ-S-]MM GV]28  &.!C ^G3\J /CR/]F[Q''\"=)^$_\
MPE.C'5M/_:&_X7,^LG3[_P#LZ72A^U;=_M")H:VIF^U+J']B7">'!=L[6O\
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MOY-)\,/^T/;^,[?1)=6T]9UN]0C\-MXHMVU5+*:#[<MI.EDT1>,C[8    Z
M8'T%)@9SCDX'Y$D?D22* /@[QK^S9\4/%'Q[MOB3HNH_"+P#IH\7>%/$%S\0
M_ NG_$OPQ\9]7\/>&[W3)[OP5XNL-.\6Q?#?Q\^OZ;ILGA.]\4>,--U".S\(
M:F^DV?A(7NEZ;JU>P_%3X!VGQ6^*_P /O%GB.?3KWP)H7P;_ &A_A'XT\&W"
M:C'>>*-,^.C_  DAF$&IV%W:OI]E::9\/]:LM0,<BW\S:S9RV%S;R6LK-](
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MW[+/C[XT2>/M7\?>+/"7AWQ)XW^#/P,\+VS^#-+UO5=)\-_%'X'?&?QU\9M
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MX]J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ R#T.:*_SE!_P5V_X*;#'_&8OQ!;CJ?#/PQ'?T'@89.#UXZ>]._X>[_\
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M&7_A&_AKN!+[3_S)! PHSC&1N )/2KG_  ]G_P""E?\ T=_\0?\ PG?AI_\
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MKFE[&IVC_P"!K_(?S3^__(_OK_K17\"T7_!4;_@H>Y&?VK_'O!/']A_#XAL
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M_P %=O\ @IJJ\_MA_$$-P,'PU\,BP(.",#P,<E>6;.21[\%^QJ=H_P#@:7Z
M?Z--%?YR:_\ !7G_ (*:MC_C,/X@8(R"?#'PQR0.#D?\(0,$'C&/X6.>**GV
M-;^2/_@V'^0'YUU$PR<\XR,[0 P&>Q/))(# +GA3D@@"I:82 RCC+ ]3Z>@Y
MY.[GV]>!7:!8&-@*KP0"% VCGY@N,C&>G)[X.>:MVR,D8R<[COYQD;@."02"
MP(&2#@YX]320X1.>2J 9S\SE5 ! !;T P"3@@#(YT8QF- 01A5X/4%0.H[$,
M.G;B@!YQE<G #*3_ ,!(;IUZ@#\:DRI(.T@ED'W6Z!UQV Y&.G/&.<+EUH@G
MO;.WQO,]Y91;!R7,UU%$JA1U#;\8/#;BHSDBO7AX54D'R>2.6:-#DD<D<8)8
MY]#SGO0!Y+&<3NQ&%WR#)'7<4(('4\ G)QP!SR*L^:N. [\\A59FYYX !RHY
M'MCICFO4QX15R L(*Y &(R>,JO0H3R,'U^Z.,#+XO" W*6@"CDD%!@KC.<A3
MQQ@$<GKP#B@+J[75)-KJD]F_6S/*C, ,E)1R!S&1DGIR<*/Q(ZYZ TY&&]F*
M,QP@4!=QR#*>!R <$<YS@\8YKUT>$5/W88\_[+%1@#G)*X(YQ@DY/3G@31>$
M<;P84&[:<%XSG:7YW-SW4!> !C@=  >3PMAV<@J-KCY@5+%BH VGY@,)R2JC
MH!D[L6_.0 Y;.,]%;)QTQQU(^GX5ZF/"*X'[A2!D#;(,'IG.T]01@D@DC Z$
MT?\ "(J,?Z/TQ_RV)Z>N>OOGKWHL.S[/[F>5K)A0&W,?7:>?0]._4=R.N3FG
M;MV,)(1ZA3C\,D<Y^7\3VY'K2^$%"J# A.!RS#/X_*W/J2<GJ>M2+X0!P5@0
M?[0R0#GC!5,]#G(Z<@XZT"LSR9'8+@I(3R<B-RH!9B#G&<;2#CL,9Q5R)@J*
M&1U(WG&PDC+L0.!M/&0<$@;L X+$>K?\(FNT Q@L !DC)..,DE,X."2>?E.2
M3G)?_P (@?\ GW4#.!GRQQG [$#/UXH#8\L5RW"K)QC)*'ID X/()&<XZ@<D
M'J798C!C?/'\.!D8/][G'7KSCCGBO55\)1A0&MRQ!SQN4 ,!QQA2%QDD9!)R
MN><O7PG"2H^S.,$+N/F%0S9))))7:<<AN"3EL@,* >B<GHEJV[V7Y_@CRR,[
M(T5\Y5%!.TD#"@$9 QP00",@C!R>M.#,SJ " &5B3\IVATY^;:/7(4ELCICD
M^IMX<"(Q='"1H^3EMBJ@&X\[1LV\]@$QCK5:/0K65I(K>2&62!BLB1R!VB .
M2DD<;%U.XJ1&P4@!F"LP4$$FFKQ::[J]GZ72_(X(RJ.FXDX&$5CRQQ@<?]]'
M@@N#C S3D8NV0KG@CD!<[0A/#$9'/RD9Y,@XQ7H/_"-D AHE&,#"($.3C^(#
M.04SSN!R2?O#&7?Z*MO-%%(L:NT".I"')4O./FW=3N7 ;YB22NX@ A-J*;;L
MEN^W]70SF-K_ -P^W*_X_P"--9'./E.-R9'R] P))^;T_K^&M)IZQ#'4G=C8
M\J\*4&2B@8/S@D %B,LWS9%5OLV,.3N  ROF.4(8E1N4DJPY.3R, 'GJ(]M2
M_G7W/_Y$"L6QM;D\XXP>.2< E<@@8P<9^7=@J<6[>)XQESEF)+!L%ERH!&X$
MY(9!D@X)8Y4 *:@,$OW59<'[IWLKJ=H5AP!G'3#?>XW9R*LL6CRVT.2H?"Y+
M8SDKC'*X<D<-QD<G:*/;4G]M=MG_ ) 3DX!/H"?RJ-Y54'N1U48+#J22,]@/
M7#<X(QS5>\A201,^Z0%"\%H#<3HK D"78JPP'<N-K2XW,=Y0 BI[!'ECNI7C
M6W6...4Q22/-,?-\XJ'E1GC1E$#[EB>16+K\[%.7[2'\R_'_ " D5'RY"'D#
M'W 2!NVG.\[L\Y+$'!7(Y.V14*EW( 8X5<X/!QV&>=Q.,Y)Y' .:;YV#A1'R
M?F.YL$X5>#MSU^53C! '0$586-YL%2FT$[@&.X'"LH.5VY&>1R/T-+VM-?:7
MW/\ R :3DJ%R2SJ .NTDCYO^ ^9DC/.>H&:0@!MF2?XLC&TNRJ&8Y.1NS]P#
MD85LA3ML6\! >15.%"DR%2RQER8U!PNU%=QL.""2N . 0/!OY79&02S$?WCC
ME\KL )S@\ ..OS<MS@HJ;DN5Z*6MM;^5^CZ='\P+=L&0D8W;=G(/"J0V<$E<
M'(8,0?J.:LAU&1N&0>?4=!EN_)[D9)/0= 6]BTQBMUE\MI+J.+SAN+C,$\HR
M?D?E8G)R01M8LIYIFIZ9+IXDE\QIHE!\^0R$/&J*C;WPY#0_,#N!/E@$GA@2
M^>'+S<R4;VYG>U[I6VOU73J X2IZX_ ^_M]#^..V28WDDD>603SQG@# _N_-
MDEB!M'*G&[',QWZ7#.MI'/=;-S;H89I5*#N'0D,O!P1R1DXX-:2Z?K<ZEUT]
M[>-AM#7DB62D8R"/MLT(<$YYC)*C<K$<!I]M2_G73OUVZ?J!N*ZJ.AXR?E!*
M\DGAB!U[YP,^W-/W+QR,$=<_B./<9^F/>LG[#K$N(WDL]L9950W-W.JABN40
M6L,L(9OE8 RA  H\U" *:-+O4.))8?F^\I+)C.&) )3'RLOWCM(7*G)&6JE-
MNRG%M[)7;T3;MI9V2;>MK>;L!K[U &X@$@<9'X]^W/UQQDTAD7(Y'<]N@Z9Y
MXR.GOC..ASEMS&N!<P,S<@%O,3G/S[,Y50PP>C <!06YB:)P.+Z%6[J6V* R
MD?P'?N.5W/RQ!8$\C)[6G_,OQ_R V=P]1^8^O_ZO4X'>F!P2!G!P3M/7 !)/
M&<@ #!&1S@XZC)M[7S& >X0Y./\ 1P[G<"O=G"X&=K#DYP,$-BM1;*.+8(VF
M9G;:9)7:1"JX; )!12'(?;A-Y4@ D<BJ0DTHR3;NK:WTU?1>?7H!(6YQ@Y_#
M\ >>YX!!/.3@A333( <!78YP=JDX^N!^'UX.#BIS;#*G>[<YVMC!..C 8W <
MDX[9 /SC=MVGAO7M1ACGL[VSM-/E,\<0"W37/RN\,_F*D4<+9=6,8,[G: S%
M"R@V)RC%7DU%=V[(YSS0,;E=<X^9E*J/4DGH!P2?0]Z4R!<[N,=3QQD9P><Y
MR&'3/&2 "*[2/P%*V&N=1NYCSD11)"A8GC:'60@[<%L@DGA2&!)OIX+TZW4_
MZ$TA8+LDN&$[H5R O[Y=@+;5+E?+W=6SN) 1*K!-)>\V[>ZUIJEKS6WOIJ>?
M*P89!!'J#D=O\1@]#S@D $J3CL3QGMZ@=20._K79W7@XR*&L7CM9CDF-E(MG
M8] 40!HOX58JA!SND0L%-<9J$%WI4H@U&V>U=\A&<[HIMA +VTH!2:/D%2IW
ME=NY%<,@&TDVVDENWLOS_)FFMDVG&_1VT\FUI?\ S0PNI('0D C(QU' QUR<
MC/&,9&<\4[&>HZ=\ ^O3.>1U##!&2!T.:!G5TGD#LP3R#M4L2I>55 VCE>5*
MED))W,/FQ@Q?:E_N77;^*4?^S_D/UJ/:4_YU^/\ D!>FCR"P;:P!(/MM"D$]
M#T&"1\IW'/)J#S ,DY(R257!*]2.Y4C'R_(2JD*5QG(@%RC9#&1> 1OEE4,#
MZ88Y*Y4.I^Z"03R:JRR2*[O;A9488FM]Q2*0Y&WRY-K&*;:6 D0 '<4RRR,K
M+VM/;G7W/_Y']6!JEACUR./?(';KU('."<C@9P(VB20)D$@,"-K8ZJ 3G(XS
MZ#.0"%!JE]J6>!KFTD:2WA8)<;QY5Q92X#1VUY"I+02$#*OEK6[SF"9BKQHP
M2,1PT@^]SY\N.#C.=_&3SW..X-'M:?\ .OQ_R  6!!4C.[!R 0%S(IRIRI7:
M2."#QC.!@/9@#N("A@S?*P8!P6#*JY##=M!&5 )P =P&*S^9@!%7G?N+$DY(
M # Y)!#;F7!&#@\$<Q"1MS1;AOV;EYRV-PX,I!)8\X^8L!M)/' JM)_;7W2_
M^1_S] +#D.CCRY,LN%9HC@DJ=N#@Y/(Y[$@G"L*85W  J<EL_-Y8_B+$$,P!
M"\$C!&,<$YQT&@7%O-/'IUZ8XFE+"TF+JL9<$EK>5FPH+<& ,<'F-<, *ZC4
MO"+S6\BP((;C#R02.^UO-*8\O=P41S@*Y(#-MPQVMMN+4DI1=T]GKKZ72?1K
M;=-";2M=VNTOFW9+9O\  \XC)P5/53C!Y.W^$Y!(.<$YSG.00"" K.JXR>N0
M.">1U'UZ_D:=/&T-Q+"4V21LL4D+*0\4P7,B-'@8\N1G5U&2@0$@L>8BADVJ
M51SD#&2Q#8(8 *.>203@D@9QFI=2FMY)6DXO1_%%7<?AW2U[6V;'^8,Z,I4D
M@,"I.#T((.,#G@C'^\#[50W!"0^1C)7+%MRY.TYR<G:1C.&R6W*#RUD6XPZJ
M5;>#MRY)4 ,!MSU^4G))QDCH%6J[VP4@CYCD*=S2;3G. .VY> >,D%?[W JM
M.5^6:=DY/?:*NWJELM[7\DP&O(C*5#8+< D-P3T/W3SGIQUQTZB%3M&TX)!8
M<.IX5B!R6)Z8P#SSR< D/*;'VE%4@@AMS[3M'8GJ,X^;&TD.#G@M!M?+8CC.
M26R3QD@[L?+_ 'QSVY)&1C*]K2_GC][_ /D?^'Z7';S7W_\  )2WICJ!G?&.
MI XRXSP21C/3ITRJG*AC@9&>O'//7)'3WJ(J_P#SRC^N<'_T'\QR#T.12$R?
M=*I@=0&/(QTY7;CG@-\IX4@YP3VM/^=?.Z7WM:!;S7W_ / ([@;XLA@0,O@#
M=O!4Y P0>>?7C!&"2U5U9<8Z8ZDC R3R1C ZG.!@#('R]!:5,J44(@C(7 ?&
MT!01L(&<88 %3PQ)X/-/6TC?)"C/WOO;MPYW%7P060G.0QP&4]%#4XU:<VHQ
MFFWK;7:S;>VR2;?E]PC/.2S$#C([J.0H!')&<8QGN<@#CF)G*@-M;&<=CDXR
M!@9Z\@'C+ 8RI+#9_LXCAE0-G!#2L^,DD85OND$D*00W4Y&XT^33=B0.(T^>
M&-B041B2"B@E,'HI&Q@H_/@]I3MS<\>6Z5];7:NEM>[] ,$3*2HPW.,X1F(S
MTR%'7IG (Z[=Q !SU8HNPQR<;N2AVXW=21D8^89QG&>E=0J"( ""%R69OWX9
MF!4H&0EP"<A1C=]WD# '.9<O(Q5'$"!6W*(D$8. -S$A <*& RV-I.0%^\J]
MK2_Y^1_'_P"1U[:7=T] ,/#+ECG;N?/08PS8) +-@9)Q@D%@3PH(=O  8\ @
M'U['.",@X. ,'!SQD<B:0-YK84+RI8Y(ZD,S#ISD_,,@<8/1=O1^&_#<^J1#
M4# PM%+I;J8V;SI$ #2$8(6*,?+'C*O+N+']V=SC4C*7+%\WN\S:V6J5G=)W
MUOU6^MT!ROFIW./P;T&>W8Y'OC/?%5YV0J"!O(<$!4+.!N)R..!N(Z'..2!F
MO4I/"PCR7CB1!D;Y $ "X')<+SV(Y8,,'G<1E3V6D6NYI]0TJ#8& /V^V&&Q
MG+!'W C"\G.S@ D$BK \U<[@-L<@.[/^K([AB,GCYF"ELX)P,DX4",R%<!HY
M < \1L03SGD<#IP"=V >,<CTZ#1+34H#/9S07=MYAC$]LXGB$@SNC#AB!( N
M&&0R\$E<KF3_ (18;0OE)RPY(&5)R.4^\ ,8(Q[\9Y=@/+?.7/*NOH60J,_7
MOCC. >O.,<U)W^?S."@5!D\$,CLV&!((W#! Y&00Q4;2WI6K:9IFBVJ7&H,J
M;W$-M;HGF7M[/*P6.WM8/O3NSA<"-206  ZU'IW@S4K]X;G5+,V*R.GV?2"$
M+0AF.'U%T,D+7"@M^X)>.&3#.2Y 5 >:)R!@YQD9]22"<$X) .23C!V@8Y-1
M-@.5SRXW8!SQE@3G''RA1C^%ACGG,D;*ZHRC*MM8<$8.P$D@GY&.<X .26SS
MN)28#,?KN;GN?D?O^)/U- $.5 /10#M(/RC(QT/!/(X(&0,D<X%43_K),_\
M/9NG//&/H,9)_+IDUH/&DB[74,IYP>F<Y' ]".!V[=3FG.N)3L !(1VX^\=\
M@))Y() 49Q]P<< "@"C'@[FQ@AW )ZD$\D=P#P,>V<#)R5+W;_>;]"0/R  %
M% !4+K@C !RH4<#*E&W#:3G!*[AG'8#O4U-8!ASV.1@D<]!R/KB@"95P$!QE
M6B'J 05!P>YY()X/&#TK3  &.Q_#CH!^ P*S5.4C/)R8CD]3EDZ^]:= %[1
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M?73]#QVUN[.YC\^UFCFBCRC,C,QC=5.5ECD5'CD7[HCF1' VY53\HO?:/)#
M' 8%L$A5W$-C)RK ,J  9QC+* 0<^+7_ (WEU2Y6ZT[3H]*D6.25-2:ZDDU
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M"MD'@,IP.0,-R0<A<@#D[\J;XMFTLR;0@4$\H0I8'J,X8 =><\'!K.D*?>P
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M"Y6\D=G\F(2'=;<)YI5)6C55#"$L8C*Q94\SYCG7%@!&K(%4B5=NT87) VL
M6P00"&X*YP5Y&37_ .$]\,16I!U:.2?[6T@@AL[^>4IY!4E1';[2!)M56WCY
MB#PN2,?4?'FAD!;&+4=19XDE+Q:9)91I<LKF2T8:E+;2RO S#?- CVTA+/!*
MXR:F4DW&T.22:::E*6JW5I)Q>RLK7>VJ;BZ);F"-8VP3L!R",Y&$+;@6.XG
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MS8*6D<8&]=[2[^&VJFY3$F 3%SSE@V,@ FND%M; AE:(_/U*9.P\93(.&8=
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M9"??@=1C/!XSQ0!4[M_O-_Z$:*.[?[S?^A&B@ J-B6.P':<_>)X VDY[9/7
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MBEP:H2:7<3<7.JZA.X.68WTR@D[#\L43QQ G!Z <;0N<#;PUKJ?C%)[B73-
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M^;M^'R//Q#7)V]Y6N^FKL=8_W3SMZ#<>0N6 W$=#CKSD'H<@D%Z1Q'YE^;J
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M-+2+YMJO@C 1 ,X.3U!X&/XAR#@$$U =$GF;)'DIS'B,!,%A@G 4'&0< X)
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M8+*T5W^R;\*KW;&>,AK+]I2$;E8*W"A@H'R],5F^$/[ 4KL;3]N/]I[2-P
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M_P!J6:#9D^63%.J$>4 4/R2%MK8RH);"KGY*_P""F,7V?]EGX&R@*K2_M/\
M[&<8=3M(W>)+4Y8 #!X&"2"<'#$UC5FI4I.,G:<Y1BXMJR4(J5GHU>[MT3OO
MUTOJO\2U>UK2WOTV77TNE;])+[3G^VWRQQ;#_:-V 5CC1 BW,RG"+P" !M'
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M;(S_ !!2?E"M\OEY(7+!>&;=GW4V RJ?G+$Y4LI!W+]X@98.0,!<B- <GDT
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MG0[&R N"^3M8[E(Y?A0 W ZD$$')4$U=21@X!*-NSAL<!@&R"N,'((^8$G(
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M4K-[7L]5Y4=)VL21*V.,;%!R,AMW."HZ>I8Y( )-3#2,,%92%& 0?+W*0S%
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M+(8M@[0<2  992RY.W:"#]XM@2V=V  \P9'4"3"G:4R"WS! ROCYA@A3A><
M ]$MH%4@H(RI+(K@EDPF"?D)W %2H+$DY&6.[-2RVVQ0!&V2KAE#JP;:IS\Q
M("J5R.0#G&,XS0JT4O?4HRM>W+I9_#JVGJM]+=KE)**Y4N5+IK=?XKZW>[O9
MK2Z5T<38Q13QW,L;,(O/*C:-[$[,8<!MJG=RI4X))P!@FFW[PZ=:75]-]IE6
MV0N8+.W%S/,<8"00*JF1V8<+_$2&.!Q4WA6+=ITQ+!@;V5<%F!(C@A;EE(.,
MW"@':2"&((+ UTOEE<$KL!P Z(%QDX<97<4 ;.,#9\Q!R I)[1N44G3Y9.U^
M=*=O*+NN;2W+TOT=A34W"2IRC";C)0G**FH2::C-P;BI\K:ERMJ,FDI.S9\<
M:Y\8/B#H\\[WOP]DTW3S<F&UDOTN4E9'(=$ED,J0R2^4G*Q%@2,#:6)&U8_$
MKQSJ-E!-;>"99'N)H%@F>&^CLWCD=$$S31ER JR%MX<[PCEV7''TIJ6AZ?K-
MHUCJEM;:C9,^\6MS&73<F=A(RCACGY2K@Y9\XW\6TT^""..*!+>*&)3'##'&
M\:1QJ B1HK(^ %  WYSG);[V[IJ5::A_!3=]7%R>FCBTF]F[J>W*DFM['Q=/
MAWB6&+KREQGF-7!3@G3B\)@8XF%6I.3JQ]V@J$:4*;Y:,H^\G\5/W(N?)P6\
MACB^T^4)MBB:.$N(?,*X<(9&,HA$F1&"P8*3OQN*C^<__@L?=?9/VJ?A@25'
M_&,?@F1E..?-^,G[02JP4G"J-C]%SO!'.,#^DR>(QH0T2JX"AG4J._ ^4<8S
MD$D,1P",E:_F1_X+5S/#^UE\*\,BE_V5_ W #,"O_"Z/VB?,R%VCY<#: !C>
M<9->:Y.4-4K.JYV32=[.2;CORK5J6SE9-[GW>'5I6NVU&UY.\GHHMR=E=NUV
M[*[;=E<_.I-:$2K@_*$(4_*D6.5;Y5;<P.0%+ M\N5(RPK] _P!AWXB?$;0?
M'M_I?PO\3Q>$M:\>6_A_P)?:I-X;\/>)8_[&UWQ/IV8C9>(M,U2VB-OJ,%C=
MM-81P7Y$1MTNEBF=3^5[ZH6PD;C:PVDL%XV@>4!AB6+,QRQ7(()."PV_3/P*
M\=ZEX17Q-K=CX;\7^*)=/TVQ\U?!USH=AJFBP0WOVT>(?/US7_#P6&UFLX;:
M(:5=W6LO>75L+*QE'F2P^YPO/+H\192\UG@Z67^WK+$U,PHQKX.DG@,SC1J8
MFC.E656G#%3PL_9NE4YI1A%1;EIYW$BQLLBS..74L37QSH4WAZ.#G[/%57'&
M8"52&'FIT^6K+#K%*,O:0M[S<M+/^JSX:^#/B5X7M_%'PC^)/Q,?QG!X;\)>
M +?PF-&\"^$O"-GIGA&\L_$_ANRTJ\!\)S7.LW-D_@ZSEBU"34!?(H!N#O;S
MF]#\/6OA[PC+:^"- T^RT^..-YY?L=K]D76-66"!M5UV:S51!:7.H31*7C@6
M.,+&B^6#'D?"/_!.O4]?M]%^/7C;XC-K-A#"?AE-:_\ "3^,_#GC:^?2;6#X
MC2(\6L:%XT\5O!'<WMM=1IHFJ/I-Y'=F:5K1H;F*XE^Q/"DNIZGXNTWQ!J]G
M)8WFL--,-.N)R;J"REBN+BVGGB"1FUN+@2^?);,Y> 2>3*I=51/3SO#X=8[,
MZM#$9?F$*-'"0P^999@:> P5?GP5/$5JF!PD:-!X6A4K7FX>S2<XRE*4E-7\
MG!8K$1I8"C.&/P7M*E:I5P./Q,L9BZ4EB:F'I1QF(52I3Q%:E2O&4XZ1YU9*
M<9F#\?HROA@(D09FUK2@%+7*JV%NOFS&_F#:6&Q?N[&Y&/EKXZ_X*B1NG[(_
MP G0LL4W[4O[$"E@F3MGUZR>-0'R"[[EQND^;#%6=NOV3^T--''X.??((WCU
M;2+F?,CQ[46:6VV[T=2C.]S$457"NH<EE>-5?\^/VR?#WCS]HRZ\-?!S2?$>
MF:-\/_A98_LG?%*YN[O2-2U6^3XCZ)HEWXITK1;:VM?$&D6D6AZG:1V+:^EQ
MIU[JLHBM_P"S]4T?RE$WQ^65L-G4<WC@<PPM6?#]5T\VIJ4G+#8VK0R:O0P-
M3DI6ABJF%SK 8N$4JL7A\1&3FI\T:?N8FK]5E@X5*51RQM6<*3244H4J&*KU
M*_O+WJ</J_LFH6DIU8MVBFS]MM6M"NK:F)$6-TU"\QD,')-U.JGG8P!Q@!E.
M0.FP8K\'?^"KUTEA\:/A+ VZ19OA!<R$?*KA?^$\\0*Q8Y5@7+XVLQ161<\@
MN/T+_9J^(OQ+UC_A<%C\09]%FURT^*O]LV=EI$&L#1-&T3Q=X0\.ZA:Z1X?M
M-8UW6;[3=(AU'3]7N[?3VU.>"*[U"_DA5$=E'PQ_P4B\!7WQ(^+_ ,-M1;5[
M729;/X4R:9;HMF\L=U(_C?7KUY';<Y14$Z)A@I8L"OF",XWQ>'6$Q57#*I&L
MJ?LY1JPC.,:D*U##8FG.,9I2Y94\5%)M)2Y>:*491C'3#5555.K;V=Y233DI
M<KC*I"47*-D]8:V2M=+>+O\ D^^I*MN9%?>TFS8K! RERV!E5&WYF8MC<Z$
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M@Y/S9()&.?:P:<JKBK)N/7IJCR,8U&FN9V2G^/*]%Y[V.K2<&,Y9C\KC( +
M_P"UR#Y@Y^7)!RI4_-DW8IH\A,1K$2<'<6"X+,/FDZD$=<'=N(/ Q7,*W!\P
ML%(;#Q[F<9&P G#-N"AFSCL. Q(>Y'<Y8X;*@$C:I4'>"=FUL [LL5/1<9+
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M3BXM],BU+7="M-7U^8_8]&CU2WGN$?>%'Z*R:8K/(S.WFO\ , &  ;.%7<%
MR69@3M!Q\Q SQ^=/_!3]O$7@2X_8=^(_AGQ'>:%J-S_P4 _8]^$-U8QV6E7=
MGJ6A?$#XX>'-6U>6634K>X(N63PQ'I<$4%N&%OJ5S.ES'-'$#^JMQIOD32J8
MG1?,E11M=OE1W^4-Y!(V@D!B0QZAFP#0IP=G[2FTVTFJE/5KXO\ E[NGOUUZ
M,NIS<B7L:\N9KW94:J5DU=RM3;BKN\;Z2MNM&>='2W(&5W\Y&9=PP< L2(CM
M!'&>O53C=S9BTD @HB#&5.Y&&\'G"(VX!C@  D,#@ X'':MIZ,F"DH5F(\P"
M4IR,L&!A/ )!7.,$_+C)PY;)5DRT+X//SA@A'S*3EDCY!&1@GG!*[EIJ4&^5
M3@VWHN>#;Z:)3;;OTML<_(GS*6'JP5FU)0K-Q>B^W"*4=;7=U=JZ>YR*Z6 "
M&CADSN(;$H^7M@#@^H/)8>N*W?#.F,/$>@*/F/\ ;6E#>6E!.[4(,;LC;R=H
MR5P"#U!.=D6'  4J"HP"V0.GRG 8Y QP<]!AFS6_X3L%/BCPV&C# ^(=#P27
M+,!J=N2!E N!PP9CM.[!(J)5J<>K;O9I1>FMN]M-]6M/PZ8R3Z33V]Z#2T6]
M[VUMTNFS_-_T; T33]N=K6L8"C!.&38@P<8!W(3ELCDD@XSJ_I]?Y>E8^BDG
M1M)&3@V<3,0/O>7Y90#T!+;LD\@Y.!FM8D<#/.1^&#G)] ,<GMZ'%:#*5PZ.
M8PCJ1DYVX;# J%+;?F 4%B!N"DC!! P:DC'(4*3P7/ (^8LJ\YZCYL@<$9.[
M-3L4RQ0 *"2!T/RJJMD'##YBQY!)^9E+ <UE.YMP&% "@C.& R<X/0-ORO<
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MI#)$$V/P -JE02H."Q! 8G<V !MY.T<<GANU"6;@C)<@G<<;2>I4'DG('4<
MGDD0231A,@'!RN2K@_,I.0,<L<=#A?<?-5-R?VI:Z/WI:I[K>VO6ZU5^X;F7
M<??8X&01@X.!E5.W:"&) !Y !W98<\5_+C_P7$81?M?_  H5A\S?LI>!=P?[
MJ@_&G]HT8920!D ;EZX' ZU_4;<. ))6 C!,8/<J% 3&=N27'\/*E1ASV/\
M*Y_P75F;_AL#X3D'&?V3?A_GYOFQ)\;?VCER!V8&('<R@@.PX(Q0^6R233TN
MW*Z;L_A22MKK9MI*_5W-*3ESKE5_YO\ #U/R<-Q*ZH$VA1%@[#NWY\K&\'D
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MTZT-6UK*-:*D[IZ*.EM=FC"%>;@M9N3:DN:5-VMS-Q_=NUM%>^^FZV^3=/\
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M<>5))R>B47[KD^FJNU=WWUOOK]71E-R2NO>BG=WEHHIV5WHVFU?OJ^R_S,M
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M8(R@/ ^\,'(!!.[9G#HW=6C:ZZN[MHNMMW;H5&$I72M=6O%NSUVT/X\?AO\
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MPSL4!CR!\H)SM[L"#N/S8I9I_-8#)2,;BO09P4!VD\L-QR05XQD<;:SKDJ)
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M)OXI<WVG:SMHK*W4!T,0C&02Y8EF?'WNRY&3C ( Q@8'/:G/\P9<' ZG(&.
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M2ZC&-D-W/RZ\U?XH_P"%_F5&VSFX[V2YM7:Z;MHK6Z[]S^DB8D!@LCA\;PX
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ME"FJ7*@_:+F_U66YOY(Y&2:_N,LB>9B*[KTW3A3GS1E:<_=CK!OFBDVIVO\
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MA6=0"1O"A\Y+;B_4*,CD 8P>'X/3->G:,O\ Q-]+?<3MU.R1>F"INXEP".N
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MO^N_]?(Y3P+H%]\)M/N=+^)7C7PUXYTM;9$A^$_@_0=0\2:DMQ:HD4$FA^+
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M/QS+9,73IM3^%O@/QE^UU^WOJFKQ7MEJT&C_ /!/J.XUGPC>C1]5>V/P5_:
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M>Y/)RX)(88>))!@@;"NW+9*DAB3CCJ<9#Y(7*EB1E#6>55QSU;(/)';:3P<
MA3CC/S$'MD2I-(&S(68'Y<@*=HP<8"C+!B<<X8#!SDBO>C)2O;I;S5^MNMDW
M:[2/!-19I" Z$OE5+)*20K##$ C^(*=K G!!P <$J37 8A60C8Q95*J0_P I
M  Y(RQ.0"0O!X'RBJ7VE1D*TJDYQ^[S\V.#\RM_"1GD X'<G*&1,%QEVP[DM
MA<D*X"$?P>@^7IC&<U@TTW?K=KJ[7:[;WO\ UO=-KFVO?2Z^SYDKN"KC!VKN
M^4L>20 P3!*A\(Q&0",J 5!JJ]R-I?80Q8/ERI55SU!#EL9;( !4=>I8&O)+
M(P(+')W!L*@ '! 8D #!.&((8X.05^[4GN4P#&RR$;2%'"G)<X+X& %500?E
MQR06(-<M;XOB[Z7VTNVU;3U>EM>YM&+<E9.6MVEJ[)KFTTV5_D]78@N'#2'(
M(56QD >6X.)"2 2V%SE,@=3D;=]8=Y*F\A&+8="",;5^1_E )!PH^9@,$YQR
M#1J.J6FG1/)=74%I K2AYKJ:&"$'8 H$D[!?EY!"N".!R64'TGX3_ ']H#]H
M"^LX?@[\)O%/B73M0)9O'^NV4_@WX4V4&^1#<7GQ UVUCTZZC,@<PV_AZWUG
M4;IHV2VLG ++Y=2T9RE*<>5^_P R=U9NS=DMUJVDK^1Z,%%/LDM-K6O;9OMT
M/)99XX8WN))0L"+(\T[R;(XT0-N+F1E1 HY)/"X& >!7]+'_  2G_9L\2_#G
MX0^*?B#X]TR;1M0^,OB'PCKN@>&];@:WDL/!W@O3=?MM!U34M/EV,U]XIF\7
MZIJEK:2$O;Z1!IAFMHI)F$>7^R=_P2[\#_ 74=-^(_Q]G\._&'XE6C6VJ^%-
M#U**.P^&/A&_@1W_ +;T?PKK$VG7GC75;>Y1_P"SM<\?VR:%:S1)-IWANUOX
M8-4B_6./Q%I^HW5U!,=.6[5XO+:[NMDLEQ'#(D4,D^D_9+?2$B!N%-W!<.L;
MO&PD=4:9O-Q%2-6/*D[<T6[Z7Y;N-NMKZWTUMTT-XUE&SY4FE)<RZWV;L_L]
M++7=W=SKHM.\DR/'<6VEQ_)!)*@DLD2/S'E,5O:O;@QS[D$AGN$D1 I>WEDC
M(8;NCS7TUH)8]0B2!3#)?:C=HUA'<S;=\\<.RU^US*5XCN-\5G$X5!)-\X7C
M9CHUE+=2:I?7FL&&[=K.PTZ^:QL;,H)"\UTMQJUY'=S/"(]HUM=EH.8M/@N+
MC+W(M1O=019;6'[!I5G',\):\6.WBC2,B=Y[>[N+::>.WN5C@8RQ7^&EEEA6
M-?*K"_3;6_?\'I\_\D+FYKRO?JV]^U_O^\Z5M9A@N()(M)O-7O+R00Q7BQVV
MHZDNQF%RNGV=Q-;M;QVK.5FOE,$+Q^887<JS#4BU?9<W7V2TL[RXM1_I%Q#]
MG_LW3KP;S*VHW$L<$EY<R;2_EVT2.8T556- JCF-,EUC6TOTL[:PL=-+VG]J
MZT^ISSZGJ!965X\0B"*TAA,TH,-DD$G[R+[0LAB*+MRV=A9QC3;6^N;.(;BM
MS;Z-8R11;A+FXBFG:=M08+P/,MY%^U"2-K)T8E%^O]?/<#JK37--B+((EU.[
MF)2X:ZM)8X(2-J?:[I+>W%G91R-(<VC&.>XC!1?M B")<GU8O<&SM)5MI)+>
M'S)?LML9$!78\+7:6R.%V@>7:"X$%FH\R6..63>W,KI4FF[9;.R%[(\JRV%M
M>B6UNTGB0Q6L]W'#/YF73R]B%)4M;>*?]Q]HG>1FP"]74;G34LF?Q#/DFZLA
M/)'96XB#27SP%5='@ECFLH[5$\VX""XS)$K!6D]6TK7:5M=%HN:]K2NK.UTG
M=)Z!_7]?E\SK/LEKJD&IV4>N:F(DC2VOA:6\]MI]NMV!N47L<UO(\O16F@8R
MV,LN895O/-6&A9^&-/1+..;5/$.M:G=01QK?>(-7UKQ1-:)9/,]I961\0WVH
MW5KIMN+N:6*QFNI_M$\LD\\MU-(3!'!HEM!:V]C )WA@NOM.LW+O=VLE_K89
M%!:1Y?ML3P,KDM/%(CR,Y2.>4FXCT)!?R2172Z@RK+;[K4PJJC9YX@LE@D.'
MWW+DJ&D<RQW B,<>XN)(<(N49RA%S@G:6LW%RD^;E<M$K*#3LY*7-K%I.5JI
M-1E!3DHR:<HIV4K;7T=[+3=:75CB_'7@'Q;JRGP@6\(W?A/544>*4U_2(M<F
M\1Z" EW:^&[2RU2:6WLK&37-,TS5]1N[>UO)YY_#^CS7%L\L%D8_-M,\'ZQJ
MFG^'? =]X4CMM$T#Q;KGB0>+]#FLM'U+Q)/K]V)=3N]>T@6UI=:GK6NWT27V
MNZ]J.HI<74K6H:))H;B4_0_D/Y<JSSW+7'VA&EDG*L(RUM(9&@EACAGF^SR2
MI'$L*LD9MMX4>?(PW=/TU;>224CR$)6.VEDFBB\^Y*K]F6$A%#7$[,Q(:/RT
M*N)'N9&B637VDVN7FDXVMRM^[:Z>VS=TM6FUJE))M..RLM&VM%I?>SM=?><9
M'H.G6BK%9VJV\DA<(=MJI8A);<W%SY\<N<(GF$0R+,4N&>)9#&S1[:VT4EK;
MR-/N#O);(C.8+A@K3;, 0PF>$!54),1D#,KE4+5U-YI5DKPW?DV/VSRIB\4M
MO:)(!9VB&-F>.. !RL$H,LK,[M*BJ4?9C,7[)-#I)AC\U9%G9HI9(C*\MM(B
M7;2F2:6X 4S*3LF\M@-KM&60M+=[Z)7NM$EO>]K));V=DK]NH'-7GA*ZNKFU
MFBU80P3S:A,+6."#&;B"-?*\Z&(75NS%%:3R7^9BK X*J*O_  BDLUO';0O!
M:O9W,,:W<XMYO-1"T,D0-]<37'GD*OGDQVL\C+"0X(4)ZQ,9K*?2'>&Z@1K&
MV4XL+5SNCNHPTD1Y$DR6\LSK'-#.K,FY-SEBUJZ\F:/[1%:3VDA2SF2-[5[F
MWG621VD>13=>86BCX0I.PDBQ(QF-MFA:M7OJU??YZ==.CNOG9H/'-1\-O/:M
M'JL.GZA%:L2(Y%GD_P!#)>*X\D?9[J.-U=DE!\]VC+D1X ?'(7O@?3%LM$?3
M[I[?5M+99;&Y4+]HNK+RT6:PF0A8!YJHKQNBPB$J95C)D9S[]/=WUKYU['%/
M)$7>":*2PELS$LQ\N=;>)G\J:(HJR?:FCFD5UW)+(L4BQX>H6@O4\F> AQ,W
MEM'!&)@\&]+2XCEM9(28;R$*(G$H=&#&=+*0.$=2G%2O9237NRE9IQ33NK::
M3BM=+<KZIC3M:W3;R_/N^CWV/Q+_ &VOA7\1_A'XBO\ XX^"_%'CRS^%GB*>
M"3XN>'M$\;>+[!O >LP:?9:+;^-](\.^%O'WA?3;O0-4LH;;2_&+O_:4NDSV
MVDW=C=6^CWFIVT'SGX/O_$P\3:G<P_$#QG'JD&GV2PZQXE\.?&#7?$+V\ULR
M6L&B7ECH?Q%_LN*VBNI+ZUBUN=?".M-<7UEID]W=VE\:_H%UOPUX<\4>%+O1
MM2T^&]MGL-2MW.K0M-9EC;M#<6>I:=-/(U_:SQ,D5_8M!+%>VRO#/%()/)N/
MYWOB]\'M7_9B^),7AO2;'QKJ?@;Q1JM]+\.KCPUXJUF#4M$GTJTB2^^&\UQI
MNK?VSJ,FDPXF\)W#:D$UG2'<+-->V6H20_M?!N;X3.\CS3(,>J#S&AP[C,%E
M]2KALO4LTR[#+ UUA95JV'H+Z]DF'P%:M2GB<=.&+R7"<KHU<7E$UBOS7BC+
ML5EV999G&!]JL'_;N&Q>+Y<3B4\OQ-98_#SKPIQK.^'S"OF-*#C0PW/1Q];V
ML*E.&,OAVS_M 7'PKTR/1O$8UG4=!UR.6]L_B'/?Z'IFD2:O;:Y?/=6&K6^I
MZ9X>M+#6?$4T-WJMC8:OIOV>:ZU.]@T<:!J-JVBVV=+\<_#FJ:CKUA\3CX+^
M)OP1\51;K_P+!"FNZSX5O)+-1)=>$==\-CQ!+:ZM+ S2W,-\EO9:F;.&RDO%
M =9X_$?A;Q;XNT6SD:'XEZKX.U^+Q!;>._!M_J6FZGI=U<3W]S<G5(X_$1U=
M;7Q;I[)<6WB%E\.6.H:Q>1WVH1:M!J,-TY^.O%WA[QU\"]2U!]!&KVWPMU]+
M2*8^/_"NBWMYI%P)A9V6F:A#K8\0#5X(FO'%CXIM+VSO"FR#7(U@M[=5^OS+
MAC*<ZS7.5@ZE*AFD\;4K5\/1JY:WC94*>#]CB, J4:V-HYDZOL*,<OP=&G.O
MA:,JN"Y*M2ME]7Y[A_/<7@LFR95'.K0I8&%.$Y4\;"%*%7$YBIT:GM,+3P]3
M#J#JSG6Q&)DH5*D8U%2I0A6I^F_MDZC\8_@%K/P;^+'['W[<_P 3=6F5=9L/
M#_P*\:_$NS\;_#F]\)VNEZ/=O;CPIXAU*'PQ;>&-814TV\TGQS:#3] U!])M
M?!>J^ 3IMNUE]9?L:?\ !7SX6_&Z_LOA=\=[*W_9[^/"O9Z>FA^(I;VU^&OC
MR_NWDC-MX/\ $VJS32>%]>6'[+*OA+QW=V;:NER&\(Z[XBDM[BPM_P PO&/A
M4ZCX:FDTG5]&UO3+H//=>&((]9\/WUF6B!8:&ND:/:Z9>7-OM6>.&VO+B*S0
M+)IHDW&V?Y)\?_#K3_&.F6^F?$#P]>WRP)-!I/CNSM7?Q%X?:4Q*&U2WTC3S
M9ZIH\6V(76GRV$AW1I)):6=]&FI0?$YCP)F$8K%9+#&XW$K2ME.(PV95)XVH
MY349Y57>2T*+JV3C4PF*Q=*I7J.4L%B:M63P,?MLNXIPE6*H8ZOAZ*;<J>)I
MUL!35*/N^[B:"QR:AJO?A2480M[:$8VKR_N]\,:S#<3- Z-#<1$B>&16CE!;
M85 !VX;<O*L<%<E00P)Y*SD<?MNZ>%;@_LA:D4XYWI\8U"%3\VQCO\L8/W78
M8. *_D6_9J_X*$?M;?L!S:3X8^-UAK'[1G[,C7-OIOAW56OX+GQ'X AAN6-W
M;>$/B-+%//,)K>ZAS\./B-JFI:&)+&U'P[\0>'K8^(A>_P!(O[*?[5?P6_:Q
M_:3T7XI_ _QO!XX\*I^RMJ6A:M!<6KZ'XN\&:\OQ5M=2N/#7Q!\)W#R7WA7Q
M+9VLD%U+9W$MUIU_8W-KJFA:QK.C75GJ5QXF0V]IQ!%QG0KTN%^):=;#8B,J
M5>C5I8?*X5*4Z<X4VIPFG"<7"$X24H5:=*:C!]>>2YJ60RA4A7I2XJX9E"O1
MG"K3J1>88U*4:D)26W*WIRVL^?57_:#0I,O;@&4C;@X92P88(VDL!M.&P3NX
M/)]/6M%D']IZ7P,?VEIA4C))\V]0#)ZC'/RGY1QP< 5XKX<N('>!TW$,!O\
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ME5 Q@9))]^.G KZN[?&K^46OU?\ 74T]K4[K3^ZK]/E^%S[\\0_L\?\ !/\
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M6+?)CQ'%,0-N!N0  ;B 6P>H'P[\?%1GPIJ2L0"1_:/AT$,1@Y']N<'=T'(
M(.,XKZ_5%PRL,^IY'&><9Y!P1G'7H.0<2;(S_".<Y&/S^G7M]15>P?2:?R?W
MNSW\MAJ35[/=-?)[V[>JL]7W/CO_ (5U\0/+_P"13O=XRV'U#P_Y>[CC#:X7
M Z@*0",]00:K2?#?XC2#/_"(W@"CD&_\/@-\RG)!UP=&5B@;&-W&Y6Q7V68H
MR3N4$''&.!UR<#'/S ?0+W!(=L3)RJ^F<<CKC!ZXP2?EP!WY (?U=[\^O;ET
M]5KS-OL]%TN"NG>]WYW:2Z*S;3MTNM-UJCX?D^&'Q'8EE\(:DS$@*#J7AK*#
M)SN_XGBAPIR2%8\D8/1AGR?"CXF,^X^#=1?=G!_M/PPN-FT!2/\ A(  F3T&
M#C<2"0I'WCY:<_*.<]!CKUQC'Y]1V/ HV)_='KT_SQZ@<'N#1[#^_P#^2_\
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M/7]1_C1YJ>O\O\:/:U/^?DON7_R(?)_<S^>K_B')_9;_ .BY?M!_^!OP^_\
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ME9.;'_!6?XC8C/\ PI7P3^\*JF/&&OXSC)W;M(SR!@=2"<$C[P_,F\\0VD\
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M_@I=XZ) _P"%5>$.0H^;Q1K.,G&<D:3QM)QG.<GH<9'YS0R0ZJSSL)(;:V(
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MEB(1Q&.M%P;5H8?V;=HVNOJR<?>YDV[1D[-:63_1V;_@HAXZB 9?AAX0:,L
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MDEBDW%/-RS(K;@X(1I&0LJG"-A5X<$2;7 )#7#>0R?Z);ECYBM'YNV7"*3N
MVD>8Y;:,'"H% W*SA27/Z0GC3S^[QQCXP2C))9?P]+W>7FFW)9$K;62M?WMF
M^6Q3SK'>S;>+_>)RT]E16NJC9*AW\[:-.VMOT"'_  4*\:%E/_"L_"N2!T\1
MZSG@ \@:<>26([*3CDX $T'_  4%\;SR8'PS\* *0&(\1ZNI))QA4_L\N> "
M6 *)G+D+G;\!+:PX526W?,,[R&_@QN9<Q*PVX+X\UN ;8MR8()OL<LL<F'(*
MHZ@>6RJN3N*R;AP9/F52K\;E<,PK:'TA?&.JI0I<<Y@YQNTY9=P\KQ35VO\
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M=S+< 6VQ-EK86\U\Z?:%EDENK^:U\3^);IEC>XN+NTMS#%T5Z.80QE3VL/\
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M&0'!*^7(L<BE6VK@L-R3>:#_ *R-/LD;?+;3S%7(H6=]% 'B>/='(Q)DW*C
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MV7AG6/#TVHV&IWES+?7NL?8+"SU&WTC6=0LMJ_\ #L$CZEI.G:Q8ZCIUS;_
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MZSI!L);>*%Y;=+>4RZB/M/V>58[9Y!T.NZ)IGANQU:7Q1KFJ6D^F^/\ QO\
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M.&<)3BL+!86=%*IAHU,3.<?98B#IU*=2?J7[/_@T7FI_!_QM-*\U_P#\-,?
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MR+B*#6\':WIKV%GI4DL-K?P'S((+W[/86]VTLCEA;7S7NFV"7"1.L:7-Q?\
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MJM.O7I5<&ISC.G+"4(<]5QA.'NMK,?$MWI&L:5\.;;7=9UCX<6E^;'PA\,?
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M"_AC3M-\*Z#X@M=1U.6WNVLM,T"Z9M/T_5+BSFN[>>]?L_#-K!IU_)I2^#?
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M-087$;L9&N[ZTDLV54 )+Q16D^DVJ-Y[D^(;?2_$-R^S3;#PM=R0W5['SO\
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M]N;"WLKV65?L5M?6*R7#==%KND/ ;PWD-N(BH,<D30:M:MEMD-@+:VDU)8)
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MDHS2IJI+#*SIRE>+FH2CRU.?DNERR2YM9Z4?AJ\,+2S2QVTL(;S+5HI)&0%
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MB1R10E(W1%5E*J "BO'XD;_M*+N[^QP#O=WNXSN[WO=]7>[ZMG;E_P#N$?\
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M!-%%</$S?UR.K_Y%M1[O?ZS65]][:7W\S?)?X:_Z_/\ ],P?YZ^NNY\YW/\
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M';3_ )>8E?DDO1);))>>>*"3K4>23MAFB7)SB.+4;A(HQGHD: *B#Y44!5
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M1<_GWHHKGR=_['4\JU:WE[E/;M\K&N:*^/L]4T[IZIVEI=.Z=O-,]!\(JO\
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MKARGX<3Y5</;R]RGMV^5CTLW5ZF#OUH8B_G[_7O\[G1^&@&U&-& *210)(A
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+$O92T6\?_2&?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  ^ 2\# 2(  A$! Q$!_\0
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' HHHH#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>urgo-20191231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:urgo="http://urbangro.com/20191231">
    <link:schemaRef xlink:href="urgo-20191231.xsd" xlink:type="simple" />
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PrepaidServicesAndFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:PrepaidServicesAndFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_PrepaidServicesAndFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:PrepaidServicesAndFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_VendorPrepaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:VendorPrepaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_VendorPrepaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:VendorPrepaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_InProcessResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_InProcessResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedOperatingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedOperatingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AccruedOperatingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedOperatingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedWagesAndRelatedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedWagesAndRelatedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AccruedWagesAndRelatedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedWagesAndRelatedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedSalesTaxPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedSalesTaxPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AccruedSalesTaxPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedSalesTaxPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_FirstLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">urgo:FirstLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_BravoLightingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:BravoLightingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_BravoLightingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:BravoLightingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccountsPayableMember_custom_AutomatedFertigationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:AutomatedFertigationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccountsPayableMember_custom_AutomatedFertigationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:AutomatedFertigationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CommonStockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CommonStockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember_custom_Grant1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Grant1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Grant1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember_custom_Grant2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Grant2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Grant2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">urgo:Option3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">urgo:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EdyzaSensorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EdyzaSensorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TotalGrowControlsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowControlsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember311471265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember311471265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_BravoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_BravoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_BravoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_BravoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_JamesLoweMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:JamesLoweMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EdyzaSensorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_NotePayable5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SecondLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">urgo:SecondLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_AnotherVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:AnotherVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Year2016Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2016Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_Year2016Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2016Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Year2017Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2017Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_Year2017Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2017Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Year2018Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2018Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-07_custom_ImpactEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">urgo:ImpactEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-07_custom_ImpactEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">urgo:ImpactEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TotalGrowHoldingsCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TotalGrowHoldingsCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NotePayable5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Year2019Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">urgo:Year2019Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NewEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">urgo:NewEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_FirstLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">urgo:FirstLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SecondLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">urgo:SecondLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TotalGrowHoldingsCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_TotalGrowHoldingsCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_OtherMachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_JamesLoweMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:JamesLoweMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EdyzaMember_custom_StockPurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:StockPurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TotalGrowHoldingsCostMember_custom_InitialPurchaseMembershipInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:InitialPurchaseMembershipInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EdyzaMember_custom_StockPurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:StockPurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_InitialPurchaseMembershipInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:InitialPurchaseMembershipInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_AddtlMembershipInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:AddtlMembershipInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_AddtlMembershipInterest2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowHoldingsCostMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:AddtlMembershipInterest2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-08-31_custom_EdyzaSensorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EdyzaSensorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-08-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:StockPurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaSensorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:StockPurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_ConvertibleDebentureHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">urgo:ConvertibleDebentureHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_Front4CompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">urgo:Front4CompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NotePayable6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_NotePayable6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NotePayable6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_AnotherCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:AnotherCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember_custom_AnotherCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:AnotherCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_BravoAndEnviroMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:BravoAndEnviroMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_Cloud9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:Cloud9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_DeferredFinancingAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:DeferredFinancingAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_VendorPrepaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:VendorPrepaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_PrepaidServicesAndFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:PrepaidServicesAndFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_DeferredFinancingAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:DeferredFinancingAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_OtherAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_EdyzaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:EdyzaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_TotalGrowMember41049140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TotalGrowMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TotalGrowMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-02to2020-01-24_custom_TghLTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">urgo:TghLTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-02</xbrli:startDate>
        <xbrli:endDate>2020-01-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-01to2020-09-24_custom_MrPullarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:MrPullarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-01</xbrli:startDate>
        <xbrli:endDate>2020-09-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-24_custom_MrPullarMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">urgo:MrPullarMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_ImpactEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">urgo:ImpactEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_custom_ImpactEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">urgo:ImpactEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_AccruedOperatingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedOperatingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_AccruedWagesAndRelatedExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedWagesAndRelatedExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_AccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_AccruedSalesTaxPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">urgo:AccruedSalesTaxPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NotePayable4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NotePayable5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_NotePayable4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">urgo:NotePayable4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_RevolvingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:RevolvingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_RevolvingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:RevolvingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_TermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:TermLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:TermLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_RevolvingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:RevolvingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_RevolvingFacilityMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:RevolvingFacilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_TermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:TermLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_TermLoanMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_CreditAgreementMember_custom_AmortDebtIssuanceCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">urgo:AmortDebtIssuanceCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_CreditAgreementMember_custom_AmortDebtIssuanceCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">urgo:AmortDebtIssuanceCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_custom_CreditAgreementMember_custom_CommonStockAndWarrantIssuancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:CommonStockAndWarrantIssuancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_custom_CreditAgreementMember_custom_AmortizationOfConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">urgo:AmortizationOfConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_custom_CreditAgreementMember_custom_AmortizationOfConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">urgo:AmortizationOfConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-01to2020-09-04_custom_CreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">urgo:CreditAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-01</xbrli:startDate>
        <xbrli:endDate>2020-09-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_UnitOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">urgo:UnitOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_UnitOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">urgo:UnitOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">urgo:OneVendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_AccountsReceivableMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_AnotherClientMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">urgo:AnotherClientMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_CommonStockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_CommonStockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:CommonStockGrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_NewEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">urgo:NewEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">urgo:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">urgo:ExecutiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:SeparationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">urgo:ExecutiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">urgo:SeparationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001706524</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>urgo:Integer</xbrli:measure>
    </xbrli:unit>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1258700</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">928682</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31_custom_PrepaidServicesAndFeesMember" unitRef="USD" decimals="0">187912</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2018-12-31_custom_PrepaidServicesAndFeesMember" unitRef="USD" decimals="0">152204</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31_custom_VendorPrepaymentsMember" unitRef="USD" decimals="0">1070788</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2018-12-31_custom_VendorPrepaymentsMember" unitRef="USD" decimals="0">776478</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">2734382</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31_custom_DeferredFinancingAssetMember" unitRef="USD" decimals="0">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31_us-gaap_OtherAssetsMember" unitRef="USD" decimals="0">20028</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30_custom_VendorPrepaymentsMember" unitRef="USD" decimals="0">1828531</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30_custom_PrepaidServicesAndFeesMember" unitRef="USD" decimals="0">268655</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30_custom_DeferredFinancingAssetMember" unitRef="USD" decimals="0">630805</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30_us-gaap_OtherAssetsMember" unitRef="USD" decimals="0">6391</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">165035</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">441141</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">152577</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1686841</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1144142</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31_custom_AccruedOperatingExpensesMember" unitRef="USD" decimals="0">854056</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31_custom_AccruedOperatingExpensesMember" unitRef="USD" decimals="0">240941</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31_custom_AccruedWagesAndRelatedExpensesMember" unitRef="USD" decimals="0">487327</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31_custom_AccruedWagesAndRelatedExpensesMember" unitRef="USD" decimals="0">490961</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31_custom_AccruedSalesTaxPayableMember" unitRef="USD" decimals="0">345458</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31_custom_AccruedSalesTaxPayableMember" unitRef="USD" decimals="0">401282</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31_custom_EdyzaSensorsMember" unitRef="USD" decimals="0">0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31_custom_AccruedInterestMember" unitRef="USD" decimals="0">0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31_custom_AccruedInterestMember" unitRef="USD" decimals="0">10958</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31_custom_EdyzaSensorsMember" unitRef="USD" decimals="0">75000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1863096</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-09-30_custom_AccruedOperatingExpensesMember" unitRef="USD" decimals="0">798752</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-09-30_custom_AccruedWagesAndRelatedExpensesMember" unitRef="USD" decimals="0">402710</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-09-30_custom_AccruedInterestMember" unitRef="USD" decimals="0">44635</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-09-30_custom_AccruedSalesTaxPayableMember" unitRef="USD" decimals="0">616999</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-16890626</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-8540053</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">-20850508</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-5008334</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-3826551</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember311471265" unitRef="USD" decimals="0">25230</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_CommonStockMember311471265" unitRef="USD" decimals="0">28209</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">-1361028</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">25036</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3258116</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4688272</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-4644180</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8540053</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">11854083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-16890626</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">-6703947</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">28830</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">28272</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">25821</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">26981</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">13522833</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14118289</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8438943</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8967004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-20156227</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-20850508</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-11449927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-14259457</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" unitRef="USD" decimals="0">-6604564</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">-2985163</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-09-30" unitRef="USD" decimals="0">-5265472</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">28209312</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">25229833</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">28272285</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">17563594</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">13892025</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-12-31_us-gaap_ShippingAndHandlingMember" unitRef="USD" decimals="0">490526</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31_us-gaap_ShippingAndHandlingMember" unitRef="USD" decimals="0">679911</us-gaap:CostOfRevenue>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">67633</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">106464</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">43849</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">12252</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1830426</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">1245826</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">1391807</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">399258</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">509219</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">1606355</us-gaap:ShareBasedCompensation>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1085975</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">861649</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31_custom_EdyzaSensorsMember" unitRef="USD" decimals="0">897475</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31_custom_EdyzaSensorsMember" unitRef="USD" decimals="0">325000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31_custom_EdyzaMember_custom_StockPurchaseOptionMember" unitRef="USD" decimals="0">897475</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31_custom_TotalGrowHoldingsCostMember_custom_InitialPurchaseMembershipInterestMember" unitRef="USD" decimals="0">367000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31_custom_EdyzaMember_custom_StockPurchaseOptionMember" unitRef="USD" decimals="0">400000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_InitialPurchaseMembershipInterestMember" unitRef="USD" decimals="0">125000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_AddtlMembershipInterestMember" unitRef="USD" decimals="0">150000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember_custom_AddtlMembershipInterest2Member" unitRef="USD" decimals="0">158000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2017-01-01to2017-08-31_custom_EdyzaSensorsMember" unitRef="USD" decimals="0">400000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">572250</us-gaap:PaymentsToAcquireInvestments>
    <urgo:WorkingCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-7318980</urgo:WorkingCapital>
    <urgo:WorkingCapital contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">-4833132</urgo:WorkingCapital>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1178852</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">18920</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">18920</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AssetImpairmentCharges contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_ComputerEquipmentMember">3 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_LeaseholdImprovementsMember">Lease term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_VehiclesMember">3 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_EquipmentMember">5 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember">3 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_OtherMachineryAndEquipmentMember">3 or 5 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">86151</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">63755</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1879</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">974</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AdvertisingExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">159728</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">153878</us-gaap:AdvertisingExpense>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2019-01-01to2019-12-31_custom_BravoMember" unitRef="USD" decimals="0">45129</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2018-01-01to2018-12-31_custom_BravoMember" unitRef="USD" decimals="0">276443</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2020-01-01to2020-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2019-01-01to2019-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">43912</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2020-07-01to2020-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="From2019-07-01to2019-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">7442</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">370376</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">309975</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="0">87300</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="0">61910</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="0">42518</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="0">30162</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="0">164072</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="0">143215</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_VehiclesMember" unitRef="USD" decimals="0">57414</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_VehiclesMember" unitRef="USD" decimals="0">132875</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="0">38355</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="0">65140</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_SoftwareDevelopmentMember" unitRef="USD" decimals="0">142721</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_SoftwareDevelopmentMember" unitRef="USD" decimals="0">233783</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="USD" decimals="0">3031</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="USD" decimals="0">84031</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">264597</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">153162</us-gaap:Depreciation>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2812709</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">2478869</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">60000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2812709</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">2478869</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable1Member" unitRef="USD" decimals="0">80000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31_custom_NotePayable1Member" unitRef="USD" decimals="0">80000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable2Member" unitRef="USD" decimals="0">100000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31_custom_NotePayable2Member" unitRef="USD" decimals="0">100000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable3Member" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31_custom_NotePayable3Member" unitRef="USD" decimals="0">298869</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable4Member" unitRef="USD" decimals="0">632709</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable5Member" unitRef="USD" decimals="0">2000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31_custom_NotePayable5Member" unitRef="USD" decimals="0">2000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NotePayable6Member" unitRef="USD" decimals="0">632709</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2018-12-31_custom_NotePayable6Member" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1080600</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30_custom_NotePayable1Member" unitRef="USD" decimals="0">20000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30_custom_NotePayable2Member" unitRef="USD" decimals="0">40000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30_custom_NotePayable3Member" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30_custom_NotePayable4Member" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-09-30_custom_NotePayable5Member" unitRef="USD" decimals="0">1020600</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_JamesLoweMember">2019-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_NotePayable1Member">2020-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_NotePayable2Member">2020-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_NotePayable3Member">2019-04-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_NotePayable5Member">2023-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-12-31_custom_NotePayable6Member">2020-05-07</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-01to2020-09-30_custom_NotePayable1Member">2020-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-01to2020-09-30_custom_NotePayable2Member">2020-03-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-09-01to2020-09-04_custom_CreditAgreementMember">2021-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">177688</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">91688</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:LeaseExpirationDate1 contextRef="From2019-01-01to2019-12-31_custom_FirstLeaseMember">2020-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="From2019-01-01to2019-12-31_custom_SecondLeaseMember">2021-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_BravoLightingMember" unitRef="Percent" decimals="INF">0.002</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_BravoLightingMember" unitRef="Percent" decimals="INF">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_AccountsPayableMember_custom_AutomatedFertigationMember" unitRef="Percent" decimals="INF">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_AccountsPayableMember_custom_AutomatedFertigationMember" unitRef="Percent" decimals="INF">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_AnotherVendorMember" unitRef="Percent" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductConcentrationRiskMember_custom_Cloud9Member" unitRef="Percent" decimals="INF">0.004</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_ProductConcentrationRiskMember_custom_Cloud9Member" unitRef="Percent" decimals="INF">.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_AnotherCustomerMember" unitRef="Percent" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember_custom_AnotherCustomerMember" unitRef="Percent" decimals="INF">.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-07-01to2020-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-07-01to2019-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-09-30_us-gaap_ProductConcentrationRiskMember_custom_OneVendorMember" unitRef="Percent" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-07-01to2020-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-07-01to2019-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-09-30_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-09-30_us-gaap_AccountsReceivableMember_custom_OneCustomerMember" unitRef="Percent" decimals="INF">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_AccountsReceivableMember_custom_AnotherClientMember" unitRef="Percent" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2018-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">1802667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">412501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant1Member" unitRef="Shares" decimals="INF">264167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant2Member" unitRef="Shares" decimals="INF">148334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2020-09-30_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">753334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">41800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_ConvertibleDebentureHoldersMember" unitRef="Shares" decimals="INF">532134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_Front4CompensationMember" unitRef="Shares" decimals="INF">153900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2020-01-01to2020-09-30_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">794166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2020-01-01to2020-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">124481</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember_custom_Grant1Member">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember_custom_Grant2Member">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2020-01-01to2020-09-30_us-gaap_WarrantMember">P2Y6M0D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1184000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1702167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option1Member" unitRef="Shares" decimals="INF">540998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option2Member" unitRef="Shares" decimals="INF">408964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option3Member" unitRef="Shares" decimals="INF">48667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">3829666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">736499</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1259000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2018-01-01to2018-12-31_custom_JamesLoweMember" unitRef="Shares" decimals="INF">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2018-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1995499</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">2425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P9Y8M5D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option1Member">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option2Member">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember_custom_Option3Member">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">P9Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2019-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2019-12-31_custom_NewEquityIncentivePlanMember" unitRef="Shares" decimals="INF">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2020-09-30_custom_NewEquityIncentivePlanMember" unitRef="Shares" decimals="INF">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2018-01-01to2018-12-31_custom_JamesLoweMember" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <urgo:StockReceivedForAcquisitionShares contextRef="From2019-01-01to2019-12-31_custom_EdyzaSensorsMember" unitRef="Shares" decimals="INF">827018</urgo:StockReceivedForAcquisitionShares>
    <urgo:StockReceivedForAcquisitionShares contextRef="From2018-01-01to2018-08-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember" unitRef="Shares" decimals="INF">442685</urgo:StockReceivedForAcquisitionShares>
    <urgo:StockReceivedForAcquisitionShares contextRef="From2018-01-01to2018-12-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember" unitRef="Shares" decimals="INF">442685</urgo:StockReceivedForAcquisitionShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">70000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2020-01-01to2020-09-30_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">49658</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">122356</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_BravoMember" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2018-12-31_custom_BravoMember" unitRef="USD" decimals="0">43120</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">49659</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2018-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">79235</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">9772</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2020-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">9772</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">24972</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">18802</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_BravoMember" unitRef="USD" decimals="0">8570</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2018-12-31_custom_BravoMember" unitRef="USD" decimals="0">5562</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">16402</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2018-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">13240</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2020-09-30_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2019-12-31_custom_BravoAndEnviroMember" unitRef="USD" decimals="0">8570</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2019-01-01to2019-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">97329</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2018-01-01to2018-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">84746</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2020-01-01to2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">0</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2019-01-01to2019-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">75617</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2020-07-01to2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">0</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2019-07-01to2019-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">24368</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:RevenueFromRelatedParties contextRef="From2019-01-01to2019-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">392963</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2018-01-01to2018-12-31_custom_Cloud9Member" unitRef="USD" decimals="0">273760</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2020-01-01to2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">359562</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2019-01-01to2019-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">229688</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2020-07-01to2020-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">112405</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2019-07-01to2019-09-30_custom_Cloud9Member" unitRef="USD" decimals="0">103088</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="From2019-01-01to2019-12-31_custom_JamesLoweMember" unitRef="Percent" decimals="INF">0.090</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <urgo:LeaseCommencementDate contextRef="From2019-01-01to2019-12-31_custom_FirstLeaseMember">2018-09-01</urgo:LeaseCommencementDate>
    <urgo:LeaseCommencementDate contextRef="From2019-01-01to2019-12-31_custom_SecondLeaseMember">2019-09-01</urgo:LeaseCommencementDate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">3500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2019-01-01to2019-12-31_custom_Year2016Member">2036-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2019-01-01to2019-12-31_custom_Year2017Member">2037-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <urgo:SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">0</urgo:SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1>
    <urgo:SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1 contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">0</urgo:SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="From2019-01-01to2019-03-07_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">1000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="From2020-01-02to2020-01-24_custom_TghLTermMember" unitRef="USD" decimals="0">370000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="AsOf2019-03-07_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">49742</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="AsOf2019-03-07_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">93811</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:Goodwill contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">902067</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2019-03-07_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">902067</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">902067</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="AsOf2019-03-07_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">45620</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">222236</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">123395</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">80339</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">98841</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">49347</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2019-12-31_custom_NotePayable1Member" unitRef="Percent" decimals="INF">.09</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2019-12-31_custom_NotePayable2Member" unitRef="Percent" decimals="INF">0.09</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2019-12-31_custom_NotePayable3Member" unitRef="Percent" decimals="INF">0.198</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2019-12-31_custom_NotePayable5Member" unitRef="Percent" decimals="INF">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2020-09-30_custom_NotePayable1Member" unitRef="Percent" decimals="INF">0.09</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2020-09-30_custom_NotePayable2Member" unitRef="Percent" decimals="INF">0.09</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2020-09-30_custom_NotePayable3Member" unitRef="Percent" decimals="INF">0.080</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2020-09-30_custom_NotePayable5Member" unitRef="Percent" decimals="INF">0.010</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares contextRef="From2019-01-01to2019-12-31_custom_NotePayable1Member" unitRef="Shares" decimals="INF">3000</urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares>
    <urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares contextRef="From2019-01-01to2019-12-31_custom_NotePayable2Member" unitRef="Shares" decimals="INF">3000</urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares>
    <urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares contextRef="From2019-01-01to2019-12-31_custom_NotePayable6Member" unitRef="Shares" decimals="INF">1350000</urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares>
    <urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares contextRef="From2020-01-01to2020-09-30_custom_NotePayable1Member" unitRef="Shares" decimals="INF">3000</urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares>
    <urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares contextRef="From2020-01-01to2020-09-30_custom_NotePayable2Member" unitRef="Shares" decimals="INF">3000</urgo:StockIssuedInConsiderationForExtendingDueDateOfNoteShares>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2565000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2019-01-01to2019-12-31_custom_UnitOfferingMember" unitRef="USD" decimals="0">2565000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <urgo:DebtConversionConvertedInterestAmount1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">92037</urgo:DebtConversionConvertedInterestAmount1>
    <urgo:DebtConversionConvertedInterestAmount1 contextRef="From2019-01-01to2019-12-31_custom_UnitOfferingMember" unitRef="USD" decimals="0">92037</urgo:DebtConversionConvertedInterestAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">1102513</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2019-01-01to2019-12-31_custom_UnitOfferingMember" unitRef="Shares" decimals="INF">1102513</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2565000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">2565000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2019-01-01to2019-12-31_custom_UnitOfferingMember" unitRef="USD" decimals="0">2565000</us-gaap:ProceedsFromConvertibleDebt>
    <urgo:WarrantsExpireDate contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember">2021-06-30</urgo:WarrantsExpireDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2018-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">6000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">692034</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">1216515</us-gaap:ClassOfWarrantOrRightOutstanding>
    <urgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">692034</urgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber>
    <urgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">1216515</urgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">2.88</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-09-24_custom_MrPullarMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">2.21</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <urgo:WeightedAverageExercisePriceExercisable contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">2.88</urgo:WeightedAverageExercisePriceExercisable>
    <urgo:WeightedAverageExercisePriceExercisable contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">2.21</urgo:WeightedAverageExercisePriceExercisable>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember" unitRef="USD" decimals="0">177327</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant1Member" unitRef="USD" decimals="0">142552</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_custom_CommonStockGrantsMember_custom_Grant2Member" unitRef="USD" decimals="0">34775</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="0">489936</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option1Member" unitRef="USD" decimals="0">359521</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option2Member" unitRef="USD" decimals="0">120015</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_StockOptionMember_custom_Option3Member" unitRef="USD" decimals="0">10400</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2020-09-30_custom_CommonStockGrantsMember" unitRef="USD" decimals="0">393215</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2020-09-30_custom_StockOptionsMember" unitRef="USD" decimals="0">1919523</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">218332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">297501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">703538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1437578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-09-30_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-09-30_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <urgo:WeightedAverageRemainingLifeExercisable contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P8Y10M21D</urgo:WeightedAverageRemainingLifeExercisable>
    <urgo:WeightedAverageRemainingLifeOutstanding contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P9Y2M16D</urgo:WeightedAverageRemainingLifeOutstanding>
    <urgo:WeightedAverageRemainingLifeOutstanding contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">P9Y4M6D</urgo:WeightedAverageRemainingLifeOutstanding>
    <urgo:WeightedAverageRemainingLifeExpired contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P9Y1M13D</urgo:WeightedAverageRemainingLifeExpired>
    <urgo:WeightedAverageRemainingLifeExpired contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">P9Y2M8D</urgo:WeightedAverageRemainingLifeExpired>
    <urgo:WeightedAverageRemainingLifeIssued contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P9Y2M12D</urgo:WeightedAverageRemainingLifeIssued>
    <urgo:WeightedAverageRemainingLifeIssued contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">P9Y5M27D</urgo:WeightedAverageRemainingLifeIssued>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2019-01-01to2019-12-31_custom_NotePayable1Member" unitRef="USD" decimals="0">10000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2019-01-01to2019-12-31_custom_NotePayable2Member" unitRef="USD" decimals="0">10000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2019-01-01to2019-12-31_custom_NotePayable6Member" unitRef="USD" decimals="0">42190</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2020-01-01to2020-09-30_custom_NotePayable1Member" unitRef="USD" decimals="0">10000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2020-01-01to2020-09-30_custom_NotePayable2Member" unitRef="USD" decimals="0">10000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:InterestExpenseDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">596075</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">119961</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">796233</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">796233</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-01-01to2020-09-30_custom_CreditAgreementMember" unitRef="USD" decimals="0">1057501</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-01-01to2020-09-30_custom_CreditAgreementMember_custom_AmortDebtIssuanceCostsMember" unitRef="USD" decimals="0">368661</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-07-01to2020-09-30_custom_CreditAgreementMember_custom_AmortDebtIssuanceCostsMember" unitRef="USD" decimals="0">164941</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-07-01to2020-09-30_custom_CreditAgreementMember" unitRef="USD" decimals="0">393158</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-07-01to2019-09-30_custom_CreditAgreementMember_custom_AmortizationOfConvertibleDebenturesMember" unitRef="USD" decimals="0">796233</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-07-01to2019-09-30_custom_CreditAgreementMember" unitRef="USD" decimals="0">125733</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-01-01to2019-09-30_custom_CreditAgreementMember" unitRef="USD" decimals="0">374850</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-01-01to2019-09-30_custom_CreditAgreementMember_custom_AmortizationOfConvertibleDebenturesMember" unitRef="USD" decimals="0">796233</us-gaap:InterestExpenseDebt>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">505766</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31_custom_TotalGrowControlsMember" unitRef="USD" decimals="0">505766</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">-505766</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">310000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">506000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">506000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:LegalFees contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">28649</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2019-01-01to2019-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">0</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2019-01-01to2019-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">0</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2018-01-01to2018-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">12883</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2018-01-01to2018-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">15766</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="From2020-01-02to2020-01-24_custom_TghLTermMember" unitRef="USD" decimals="0">25000</us-gaap:LegalFees>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2019-12-31" unitRef="Percent" decimals="INF">0.08</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2019-12-31_custom_FirstLeaseMember" unitRef="Percent" decimals="INF">0.08</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2019-12-31_custom_SecondLeaseMember" unitRef="Percent" decimals="INF">0.08</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2019-12-31_custom_FirstLeaseMember">P24M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2019-12-31_custom_SecondLeaseMember">P28M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">215848</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">114017</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2019-01-01to2019-12-31_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">1361966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2020-01-01to2020-09-30_custom_CommonStockGrantsMember" unitRef="Shares" decimals="INF">253333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &amp;#8211; PREPAYMENTS &amp;#38; ADVANCES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;Prepayments and advances are comprised&#13;of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Vendor Prepayments&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,070,788&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;776,478&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Prepaid Services and Fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;187,912&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;152,204&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Prepayments and Advances&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,258,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;928,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &amp;#8211; PREPAYMENTS AND OTHER ASSETS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;Prepayments and other assets are comprised&#13;of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Vendor prepayments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,828,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,070,788&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Prepaid services and fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;268,655&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;187,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred financing asset (See Note 9 - Debt)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;630,805&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,391&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,028&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Prepayments and other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,734,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,278,728&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 - PROPERTY PLANT &amp;#38; EQUIPMENT,&#13;NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property Plant and Equipment balances are&#13;summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Computers &amp;#38; Technology Equip&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;87,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;61,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold Improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;164,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Vehicles&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;132,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Software&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;R&amp;#38;D Assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Other Equipment&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(370,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(309,975&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property plant and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;165,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;441,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation expense for the years ended&#13;December 31, 2019 and 2018 totaled $264,597 and $153,162, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 &amp;#8211; OTHER ASSETS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Included in other assets are the following&#13;intangible assets:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 27px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Patents, consisting of legal costs paid to third parties to establish a patent, which are capitalized until such time that the patents are approved and issued or rejected. If approved, capitalized costs are amortized using the straight-line method over the estimated lives of the patents, generally five years. The Company has two issued patents as of December 31, 2019 and had no issued patents at December 31, 2018.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 27px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;License fees, which consist of fees paid to have the Company&amp;#8217;s products certified by a nationally recognized organization. License fees are amortized over ten years.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The net balance of intangible assets as&#13;of December 31, 2019 and December 31, 2018 was $86,151 and $63,755, respectively. Amortization expense totaled $1,879 and $974&#13;for the years ended December 31, 2019 and 2018, respectively.&lt;/p&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 &amp;#8211; ACCRUED EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued expenses are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Accrued operating expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;854,056&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;240,941&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Accrued wages and related expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;487,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Accrued interest expense&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued sales tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;345,458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;401,282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,686,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,144,142&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued sales tax payable is comprised&#13;of prior period sales tax payable to various states for 2015 through 2019. The Company has set up payment plans with the various&#13;taxing agencies to relieve the obligation. The payment plans require monthly payments in various amounts over a period of 12 months.&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 &amp;#8211; ACCRUED EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued expenses are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Accrued operating expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;798,752&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;854,056&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued wages and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;402,710&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;487,327&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued interest expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,635&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued sales tax payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;616,999&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;345,458&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,863,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,686,841&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued sales tax payable is comprised&#13;of amounts due to various states and Canadian provinces for 2015 through 2020.&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 &amp;#8211; DEBT&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's borrowings as of September 30,&#13;2020 and December 31, 2019 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Revolving Facility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,276,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Term Loan, net of $315,402 unamortized debt issuance costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,684,598&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,961,091&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;Less current debt due within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,196,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,764,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 21, 2020, we entered into a letter&#13;agreement (the &amp;#8220;Credit Agreement&amp;#8221;) by and among the Company, as borrower, urban-gro Canada Technologies Inc. and Impact.,&#13;as guarantors, the lenders party thereto (the &amp;#8220;Lenders&amp;#8221;), and Bridging Finance Inc., as administrative agent for the&#13;Lenders (the &amp;#8220;Agent&amp;#8221;). The Credit Agreement, which is denominated in Canadian dollars (C$), is comprised of (i) a 12-month&#13;senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which was funded in its entirety on the&#13;closing date (the &amp;#8220;Term Loan&amp;#8221;); and (ii) a 12-month demand revolving credit facility of up to C$5.4 million ($4.0 million),&#13;which may be drawn from time to time, subject to the terms and conditions set forth in the Credit Agreement and described further&#13;below (the &amp;#8220;Revolving Facility,&amp;#8221; and together with the Term Loan, the &amp;#8220;Facilities&amp;#8221;). The Credit Agreement&#13;is personally guaranteed by the Company&amp;#8217;s CEO and Chairman, Brad Nattrass, and was to be in place for the original term of&#13;the Credit Agreement (1 year) plus a 1-year extension period at the discretion of the Lender as provided in the Credit Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The final maturity date of the Facilities&#13;was initially stipulated in the Credit Agreement as the earlier of (i) demand, and (ii) the date that is 12 months after the closing&#13;date, with a potential extension to the date that is 24 months after the closing date (the &amp;#8220;Initial Maturity Date&amp;#8221;).&#13;The Facilities bore interest at the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11%&#13;per annum. Accrued interest on the outstanding principal amount of the Facilities is due and payable monthly in arrears, on the&#13;last business day of each month, and on the Initial Maturity Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Revolving Facility could initially&#13;be borrowed and re-borrowed on a revolving basis by the Company during the term of the Facilities, provided that borrowings under&#13;the Revolving Facility were limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable,&#13;(ii) 85% of investment grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser&#13;of C$4.05 million ($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts&#13;and (B) 85% of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility&#13;may be prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan may be prepaid&#13;in full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 4, 2020, the Company executed&#13;an amendment to the Credit Agreement (the &amp;#8220;First Amendment&amp;#8221;) whereas the Facilities described above are now due on&#13;December 31, 2021 (the &amp;#8220;Revised Maturity Date&amp;#8221;). The First Amendment also increased the rate at which the Facilities&#13;will bear interest to the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 12% per annum&#13;(14.5% as of September 30, 2020).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the First Amendment, the&#13;Company is required to prepay, on or before January 31, 2021, $1,000,000 of the balance of the Term Loan and begin making monthly&#13;payments of $100,000 on the balance on the Term Loan starting on March 1, 2021. Additionally, the Company is required to make monthly&#13;payments of $50,000 on the balance under the Revolving Facility beginning October 1, 2020 and can make no more draws under the&#13;Revolving Facility.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company incurred $1,314,868 of debt&#13;issuance costs in connection with these Facilities, of which $676,822 was non-cash in the form of Common Stock and warrant issuances.&#13;The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing&#13;based on the market value of the underlying Common Stock at the valuation measurement date of $1.00, the remaining contractual&#13;terms of the warrants of 5 years, risk free interest rate of 1.14% an expected volatility of the price of the underlying Common&#13;Stock of 100%. The Company recorded the debt issuance costs as either a deferred financing asset or a direct reduction of the loan&#13;obligation based on the pro-rata value of the Revolving Facility and Term Loan, respectively, on the closing date. The debt issuance&#13;costs are amortized as interest expense over the life of the Facilities, until the Revised Maturity Date. As of September 30, 2020,&#13;there were $630,805 and $315,402 of unamortized debt issuance costs remaining related to the Revolving Facility and Term Loan,&#13;respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recorded interest expense&#13;of $1,057,501 in the nine months ended September 30, 2020, of which $368,661 related to the amortization of debt issuance costs&#13;on the Credit Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company&#13;recorded interest expense of $374,850 in the nine months ended September 30, 2019. The Company recorded interest expense of $393,158&#13;in the three months ended September 30, 2020, of which $164,941 related to the amortization of debt issuance costs on the Credit&#13;Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company recorded&#13;interest expense of $125,733 in the three months ended September 30, 2019.&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 - INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in&#13;accordance with the asset and liability method prescribed in ASC 740, &amp;#8220;Accounting for Income Taxes&amp;#8221;. The Company has&#13;adopted the provisions of ASC 740-10-25, which provides recognition criteria and a related measurement model for uncertain tax&#13;positions taken or expected to be taken in income tax returns. ASC 740-10-25 requires that a position taken or expected to be taken&#13;in a tax return be recognized in the financial statements when it is more likely than not that the position would be sustained&#13;upon examination by tax authorities. Tax positions that meet the more likely than not threshold are then measured using a probability&#13;weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate&#13;settlement. The Company had no tax positions relating to open income tax returns that were considered to be uncertain. The Company&#13;determined the valuation allowances are established when management determines is more likely than not that some portion or all&#13;of the deferred tax asset will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company files income federal tax returns&#13;in the United States and Canada and state and local tax return in applicable jurisdictions&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has experienced substantial&#13;losses for both book and tax purposes since inception and has no tax provision for the years ended December 31, 2019 and 2018.&#13;The potential future recovery of any tax assets that the Company may be entitled to due to these accumulated losses is uncertain&#13;and these tax assets are fully reserved based on management&amp;#8217;s current estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s estimated operating&#13;loss carryforwards and expiration dates for tax purposes are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;2016 - $1,618,386 expiring&#13;in 2036&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;2017 - $2,182,354 expiring&#13;in 2037&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;2018 - $3,060,443 no&#13;expiration&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;2019 - $6,819,954 no&#13;expiration&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Realization of operating loss carryforwards&#13;to offset future operating income for tax purposes are subject to various limitations including change of ownership and current&#13;year taxable income percentage limitations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has no credit carryforwards&#13;for tax purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s tax returns since inception&#13;are subject to examination by taxing jurisdictions in the United States and Canada.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Recently Issued Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Financial Accounting&#13;Standards Board (the &amp;#8220;FASB&amp;#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues&#13;updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&amp;#34;ASU&amp;#34;). Unless otherwise&#13;discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is&#13;not expected to have a material impact on the Company&amp;#8217;s financial statements upon adoption.&lt;/p&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify"&gt;The Company&amp;#8217;s financial instruments&#13;consist principally of cash and cash equivalents, accounts receivable, accounts payable, notes payable and other current assets&#13;and liabilities. We value our financial assets and liabilities using fair value measurements. Fair value is based on the price&#13;that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at&#13;the measurement date. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable&#13;in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy&#13;is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three&#13;levels (with Level 3 being the lowest) defined as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Level 1:&amp;#160;Quoted prices in active markets for identical&#13;assets or liabilities that the entity has the ability to access.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"&gt;Level 2:&amp;#160;Observable inputs other&#13;than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for&#13;identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated&#13;with observable market data.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify"&gt;Level 3:&amp;#160;Unobservable inputs&#13;that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This&#13;includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify"&gt;The carrying amount of our cash and&#13;cash equivalents, accounts receivable, accounts payable, and other current assets and liabilities in our consolidated financial&#13;statements approximates fair value because of the short-term nature of the instruments. Investments in non-marketable equity securities&#13;are carried at cost less other-than-temporary impairments. The carrying amount of our notes payable and convertible debt at December&#13;31, 2019 and December 31, 2018 approximates their fair values based on our incremental borrowing rates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There have been no changes in Level 1,&#13;Level 2, and Level 3 categorizations and no changes in valuation techniques for these assets or liabilities for the years ended&#13;December 31, 2019 and 2018.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Accounts Receivable, Net&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trade accounts receivables are carried&#13;at the original invoiced amounts less an allowance for doubtful accounts. As of December 31, 2019 and 2018, the balance of allowance&#13;for doubtful accounts was $18,920. The allowances for doubtful accounts are calculated based on a detailed review of certain individual&#13;customer accounts and an estimation of the overall economic conditions affecting the Company's customer base. The Company reviews&#13;a customer's credit history before extending credit to the customer. If the financial condition of its customers were to deteriorate,&#13;resulting in an impairment of their ability to make payments, additions to the allowance would be required. A provision is made&#13;against accounts receivable to the extent they are considered unlikely to be collected. Occasionally the Company will write off&#13;bad debt directly to the bad debt expense account when the balance is determined to be uncollectable. Bad debt expense for the&#13;years ended December 31, 2019 and 2018 was $67,633 and $106,464, respectively.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Inventories&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventories, consisting entirely of finished&#13;goods, are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost&#13;method. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based&#13;on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold at the realization of change&#13;in value. Once written down, inventories are carried at this lower basis until sold or scrapped.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Property and Equipment &lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;Property and equipment is stated at&#13;cost less accumulated depreciation and impairment. Expenditures for major additions and improvements are capitalized and minor&#13;replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise&#13;disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in&#13;the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets&#13;using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated)&#13;for tax purposes where appropriate. No impairment charges were recorded for the years ended December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The estimated useful lives for significant property and equipment&#13;categories are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer and Technology Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 23%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold Improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lease term&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 or 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Operating Lease Right of Use Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Operating lease right of use assets are&#13;stated at cost less accumulated depreciation, amortization and impairment. The Company has two operating leases with an imputed&#13;annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on August 31,&#13;2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021. Operating lease&#13;right of use asset costs incurred in 2019 were $123,563.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Intangible Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s intangible assets,&#13;consisting of legal fees for application of patents and trademarks and license fees paid for inspection services, are recorded&#13;at cost. Patents and trademarks, once approved, will be amortized using the straight-line method over an estimated life, generally&#13;5 years for patents and 10 to 20 years for trademarks. License fees are amortized over 10 years. Intangible assets are included&#13;in &amp;#8220;other assets&amp;#8221; on the balance sheets. The net balance of intangible assets for December 31, 2019 and 2018 was $86,151&#13;and $63,755, respectively. Amortization expense totaled $1,879 and $974 for the years ended December 31, 2019 and 2018, respectively.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Advertising Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company expenses advertisings costs&#13;in the periods the costs are incurred. Prepayments made under contracts are included in prepaid expenses and expensed when the&#13;advertisement is run. Total advertising expense incurred for the years ended December 31, 2019 and 2018 was $159,728 and $153,878,&#13;respectively.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company files&#13;income federal tax returns in the United States and Canada and state and local tax return in applicable jurisdictions. Provisions&#13;for current income tax liabilities, if any, would be calculated and accrued on income and expense amounts expected to be included&#13;in the income tax returns for the current year. Income taxes reported in earnings, if any, would also include deferred income tax&#13;provisions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred income&#13;tax assets and liabilities, if any, would be computed on differences between the financial statement bases of assets and liabilities&#13;at the enacted tax rates. Changes in deferred income tax assets and liabilities would be included as a component of income tax&#13;expense. The effect on deferred income tax assets and liabilities attributable to changes in enacted tax rates would be charged&#13;or credited to income tax expense in the period of enactment. Valuation allowances would be established for certain deferred tax&#13;assets when realization is not likely.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Assets and liabilities&#13;would be established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions,&#13;in the judgement of the Company, do not meet a more-likely-than-not threshold based on the technical merits of the positions. Valuation&#13;allowances would be established for certain deferred tax assets when realization is not likely.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Loss Per Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company computes net loss per share&#13;by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period.&#13;Diluted earnings per share would be computed by dividing net loss by the weighted-average of all potentially dilutive shares of&#13;common stock that were outstanding during the periods presented. The diluted earnings per share calculation is not presented as&#13;it results in an anti-dilutive calculation of net loss per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The treasury stock method would be used&#13;to calculate diluted earnings per share for potentially dilutive stock options and share purchase warrants. This method assumes&#13;that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase&#13;common shares at the average market price for the period.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Recently Adopted Accounting Pronouncements&lt;/u&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued an Accounting&#13;Standards Update (&amp;#8220;ASU&amp;#8221;) amending the accounting for leases. The new guidance requires the recognition of lease assets&#13;and liabilities for operating leases with terms of more than 12 months, in addition to those currently recorded, on the Company&amp;#8217;s&#13;consolidated balance sheets. Presentation of leases within the consolidated statements of operations and comprehensive loss and&#13;consolidated cash flows will be generally consistent with the prior lease accounting guidance. The ASU was effective for reporting&#13;periods beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU effective January 1, 2019&#13;under the modified retrospective method with respect to lease contracts in effect as of the adoption date. The adoption of the&#13;ASU increased our assets and liabilities by $326,095 in 2019 due to the recognition of right of use assets and lease liabilities&#13;with respect to operating leases.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recently Issued Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;From time to time, the Financial Accounting&#13;Standards Board (the &amp;#8220;FASB&amp;#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues&#13;updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&amp;#34;ASU&amp;#34;). Unless otherwise&#13;discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is&#13;not expected to have a material impact on the Company&amp;#8217;s financial statements upon adoption.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationSegmentAllocationTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has initially accounted for the acquisition of Impact as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 85%"&gt;Purchase Price&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Allocation of Purchase Price:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;49,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts receivable, net&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;93,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Goodwill&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;902,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;45,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationSegmentAllocationTableTextBlock>
    <us-gaap:BusinessCombinationSegmentAllocationTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has accounted for the initial acquisition&#13;of Impact as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Allocation of Purchase Price:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,742&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accounts receivable, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;93,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;902,067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,620&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:BusinessCombinationSegmentAllocationTableTextBlock>
    <urgo:ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The estimated useful lives for significant property and equipment&#13;categories are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer and Technology Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 23%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold Improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lease term&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 or 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</urgo:ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;The prepaid balances are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Vendor Prepayments&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,070,788&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;776,478&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Prepaid Services and Fees&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;187,912&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;152,204&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Prepayments and Advances&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,258,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;928,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;The prepaid balances are summarized&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Vendor prepayments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,828,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,070,788&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Prepaid services and fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;268,655&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;187,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred financing asset (See Note 9 - Debt)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;630,805&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,391&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,028&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Prepayments and other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,734,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,278,728&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property Plant and Equipment balances are&#13;summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Computers &amp;#38; Technology Equip&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;87,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;61,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold Improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;164,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Vehicles&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;132,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Software&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;R&amp;#38;D Assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Other Equipment&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(370,376&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(309,975&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property plant and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;165,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;441,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued expenses are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Accrued operating expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;854,056&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;240,941&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Accrued wages and related expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;487,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Accrued interest expense&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued sales tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;345,458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;401,282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,686,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,144,142&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued expenses are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Accrued operating expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;798,752&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;854,056&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued wages and related expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;402,710&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;487,327&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued interest expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,635&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued sales tax payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;616,999&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;345,458&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,863,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,686,841&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a summary of operating&#13;lease liabilities:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;br /&gt; 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;br /&gt; 2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Operating lease liabilities related to right of use assets.&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;222,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(123,395&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;98,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following schedule shows stock grant activity for the year ended December 31, 2019&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; font-weight: bold"&gt;Grants outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,802,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: left"&gt;Grants awarded&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Forfeiture/Cancelled&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Grants vested&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,361,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Grants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table shows stock grant activity&#13;for the nine months ended September 30, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; font-size: 10pt; font-weight: bold"&gt;Grants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;Grants awarded&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;794,166&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;Forfeiture/Cancelled&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(200,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Grants vested&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(253,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;Grants outstanding as of September 30, 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;753,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <urgo:ScheduleOfStockGrantVestingPeriodsTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes stock grant&#13;vesting periods.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Unrecognized stock compensation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center"&gt;Year Ending&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt; expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;264,167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;142,552&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: center"&gt;2020&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;148,334&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;2021&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;177,327&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</urgo:ScheduleOfStockGrantVestingPeriodsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;The following schedule shows stock option activity for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Number of &lt;br /&gt; Shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Weighted Average Remaining &lt;br /&gt; Life (Years)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Weighted Average &lt;br /&gt; Exercise &lt;br /&gt; Price&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Stock options outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,184,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9.68&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Issued&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;736,499&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;218,332&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;9.12&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;1.33&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options outstanding at December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,702,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;9.21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options exercisable at December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;703,538&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;8.89&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.17&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"&gt;The following table shows stock option&#13;activity for the nine months ended September 30, 2020:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of &lt;br /&gt;&#13;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average&lt;br /&gt;&#13;Remaining &lt;br /&gt;&#13;Life (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average &lt;br /&gt;&#13;Exercise &lt;br /&gt;&#13;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock options outstanding as of December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,702,167&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,425,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(297,501&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock options outstanding at September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,829,666&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock options exercisable at September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,437,578&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <urgo:ScheduleOfStockOptionVestingPeriodsTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes stock option&#13;vesting periods under the two stock options plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Unrecognized stock compensation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center"&gt;Year Ending&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt; expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;540,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;359,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: center"&gt;2020&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;408,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;48,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;2022&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;998,629&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;489,936&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</urgo:ScheduleOfStockOptionVestingPeriodsTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;The following table shows warrant&#13;activity for the years ended December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Number of shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 40%; font-weight: bold"&gt;Warrants outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Warrants issued in connection with convertible debenture offering (see Note 10):&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Issued to convertible debenture holders&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,134&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Issued to 4Front as part of compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Warrants exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Warrants expired&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Warrants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;692,034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Warrants exercisable as of December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;692,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;Warrants are immediately exercisable&#13;upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average&lt;br /&gt;&#13;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 68%"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants outstanding as of December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;692,034&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued in conjunction with debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;124,481&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;font style="font-size: 10pt"&gt;Issued in conjunction with agreement with former executive (see Note 13 &amp;#8211; Shareholders&amp;#8217; Equity)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants outstanding as of September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,216,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants exercisable as of September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,216,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:Cash contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">448703</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1178852</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">1656791</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">213392</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2019-09-30" unitRef="USD" decimals="0">3505636</us-gaap:Cash>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1564969</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">501191</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">853585</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">676175</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1214224</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">775064</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3998205</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">3945305</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">4586195</us-gaap:AssetsCurrent>
    <us-gaap:Investments contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2020358</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1261649</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2019-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">1710358</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2018-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">812883</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2019-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">310000</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2018-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">448766</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2017-12-31_custom_EdyzaMember" unitRef="USD" decimals="0">400000</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2017-12-31_custom_TotalGrowHoldingsCostMember" unitRef="USD" decimals="0">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">400000</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1710358</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2020-09-30_custom_EdyzaMember" unitRef="USD" decimals="0">1710358</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2020-09-30_custom_TotalGrowMember41049140" unitRef="USD" decimals="0">0</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2019-12-31_custom_TotalGrowMember" unitRef="USD" decimals="0">310000</us-gaap:Investments>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">106179</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">96669</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">84924</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3409487</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1799459</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">2963943</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">7407692</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">5744764</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">7550138</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3753862</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1630893</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1132020</us-gaap:AccountsPayableCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">12317185</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">9571315</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">9419327</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">98841</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">4834758</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">12416026</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">9571315</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">14254085</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">28209</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">25230</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">28272</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">11854083</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">4688272</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">14118289</us-gaap:AdditionalPaidInCapital>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">7407692</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">5744764</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">7550138</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-09-30" unitRef="USDPShares" decimals="INF">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">28209312</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">25229833</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-09-30" unitRef="Shares" decimals="INF">28272285</us-gaap:CommonStockSharesIssued>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">6626209</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">6158751</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">4012227</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">1705288</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">1932099</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">5527289</us-gaap:GrossProfit>
    <us-gaap:MarketingExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1016073</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">992288</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">236093</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">42749</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">263948</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">914563</us-gaap:MarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">9207737</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">7721221</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">4874383</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">1411821</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">2383920</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">6892623</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">12486814</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">9959335</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">6502283</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">1853828</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">3324921</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">9581375</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-5860605</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-3800584</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-2490056</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-148540</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-1392822</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-4054086</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">704230</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">119961</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">53548</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">24672</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-1469826</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-545741</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-1416708</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-1665318</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-2489968</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-95289</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-1057501</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-393158</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-125733</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-374850</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-8350573</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-3895873</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-3959882</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-694281</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-2809530</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-5719404</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-8350573</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-3895873</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-3895873</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8350573</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-3959882</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-694281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-2809530</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-5719404</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-07-01to2020-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-694281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-07-01to2019-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-2809530</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-8350573</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-3895873</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-3959882</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">-694281</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-2809530</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-5719404</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.32</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-09-30" unitRef="USDPShares" decimals="INF">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-07-01to2020-09-30" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-07-01to2019-09-30" unitRef="USDPShares" decimals="INF">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-09-30" unitRef="USDPShares" decimals="INF">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">26318059</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">24848239</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-09-30" unitRef="Shares" decimals="INF">28706905</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-07-01to2020-09-30" unitRef="Shares" decimals="INF">28888194</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-07-01to2019-09-30" unitRef="Shares" decimals="INF">26175098</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-09-30" unitRef="Shares" decimals="INF">25772134</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember311471265" unitRef="Shares" decimals="INF">25229833</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember311471265" unitRef="Shares" decimals="INF">28209312</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">25046000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">28830978</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">28272285</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">25820633</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">26981466</us-gaap:SharesOutstanding>
    <urgo:ClawbackOfStockGrantedShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">375000</urgo:ClawbackOfStockGrantedShares>
    <urgo:ClawbackOfStockGrantedShares contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1000000</urgo:ClawbackOfStockGrantedShares>
    <urgo:ClawbackOfStockGrantedValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <urgo:ClawbackOfStockGrantedValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">375</urgo:ClawbackOfStockGrantedValue>
    <urgo:ClawbackOfStockGrantedValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-375</urgo:ClawbackOfStockGrantedValue>
    <urgo:ClawbackOfStockGrantedValue contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <urgo:ClawbackOfStockGrantedValue contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1000</urgo:ClawbackOfStockGrantedValue>
    <urgo:ClawbackOfStockGrantedValue contextRef="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1000</urgo:ClawbackOfStockGrantedValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">80000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">80000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1830426</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">1345825</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1345825</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1830426</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">509219</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-07-01to2019-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">509219</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">558833</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1360966</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">131667</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2019-07-01to2019-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1160833</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">568</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-568</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1360</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1360</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">132</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-07-01to2019-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1160</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-132</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-07-01to2019-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1160</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">614041</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">4525</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4525</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">614041</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">37829</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">37829</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">20002</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-07-01to2019-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">20002</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <urgo:StockGrantsIssuedForLoanTermRevisionsShares contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">16000</urgo:StockGrantsIssuedForLoanTermRevisionsShares>
    <urgo:StockGrantsIssuedForLoanTermRevisionsValue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">31300</urgo:StockGrantsIssuedForLoanTermRevisionsValue>
    <urgo:StockGrantsIssuedForLoanTermRevisionsValue contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">16</urgo:StockGrantsIssuedForLoanTermRevisionsValue>
    <urgo:StockGrantsIssuedForLoanTermRevisionsValue contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">31284</urgo:StockGrantsIssuedForLoanTermRevisionsValue>
    <urgo:StockGrantsIssuedForLoanTermRevisionsValue contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1102513</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2657037</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1103</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2655934</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2019-01-01to2019-03-07_custom_ImpactEngineeringMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">250000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">500</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">999500</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">155000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">250</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">154750</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <urgo:EquityValueOfExercisePriceAssociatedWithConvertibleDebentures contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">719479</urgo:EquityValueOfExercisePriceAssociatedWithConvertibleDebentures>
    <urgo:EquityValueOfExercisePriceAssociatedWithConvertibleDebentures contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">719479</urgo:EquityValueOfExercisePriceAssociatedWithConvertibleDebentures>
    <urgo:EquityValueOfExercisePriceAssociatedWithConvertibleDebentures contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <urgo:BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">278678</urgo:BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures>
    <urgo:BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">278678</urgo:BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures>
    <urgo:BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepreciationAndAmortization contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">266476</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">154136</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">181750</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">193956</us-gaap:DepreciationAndAmortization>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3394</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:InventoryWriteDown contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">94727</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">77531</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">72258</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">57352</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">72416</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-3468</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">9572</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">849355</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">73917</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-658706</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">899859</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-443322</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">167040</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">171147</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-142745</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">324273</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">88684</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">784210</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-123376</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2671838</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">205667</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-2470559</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">2164412</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-2487435</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-2285136</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-3028113</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-86299</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">192954</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">369480</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">122817</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">387160</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">121500</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">40500</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">49742</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">49742</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">40255</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">33674</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">25000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1147942</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-1264803</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-122817</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">-894168</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">80000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2905228</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3072000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">2915619</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">3307251</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-730149</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-477939</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">-235311</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">2326784</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">612138</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">119961</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">670165</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">291441</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <urgo:ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2657037</urgo:ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock>
    <urgo:ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</urgo:ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock>
    <urgo:CommonStockRetired contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</urgo:CommonStockRetired>
    <urgo:CommonStockRetired contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">375</urgo:CommonStockRetired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">326092</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">326095</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2915406</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">3298609</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">4087592</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">432578</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1333520</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:OperatingLeaseCost contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">123563</us-gaap:OperatingLeaseCost>
    <urgo:StockOptionsIssuedForLoanTermRevisionsShares contextRef="From2019-01-01to2019-12-31_custom_JamesLoweMember" unitRef="Shares" decimals="INF">10000</urgo:StockOptionsIssuedForLoanTermRevisionsShares>
    <urgo:StockReceivedForAcquisitionValue contextRef="From2018-01-01to2018-08-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember" unitRef="USD" decimals="0">400000</urgo:StockReceivedForAcquisitionValue>
    <urgo:StockReceivedForAcquisitionValue contextRef="From2018-01-01to2018-12-31_custom_EdyzaSensorsMember_custom_StockPurchaseOptionMember" unitRef="USD" decimals="0">400000</urgo:StockReceivedForAcquisitionValue>
    <urgo:PatentsIssued contextRef="AsOf2019-12-31" unitRef="Integer" decimals="INF">2</urgo:PatentsIssued>
    <urgo:PatentsIssued contextRef="AsOf2018-12-31" unitRef="Integer" decimals="INF">0</urgo:PatentsIssued>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="AsOf2019-12-31_custom_Year2016Member" unitRef="USD" decimals="0">1618386</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="AsOf2019-12-31_custom_Year2017Member" unitRef="USD" decimals="0">2182354</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="AsOf2019-12-31_custom_Year2018Member" unitRef="USD" decimals="0">3060443</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="AsOf2019-12-31_custom_Year2019Member" unitRef="USD" decimals="0">6819954</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_ConvertibleDebentureHoldersMember" unitRef="USDPShares" decimals="INF">3.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember_custom_Front4CompensationMember" unitRef="USDPShares" decimals="INF">2.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">2.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-383203</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">147360</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">1172186</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">925922</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">970000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">1992000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">1020600</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">970000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 1&amp;#160;&amp;#8211; ORGANIZATION AND&#13;ACQUISITIONS, BUSINESS PLAN, AND LIQUIDITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Organization and Acquisitions&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;urban-gro, Inc. (&amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221;&#13;our&amp;#8221; or the &amp;#8220;Company&amp;#8221;) is a leading&amp;#160;engineering design services company that integrates complex environmental&#13;equipment systems to create high performance indoor cultivation facilities for the global commercial horticulture market. Our custom&#13;tailored, plant-centric approach to design, procurement, and integration provides a single point of accountability across all aspects&#13;of indoor cultivation operations. Our solution offers functionality that helps customers manage the entire cultivation lifecycle,&#13;from facility engineering and design to operation and day-to-day management. We offer a full range of custom services that are&#13;integrated with select cultivation equipment and product solutions, which we primarily source from third party technology and&#13;manufacturing partners but also develop in-house.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our service offerings include full facility&#13;programming, engineering and design services, start-up commissioning services, facility optimization services and IPM planning&#13;and strategy services. Complementing these services, we work with customers to source an integrated suite of select cultivation&#13;equipment systems and crop management products, which include: (1)&amp;#160;environmental controls, fertigation, and irrigation distribution&#13;systems; (2)&amp;#160;freshwater, wastewater, and condensation treatment systems; (3)&amp;#160;light emitting diode (&amp;#8220;LED&amp;#8221;),&#13;high-pressure sodium (&amp;#8220;HPS&amp;#8221;) and ceramic metal halide (&amp;#8220;CMH&amp;#8221;) lighting systems; (4)&amp;#160;rolltop, multi-tier,&#13;and automated container benching systems; (5)&amp;#160;odor mitigation &amp;#38; microbial reduction systems; (6)&amp;#160;air flow systems;&#13;(7)&amp;#160;industrial spray applicators; (8)&amp;#160;pesticides and bio-controls; (9)&amp;#160;plant nutrition products; (10)&amp;#160;substrate&#13;and coco bag solutions; and (11)&amp;#160;our Soleil&amp;#174; technology data analytics platform that includes wireless environmental &amp;#38;&#13;substrate sensing and remote monitoring and support.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2018, the Company formed urban-gro&#13;Canada Technologies, Inc. as a wholly owned Canadian subsidiary which it currently utilizes for its Canadian sales operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective March 7, 2019, the Company acquired&#13;100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&amp;#8220;Impact&amp;#8221;), a provider of mechanical electrical and&#13;plumbing (&amp;#8220;MEP&amp;#8221;) engineering services predominantly focused on the cannabis industry. Management believes the acquisition&#13;of Impact will improve the Company&amp;#8217;s ability to better serve its current and future customer base by expanding on the fully&#13;integrated products and services offered by the Company. The Company issued 500,000 shares of Common Stock (&amp;#8220;Common Stock&amp;#8221;)&#13;valued at $2.00 per share to effect the acquisition of Impact. The Company has initially accounted for the acquisition of Impact&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 85%"&gt;Purchase Price&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Allocation of Purchase Price:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;49,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accounts receivable, net&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;93,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Goodwill&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;902,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;45,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Basis of Presentation &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements&#13;are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles&#13;(&amp;#8220;GAAP&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidity and Going Concern&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Since inception, the Company has incurred&#13;significant operating losses and has funded its operations primarily through issuance of equity securities, debt, and operating&#13;revenue. As of December 31, 2019, the Company had an accumulated deficit of $16,890,626, a working capital deficit of $7,318,980,&#13;and negative stockholders&amp;#8217; equity of $5,008,334. These facts and conditions raise substantial doubt about the Company&amp;#8217;s&#13;ability to continue as a going concern, within one year after the date that the financial statements are issued. The Company continually&#13;evaluates opportunities to raise equity and debt financing as well as implementing cost reduction and revenue enhancing measures&#13;that will allow it to increase profitability and continue operations. There can, however, be no assurances that the Company will&#13;be able to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can there&#13;be any assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable the&#13;Company to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going concern&#13;basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to Accounting Standards&#13;Codification (&amp;#8220;ASC&amp;#8221;) 205-40, &lt;i&gt;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going&#13;Concern, &lt;/i&gt;we assess going concern uncertainty for our consolidated financial statements to determine if we have sufficient&#13;cash and cash equivalents on hand and working capital to operate for a period of at least one year from the date the consolidated&#13;financial statements are issued or are available to be issued. As part of this assessment, based on conditions that are known&#13;and reasonably knowable to us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key&#13;assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those&#13;expenditures or programs, among other factors, if necessary. It is probable that management&amp;#8217;s plans, when implemented, will&#13;mitigate the relevant conditions or events that raise substantial doubt about the entity&amp;#8217;s ability to continue as a going&#13;concern within one year after the date that the financial statements are issued.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 1 &amp;#8211; ORGANIZATION AND ACQUISITIONS,&#13;LIQUIDITY AND GOING CONCERN&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Organization and Acquisitions&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;urban-gro, Inc. (&amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221;&#13;&amp;#8220;our,&amp;#8221; the &amp;#8220;Company,&amp;#8221; or &amp;#8220;urban-gro&amp;#8221;) is a leading engineering design and services company&#13;focused on the commercial indoor horticulture market. We engineer and design indoor &lt;font style="color: #000712"&gt;controlled environment&#13;agriculture (&amp;#8220;CEA&amp;#8221;) facilities a&lt;/font&gt;nd then integrate complex environmental equipment systems into those facilities.&#13;Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including&#13;leafy greens, vegetables, herbs, and plant-based medicines like cannabis and hemp. Our custom-tailored approach to design, procurement,&#13;and equipment integration provides a single point of accountability across all aspects of indoor growing operations. We also help&#13;our clients achieve operational efficiency and economic advantages through a full spectrum of professional services and programs&#13;focused on facility optimization and environmental health which allows &lt;font style="color: #000712"&gt;clients to manage their entire&#13;cultivation lifecycle, establishing facilities that operate and perform at the highest level.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #000712"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our indoor commercial cultivation solution&#13;offers an integrated suite of services and equipment systems that generally fall within the following categories:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Service Solutions:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Engineering Design Services &amp;#8211; A comprehensive triad of services including:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;i.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Cultivation Space Programming (&amp;#8220;CSP&amp;#8221;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;ii.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Integrated Cultivation Design (&amp;#8220;ICD&amp;#8221;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;iii.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Full-Facility Mechanical, Electrical, and Plumbing (&amp;#8220;MEP&amp;#8221;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;gro-care&amp;#174; - A recurring revenue subscription-based managed service offering including:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;i.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Remote Monitoring, Reporting, Support, and Training Services&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;ii.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Facility and Equipment Commissioning &amp;#38; Audit Services&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 15%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;iii.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Environmental Sciences Groups&amp;#8217; (&amp;#8220;ESG&amp;#8221;) Compliance and Program Services&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 94%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Integrated Equipment Solutions:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Design, Source, and Integration of Complex Environmental Equipment Systems Including Purpose-Built Heating, Ventilation, and Air Conditioning (&amp;#8220;HVAC&amp;#8221;) solutions, Environmental Controls, Fertigation, and Irrigation Distribution.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Value-Added Reselling (&amp;#8220;VAR&amp;#8221;) of Cultivation Equipment including a Complete line of Lighting and Rolling Benching Systems&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;font style="font: 10pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Strategic Vendor Relationships with Premier Manufacturers&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="color: #000712"&gt;Since&#13;commencing business in March 2014, we have introduced new equipment solutions, products and services to the CEA market, expanded&#13;our ongoing operations across North America, and most recently, we have entered into several engagements in Europe. &lt;/font&gt;In June&#13;2018, the Company formed urban-gro Canada Technologies, Inc. as a wholly owned Canadian subsidiary, which it utilizes for its Canadian&#13;sales operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective March 7, 2019, the Company acquired&#13;100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&amp;#8220;Impact&amp;#8221;), a provider of mechanical electrical and&#13;plumbing (&amp;#8220;MEP&amp;#8221;) engineering services predominantly focused on the indoor commercial horticulture industry. The Company&#13;believes the acquisition of Impact will improve the Company&amp;#8217;s ability to better serve its current and future client base&#13;by expanding on the fully integrated products and services offered by the Company. The Company initially issued 500,000 shares&#13;of Common Stock valued at $2.00 per share to effect the acquisition of Impact. The Company  accounted for the initial acquisition&#13;of Impact as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Allocation of Purchase Price:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,742&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accounts receivable, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;93,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;902,067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,620&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under the terms of the agreement to&#13;acquire Impact, the Company was required to issue additional shares of Common Stock to the former Impact owner if the average&#13;closing price per share of the Company&amp;#8217;s Common Stock was less than or equal to $2.00 per share for the 30-day period&#13;beginning on the date that was 150 days after the initial date of the listing of the Company&amp;#8217;s Common Stock on a&#13;national securities exchange or quotation on the OTCQB or OTCQX (the &amp;#8220;Valuation Period&amp;#8221;). The Company&amp;#8217;s&#13;Common Stock price was lower than $2.00 per share during the Valuation Period and the Company was required to issue&#13;additional shares of the Company&amp;#8217;s Common Stock to the former Impact owner. In September 2020, however, the Company and&#13;the former Impact owner agreed to satisfy this provision of the agreement by the Company issuing 250,000 additional shares of&#13;Common Stock to the former Impact owner. The Company valued the issuance of these additional 250,000 shares at $0.62 per&#13;share of Common Stock based on the market price of our shares on the date of the agreement and recorded the additional&#13;issuance of shares as contingent consideration in the statements of operations and comprehensive income (loss).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Liquidity and Going Concern&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Since inception, the Company has incurred significant&#13;operating losses and has funded its operations primarily through the issuance of equity securities, debt, and operating revenue.&#13;As of September 30, 2020, the Company had an accumulated deficit of $20,850,508, a working capital deficit of $4,833,132, and negative&#13;stockholders&amp;#8217; equity of $6,703,947. These facts and conditions raise substantial doubt about the Company&amp;#8217;s ability&#13;to continue as a going concern, within one year after the date that these financial statements are issued. The Company continually&#13;evaluates opportunities to raise equity and debt financing and has also sought to implement cost reduction and revenue enhancing&#13;measures to help achieve profitability and continue operations. There can, however, be no assurances that the Company will be able&#13;to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can there be any&#13;assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable the Company&#13;to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going concern basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pursuant to Accounting Standards Codification&#13;(&amp;#8220;ASC&amp;#8221;) 205-40, &lt;i&gt;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern, &lt;/i&gt;we&#13;assess going concern uncertainty for our condensed consolidated financial statements to determine if we have sufficient cash and&#13;cash equivalents on hand and working capital to operate for a period of at least one year from the date the condensed consolidated&#13;financial statements are issued or are available to be issued. As part of this assessment, based on conditions that are known and&#13;reasonably knowable to us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key assumptions,&#13;including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those expenditures&#13;or programs, among other factors, if necessary. We believe it is probable that management&amp;#8217;s plans, when implemented, will&#13;mitigate the relevant conditions or events that raise substantial doubt about the Company&amp;#8217;s ability to continue as a going&#13;concern within one year after the date that the financial statements are issued.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 2&amp;#160;&amp;#8211; SUMMARY OF SIGNIFICANT&#13;ACCOUNTING POLICIES &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In preparing consolidated financial&#13;statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts&#13;of assets and liabilities and the disclosure of assets and liabilities at the date of the consolidated financial statements&#13;and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates&#13;include estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for&#13;deferred tax assets, and allowance for bad debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation and Principles&#13;of Consolidation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements&#13;are presented in United States dollars and they include the accounts of urban-gro, Inc. and its wholly-owned subsidiaries. The&#13;financial results of Impact have been included in the Company&amp;#8217;s consolidated financial statements from the date of acquisition&#13;on March 7, 2019 and all intercompany transactions have been eliminated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Recently Issued Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Financial Accounting&#13;Standards Board (the &amp;#8220;FASB&amp;#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues&#13;updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&amp;#34;ASU&amp;#34;). Unless otherwise&#13;discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is&#13;not expected to have a material impact on the Company&amp;#8217;s financial statements upon adoption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Functional and reporting currency and&#13;foreign currency translation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The functional and reporting currency of&#13;the Company and its subsidiaries is US dollars. All transactions in currencies other than US dollars are translated into US dollars&#13;on the date of the transaction. Any exchange gains and losses related to these transactions are recognized in the current period&amp;#8217;s&#13;earnings as other income (expense).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s financial instruments&#13;consist principally of cash and cash equivalents, accounts receivable, accounts payable, notes payable and other current assets&#13;and liabilities. We value our financial assets and liabilities using fair value measurements. Fair value is based on the price&#13;that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at&#13;the measurement date. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable&#13;in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy&#13;is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three&#13;levels (with Level 3 being the lowest) defined as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 1:&amp;#160;Quoted prices in active markets for identical&#13;assets or liabilities that the entity has the ability to access.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 2:&amp;#160;Observable inputs other&#13;than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for&#13;identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated&#13;with observable market data.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 3:&amp;#160;Unobservable inputs&#13;that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This&#13;includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amount of our cash and&#13;cash equivalents, accounts receivable, accounts payable, and other current assets and liabilities in our consolidated financial&#13;statements approximates fair value because of the short-term nature of the instruments. Investments in non-marketable equity securities&#13;are carried at cost less other-than-temporary impairments. The carrying amount of our notes payable and convertible debt at December&#13;31, 2019 and December 31, 2018 approximates their fair values based on our incremental borrowing rates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There have been no changes in Level 1,&#13;Level 2, and Level 3 categorizations and no changes in valuation techniques for these assets or liabilities for the years ended&#13;December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all highly&#13;liquid short-term cash investments with an original maturity of three months or less to be cash equivalents. As of December 31,&#13;2019 and 2018, the Company did not maintain any cash equivalents. The Company maintains cash with financial institutions that&#13;may from time to time exceed federally-insured limits. The Company has not experienced any losses related to these balances and&#13;believes the risk to be minimal. There are no restricted or compensating cash balances as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Accounts Receivable, Net&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trade accounts receivables are carried&#13;at the original invoiced amounts less an allowance for doubtful accounts. As of December 31, 2019 and 2018, the balance of allowance&#13;for doubtful accounts was $18,920. The allowances for doubtful accounts are calculated based on a detailed review of certain individual&#13;customer accounts and an estimation of the overall economic conditions affecting the Company's customer base. The Company reviews&#13;a customer's credit history before extending credit to the customer. If the financial condition of its customers were to deteriorate,&#13;resulting in an impairment of their ability to make payments, additions to the allowance would be required. A provision is made&#13;against accounts receivable to the extent they are considered unlikely to be collected. Occasionally the Company will write off&#13;bad debt directly to the bad debt expense account when the balance is determined to be uncollectable. Bad debt expense for the&#13;years ended December 31, 2019 and 2018 was $67,633 and $106,464, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Inventories&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventories, consisting entirely of finished&#13;goods, are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost&#13;method. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based&#13;on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold at the realization of change&#13;in value. Once written down, inventories are carried at this lower basis until sold or scrapped.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Property and Equipment &lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;Property and equipment is stated at&#13;cost less accumulated depreciation and impairment. Expenditures for major additions and improvements are capitalized and minor&#13;replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise&#13;disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in&#13;the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets&#13;using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated)&#13;for tax purposes where appropriate. No impairment charges were recorded for the years ended December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The estimated useful lives for significant property and equipment&#13;categories are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer and Technology Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 23%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold Improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lease term&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 or 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Operating Lease Right of Use Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Operating lease right of use assets are&#13;stated at cost less accumulated depreciation, amortization and impairment. The Company has two operating leases with an imputed&#13;annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on August 31,&#13;2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021. Operating lease&#13;right of use asset costs incurred in 2019 were $123,563.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Convertible Notes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its convertible&#13;notes at issuance by allocating the proceeds received from a convertible note among freestanding instruments according to ASC&#13;470, Debt, based upon their relative fair values. The fair value of debt and common stock is determined based on the closing price&#13;of the common stock on the date of the transaction, and the fair value of warrants, if any, is determined using the Black-Scholes&#13;option-pricing model. Convertible notes are subsequently carried at amortized cost. The fair value of the warrants is recorded&#13;as additional paid-in capital, with a corresponding as a debt discount from the face amount of the convertible note. Each convertible&#13;note is analyzed for the existence of a beneficial conversion feature (&amp;#8220;BCF&amp;#8221;), defined as the fair value of the common&#13;stock at the commitment date for the convertible note, less the effective conversion price. Beneficial conversion features are&#13;recognized at their intrinsic value, and recorded as an increase to additional paid-in capital, with a corresponding reduction&#13;in the carrying amount of the convertible note (as a debt discount from the face amount of the convertible note). The discounts&#13;on the convertible notes, consisting of amounts ascribed to warrants and beneficial conversion features, are amortized to interest&#13;expense, using the effective interest method, over the terms of the related convertible notes. Beneficial conversion features&#13;that are contingent upon the occurrence of a future event are recorded when the contingency is resolved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Intangible Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s intangible assets,&#13;consisting of legal fees for application of patents and trademarks and license fees paid for inspection services, are recorded&#13;at cost. Patents and trademarks, once approved, will be amortized using the straight-line method over an estimated life, generally&#13;5 years for patents and 10 to 20 years for trademarks. License fees are amortized over 10 years. Intangible assets are included&#13;in &amp;#8220;other assets&amp;#8221; on the balance sheets. The net balance of intangible assets for December 31, 2019 and 2018 was $86,151&#13;and $63,755, respectively. Amortization expense totaled $1,879 and $974 for the years ended December 31, 2019 and 2018, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Goodwill&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the purchase&#13;price over the fair value of net assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment&#13;annually as of December 31st and at any time when events or circumstances suggest impairment may have occurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The testing for impairment consists of&#13;a comparison of the fair value of with its carrying amount. If the carrying amount of the reporting unit, including goodwill, exceeds&#13;the fair value, an impairment will be recognized equal to the difference between the carrying value of the reporting unit goodwill&#13;and the implied fair value of the goodwill. In testing goodwill for impairment, we determine the estimated fair value of our reporting&#13;units based upon a discounted future cash flow analysis. Goodwill is our only indefinite-lived intangible asset. Definite-lived&#13;intangible assets are amortized using the straight line method over the shorter of their contractual term or estimated useful lives.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Investments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments without readily determinable&#13;fair values and for which the Company does not have the ability to exercise significant influence are accounted for at cost with&#13;adjustments for observable changes in prices or impairments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Impairment of Long-lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates potential impairment&#13;of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#13;The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to&#13;result from the use and eventual disposition of the asset. An impairment will be recognized as the amount by which the carrying&#13;amount of a long-lived asset exceeds its fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance&#13;with ASC 606, &lt;i&gt;Revenue from Contracts with Customers,&lt;/i&gt; which requires that five basic steps be followed to recognize revenue:&#13;(1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance&#13;obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration&#13;given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance&#13;obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration&#13;given to whether that control happens&amp;#160;over time&amp;#160;or not. Determination of criteria (3) and (4) are based on our management's&#13;judgments regarding the fixed nature of the selling prices of the services and products delivered and the collectability of those&#13;amounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our service and product revenues arise&#13;from contracts with customers. Service revenues include full facility programming, engineering and design services, start-up commissioning&#13;services, facility optimization services and IPM planning and strategy services. Product revenues include an integrated suite of&#13;select cultivation equipment systems and crop management products. We enter into separate contracts for the service and product&#13;revenues we provide to our customers so to clarify our obligations under the terms of the contracts. New contracts are entered&#13;into if the services to be performed or products to be delivered need to be modified. Service revenues are satisfied when services&#13;are rendered or completed in accordance with the terms of the contract. Product revenues are satisfied when control of the products&#13;is transferred to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenues for services and products for&#13;the year ended December 31, 2019 were $3,167,237 and 21,022,566, respectively. Revenues for services and products for the year&#13;ended December 31, 2018 were $928,063 and $19,122,713, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Customer Deposits&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s policy is to collect&#13;deposits from customers at the beginning of the contract. The customer payments received are recorded as a customer deposit liability&#13;on the balance sheet. When the contract is complete and meets all the criteria for revenue recognition, the customer is billed&#13;for the entire contract amount and the deposit is recorded against the customer&amp;#8217;s receivable balance. In certain situations&#13;when the customer has paid the deposit and services have been performed but the customer chooses not to proceed with the contract,&#13;the Company may keep the deposit and recognize revenue.&amp;#160;Of the outstanding customer deposit balance of $3,298,609 at December&#13;31, 2018, $2,678,565 was recognized as revenue in the year ended December 31, 2019. At December 31, 2017, the entire customer&#13;deposit balance of $3,151,250 was recognized as revenue in the year ended December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Cost of Revenue&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s policy is to recognize&#13;cost of revenues in the same manner as, and in conjunction with, revenue recognition. The Company&amp;#8217;s cost of revenues includes&#13;the costs directly attributable to revenue recognized and includes expenses related to the purchasing of products and providing&#13;services, fees for third-party commissions and shipping costs. Total shipping costs included in the cost of goods sold for the&#13;years ended December 31, 2019 and 2018 was $679,911 and $490,526, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Advertising Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company expenses advertisings costs&#13;in the periods the costs are incurred. Prepayments made under contracts are included in prepaid expenses and expensed when the&#13;advertisement is run. Total advertising expense incurred for the years ended December 31, 2019 and 2018 was $159,728 and $153,878,&#13;respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Warrants&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;The Company accounts for its&#13;warrants issued in accordance with the GAAP accounting guidance under ASC 480, &amp;#8220;Distinguishing Liabilities from Equity&amp;#8221;.&#13;The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing&#13;based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual&#13;term, risk-free interest rate, and expected volatility of the price of the underlying common stock. There is a moderate degree&#13;of subjectivity involved when using option pricing models to estimate the warrants and the assumptions used in the Black-Scholes&#13;option-pricing model are moderately judgmental.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Stock-Based Compensation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company periodically issue shares of&#13;its common stock to employees and consultants in non-capital raising transactions for fees and services.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock issued to&#13;non-employees with the value of the stock compensation based upon the measurement date as determined at the grant date of the award.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock grants issued&#13;and vesting to employees with the award being measured at its fair value at the date of grant and amortized ratably over the vesting&#13;period. The Company also estimates forfeitures at the time of grant and revises those estimates in subsequent periods if actual&#13;forfeitures differ from its estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company files&#13;income federal tax returns in the United States and Canada and state and local tax return in applicable jurisdictions. Provisions&#13;for current income tax liabilities, if any, would be calculated and accrued on income and expense amounts expected to be included&#13;in the income tax returns for the current year. Income taxes reported in earnings, if any, would also include deferred income tax&#13;provisions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred income&#13;tax assets and liabilities, if any, would be computed on differences between the financial statement bases of assets and liabilities&#13;at the enacted tax rates. Changes in deferred income tax assets and liabilities would be included as a component of income tax&#13;expense. The effect on deferred income tax assets and liabilities attributable to changes in enacted tax rates would be charged&#13;or credited to income tax expense in the period of enactment. Valuation allowances would be established for certain deferred tax&#13;assets when realization is not likely.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Assets and liabilities&#13;would be established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions,&#13;in the judgement of the Company, do not meet a more-likely-than-not threshold based on the technical merits of the positions.&#13;Valuation allowances would be established for certain deferred tax assets when realization is not likely.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Loss Per Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company computes net loss per share&#13;by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period.&#13;Diluted earnings per share would be computed by dividing net loss by the weighted-average of all potentially dilutive shares of&#13;common stock that were outstanding during the periods presented. The diluted earnings per share calculation is not presented as&#13;it results in an anti-dilutive calculation of net loss per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The treasury stock method would be used&#13;to calculate diluted earnings per share for potentially dilutive stock options and share purchase warrants. This method assumes&#13;that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase&#13;common shares at the average market price for the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Recently Adopted Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued an Accounting&#13;Standards Update (&amp;#8220;ASU&amp;#8221;) amending the accounting for leases. The new guidance requires the recognition of lease assets&#13;and liabilities for operating leases with terms of more than 12 months, in addition to those currently recorded, on the Company&amp;#8217;s&#13;consolidated balance sheets. Presentation of leases within the consolidated statements of operations and comprehensive loss and&#13;consolidated cash flows will be generally consistent with the prior lease accounting guidance. The ASU was effective for reporting&#13;periods beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU effective January 1, 2019&#13;under the modified retrospective method with respect to lease contracts in effect as of the adoption date. The adoption of the&#13;ASU increased our assets and liabilities by $326,095 in 2019 due to the recognition of right of use assets and lease liabilities&#13;with respect to operating leases.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 &amp;#8211; SUMMARY OF SIGNIFICANT ACCOUNTING&#13;POLICIES &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Unaudited Condensed Consolidated Financial&#13;Statements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has prepared the accompanying condensed&#13;consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting. The condensed&#13;consolidated financial statements are unaudited and, in the Company&amp;#8217;s opinion, include all adjustments, consisting of normal&#13;recurring adjustments and accruals necessary for a fair presentation of the Company&amp;#8217;s condensed consolidated balance sheets,&#13;condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of shareholders&amp;#8217;&#13;deficit and condensed consolidated statements of cash flows for the periods presented. The results reported in these condensed&#13;consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire&#13;year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting&#13;principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) have been omitted in accordance with regulations of the&#13;SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto&#13;included in the Company&amp;#8217;s consolidated financial statements in the Company&amp;#8217;s Annual Report on Form 10-K for the year&#13;ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Significant Accounting Policies&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For a detailed discussion about the Company&amp;#8217;s&#13;significant accounting policies, refer to Note 2 &amp;#8212; &amp;#8220;Summary of Significant Accounting Policies,&amp;#8221; in the Company&amp;#8217;s&#13;consolidated financial statements included in the Company&amp;#8217;s 2019 Form 10-K. During the nine months ended September 30, 2020,&#13;there were no material changes made to the Company&amp;#8217;s significant accounting policies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing condensed consolidated financial&#13;statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of&#13;assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements&#13;and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include&#13;estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for deferred&#13;tax assets, and allowance for bad debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Reclassification&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain prior year amounts have been reclassified&#13;for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recently Issued Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;From time to time, the Financial Accounting&#13;Standards Board (the &amp;#8220;FASB&amp;#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues&#13;updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&amp;#34;ASU&amp;#34;). Unless otherwise&#13;discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is&#13;not expected to have a material impact on the Company&amp;#8217;s financial statements upon adoption.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation and Principles&#13;of Consolidation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements&#13;are presented in United States dollars and they include the accounts of urban-gro, Inc. and its wholly-owned subsidiaries. The&#13;financial results of Impact have been included in the Company&amp;#8217;s consolidated financial statements from the date of acquisition&#13;on March 7, 2019 and all intercompany transactions have been eliminated.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Functional and reporting currency and&#13;foreign currency translation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The functional and reporting currency of&#13;the Company and its subsidiaries is US dollars. All transactions in currencies other than US dollars are translated into US dollars&#13;on the date of the transaction. Any exchange gains and losses related to these transactions are recognized in the current period&amp;#8217;s&#13;earnings as other income (expense).&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all highly&#13;liquid short-term cash investments with an original maturity of three months or less to be cash equivalents. As of December 31,&#13;2019 and 2018, the Company did not maintain any cash equivalents. The Company maintains cash with financial institutions that&#13;may from time to time exceed federally-insured limits. The Company has not experienced any losses related to these balances and&#13;believes the risk to be minimal. There are no restricted or compensating cash balances as of December 31, 2019.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Goodwill&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the purchase&#13;price over the fair value of net assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment&#13;annually as of December 31st and at any time when events or circumstances suggest impairment may have occurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The testing for impairment consists of&#13;a comparison of the fair value of with its carrying amount. If the carrying amount of the reporting unit, including goodwill, exceeds&#13;the fair value, an impairment will be recognized equal to the difference between the carrying value of the reporting unit goodwill&#13;and the implied fair value of the goodwill. In testing goodwill for impairment, we determine the estimated fair value of our reporting&#13;units based upon a discounted future cash flow analysis. Goodwill is our only indefinite-lived intangible asset. Definite-lived&#13;intangible assets are amortized using the straight line method over the shorter of their contractual term or estimated useful lives.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Investments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments without readily determinable&#13;fair values and for which the Company does not have the ability to exercise significant influence are accounted for at cost with&#13;adjustments for observable changes in prices or impairments.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Stock-Based Compensation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company periodically issue shares of&#13;its common stock to employees and consultants in non-capital raising transactions for fees and services.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock issued to&#13;non-employees with the value of the stock compensation based upon the measurement date as determined at the grant date of the award.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock grants issued&#13;and vesting to employees with the award being measured at its fair value at the date of grant and amortized ratably over the vesting&#13;period. The Company also estimates forfeitures at the time of grant and revises those estimates in subsequent periods if actual&#13;forfeitures differ from its estimates.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Warrants&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;The Company accounts for its&#13;warrants issued in accordance with the GAAP accounting guidance under ASC 480, &amp;#8220;Distinguishing Liabilities from Equity&amp;#8221;.&#13;The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing&#13;based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual&#13;term, risk-free interest rate, and expected volatility of the price of the underlying common stock. There is a moderate degree&#13;of subjectivity involved when using option pricing models to estimate the warrants and the assumptions used in the Black-Scholes&#13;option-pricing model are moderately judgmental.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2019-01-01to2019-12-31_custom_NotePayable1Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2019-01-01to2019-12-31_custom_NotePayable2Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2020-01-01to2020-09-30_custom_NotePayable1Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2020-01-01to2020-09-30_custom_NotePayable2Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-2812709</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-2478869</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">60000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1020600</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 11 &amp;#8211; OPERATING LEASE LIABILITIES &amp;#38; COMMITMENTS&#13;AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has two operating leases with&#13;an imputed annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on&#13;August 31, 2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a summary of operating&#13;lease liabilities:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br /&gt; 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br /&gt; 2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; text-align: left"&gt;Operating lease liabilities related to right of use assets.&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;222,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(123,395&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;98,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a schedule showing future&#13;minimum lease payments:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 44%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year ending&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total Minimum&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lease Payments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 20%; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;177,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;91,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Company is involved&#13;in routine litigation that arises in the ordinary course of business. There are no legal proceedings for which management believes&#13;the ultimate outcome would have a material adverse effect on the Company&amp;#8217;s results of operations and cash flows.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 44%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year ending&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total Minimum&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lease Payments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 20%; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;177,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;91,688&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&lt;b&gt;NOTE 12 &amp;#8211; RISKS AND UNCERTAINTIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"&gt;&lt;u&gt;Concentration Risk&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2019,&#13;one vendor composed 24% of total purchases. During the year ended December 31, 2018, two unrelated vendors composed 18% and 11%&#13;of total purchases.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s primary suppliers of&#13;automated environmental controls and fertigation represented 3% and 46% of total accounts payable outstanding as of December 31,&#13;2019 and 2018, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2019,&#13;one customer represented 21% of total revenue. During the year ended December 31, 2018, one customer represented 14% of total&#13;revenue. At December 31, 2019, one customer represented 15% and another represented 11% of total outstanding accounts receivables.&#13;At December 31, 2018, one customer represented 19% and another represented 13% of total outstanding receivables.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Coronavirus Pandemic&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #000712"&gt;In December 2019, a novel&#13;strain of coronavirus (COVID-19) was reported to have surfaced in Wuhan, China. In January 2020, this coronavirus spread to other&#13;countries, including the United States, and efforts to contain the spread of this coronavirus intensified. In March 2020, the World&#13;Health Organization declared the outbreak of the coronavirus a pandemic. We are a business that supplies other Essential Businesses&#13;with support and supplies necessary to operate and we therefore are an Essential Business and allowed to continue operating under&#13;Stay-At-Home Orders issued by many states and cities. However, the extent to which the coronavirus impacts our results will depend&#13;on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning&#13;the severity of the coronavirus and the actions to contain the coronavirus or treat its impact. The outbreak and any preventative&#13;or protective actions that governments or we may take in respect of this coronavirus may result in a period of business disruption,&#13;reduced customer business and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but&#13;may materially affect our business, financial condition, results of operations, and cash flows. Effects from the COVID-19 pandemic&#13;began in the latter portion of the first quarter of 2020; therefore, there was no impact to our 2019 results of operations, financial&#13;condition and cash flows.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&lt;b&gt;NOTE 11 &amp;#8211; RISKS AND UNCERTAINTIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&lt;u&gt;Concentration Risk&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the nine months ended September 30,&#13;2020 and 2019, one client represented 26% and 15% of total revenue, respectively. During the three months ended September 30, 2020&#13;and 2019, one client represented 51% and 17% of total revenue, respectively. At September 30, 2020 one client represented 26% of&#13;total outstanding receivables. At December 31, 2019, one client represented 15% and another represented 11% of total outstanding&#13;accounts receivables.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the nine months ended September 30,&#13;2020, 27% of the Company&amp;#8217;s total purchases were from one vendor. During the nine months ended September 30, 2019, 15% of&#13;the Company&amp;#8217;s total purchases were from one vendor. During the three months ended September 30, 2020, 48% of the Company&amp;#8217;s&#13;total purchases were from one vendor. During the three months ended September 30, 2019, 20% of the Company&amp;#8217;s total purchases&#13;were from one vendor.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Coronavirus Pandemic&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The outbreak of COVID-19, a novel strain&#13;of coronavirus first identified in China, which has spread across the globe including the U.S., has had an adverse impact on our&#13;operations and financial condition. The response to this coronavirus by federal, state and local governments in the U.S. has resulted&#13;in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has&#13;also caused significant stock market volatility and further tightened capital access for most businesses. Given that the COVID-19&#13;pandemic and its disruptions are of an unknown duration, they could have an adverse effect on our liquidity and profitability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of these events, we assessed our&#13;near-term operations, working capital, finances and capital formation opportunities, and implemented, in late March 2020, a downsizing&#13;of our operations and workforce to preserve cash resources and focus our operations on client-centric sales and project management&#13;activities. The duration and likelihood of success of this workforce reduction are uncertain; however, we have since rehired several&#13;employees who were impacted by the downsizing effort. If this downsizing effort does not meet our expectations, or additional capital&#13;is not available, we may not be able to continue our operations. The pandemic and its effects resulted in temporary delays in our&#13;projects, however, work on all such projects has resumed. Other factors that will affect our ability to continue operations include&#13;the market demand for our products and services, our ability to service the needs of our clients and prospects with a reduced workforce,&#13;potential contract cancellations, project scope reductions and project delays, our ability to fulfill our current backlog, management&#13;of our working capital, the availability of cash to fund our operations, and the continuation of normal payment terms and conditions&#13;for purchase of our products. In light of these extenuating circumstances, there is no assurance that we will be successful in&#13;growing and maintaining our business with our clients. If our clients or prospects are unable to obtain project financing and we&#13;are unable to increase revenues, or otherwise generate cash flows from operations, we will not be able to successfully execute&#13;on the various strategies and initiatives we have set forth in this Report to grow our business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ultimate magnitude of COVID-19, including&#13;the extent of its impact on our financial and operational results, which could be material, will depend on the length of time that&#13;the pandemic continues, its effect on the demand for our products and our supply chain, the effect of governmental regulations&#13;imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing. We cannot at this time predict the&#13;full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on our business, financial condition,&#13;results of operations and cash flows beyond what is discussed within this Report.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 &amp;#8211; SHAREHOLDERS&amp;#8217;&#13;EQUITY &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In 2018, an executive left the Company&#13;and returned 375,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its&#13;issued and outstanding stock by 375,000 shares.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 &amp;#8211; SHAREHOLDERS&amp;#8217; EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2020, an executive left the Company&#13;and returned 100,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its&#13;issued and outstanding stock by 100,000 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In September 2020, a former executive who had&#13;the right to receive 1,000,000 shares of Common Stock per the terms of his separation agreement that was reached in September 2019,&#13;entered into an agreement with the Company to exchange the right to receive those 1,000,000 shares of Common Stock for the Company&amp;#8217;s&#13;ownership interest in TGH (see Note 5 &amp;#8211; Investments) and a warrant to purchase 400,000 shares of the Company&amp;#8217;s Common&#13;Stock at $1.00 per share. The Company retired the shares and reduced its issued and outstanding stock by 1,000,000 shares.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">375000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2020-01-01to2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember" unitRef="Shares" decimals="INF">100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 16 &amp;#8211; WARRANTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;The following table shows warrant&#13;activity for the years ended December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 66%; font-weight: bold"&gt;Warrants outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;6,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Warrants issued in connection with convertible debenture offering (see Note 10):&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Issued to convertible debenture holders&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,134&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; text-align: left"&gt;Issued to 4Front as part of compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Warrants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;692,034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Warrants exercisable as of December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;692,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;The warrants issued to convertible&#13;debenture holders expire June 24, 2021. The warrants issued to 4Front as part of compensation expire May 31, 2021. Warrants issued&#13;to Mr. Lowe in 2018 expire March 31, 2023. The aggregate intrinsic value of the warrants outstanding and exercisable at December&#13;31, 2019 is $0.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 &amp;#8211; WARRANTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;Warrants are immediately exercisable&#13;upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average&lt;br /&gt;&#13;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 68%"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants outstanding as of December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;692,034&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued in conjunction with debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;124,481&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;font style="font-size: 10pt"&gt;Issued in conjunction with agreement with former executive (see Note 13 &amp;#8211; Shareholders&amp;#8217; Equity)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants outstanding as of September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,216,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants exercisable as of September 30, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,216,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;The weighted-average life of the&#13;warrants is 2.5 years. The aggregate intrinsic value of the warrants outstanding and exercisable at September 30, 2020 is $0.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">629772</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">2743428</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">227749</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-01-01to2020-09-30_custom_NotePayable3Member" unitRef="USD" decimals="0">2000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-01-01to2020-09-30_custom_NotePayable4Member" unitRef="USD" decimals="0">632709</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:StockIssued1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">155000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">1020003</us-gaap:StockIssued1>
    <us-gaap:UseOfEstimates contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In preparing consolidated financial&#13;statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts&#13;of assets and liabilities and the disclosure of assets and liabilities at the date of the consolidated financial statements&#13;and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates&#13;include estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for&#13;deferred tax assets, and allowance for bad debt.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing condensed consolidated financial&#13;statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of&#13;assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements&#13;and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include&#13;estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for deferred&#13;tax assets, and allowance for bad debt.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance&#13;with ASC 606, &lt;i&gt;Revenue from Contracts with Customers,&lt;/i&gt; which requires that five basic steps be followed to recognize revenue:&#13;(1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance&#13;obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration&#13;given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance&#13;obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration&#13;given to whether that control happens&amp;#160;over time&amp;#160;or not. Determination of criteria (3) and (4) are based on our management's&#13;judgments regarding the fixed nature of the selling prices of the services and products delivered and the collectability of those&#13;amounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our service and product revenues arise&#13;from contracts with customers. Service revenues include full facility programming, engineering and design services, start-up commissioning&#13;services, facility optimization services and IPM planning and strategy services. Product revenues include an integrated suite of&#13;select cultivation equipment systems and crop management products. We enter into separate contracts for the service and product&#13;revenues we provide to our customers so to clarify our obligations under the terms of the contracts. New contracts are entered&#13;into if the services to be performed or products to be delivered need to be modified. Service revenues are satisfied when services&#13;are rendered or completed in accordance with the terms of the contract. Product revenues are satisfied when control of the products&#13;is transferred to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenues for services and products for&#13;the year ended December 31, 2019 were $3,167,237 and 21,022,566, respectively. Revenues for services and products for the year&#13;ended December 31, 2018 were $928,063 and $19,122,713, respectively.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Customer Deposits&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s policy is to collect&#13;deposits from customers at the beginning of the contract. The customer payments received are recorded as a customer deposit liability&#13;on the balance sheet. When the contract is complete and meets all the criteria for revenue recognition, the customer is billed&#13;for the entire contract amount and the deposit is recorded against the customer&amp;#8217;s receivable balance. In certain situations&#13;when the customer has paid the deposit and services have been performed but the customer chooses not to proceed with the contract,&#13;the Company may keep the deposit and recognize revenue.&amp;#160;Of the outstanding customer deposit balance of $3,298,609 at December&#13;31, 2018, $2,678,565 was recognized as revenue in the year ended December 31, 2019. At December 31, 2017, the entire customer&#13;deposit balance of $3,151,250 was recognized as revenue in the year ended December 31, 2018.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">24189803</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">20050776</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">3167237</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">21022566</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ServiceMember" unitRef="USD" decimals="0">928063</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31_us-gaap_ServiceMember" unitRef="USD" decimals="0">19122713</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">16625688</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">8359422</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">5583064</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">17056737</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-07-01to2020-09-30_us-gaap_ProductMember" unitRef="USD" decimals="0">7910540</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-07-01to2019-09-30_us-gaap_ProductMember" unitRef="USD" decimals="0">4633974</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-09-30_us-gaap_ProductMember" unitRef="USD" decimals="0">15135472</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-09-30_us-gaap_ProductMember" unitRef="USD" decimals="0">14469616</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-07-01to2020-09-30_us-gaap_ServiceMember" unitRef="USD" decimals="0">448882</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-07-01to2019-09-30_us-gaap_ServiceMember" unitRef="USD" decimals="0">949090</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-09-30_us-gaap_ServiceMember" unitRef="USD" decimals="0">1490216</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-09-30_us-gaap_ServiceMember" unitRef="USD" decimals="0">2587121</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">17563594</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">13892025</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">12613461</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">6654134</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">3650965</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">11529448</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2678565</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3151250</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Cost of Revenue&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&amp;#8217;s policy is to recognize&#13;cost of revenues in the same manner as, and in conjunction with, revenue recognition. The Company&amp;#8217;s cost of revenues includes&#13;the costs directly attributable to revenue recognized and includes expenses related to the purchasing of products and providing&#13;services, fees for third-party commissions and shipping costs. Total shipping costs included in the cost of goods sold for the&#13;years ended December 31, 2019 and 2018 was $679,911 and $490,526, respectively.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 3&amp;#160;&amp;#8211; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2018, the Company received&#13;a $1,000,000, unsecured, interest only, promissory note (the &amp;#8220;Promissory Note&amp;#8221;) from Cloud9 Support Inc. (&amp;#8220;Cloud9&amp;#8221;),&#13;an entity owned 100% by James Lowe, a director of the Company. The Promissory Note was originally due April 30, 2019. The Promissory&#13;Note is personally guaranteed by the Company&amp;#8217;s two majority shareholders, Bradley Nattrass, who is the Company&amp;#8217;s Chairman&#13;and Chief Executive Officer, and Octavio Gutierrez, a director and former officer of the Company. The Promissory Note includes&#13;additional consideration of 30,000 options at an exercise price of $1.20 per share. Under the initial terms of the Promissory&#13;Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019, the due date of the Promissory Note was&#13;extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable monthly. In connection with the execution&#13;of the Credit Agreement (see Note 17), on February 21, 2020, the Company entered into an agreement to amend the Promissory Note&#13;(the &amp;#8220;Amending Agreement&amp;#8221;). Pursuant to the Amending Agreement, Cloud9 agreed to extend the maturity date of the Promissory&#13;Note from December 31, 2019 to the date which is the earlier of 60 days following the date: (a) on which demand for repayment&#13;is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit Agreement. &lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company purchases some cultivation&#13;products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&amp;#8220;Bravo&amp;#8221;) and Enviro-Glo, LLC (&amp;#8220;Enviro-Glo&amp;#8221;),&#13;manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&amp;#8217;s&#13;two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $45,129 and $276,443&#13;for the years ended 2019 and 2018, respectively. Outstanding receivables from Bravo and Enviro-Glo for the years ended 2019 and&#13;2018 totaled $0 and $43,120, respectively. Net outstanding payables incurred for purchases of inventory and other services to Bravo&#13;and Enviro-Glo as of December 31, 2019 and 2018, was $8,570 and $5,562, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has purchased goods from Cloud&#13;9 Support, LLC (&amp;#8220;Cloud 9&amp;#8221;), a company owned by James Lowe, a director, shareholder, and debt holder. Purchases from&#13;Cloud 9 were $97,329 and $84,746 during the years ended 2019 and 2018, respectively. Cloud 9 also purchases materials from the&#13;Company for use with their customers. Total sales to Cloud 9 from the Company were $392,963 and $273,760 during the years ended&#13;2019 and 2018, respectively. Outstanding receivables from Cloud 9 as of December 31, 2019 and 2018 totaled $49,659 and $79,235,&#13;respectively. Net outstanding payables for purchases of inventory and other services to Cloud 9 as of December 31, 2019 and 2018,&#13;totaled $16,402 and $13,240, respectively.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company previously purchased certain cultivation&#13;products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&amp;#8220;Bravo&amp;#8221;) and Enviro-Glo, LLC (&amp;#8220;Enviro-Glo&amp;#8221;),&#13;manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&amp;#8217;s&#13;two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $0 and $43,912 for&#13;the nine months ended September 30, 2020 and 2019, respectively, and $0 and $7,442 for the three months ended September 30, 2020&#13;and 2019, respectively. There were no outstanding receivables from Bravo and Enviro-Glo as of September 30, 2020 and December 31,&#13;2019. Net outstanding payables incurred for purchases of inventory and other services to Bravo and Enviro-Glo as of September 30,&#13;2020 and December 31, 2019 were $0 and $8,570, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has made payments to Cloud&#13;9 Support, LLC (&amp;#8220;Cloud 9&amp;#8221;), a company owned by James Lowe, a director, shareholder, and debt holder. Payments to Cloud&#13;9 were $0 and $75,617 during the nine months ended September 30, 2020 and 2019, respectively, and $0 and $24,368 during the three&#13;months ended September 30, 2020 and 2019, respectively. Cloud 9 also purchases materials from the Company. Total sales to Cloud&#13;9 from the Company were $359,562 and $229,688 during the nine months ended September 30, 2020 and 2019, respectively, and $112,405&#13;and $103,088 during the three months ended September 30, 2020 and 2019, respectively. Outstanding receivables from Cloud 9 as&#13;of September 30, 2020 and December 31, 2019 totaled $9,772 and $49,659, respectively. Net outstanding payables to Cloud 9 as of&#13;September 30, 2020 and December 31, 2019 were $0 and $16,402, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In October 2018, the Company received a $1,000,000,&#13;unsecured, interest only, promissory note (the &amp;#8220;Promissory Note&amp;#8221;) from Cloud 9. The Promissory Note was originally&#13;due April 30, 2019. The Promissory Note is personally guaranteed by the Company&amp;#8217;s largest shareholders, Bradley Nattrass,&#13;who is the Company&amp;#8217;s Chairman and Chief Executive Officer, and Octavio Gutierrez, a former officer and director of the Company.&#13;The Promissory Note includes additional consideration of 30,000 options at an exercise price of $1.20 per share. Under the initial&#13;terms of the Promissory Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019, the due date of&#13;the Promissory Note was extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable monthly. In&#13;connection with the execution of the Credit Agreement (see Note 9 &amp;#8211; Debt) on February 21, 2020, the Company entered into&#13;an agreement to amend the Promissory Note (the &amp;#8220;Amending Agreement&amp;#8221;). Pursuant to the Amending Agreement, Cloud 9 agreed&#13;to extend the maturity date of the Promissory Note from December 31, 2019 to the date which is the earlier of 60 days following&#13;the date: (a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the maturity date&#13;of the Credit Agreement. As part of the Amending Agreement, the Company issued 100,000 shares of Common Stock to James Lowe as&#13;designee of Cloud 9.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &amp;#8211; INVESTMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The changes in the components of the Investments for the years&#13;ended December 31, 2019 and 2018 are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Edyza&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;TGH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 10pt"&gt;Beginning Balances as of 1/1/2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;812,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;448,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,261,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Purchase of additional shares under SPOA&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;897,475&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;897,475&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Initial purchase of Membership interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;367,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;367,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with first option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Impairment of investment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(505,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(505,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Ending Balances as of 12/31/2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;310,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,020,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Edyza&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;TGH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 10pt"&gt;Beginning Balances as of 1/1/2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Purchase of additional shares under SPOA, including $75,000 reflected in Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Initial purchase of Membership Interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with first option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with second option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;158,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;158,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Ending Balances as of 12/31/2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;812,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;448,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,261,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Edyza&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August 2017, the Company entered into&#13;a Simple Agreement for Future Equity (&amp;#8220;SAFE&amp;#8221;) with Edyza, Inc. (&amp;#8220;Edyza&amp;#8221;), a developer of wireless sensor&#13;technology, to provide the Company with the right to obtain an ownership interest in Edyza to be issued when Edyza engaged in a&#13;priced round of investment. The Company paid Edyza $400,000 for the SAFE.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August 2018, the Company and Edyza&#13;entered into a Stock Purchase and Option Agreement (&amp;#8220;SPOA&amp;#8221;) whereby the Company and Edyza agreed to terminate the&#13;SAFE in exchange for Edyza issuing the Company 442,685 shares of Edyza Common Stock at $0.903577 per share, or $400,000 in the&#13;aggregate. In connection with the SPOA, the Company agreed to pay Edyza an additional $400,000 in six monthly installments ($50,000&#13;a month in August and September 2018 and $75,000 a month from October 2018 thru January 2019) in exchange for Edyza issuing the&#13;Company an additional 442,685 shares of Edyza Common Stock at $0.903577 per share. As of December 31, 2018, the Company had paid&#13;$325,000 of the additional $400,000 to Edyza under this installment payment plan. The remaining installment payment of $75,000&#13;is included in Accrued Expenses on the Company&amp;#8217;s Balance Sheet as of December 31, 2018 and was paid to Edyza in January&#13;2019. During 2019, the Company acquired an additional 827,018 shares for $897,475. The Company has capitalized an additional $12,883&#13;in legal fees associated with the purchases of the Edyza Common Stock. The Company measures this investment at cost, less any&#13;impairment changes resulting from observable price changes in orderly transactions for an identical or similar investment of the&#13;same issuer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;TGH&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2018, the Company entered into&#13;a Membership Interest and Purchase Agreement (&amp;#8220;MIPA&amp;#8221;) with Total Grow Holdings, LLC (d/b/a/ Total Grow Control, LLC)&#13;(&amp;#8220;TGH&amp;#8221;), a developer of environmental controls and fertigation/irrigation distribution products, to purchase 5% of&#13;TGH&amp;#8217;s membership interests on a fully diluted basis for $125,000. The MIPA also contained two separate options for the Company&#13;to purchase additional membership interests in TGH and a purchase right for the Company to acquire all of the outstanding membership&#13;interests in TGH. The first option was exercisable from July 1, 2018 thru August 31, 2018 and allowed the Company to acquire an&#13;additional 5% of TGH&amp;#8217;s membership interests on a fully diluted basis for $150,000. The second option was initially exercisable&#13;from February 15, 2019 thru May 15, 2019 and allowed the Company to acquire an additional 15% of TGH&amp;#8217;s membership interests&#13;on a fully diluted basis for $600,000. The purchase right is exercisable from May 15, 2019 thru February 15, 2020 and allows the&#13;Company to acquire all of the outstanding membership interests in TGH based on a total valuation of TGH of $7,500,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In July 2018, the Company exercised its&#13;initial option and purchased an additional 5% of TGH&amp;#8217;s fully diluted membership interests for $150,000. As of December 31,&#13;2018, the Company owned 10% of the membership interests in TGH.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In January 2019, the Company and TGH renegotiated&#13;the terms of the second option, accelerating the beginning of the exercise period to January 2019 from February 15, 2019, and reducing&#13;the purchase price for the additional 15% of TGH&amp;#8217;s membership interests on a fully diluted basis from $600,000 to $525,000.&#13;In January 2019, the Company elected to exercise this renegotiated second option and purchased an additional 15% of TGH&amp;#8217;s&#13;fully diluted membership interests for $525,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to December 31, 2018, the Company&#13;had advanced TGH $158,000 for equipment orders the Company had placed with TGH. TGH agreed to apply this $158,000 in equipment&#13;advances toward the second option membership interest purchase price of $525,000, and the Company has reflected this $158,000 as&#13;an investment in TGH as of December 31, 2018. The remaining balance of $367,000 for the second option membership interest was due&#13;in installments of $35,000 every two weeks through May 2019. As of March 31, 2019, the Company had made total payments of $336,000.&#13;The Company capitalized an additional $15,766 in legal fees associated with the purchases of the TGH membership interests. As of&#13;December 31, 2018, the Company&amp;#8217;s fully diluted ownership interest in TGH was less than 20% and, the Company measured these&#13;investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions&#13;for an identical or similar investment of the same issuer. As of December 31, 2018, the Company determined that no impairment of&#13;its investment in TGH was necessary given the recent valuations and no change in qualitative factors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also made the remaining $367,000&#13;in additional payments to TGH under the renegotiated agreement reached in January 2019 to acquire additional Membership Interests&#13;in TGH. When the payment plan was completed in May 2019, the Company was issued the additional ownership interest in TGH resulting&#13;in the Company owning 24% of TGH&amp;#8217;s membership interest. The Company believed that this ownership interest in TGH resulted&#13;in the Company being able to exercise significant influence over TGH and that the Company should begin to account for its investment&#13;in TGH under the equity method beginning in July 2019 since the operations of TGH were insignificant in June 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In September 2019, the Company decided&#13;that it should remain independent with regard to any investments in environmental controls and fertigation/irrigation distribution&#13;entities and decided it should divest itself of the ownership interest in TGH. The Company entered into preliminary negotiations&#13;with TGH to sell its ownership interest in TGH back to TGH. In connection with those negotiations, the Company determined it should&#13;not record any equity interests in TGH and the Company recorded a $505,766 write-down of its investment in TGH to an amount the&#13;Company anticipates receiving in proceeds from the sale of the TGH investment back to TGH.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In January 2020, the Company and TGH&#13;entered into an agreement whereby TGH agreed to purchase the Company&amp;#8217;s remaining investment in TGH in consideration for&#13;a short-term note due April 24, 2020 in the amount of $200,000 and a long-term note due in a lump sum on January 27, 2025 in the&#13;amount of $110,000 with interest of 4.0% payable annually in arrears. Per the terms of the agreement, the Company retains its&#13;ownership interest in TGH until the $200,000 short-term note is repaid. As of the date of this report, TGH has not made any payments&#13;on the $200,000 short-term note and the Company has retained its ownership interest in TGH. The Company does not have the ability&#13;to exert significant influence on TGH and therefore has recorded the investment at its adjusted cost basis.&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 &amp;#8211; INVESTMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The components of investments are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, &lt;br /&gt;&#13;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Investment in Edyza&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Investment in TGH&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;310,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,020,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;On January 24, 2020, the Company entered&#13;into a Membership Interest Redemption Agreement (the &amp;#8220;Redemption Agreement&amp;#8221;) with Total Grow Holdings LLC (d/b/a Total&#13;Grow Control, LLC) (&amp;#8220;TGH&amp;#8221;), whereby the Company agreed to sell the Company&amp;#8217;s 24.4% membership interests in TGH&#13;back to TGH for total consideration of $370,000. As a result of TGH&amp;#8217;s failure to perform its obligations under the Redemption&#13;Agreement, the Company initiated a lawsuit against TGH seeking damages (the &amp;#8220;Lawsuit&amp;#8221;), and subsequently fully impaired&#13;the remaining investment in TGH during the three months ended June 30, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;On September 24, 2020, the Company and&#13;TGH entered into a Settlement Agreement (the &amp;#8220;Settlement Agreement&amp;#8221;), pursuant to which the parties agreed to settle&#13;all claims brought in the Lawsuit. Pursuant to the Settlement Agreement, TGH agreed to pay the Company a total of $61,919 in six&#13;equal installments. TGH&amp;#8217;s first payment was due by October 4, 2020. TGH also agreed to reimburse the Company for up to $25,000&#13;of its attorney&amp;#8217;s fees related to the Lawsuit and the Settlement Agreement. In consideration of the foregoing and subject&#13;to TGH satisfying its payment obligations, the Company agreed to release any and all claims related to the Lawsuit. The Settlement&#13;Agreement also provides for a mutual release between the parties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;On September 24, 2020, in connection&#13;with the Settlement Agreement, the Company also entered into an agreement (the &amp;#8220;Pullar Agreement&amp;#8221;) by and between the&#13;Company and George R. Pullar, a former director of the Company and the Company&amp;#8217;s former chief financial officer and the current&#13;chief financial officer of TGH. Pursuant to the Pullar Agreement, in exchange for Mr. Pullar relinquishing all right, title and&#13;interest in and to 1,000,000 shares of the Company&amp;#8217;s common stock, the Company agreed to (i) execute the Settlement Agreement,&#13;(ii) transfer, sell and assign to Mr. Pullar the Company&amp;#8217;s 24.4% membership interest in TGH pursuant to the Settlement Agreement&#13;and (iii) issue Mr. Pullar a fully vested warrant, to purchase 400,000 shares of Common Stock at an exercise price of $1.00 per&#13;share which expires five years from the date of issuance. The Pullar Agreement also provides for a mutual release between the Company&#13;and Mr. Pullar.&lt;/p&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:ScheduleOfCostMethodInvestmentsTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The changes in the components of the Investments for the years&#13;ended December 31, 2019 and 2018 are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Edyza&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;TGH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 10pt"&gt;Beginning Balances as of 1/1/2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;812,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;448,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,261,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Purchase of additional shares under SPOA&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;897,475&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;897,475&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Initial purchase of Membership interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;367,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;367,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with first option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Impairment of investment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(505,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(505,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Ending Balances as of 12/31/2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;310,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,020,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Edyza&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;TGH&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 10pt"&gt;Beginning Balances as of 1/1/2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Purchase of additional shares under SPOA, including $75,000 reflected in Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Initial purchase of Membership Interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with first option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Additional Membership interest purchased with second option&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;158,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;158,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Ending Balances as of 12/31/2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;812,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;448,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,261,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfCostMethodInvestmentsTableTextBlock>
    <us-gaap:ScheduleOfCostMethodInvestmentsTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The components of investments are summarized as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, &lt;br /&gt;&#13;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Investment in Edyza&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Investment in TGH&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;310,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,710,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,020,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfCostMethodInvestmentsTableTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 &amp;#8211; NOTES PAYABLE &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Notes payable balances totaled $2,812,709&#13;and $2,478,869 at December 31, 2019 and December 31, 2018, respectively. Interest expense incurred on the notes payable was $596,075&#13;and $119,961 for the years ended December 31, 2019 and 2018, respectively.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a summary of notes payable:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 70%; text-align: left"&gt;Unsecured, interest only, note payable with Chris Parkes originally due December 31,&#13;    2018. Interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending the maturity&#13;    date to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was&#13;    decreased to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate,&#13;    the Company issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000.&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;80,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;80,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.&#13;    Interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date&#13;    to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased&#13;    to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company&#13;    issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Unsecured, interest only, note payable with Michael S. Bank originally due April 30, 2019. Interest at 19.8% per year is paid twice per month. The note contains a demand re-payment provision that can be executed by Mr. Bank at any time by providing a one-time notice. The Company may re-pay any part or the entire principal sum at any time with penalty and abatement of interest expense from date of early payment. The note includes six thousand warrants, each exercisable to purchase one share of the Company's Common Stock at a price of $1.00 per share. In March 2019, the Company repaid $35,000 of the principal and extended the maturity date to April 30, 2019. The note was repaid in full on April 30, 2019.&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;298,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Note payable with Hydrofarm Holdings Group, Inc. (&amp;#8220;Hydrofarm&amp;#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&amp;#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023.&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matures on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments.&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;632,709&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,812,709&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,478,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,812,709&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,478,869&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective November 20, 2018, the Company&#13;entered into a letter of intent (&amp;#8220;LOI&amp;#8221;) with Hydrofarm Holdings Group, Inc. (&amp;#8220;Hydrofarm&amp;#8221;) whereby Hydrofarm&#13;agreed to acquire all of the Company&amp;#8217;s issued and outstanding common stock (the &amp;#8220;Merger&amp;#8221;). Pursuant to the terms&#13;of the LOI, Hydrofarm extended to the Company a secured, interest only note in the principal amount of $2 million. The note was&#13;secured by all of our currently existing and future assets. In connection with the execution of the Credit Agreement (see Note&#13;17), the Company repaid the note and the Merger was abandoned.&amp;#160;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 &amp;#8211; NOTES PAYABLE &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following is a summary of notes payable&#13;excluding related party notes payable:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Unsecured, interest only, note payable with Chris Parkes originally due&#13;    December 31, 2018. Initial interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018&#13;    extending the maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the&#13;    interest rate was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the&#13;    interest rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making&#13;    monthly principal payments in the amount of $10,000.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.&#13;    Initial interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the&#13;    maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate&#13;    was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest&#13;    rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly&#13;    principal payments in the amount of $10,000.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Note payable with Hydrofarm Holdings Group, Inc. (&amp;#8220;Hydrofarm&amp;#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&amp;#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023. The note was repaid in full on February 27, 2020.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matured on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments. The note was repaid in full on February 27, 2020.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;632,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Paycheck Protection Program (&amp;#8220;PPP&amp;#8221;) loan entered into on April 16, 2020. Interest rate of 1.0% per annum. Payments of principal and interest are deferred until August 1, 2021 (the &amp;#8220;Deferral Period&amp;#8221;). The PPP loan may be forgiven in part or fully depending on the Company meeting certain PPP loan forgiveness guidelines. The Company has not yet determined if any of the PPP loan is subject to forgiveness and has therefore continued to present the entire PPP loan as an obligation on its financial statements. Any unforgiven portion of the PPP loan is payable over a two-year term, with payments deferred during the Deferral Period. The Company may prepay the unforgiven loan balance at any time without payment of any premium.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,020,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,080,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,812,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(60,00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,812,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Long Term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,020,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 70%; text-align: left"&gt;Unsecured, interest only, note payable with Chris Parkes originally due December 31,&#13;    2018. Interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending the maturity&#13;    date to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was&#13;    decreased to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate,&#13;    the Company issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000.&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;80,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;80,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.&#13;    Interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date&#13;    to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased&#13;    to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company&#13;    issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Unsecured, interest only, note payable with Michael S. Bank originally due April 30, 2019. Interest at 19.8% per year is paid twice per month. The note contains a demand re-payment provision that can be executed by Mr. Bank at any time by providing a one-time notice. The Company may re-pay any part or the entire principal sum at any time with penalty and abatement of interest expense from date of early payment. The note includes six thousand warrants, each exercisable to purchase one share of the Company's Common Stock at a price of $1.00 per share. In March 2019, the Company repaid $35,000 of the principal and extended the maturity date to April 30, 2019. The note was repaid in full on April 30, 2019.&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;298,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;Note payable with Hydrofarm Holdings Group, Inc. (&amp;#8220;Hydrofarm&amp;#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&amp;#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023.&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matures on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments.&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;632,709&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,812,709&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,478,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current maturities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,812,709&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,478,869&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 72%"&gt;&lt;font style="font-size: 10pt"&gt;Unsecured, interest only, note payable with Chris Parkes originally due&#13;    December 31, 2018. Initial interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018&#13;    extending the maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the&#13;    interest rate was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the&#13;    interest rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making&#13;    monthly principal payments in the amount of $10,000.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.&#13;    Initial interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the&#13;    maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate&#13;    was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest&#13;    rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly&#13;    principal payments in the amount of $10,000.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Note payable with Hydrofarm Holdings Group, Inc. (&amp;#8220;Hydrofarm&amp;#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&amp;#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023. The note was repaid in full on February 27, 2020.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matured on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments. The note was repaid in full on February 27, 2020.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;632,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Paycheck Protection Program (&amp;#8220;PPP&amp;#8221;) loan entered into on April 16, 2020. Interest rate of 1.0% per annum. Payments of principal and interest are deferred until August 1, 2021 (the &amp;#8220;Deferral Period&amp;#8221;). The PPP loan may be forgiven in part or fully depending on the Company meeting certain PPP loan forgiveness guidelines. The Company has not yet determined if any of the PPP loan is subject to forgiveness and has therefore continued to present the entire PPP loan as an obligation on its financial statements. Any unforgiven portion of the PPP loan is payable over a two-year term, with payments deferred during the Deferral Period. The Company may prepay the unforgiven loan balance at any time without payment of any premium.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,020,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,080,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,812,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(60,00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,812,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Long Term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,020,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 &amp;#8211; STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Stock-based compensation expense for the&#13;years ended December 31, 2019 and 2018 was $1,830,426 and $1,245,826, respectively based on the vesting schedule of the stock grants&#13;and options. During the year ended December 31, 2019, 1,361,966 shares vested and were issued to employees. No cash flow affects&#13;are anticipated for stock grants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In January 2017, the Company began granting&#13;stock to attract, retain, and reward employees with Common Stock. Stock grants are offered as part of the employment offer package,&#13;to ensure continuity of employment or as a reward for performance. Each of these grants requires a specific tenure of employment&#13;before the grant vests with typical vesting periods of 1 to 3 years of employment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In January 2018, the Company implemented&#13;an equity incentive plan to reward and attract employees and compensate vendors for services when applicable. Stock options are&#13;offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. The stock option&#13;plan authorizes 3,000,000 shares of common stock. 1,995,499 options have been awarded under the Plan as of December 31, 2019 and&#13;1,259,000 options were awarded as of December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In May 2019, the Company adopted a new&#13;equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. Stock grants under&#13;the equity incentive programs are valued at the price of the stock on the date of grant. The fair value of the options is calculated&#13;using the Black-Scholes pricing model based on the estimated market value of the underlying common stock at the valuation measurement&#13;date $0.90, the remaining contractual term of the options of 10 years, risk-free interest rate of 2.75% and expected volatility&#13;of the price of the underlying common stock of 100%. There is a moderate degree of subjectivity involved when using option pricing&#13;models to estimate the options and the assumptions used in the Black Scholes option-pricing model are moderately judgmental. Stock&#13;options and stock grants are sometimes offered as part of an employment offer package, to ensure continuity of service or as a&#13;reward for performance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following schedule shows stock grant&#13;activity for the year ended December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 67%; font-size: 10pt; font-weight: bold"&gt;Grants outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;1,802,667&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Grants awarded&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;41,800&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Forfeiture/Cancelled&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(70,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Grants vested&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(1,361,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;Grants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes stock grant&#13;vesting periods.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 47%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Unrecognized stock compensation&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ending&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;264,167&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;142,552&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; font-size: 10pt; text-align: center"&gt;2020&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;148,334&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;34,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;2021&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;177,327&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;The following schedule shows&#13;stock option activity for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br /&gt; Shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining &lt;br /&gt; Life (Years)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average &lt;br /&gt; Exercise &lt;br /&gt; Price&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Stock options outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,184,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9.68&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Issued&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;736,499&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;218,332&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;9.12&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;1.33&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options outstanding at December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,702,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;9.21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options exercisable at December 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;703,538&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;8.89&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.17&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes stock option&#13;vesting periods under the two stock options plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;Unrecognized stock compensation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center"&gt;Year Ending&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt; expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;540,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;359,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: center"&gt;2020&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;408,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;48,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;2022&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;998,629&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;489,936&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 &amp;#8211; STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Stock-based compensation expense for the&#13;nine months ended September 30, 2020 and 2019 was $1,391,807 and $1,606,355, respectively, based on the vesting schedule of the&#13;stock grants and options. Stock based compensation expense for the three months ended September 30, 2020 and 2019 was $399,258&#13;and $509,219, respectively, based on the vesting schedule of the stock grants and options. No cash flow effects are anticipated&#13;for stock grants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In January 2017, the Company began granting&#13;Common Stock to attract, retain, and reward employees. In January 2018, the Company implemented an equity incentive plan to reward&#13;and attract employees and directors and compensate vendors for services when applicable. In May 2019, the Company adopted a new&#13;equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. This equity incentive&#13;plan was approved by the Company&amp;#8217;s shareholders on May 23, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Stock grants under the equity incentive&#13;plans are valued at the price of the stock on the date of grant. The fair value of stock options granted under the equity incentive&#13;plans is calculated using the Black-Scholes pricing model based on the estimated market value of the underlying stock at the valuation&#13;measurement date, the remaining contractual term of the stock options, risk-free interest rate, and expected volatility of the&#13;underlying Common Stock. There is a moderate degree of subjectivity involved when estimating the value of stock options with the&#13;Black-Scholes option pricing model as the assumptions used are moderately judgmental. Stock grants and stock options are sometimes&#13;offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. Stock grants and&#13;stock options typically require a 1 to 3 year period of continued employment or service performance before the stock grant or stock&#13;option vests.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Stock Grants:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table shows stock grant activity&#13;for the nine months ended September 30, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 45%; font-size: 10pt; font-weight: bold"&gt;Grants outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;412,501&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;Grants awarded&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;794,166&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;Forfeiture/Cancelled&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(200,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Grants vested&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(253,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;Grants outstanding as of September 30, 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;753,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of September 30, 2020, the Company has&#13;$393,215 in unrecognized share-based compensation expense related to these stock grants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Stock Options:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;The following table shows stock&#13;option activity for the nine months ended September 30, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br /&gt; Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Remaining &lt;br /&gt; Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br /&gt; Average &lt;br /&gt; Exercise &lt;br /&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 40%; font-weight: bold"&gt;Stock options outstanding as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,702,167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9.21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Issued&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.49&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8211;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,501&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;9.19&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;1.21&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options outstanding at September 30, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,829,666&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;9.35&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.05&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Stock options exercisable at September 30, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,437,578&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;8.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;1.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of September 30, 2020, the Company has&#13;$1,919,523 in unrecognized share-based compensation expense related to these stock options. &amp;#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 17 &amp;#8211; SUBSEQUENT&#13;EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"&gt;&lt;b&gt;Credit Agreement&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 21, 2020, we entered into a&#13;letter agreement (the &amp;#8220;Credit Agreement&amp;#8221;) by and among the Company, as borrower, urban-gro Canada Technologies Inc.&#13;and Impact Engineering, Inc., as guarantors, the lenders party thereto (the &amp;#8220;Lenders&amp;#8221;), and Bridging Finance Inc.,&#13;as administrative agent for the Lenders (the &amp;#8220;Agent&amp;#8221;). The Credit Agreement, which is denominated in Canadian dollars&#13;(C$), is comprised of (i) a 12-month senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which&#13;was funded in its entirety on the closing date (the &amp;#8220;Term Loan&amp;#8221;); and (ii) a 12-month demand revolving credit facility&#13;of up to C$5.4 million ($4.0 million), which may be drawn from time to time, subject to the terms and conditions set forth in the&#13;Credit Agreement and described further below (the &amp;#8220;Revolving Facility,&amp;#8221; and together with the Term Loan, &amp;#8220;the&#13;Facilities&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The final maturity date of the Facilities&#13;will be the earlier of (i) demand, and (ii) the date that is 12 months after the closing date, with a potential extension to the&#13;date that is 24 months after the closing date (the &amp;#8220;Maturity Date&amp;#8221;). The Facilities will bear interest at the annual&#13;rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11% per annum. Accrued interest on the outstanding&#13;principal amount of the Facilities will be due and payable monthly in arrears, on the last business day of each month, and on the&#13;Maturity Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Revolving Facility may be borrowed&#13;and re-borrowed on a revolving basis by us during the term of the Facilities, provided that borrowings under the Revolving Facility&#13;will be limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable, (ii) 85% of investment&#13;grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser of C$4.05 million&#13;($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts and (B) 85%&#13;of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility may be&#13;prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan may be prepaid in&#13;full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions. As of April&#13;30, 2020, C$0.4 million ($0.3 million) of the Revolving Facility was available for future borrowings.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company utilized a portion of the proceeds&#13;from the Term Loan to refinance existing indebtedness, including a $2.0 million loan with Hydrofarm. The Company terminated the&#13;Hydrofarm loan concurrently with the closing of the transactions contemplated by the Credit Agreement. Remaining proceeds from&#13;the Facilities are expected to be used (i) to pay down existing debt obligations and (ii) for general working capital purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The obligations of the Company under the&#13;Facilities will be secured on a first lien basis (subject to certain permitted liens as set forth in the Credit Agreement) by substantially&#13;all of the assets of the Company and certain wholly-owned subsidiaries of the Company, as well as a limited recourse personal guarantee&#13;of Bradley Nattrass, the Chief Executive Officer of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Credit Agreement also contains customary&#13;provisions, representations, warranties and events of default for facilities of this nature and affirmative and negative covenants,&#13;including without limitation, covenants relating to maintenance of collateral, reorganization and change of control transactions,&#13;creation of liens and incurrence of indebtedness.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Amendment of Promissory Note and Subordination&#13;Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the execution of the&#13;Credit Agreement, the Company entered into an agreement to amend the promissory note (the &amp;#8220;Promissory Note&amp;#8221;) dated&#13;October 18, 2018, as amended on May 20, 2019, between the Company and Cloud9 Support Inc., an entity owned 100% by James Lowe,&#13;a director of the Company (the &amp;#8220;Amending Agreement&amp;#8221;). Pursuant to the Amending Agreement, Mr. Lowe agreed to extend&#13;the maturity date of the promissory note from December 31, 2019 to the date which is the earlier of 60 days following the date:&#13;(a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit&#13;Agreement.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 &amp;#8211; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management has assessed and determined that&#13;no significant subsequent events are to be disclosed according to ASC 855.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;u&gt;Convertible Notes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its convertible&#13;notes at issuance by allocating the proceeds received from a convertible note among freestanding instruments according to ASC&#13;470, Debt, based upon their relative fair values. The fair value of debt and common stock is determined based on the closing price&#13;of the common stock on the date of the transaction, and the fair value of warrants, if any, is determined using the Black-Scholes&#13;option-pricing model. Convertible notes are subsequently carried at amortized cost. The fair value of the warrants is recorded&#13;as additional paid-in capital, with a corresponding as a debt discount from the face amount of the convertible note. Each convertible&#13;note is analyzed for the existence of a beneficial conversion feature (&amp;#8220;BCF&amp;#8221;), defined as the fair value of the common&#13;stock at the commitment date for the convertible note, less the effective conversion price. Beneficial conversion features are&#13;recognized at their intrinsic value, and recorded as an increase to additional paid-in capital, with a corresponding reduction&#13;in the carrying amount of the convertible note (as a debt discount from the face amount of the convertible note). The discounts&#13;on the convertible notes, consisting of amounts ascribed to warrants and beneficial conversion features, are amortized to interest&#13;expense, using the effective interest method, over the terms of the related convertible notes. Beneficial conversion features&#13;that are contingent upon the occurrence of a future event are recorded when the contingency is resolved.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Impairment of Long-lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates potential impairment&#13;of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#13;The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result&#13;from the use and eventual disposition of the asset. An impairment will be recognized as the amount by which the carrying amount&#13;of a long-lived asset exceeds its fair value.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-09-30">urban-gro, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-09-30">0001706524</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2020-01-01to2020-09-30">S-1/A</dei:DocumentType>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-09-30">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2020-01-01to2020-09-30">false</dei:EntityExTransitionPeriod>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-09-30">CO</dei:EntityIncorporationStateCountryCode>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">600000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:MediumtermNotesCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1596280</us-gaap:MediumtermNotesCurrent>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">2676493</us-gaap:LongTermLineOfCredit>
    <us-gaap:MediumtermNotesNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">88318</us-gaap:MediumtermNotesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1000000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">1020600</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">0</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">167834</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">167834</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">155000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">155000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNonoperatingIncome contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">52675</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">2417</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">11258</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">11765</us-gaap:OtherNonoperatingIncome>
    <urgo:StockGrantToSatisfyAccountsPayableShares contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">9640</urgo:StockGrantToSatisfyAccountsPayableShares>
    <urgo:StockGrantToSatisfyAccountsPayableValue contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">9640</urgo:StockGrantToSatisfyAccountsPayableValue>
    <urgo:StockGrantToSatisfyAccountsPayableValue contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">10</urgo:StockGrantToSatisfyAccountsPayableValue>
    <urgo:StockGrantToSatisfyAccountsPayableValue contextRef="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">9630</urgo:StockGrantToSatisfyAccountsPayableValue>
    <urgo:StockIssuedForLeaseRevisionShares contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">50000</urgo:StockIssuedForLeaseRevisionShares>
    <urgo:StockIssuedForLeaseRevisionValue contextRef="From2020-07-01to2020-09-30" unitRef="USD" decimals="0">31000</urgo:StockIssuedForLeaseRevisionValue>
    <urgo:StockIssuedForLeaseRevisionValue contextRef="From2020-07-01to2020-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">50</urgo:StockIssuedForLeaseRevisionValue>
    <urgo:StockIssuedForLeaseRevisionValue contextRef="From2020-07-01to2020-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">30950</urgo:StockIssuedForLeaseRevisionValue>
    <urgo:AmortizationOfConvertibleDebentureComponents contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1612197</urgo:AmortizationOfConvertibleDebentureComponents>
    <urgo:AmortizationOfConvertibleDebentureComponents contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</urgo:AmortizationOfConvertibleDebentureComponents>
    <urgo:AmortizationOfConvertibleDebentureComponents contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">0</urgo:AmortizationOfConvertibleDebentureComponents>
    <urgo:AmortizationOfConvertibleDebentureComponents contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">810166</urgo:AmortizationOfConvertibleDebentureComponents>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">368661</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <urgo:ContingentConsiderationExpense contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">155000</urgo:ContingentConsiderationExpense>
    <urgo:ContingentConsiderationExpense contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</urgo:ContingentConsiderationExpense>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">2207432</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLoans contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">2000000</us-gaap:ProceedsFromLoans>
    <us-gaap:ProceedsFromLoans contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromLoans>
    <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">1069061</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:PaymentsOfFinancingCosts contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">638046</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="From2020-01-01to2020-09-30" unitRef="USD" decimals="0">676822</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="From2019-01-01to2019-09-30" unitRef="USD" decimals="0">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &amp;#8211; GOODWILL &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recorded goodwill in conjunction&#13;with the initial acquisition of Impact on March 7, 2019. The goodwill balance as of September 30, 2020 and December 31, 2019 was&#13;$902,067. Goodwill is not amortized. There is no goodwill for income tax purposes. The Company did not record any impairment charges&#13;related to goodwill for the periods ended September 30, 2020 and 2019.&lt;/p&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <urgo:UnitOfferingTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 10 &amp;#8211; UNIT OFFERING &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective January 9, 2019, the Company&#13;executed a letter agreement with 4Front Capital Partners, Inc., Toronto, Canada (&amp;#8220;4Front&amp;#8221;), whereby 4Front agreed to&#13;act as the Company&amp;#8217;s exclusive placement agent in connection with a private placement offering. Beginning in March 2019,&#13;4Front initiated an offering (the &amp;#8220;Offering&amp;#8221;) of up to $6,000,000 from the sale of Units, with each Unit consisting&#13;of a $1,000 Convertible Debenture (the &amp;#8220;Debentures&amp;#8221; or a &amp;#8220;Debenture&amp;#8221;) and Common Stock Purchase Warrants&#13;(the &amp;#8220;Warrants&amp;#8221;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share for a period of two years&#13;from the purchase date. The Debentures are due May 31, 2021 and bear interest at 8%, compounded annually, with interest due at&#13;maturity. The Debentures, plus any accrued but unpaid interest, will automatically convert for no additional consideration into&#13;Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity event means: (a) the&#13;date on which the Company&amp;#8217;s Common Stock is listed for trading on a recognized stock exchange in either Canada or the United&#13;States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying both the conversion right included&#13;in the Debentures and underlying the Warrants, have been duly qualified by a registration statement in the United States, allowing&#13;the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in Canada. The Company filed a registration&#13;statement with the SEC on September 17, 2019, to register the securities in connection with the Offering. That registration statement&#13;was declared effective October 16, 2019, triggering the liquidity event indicated above and the $2,565,000 in Debentures plus $92,037&#13;in accrued interest were converted into 1,102,513 Common Shares at $2.41 per share. The Warrants contain a mandatory exercise provision&#13;if the weighted average share price of the Company&amp;#8217;s Common Stock exceeds $5.00 per share for a period of five consecutive&#13;days.&lt;/p&gt;</urgo:UnitOfferingTextBlock>
    <urgo:UnitOfferingTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 &amp;#8211; UNIT OFFERING &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective January 9, 2019, the Company executed&#13;a letter agreement with an exclusive placement agent in connection with a private placement offering. Beginning in March 2019,&#13;the placement agent initiated an offering (the &amp;#8220;Offering&amp;#8221;) of up to $6,000,000 from the sale of Units, with each Unit&#13;consisting of a $1,000 Convertible Debenture (the &amp;#8220;Debentures&amp;#8221; or a &amp;#8220;Debenture&amp;#8221;) and Common Stock Purchase&#13;Warrants (the &amp;#8220;Warrants&amp;#8221;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share for a period of&#13;two years from the purchase date. The Debentures were due May 31, 2021 and bore interest at 8%, compounded annually, with interest&#13;due at maturity. The Debentures, plus any accrued but unpaid interest, were to automatically convert for no additional consideration&#13;into Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity event was defined&#13;as: (a) the date on which the Company&amp;#8217;s Common Stock is listed for trading on a recognized stock exchange in either Canada&#13;or the United States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying both the conversion&#13;right included in the Debentures and underlying the Warrants, have been duly qualified by a registration statement in the United&#13;States, allowing the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in Canada. The Company&#13;filed a registration statement with the SEC on September 17, 2019, to register the securities in connection with the Offering.&#13;That registration statement was declared effective October 16, 2019, triggering the liquidity event indicated above and the $2,565,000&#13;in Debentures plus $92,037 in accrued interest were converted into 1,102,513 Common Shares at $2.41 per share. The Warrants contain&#13;a mandatory exercise provision if the weighted average share price of the Company&amp;#8217;s Common Stock exceeds $5.00 per share&#13;for a period of five consecutive days. As of September 30, 2020, no Warrants had been exercised.&lt;/p&gt;</urgo:UnitOfferingTextBlock>
    <urgo:UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Unaudited Condensed Consolidated Financial&#13;Statements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has prepared the accompanying condensed&#13;consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting. The condensed&#13;consolidated financial statements are unaudited and, in the Company&amp;#8217;s opinion, include all adjustments, consisting of normal&#13;recurring adjustments and accruals necessary for a fair presentation of the Company&amp;#8217;s condensed consolidated balance sheets,&#13;condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of shareholders&amp;#8217;&#13;deficit and condensed consolidated statements of cash flows for the periods presented. The results reported in these condensed&#13;consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire&#13;year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting&#13;principles generally accepted in the United States (&amp;#8220;GAAP&amp;#8221;) have been omitted in accordance with regulations of the&#13;SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto&#13;included in the Company&amp;#8217;s consolidated financial statements in the Company&amp;#8217;s Annual Report on Form 10-K for the year&#13;ended December 31, 2019.&lt;/p&gt;</urgo:UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock>
    <urgo:SignificantAccountingPoliciesPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Significant Accounting Policies&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For a detailed discussion about the Company&amp;#8217;s&#13;significant accounting policies, refer to Note 2 &amp;#8212; &amp;#8220;Summary of Significant Accounting Policies,&amp;#8221; in the Company&amp;#8217;s&#13;consolidated financial statements included in the Company&amp;#8217;s 2019 Form 10-K. During the nine months ended September 30, 2020,&#13;there were no material changes made to the Company&amp;#8217;s significant accounting policies.&lt;/p&gt;</urgo:SignificantAccountingPoliciesPolicyTextBlock>
    <us-gaap:Reclassifications contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Reclassification&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain prior year amounts have been reclassified&#13;for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.&lt;/p&gt;</us-gaap:Reclassifications>
    <us-gaap:ScheduleOfShortTermDebtTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's borrowings as of September 30,&#13;2020 and December 31, 2019 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 10pt"&gt;Revolving Facility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,276,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;Term Loan, net of $315,402 unamortized debt issuance costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,684,598&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,961,091&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;Less current debt due within one year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,196,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #EEEEEE"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,764,811&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:SharesIssued contextRef="AsOf2020-09-24_custom_MrPullarMember" unitRef="Shares" decimals="INF">1000000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember" unitRef="Shares" decimals="INF">1000000</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-09-24_custom_MrPullarMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2020-09-01to2020-09-24_custom_MrPullarMember" unitRef="USD" decimals="0">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2020-01-01to2020-09-30_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2019-01-01to2019-09-30_custom_ImpactEngineeringMember" unitRef="USD" decimals="0">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">4961091</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2020-09-30_custom_RevolvingFacilityMember" unitRef="USD" decimals="0">3276493</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2019-12-31_custom_RevolvingFacilityMember" unitRef="USD" decimals="0">0</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2020-09-30_custom_TermLoanMember" unitRef="USD" decimals="0">1684598</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable contextRef="AsOf2019-12-31_custom_TermLoanMember" unitRef="USD" decimals="0">0</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">2196280</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:LongTermNotesAndLoans contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:LongTermNotesAndLoans>
    <us-gaap:LongTermNotesAndLoans contextRef="AsOf2020-09-30" unitRef="USD" decimals="0">2764811</us-gaap:LongTermNotesAndLoans>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2020-02-21_custom_RevolvingFacilityMember" unitRef="USD" decimals="0">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2020-02-21_custom_RevolvingFacilityMember_currency_CAD" unitRef="USD" decimals="0">2700000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2020-02-21_custom_TermLoanMember" unitRef="USD" decimals="0">4000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2020-02-21_custom_TermLoanMember_currency_CAD" unitRef="USD" decimals="0">5400000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDescription contextRef="From2020-01-01to2020-09-30_custom_CreditAgreementMember">Bank of Nova Scotia as the prime rate, plus 11% per annum</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:DeferredFinanceCostsGross contextRef="AsOf2020-02-21_custom_CreditAgreementMember" unitRef="USD" decimals="0">1314868</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross contextRef="AsOf2020-02-21_custom_CreditAgreementMember_custom_CommonStockAndWarrantIssuancesMember" unitRef="USD" decimals="0">676822</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-09-30_custom_RevolvingFacilityMember" unitRef="USD" decimals="0">630805</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-09-30_custom_TermLoanMember" unitRef="USD" decimals="0">315402</us-gaap:DebtInstrumentUnamortizedDiscount>
    <urgo:WarrantsExercised contextRef="From2020-01-01to2020-09-30_custom_UnitOfferingMember" unitRef="Shares" decimals="INF">0</urgo:WarrantsExercised>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-09-30_us-gaap_StockOptionMember">P8Y10M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <urgo:IssuedInConjunctionWithAgreementWithFormerExecutive contextRef="From2020-01-01to2020-09-30_custom_ExecutiveMember_custom_SeparationAgreementMember" unitRef="Shares" decimals="INF">400000</urgo:IssuedInConjunctionWithAgreementWithFormerExecutive>
    <urgo:IssuedInConjunctionWithAgreementWithFormerExecutive contextRef="From2020-01-01to2020-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">400000</urgo:IssuedInConjunctionWithAgreementWithFormerExecutive>
    <urgo:WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive contextRef="From2020-01-01to2020-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.00</urgo:WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-09-30">false</dei:AmendmentFlag>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>urgo-20191231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaKE+aPty552qYkxvmR9fTmaryouhNt6QyrH75n2MRoI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:urgo="http://urbangro.com/20191231" elementFormDefault="qualified" targetNamespace="http://urbangro.com/20191231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://urbangro.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" id="StatementsOfOperationsAndComprehensiveIncome">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" id="StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StatementsOfShareholdersDeficit" id="StatementsOfShareholdersDeficit">
	  <link:definition>00000006 - Statement - Consolidated Statements of Shareholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" id="OrganizationAndAcquisitionsBusinessPlanAndLiquidity">
	  <link:definition>00000008 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - 2. Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000010 - Disclosure - 3. Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PrepaymentsAndAdvances" id="PrepaymentsAndAdvances">
	  <link:definition>00000011 - Disclosure - 4. Prepayments and Advances</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNet" id="PropertyPlantAndEquipmentNet">
	  <link:definition>00000012 - Disclosure - 5. Property Plant and Equipment, net</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/Investments" id="Investments">
	  <link:definition>00000013 - Disclosure - 6. Investments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OtherAssets" id="OtherAssets">
	  <link:definition>00000014 - Disclosure - 7. Other Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000015 - Disclosure - 8. Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayable" id="NotesPayable">
	  <link:definition>00000016 - Disclosure - 9. Notes Payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/UnitOffering" id="UnitOffering">
	  <link:definition>00000017 - Disclosure - 10. Unit Offering</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" id="OperatingLeaseLiabilitiesCommitmentsAndContingencies">
	  <link:definition>00000018 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RisksAndUncertainties" id="RisksAndUncertainties">
	  <link:definition>00000019 - Disclosure - 12. Risks and Uncertainties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/Stock-basedCompensation" id="Stock-basedCompensation">
	  <link:definition>00000020 - Disclosure - 13. Stock-Based Compensation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000021 - Disclosure - 14. Shareholder's Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000022 - Disclosure - 15. Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/Warrants" id="Warrants">
	  <link:definition>00000023 - Disclosure - 16. Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000024 - Disclosure - 17. Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/GoodwillSept2020Note" id="GoodwillSept2020Note">
	  <link:definition>00000025 - Disclosure - 6. Goodwill (Sept 2020 Note)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DebtSept2020Note" id="DebtSept2020Note">
	  <link:definition>00000026 - Disclosure - 9. Debt (Sept 2020 Note)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000027 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" id="OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables">
	  <link:definition>00000028 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesTables" id="PrepaymentsAndAdvancesTables">
	  <link:definition>00000030 - Disclosure - 4. Prepayments and Advances (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" id="PropertyPlantAndEquipmentNetTables">
	  <link:definition>00000031 - Disclosure - 5. Property Plant and Equipment, net (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/InvestmentsTables" id="InvestmentsTables">
	  <link:definition>00000032 - Disclosure - 6. Investments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000033 - Disclosure - 8. Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" id="NotesPayableAndOperatingLeaseLiabilitiesTables">
	  <link:definition>00000034 - Disclosure - 9. Notes Payable and Operating Lease Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" id="OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables">
	  <link:definition>00000035 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables">
	  <link:definition>00000036 - Disclosure - 13. Stock-Based Compensation (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" id="DerivativeFinancialInstrumentsTables">
	  <link:definition>00000037 - Disclosure - 16. Derivative Financial Instruments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" id="OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails">
	  <link:definition>00000038 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" id="OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative">
	  <link:definition>00000039 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" id="SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment">
	  <link:definition>00000040 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Property and Equipment)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000041 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000042 - Disclosure - 3. Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" id="PrepaymentsAndAdvancesDetails">
	  <link:definition>00000043 - Disclosure - 4. Prepayments and Advances (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" id="PropertyPlantAndEquipmentNetDetails">
	  <link:definition>00000044 - Disclosure - 5. Property Plant and Equipment, net (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" id="PropertyPlantAndEquipmentNetDetailsNarrative">
	  <link:definition>00000045 - Disclosure - 5. Property Plant and Equipment, net (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/InvestmentsDetails" id="InvestmentsDetails">
	  <link:definition>00000046 - Disclosure - 6. Investments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/InvestmentDetailsNarrative" id="InvestmentDetailsNarrative">
	  <link:definition>00000047 - Disclosure - 6. Investment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OtherAssetsDetailsNarrative" id="OtherAssetsDetailsNarrative">
	  <link:definition>00000048 - Disclosure - 7. Other Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
	  <link:definition>00000049 - Disclosure - 8. Accrued Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayableDetails" id="NotesPayableDetails">
	  <link:definition>00000050 - Disclosure - 9. Notes Payable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
	  <link:definition>00000051 - Disclosure - 9. Notes Payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/UnitOfferingDetailsNarrative" id="UnitOfferingDetailsNarrative">
	  <link:definition>00000052 - Disclosure - 10. Unit Offering (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" id="OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease">
	  <link:definition>00000053 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" id="OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments">
	  <link:definition>00000054 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" id="OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000055 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" id="RisksAndUncertaintiesDetailsNarrative">
	  <link:definition>00000056 - Disclosure - 12. Risks and Uncertainties (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationDetails-GrantActivity" id="StockCompensationDetails-GrantActivity">
	  <link:definition>00000057 - Disclosure - 13. Stock Compensation (Details - Grant activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" id="StockCompensationDetails-GrantVestingPeriods">
	  <link:definition>00000058 - Disclosure - 13. Stock Compensation (Details - Grant vesting periods)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationDetails-OptionActivity" id="StockCompensationDetails-OptionActivity">
	  <link:definition>00000059 - Disclosure - 13. Stock Compensation (Details - Option activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" id="StockCompensationDetails-OptionsVestingSchedule">
	  <link:definition>00000060 - Disclosure - 13. Stock Compensation (Details - Options vesting schedule)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationDetailsNarrative" id="StockCompensationDetailsNarrative">
	  <link:definition>00000061 - Disclosure - 13. Stock Compensation (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
	  <link:definition>00000062 - Disclosure - 14. Shareholder's Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000063 - Disclosure - 15. Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" id="DerivativeFinancialInstrumentsDetails">
	  <link:definition>00000064 - Disclosure - 16. Derivative Financial Instruments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" id="DerivativeFinancialInstrumentsDetailsNarrative">
	  <link:definition>00000065 - Disclosure - 16. Derivative Financial Instruments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" id="RelatedPartyTransactionsSept2020NoteDetailsNarrative">
	  <link:definition>00000066 - Disclosure - 3. Related Party Transactions (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" id="PrepaymentsAndOtherAssetsSept2020NoteDetails">
	  <link:definition>00000067 - Disclosure - 4. Prepayments And Other Assets (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetails" id="InvestmentsSept2020NoteDetails">
	  <link:definition>00000068 - Disclosure - 5. Investments (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" id="InvestmentsSept2020NoteDetailsNarrative">
	  <link:definition>00000069 - Disclosure - 5. Investments (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" id="GoodwillSept2020NoteDetailsNarrative">
	  <link:definition>00000070 - Disclosure - 6. Goodwill (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" id="AccruedExpensesSept2020NoteDetails">
	  <link:definition>00000071 - Disclosure - 7. Accrued Expenses (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetails" id="NotesPayableSept2020NoteDetails">
	  <link:definition>00000072 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" id="NotesPayableSept2020NoteDetailsNarrative">
	  <link:definition>00000073 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DebtSept2020NoteDetails" id="DebtSept2020NoteDetails">
	  <link:definition>00000074 - Disclosure - 9. Debt (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" id="DebtSept2020NoteDetailsNarrative">
	  <link:definition>00000075 - Disclosure - 9. Debt (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" id="UnitOfferingSept2020NoteDetailsNarrative">
	  <link:definition>00000076 - Disclosure - 10. Unit Offering (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" id="RisksAndUncertaintiesSept2020NoteDetailsNarrative">
	  <link:definition>00000077 - Disclosure - 11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" id="StockCompensationSept2020NoteDetails-GrantActivity">
	  <link:definition>00000078 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" id="StockCompensationSept2020NoteDetails-OptionActivity">
	  <link:definition>00000079 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Option activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" id="StockCompensationSept2020NoteDetailsNarrative">
	  <link:definition>00000080 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" id="ShareholdersEquitySept2020NoteDetailsNarrative">
	  <link:definition>00000081 - Disclosure - 13. Shareholder's Equity (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetails" id="WarrantsSept2020NoteDetails">
	  <link:definition>00000082 - Disclosure - 14. Warrants (Sept 2020 Note) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" id="WarrantsSept2020NoteDetailsNarrative">
	  <link:definition>00000083 - Disclosure - 14. Warrants (Sept 2020 Note) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="urgo-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="urgo-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="urgo-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="urgo-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
    <element id="urgo_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockReceivedForAcquisitionShares" name="StockReceivedForAcquisitionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_LeaseCommencementDate" name="LeaseCommencementDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" name="StockIssuedInConsiderationForExtendingDueDateOfNoteShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_DebtConversionConvertedInterestAmount1" name="DebtConversionConvertedInterestAmount1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WarrantsExpireDate" name="WarrantsExpireDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageExercisePriceExercisable" name="WeightedAverageExercisePriceExercisable" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageRemainingLifeExercisable" name="WeightedAverageRemainingLifeExercisable" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageRemainingLifeOutstanding" name="WeightedAverageRemainingLifeOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageRemainingLifeExpired" name="WeightedAverageRemainingLifeExpired" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageRemainingLifeIssued" name="WeightedAverageRemainingLifeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" name="ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" name="ScheduleOfStockGrantVestingPeriodsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" name="ScheduleOfStockOptionVestingPeriodsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ClawbackOfStockGrantedShares" name="ClawbackOfStockGrantedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ClawbackOfStockGrantedValue" name="ClawbackOfStockGrantedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockGrantsIssuedForLoanTermRevisionsShares" name="StockGrantsIssuedForLoanTermRevisionsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockGrantsIssuedForLoanTermRevisionsValue" name="StockGrantsIssuedForLoanTermRevisionsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" name="EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" name="BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" name="ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_CommonStockRetired" name="CommonStockRetired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockOptionsIssuedForLoanTermRevisionsShares" name="StockOptionsIssuedForLoanTermRevisionsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockReceivedForAcquisitionValue" name="StockReceivedForAcquisitionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_PatentsIssued" name="PatentsIssued" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockGrantToSatisfyAccountsPayableShares" name="StockGrantToSatisfyAccountsPayableShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockGrantToSatisfyAccountsPayableValue" name="StockGrantToSatisfyAccountsPayableValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockIssuedForLeaseRevisionShares" name="StockIssuedForLeaseRevisionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockIssuedForLeaseRevisionValue" name="StockIssuedForLeaseRevisionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AmortizationOfConvertibleDebentureComponents" name="AmortizationOfConvertibleDebentureComponents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ContingentConsiderationExpense" name="ContingentConsiderationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_UnitOfferingTextBlock" name="UnitOfferingTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" name="UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_SignificantAccountingPoliciesPolicyTextBlock" name="SignificantAccountingPoliciesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WarrantsExercised" name="WarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" name="IssuedInConjunctionWithAgreementWithFormerExecutive" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" name="WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_PrepaidServicesAndFeesMember" name="PrepaidServicesAndFeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_VendorPrepaymentsMember" name="VendorPrepaymentsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AccruedOperatingExpensesMember" name="AccruedOperatingExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AccruedWagesAndRelatedExpensesMember" name="AccruedWagesAndRelatedExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AccruedSalesTaxPayableMember" name="AccruedSalesTaxPayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable1Member" name="NotePayable1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable2Member" name="NotePayable2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable3Member" name="NotePayable3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable4Member" name="NotePayable4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_FirstLeaseMember" name="FirstLeaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_OneVendorMember" name="OneVendorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_BravoLightingMember" name="BravoLightingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AutomatedFertigationMember" name="AutomatedFertigationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_CommonStockGrantsMember" name="CommonStockGrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Grant1Member" name="Grant1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Grant2Member" name="Grant2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Option1Member" name="Option1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Option2Member" name="Option2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Option3Member" name="Option3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockOptionPlanMember" name="StockOptionPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_EdyzaSensorsMember" name="EdyzaSensorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_TotalGrowControlsMember" name="TotalGrowControlsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_BravoMember" name="BravoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Cloud9Member" name="Cloud9Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_JamesLoweMember" name="JamesLoweMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AccruedInterestMember" name="AccruedInterestMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable5Member" name="NotePayable5Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_SecondLeaseMember" name="SecondLeaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AnotherVendorMember" name="AnotherVendorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Year2016Member" name="Year2016Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Year2017Member" name="Year2017Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Year2018Member" name="Year2018Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ImpactEngineeringMember" name="ImpactEngineeringMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_EdyzaMember" name="EdyzaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_TotalGrowHoldingsCostMember" name="TotalGrowHoldingsCostMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Year2019Member" name="Year2019Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NewEquityIncentivePlanMember" name="NewEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockPurchaseOptionMember" name="StockPurchaseOptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_InitialPurchaseMembershipInterestMember" name="InitialPurchaseMembershipInterestMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AddtlMembershipInterestMember" name="AddtlMembershipInterestMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AddtlMembershipInterest2Member" name="AddtlMembershipInterest2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ConvertibleDebentureHoldersMember" name="ConvertibleDebentureHoldersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_Front4CompensationMember" name="Front4CompensationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_NotePayable6Member" name="NotePayable6Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AnotherCustomerMember" name="AnotherCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_BravoAndEnviroMember" name="BravoAndEnviroMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_DeferredFinancingAssetMember" name="DeferredFinancingAssetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_TotalGrowMember" name="TotalGrowMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_TghLTermMember" name="TghLTermMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_MrPullarMember" name="MrPullarMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_RevolvingFacilityMember" name="RevolvingFacilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_TermLoanMember" name="TermLoanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_CreditAgreementMember" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AmortDebtIssuanceCostsMember" name="AmortDebtIssuanceCostsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_CommonStockAndWarrantIssuancesMember" name="CommonStockAndWarrantIssuancesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AmortizationOfConvertibleDebenturesMember" name="AmortizationOfConvertibleDebenturesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_UnitOfferingMember" name="UnitOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_AnotherClientMember" name="AnotherClientMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_StockOptionsMember" name="StockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_ExecutiveMember" name="ExecutiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_SeparationAgreementMember" name="SeparationAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageRemainingLifeExercised" name="WeightedAverageRemainingLifeExercised" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageExercisePriceExercised" name="WeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="urgo_WeightedAverageExercisePriceExpired" name="WeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>urgo-20191231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://urbangro.com/role/DocumentAndEntityInformation" xlink:href="urgo-20191231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheets" xlink:href="urgo-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:href="urgo-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:href="urgo-20191231.xsd#StatementsOfShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfCashFlows" xlink:href="urgo-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactions" xlink:href="urgo-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvances" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Investments" xlink:href="urgo-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssets" xlink:href="urgo-20191231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpenses" xlink:href="urgo-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayable" xlink:href="urgo-20191231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOffering" xlink:href="urgo-20191231.xsd#UnitOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertainties" xlink:href="urgo-20191231.xsd#RisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensation" xlink:href="urgo-20191231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquity" xlink:href="urgo-20191231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxes" xlink:href="urgo-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Warrants" xlink:href="urgo-20191231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SubsequentEvents" xlink:href="urgo-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020Note" xlink:href="urgo-20191231.xsd#GoodwillSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020Note" xlink:href="urgo-20191231.xsd#DebtSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsTables" xlink:href="urgo-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesTables" xlink:href="urgo-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:href="urgo-20191231.xsd#NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensationTables" xlink:href="urgo-20191231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsDetails" xlink:href="urgo-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:href="urgo-20191231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetails" xlink:href="urgo-20191231.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantVestingPeriods" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionsVestingSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:href="urgo-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#GoodwillSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquitySept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesCurrent" xlink:label="loc_us-gaapMediumtermNotesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapMediumtermNotesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesNoncurrent" xlink:label="loc_us-gaapMediumtermNotesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapMediumtermNotesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebentureComponents" xlink:label="loc_urgoAmortizationOfConvertibleDebentureComponents" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_urgoAmortizationOfConvertibleDebentureComponents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ContingentConsiderationExpense" xlink:label="loc_urgoContingentConsiderationExpense" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_urgoContingentConsiderationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLongTermLinesOfCredit" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLongTermLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:title="00000008 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - 3. Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:title="00000011 - Disclosure - 4. Prepayments and Advances" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:title="00000012 - Disclosure - 5. Property Plant and Equipment, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Investments" xlink:title="00000013 - Disclosure - 6. Investments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssets" xlink:title="00000014 - Disclosure - 7. Other Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpenses" xlink:title="00000015 - Disclosure - 8. Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayable" xlink:title="00000016 - Disclosure - 9. Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOffering" xlink:title="00000017 - Disclosure - 10. Unit Offering" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:title="00000018 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertainties" xlink:title="00000019 - Disclosure - 12. Risks and Uncertainties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensation" xlink:title="00000020 - Disclosure - 13. Stock-Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquity" xlink:title="00000021 - Disclosure - 14. Shareholder&apos;s Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxes" xlink:title="00000022 - Disclosure - 15. Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Warrants" xlink:title="00000023 - Disclosure - 16. Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - 17. Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020Note" xlink:title="00000025 - Disclosure - 6. Goodwill (Sept 2020 Note)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020Note" xlink:title="00000026 - Disclosure - 9. Debt (Sept 2020 Note)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:title="00000028 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:title="00000030 - Disclosure - 4. Prepayments and Advances (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:title="00000031 - Disclosure - 5. Property Plant and Equipment, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsTables" xlink:title="00000032 - Disclosure - 6. Investments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesTables" xlink:title="00000033 - Disclosure - 8. Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:title="00000034 - Disclosure - 9. Notes Payable and Operating Lease Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:title="00000035 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensationTables" xlink:title="00000036 - Disclosure - 13. Stock-Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:title="00000037 - Disclosure - 16. Derivative Financial Instruments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:title="00000038 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:title="00000039 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:title="00000040 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Property and Equipment)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - 3. Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:title="00000043 - Disclosure - 4. Prepayments and Advances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - 5. Property Plant and Equipment, net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - 5. Property Plant and Equipment, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsDetails" xlink:title="00000046 - Disclosure - 6. Investments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:title="00000047 - Disclosure - 6. Investment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - 7. Other Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesDetails" xlink:title="00000049 - Disclosure - 8. Accrued Expenses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetails" xlink:title="00000050 - Disclosure - 9. Notes Payable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:title="00000051 - Disclosure - 9. Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:title="00000052 - Disclosure - 10. Unit Offering (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:title="00000053 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:title="00000054 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:title="00000056 - Disclosure - 12. Risks and Uncertainties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:title="00000057 - Disclosure - 13. Stock Compensation (Details - Grant activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:title="00000058 - Disclosure - 13. Stock Compensation (Details - Grant vesting periods)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:title="00000059 - Disclosure - 13. Stock Compensation (Details - Option activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:title="00000060 - Disclosure - 13. Stock Compensation (Details - Options vesting schedule)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:title="00000061 - Disclosure - 13. Stock Compensation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000062 - Disclosure - 14. Shareholder&apos;s Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000063 - Disclosure - 15. Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:title="00000064 - Disclosure - 16. Derivative Financial Instruments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000065 - Disclosure - 16. Derivative Financial Instruments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:title="00000066 - Disclosure - 3. Related Party Transactions (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:title="00000067 - Disclosure - 4. Prepayments And Other Assets (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:title="00000068 - Disclosure - 5. Investments (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:title="00000069 - Disclosure - 5. Investments (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:title="00000070 - Disclosure - 6. Goodwill (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:title="00000071 - Disclosure - 7. Accrued Expenses (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:title="00000072 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:title="00000073 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:title="00000074 - Disclosure - 9. Debt (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:title="00000075 - Disclosure - 9. Debt (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:title="00000076 - Disclosure - 10. Unit Offering (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:title="00000077 - Disclosure - 11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:title="00000078 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:title="00000079 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Option activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:title="00000080 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:title="00000081 - Disclosure - 13. Shareholder&apos;s Equity (Sept 2020 Note) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:title="00000082 - Disclosure - 14. Warrants (Sept 2020 Note) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:title="00000083 - Disclosure - 14. Warrants (Sept 2020 Note) (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>urgo-20191231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://urbangro.com/role/DocumentAndEntityInformation" xlink:href="urgo-20191231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheets" xlink:href="urgo-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:href="urgo-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:href="urgo-20191231.xsd#StatementsOfShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfCashFlows" xlink:href="urgo-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactions" xlink:href="urgo-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvances" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Investments" xlink:href="urgo-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssets" xlink:href="urgo-20191231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpenses" xlink:href="urgo-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayable" xlink:href="urgo-20191231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOffering" xlink:href="urgo-20191231.xsd#UnitOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertainties" xlink:href="urgo-20191231.xsd#RisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensation" xlink:href="urgo-20191231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquity" xlink:href="urgo-20191231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxes" xlink:href="urgo-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Warrants" xlink:href="urgo-20191231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SubsequentEvents" xlink:href="urgo-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020Note" xlink:href="urgo-20191231.xsd#GoodwillSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020Note" xlink:href="urgo-20191231.xsd#DebtSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsTables" xlink:href="urgo-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesTables" xlink:href="urgo-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:href="urgo-20191231.xsd#NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensationTables" xlink:href="urgo-20191231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsDetails" xlink:href="urgo-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:href="urgo-20191231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetails" xlink:href="urgo-20191231.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantVestingPeriods" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionsVestingSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:href="urgo-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#GoodwillSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquitySept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapMarketingExpense_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapShareBasedCompensation_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapOperatingExpenses_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapNonoperatingIncomeExpense_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapInterestExpenseDebt_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapImpairmentOfInvestments_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapOtherNonoperatingIncome_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_130" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedShares" xlink:label="loc_urgoClawbackOfStockGrantedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoClawbackOfStockGrantedShares_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedValue" xlink:label="loc_urgoClawbackOfStockGrantedValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoClawbackOfStockGrantedValue_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockGrantsIssuedForLoanTermRevisionsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantsIssuedForLoanTermRevisionsShares_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsValue" xlink:label="loc_urgoStockGrantsIssuedForLoanTermRevisionsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantsIssuedForLoanTermRevisionsValue_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableShares" xlink:label="loc_urgoStockGrantToSatisfyAccountsPayableShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantToSatisfyAccountsPayableShares_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableValue" xlink:label="loc_urgoStockGrantToSatisfyAccountsPayableValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantToSatisfyAccountsPayableValue_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionShares" xlink:label="loc_urgoStockIssuedForLeaseRevisionShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedForLeaseRevisionShares_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionValue" xlink:label="loc_urgoStockIssuedForLeaseRevisionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedForLeaseRevisionValue_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:label="loc_urgoEquityValueOfExercisePriceAssociatedWithConvertibleDebentures_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoEquityValueOfExercisePriceAssociatedWithConvertibleDebentures_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:label="loc_urgoBrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoBrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:title="00000008 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - 3. Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:title="00000011 - Disclosure - 4. Prepayments and Advances" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:title="00000012 - Disclosure - 5. Property Plant and Equipment, net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/Investments" xlink:title="00000013 - Disclosure - 6. Investments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssets" xlink:title="00000014 - Disclosure - 7. Other Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpenses" xlink:title="00000015 - Disclosure - 8. Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayable" xlink:title="00000016 - Disclosure - 9. Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOffering" xlink:title="00000017 - Disclosure - 10. Unit Offering" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:title="00000018 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertainties" xlink:title="00000019 - Disclosure - 12. Risks and Uncertainties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensation" xlink:title="00000020 - Disclosure - 13. Stock-Based Compensation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquity" xlink:title="00000021 - Disclosure - 14. Shareholder&apos;s Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxes" xlink:title="00000022 - Disclosure - 15. Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/Warrants" xlink:title="00000023 - Disclosure - 16. Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - 17. Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020Note" xlink:title="00000025 - Disclosure - 6. Goodwill (Sept 2020 Note)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020Note" xlink:title="00000026 - Disclosure - 9. Debt (Sept 2020 Note)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:title="00000028 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:title="00000030 - Disclosure - 4. Prepayments and Advances (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:title="00000031 - Disclosure - 5. Property Plant and Equipment, net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsTables" xlink:title="00000032 - Disclosure - 6. Investments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesTables" xlink:title="00000033 - Disclosure - 8. Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:title="00000034 - Disclosure - 9. Notes Payable and Operating Lease Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:title="00000035 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensationTables" xlink:title="00000036 - Disclosure - 13. Stock-Based Compensation (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:title="00000037 - Disclosure - 16. Derivative Financial Instruments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:title="00000038 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract_30" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:title="00000039 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WorkingCapital" xlink:label="loc_urgoWorkingCapital_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWorkingCapital_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:title="00000040 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Property and Equipment)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_FirstLeaseMember" xlink:label="loc_urgoFirstLeaseMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoFirstLeaseMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SecondLeaseMember" xlink:label="loc_urgoSecondLeaseMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoSecondLeaseMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseCost_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="loc_us-gaapContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - 3. Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoMember" xlink:label="loc_urgoBravoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoBravoMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoCloud9Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_JamesLoweMember" xlink:label="loc_urgoJamesLoweMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoJamesLoweMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:title="00000043 - Disclosure - 4. Prepayments and Advances (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_VendorPrepaymentsMember" xlink:label="loc_urgoVendorPrepaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoVendorPrepaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PrepaidServicesAndFeesMember" xlink:label="loc_urgoPrepaidServicesAndFeesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoPrepaidServicesAndFeesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - 5. Property Plant and Equipment, net (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaapInProcessResearchAndDevelopmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapInProcessResearchAndDevelopmentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_170" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - 5. Property Plant and Equipment, net (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsDetails" xlink:title="00000046 - Disclosure - 6. Investments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaMember" xlink:label="loc_urgoEdyzaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowHoldingsCostMember" xlink:label="loc_urgoTotalGrowHoldingsCostMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowHoldingsCostMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockPurchaseOptionMember" xlink:label="loc_urgoStockPurchaseOptionMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoStockPurchaseOptionMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_InitialPurchaseMembershipInterestMember" xlink:label="loc_urgoInitialPurchaseMembershipInterestMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoInitialPurchaseMembershipInterestMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterestMember" xlink:label="loc_urgoAddtlMembershipInterestMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoAddtlMembershipInterestMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterest2Member" xlink:label="loc_urgoAddtlMembershipInterest2Member_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoAddtlMembershipInterest2Member_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestments_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_190" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:title="00000047 - Disclosure - 6. Investment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaSensorsMember" xlink:label="loc_urgoEdyzaSensorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaSensorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowControlsMember" xlink:label="loc_urgoTotalGrowControlsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowControlsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockPurchaseOptionMember" xlink:label="loc_urgoStockPurchaseOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoStockPurchaseOptionMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionShares" xlink:label="loc_urgoStockReceivedForAcquisitionShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockReceivedForAcquisitionShares_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionValue" xlink:label="loc_urgoStockReceivedForAcquisitionValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockReceivedForAcquisitionValue_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - 7. Other Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesDetails" xlink:title="00000049 - Disclosure - 8. Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedOperatingExpensesMember" xlink:label="loc_urgoAccruedOperatingExpensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedOperatingExpensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedWagesAndRelatedExpensesMember" xlink:label="loc_urgoAccruedWagesAndRelatedExpensesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedWagesAndRelatedExpensesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedInterestMember" xlink:label="loc_urgoAccruedInterestMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedInterestMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedSalesTaxPayableMember" xlink:label="loc_urgoAccruedSalesTaxPayableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedSalesTaxPayableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetails" xlink:title="00000050 - Disclosure - 9. Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable6Member" xlink:label="loc_urgoNotePayable6Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable6Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:title="00000051 - Disclosure - 9. Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable6Member" xlink:label="loc_urgoNotePayable6Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable6Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:label="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:title="00000052 - Disclosure - 10. Unit Offering (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:title="00000053 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:title="00000054 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_FirstLeaseMember" xlink:label="loc_urgoFirstLeaseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoFirstLeaseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SecondLeaseMember" xlink:label="loc_urgoSecondLeaseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoSecondLeaseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_LeaseCommencementDate" xlink:label="loc_urgoLeaseCommencementDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoLeaseCommencementDate_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:title="00000056 - Disclosure - 12. Risks and Uncertainties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AutomatedFertigationMember" xlink:label="loc_urgoAutomatedFertigationMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAutomatedFertigationMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneCustomerMember" xlink:label="loc_urgoOneCustomerMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoOneCustomerMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherCustomerMember" xlink:label="loc_urgoAnotherCustomerMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAnotherCustomerMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneVendorMember" xlink:label="loc_urgoOneVendorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoOneVendorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherVendorMember" xlink:label="loc_urgoAnotherVendorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoAnotherVendorMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoLightingMember" xlink:label="loc_urgoBravoLightingMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoBravoLightingMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoCloud9Member_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_160" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:title="00000057 - Disclosure - 13. Stock Compensation (Details - Grant activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:title="00000058 - Disclosure - 13. Stock Compensation (Details - Grant vesting periods)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant1Member" xlink:label="loc_urgoGrant1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoGrant1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant2Member" xlink:label="loc_urgoGrant2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoGrant2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:title="00000059 - Disclosure - 13. Stock Compensation (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeIssued" xlink:label="loc_urgoWeightedAverageRemainingLifeIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeIssued_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercised" xlink:label="loc_urgoWeightedAverageRemainingLifeExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercised_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExpired" xlink:label="loc_urgoWeightedAverageRemainingLifeExpired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExpired_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeOutstanding" xlink:label="loc_urgoWeightedAverageRemainingLifeOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeOutstanding_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercisable" xlink:label="loc_urgoWeightedAverageRemainingLifeExercisable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercisable_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:title="00000060 - Disclosure - 13. Stock Compensation (Details - Options vesting schedule)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option1Member" xlink:label="loc_urgoOption1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption1Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option2Member" xlink:label="loc_urgoOption2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option3Member" xlink:label="loc_urgoOption3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:title="00000061 - Disclosure - 13. Stock Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NewEquityIncentivePlanMember" xlink:label="loc_urgoNewEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoNewEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionPlanMember" xlink:label="loc_urgoStockOptionPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoStockOptionPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000062 - Disclosure - 14. Shareholder&apos;s Equity (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000063 - Disclosure - 15. Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTaxPeriodAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2016Member" xlink:label="loc_urgoYear2016Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2016Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2017Member" xlink:label="loc_urgoYear2017Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2017Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2018Member" xlink:label="loc_urgoYear2018Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2018Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2019Member" xlink:label="loc_urgoYear2019Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2019Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:title="00000064 - Disclosure - 16. Derivative Financial Instruments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ConvertibleDebentureHoldersMember" xlink:label="loc_urgoConvertibleDebentureHoldersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoConvertibleDebentureHoldersMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Front4CompensationMember" xlink:label="loc_urgoFront4CompensationMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoFront4CompensationMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:label="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercised" xlink:label="loc_urgoWeightedAverageExercisePriceExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercised_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExpired" xlink:label="loc_urgoWeightedAverageExercisePriceExpired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExpired_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercisable" xlink:label="loc_urgoWeightedAverageExercisePriceExercisable_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercisable_50" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000065 - Disclosure - 16. Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExpireDate" xlink:label="loc_urgoWarrantsExpireDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWarrantsExpireDate_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:label="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:title="00000066 - Disclosure - 3. Related Party Transactions (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoAndEnviroMember" xlink:label="loc_urgoBravoAndEnviroMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoBravoAndEnviroMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoCloud9Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_JamesLoweMember" xlink:label="loc_urgoJamesLoweMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoJamesLoweMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares_150" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:title="00000067 - Disclosure - 4. Prepayments And Other Assets (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_VendorPrepaymentsMember" xlink:label="loc_urgoVendorPrepaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoVendorPrepaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PrepaidServicesAndFeesMember" xlink:label="loc_urgoPrepaidServicesAndFeesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoPrepaidServicesAndFeesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DeferredFinancingAssetMember" xlink:label="loc_urgoDeferredFinancingAssetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoDeferredFinancingAssetMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:title="00000068 - Disclosure - 5. Investments (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaMember" xlink:label="loc_urgoEdyzaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowMember" xlink:label="loc_urgoTotalGrowMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestments_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:title="00000069 - Disclosure - 5. Investments (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TghLTermMember" xlink:label="loc_urgoTghLTermMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTghLTermMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_MrPullarMember" xlink:label="loc_urgoMrPullarMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoMrPullarMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:title="00000070 - Disclosure - 6. Goodwill (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:title="00000071 - Disclosure - 7. Accrued Expenses (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedOperatingExpensesMember" xlink:label="loc_urgoAccruedOperatingExpensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedOperatingExpensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedWagesAndRelatedExpensesMember" xlink:label="loc_urgoAccruedWagesAndRelatedExpensesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedWagesAndRelatedExpensesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedInterestMember" xlink:label="loc_urgoAccruedInterestMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedInterestMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedSalesTaxPayableMember" xlink:label="loc_urgoAccruedSalesTaxPayableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedSalesTaxPayableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:title="00000072 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable4Member" xlink:label="loc_urgoNotePayable4Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable4Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:title="00000073 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable4Member" xlink:label="loc_urgoNotePayable4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable4Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:label="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfNotesPayable_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:title="00000074 - Disclosure - 9. Debt (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_RevolvingFacilityMember" xlink:label="loc_urgoRevolvingFacilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoRevolvingFacilityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TermLoanMember" xlink:label="loc_urgoTermLoanMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoTermLoanMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaapNotesAndLoansPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayable_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="loc_us-gaapLongTermNotesAndLoans_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermNotesAndLoans_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:title="00000075 - Disclosure - 9. Debt (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_RevolvingFacilityMember" xlink:label="loc_urgoRevolvingFacilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoRevolvingFacilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TermLoanMember" xlink:label="loc_urgoTermLoanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoTermLoanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CreditAgreementMember" xlink:label="loc_urgoCreditAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoCreditAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="loc_currencyCAD_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockAndWarrantIssuancesMember" xlink:label="loc_urgoCommonStockAndWarrantIssuancesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoCommonStockAndWarrantIssuancesMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortDebtIssuanceCostsMember" xlink:label="loc_urgoAmortDebtIssuanceCostsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_urgoAmortDebtIssuanceCostsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebenturesMember" xlink:label="loc_urgoAmortizationOfConvertibleDebenturesMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_urgoAmortizationOfConvertibleDebenturesMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsGross_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsGross_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_180" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:title="00000076 - Disclosure - 10. Unit Offering (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnitOfferingMember" xlink:label="loc_urgoUnitOfferingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_urgoUnitOfferingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DebtConversionConvertedInterestAmount1" xlink:label="loc_urgoDebtConversionConvertedInterestAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoDebtConversionConvertedInterestAmount1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExercised" xlink:label="loc_urgoWarrantsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWarrantsExercised_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:title="00000077 - Disclosure - 11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneCustomerMember" xlink:label="loc_urgoOneCustomerMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoOneCustomerMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherClientMember" xlink:label="loc_urgoAnotherClientMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAnotherClientMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneVendorMember" xlink:label="loc_urgoOneVendorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoOneVendorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:title="00000078 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:title="00000079 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeIssued" xlink:label="loc_urgoWeightedAverageRemainingLifeIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeIssued_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercised" xlink:label="loc_urgoWeightedAverageRemainingLifeExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercised_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExpired" xlink:label="loc_urgoWeightedAverageRemainingLifeExpired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExpired_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeOutstanding" xlink:label="loc_urgoWeightedAverageRemainingLifeOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeOutstanding_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:title="00000080 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NewEquityIncentivePlanMember" xlink:label="loc_urgoNewEquityIncentivePlanMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoNewEquityIncentivePlanMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsMember" xlink:label="loc_urgoStockOptionsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoStockOptionsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:title="00000081 - Disclosure - 13. Shareholder&apos;s Equity (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ExecutiveMember" xlink:label="loc_urgoExecutiveMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoExecutiveMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SeparationAgreementMember" xlink:label="loc_urgoSeparationAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoSeparationAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:title="00000082 - Disclosure - 14. Warrants (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:label="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoWeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercisable" xlink:label="loc_urgoWeightedAverageExercisePriceExercisable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercisable_30" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:title="00000083 - Disclosure - 14. Warrants (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:label="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_30" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>urgo-20191231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer and Technology Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PrepaidServicesAndFeesMember" xlink:label="urgo_PrepaidServicesAndFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_PrepaidServicesAndFeesMember" xlink:to="urgo_PrepaidServicesAndFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_PrepaidServicesAndFeesMember_lbl" xml:lang="en-US">Prepaid Services and Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_VendorPrepaymentsMember" xlink:label="urgo_VendorPrepaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_VendorPrepaymentsMember" xlink:to="urgo_VendorPrepaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_VendorPrepaymentsMember_lbl" xml:lang="en-US">Vendor Prepayments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Other Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US">Research and Development Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedOperatingExpensesMember" xlink:label="urgo_AccruedOperatingExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AccruedOperatingExpensesMember" xlink:to="urgo_AccruedOperatingExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AccruedOperatingExpensesMember_lbl" xml:lang="en-US">Accrued Operating Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedWagesAndRelatedExpensesMember" xlink:label="urgo_AccruedWagesAndRelatedExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AccruedWagesAndRelatedExpensesMember" xlink:to="urgo_AccruedWagesAndRelatedExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AccruedWagesAndRelatedExpensesMember_lbl" xml:lang="en-US">Accrued Wages and Related Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedSalesTaxPayableMember" xlink:label="urgo_AccruedSalesTaxPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AccruedSalesTaxPayableMember" xlink:to="urgo_AccruedSalesTaxPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AccruedSalesTaxPayableMember_lbl" xml:lang="en-US">Accrued Sales Tax Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="urgo_NotePayable1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable1Member" xlink:to="urgo_NotePayable1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable1Member_lbl" xml:lang="en-US">Note Payable 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="urgo_NotePayable2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable2Member" xlink:to="urgo_NotePayable2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable2Member_lbl" xml:lang="en-US">Note Payable 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="urgo_NotePayable3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable3Member" xlink:to="urgo_NotePayable3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable3Member_lbl" xml:lang="en-US">Note Payable 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable4Member" xlink:label="urgo_NotePayable4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable4Member" xlink:to="urgo_NotePayable4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable4Member_lbl" xml:lang="en-US">Note Payable 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_FirstLeaseMember" xlink:label="urgo_FirstLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_FirstLeaseMember" xlink:to="urgo_FirstLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_FirstLeaseMember_lbl" xml:lang="en-US">First Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="us-gaap_ProductConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductConcentrationRiskMember" xlink:to="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk By Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneVendorMember" xlink:label="urgo_OneVendorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_OneVendorMember" xlink:to="urgo_OneVendorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_OneVendorMember_lbl" xml:lang="en-US">One Vendor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoLightingMember" xlink:label="urgo_BravoLightingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BravoLightingMember" xlink:to="urgo_BravoLightingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_BravoLightingMember_lbl" xml:lang="en-US">Bravo Lighting [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AutomatedFertigationMember" xlink:label="urgo_AutomatedFertigationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AutomatedFertigationMember" xlink:to="urgo_AutomatedFertigationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AutomatedFertigationMember_lbl" xml:lang="en-US">Automated Fertigation Controls [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneCustomerMember" xlink:label="urgo_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_OneCustomerMember" xlink:to="urgo_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="urgo_CommonStockGrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_CommonStockGrantsMember" xlink:to="urgo_CommonStockGrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_CommonStockGrantsMember_lbl" xml:lang="en-US">Common Stock Grants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant1Member" xlink:label="urgo_Grant1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Grant1Member" xlink:to="urgo_Grant1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Grant1Member_lbl" xml:lang="en-US">Grant 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant2Member" xlink:label="urgo_Grant2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Grant2Member" xlink:to="urgo_Grant2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Grant2Member_lbl" xml:lang="en-US">Grant 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option1Member" xlink:label="urgo_Option1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Option1Member" xlink:to="urgo_Option1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Option1Member_lbl" xml:lang="en-US">Options 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option2Member" xlink:label="urgo_Option2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Option2Member" xlink:to="urgo_Option2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Option2Member_lbl" xml:lang="en-US">Options 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option3Member" xlink:label="urgo_Option3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Option3Member" xlink:to="urgo_Option3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Option3Member_lbl" xml:lang="en-US">Options 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionPlanMember" xlink:label="urgo_StockOptionPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockOptionPlanMember" xlink:to="urgo_StockOptionPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockOptionPlanMember_lbl" xml:lang="en-US">Stock Option Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaSensorsMember" xlink:label="urgo_EdyzaSensorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_EdyzaSensorsMember" xlink:to="urgo_EdyzaSensorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_EdyzaSensorsMember_lbl" xml:lang="en-US">Edyza Sensors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowControlsMember" xlink:label="urgo_TotalGrowControlsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_TotalGrowControlsMember" xlink:to="urgo_TotalGrowControlsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_TotalGrowControlsMember_lbl" xml:lang="en-US">Total Grow Controls [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoMember" xlink:label="urgo_BravoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BravoMember" xlink:to="urgo_BravoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_BravoMember_lbl" xml:lang="en-US">Bravo and Enviro-Glo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="urgo_Cloud9Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Cloud9Member" xlink:to="urgo_Cloud9Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Cloud9Member_lbl" xml:lang="en-US">Cloud 9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_JamesLoweMember" xlink:label="urgo_JamesLoweMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_JamesLoweMember" xlink:to="urgo_JamesLoweMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_JamesLoweMember_lbl" xml:lang="en-US">James Lowe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedInterestMember" xlink:label="urgo_AccruedInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AccruedInterestMember" xlink:to="urgo_AccruedInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AccruedInterestMember_lbl" xml:lang="en-US">Accrued Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="urgo_NotePayable5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable5Member" xlink:to="urgo_NotePayable5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable5Member_lbl" xml:lang="en-US">Note Payable 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SecondLeaseMember" xlink:label="urgo_SecondLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SecondLeaseMember" xlink:to="urgo_SecondLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_SecondLeaseMember_lbl" xml:lang="en-US">Second Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherVendorMember" xlink:label="urgo_AnotherVendorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AnotherVendorMember" xlink:to="urgo_AnotherVendorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AnotherVendorMember_lbl" xml:lang="en-US">Second Vendor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxPeriodAxis_lbl" xml:lang="en-US">Tax Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2016Member" xlink:label="urgo_Year2016Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Year2016Member" xlink:to="urgo_Year2016Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Year2016Member_lbl" xml:lang="en-US">2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2017Member" xlink:label="urgo_Year2017Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Year2017Member" xlink:to="urgo_Year2017Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Year2017Member_lbl" xml:lang="en-US">2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2018Member" xlink:label="urgo_Year2018Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Year2018Member" xlink:to="urgo_Year2018Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Year2018Member_lbl" xml:lang="en-US">2018 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="urgo_ImpactEngineeringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ImpactEngineeringMember" xlink:to="urgo_ImpactEngineeringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ImpactEngineeringMember_lbl" xml:lang="en-US">Impact Engineering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaMember" xlink:label="urgo_EdyzaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_EdyzaMember" xlink:to="urgo_EdyzaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_EdyzaMember_lbl" xml:lang="en-US">Edyza [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowHoldingsCostMember" xlink:label="urgo_TotalGrowHoldingsCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_TotalGrowHoldingsCostMember" xlink:to="urgo_TotalGrowHoldingsCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_TotalGrowHoldingsCostMember_lbl" xml:lang="en-US">Total Grow Holdings Cost [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2019Member" xlink:label="urgo_Year2019Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Year2019Member" xlink:to="urgo_Year2019Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Year2019Member_lbl" xml:lang="en-US">2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NewEquityIncentivePlanMember" xlink:label="urgo_NewEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NewEquityIncentivePlanMember" xlink:to="urgo_NewEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NewEquityIncentivePlanMember_lbl" xml:lang="en-US">New Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Furniture and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="us-gaap_OtherMachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMachineryAndEquipmentMember" xlink:to="us-gaap_OtherMachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherMachineryAndEquipmentMember_lbl" xml:lang="en-US">Other Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings (deficits)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockPurchaseOptionMember" xlink:label="urgo_StockPurchaseOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockPurchaseOptionMember" xlink:to="urgo_StockPurchaseOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockPurchaseOptionMember_lbl" xml:lang="en-US">Stock Purchase and Option Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_InitialPurchaseMembershipInterestMember" xlink:label="urgo_InitialPurchaseMembershipInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_InitialPurchaseMembershipInterestMember" xlink:to="urgo_InitialPurchaseMembershipInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_InitialPurchaseMembershipInterestMember_lbl" xml:lang="en-US">Initial Purchase of Membership Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterestMember" xlink:label="urgo_AddtlMembershipInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AddtlMembershipInterestMember" xlink:to="urgo_AddtlMembershipInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AddtlMembershipInterestMember_lbl" xml:lang="en-US">Additional Membership Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterest2Member" xlink:label="urgo_AddtlMembershipInterest2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AddtlMembershipInterest2Member" xlink:to="urgo_AddtlMembershipInterest2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AddtlMembershipInterest2Member_lbl" xml:lang="en-US">Additional Membership Interest with Second Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ConvertibleDebentureHoldersMember" xlink:label="urgo_ConvertibleDebentureHoldersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ConvertibleDebentureHoldersMember" xlink:to="urgo_ConvertibleDebentureHoldersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ConvertibleDebentureHoldersMember_lbl" xml:lang="en-US">Convertible Debenture Holders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Front4CompensationMember" xlink:label="urgo_Front4CompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_Front4CompensationMember" xlink:to="urgo_Front4CompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_Front4CompensationMember_lbl" xml:lang="en-US">4Front Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable6Member" xlink:label="urgo_NotePayable6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_NotePayable6Member" xlink:to="urgo_NotePayable6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_NotePayable6Member_lbl" xml:lang="en-US">Note Payable 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherCustomerMember" xlink:label="urgo_AnotherCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AnotherCustomerMember" xlink:to="urgo_AnotherCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AnotherCustomerMember_lbl" xml:lang="en-US">Another Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceMember" xlink:to="us-gaap_ServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServiceMember_lbl" xml:lang="en-US">Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProductMember_2_lbl" xml:lang="en-US">Product Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoAndEnviroMember" xlink:label="urgo_BravoAndEnviroMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BravoAndEnviroMember" xlink:to="urgo_BravoAndEnviroMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_BravoAndEnviroMember_lbl" xml:lang="en-US">Bravo and Enviro-Glo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DeferredFinancingAssetMember" xlink:label="urgo_DeferredFinancingAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_DeferredFinancingAssetMember" xlink:to="urgo_DeferredFinancingAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_DeferredFinancingAssetMember_lbl" xml:lang="en-US">Deferred Financing Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMember_lbl" xml:lang="en-US">Other Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowMember" xlink:label="urgo_TotalGrowMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_TotalGrowMember" xlink:to="urgo_TotalGrowMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_TotalGrowMember_lbl" xml:lang="en-US">Total Grow [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TghLTermMember" xlink:label="urgo_TghLTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_TghLTermMember" xlink:to="urgo_TghLTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_TghLTermMember_lbl" xml:lang="en-US">TGH [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_MrPullarMember" xlink:label="urgo_MrPullarMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_MrPullarMember" xlink:to="urgo_MrPullarMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_MrPullarMember_lbl" xml:lang="en-US">Mr Pullar [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_RevolvingFacilityMember" xlink:label="urgo_RevolvingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_RevolvingFacilityMember" xlink:to="urgo_RevolvingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_RevolvingFacilityMember_lbl" xml:lang="en-US">Revolving Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TermLoanMember" xlink:label="urgo_TermLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_TermLoanMember" xlink:to="urgo_TermLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_TermLoanMember_lbl" xml:lang="en-US">Term Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="currency_CAD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CAD" xlink:to="currency_CAD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CAD_lbl" xml:lang="en-US">Canada, Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CreditAgreementMember" xlink:label="urgo_CreditAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_CreditAgreementMember" xlink:to="urgo_CreditAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_CreditAgreementMember_lbl" xml:lang="en-US">Credit Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortDebtIssuanceCostsMember" xlink:label="urgo_AmortDebtIssuanceCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AmortDebtIssuanceCostsMember" xlink:to="urgo_AmortDebtIssuanceCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AmortDebtIssuanceCostsMember_lbl" xml:lang="en-US">Amortization of Debt Issuance Costs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TransactionTypeAxis_2_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockAndWarrantIssuancesMember" xlink:label="urgo_CommonStockAndWarrantIssuancesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_CommonStockAndWarrantIssuancesMember" xlink:to="urgo_CommonStockAndWarrantIssuancesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_CommonStockAndWarrantIssuancesMember_lbl" xml:lang="en-US">Common Stock and Warrant Issuances [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebenturesMember" xlink:label="urgo_AmortizationOfConvertibleDebenturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AmortizationOfConvertibleDebenturesMember" xlink:to="urgo_AmortizationOfConvertibleDebenturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AmortizationOfConvertibleDebenturesMember_lbl" xml:lang="en-US">Amortization Of Convertible Debentures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnitOfferingMember" xlink:label="urgo_UnitOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_UnitOfferingMember" xlink:to="urgo_UnitOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_UnitOfferingMember_lbl" xml:lang="en-US">Unit Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_OneCustomerMember" xlink:to="urgo_OneCustomerMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_OneCustomerMember_2_lbl" xml:lang="en-US">One Client [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherClientMember" xlink:label="urgo_AnotherClientMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AnotherClientMember" xlink:to="urgo_AnotherClientMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AnotherClientMember_lbl" xml:lang="en-US">Another Client [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsMember" xlink:label="urgo_StockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockOptionsMember" xlink:to="urgo_StockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockOptionsMember_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ExecutiveMember" xlink:label="urgo_ExecutiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ExecutiveMember" xlink:to="urgo_ExecutiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ExecutiveMember_lbl" xml:lang="en-US">Executive [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SeparationAgreementMember" xlink:label="urgo_SeparationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SeparationAgreementMember" xlink:to="urgo_SeparationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_SeparationAgreementMember_lbl" xml:lang="en-US">Separation Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex-transition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Code</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Related party receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepayments and advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant, and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right of use assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Related party payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Related party note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Revolving facility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesCurrent" xlink:label="us-gaap_MediumtermNotesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MediumtermNotesCurrent" xlink:to="us-gaap_MediumtermNotesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MediumtermNotesCurrent_lbl" xml:lang="en-US">Term loan, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Revolving Facility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesNoncurrent" xlink:label="us-gaap_MediumtermNotesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MediumtermNotesNoncurrent" xlink:to="us-gaap_MediumtermNotesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MediumtermNotesNoncurrent_lbl" xml:lang="en-US">Term Loan, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Related Party note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies, Note 11</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="us-gaap_MarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingExpense_lbl" xml:lang="en-US">Marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">General and administrative - amortization of broker issuing costs and broker warrants associated with convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Non-operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Interest expense - amortization of warrants and conversion price associated with convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="us-gaap_ImpairmentOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xml:lang="en-US">Write-down of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total non-operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes and equity-method investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average outstanding shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative - amortization of broker issuing costs and broker warrants associated with convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_2_lbl" xml:lang="en-US">Non-operating income (expenses):</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense - amortization of convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US">Contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ImpairmentOfInvestments_2_lbl" xml:lang="en-US">Impairment of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Total other non-operating income (expenses), net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (loss) before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedShares" xlink:label="urgo_ClawbackOfStockGrantedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedShares" xlink:to="urgo_ClawbackOfStockGrantedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="urgo_ClawbackOfStockGrantedShares_lbl" xml:lang="en-US">Clawback of stock granted, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedValue" xlink:label="urgo_ClawbackOfStockGrantedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedValue" xlink:to="urgo_ClawbackOfStockGrantedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="urgo_ClawbackOfStockGrantedValue_lbl" xml:lang="en-US">Clawback of stock granted, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Payment of outstanding balance for PPM</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="urgo_StockOptionsIssuedForLoanTermRevisionsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:to="urgo_StockOptionsIssuedForLoanTermRevisionsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockOptionsIssuedForLoanTermRevisionsShares_lbl" xml:lang="en-US">Stock Options Issued for loan term revisions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock Options Issued for loan term revisions, value</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsShares" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantsIssuedForLoanTermRevisionsShares" xlink:to="urgo_StockGrantsIssuedForLoanTermRevisionsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsShares_lbl" xml:lang="en-US">Stock grants issued for loan term revisions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsValue" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantsIssuedForLoanTermRevisionsValue" xlink:to="urgo_StockGrantsIssuedForLoanTermRevisionsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsValue_lbl" xml:lang="en-US">Stock grants issued for loan term revisions, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock grant program vesting, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock grant program vesting, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock issuance related to conversion of convertible debentures, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock issuance related to conversion of convertible debentures, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Stock issuance related to acquisition, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Stock issuance related to acquisition, value</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableShares" xlink:label="urgo_StockGrantToSatisfyAccountsPayableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantToSatisfyAccountsPayableShares" xlink:to="urgo_StockGrantToSatisfyAccountsPayableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockGrantToSatisfyAccountsPayableShares_lbl" xml:lang="en-US">Stock grant to satisfy accounts payable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableValue" xlink:label="urgo_StockGrantToSatisfyAccountsPayableValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantToSatisfyAccountsPayableValue" xlink:to="urgo_StockGrantToSatisfyAccountsPayableValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockGrantToSatisfyAccountsPayableValue_lbl" xml:lang="en-US">Stock grant to satisfy accounts payable, value</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionShares" xlink:label="urgo_StockIssuedForLeaseRevisionShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedForLeaseRevisionShares" xlink:to="urgo_StockIssuedForLeaseRevisionShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockIssuedForLeaseRevisionShares_lbl" xml:lang="en-US">Stock issued for lease revision, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionValue" xlink:label="urgo_StockIssuedForLeaseRevisionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedForLeaseRevisionValue" xlink:to="urgo_StockIssuedForLeaseRevisionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockIssuedForLeaseRevisionValue_lbl" xml:lang="en-US">Stock issued for lease revision, value</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:label="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:to="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures_lbl" xml:lang="en-US">Equity value of exercise price associated with convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:label="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:to="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_lbl" xml:lang="en-US">Broker warrants associated with issuance of convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net loss from operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebentureComponents" xlink:label="urgo_AmortizationOfConvertibleDebentureComponents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AmortizationOfConvertibleDebentureComponents" xlink:to="urgo_AmortizationOfConvertibleDebentureComponents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_AmortizationOfConvertibleDebentureComponents_lbl" xml:lang="en-US">Amortization of convertible debenture components</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of deferred financing costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ContingentConsiderationExpense" xlink:label="urgo_ContingentConsiderationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ContingentConsiderationExpense" xlink:to="urgo_ContingentConsiderationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ContingentConsiderationExpense_lbl" xml:lang="en-US">Contingent consideration expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfInvestments_3_lbl" xml:lang="en-US">Impairment of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Warrant expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventory write-offs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Gain on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xml:lang="en-US">Changes in Operating Assets and Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepayments and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Purchase of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired in acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchases of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash Used Provided By (Used In) Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from issuance of Revolving Facility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="us-gaap_ProceedsFromLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLoans" xlink:to="us-gaap_ProceedsFromLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLoans_lbl" xml:lang="en-US">Proceeds from issuance of Term Loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xml:lang="en-US">Proceeds from Revolving Facilty advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Debt financing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related party loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided by (Used In) Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="us-gaap_CashPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net Increase (Decrease) in Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash at Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Cash_3_lbl" xml:lang="en-US">Cash at End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income Tax Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" xlink:label="urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" xlink:to="urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock_lbl" xml:lang="en-US">Convertible debentures and accrued interest converted into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Stock issuance related to acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockRetired" xlink:label="urgo_CommonStockRetired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_CommonStockRetired" xlink:to="urgo_CommonStockRetired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_CommonStockRetired_lbl" xml:lang="en-US">Common stock retired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xml:lang="en-US">Debt financing costs booked in equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization and Acquisitions, Business Plan, and Liquidity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Prepayments and Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property Plant and Equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnitOfferingTextBlock" xlink:label="urgo_UnitOfferingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_UnitOfferingTextBlock" xlink:to="urgo_UnitOfferingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_UnitOfferingTextBlock_lbl" xml:lang="en-US">Unit Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Risks and Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Shareholder's Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" xlink:label="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" xlink:to="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock_lbl" xml:lang="en-US">Unaudited Condensed Consolidated Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SignificantAccountingPoliciesPolicyTextBlock" xlink:label="urgo_SignificantAccountingPoliciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SignificantAccountingPoliciesPolicyTextBlock" xlink:to="urgo_SignificantAccountingPoliciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_SignificantAccountingPoliciesPolicyTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional and reporting currency and foreign currency translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Operating Lease Right of Use Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Customer Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Reclassifications" xlink:label="us-gaap_Reclassifications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Reclassifications" xlink:to="us-gaap_Reclassifications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Reclassifications_lbl" xml:lang="en-US">Reclassification</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Adopted Accounting Pronoucements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:label="us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:to="us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_lbl" xml:lang="en-US">Acquisition of Impact Engineering</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" xlink:label="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" xlink:to="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock_lbl" xml:lang="en-US">Property, plant and equipment useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of prepaid balances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock_lbl" xml:lang="en-US">Cost Method Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xml:lang="en-US">Schedule of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Future minimum operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock grant activity</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" xlink:label="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" xlink:to="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock_lbl" xml:lang="en-US">Schedule of stock grant vesting periods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" xlink:label="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" xlink:to="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option vesting periods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of warrant activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xml:lang="en-US">Allocation of Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WorkingCapital" xlink:label="urgo_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WorkingCapital" xlink:to="urgo_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Stock issued for acquisition, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating lease discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Shipping expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_lbl" xml:lang="en-US">Revenue recognized in current year accrued from prior year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xml:lang="en-US">Related party purchases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Related party receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Related party payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xml:lang="en-US">Related party cost of services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US">Related party sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt stated interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Investments_2_lbl" xml:lang="en-US">Beginning Balances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_2_lbl" xml:lang="en-US">Purchase of investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Investments_3_lbl" xml:lang="en-US">Ending Balances</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionShares" xlink:label="urgo_StockReceivedForAcquisitionShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockReceivedForAcquisitionShares" xlink:to="urgo_StockReceivedForAcquisitionShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockReceivedForAcquisitionShares_lbl" xml:lang="en-US">Stock received for acquisition, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionValue" xlink:label="urgo_StockReceivedForAcquisitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockReceivedForAcquisitionValue" xlink:to="urgo_StockReceivedForAcquisitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockReceivedForAcquisitionValue_lbl" xml:lang="en-US">Stock received for acquisition, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_3_lbl" xml:lang="en-US">Purchase of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PatentsIssued" xlink:label="urgo_PatentsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_PatentsIssued" xlink:to="urgo_PatentsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_PatentsIssued_lbl" xml:lang="en-US">Number of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Notes payable, current maturities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Notes payable, long term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Debt interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:label="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:to="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares_lbl" xml:lang="en-US">Stock issued in consideration for extending due date of note, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xml:lang="en-US">Periodic payment frequency</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Periodic payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpenseDebt_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt converted, amount converted</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DebtConversionConvertedInterestAmount1" xlink:label="urgo_DebtConversionConvertedInterestAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_DebtConversionConvertedInterestAmount1" xlink:to="urgo_DebtConversionConvertedInterestAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_DebtConversionConvertedInterestAmount1_lbl" xml:lang="en-US">Debt converted, interest converted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt converted, shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Proceeds from convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating lease liability - current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liability - noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Minimum future lease payment 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">Minimum future lease payment 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_LeaseCommencementDate" xlink:label="urgo_LeaseCommencementDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_LeaseCommencementDate" xlink:to="urgo_LeaseCommencementDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_LeaseCommencementDate_lbl" xml:lang="en-US">Lease commencement date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease expiration date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_2_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Common stock grants, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Common stock grants, awards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Common stock grants, forfeiture/cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Common stock grants, vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Common stock grants, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Common stock grants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized stock compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock options outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Stock options issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Stock options expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Stock options outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Stock options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining life</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeIssued" xlink:label="urgo_WeightedAverageRemainingLifeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeIssued" xlink:to="urgo_WeightedAverageRemainingLifeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageRemainingLifeIssued_lbl" xml:lang="en-US">Weighted average remaining life, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercised" xlink:label="urgo_WeightedAverageRemainingLifeExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExercised" xlink:to="urgo_WeightedAverageRemainingLifeExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageRemainingLifeExercised_lbl" xml:lang="en-US">Weighted average remaining life, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExpired" xlink:label="urgo_WeightedAverageRemainingLifeExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExpired" xlink:to="urgo_WeightedAverageRemainingLifeExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageRemainingLifeExpired_lbl" xml:lang="en-US">Weighted average remaining life, expired</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeOutstanding" xlink:label="urgo_WeightedAverageRemainingLifeOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeOutstanding" xlink:to="urgo_WeightedAverageRemainingLifeOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageRemainingLifeOutstanding_lbl" xml:lang="en-US">Weighted average remaining life, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercisable" xlink:label="urgo_WeightedAverageRemainingLifeExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExercisable" xlink:to="urgo_WeightedAverageRemainingLifeExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageRemainingLifeExercisable_lbl" xml:lang="en-US">Weighted average remaining life, exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Stock options outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_3_lbl" xml:lang="en-US">Stock based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Stock grants vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Stock reserved for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Stock authorized for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Stock returned</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US">NOL carryforward without expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US">NOL carryforward with expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">Operating loss carryforward expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax credit carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Warrants expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:label="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:to="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_lbl" xml:lang="en-US">Warrants exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Weighted average exercise price, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercised" xlink:label="urgo_WeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercised" xlink:to="urgo_WeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_WeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExpired" xlink:label="urgo_WeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExpired" xlink:to="urgo_WeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_WeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted average exercise price, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Weighted average exercise price, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercisable" xlink:label="urgo_WeightedAverageExercisePriceExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercisable" xlink:to="urgo_WeightedAverageExercisePriceExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_WeightedAverageExercisePriceExercisable_lbl" xml:lang="en-US">Weighted average exercise price, exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExpireDate" xlink:label="urgo_WarrantsExpireDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WarrantsExpireDate" xlink:to="urgo_WarrantsExpireDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WarrantsExpireDate_lbl" xml:lang="en-US">Warrants expire date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregate intrinsic value of warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:label="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:to="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value of warrants exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Prepayments And Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LegalFees_2_lbl" xml:lang="en-US">Attorney's fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Stock issued per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US">Fully vested warrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Goodwill impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Notes payable, current maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayable" xlink:label="us-gaap_NotesAndLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayable" xlink:to="us-gaap_NotesAndLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayable_lbl" xml:lang="en-US">Total debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="us-gaap_NotesAndLoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NotesAndLoansPayableCurrent_lbl" xml:lang="en-US">Less: current debt due within one yar</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="us-gaap_LongTermNotesAndLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesAndLoans" xlink:to="us-gaap_LongTermNotesAndLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesAndLoans_lbl" xml:lang="en-US">Total long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Credit line maximum amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xml:lang="en-US">Credit line interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xml:lang="en-US">Debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortized debt issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExercised" xlink:label="urgo_WarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WarrantsExercised" xlink:to="urgo_WarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="urgo_WarrantsExercised_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3_lbl" xml:lang="en-US">Weighted average remaining life, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining life, exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock returned and retired</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:to="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive_lbl" xml:lang="en-US">Issued in conjunction with agreement with former executive</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted average exercise price, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:to="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_lbl" xml:lang="en-US">Weighted average exercise price, Issued in conjunction with agreement with former executive</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_2_lbl" xml:lang="en-US">Weighted average life of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedShares" xlink:to="urgo_ClawbackOfStockGrantedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ClawbackOfStockGrantedShares_doc" xml:lang="en-US">Clawback of stock granted, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedValue" xlink:to="urgo_ClawbackOfStockGrantedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ClawbackOfStockGrantedValue_doc" xml:lang="en-US">Clawback of stock granted, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_CommonStockRetired" xlink:to="urgo_CommonStockRetired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_CommonStockRetired_doc" xml:lang="en-US">Common stock retired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_LeaseCommencementDate" xlink:to="urgo_LeaseCommencementDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_LeaseCommencementDate_doc" xml:lang="en-US">Lease commencement date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" xlink:to="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock_doc" xml:lang="en-US">Schedule of property, plant and equipment useful lives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" xlink:to="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock_doc" xml:lang="en-US">Schedule of stock grant vesting periods [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" xlink:to="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock_doc" xml:lang="en-US">Schedule of stock option vesting periods [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:to="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_doc" xml:lang="en-US">Warrants exercisable, end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:to="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1_doc" xml:lang="en-US">Aggregate intrinsic value of warrants exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockReceivedForAcquisitionShares" xlink:to="urgo_StockReceivedForAcquisitionShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockReceivedForAcquisitionShares_doc" xml:lang="en-US">Stock received for acquisition, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercisable" xlink:to="urgo_WeightedAverageExercisePriceExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageExercisePriceExercisable_doc" xml:lang="en-US">Weighted average exercise price, exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercised" xlink:to="urgo_WeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WorkingCapital" xlink:to="urgo_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WorkingCapital_doc" xml:lang="en-US">Working capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:to="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares_doc" xml:lang="en-US">Stock issued in consideration for extending due date of note, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_DebtConversionConvertedInterestAmount1" xlink:to="urgo_DebtConversionConvertedInterestAmount1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_DebtConversionConvertedInterestAmount1_doc" xml:lang="en-US">Debt converted, interest converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExpired" xlink:to="urgo_WeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted average exercise price, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeIssued" xlink:to="urgo_WeightedAverageRemainingLifeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageRemainingLifeIssued_doc" xml:lang="en-US">Weighted average remaining life, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExercised" xlink:to="urgo_WeightedAverageRemainingLifeExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageRemainingLifeExercised_doc" xml:lang="en-US">Weighted average remaining life, exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExpired" xlink:to="urgo_WeightedAverageRemainingLifeExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageRemainingLifeExpired_doc" xml:lang="en-US">Weighted average remaining life, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeOutstanding" xlink:to="urgo_WeightedAverageRemainingLifeOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageRemainingLifeOutstanding_doc" xml:lang="en-US">Weighted average remaining life, outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageRemainingLifeExercisable" xlink:to="urgo_WeightedAverageRemainingLifeExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageRemainingLifeExercisable_doc" xml:lang="en-US">Weighted average remaining life, exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:to="urgo_StockOptionsIssuedForLoanTermRevisionsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockOptionsIssuedForLoanTermRevisionsShares_doc" xml:lang="en-US">Stock Options Issued for loan term revisions, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantsIssuedForLoanTermRevisionsShares" xlink:to="urgo_StockGrantsIssuedForLoanTermRevisionsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsShares_doc" xml:lang="en-US">Stock grants issued for loan term revisions, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantsIssuedForLoanTermRevisionsValue" xlink:to="urgo_StockGrantsIssuedForLoanTermRevisionsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockGrantsIssuedForLoanTermRevisionsValue_doc" xml:lang="en-US">Stock grants issued for loan term revisions, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:to="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures_doc" xml:lang="en-US">Equity value of exercise price associated with convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:to="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures_doc" xml:lang="en-US">Broker warrants associated with issuance of convertible debentures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockReceivedForAcquisitionValue" xlink:to="urgo_StockReceivedForAcquisitionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockReceivedForAcquisitionValue_doc" xml:lang="en-US">Stock received for acquisition, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_PatentsIssued" xlink:to="urgo_PatentsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_PatentsIssued_doc" xml:lang="en-US">Number of patents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantToSatisfyAccountsPayableShares" xlink:to="urgo_StockGrantToSatisfyAccountsPayableShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockGrantToSatisfyAccountsPayableShares_doc" xml:lang="en-US">Stock grant to satisfy accounts payable, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockGrantToSatisfyAccountsPayableValue" xlink:to="urgo_StockGrantToSatisfyAccountsPayableValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockGrantToSatisfyAccountsPayableValue_doc" xml:lang="en-US">Stock grant to satisfy accounts payable, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedForLeaseRevisionShares" xlink:to="urgo_StockIssuedForLeaseRevisionShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockIssuedForLeaseRevisionShares_doc" xml:lang="en-US">Stock issued for lease revision, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_StockIssuedForLeaseRevisionValue" xlink:to="urgo_StockIssuedForLeaseRevisionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_StockIssuedForLeaseRevisionValue_doc" xml:lang="en-US">Stock issued for lease revision, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_AmortizationOfConvertibleDebentureComponents" xlink:to="urgo_AmortizationOfConvertibleDebentureComponents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_AmortizationOfConvertibleDebentureComponents_doc" xml:lang="en-US">Amortization of convertible debenture components</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ContingentConsiderationExpense" xlink:to="urgo_ContingentConsiderationExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_ContingentConsiderationExpense_doc" xml:lang="en-US">Contingent consideration expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" xlink:to="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock_doc" xml:lang="en-US">Unaudited Condensed Consolidated Financial Statements [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_SignificantAccountingPoliciesPolicyTextBlock" xlink:to="urgo_SignificantAccountingPoliciesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_SignificantAccountingPoliciesPolicyTextBlock_doc" xml:lang="en-US">Significant Accounting Policies [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WarrantsExercised" xlink:to="urgo_WarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WarrantsExercised_doc" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:to="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_IssuedInConjunctionWithAgreementWithFormerExecutive_doc" xml:lang="en-US">Issued in conjunction with agreement with former executive</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:to="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive_doc" xml:lang="en-US">Weighted average exercise price, Issued in conjunction with agreement with former executive</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_2_lbl" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMachineryAndEquipmentMember" xlink:to="us-gaap_OtherMachineryAndEquipmentMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherMachineryAndEquipmentMember_2_lbl" xml:lang="en-US">Other Machinery and Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_BravoAndEnviroMember" xlink:to="urgo_BravoAndEnviroMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_BravoAndEnviroMember_2_lbl" xml:lang="en-US">BravoAndEnviroMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_2_lbl" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_2_lbl" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Other General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_3_lbl" xml:lang="en-US">Interest Expense, Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_lbl" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedShares" xlink:to="urgo_ClawbackOfStockGrantedShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ClawbackOfStockGrantedShares_3_lbl" xml:lang="en-US">ClawbackOfStockGrantedShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_ClawbackOfStockGrantedValue" xlink:to="urgo_ClawbackOfStockGrantedValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_ClawbackOfStockGrantedValue_3_lbl" xml:lang="en-US">ClawbackOfStockGrantedValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_2_lbl" xml:lang="en-US">Payments of Financing Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_2_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_2_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_2_lbl" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2_lbl" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercised" xlink:to="urgo_WeightedAverageExercisePriceExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageExercisePriceExercised_3_lbl" xml:lang="en-US">WeightedAverageExercisePriceExercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExpired" xlink:to="urgo_WeightedAverageExercisePriceExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageExercisePriceExpired_3_lbl" xml:lang="en-US">WeightedAverageExercisePriceExpired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WeightedAverageExercisePriceExercisable" xlink:to="urgo_WeightedAverageExercisePriceExercisable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WeightedAverageExercisePriceExercisable_3_lbl" xml:lang="en-US">WeightedAverageExercisePriceExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayableCurrent_2_lbl" xml:lang="en-US">Notes and Loans Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgo_WarrantsExercised" xlink:to="urgo_WarrantsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="urgo_WarrantsExercised_3_lbl" xml:lang="en-US">WarrantsExercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>urgo-20191231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: urbangro_s1%2D2020.xfr; Date: 2021%2D01%2D11T00:37:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://urbangro.com/role/DocumentAndEntityInformation" xlink:href="urgo-20191231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheets" xlink:href="urgo-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:href="urgo-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:href="urgo-20191231.xsd#StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:href="urgo-20191231.xsd#StatementsOfShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StatementsOfCashFlows" xlink:href="urgo-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactions" xlink:href="urgo-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvances" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Investments" xlink:href="urgo-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssets" xlink:href="urgo-20191231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpenses" xlink:href="urgo-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayable" xlink:href="urgo-20191231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOffering" xlink:href="urgo-20191231.xsd#UnitOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertainties" xlink:href="urgo-20191231.xsd#RisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensation" xlink:href="urgo-20191231.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquity" xlink:href="urgo-20191231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxes" xlink:href="urgo-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Warrants" xlink:href="urgo-20191231.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SubsequentEvents" xlink:href="urgo-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020Note" xlink:href="urgo-20191231.xsd#GoodwillSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020Note" xlink:href="urgo-20191231.xsd#DebtSept2020Note" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsTables" xlink:href="urgo-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesTables" xlink:href="urgo-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:href="urgo-20191231.xsd#NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/Stock-basedCompensationTables" xlink:href="urgo-20191231.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:href="urgo-20191231.xsd#OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="urgo-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndAdvancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:href="urgo-20191231.xsd#PropertyPlantAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsDetails" xlink:href="urgo-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:href="urgo-20191231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetails" xlink:href="urgo-20191231.xsd#NotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:href="urgo-20191231.xsd#OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:href="urgo-20191231.xsd#StockCompensationDetails-GrantVestingPeriods" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:href="urgo-20191231.xsd#StockCompensationDetails-OptionsVestingSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:href="urgo-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:href="urgo-20191231.xsd#DerivativeFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#InvestmentsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#GoodwillSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:href="urgo-20191231.xsd#AccruedExpensesSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#NotesPayableSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#DebtSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#UnitOfferingSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-GrantActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#StockCompensationSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#ShareholdersEquitySept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:href="urgo-20191231.xsd#WarrantsSept2020NoteDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesCurrent" xlink:label="loc_us-gaapMediumtermNotesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapMediumtermNotesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumtermNotesNoncurrent" xlink:label="loc_us-gaapMediumtermNotesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapMediumtermNotesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketingExpense" xlink:label="loc_us-gaapMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfShareholdersDeficit" xlink:title="00000006 - Statement - Consolidated Statements of Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedShares" xlink:label="loc_urgoClawbackOfStockGrantedShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoClawbackOfStockGrantedShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ClawbackOfStockGrantedValue" xlink:label="loc_urgoClawbackOfStockGrantedValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoClawbackOfStockGrantedValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockGrantsIssuedForLoanTermRevisionsShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantsIssuedForLoanTermRevisionsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantsIssuedForLoanTermRevisionsValue" xlink:label="loc_urgoStockGrantsIssuedForLoanTermRevisionsValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantsIssuedForLoanTermRevisionsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableShares" xlink:label="loc_urgoStockGrantToSatisfyAccountsPayableShares" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantToSatisfyAccountsPayableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockGrantToSatisfyAccountsPayableValue" xlink:label="loc_urgoStockGrantToSatisfyAccountsPayableValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockGrantToSatisfyAccountsPayableValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionShares" xlink:label="loc_urgoStockIssuedForLeaseRevisionShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedForLeaseRevisionShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedForLeaseRevisionValue" xlink:label="loc_urgoStockIssuedForLeaseRevisionValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedForLeaseRevisionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:label="loc_urgoEquityValueOfExercisePriceAssociatedWithConvertibleDebentures" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoEquityValueOfExercisePriceAssociatedWithConvertibleDebentures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:label="loc_urgoBrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoBrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebentureComponents" xlink:label="loc_urgoAmortizationOfConvertibleDebentureComponents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_urgoAmortizationOfConvertibleDebentureComponents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ContingentConsiderationExpense" xlink:label="loc_urgoContingentConsiderationExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_urgoContingentConsiderationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLongTermLinesOfCredit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLongTermLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_2" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCash_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" xlink:label="loc_urgoConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_urgoConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockRetired" xlink:label="loc_urgoCommonStockRetired" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_urgoCommonStockRetired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaapDebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity" xlink:title="00000008 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - 3. Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvances" xlink:title="00000011 - Disclosure - 4. Prepayments and Advances">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNet" xlink:title="00000012 - Disclosure - 5. Property Plant and Equipment, net">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Investments" xlink:title="00000013 - Disclosure - 6. Investments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssets" xlink:title="00000014 - Disclosure - 7. Other Assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpenses" xlink:title="00000015 - Disclosure - 8. Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayable" xlink:title="00000016 - Disclosure - 9. Notes Payable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOffering" xlink:title="00000017 - Disclosure - 10. Unit Offering">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnitOfferingTextBlock" xlink:label="loc_urgoUnitOfferingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_urgoUnitOfferingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies" xlink:title="00000018 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertainties" xlink:title="00000019 - Disclosure - 12. Risks and Uncertainties">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensation" xlink:title="00000020 - Disclosure - 13. Stock-Based Compensation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquity" xlink:title="00000021 - Disclosure - 14. Shareholder&apos;s Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxes" xlink:title="00000022 - Disclosure - 15. Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Warrants" xlink:title="00000023 - Disclosure - 16. Warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - 17. Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020Note" xlink:title="00000025 - Disclosure - 6. Goodwill (Sept 2020 Note)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020Note" xlink:title="00000026 - Disclosure - 9. Debt (Sept 2020 Note)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000027 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" xlink:label="loc_urgoUnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_urgoUnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SignificantAccountingPoliciesPolicyTextBlock" xlink:label="loc_urgoSignificantAccountingPoliciesPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_urgoSignificantAccountingPoliciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Reclassifications" xlink:label="loc_us-gaapReclassifications" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReclassifications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables" xlink:title="00000028 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:label="loc_us-gaapBusinessCombinationSegmentAllocationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBusinessCombinationSegmentAllocationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" xlink:label="loc_urgoScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_urgoScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesTables" xlink:title="00000030 - Disclosure - 4. Prepayments and Advances (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetTables" xlink:title="00000031 - Disclosure - 5. Property Plant and Equipment, net (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsTables" xlink:title="00000032 - Disclosure - 6. Investments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfCostMethodInvestmentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfCostMethodInvestmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesTables" xlink:title="00000033 - Disclosure - 8. Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables" xlink:title="00000034 - Disclosure - 9. Notes Payable and Operating Lease Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="loc_us-gaapScheduleOfShortTermDebtTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables" xlink:title="00000035 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/Stock-basedCompensationTables" xlink:title="00000036 - Disclosure - 13. Stock-Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock" xlink:label="loc_urgoScheduleOfStockGrantVestingPeriodsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_urgoScheduleOfStockGrantVestingPeriodsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock" xlink:label="loc_urgoScheduleOfStockOptionVestingPeriodsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_urgoScheduleOfStockOptionVestingPeriodsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsTables" xlink:title="00000037 - Disclosure - 16. Derivative Financial Instruments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails" xlink:title="00000038 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative" xlink:title="00000039 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WorkingCapital" xlink:label="loc_urgoWorkingCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment" xlink:title="00000040 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Property and Equipment)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000041 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_FirstLeaseMember" xlink:label="loc_urgoFirstLeaseMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoFirstLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SecondLeaseMember" xlink:label="loc_urgoSecondLeaseMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoSecondLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="loc_us-gaapContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - 3. Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoMember" xlink:label="loc_urgoBravoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoBravoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoCloud9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_JamesLoweMember" xlink:label="loc_urgoJamesLoweMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoJamesLoweMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndAdvancesDetails" xlink:title="00000043 - Disclosure - 4. Prepayments and Advances (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_VendorPrepaymentsMember" xlink:label="loc_urgoVendorPrepaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoVendorPrepaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PrepaidServicesAndFeesMember" xlink:label="loc_urgoPrepaidServicesAndFeesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoPrepaidServicesAndFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails" xlink:title="00000044 - Disclosure - 5. Property Plant and Equipment, net (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaapInProcessResearchAndDevelopmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapInProcessResearchAndDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:title="00000045 - Disclosure - 5. Property Plant and Equipment, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsDetails" xlink:title="00000046 - Disclosure - 6. Investments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaMember" xlink:label="loc_urgoEdyzaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowHoldingsCostMember" xlink:label="loc_urgoTotalGrowHoldingsCostMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowHoldingsCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockPurchaseOptionMember" xlink:label="loc_urgoStockPurchaseOptionMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoStockPurchaseOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_InitialPurchaseMembershipInterestMember" xlink:label="loc_urgoInitialPurchaseMembershipInterestMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoInitialPurchaseMembershipInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterestMember" xlink:label="loc_urgoAddtlMembershipInterestMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoAddtlMembershipInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AddtlMembershipInterest2Member" xlink:label="loc_urgoAddtlMembershipInterest2Member" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoAddtlMembershipInterest2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentDetailsNarrative" xlink:title="00000047 - Disclosure - 6. Investment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaSensorsMember" xlink:label="loc_urgoEdyzaSensorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaSensorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowControlsMember" xlink:label="loc_urgoTotalGrowControlsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowControlsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockPurchaseOptionMember" xlink:label="loc_urgoStockPurchaseOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoStockPurchaseOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionShares" xlink:label="loc_urgoStockReceivedForAcquisitionShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockReceivedForAcquisitionShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockReceivedForAcquisitionValue" xlink:label="loc_urgoStockReceivedForAcquisitionValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockReceivedForAcquisitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OtherAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - 7. Other Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PatentsIssued" xlink:label="loc_urgoPatentsIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_urgoPatentsIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesDetails" xlink:title="00000049 - Disclosure - 8. Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedOperatingExpensesMember" xlink:label="loc_urgoAccruedOperatingExpensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedOperatingExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedWagesAndRelatedExpensesMember" xlink:label="loc_urgoAccruedWagesAndRelatedExpensesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedWagesAndRelatedExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedInterestMember" xlink:label="loc_urgoAccruedInterestMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedSalesTaxPayableMember" xlink:label="loc_urgoAccruedSalesTaxPayableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedSalesTaxPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetails" xlink:title="00000050 - Disclosure - 9. Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable6Member" xlink:label="loc_urgoNotePayable6Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableDetailsNarrative" xlink:title="00000051 - Disclosure - 9. Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable6Member" xlink:label="loc_urgoNotePayable6Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:label="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingDetailsNarrative" xlink:title="00000052 - Disclosure - 10. Unit Offering (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DebtConversionConvertedInterestAmount1" xlink:label="loc_urgoDebtConversionConvertedInterestAmount1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_urgoDebtConversionConvertedInterestAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease" xlink:title="00000053 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments" xlink:title="00000054 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_FirstLeaseMember" xlink:label="loc_urgoFirstLeaseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoFirstLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SecondLeaseMember" xlink:label="loc_urgoSecondLeaseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_urgoSecondLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_LeaseCommencementDate" xlink:label="loc_urgoLeaseCommencementDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoLeaseCommencementDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative" xlink:title="00000056 - Disclosure - 12. Risks and Uncertainties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AutomatedFertigationMember" xlink:label="loc_urgoAutomatedFertigationMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAutomatedFertigationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneCustomerMember" xlink:label="loc_urgoOneCustomerMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherCustomerMember" xlink:label="loc_urgoAnotherCustomerMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAnotherCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneVendorMember" xlink:label="loc_urgoOneVendorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoOneVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherVendorMember" xlink:label="loc_urgoAnotherVendorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoAnotherVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoLightingMember" xlink:label="loc_urgoBravoLightingMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoBravoLightingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoCloud9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantActivity" xlink:title="00000057 - Disclosure - 13. Stock Compensation (Details - Grant activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods" xlink:title="00000058 - Disclosure - 13. Stock Compensation (Details - Grant vesting periods)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant1Member" xlink:label="loc_urgoGrant1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoGrant1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Grant2Member" xlink:label="loc_urgoGrant2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoGrant2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionActivity" xlink:title="00000059 - Disclosure - 13. Stock Compensation (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeIssued" xlink:label="loc_urgoWeightedAverageRemainingLifeIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercised" xlink:label="loc_urgoWeightedAverageRemainingLifeExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExpired" xlink:label="loc_urgoWeightedAverageRemainingLifeExpired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeOutstanding" xlink:label="loc_urgoWeightedAverageRemainingLifeOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercisable" xlink:label="loc_urgoWeightedAverageRemainingLifeExercisable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule" xlink:title="00000060 - Disclosure - 13. Stock Compensation (Details - Options vesting schedule)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option1Member" xlink:label="loc_urgoOption1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option2Member" xlink:label="loc_urgoOption2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Option3Member" xlink:label="loc_urgoOption3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_urgoOption3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationDetailsNarrative" xlink:title="00000061 - Disclosure - 13. Stock Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NewEquityIncentivePlanMember" xlink:label="loc_urgoNewEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoNewEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionPlanMember" xlink:label="loc_urgoStockOptionPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoStockOptionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000062 - Disclosure - 14. Shareholder&apos;s Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000063 - Disclosure - 15. Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTaxPeriodAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2016Member" xlink:label="loc_urgoYear2016Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2016Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2017Member" xlink:label="loc_urgoYear2017Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2017Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2018Member" xlink:label="loc_urgoYear2018Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2018Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Year2019Member" xlink:label="loc_urgoYear2019Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_urgoYear2019Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetails" xlink:title="00000064 - Disclosure - 16. Derivative Financial Instruments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ConvertibleDebentureHoldersMember" xlink:label="loc_urgoConvertibleDebentureHoldersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoConvertibleDebentureHoldersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Front4CompensationMember" xlink:label="loc_urgoFront4CompensationMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoFront4CompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:label="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercised" xlink:label="loc_urgoWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExpired" xlink:label="loc_urgoWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercisable" xlink:label="loc_urgoWeightedAverageExercisePriceExercisable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative" xlink:title="00000065 - Disclosure - 16. Derivative Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExpireDate" xlink:label="loc_urgoWarrantsExpireDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWarrantsExpireDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:label="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative" xlink:title="00000066 - Disclosure - 3. Related Party Transactions (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_BravoAndEnviroMember" xlink:label="loc_urgoBravoAndEnviroMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoBravoAndEnviroMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_Cloud9Member" xlink:label="loc_urgoCloud9Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoCloud9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_JamesLoweMember" xlink:label="loc_urgoJamesLoweMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoJamesLoweMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsIssuedForLoanTermRevisionsShares" xlink:label="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockOptionsIssuedForLoanTermRevisionsShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails" xlink:title="00000067 - Disclosure - 4. Prepayments And Other Assets (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_VendorPrepaymentsMember" xlink:label="loc_urgoVendorPrepaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoVendorPrepaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_PrepaidServicesAndFeesMember" xlink:label="loc_urgoPrepaidServicesAndFeesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoPrepaidServicesAndFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DeferredFinancingAssetMember" xlink:label="loc_urgoDeferredFinancingAssetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoDeferredFinancingAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetails" xlink:title="00000068 - Disclosure - 5. Investments (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_EdyzaMember" xlink:label="loc_urgoEdyzaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoEdyzaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TotalGrowMember" xlink:label="loc_urgoTotalGrowMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTotalGrowMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative" xlink:title="00000069 - Disclosure - 5. Investments (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TghLTermMember" xlink:label="loc_urgoTghLTermMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_urgoTghLTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_MrPullarMember" xlink:label="loc_urgoMrPullarMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_urgoMrPullarMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative" xlink:title="00000070 - Disclosure - 6. Goodwill (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ImpactEngineeringMember" xlink:label="loc_urgoImpactEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_urgoImpactEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/AccruedExpensesSept2020NoteDetails" xlink:title="00000071 - Disclosure - 7. Accrued Expenses (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedOperatingExpensesMember" xlink:label="loc_urgoAccruedOperatingExpensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedOperatingExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedWagesAndRelatedExpensesMember" xlink:label="loc_urgoAccruedWagesAndRelatedExpensesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedWagesAndRelatedExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedInterestMember" xlink:label="loc_urgoAccruedInterestMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AccruedSalesTaxPayableMember" xlink:label="loc_urgoAccruedSalesTaxPayableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_urgoAccruedSalesTaxPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetails" xlink:title="00000072 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable4Member" xlink:label="loc_urgoNotePayable4Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative" xlink:title="00000073 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable1Member" xlink:label="loc_urgoNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable2Member" xlink:label="loc_urgoNotePayable2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable3Member" xlink:label="loc_urgoNotePayable3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable4Member" xlink:label="loc_urgoNotePayable4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NotePayable5Member" xlink:label="loc_urgoNotePayable5Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_urgoNotePayable5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:label="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoStockIssuedInConsiderationForExtendingDueDateOfNoteShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetails" xlink:title="00000074 - Disclosure - 9. Debt (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_RevolvingFacilityMember" xlink:label="loc_urgoRevolvingFacilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoRevolvingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TermLoanMember" xlink:label="loc_urgoTermLoanMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoTermLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaapNotesAndLoansPayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="loc_us-gaapLongTermNotesAndLoans" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermNotesAndLoans" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/DebtSept2020NoteDetailsNarrative" xlink:title="00000075 - Disclosure - 9. Debt (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_RevolvingFacilityMember" xlink:label="loc_urgoRevolvingFacilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoRevolvingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_TermLoanMember" xlink:label="loc_urgoTermLoanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoTermLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CreditAgreementMember" xlink:label="loc_urgoCreditAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_urgoCreditAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockAndWarrantIssuancesMember" xlink:label="loc_urgoCommonStockAndWarrantIssuancesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoCommonStockAndWarrantIssuancesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortDebtIssuanceCostsMember" xlink:label="loc_urgoAmortDebtIssuanceCostsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_urgoAmortDebtIssuanceCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AmortizationOfConvertibleDebenturesMember" xlink:label="loc_urgoAmortizationOfConvertibleDebenturesMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_urgoAmortizationOfConvertibleDebenturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative" xlink:title="00000076 - Disclosure - 10. Unit Offering (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_UnitOfferingMember" xlink:label="loc_urgoUnitOfferingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_urgoUnitOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_DebtConversionConvertedInterestAmount1" xlink:label="loc_urgoDebtConversionConvertedInterestAmount1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoDebtConversionConvertedInterestAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WarrantsExercised" xlink:label="loc_urgoWarrantsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWarrantsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative" xlink:title="00000077 - Disclosure - 11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneCustomerMember" xlink:label="loc_urgoOneCustomerMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoOneCustomerMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_AnotherClientMember" xlink:label="loc_urgoAnotherClientMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_urgoAnotherClientMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_OneVendorMember" xlink:label="loc_urgoOneVendorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_urgoOneVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity" xlink:title="00000078 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity" xlink:title="00000079 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeIssued" xlink:label="loc_urgoWeightedAverageRemainingLifeIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExercised" xlink:label="loc_urgoWeightedAverageRemainingLifeExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeExpired" xlink:label="loc_urgoWeightedAverageRemainingLifeExpired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageRemainingLifeOutstanding" xlink:label="loc_urgoWeightedAverageRemainingLifeOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageRemainingLifeOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative" xlink:title="00000080 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_NewEquityIncentivePlanMember" xlink:label="loc_urgoNewEquityIncentivePlanMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_urgoNewEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_StockOptionsMember" xlink:label="loc_urgoStockOptionsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_CommonStockGrantsMember" xlink:label="loc_urgoCommonStockGrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_urgoCommonStockGrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative" xlink:title="00000081 - Disclosure - 13. Shareholder&apos;s Equity (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ExecutiveMember" xlink:label="loc_urgoExecutiveMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_urgoExecutiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SeparationAgreementMember" xlink:label="loc_urgoSeparationAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_urgoSeparationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetails" xlink:title="00000082 - Disclosure - 14. Warrants (Sept 2020 Note) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_IssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:label="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:label="loc_urgoWeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_WeightedAverageExercisePriceExercisable" xlink:label="loc_urgoWeightedAverageExercisePriceExercisable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoWeightedAverageExercisePriceExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative" xlink:title="00000083 - Disclosure - 14. Warrants (Sept 2020 Note) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="urgo-20191231.xsd#urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:label="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_urgoSharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256925272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">urban-gro, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001706524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex-transition period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Code</a></td>
<td class="text">CO<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248410008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 213,392<span></span>
</td>
<td class="nump">$ 448,703<span></span>
</td>
<td class="nump">$ 1,178,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">853,585<span></span>
</td>
<td class="nump">1,564,969<span></span>
</td>
<td class="nump">501,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">775,064<span></span>
</td>
<td class="nump">676,175<span></span>
</td>
<td class="nump">1,214,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivable</a></td>
<td class="nump">9,772<span></span>
</td>
<td class="nump">49,658<span></span>
</td>
<td class="nump">122,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and advances</a></td>
<td class="nump">2,734,382<span></span>
</td>
<td class="nump">1,258,700<span></span>
</td>
<td class="nump">928,682<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,586,195<span></span>
</td>
<td class="nump">3,998,205<span></span>
</td>
<td class="nump">3,945,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">152,577<span></span>
</td>
<td class="nump">165,035<span></span>
</td>
<td class="nump">441,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets, net</a></td>
<td class="nump">114,017<span></span>
</td>
<td class="nump">215,848<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">1,710,358<span></span>
</td>
<td class="nump">2,020,358<span></span>
</td>
<td class="nump">1,261,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">902,067<span></span>
</td>
<td class="nump">902,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">84,924<span></span>
</td>
<td class="nump">106,179<span></span>
</td>
<td class="nump">96,669<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">2,963,943<span></span>
</td>
<td class="nump">3,409,487<span></span>
</td>
<td class="nump">1,799,459<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,550,138<span></span>
</td>
<td class="nump">7,407,692<span></span>
</td>
<td class="nump">5,744,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,132,020<span></span>
</td>
<td class="nump">3,753,862<span></span>
</td>
<td class="nump">1,630,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,863,096<span></span>
</td>
<td class="nump">1,686,841<span></span>
</td>
<td class="nump">1,144,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,972<span></span>
</td>
<td class="nump">18,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">4,087,592<span></span>
</td>
<td class="nump">2,915,406<span></span>
</td>
<td class="nump">3,298,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Related party note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">2,812,709<span></span>
</td>
<td class="nump">2,478,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving facility</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MediumtermNotesCurrent', window );">Term loan, net</a></td>
<td class="nump">1,596,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">80,339<span></span>
</td>
<td class="nump">123,395<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,419,327<span></span>
</td>
<td class="nump">12,317,185<span></span>
</td>
<td class="nump">9,571,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving Facility</a></td>
<td class="nump">2,676,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MediumtermNotesNoncurrent', window );">Term Loan, net</a></td>
<td class="nump">88,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Related Party note payable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable</a></td>
<td class="nump">1,020,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">49,347<span></span>
</td>
<td class="nump">98,841<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">4,834,758<span></span>
</td>
<td class="nump">98,841<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,254,085<span></span>
</td>
<td class="nump">12,416,026<span></span>
</td>
<td class="nump">9,571,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies, Note 11</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">28,272<span></span>
</td>
<td class="nump">28,209<span></span>
</td>
<td class="nump">25,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="nump">14,118,289<span></span>
</td>
<td class="nump">11,854,083<span></span>
</td>
<td class="nump">4,688,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(20,850,508)<span></span>
</td>
<td class="num">(16,890,626)<span></span>
</td>
<td class="num">(8,540,053)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' deficit</a></td>
<td class="num">(6,703,947)<span></span>
</td>
<td class="num">(5,008,334)<span></span>
</td>
<td class="num">(3,826,551)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' deficit</a></td>
<td class="nump">$ 7,550,138<span></span>
</td>
<td class="nump">$ 7,407,692<span></span>
</td>
<td class="nump">$ 5,744,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MediumtermNotesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value at the balance sheet date of the current portion of a financial instrument used to receive debt funding on a regular basis with original maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MediumtermNotesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MediumtermNotesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value at the balance sheet date of the noncurrent portion of a financial instrument used to receive debt funding on a regular basis with original maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MediumtermNotesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248368856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">28,272,285<span></span>
</td>
<td class="nump">28,209,312<span></span>
</td>
<td class="nump">25,229,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">28,272,285<span></span>
</td>
<td class="nump">28,209,312<span></span>
</td>
<td class="nump">25,229,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248512888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 24,189,803<span></span>
</td>
<td class="nump">$ 20,050,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">17,563,594<span></span>
</td>
<td class="nump">13,892,025<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,626,209<span></span>
</td>
<td class="nump">6,158,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing</a></td>
<td class="nump">1,016,073<span></span>
</td>
<td class="nump">992,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,207,737<span></span>
</td>
<td class="nump">7,721,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">General and administrative - amortization of broker issuing costs and broker warrants associated with convertible debentures</a></td>
<td class="nump">432,578<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based Compensation</a></td>
<td class="nump">1,830,426<span></span>
</td>
<td class="nump">1,245,826<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">12,486,814<span></span>
</td>
<td class="nump">9,959,335<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(5,860,605)<span></span>
</td>
<td class="num">(3,800,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Non-operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(704,230)<span></span>
</td>
<td class="num">(119,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Interest expense - amortization of warrants and conversion price associated with convertible debentures</a></td>
<td class="num">(1,333,520)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Write-down of investment</a></td>
<td class="num">(505,766)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">53,548<span></span>
</td>
<td class="nump">24,672<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating expenses</a></td>
<td class="num">(2,489,968)<span></span>
</td>
<td class="num">(95,289)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes and equity-method investments</a></td>
<td class="num">(8,350,573)<span></span>
</td>
<td class="num">(3,895,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(8,350,573)<span></span>
</td>
<td class="num">(3,895,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (8,350,573)<span></span>
</td>
<td class="num">$ (3,895,873)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average outstanding shares</a></td>
<td class="nump">26,318,059<span></span>
</td>
<td class="nump">24,848,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248882120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenue</a></td>
<td class="nump">$ 8,359,422<span></span>
</td>
<td class="nump">$ 5,583,064<span></span>
</td>
<td class="nump">$ 16,625,688<span></span>
</td>
<td class="nump">$ 17,056,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">6,654,134<span></span>
</td>
<td class="nump">3,650,965<span></span>
</td>
<td class="nump">12,613,461<span></span>
</td>
<td class="nump">11,529,448<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,705,288<span></span>
</td>
<td class="nump">1,932,099<span></span>
</td>
<td class="nump">4,012,227<span></span>
</td>
<td class="nump">5,527,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing</a></td>
<td class="nump">42,749<span></span>
</td>
<td class="nump">263,948<span></span>
</td>
<td class="nump">236,093<span></span>
</td>
<td class="nump">914,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,411,821<span></span>
</td>
<td class="nump">2,383,920<span></span>
</td>
<td class="nump">4,874,383<span></span>
</td>
<td class="nump">6,892,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative - amortization of broker issuing costs and broker warrants associated with convertible debentures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">167,834<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">167,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based Compensation</a></td>
<td class="nump">399,258<span></span>
</td>
<td class="nump">509,219<span></span>
</td>
<td class="nump">1,391,807<span></span>
</td>
<td class="nump">1,606,355<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,853,828<span></span>
</td>
<td class="nump">3,324,921<span></span>
</td>
<td class="nump">6,502,283<span></span>
</td>
<td class="nump">9,581,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(148,540)<span></span>
</td>
<td class="num">(1,392,822)<span></span>
</td>
<td class="num">(2,490,056)<span></span>
</td>
<td class="num">(4,054,086)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Non-operating income (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest expense</a></td>
<td class="num">(393,158)<span></span>
</td>
<td class="num">(125,733)<span></span>
</td>
<td class="num">(1,057,501)<span></span>
</td>
<td class="num">(374,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense - amortization of convertible debentures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(796,233)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(796,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="num">(155,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(155,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(506,000)<span></span>
</td>
<td class="num">(310,000)<span></span>
</td>
<td class="num">(506,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other income</a></td>
<td class="nump">2,417<span></span>
</td>
<td class="nump">11,258<span></span>
</td>
<td class="nump">52,675<span></span>
</td>
<td class="nump">11,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other non-operating income (expenses), net</a></td>
<td class="num">(545,741)<span></span>
</td>
<td class="num">(1,416,708)<span></span>
</td>
<td class="num">(1,469,826)<span></span>
</td>
<td class="num">(1,665,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(694,281)<span></span>
</td>
<td class="num">(2,809,530)<span></span>
</td>
<td class="num">(3,959,882)<span></span>
</td>
<td class="num">(5,719,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(694,281)<span></span>
</td>
<td class="num">(2,809,530)<span></span>
</td>
<td class="num">(3,959,882)<span></span>
</td>
<td class="num">(5,719,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (694,281)<span></span>
</td>
<td class="num">$ (2,809,530)<span></span>
</td>
<td class="num">$ (3,959,882)<span></span>
</td>
<td class="num">$ (5,719,404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average outstanding shares</a></td>
<td class="nump">28,888,194<span></span>
</td>
<td class="nump">26,175,098<span></span>
</td>
<td class="nump">28,706,905<span></span>
</td>
<td class="nump">25,772,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenue</a></td>
<td class="nump">$ 7,910,540<span></span>
</td>
<td class="nump">$ 4,633,974<span></span>
</td>
<td class="nump">$ 15,135,472<span></span>
</td>
<td class="nump">$ 14,469,616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenue</a></td>
<td class="nump">$ 448,882<span></span>
</td>
<td class="nump">$ 949,090<span></span>
</td>
<td class="nump">$ 1,490,216<span></span>
</td>
<td class="nump">$ 2,587,121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245946968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (deficits)</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2017</a></td>
<td class="nump">25,046,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2017</a></td>
<td class="nump">$ 25,036<span></span>
</td>
<td class="nump">$ 3,258,116<span></span>
</td>
<td class="num">$ (4,644,180)<span></span>
</td>
<td class="num">$ (1,361,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ClawbackOfStockGrantedShares', window );">Clawback of stock granted, shares</a></td>
<td class="num">(375,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ClawbackOfStockGrantedValue', window );">Clawback of stock granted, value</a></td>
<td class="num">$ (375)<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Payment of outstanding balance for PPM</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock Based Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,345,825<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,345,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock grant program vesting, shares</a></td>
<td class="nump">558,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock grant program vesting, value</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,525<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,895,873)<span></span>
</td>
<td class="num">(3,895,873)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2018</a></td>
<td class="nump">25,229,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 25,230<span></span>
</td>
<td class="nump">4,688,272<span></span>
</td>
<td class="num">(8,540,053)<span></span>
</td>
<td class="num">(3,826,551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,719,404)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2019</a></td>
<td class="nump">26,981,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="nump">$ 26,981<span></span>
</td>
<td class="nump">8,967,004<span></span>
</td>
<td class="num">(14,259,457)<span></span>
</td>
<td class="num">(5,265,472)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2018</a></td>
<td class="nump">25,229,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 25,230<span></span>
</td>
<td class="nump">4,688,272<span></span>
</td>
<td class="num">(8,540,053)<span></span>
</td>
<td class="num">(3,826,551)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock Based Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,830,426<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,830,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock Options Issued for loan term revisions, value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37,829<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockGrantsIssuedForLoanTermRevisionsShares', window );">Stock grants issued for loan term revisions, shares</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockGrantsIssuedForLoanTermRevisionsValue', window );">Stock grants issued for loan term revisions, value</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">31,284<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock grant program vesting, shares</a></td>
<td class="nump">1,360,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock grant program vesting, value</a></td>
<td class="nump">$ 1,360<span></span>
</td>
<td class="num">(1,360)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issuance related to conversion of convertible debentures, shares</a></td>
<td class="nump">1,102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issuance related to conversion of convertible debentures, value</a></td>
<td class="nump">$ 1,103<span></span>
</td>
<td class="nump">2,655,934<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,657,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issuance related to acquisition, shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock issuance related to acquisition, value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">999,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures', window );">Equity value of exercise price associated with convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719,479<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">719,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures', window );">Broker warrants associated with issuance of convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278,678<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">278,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,350,573)<span></span>
</td>
<td class="num">(8,350,573)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="nump">28,209,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 28,209<span></span>
</td>
<td class="nump">11,854,083<span></span>
</td>
<td class="num">(16,890,626)<span></span>
</td>
<td class="num">(5,008,334)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2019</a></td>
<td class="nump">25,820,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2019</a></td>
<td class="nump">$ 25,821<span></span>
</td>
<td class="nump">8,438,943<span></span>
</td>
<td class="num">(11,449,927)<span></span>
</td>
<td class="num">(2,985,163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock Options Issued for loan term revisions, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock grant program vesting, shares</a></td>
<td class="nump">1,160,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock grant program vesting, value</a></td>
<td class="nump">$ 1,160<span></span>
</td>
<td class="num">(1,160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,809,530)<span></span>
</td>
<td class="num">(2,809,530)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2019</a></td>
<td class="nump">26,981,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="nump">$ 26,981<span></span>
</td>
<td class="nump">8,967,004<span></span>
</td>
<td class="num">(14,259,457)<span></span>
</td>
<td class="num">(5,265,472)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">28,209,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 28,209<span></span>
</td>
<td class="nump">11,854,083<span></span>
</td>
<td class="num">(16,890,626)<span></span>
</td>
<td class="num">(5,008,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,959,882)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="nump">28,272,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 28,272<span></span>
</td>
<td class="nump">14,118,289<span></span>
</td>
<td class="num">(20,850,508)<span></span>
</td>
<td class="num">(6,703,947)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2020</a></td>
<td class="nump">28,830,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 28,830<span></span>
</td>
<td class="nump">13,522,833<span></span>
</td>
<td class="num">(20,156,227)<span></span>
</td>
<td class="num">(6,604,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ClawbackOfStockGrantedShares', window );">Clawback of stock granted, shares</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ClawbackOfStockGrantedValue', window );">Clawback of stock granted, value</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock grant program vesting, shares</a></td>
<td class="nump">131,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock grant program vesting, value</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issuance related to acquisition, shares</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock issuance related to acquisition, value</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">154,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockGrantToSatisfyAccountsPayableShares', window );">Stock grant to satisfy accounts payable, shares</a></td>
<td class="nump">9,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockGrantToSatisfyAccountsPayableValue', window );">Stock grant to satisfy accounts payable, value</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">9,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedForLeaseRevisionShares', window );">Stock issued for lease revision, shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedForLeaseRevisionValue', window );">Stock issued for lease revision, value</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">30,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(694,281)<span></span>
</td>
<td class="num">(694,281)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="nump">28,272,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 28,272<span></span>
</td>
<td class="nump">$ 14,118,289<span></span>
</td>
<td class="num">$ (20,850,508)<span></span>
</td>
<td class="num">$ (6,703,947)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Broker warrants associated with issuance of convertible debentures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_BrokerWarrantsAssociatedWithIssuanceOfConvertibleDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ClawbackOfStockGrantedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Clawback of stock granted, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ClawbackOfStockGrantedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ClawbackOfStockGrantedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Clawback of stock granted, value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ClawbackOfStockGrantedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity value of exercise price associated with convertible debentures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_EquityValueOfExercisePriceAssociatedWithConvertibleDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockGrantToSatisfyAccountsPayableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock grant to satisfy accounts payable, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockGrantToSatisfyAccountsPayableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockGrantToSatisfyAccountsPayableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock grant to satisfy accounts payable, value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockGrantToSatisfyAccountsPayableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockGrantsIssuedForLoanTermRevisionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock grants issued for loan term revisions, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockGrantsIssuedForLoanTermRevisionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockGrantsIssuedForLoanTermRevisionsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock grants issued for loan term revisions, value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockGrantsIssuedForLoanTermRevisionsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockIssuedForLeaseRevisionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued for lease revision, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockIssuedForLeaseRevisionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockIssuedForLeaseRevisionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued for lease revision, value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockIssuedForLeaseRevisionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672246193704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (3,959,882)<span></span>
</td>
<td class="num">$ (5,719,404)<span></span>
</td>
<td class="num">$ (8,350,573)<span></span>
</td>
<td class="num">$ (3,895,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net loss from operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">181,750<span></span>
</td>
<td class="nump">193,956<span></span>
</td>
<td class="nump">266,476<span></span>
</td>
<td class="nump">154,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_AmortizationOfConvertibleDebentureComponents', window );">Amortization of convertible debenture components</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">810,166<span></span>
</td>
<td class="nump">1,612,197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">368,661<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,391,807<span></span>
</td>
<td class="nump">1,606,355<span></span>
</td>
<td class="nump">1,830,426<span></span>
</td>
<td class="nump">1,245,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ContingentConsiderationExpense', window );">Contingent consideration expense</a></td>
<td class="nump">155,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="nump">310,000<span></span>
</td>
<td class="nump">506,000<span></span>
</td>
<td class="nump">505,766<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-offs</a></td>
<td class="nump">72,258<span></span>
</td>
<td class="nump">57,352<span></span>
</td>
<td class="nump">94,727<span></span>
</td>
<td class="nump">77,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">43,849<span></span>
</td>
<td class="nump">12,252<span></span>
</td>
<td class="nump">67,633<span></span>
</td>
<td class="nump">106,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on disposal of assets</a></td>
<td class="nump">3,468<span></span>
</td>
<td class="num">(9,572)<span></span>
</td>
<td class="num">(72,416)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in Operating Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">658,706<span></span>
</td>
<td class="num">(899,859)<span></span>
</td>
<td class="num">(849,355)<span></span>
</td>
<td class="num">(73,917)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(171,147)<span></span>
</td>
<td class="nump">142,745<span></span>
</td>
<td class="nump">443,322<span></span>
</td>
<td class="num">(167,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and other assets</a></td>
<td class="num">(784,210)<span></span>
</td>
<td class="nump">123,376<span></span>
</td>
<td class="num">(324,273)<span></span>
</td>
<td class="num">(88,684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,470,559)<span></span>
</td>
<td class="nump">2,164,412<span></span>
</td>
<td class="nump">2,671,838<span></span>
</td>
<td class="nump">205,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Customer deposits</a></td>
<td class="nump">1,172,186<span></span>
</td>
<td class="nump">925,922<span></span>
</td>
<td class="num">(383,203)<span></span>
</td>
<td class="nump">147,360<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="num">(3,028,113)<span></span>
</td>
<td class="num">(86,299)<span></span>
</td>
<td class="num">(2,487,435)<span></span>
</td>
<td class="num">(2,285,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(572,250)<span></span>
</td>
<td class="num">(1,085,975)<span></span>
</td>
<td class="num">(861,649)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(122,817)<span></span>
</td>
<td class="num">(387,160)<span></span>
</td>
<td class="num">(192,954)<span></span>
</td>
<td class="num">(369,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
<td class="nump">121,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49,742<span></span>
</td>
<td class="nump">49,742<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(40,255)<span></span>
</td>
<td class="num">(33,674)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used Provided By (Used In) Investing Activities</a></td>
<td class="num">(122,817)<span></span>
</td>
<td class="num">(894,168)<span></span>
</td>
<td class="num">(1,147,942)<span></span>
</td>
<td class="num">(1,264,803)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from issuance of Revolving Facility</a></td>
<td class="nump">2,207,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Proceeds from issuance of Term Loan</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from Revolving Facilty advances</a></td>
<td class="nump">1,069,061<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible debentures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,565,000<span></span>
</td>
<td class="nump">2,565,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="nump">1,020,600<span></span>
</td>
<td class="nump">970,000<span></span>
</td>
<td class="nump">970,000<span></span>
</td>
<td class="nump">1,992,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Debt financing costs</a></td>
<td class="num">(638,046)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable</a></td>
<td class="num">(2,743,428)<span></span>
</td>
<td class="num">(227,749)<span></span>
</td>
<td class="num">(629,772)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used In) Financing Activities</a></td>
<td class="nump">2,915,619<span></span>
</td>
<td class="nump">3,307,251<span></span>
</td>
<td class="nump">2,905,228<span></span>
</td>
<td class="nump">3,072,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Net Increase (Decrease) in Cash</a></td>
<td class="num">(235,311)<span></span>
</td>
<td class="nump">2,326,784<span></span>
</td>
<td class="num">(730,149)<span></span>
</td>
<td class="num">(477,939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at Beginning of Period</a></td>
<td class="nump">448,703<span></span>
</td>
<td class="nump">1,178,852<span></span>
</td>
<td class="nump">1,178,852<span></span>
</td>
<td class="nump">1,656,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at End of Period</a></td>
<td class="nump">213,392<span></span>
</td>
<td class="nump">3,505,636<span></span>
</td>
<td class="nump">448,703<span></span>
</td>
<td class="nump">1,178,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid</a></td>
<td class="nump">670,165<span></span>
</td>
<td class="nump">291,441<span></span>
</td>
<td class="nump">612,138<span></span>
</td>
<td class="nump">119,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Tax Paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock', window );">Convertible debentures and accrued interest converted into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,657,037<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issuance related to acquisition</a></td>
<td class="nump">155,000<span></span>
</td>
<td class="nump">1,020,003<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_CommonStockRetired', window );">Common stock retired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right of use asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">326,095<span></span>
</td>
<td class="nump">$ 326,092<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Debt financing costs booked in equity</a></td>
<td class="nump">$ 676,822<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_AmortizationOfConvertibleDebentureComponents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of convertible debenture components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_AmortizationOfConvertibleDebentureComponents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_CommonStockRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock retired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_CommonStockRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ContingentConsiderationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ContingentConsiderationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ConvertibleDebenturesAndAccruedInterestConvertedIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255951688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Acquisitions, Business Plan, and Liquidity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Acquisitions, Business Plan, and Liquidity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 &#8211; ORGANIZATION AND ACQUISITIONS,
LIQUIDITY AND GOING CONCERN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Organization and Acquisitions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">urban-gro, Inc. (&#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; the &#8220;Company,&#8221; or &#8220;urban-gro&#8221;) is a leading engineering design and services company
focused on the commercial indoor horticulture market. We engineer and design indoor <font style="color: #000712">controlled environment
agriculture (&#8220;CEA&#8221;) facilities a</font>nd then integrate complex environmental equipment systems into those facilities.
Through this work, we create high-performance indoor cultivation facilities for our clients to grow specialty crops, including
leafy greens, vegetables, herbs, and plant-based medicines like cannabis and hemp. Our custom-tailored approach to design, procurement,
and equipment integration provides a single point of accountability across all aspects of indoor growing operations. We also help
our clients achieve operational efficiency and economic advantages through a full spectrum of professional services and programs
focused on facility optimization and environmental health which allows <font style="color: #000712">clients to manage their entire
cultivation lifecycle, establishing facilities that operate and perform at the highest level.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #000712">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our indoor commercial cultivation solution
offers an integrated suite of services and equipment systems that generally fall within the following categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><font style="font-size: 10pt">Service Solutions:</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">Engineering Design Services &#8211; A comprehensive triad of services including:</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">i.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Cultivation Space Programming (&#8220;CSP&#8221;)</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">ii.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Integrated Cultivation Design (&#8220;ICD&#8221;)</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">iii.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Full-Facility Mechanical, Electrical, and Plumbing (&#8220;MEP&#8221;)</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">gro-care&#174; - A recurring revenue subscription-based managed service offering including:</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">i.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Remote Monitoring, Reporting, Support, and Training Services</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">ii.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Facility and Equipment Commissioning &#38; Audit Services</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 15%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">iii.</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 83%; text-align: justify"><font style="font-size: 10pt">Environmental Sciences Groups&#8217; (&#8220;ESG&#8221;) Compliance and Program Services</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><font style="font-size: 10pt">Integrated Equipment Solutions:</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">Design, Source, and Integration of Complex Environmental Equipment Systems Including Purpose-Built Heating, Ventilation, and Air Conditioning (&#8220;HVAC&#8221;) solutions, Environmental Controls, Fertigation, and Irrigation Distribution.</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">Value-Added Reselling (&#8220;VAR&#8221;) of Cultivation Equipment including a Complete line of Lighting and Rolling Benching Systems</font></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 3%"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><font style="font-size: 10pt">Strategic Vendor Relationships with Premier Manufacturers</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="color: #000712">Since
commencing business in March 2014, we have introduced new equipment solutions, products and services to the CEA market, expanded
our ongoing operations across North America, and most recently, we have entered into several engagements in Europe. </font>In June
2018, the Company formed urban-gro Canada Technologies, Inc. as a wholly owned Canadian subsidiary, which it utilizes for its Canadian
sales operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 7, 2019, the Company acquired
100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&#8220;Impact&#8221;), a provider of mechanical electrical and
plumbing (&#8220;MEP&#8221;) engineering services predominantly focused on the indoor commercial horticulture industry. The Company
believes the acquisition of Impact will improve the Company&#8217;s ability to better serve its current and future client base
by expanding on the fully integrated products and services offered by the Company. The Company initially issued 500,000 shares
of Common Stock valued at $2.00 per share to effect the acquisition of Impact. The Company  accounted for the initial acquisition
of Impact as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 77%"><font style="font-size: 10pt">Purchase Price</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Allocation of Purchase Price:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Cash</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">49,742</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accounts receivable, net</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">93,811</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Goodwill</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">902,067</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accrued expenses</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">45,620</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the agreement to
acquire Impact, the Company was required to issue additional shares of Common Stock to the former Impact owner if the average
closing price per share of the Company&#8217;s Common Stock was less than or equal to $2.00 per share for the 30-day period
beginning on the date that was 150 days after the initial date of the listing of the Company&#8217;s Common Stock on a
national securities exchange or quotation on the OTCQB or OTCQX (the &#8220;Valuation Period&#8221;). The Company&#8217;s
Common Stock price was lower than $2.00 per share during the Valuation Period and the Company was required to issue
additional shares of the Company&#8217;s Common Stock to the former Impact owner. In September 2020, however, the Company and
the former Impact owner agreed to satisfy this provision of the agreement by the Company issuing 250,000 additional shares of
Common Stock to the former Impact owner. The Company valued the issuance of these additional 250,000 shares at $0.62 per
share of Common Stock based on the market price of our shares on the date of the agreement and recorded the additional
issuance of shares as contingent consideration in the statements of operations and comprehensive income (loss).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Liquidity and Going Concern</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since inception, the Company has incurred significant
operating losses and has funded its operations primarily through the issuance of equity securities, debt, and operating revenue.
As of September 30, 2020, the Company had an accumulated deficit of $20,850,508, a working capital deficit of $4,833,132, and negative
stockholders&#8217; equity of $6,703,947. These facts and conditions raise substantial doubt about the Company&#8217;s ability
to continue as a going concern, within one year after the date that these financial statements are issued. The Company continually
evaluates opportunities to raise equity and debt financing and has also sought to implement cost reduction and revenue enhancing
measures to help achieve profitability and continue operations. There can, however, be no assurances that the Company will be able
to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can there be any
assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable the Company
to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going concern basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to Accounting Standards Codification
(&#8220;ASC&#8221;) 205-40, <i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern, </i>we
assess going concern uncertainty for our condensed consolidated financial statements to determine if we have sufficient cash and
cash equivalents on hand and working capital to operate for a period of at least one year from the date the condensed consolidated
financial statements are issued or are available to be issued. As part of this assessment, based on conditions that are known and
reasonably knowable to us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key assumptions,
including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those expenditures
or programs, among other factors, if necessary. We believe it is probable that management&#8217;s plans, when implemented, will
mitigate the relevant conditions or events that raise substantial doubt about the Company&#8217;s ability to continue as a going
concern within one year after the date that the financial statements are issued.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1&#160;&#8211; ORGANIZATION AND
ACQUISITIONS, BUSINESS PLAN, AND LIQUIDITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Organization and Acquisitions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">urban-gro, Inc. (&#8220;we,&#8221; &#8220;us,&#8221;
our&#8221; or the &#8220;Company&#8221;) is a leading&#160;engineering design services company that integrates complex environmental
equipment systems to create high performance indoor cultivation facilities for the global commercial horticulture market. Our custom
tailored, plant-centric approach to design, procurement, and integration provides a single point of accountability across all aspects
of indoor cultivation operations. Our solution offers functionality that helps customers manage the entire cultivation lifecycle,
from facility engineering and design to operation and day-to-day management. We offer a full range of custom services that are
integrated with select cultivation equipment and product solutions, which we primarily source from third party technology and
manufacturing partners but also develop in-house.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our service offerings include full facility
programming, engineering and design services, start-up commissioning services, facility optimization services and IPM planning
and strategy services. Complementing these services, we work with customers to source an integrated suite of select cultivation
equipment systems and crop management products, which include: (1)&#160;environmental controls, fertigation, and irrigation distribution
systems; (2)&#160;freshwater, wastewater, and condensation treatment systems; (3)&#160;light emitting diode (&#8220;LED&#8221;),
high-pressure sodium (&#8220;HPS&#8221;) and ceramic metal halide (&#8220;CMH&#8221;) lighting systems; (4)&#160;rolltop, multi-tier,
and automated container benching systems; (5)&#160;odor mitigation &#38; microbial reduction systems; (6)&#160;air flow systems;
(7)&#160;industrial spray applicators; (8)&#160;pesticides and bio-controls; (9)&#160;plant nutrition products; (10)&#160;substrate
and coco bag solutions; and (11)&#160;our Soleil&#174; technology data analytics platform that includes wireless environmental &#38;
substrate sensing and remote monitoring and support.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2018, the Company formed urban-gro
Canada Technologies, Inc. as a wholly owned Canadian subsidiary which it currently utilizes for its Canadian sales operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective March 7, 2019, the Company acquired
100% of the stock of Impact Engineering, Inc. (d/b/a Grow2Guys) (&#8220;Impact&#8221;), a provider of mechanical electrical and
plumbing (&#8220;MEP&#8221;) engineering services predominantly focused on the cannabis industry. Management believes the acquisition
of Impact will improve the Company&#8217;s ability to better serve its current and future customer base by expanding on the fully
integrated products and services offered by the Company. The Company issued 500,000 shares of Common Stock (&#8220;Common Stock&#8221;)
valued at $2.00 per share to effect the acquisition of Impact. The Company has initially accounted for the acquisition of Impact
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%">Purchase Price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Allocation of Purchase Price:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">49,742</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">93,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">902,067</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45,620</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Basis of Presentation </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles
(&#8220;GAAP&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Liquidity and Going Concern</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since inception, the Company has incurred
significant operating losses and has funded its operations primarily through issuance of equity securities, debt, and operating
revenue. As of December 31, 2019, the Company had an accumulated deficit of $16,890,626, a working capital deficit of $7,318,980,
and negative stockholders&#8217; equity of $5,008,334. These facts and conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern, within one year after the date that the financial statements are issued. The Company continually
evaluates opportunities to raise equity and debt financing as well as implementing cost reduction and revenue enhancing measures
that will allow it to increase profitability and continue operations. There can, however, be no assurances that the Company will
be able to raise equity or debt financing in sufficient amounts, when and if needed, on acceptable terms or at all, nor can there
be any assurances that the Company will be able to implement cost reduction and revenue enhancing measures that will enable the
Company to achieve profitable operations going forward. The accompanying financial statements have been prepared on a going concern
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Accounting Standards
Codification (&#8220;ASC&#8221;) 205-40, <i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going
Concern, </i>we assess going concern uncertainty for our consolidated financial statements to determine if we have sufficient
cash and cash equivalents on hand and working capital to operate for a period of at least one year from the date the consolidated
financial statements are issued or are available to be issued. As part of this assessment, based on conditions that are known
and reasonably knowable to us, we will consider various scenarios, forecasts, projections, and estimates, and make certain key
assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those
expenditures or programs, among other factors, if necessary. It is probable that management&#8217;s plans, when implemented, will
mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going
concern within one year after the date that the financial statements are issued.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256100696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Unaudited Condensed Consolidated Financial
Statements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has prepared the accompanying condensed
consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting. The condensed
consolidated financial statements are unaudited and, in the Company&#8217;s opinion, include all adjustments, consisting of normal
recurring adjustments and accruals necessary for a fair presentation of the Company&#8217;s condensed consolidated balance sheets,
condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of shareholders&#8217;
deficit and condensed consolidated statements of cash flows for the periods presented. The results reported in these condensed
consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire
year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting
principles generally accepted in the United States (&#8220;GAAP&#8221;) have been omitted in accordance with regulations of the
SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto
included in the Company&#8217;s consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year
ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Significant Accounting Policies</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For a detailed discussion about the Company&#8217;s
significant accounting policies, refer to Note 2 &#8212; &#8220;Summary of Significant Accounting Policies,&#8221; in the Company&#8217;s
consolidated financial statements included in the Company&#8217;s 2019 Form 10-K. During the nine months ended September 30, 2020,
there were no material changes made to the Company&#8217;s significant accounting policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing condensed consolidated financial
statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements
and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include
estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for deferred
tax assets, and allowance for bad debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Reclassification</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified
for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recently Issued Accounting Pronouncements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &#8220;FASB&#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&#34;ASU&#34;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&#8217;s financial statements upon adoption.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2&#160;&#8211; SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing consolidated financial
statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of assets and liabilities at the date of the consolidated financial statements
and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates
include estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for
deferred tax assets, and allowance for bad debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Basis of Presentation and Principles
of Consolidation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are presented in United States dollars and they include the accounts of urban-gro, Inc. and its wholly-owned subsidiaries. The
financial results of Impact have been included in the Company&#8217;s consolidated financial statements from the date of acquisition
on March 7, 2019 and all intercompany transactions have been eliminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Recently Issued Accounting Pronouncements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &#8220;FASB&#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&#34;ASU&#34;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&#8217;s financial statements upon adoption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Functional and reporting currency and
foreign currency translation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency of
the Company and its subsidiaries is US dollars. All transactions in currencies other than US dollars are translated into US dollars
on the date of the transaction. Any exchange gains and losses related to these transactions are recognized in the current period&#8217;s
earnings as other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s financial instruments
consist principally of cash and cash equivalents, accounts receivable, accounts payable, notes payable and other current assets
and liabilities. We value our financial assets and liabilities using fair value measurements. Fair value is based on the price
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable
in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy
is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three
levels (with Level 3 being the lowest) defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1:&#160;Quoted prices in active markets for identical
assets or liabilities that the entity has the ability to access.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2:&#160;Observable inputs other
than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for
identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated
with observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3:&#160;Unobservable inputs
that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This
includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amount of our cash and
cash equivalents, accounts receivable, accounts payable, and other current assets and liabilities in our consolidated financial
statements approximates fair value because of the short-term nature of the instruments. Investments in non-marketable equity securities
are carried at cost less other-than-temporary impairments. The carrying amount of our notes payable and convertible debt at December
31, 2019 and December 31, 2018 approximates their fair values based on our incremental borrowing rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no changes in Level 1,
Level 2, and Level 3 categorizations and no changes in valuation techniques for these assets or liabilities for the years ended
December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Cash and Cash Equivalents</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly
liquid short-term cash investments with an original maturity of three months or less to be cash equivalents. As of December 31,
2019 and 2018, the Company did not maintain any cash equivalents. The Company maintains cash with financial institutions that
may from time to time exceed federally-insured limits. The Company has not experienced any losses related to these balances and
believes the risk to be minimal. There are no restricted or compensating cash balances as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Accounts Receivable, Net</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivables are carried
at the original invoiced amounts less an allowance for doubtful accounts. As of December 31, 2019 and 2018, the balance of allowance
for doubtful accounts was $18,920. The allowances for doubtful accounts are calculated based on a detailed review of certain individual
customer accounts and an estimation of the overall economic conditions affecting the Company's customer base. The Company reviews
a customer's credit history before extending credit to the customer. If the financial condition of its customers were to deteriorate,
resulting in an impairment of their ability to make payments, additions to the allowance would be required. A provision is made
against accounts receivable to the extent they are considered unlikely to be collected. Occasionally the Company will write off
bad debt directly to the bad debt expense account when the balance is determined to be uncollectable. Bad debt expense for the
years ended December 31, 2019 and 2018 was $67,633 and $106,464, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Inventories</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, consisting entirely of finished
goods, are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost
method. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based
on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold at the realization of change
in value. Once written down, inventories are carried at this lower basis until sold or scrapped.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Property and Equipment </u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Property and equipment is stated at
cost less accumulated depreciation and impairment. Expenditures for major additions and improvements are capitalized and minor
replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise
disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated)
for tax purposes where appropriate. No impairment charges were recorded for the years ended December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives for significant property and equipment
categories are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Computer and Technology Equipment</font></td>
    <td style="width: 23%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Furniture and Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Leasehold Improvements</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Lease term</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vehicles</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 or 5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Software</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Operating Lease Right of Use Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease right of use assets are
stated at cost less accumulated depreciation, amortization and impairment. The Company has two operating leases with an imputed
annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on August 31,
2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021. Operating lease
right of use asset costs incurred in 2019 were $123,563.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Convertible Notes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its convertible
notes at issuance by allocating the proceeds received from a convertible note among freestanding instruments according to ASC
470, Debt, based upon their relative fair values. The fair value of debt and common stock is determined based on the closing price
of the common stock on the date of the transaction, and the fair value of warrants, if any, is determined using the Black-Scholes
option-pricing model. Convertible notes are subsequently carried at amortized cost. The fair value of the warrants is recorded
as additional paid-in capital, with a corresponding as a debt discount from the face amount of the convertible note. Each convertible
note is analyzed for the existence of a beneficial conversion feature (&#8220;BCF&#8221;), defined as the fair value of the common
stock at the commitment date for the convertible note, less the effective conversion price. Beneficial conversion features are
recognized at their intrinsic value, and recorded as an increase to additional paid-in capital, with a corresponding reduction
in the carrying amount of the convertible note (as a debt discount from the face amount of the convertible note). The discounts
on the convertible notes, consisting of amounts ascribed to warrants and beneficial conversion features, are amortized to interest
expense, using the effective interest method, over the terms of the related convertible notes. Beneficial conversion features
that are contingent upon the occurrence of a future event are recorded when the contingency is resolved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Intangible Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s intangible assets,
consisting of legal fees for application of patents and trademarks and license fees paid for inspection services, are recorded
at cost. Patents and trademarks, once approved, will be amortized using the straight-line method over an estimated life, generally
5 years for patents and 10 to 20 years for trademarks. License fees are amortized over 10 years. Intangible assets are included
in &#8220;other assets&#8221; on the balance sheets. The net balance of intangible assets for December 31, 2019 and 2018 was $86,151
and $63,755, respectively. Amortization expense totaled $1,879 and $974 for the years ended December 31, 2019 and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Goodwill</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the purchase
price over the fair value of net assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment
annually as of December 31st and at any time when events or circumstances suggest impairment may have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The testing for impairment consists of
a comparison of the fair value of with its carrying amount. If the carrying amount of the reporting unit, including goodwill, exceeds
the fair value, an impairment will be recognized equal to the difference between the carrying value of the reporting unit goodwill
and the implied fair value of the goodwill. In testing goodwill for impairment, we determine the estimated fair value of our reporting
units based upon a discounted future cash flow analysis. Goodwill is our only indefinite-lived intangible asset. Definite-lived
intangible assets are amortized using the straight line method over the shorter of their contractual term or estimated useful lives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Investments</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments without readily determinable
fair values and for which the Company does not have the ability to exercise significant influence are accounted for at cost with
adjustments for observable changes in prices or impairments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Impairment of Long-lived Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates potential impairment
of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to
result from the use and eventual disposition of the asset. An impairment will be recognized as the amount by which the carrying
amount of a long-lived asset exceeds its fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Revenue Recognition</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with ASC 606, <i>Revenue from Contracts with Customers,</i> which requires that five basic steps be followed to recognize revenue:
(1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance
obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration
given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance
obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration
given to whether that control happens&#160;over time&#160;or not. Determination of criteria (3) and (4) are based on our management's
judgments regarding the fixed nature of the selling prices of the services and products delivered and the collectability of those
amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our service and product revenues arise
from contracts with customers. Service revenues include full facility programming, engineering and design services, start-up commissioning
services, facility optimization services and IPM planning and strategy services. Product revenues include an integrated suite of
select cultivation equipment systems and crop management products. We enter into separate contracts for the service and product
revenues we provide to our customers so to clarify our obligations under the terms of the contracts. New contracts are entered
into if the services to be performed or products to be delivered need to be modified. Service revenues are satisfied when services
are rendered or completed in accordance with the terms of the contract. Product revenues are satisfied when control of the products
is transferred to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues for services and products for
the year ended December 31, 2019 were $3,167,237 and 21,022,566, respectively. Revenues for services and products for the year
ended December 31, 2018 were $928,063 and $19,122,713, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Customer Deposits</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s policy is to collect
deposits from customers at the beginning of the contract. The customer payments received are recorded as a customer deposit liability
on the balance sheet. When the contract is complete and meets all the criteria for revenue recognition, the customer is billed
for the entire contract amount and the deposit is recorded against the customer&#8217;s receivable balance. In certain situations
when the customer has paid the deposit and services have been performed but the customer chooses not to proceed with the contract,
the Company may keep the deposit and recognize revenue.&#160;Of the outstanding customer deposit balance of $3,298,609 at December
31, 2018, $2,678,565 was recognized as revenue in the year ended December 31, 2019. At December 31, 2017, the entire customer
deposit balance of $3,151,250 was recognized as revenue in the year ended December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Cost of Revenue</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s policy is to recognize
cost of revenues in the same manner as, and in conjunction with, revenue recognition. The Company&#8217;s cost of revenues includes
the costs directly attributable to revenue recognized and includes expenses related to the purchasing of products and providing
services, fees for third-party commissions and shipping costs. Total shipping costs included in the cost of goods sold for the
years ended December 31, 2019 and 2018 was $679,911 and $490,526, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Advertising Costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertisings costs
in the periods the costs are incurred. Prepayments made under contracts are included in prepaid expenses and expensed when the
advertisement is run. Total advertising expense incurred for the years ended December 31, 2019 and 2018 was $159,728 and $153,878,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Warrants</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The Company accounts for its
warrants issued in accordance with the GAAP accounting guidance under ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;.
The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing
based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual
term, risk-free interest rate, and expected volatility of the price of the underlying common stock. There is a moderate degree
of subjectivity involved when using option pricing models to estimate the warrants and the assumptions used in the Black-Scholes
option-pricing model are moderately judgmental.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Stock-Based Compensation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically issue shares of
its common stock to employees and consultants in non-capital raising transactions for fees and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock issued to
non-employees with the value of the stock compensation based upon the measurement date as determined at the grant date of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock grants issued
and vesting to employees with the award being measured at its fair value at the date of grant and amortized ratably over the vesting
period. The Company also estimates forfeitures at the time of grant and revises those estimates in subsequent periods if actual
forfeitures differ from its estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Income Taxes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company files
income federal tax returns in the United States and Canada and state and local tax return in applicable jurisdictions. Provisions
for current income tax liabilities, if any, would be calculated and accrued on income and expense amounts expected to be included
in the income tax returns for the current year. Income taxes reported in earnings, if any, would also include deferred income tax
provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred income
tax assets and liabilities, if any, would be computed on differences between the financial statement bases of assets and liabilities
at the enacted tax rates. Changes in deferred income tax assets and liabilities would be included as a component of income tax
expense. The effect on deferred income tax assets and liabilities attributable to changes in enacted tax rates would be charged
or credited to income tax expense in the period of enactment. Valuation allowances would be established for certain deferred tax
assets when realization is not likely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Assets and liabilities
would be established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions,
in the judgement of the Company, do not meet a more-likely-than-not threshold based on the technical merits of the positions.
Valuation allowances would be established for certain deferred tax assets when realization is not likely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Loss Per Share</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes net loss per share
by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period.
Diluted earnings per share would be computed by dividing net loss by the weighted-average of all potentially dilutive shares of
common stock that were outstanding during the periods presented. The diluted earnings per share calculation is not presented as
it results in an anti-dilutive calculation of net loss per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treasury stock method would be used
to calculate diluted earnings per share for potentially dilutive stock options and share purchase warrants. This method assumes
that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase
common shares at the average market price for the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Recently Adopted Accounting Pronouncements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued an Accounting
Standards Update (&#8220;ASU&#8221;) amending the accounting for leases. The new guidance requires the recognition of lease assets
and liabilities for operating leases with terms of more than 12 months, in addition to those currently recorded, on the Company&#8217;s
consolidated balance sheets. Presentation of leases within the consolidated statements of operations and comprehensive loss and
consolidated cash flows will be generally consistent with the prior lease accounting guidance. The ASU was effective for reporting
periods beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU effective January 1, 2019
under the modified retrospective method with respect to lease contracts in effect as of the adoption date. The adoption of the
ASU increased our assets and liabilities by $326,095 in 2019 due to the recognition of right of use assets and lease liabilities
with respect to operating leases.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256912904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#8211; RELATED PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company previously purchased certain cultivation
products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&#8220;Bravo&#8221;) and Enviro-Glo, LLC (&#8220;Enviro-Glo&#8221;),
manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&#8217;s
two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $0 and $43,912 for
the nine months ended September 30, 2020 and 2019, respectively, and $0 and $7,442 for the three months ended September 30, 2020
and 2019, respectively. There were no outstanding receivables from Bravo and Enviro-Glo as of September 30, 2020 and December 31,
2019. Net outstanding payables incurred for purchases of inventory and other services to Bravo and Enviro-Glo as of September 30,
2020 and December 31, 2019 were $0 and $8,570, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has made payments to Cloud
9 Support, LLC (&#8220;Cloud 9&#8221;), a company owned by James Lowe, a director, shareholder, and debt holder. Payments to Cloud
9 were $0 and $75,617 during the nine months ended September 30, 2020 and 2019, respectively, and $0 and $24,368 during the three
months ended September 30, 2020 and 2019, respectively. Cloud 9 also purchases materials from the Company. Total sales to Cloud
9 from the Company were $359,562 and $229,688 during the nine months ended September 30, 2020 and 2019, respectively, and $112,405
and $103,088 during the three months ended September 30, 2020 and 2019, respectively. Outstanding receivables from Cloud 9 as
of September 30, 2020 and December 31, 2019 totaled $9,772 and $49,659, respectively. Net outstanding payables to Cloud 9 as of
September 30, 2020 and December 31, 2019 were $0 and $16,402, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2018, the Company received a $1,000,000,
unsecured, interest only, promissory note (the &#8220;Promissory Note&#8221;) from Cloud 9. The Promissory Note was originally
due April 30, 2019. The Promissory Note is personally guaranteed by the Company&#8217;s largest shareholders, Bradley Nattrass,
who is the Company&#8217;s Chairman and Chief Executive Officer, and Octavio Gutierrez, a former officer and director of the Company.
The Promissory Note includes additional consideration of 30,000 options at an exercise price of $1.20 per share. Under the initial
terms of the Promissory Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019, the due date of
the Promissory Note was extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable monthly. In
connection with the execution of the Credit Agreement (see Note 9 &#8211; Debt) on February 21, 2020, the Company entered into
an agreement to amend the Promissory Note (the &#8220;Amending Agreement&#8221;). Pursuant to the Amending Agreement, Cloud 9 agreed
to extend the maturity date of the Promissory Note from December 31, 2019 to the date which is the earlier of 60 days following
the date: (a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the maturity date
of the Credit Agreement. As part of the Amending Agreement, the Company issued 100,000 shares of Common Stock to James Lowe as
designee of Cloud 9.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3&#160;&#8211; RELATED PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2018, the Company received
a $1,000,000, unsecured, interest only, promissory note (the &#8220;Promissory Note&#8221;) from Cloud9 Support Inc. (&#8220;Cloud9&#8221;),
an entity owned 100% by James Lowe, a director of the Company. The Promissory Note was originally due April 30, 2019. The Promissory
Note is personally guaranteed by the Company&#8217;s two majority shareholders, Bradley Nattrass, who is the Company&#8217;s Chairman
and Chief Executive Officer, and Octavio Gutierrez, a director and former officer of the Company. The Promissory Note includes
additional consideration of 30,000 options at an exercise price of $1.20 per share. Under the initial terms of the Promissory
Note, the interest rate was 12.0% per year with interest payable monthly. In May 2019, the due date of the Promissory Note was
extended to December 31, 2019 and the interest rate was decreased to 9.0% per year payable monthly. In connection with the execution
of the Credit Agreement (see Note 17), on February 21, 2020, the Company entered into an agreement to amend the Promissory Note
(the &#8220;Amending Agreement&#8221;). Pursuant to the Amending Agreement, Cloud9 agreed to extend the maturity date of the Promissory
Note from December 31, 2019 to the date which is the earlier of 60 days following the date: (a) on which demand for repayment
is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit Agreement. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company purchases some cultivation
products from Bravo Lighting, LLC (d/b/a Bravo Enterprises) (&#8220;Bravo&#8221;) and Enviro-Glo, LLC (&#8220;Enviro-Glo&#8221;),
manufacturers and distributors of commercial building lighting and other product solutions with common control by the Company&#8217;s
two major shareholders, Bradley Nattrass and Octavio Gutierrez. Purchases from Bravo and Enviro-Glo totaled $45,129 and $276,443
for the years ended 2019 and 2018, respectively. Outstanding receivables from Bravo and Enviro-Glo for the years ended 2019 and
2018 totaled $0 and $43,120, respectively. Net outstanding payables incurred for purchases of inventory and other services to Bravo
and Enviro-Glo as of December 31, 2019 and 2018, was $8,570 and $5,562, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has purchased goods from Cloud
9 Support, LLC (&#8220;Cloud 9&#8221;), a company owned by James Lowe, a director, shareholder, and debt holder. Purchases from
Cloud 9 were $97,329 and $84,746 during the years ended 2019 and 2018, respectively. Cloud 9 also purchases materials from the
Company for use with their customers. Total sales to Cloud 9 from the Company were $392,963 and $273,760 during the years ended
2019 and 2018, respectively. Outstanding receivables from Cloud 9 as of December 31, 2019 and 2018 totaled $49,659 and $79,235,
respectively. Net outstanding payables for purchases of inventory and other services to Cloud 9 as of December 31, 2019 and 2018,
totaled $16,402 and $13,240, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672254358808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. Prepayments and Advances<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Prepayments and Advances</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; PREPAYMENTS AND OTHER ASSETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">Prepayments and other assets are comprised
of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Vendor prepayments</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,828,531</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,070,788</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Prepaid services and fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">268,655</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">187,912</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Deferred financing asset (See Note 9 - Debt)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">630,805</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Other assets</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">6,391</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">20,028</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Prepayments and other assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,734,382</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,278,728</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 &#8211; PREPAYMENTS &#38; ADVANCES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Prepayments and advances are comprised
of prepayments paid to vendors to initiate orders and prepaid services and fees. The prepaid balances are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Vendor Prepayments</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,070,788</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">776,478</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Prepaid Services and Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">187,912</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">152,204</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Prepayments and Advances</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,258,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">928,682</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256101528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Property Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property Plant and Equipment, net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 - PROPERTY PLANT &#38; EQUIPMENT,
NET</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property Plant and Equipment balances are
summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Computers &#38; Technology Equip</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">87,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">61,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and Fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,162</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Leasehold Improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">164,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,215</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,414</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132,875</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,783</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">R&#38;D Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,031</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,140</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(370,376</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(309,975</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property plant and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">165,035</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">441,141</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense for the years ended
December 31, 2019 and 2018 totaled $264,597 and $153,162, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672257010632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#8211; INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The components of investments are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>September 30,</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, <br />
2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Investment in Edyza</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Investment in TGH</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">310,000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,020,358</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">On January 24, 2020, the Company entered
into a Membership Interest Redemption Agreement (the &#8220;Redemption Agreement&#8221;) with Total Grow Holdings LLC (d/b/a Total
Grow Control, LLC) (&#8220;TGH&#8221;), whereby the Company agreed to sell the Company&#8217;s 24.4% membership interests in TGH
back to TGH for total consideration of $370,000. As a result of TGH&#8217;s failure to perform its obligations under the Redemption
Agreement, the Company initiated a lawsuit against TGH seeking damages (the &#8220;Lawsuit&#8221;), and subsequently fully impaired
the remaining investment in TGH during the three months ended June 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">On September 24, 2020, the Company and
TGH entered into a Settlement Agreement (the &#8220;Settlement Agreement&#8221;), pursuant to which the parties agreed to settle
all claims brought in the Lawsuit. Pursuant to the Settlement Agreement, TGH agreed to pay the Company a total of $61,919 in six
equal installments. TGH&#8217;s first payment was due by October 4, 2020. TGH also agreed to reimburse the Company for up to $25,000
of its attorney&#8217;s fees related to the Lawsuit and the Settlement Agreement. In consideration of the foregoing and subject
to TGH satisfying its payment obligations, the Company agreed to release any and all claims related to the Lawsuit. The Settlement
Agreement also provides for a mutual release between the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">On September 24, 2020, in connection
with the Settlement Agreement, the Company also entered into an agreement (the &#8220;Pullar Agreement&#8221;) by and between the
Company and George R. Pullar, a former director of the Company and the Company&#8217;s former chief financial officer and the current
chief financial officer of TGH. Pursuant to the Pullar Agreement, in exchange for Mr. Pullar relinquishing all right, title and
interest in and to 1,000,000 shares of the Company&#8217;s common stock, the Company agreed to (i) execute the Settlement Agreement,
(ii) transfer, sell and assign to Mr. Pullar the Company&#8217;s 24.4% membership interest in TGH pursuant to the Settlement Agreement
and (iii) issue Mr. Pullar a fully vested warrant, to purchase 400,000 shares of Common Stock at an exercise price of $1.00 per
share which expires five years from the date of issuance. The Pullar Agreement also provides for a mutual release between the Company
and Mr. Pullar.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 &#8211; INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The changes in the components of the Investments for the years
ended December 31, 2019 and 2018 are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="11" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31, 2019</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Edyza</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>TGH</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 58%"><font style="font-size: 10pt">Beginning Balances as of 1/1/2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">812,883</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">448,766</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,261,649</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Purchase of additional shares under SPOA</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">897,475</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">897,475</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Initial purchase of Membership interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">367,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">367,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with first option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Impairment of investment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(505,766</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(505,766</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Ending Balances as of 12/31/2019</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">310,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,020,358</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="11" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31, 2018</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Edyza</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>TGH</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 58%"><font style="font-size: 10pt">Beginning Balances as of 1/1/2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-indent: -10pt; padding-left: 10pt"><font style="font-size: 10pt">Purchase of additional shares under SPOA, including $75,000 reflected in Accrued Expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Initial purchase of Membership Interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with first option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">150,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with second option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">158,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">158,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,883</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">15,766</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">28,649</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Ending Balances as of 12/31/2018</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">812,883</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">448,766</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,261,649</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Edyza</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2017, the Company entered into
a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with Edyza, Inc. (&#8220;Edyza&#8221;), a developer of wireless sensor
technology, to provide the Company with the right to obtain an ownership interest in Edyza to be issued when Edyza engaged in a
priced round of investment. The Company paid Edyza $400,000 for the SAFE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the Company and Edyza
entered into a Stock Purchase and Option Agreement (&#8220;SPOA&#8221;) whereby the Company and Edyza agreed to terminate the
SAFE in exchange for Edyza issuing the Company 442,685 shares of Edyza Common Stock at $0.903577 per share, or $400,000 in the
aggregate. In connection with the SPOA, the Company agreed to pay Edyza an additional $400,000 in six monthly installments ($50,000
a month in August and September 2018 and $75,000 a month from October 2018 thru January 2019) in exchange for Edyza issuing the
Company an additional 442,685 shares of Edyza Common Stock at $0.903577 per share. As of December 31, 2018, the Company had paid
$325,000 of the additional $400,000 to Edyza under this installment payment plan. The remaining installment payment of $75,000
is included in Accrued Expenses on the Company&#8217;s Balance Sheet as of December 31, 2018 and was paid to Edyza in January
2019. During 2019, the Company acquired an additional 827,018 shares for $897,475. The Company has capitalized an additional $12,883
in legal fees associated with the purchases of the Edyza Common Stock. The Company measures this investment at cost, less any
impairment changes resulting from observable price changes in orderly transactions for an identical or similar investment of the
same issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>TGH</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2018, the Company entered into
a Membership Interest and Purchase Agreement (&#8220;MIPA&#8221;) with Total Grow Holdings, LLC (d/b/a/ Total Grow Control, LLC)
(&#8220;TGH&#8221;), a developer of environmental controls and fertigation/irrigation distribution products, to purchase 5% of
TGH&#8217;s membership interests on a fully diluted basis for $125,000. The MIPA also contained two separate options for the Company
to purchase additional membership interests in TGH and a purchase right for the Company to acquire all of the outstanding membership
interests in TGH. The first option was exercisable from July 1, 2018 thru August 31, 2018 and allowed the Company to acquire an
additional 5% of TGH&#8217;s membership interests on a fully diluted basis for $150,000. The second option was initially exercisable
from February 15, 2019 thru May 15, 2019 and allowed the Company to acquire an additional 15% of TGH&#8217;s membership interests
on a fully diluted basis for $600,000. The purchase right is exercisable from May 15, 2019 thru February 15, 2020 and allows the
Company to acquire all of the outstanding membership interests in TGH based on a total valuation of TGH of $7,500,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2018, the Company exercised its
initial option and purchased an additional 5% of TGH&#8217;s fully diluted membership interests for $150,000. As of December 31,
2018, the Company owned 10% of the membership interests in TGH.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2019, the Company and TGH renegotiated
the terms of the second option, accelerating the beginning of the exercise period to January 2019 from February 15, 2019, and reducing
the purchase price for the additional 15% of TGH&#8217;s membership interests on a fully diluted basis from $600,000 to $525,000.
In January 2019, the Company elected to exercise this renegotiated second option and purchased an additional 15% of TGH&#8217;s
fully diluted membership interests for $525,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to December 31, 2018, the Company
had advanced TGH $158,000 for equipment orders the Company had placed with TGH. TGH agreed to apply this $158,000 in equipment
advances toward the second option membership interest purchase price of $525,000, and the Company has reflected this $158,000 as
an investment in TGH as of December 31, 2018. The remaining balance of $367,000 for the second option membership interest was due
in installments of $35,000 every two weeks through May 2019. As of March 31, 2019, the Company had made total payments of $336,000.
The Company capitalized an additional $15,766 in legal fees associated with the purchases of the TGH membership interests. As of
December 31, 2018, the Company&#8217;s fully diluted ownership interest in TGH was less than 20% and, the Company measured these
investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions
for an identical or similar investment of the same issuer. As of December 31, 2018, the Company determined that no impairment of
its investment in TGH was necessary given the recent valuations and no change in qualitative factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also made the remaining $367,000
in additional payments to TGH under the renegotiated agreement reached in January 2019 to acquire additional Membership Interests
in TGH. When the payment plan was completed in May 2019, the Company was issued the additional ownership interest in TGH resulting
in the Company owning 24% of TGH&#8217;s membership interest. The Company believed that this ownership interest in TGH resulted
in the Company being able to exercise significant influence over TGH and that the Company should begin to account for its investment
in TGH under the equity method beginning in July 2019 since the operations of TGH were insignificant in June 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2019, the Company decided
that it should remain independent with regard to any investments in environmental controls and fertigation/irrigation distribution
entities and decided it should divest itself of the ownership interest in TGH. The Company entered into preliminary negotiations
with TGH to sell its ownership interest in TGH back to TGH. In connection with those negotiations, the Company determined it should
not record any equity interests in TGH and the Company recorded a $505,766 write-down of its investment in TGH to an amount the
Company anticipates receiving in proceeds from the sale of the TGH investment back to TGH.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2020, the Company and TGH
entered into an agreement whereby TGH agreed to purchase the Company&#8217;s remaining investment in TGH in consideration for
a short-term note due April 24, 2020 in the amount of $200,000 and a long-term note due in a lump sum on January 27, 2025 in the
amount of $110,000 with interest of 4.0% payable annually in arrears. Per the terms of the agreement, the Company retains its
ownership interest in TGH until the $200,000 short-term note is repaid. As of the date of this report, TGH has not made any payments
on the $200,000 short-term note and the Company has retained its ownership interest in TGH. The Company does not have the ability
to exert significant influence on TGH and therefore has recorded the investment at its adjusted cost basis.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.3A-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355119-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255995224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Other Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 &#8211; OTHER ASSETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included in other assets are the following
intangible assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 24px"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Patents, consisting of legal costs paid to third parties to establish a patent, which are capitalized until such time that the patents are approved and issued or rejected. If approved, capitalized costs are amortized using the straight-line method over the estimated lives of the patents, generally five years. The Company has two issued patents as of December 31, 2019 and had no issued patents at December 31, 2018.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 24px"><font style="font: 10pt Symbol">&#183;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">License fees, which consist of fees paid to have the Company&#8217;s products certified by a nationally recognized organization. License fees are amortized over ten years.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net balance of intangible assets as
of December 31, 2019 and December 31, 2018 was $86,151 and $63,755, respectively. Amortization expense totaled $1,879 and $974
for the years ended December 31, 2019 and 2018, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256043944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 &#8211; ACCRUED EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accrued expenses are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Accrued operating expenses</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">798,752</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">854,056</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accrued wages and related expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">402,710</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">487,327</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Accrued interest expense</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,635</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Accrued sales tax payable</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">616,999</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">345,458</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,863,096</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,686,841</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued sales tax payable is comprised
of amounts due to various states and Canadian provinces for 2015 through 2020.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 &#8211; ACCRUED EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Accrued operating expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">854,056</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">240,941</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued wages and related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">490,961</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,958</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accrued sales tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">345,458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">401,282</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,686,841</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,144,142</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued sales tax payable is comprised
of prior period sales tax payable to various states for 2015 through 2019. The Company has set up payment plans with the various
taxing agencies to relieve the obligation. The payment plans require monthly payments in various amounts over a period of 12 months.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256144184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Notes Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#8211; NOTES PAYABLE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of notes payable
excluding related party notes payable:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 72%"><font style="font-size: 10pt">Unsecured, interest only, note payable with Chris Parkes originally due
    December 31, 2018. Initial interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018
    extending the maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the
    interest rate was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the
    interest rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making
    monthly principal payments in the amount of $10,000.</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">20,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">80,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.
    Initial interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the
    maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate
    was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest
    rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly
    principal payments in the amount of $10,000.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">40,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Note payable with Hydrofarm Holdings Group, Inc. (&#8220;Hydrofarm&#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023. The note was repaid in full on February 27, 2020.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,000,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matured on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments. The note was repaid in full on February 27, 2020.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">632,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Paycheck Protection Program (&#8220;PPP&#8221;) loan entered into on April 16, 2020. Interest rate of 1.0% per annum. Payments of principal and interest are deferred until August 1, 2021 (the &#8220;Deferral Period&#8221;). The PPP loan may be forgiven in part or fully depending on the Company meeting certain PPP loan forgiveness guidelines. The Company has not yet determined if any of the PPP loan is subject to forgiveness and has therefore continued to present the entire PPP loan as an obligation on its financial statements. Any unforgiven portion of the PPP loan is payable over a two-year term, with payments deferred during the Deferral Period. The Company may prepay the unforgiven loan balance at any time without payment of any premium.</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,020,600</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,080,600</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,812,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Less current maturities</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(60,00</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(2,812,709</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Long Term</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,020,600</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 &#8211; NOTES PAYABLE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes payable balances totaled $2,812,709
and $2,478,869 at December 31, 2019 and December 31, 2018, respectively. Interest expense incurred on the notes payable was $596,075
and $119,961 for the years ended December 31, 2019 and 2018, respectively.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of notes payable:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Unsecured, interest only, note payable with Chris Parkes originally due December 31,
    2018. Interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending the maturity
    date to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was
    decreased to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate,
    the Company issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">80,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">80,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.
    Interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date
    to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased
    to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company
    issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Unsecured, interest only, note payable with Michael S. Bank originally due April 30, 2019. Interest at 19.8% per year is paid twice per month. The note contains a demand re-payment provision that can be executed by Mr. Bank at any time by providing a one-time notice. The Company may re-pay any part or the entire principal sum at any time with penalty and abatement of interest expense from date of early payment. The note includes six thousand warrants, each exercisable to purchase one share of the Company's Common Stock at a price of $1.00 per share. In March 2019, the Company repaid $35,000 of the principal and extended the maturity date to April 30, 2019. The note was repaid in full on April 30, 2019.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">298,869</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Note payable with Hydrofarm Holdings Group, Inc. (&#8220;Hydrofarm&#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matures on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments.</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">632,709</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,812,709</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,478,869</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,812,709</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,478,869</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective November 20, 2018, the Company
entered into a letter of intent (&#8220;LOI&#8221;) with Hydrofarm Holdings Group, Inc. (&#8220;Hydrofarm&#8221;) whereby Hydrofarm
agreed to acquire all of the Company&#8217;s issued and outstanding common stock (the &#8220;Merger&#8221;). Pursuant to the terms
of the LOI, Hydrofarm extended to the Company a secured, interest only note in the principal amount of $2 million. The note was
secured by all of our currently existing and future assets. In connection with the execution of the Credit Agreement (see Note
17), the Company repaid the note and the Merger was abandoned.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256912904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Unit Offering<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_UnitOfferingTextBlock', window );">Unit Offering</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 &#8211; UNIT OFFERING </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 9, 2019, the Company executed
a letter agreement with an exclusive placement agent in connection with a private placement offering. Beginning in March 2019,
the placement agent initiated an offering (the &#8220;Offering&#8221;) of up to $6,000,000 from the sale of Units, with each Unit
consisting of a $1,000 Convertible Debenture (the &#8220;Debentures&#8221; or a &#8220;Debenture&#8221;) and Common Stock Purchase
Warrants (the &#8220;Warrants&#8221;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share for a period of
two years from the purchase date. The Debentures were due May 31, 2021 and bore interest at 8%, compounded annually, with interest
due at maturity. The Debentures, plus any accrued but unpaid interest, were to automatically convert for no additional consideration
into Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity event was defined
as: (a) the date on which the Company&#8217;s Common Stock is listed for trading on a recognized stock exchange in either Canada
or the United States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying both the conversion
right included in the Debentures and underlying the Warrants, have been duly qualified by a registration statement in the United
States, allowing the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in Canada. The Company
filed a registration statement with the SEC on September 17, 2019, to register the securities in connection with the Offering.
That registration statement was declared effective October 16, 2019, triggering the liquidity event indicated above and the $2,565,000
in Debentures plus $92,037 in accrued interest were converted into 1,102,513 Common Shares at $2.41 per share. The Warrants contain
a mandatory exercise provision if the weighted average share price of the Company&#8217;s Common Stock exceeds $5.00 per share
for a period of five consecutive days. As of September 30, 2020, no Warrants had been exercised.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 &#8211; UNIT OFFERING </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 9, 2019, the Company
executed a letter agreement with 4Front Capital Partners, Inc., Toronto, Canada (&#8220;4Front&#8221;), whereby 4Front agreed to
act as the Company&#8217;s exclusive placement agent in connection with a private placement offering. Beginning in March 2019,
4Front initiated an offering (the &#8220;Offering&#8221;) of up to $6,000,000 from the sale of Units, with each Unit consisting
of a $1,000 Convertible Debenture (the &#8220;Debentures&#8221; or a &#8220;Debenture&#8221;) and Common Stock Purchase Warrants
(the &#8220;Warrants&#8221;) exercisable to purchase 207.46 shares of Common Stock at $3.00 per share for a period of two years
from the purchase date. The Debentures are due May 31, 2021 and bear interest at 8%, compounded annually, with interest due at
maturity. The Debentures, plus any accrued but unpaid interest, will automatically convert for no additional consideration into
Common Shares at a conversion price of $2.41 per share upon the occurrence of a liquidity event. A liquidity event means: (a) the
date on which the Company&#8217;s Common Stock is listed for trading on a recognized stock exchange in either Canada or the United
States; and (b) securities issued pursuant to the Offering, including the Common Stock underlying both the conversion right included
in the Debentures and underlying the Warrants, have been duly qualified by a registration statement in the United States, allowing
the securities to be freely tradeable pursuant to the U.S. securities laws, or a prospectus in Canada. The Company filed a registration
statement with the SEC on September 17, 2019, to register the securities in connection with the Offering. That registration statement
was declared effective October 16, 2019, triggering the liquidity event indicated above and the $2,565,000 in Debentures plus $92,037
in accrued interest were converted into 1,102,513 Common Shares at $2.41 per share. The Warrants contain a mandatory exercise provision
if the weighted average share price of the Company&#8217;s Common Stock exceeds $5.00 per share for a period of five consecutive
days.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_UnitOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_UnitOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256000808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Operating Lease Liabilities &amp; Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 11 &#8211; OPERATING LEASE LIABILITIES &#38; COMMITMENTS
AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two operating leases with
an imputed annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on
August 31, 2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of operating
lease liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br /> 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br /> 2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Operating lease liabilities related to right of use assets.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">222,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(123,395</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">98,841</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a schedule showing future
minimum lease payments:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 44%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year ending</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Minimum</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Lease Payments</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 20%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">177,688</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">91,688</font></td>
    <td>&#160;</td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company is involved
in routine litigation that arises in the ordinary course of business. There are no legal proceedings for which management believes
the ultimate outcome would have a material adverse effect on the Company&#8217;s results of operations and cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256088936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"><b>NOTE 11 &#8211; RISKS AND UNCERTAINTIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"><u>Concentration Risk</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30,
2020 and 2019, one client represented 26% and 15% of total revenue, respectively. During the three months ended September 30, 2020
and 2019, one client represented 51% and 17% of total revenue, respectively. At September 30, 2020 one client represented 26% of
total outstanding receivables. At December 31, 2019, one client represented 15% and another represented 11% of total outstanding
accounts receivables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30,
2020, 27% of the Company&#8217;s total purchases were from one vendor. During the nine months ended September 30, 2019, 15% of
the Company&#8217;s total purchases were from one vendor. During the three months ended September 30, 2020, 48% of the Company&#8217;s
total purchases were from one vendor. During the three months ended September 30, 2019, 20% of the Company&#8217;s total purchases
were from one vendor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Coronavirus Pandemic</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outbreak of COVID-19, a novel strain
of coronavirus first identified in China, which has spread across the globe including the U.S., has had an adverse impact on our
operations and financial condition. The response to this coronavirus by federal, state and local governments in the U.S. has resulted
in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has
also caused significant stock market volatility and further tightened capital access for most businesses. Given that the COVID-19
pandemic and its disruptions are of an unknown duration, they could have an adverse effect on our liquidity and profitability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of these events, we assessed our
near-term operations, working capital, finances and capital formation opportunities, and implemented, in late March 2020, a downsizing
of our operations and workforce to preserve cash resources and focus our operations on client-centric sales and project management
activities. The duration and likelihood of success of this workforce reduction are uncertain; however, we have since rehired several
employees who were impacted by the downsizing effort. If this downsizing effort does not meet our expectations, or additional capital
is not available, we may not be able to continue our operations. The pandemic and its effects resulted in temporary delays in our
projects, however, work on all such projects has resumed. Other factors that will affect our ability to continue operations include
the market demand for our products and services, our ability to service the needs of our clients and prospects with a reduced workforce,
potential contract cancellations, project scope reductions and project delays, our ability to fulfill our current backlog, management
of our working capital, the availability of cash to fund our operations, and the continuation of normal payment terms and conditions
for purchase of our products. In light of these extenuating circumstances, there is no assurance that we will be successful in
growing and maintaining our business with our clients. If our clients or prospects are unable to obtain project financing and we
are unable to increase revenues, or otherwise generate cash flows from operations, we will not be able to successfully execute
on the various strategies and initiatives we have set forth in this Report to grow our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate magnitude of COVID-19, including
the extent of its impact on our financial and operational results, which could be material, will depend on the length of time that
the pandemic continues, its effect on the demand for our products and our supply chain, the effect of governmental regulations
imposed in response to the pandemic, as well as uncertainty regarding all of the foregoing. We cannot at this time predict the
full impact of the COVID-19 pandemic, but it could have a larger material adverse effect on our business, financial condition,
results of operations and cash flows beyond what is discussed within this Report.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><b>NOTE 12 &#8211; RISKS AND UNCERTAINTIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify"><u>Concentration Risk</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2019,
one vendor composed 24% of total purchases. During the year ended December 31, 2018, two unrelated vendors composed 18% and 11%
of total purchases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s primary suppliers of
automated environmental controls and fertigation represented 3% and 46% of total accounts payable outstanding as of December 31,
2019 and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2019,
one customer represented 21% of total revenue. During the year ended December 31, 2018, one customer represented 14% of total
revenue. At December 31, 2019, one customer represented 15% and another represented 11% of total outstanding accounts receivables.
At December 31, 2018, one customer represented 19% and another represented 13% of total outstanding receivables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Coronavirus Pandemic</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #000712">In December 2019, a novel
strain of coronavirus (COVID-19) was reported to have surfaced in Wuhan, China. In January 2020, this coronavirus spread to other
countries, including the United States, and efforts to contain the spread of this coronavirus intensified. In March 2020, the World
Health Organization declared the outbreak of the coronavirus a pandemic. We are a business that supplies other Essential Businesses
with support and supplies necessary to operate and we therefore are an Essential Business and allowed to continue operating under
Stay-At-Home Orders issued by many states and cities. However, the extent to which the coronavirus impacts our results will depend
on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning
the severity of the coronavirus and the actions to contain the coronavirus or treat its impact. The outbreak and any preventative
or protective actions that governments or we may take in respect of this coronavirus may result in a period of business disruption,
reduced customer business and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but
may materially affect our business, financial condition, results of operations, and cash flows. Effects from the COVID-19 pandemic
began in the latter portion of the first quarter of 2020; therefore, there was no impact to our 2019 results of operations, financial
condition and cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256103752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8211; STOCK-BASED COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock-based compensation expense for the
nine months ended September 30, 2020 and 2019 was $1,391,807 and $1,606,355, respectively, based on the vesting schedule of the
stock grants and options. Stock based compensation expense for the three months ended September 30, 2020 and 2019 was $399,258
and $509,219, respectively, based on the vesting schedule of the stock grants and options. No cash flow effects are anticipated
for stock grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2017, the Company began granting
Common Stock to attract, retain, and reward employees. In January 2018, the Company implemented an equity incentive plan to reward
and attract employees and directors and compensate vendors for services when applicable. In May 2019, the Company adopted a new
equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. This equity incentive
plan was approved by the Company&#8217;s shareholders on May 23, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock grants under the equity incentive
plans are valued at the price of the stock on the date of grant. The fair value of stock options granted under the equity incentive
plans is calculated using the Black-Scholes pricing model based on the estimated market value of the underlying stock at the valuation
measurement date, the remaining contractual term of the stock options, risk-free interest rate, and expected volatility of the
underlying Common Stock. There is a moderate degree of subjectivity involved when estimating the value of stock options with the
Black-Scholes option pricing model as the assumptions used are moderately judgmental. Stock grants and stock options are sometimes
offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. Stock grants and
stock options typically require a 1 to 3 year period of continued employment or service performance before the stock grant or stock
option vests.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Stock Grants:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows stock grant activity
for the nine months ended September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; font-size: 10pt; font-weight: bold">Grants outstanding as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 11%; font-size: 10pt; text-align: right">412,501</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Grants awarded</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">794,166</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Forfeiture/Cancelled</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(200,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Grants vested</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(253,333</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of September 30, 2020</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">753,334</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2020, the Company has
$393,215 in unrecognized share-based compensation expense related to these stock grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Stock Options:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">The following table shows stock
option activity for the nine months ended September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of <br /> Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br /> Average<br /> Remaining <br /> Life (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br /> Average <br /> Exercise <br /> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Stock options outstanding as of December 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,702,167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">9.21</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1.21</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(297,501</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">9.19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">1.21</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options outstanding at September 30, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,829,666</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">9.35</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.05</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options exercisable at September 30, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,437,578</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">8.88</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.12</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2020, the Company has
$1,919,523 in unrecognized share-based compensation expense related to these stock options. &#160;</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 13 &#8211; STOCK-BASED COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock-based compensation expense for the
years ended December 31, 2019 and 2018 was $1,830,426 and $1,245,826, respectively based on the vesting schedule of the stock grants
and options. During the year ended December 31, 2019, 1,361,966 shares vested and were issued to employees. No cash flow affects
are anticipated for stock grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2017, the Company began granting
stock to attract, retain, and reward employees with Common Stock. Stock grants are offered as part of the employment offer package,
to ensure continuity of employment or as a reward for performance. Each of these grants requires a specific tenure of employment
before the grant vests with typical vesting periods of 1 to 3 years of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2018, the Company implemented
an equity incentive plan to reward and attract employees and compensate vendors for services when applicable. Stock options are
offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. The stock option
plan authorizes 3,000,000 shares of common stock. 1,995,499 options have been awarded under the Plan as of December 31, 2019 and
1,259,000 options were awarded as of December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2019, the Company adopted a new
equity incentive plan, authorizing an aggregate of 3,500,000 shares of Common Stock for issuance thereunder. Stock grants under
the equity incentive programs are valued at the price of the stock on the date of grant. The fair value of the options is calculated
using the Black-Scholes pricing model based on the estimated market value of the underlying common stock at the valuation measurement
date $0.90, the remaining contractual term of the options of 10 years, risk-free interest rate of 2.75% and expected volatility
of the price of the underlying common stock of 100%. There is a moderate degree of subjectivity involved when using option pricing
models to estimate the options and the assumptions used in the Black Scholes option-pricing model are moderately judgmental. Stock
options and stock grants are sometimes offered as part of an employment offer package, to ensure continuity of service or as a
reward for performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following schedule shows stock grant
activity for the year ended December 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 67%; font-size: 10pt; font-weight: bold">Grants outstanding as of December 31, 2018</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">1,802,667</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Grants awarded</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">41,800</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-left: 10pt">Forfeiture/Cancelled</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(70,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Grants vested</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,361,966</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">412,501</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock grant
vesting periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 47%">
<tr style="vertical-align: bottom">
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Number of</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Unrecognized stock compensation</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: center">Year Ending</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">expense</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 13%; font-size: 10pt; text-align: right">264,167</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">142,552</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 13%; font-size: 10pt; text-align: center">2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">148,334</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">34,775</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">412,501</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">177,327</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">The following schedule shows
stock option activity for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of <br /> Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Remaining <br /> Life (Years)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average <br /> Exercise <br /> Price</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Stock options outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,184,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">9.68</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1.15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.38</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">218,332</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">9.12</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">1.33</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options outstanding at December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,702,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">9.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options exercisable at December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">703,538</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">8.89</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.17</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock option
vesting periods under the two stock options plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">Unrecognized stock compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Year Ending</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">540,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">359,521</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 11%; text-align: center">2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">408,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">48,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">2022</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">998,629</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">489,936</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255953816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Shareholder's Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholder's Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 &#8211; SHAREHOLDERS&#8217; EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2020, an executive left the Company
and returned 100,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its
issued and outstanding stock by 100,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In September 2020, a former executive who had
the right to receive 1,000,000 shares of Common Stock per the terms of his separation agreement that was reached in September 2019,
entered into an agreement with the Company to exchange the right to receive those 1,000,000 shares of Common Stock for the Company&#8217;s
ownership interest in TGH (see Note 5 &#8211; Investments) and a warrant to purchase 400,000 shares of the Company&#8217;s Common
Stock at $1.00 per share. The Company retired the shares and reduced its issued and outstanding stock by 1,000,000 shares.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 14 &#8211; SHAREHOLDERS&#8217;
EQUITY </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, an executive left the Company
and returned 375,000 common shares as part of the related separation agreement. The Company retired the shares and reduced its
issued and outstanding stock by 375,000 shares.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256993160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 - INCOME TAXES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes in
accordance with the asset and liability method prescribed in ASC 740, &#8220;Accounting for Income Taxes&#8221;. The Company has
adopted the provisions of ASC 740-10-25, which provides recognition criteria and a related measurement model for uncertain tax
positions taken or expected to be taken in income tax returns. ASC 740-10-25 requires that a position taken or expected to be taken
in a tax return be recognized in the financial statements when it is more likely than not that the position would be sustained
upon examination by tax authorities. Tax positions that meet the more likely than not threshold are then measured using a probability
weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate
settlement. The Company had no tax positions relating to open income tax returns that were considered to be uncertain. The Company
determined the valuation allowances are established when management determines is more likely than not that some portion or all
of the deferred tax asset will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company files income federal tax returns
in the United States and Canada and state and local tax return in applicable jurisdictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has experienced substantial
losses for both book and tax purposes since inception and has no tax provision for the years ended December 31, 2019 and 2018.
The potential future recovery of any tax assets that the Company may be entitled to due to these accumulated losses is uncertain
and these tax assets are fully reserved based on management&#8217;s current estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s estimated operating
loss carryforwards and expiration dates for tax purposes are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2016 - $1,618,386 expiring
in 2036</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2017 - $2,182,354 expiring
in 2037</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2018 - $3,060,443 no
expiration</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2019 - $6,819,954 no
expiration</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Realization of operating loss carryforwards
to offset future operating income for tax purposes are subject to various limitations including change of ownership and current
year taxable income percentage limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has no credit carryforwards
for tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s tax returns since inception
are subject to examination by taxing jurisdictions in the United States and Canada.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672254354040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"><b>NOTE 14 &#8211; WARRANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">Warrants are immediately exercisable
upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of shares</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted<br />
Average<br />
Exercise Price</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 68%"><font style="font-size: 10pt"><b>Warrants outstanding as of December 31, 2019</b></font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">692,034</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2.88</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Issued in conjunction with debt</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">124,481</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.41</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt"><font style="font-size: 10pt">Issued in conjunction with agreement with former executive (see Note 13 &#8211; Shareholders&#8217; Equity)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt"><b>Warrants outstanding as of September 30, 2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,216,515</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">2.21</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Warrants exercisable as of September 30, 2020</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,216,515</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2.21</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">The weighted-average life of the
warrants is 2.5 years. The aggregate intrinsic value of the warrants outstanding and exercisable at September 30, 2020 is $0.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 &#8211; WARRANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The following table shows warrant
activity for the years ended December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">December 31,</td>
    </tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td>
    </tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td>
    </tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-weight: bold">Warrants outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">6,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td>
    </tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Warrants issued in connection with convertible debenture offering (see Note 10):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    </tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to convertible debenture holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,134</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.00</td><td style="text-align: left">&#160;</td>
    </tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to 4Front as part of compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.41</td><td style="text-align: left">&#160;</td>
    </tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Warrants outstanding as of December 31, 2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">692,034</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    </tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Warrants exercisable as of December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">692,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.88</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    </tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The warrants issued to convertible
debenture holders expire June 24, 2021. The warrants issued to 4Front as part of compensation expire May 31, 2021. Warrants issued
to Mr. Lowe in 2018 expire March 31, 2023. The aggregate intrinsic value of the warrants outstanding and exercisable at December
31, 2019 is $0.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672254409672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"><b>NOTE 15 &#8211; SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management has assessed and determined that
no significant subsequent events are to be disclosed according to ASC 855.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><b>NOTE 17 &#8211; SUBSEQUENT
EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify"><b>Credit Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 21, 2020, we entered into a
letter agreement (the &#8220;Credit Agreement&#8221;) by and among the Company, as borrower, urban-gro Canada Technologies Inc.
and Impact Engineering, Inc., as guarantors, the lenders party thereto (the &#8220;Lenders&#8221;), and Bridging Finance Inc.,
as administrative agent for the Lenders (the &#8220;Agent&#8221;). The Credit Agreement, which is denominated in Canadian dollars
(C$), is comprised of (i) a 12-month senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which
was funded in its entirety on the closing date (the &#8220;Term Loan&#8221;); and (ii) a 12-month demand revolving credit facility
of up to C$5.4 million ($4.0 million), which may be drawn from time to time, subject to the terms and conditions set forth in the
Credit Agreement and described further below (the &#8220;Revolving Facility,&#8221; and together with the Term Loan, &#8220;the
Facilities&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final maturity date of the Facilities
will be the earlier of (i) demand, and (ii) the date that is 12 months after the closing date, with a potential extension to the
date that is 24 months after the closing date (the &#8220;Maturity Date&#8221;). The Facilities will bear interest at the annual
rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11% per annum. Accrued interest on the outstanding
principal amount of the Facilities will be due and payable monthly in arrears, on the last business day of each month, and on the
Maturity Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Facility may be borrowed
and re-borrowed on a revolving basis by us during the term of the Facilities, provided that borrowings under the Revolving Facility
will be limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable, (ii) 85% of investment
grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser of C$4.05 million
($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts and (B) 85%
of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility may be
prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan may be prepaid in
full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions. As of April
30, 2020, C$0.4 million ($0.3 million) of the Revolving Facility was available for future borrowings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company utilized a portion of the proceeds
from the Term Loan to refinance existing indebtedness, including a $2.0 million loan with Hydrofarm. The Company terminated the
Hydrofarm loan concurrently with the closing of the transactions contemplated by the Credit Agreement. Remaining proceeds from
the Facilities are expected to be used (i) to pay down existing debt obligations and (ii) for general working capital purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The obligations of the Company under the
Facilities will be secured on a first lien basis (subject to certain permitted liens as set forth in the Credit Agreement) by substantially
all of the assets of the Company and certain wholly-owned subsidiaries of the Company, as well as a limited recourse personal guarantee
of Bradley Nattrass, the Chief Executive Officer of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Credit Agreement also contains customary
provisions, representations, warranties and events of default for facilities of this nature and affirmative and negative covenants,
including without limitation, covenants relating to maintenance of collateral, reorganization and change of control transactions,
creation of liens and incurrence of indebtedness.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Amendment of Promissory Note and Subordination
Agreement</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the execution of the
Credit Agreement, the Company entered into an agreement to amend the promissory note (the &#8220;Promissory Note&#8221;) dated
October 18, 2018, as amended on May 20, 2019, between the Company and Cloud9 Support Inc., an entity owned 100% by James Lowe,
a director of the Company (the &#8220;Amending Agreement&#8221;). Pursuant to the Amending Agreement, Mr. Lowe agreed to extend
the maturity date of the promissory note from December 31, 2019 to the date which is the earlier of 60 days following the date:
(a) on which demand for repayment is made by the Lender under the Credit Agreement; or (b) which is the Maturity Date of the Credit
Agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672325036632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Goodwill (Sept 2020 Note)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; GOODWILL </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded goodwill in conjunction
with the initial acquisition of Impact on March 7, 2019. The goodwill balance as of September 30, 2020 and December 31, 2019 was
$902,067. Goodwill is not amortized. There is no goodwill for income tax purposes. The Company did not record any impairment charges
related to goodwill for the periods ended September 30, 2020 and 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256816584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Debt (Sept 2020 Note)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 &#8211; DEBT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's borrowings as of September 30,
2020 and December 31, 2019 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Revolving Facility</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3,276,493</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Term Loan, net of $315,402 unamortized debt issuance costs</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,684,598</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,961,091</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;Less current debt due within one year</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(2,196,280</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total long-term debt</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,764,811</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 21, 2020, we entered into a letter
agreement (the &#8220;Credit Agreement&#8221;) by and among the Company, as borrower, urban-gro Canada Technologies Inc. and Impact.,
as guarantors, the lenders party thereto (the &#8220;Lenders&#8221;), and Bridging Finance Inc., as administrative agent for the
Lenders (the &#8220;Agent&#8221;). The Credit Agreement, which is denominated in Canadian dollars (C$), is comprised of (i) a 12-month
senior secured demand term loan facility in the amount of C$2.7 million ($2.0 million), which was funded in its entirety on the
closing date (the &#8220;Term Loan&#8221;); and (ii) a 12-month demand revolving credit facility of up to C$5.4 million ($4.0 million),
which may be drawn from time to time, subject to the terms and conditions set forth in the Credit Agreement and described further
below (the &#8220;Revolving Facility,&#8221; and together with the Term Loan, the &#8220;Facilities&#8221;). The Credit Agreement
is personally guaranteed by the Company&#8217;s CEO and Chairman, Brad Nattrass, and was to be in place for the original term of
the Credit Agreement (1 year) plus a 1-year extension period at the discretion of the Lender as provided in the Credit Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final maturity date of the Facilities
was initially stipulated in the Credit Agreement as the earlier of (i) demand, and (ii) the date that is 12 months after the closing
date, with a potential extension to the date that is 24 months after the closing date (the &#8220;Initial Maturity Date&#8221;).
The Facilities bore interest at the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 11%
per annum. Accrued interest on the outstanding principal amount of the Facilities is due and payable monthly in arrears, on the
last business day of each month, and on the Initial Maturity Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Facility could initially
be borrowed and re-borrowed on a revolving basis by the Company during the term of the Facilities, provided that borrowings under
the Revolving Facility were limited by a loan availability formula equal to the sum of (i) 90% of insured accounts receivable,
(ii) 85% of investment grade receivables, (iii) 75% of other accounts receivable, (iv) 50% of eligible inventory, and (v) the lesser
of C$4.05 million ($3.0 million) and (A) 75% of uncollected amounts on eligible signed equipment orders for equipment systems contracts
and (B) 85% of uncollected amounts on eligible signed professional services order forms for design contracts. The Revolving Facility
may be prepaid in part or in full without a penalty at any time during the term of the Facilities, and the Term Loan may be prepaid
in full or in part without penalty subject to 60 days prior notice in each case subject to certain customary conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 4, 2020, the Company executed
an amendment to the Credit Agreement (the &#8220;First Amendment&#8221;) whereas the Facilities described above are now due on
December 31, 2021 (the &#8220;Revised Maturity Date&#8221;). The First Amendment also increased the rate at which the Facilities
will bear interest to the annual rate established and designated by the Bank of Nova Scotia as the prime rate, plus 12% per annum
(14.5% as of September 30, 2020).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the First Amendment, the
Company is required to prepay, on or before January 31, 2021, $1,000,000 of the balance of the Term Loan and begin making monthly
payments of $100,000 on the balance on the Term Loan starting on March 1, 2021. Additionally, the Company is required to make monthly
payments of $50,000 on the balance under the Revolving Facility beginning October 1, 2020 and can make no more draws under the
Revolving Facility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurred $1,314,868 of debt
issuance costs in connection with these Facilities, of which $676,822 was non-cash in the form of Common Stock and warrant issuances.
The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing
based on the market value of the underlying Common Stock at the valuation measurement date of $1.00, the remaining contractual
terms of the warrants of 5 years, risk free interest rate of 1.14% an expected volatility of the price of the underlying Common
Stock of 100%. The Company recorded the debt issuance costs as either a deferred financing asset or a direct reduction of the loan
obligation based on the pro-rata value of the Revolving Facility and Term Loan, respectively, on the closing date. The debt issuance
costs are amortized as interest expense over the life of the Facilities, until the Revised Maturity Date. As of September 30, 2020,
there were $630,805 and $315,402 of unamortized debt issuance costs remaining related to the Revolving Facility and Term Loan,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded interest expense
of $1,057,501 in the nine months ended September 30, 2020, of which $368,661 related to the amortization of debt issuance costs
on the Credit Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company
recorded interest expense of $374,850 in the nine months ended September 30, 2019. The Company recorded interest expense of $393,158
in the three months ended September 30, 2020, of which $164,941 related to the amortization of debt issuance costs on the Credit
Agreement. Excluding interest expense related to the amortization of convertible debentures of $796,233, the Company recorded
interest expense of $125,733 in the three months ended September 30, 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672246013656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock', window );">Unaudited Condensed Consolidated Financial Statements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Unaudited Condensed Consolidated Financial
Statements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has prepared the accompanying condensed
consolidated financial statements pursuant to the rules and regulations of the SEC for condensed financial reporting. The condensed
consolidated financial statements are unaudited and, in the Company&#8217;s opinion, include all adjustments, consisting of normal
recurring adjustments and accruals necessary for a fair presentation of the Company&#8217;s condensed consolidated balance sheets,
condensed consolidated statements of operations and comprehensive income (loss), condensed consolidated statements of shareholders&#8217;
deficit and condensed consolidated statements of cash flows for the periods presented. The results reported in these condensed
consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire
year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting
principles generally accepted in the United States (&#8220;GAAP&#8221;) have been omitted in accordance with regulations of the
SEC. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto
included in the Company&#8217;s consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year
ended December 31, 2019.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_SignificantAccountingPoliciesPolicyTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Significant Accounting Policies</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For a detailed discussion about the Company&#8217;s
significant accounting policies, refer to Note 2 &#8212; &#8220;Summary of Significant Accounting Policies,&#8221; in the Company&#8217;s
consolidated financial statements included in the Company&#8217;s 2019 Form 10-K. During the nine months ended September 30, 2020,
there were no material changes made to the Company&#8217;s significant accounting policies.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing condensed consolidated financial
statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements
and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include
estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for deferred
tax assets, and allowance for bad debt.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing consolidated financial
statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of assets and liabilities at the date of the consolidated financial statements
and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates
include estimated useful lives and potential impairment of long-lived assets and goodwill, inventory write offs, allowance for
deferred tax assets, and allowance for bad debt.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Basis of Presentation and Principles
of Consolidation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are presented in United States dollars and they include the accounts of urban-gro, Inc. and its wholly-owned subsidiaries. The
financial results of Impact have been included in the Company&#8217;s consolidated financial statements from the date of acquisition
on March 7, 2019 and all intercompany transactions have been eliminated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Recently Issued Accounting Pronouncements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &#8220;FASB&#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&#34;ASU&#34;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&#8217;s financial statements upon adoption.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional and reporting currency and foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Functional and reporting currency and
foreign currency translation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency of
the Company and its subsidiaries is US dollars. All transactions in currencies other than US dollars are translated into US dollars
on the date of the transaction. Any exchange gains and losses related to these transactions are recognized in the current period&#8217;s
earnings as other income (expense).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify">The Company&#8217;s financial instruments
consist principally of cash and cash equivalents, accounts receivable, accounts payable, notes payable and other current assets
and liabilities. We value our financial assets and liabilities using fair value measurements. Fair value is based on the price
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable
in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy
is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three
levels (with Level 3 being the lowest) defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Level 1:&#160;Quoted prices in active markets for identical
assets or liabilities that the entity has the ability to access.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify">Level 2:&#160;Observable inputs other
than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for
identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated
with observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt; text-align: justify">Level 3:&#160;Unobservable inputs
that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This
includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: justify">The carrying amount of our cash and
cash equivalents, accounts receivable, accounts payable, and other current assets and liabilities in our consolidated financial
statements approximates fair value because of the short-term nature of the instruments. Investments in non-marketable equity securities
are carried at cost less other-than-temporary impairments. The carrying amount of our notes payable and convertible debt at December
31, 2019 and December 31, 2018 approximates their fair values based on our incremental borrowing rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no changes in Level 1,
Level 2, and Level 3 categorizations and no changes in valuation techniques for these assets or liabilities for the years ended
December 31, 2019 and 2018.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Cash and Cash Equivalents</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly
liquid short-term cash investments with an original maturity of three months or less to be cash equivalents. As of December 31,
2019 and 2018, the Company did not maintain any cash equivalents. The Company maintains cash with financial institutions that
may from time to time exceed federally-insured limits. The Company has not experienced any losses related to these balances and
believes the risk to be minimal. There are no restricted or compensating cash balances as of December 31, 2019.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Accounts Receivable, Net</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivables are carried
at the original invoiced amounts less an allowance for doubtful accounts. As of December 31, 2019 and 2018, the balance of allowance
for doubtful accounts was $18,920. The allowances for doubtful accounts are calculated based on a detailed review of certain individual
customer accounts and an estimation of the overall economic conditions affecting the Company's customer base. The Company reviews
a customer's credit history before extending credit to the customer. If the financial condition of its customers were to deteriorate,
resulting in an impairment of their ability to make payments, additions to the allowance would be required. A provision is made
against accounts receivable to the extent they are considered unlikely to be collected. Occasionally the Company will write off
bad debt directly to the bad debt expense account when the balance is determined to be uncollectable. Bad debt expense for the
years ended December 31, 2019 and 2018 was $67,633 and $106,464, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Inventories</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, consisting entirely of finished
goods, are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost
method. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based
on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold at the realization of change
in value. Once written down, inventories are carried at this lower basis until sold or scrapped.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Property and Equipment </u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">Property and equipment is stated at
cost less accumulated depreciation and impairment. Expenditures for major additions and improvements are capitalized and minor
replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise
disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated)
for tax purposes where appropriate. No impairment charges were recorded for the years ended December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives for significant property and equipment
categories are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Computer and Technology Equipment</font></td>
    <td style="width: 23%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Furniture and Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Leasehold Improvements</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Lease term</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vehicles</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 or 5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Software</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Operating Lease Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Operating Lease Right of Use Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease right of use assets are
stated at cost less accumulated depreciation, amortization and impairment. The Company has two operating leases with an imputed
annual interest rate of 8%. The terms of the first lease are 24 months commencing on September 1, 2018 and ending on August 31,
2020. The terms of the second lease are 28 months commencing on September 1, 2019 and ending December 31, 2021. Operating lease
right of use asset costs incurred in 2019 were $123,563.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Convertible Notes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its convertible
notes at issuance by allocating the proceeds received from a convertible note among freestanding instruments according to ASC
470, Debt, based upon their relative fair values. The fair value of debt and common stock is determined based on the closing price
of the common stock on the date of the transaction, and the fair value of warrants, if any, is determined using the Black-Scholes
option-pricing model. Convertible notes are subsequently carried at amortized cost. The fair value of the warrants is recorded
as additional paid-in capital, with a corresponding as a debt discount from the face amount of the convertible note. Each convertible
note is analyzed for the existence of a beneficial conversion feature (&#8220;BCF&#8221;), defined as the fair value of the common
stock at the commitment date for the convertible note, less the effective conversion price. Beneficial conversion features are
recognized at their intrinsic value, and recorded as an increase to additional paid-in capital, with a corresponding reduction
in the carrying amount of the convertible note (as a debt discount from the face amount of the convertible note). The discounts
on the convertible notes, consisting of amounts ascribed to warrants and beneficial conversion features, are amortized to interest
expense, using the effective interest method, over the terms of the related convertible notes. Beneficial conversion features
that are contingent upon the occurrence of a future event are recorded when the contingency is resolved.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Intangible Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s intangible assets,
consisting of legal fees for application of patents and trademarks and license fees paid for inspection services, are recorded
at cost. Patents and trademarks, once approved, will be amortized using the straight-line method over an estimated life, generally
5 years for patents and 10 to 20 years for trademarks. License fees are amortized over 10 years. Intangible assets are included
in &#8220;other assets&#8221; on the balance sheets. The net balance of intangible assets for December 31, 2019 and 2018 was $86,151
and $63,755, respectively. Amortization expense totaled $1,879 and $974 for the years ended December 31, 2019 and 2018, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Goodwill</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the purchase
price over the fair value of net assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment
annually as of December 31st and at any time when events or circumstances suggest impairment may have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The testing for impairment consists of
a comparison of the fair value of with its carrying amount. If the carrying amount of the reporting unit, including goodwill, exceeds
the fair value, an impairment will be recognized equal to the difference between the carrying value of the reporting unit goodwill
and the implied fair value of the goodwill. In testing goodwill for impairment, we determine the estimated fair value of our reporting
units based upon a discounted future cash flow analysis. Goodwill is our only indefinite-lived intangible asset. Definite-lived
intangible assets are amortized using the straight line method over the shorter of their contractual term or estimated useful lives.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Impairment of Long-lived Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates potential impairment
of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result
from the use and eventual disposition of the asset. An impairment will be recognized as the amount by which the carrying amount
of a long-lived asset exceeds its fair value.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Investments</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments without readily determinable
fair values and for which the Company does not have the ability to exercise significant influence are accounted for at cost with
adjustments for observable changes in prices or impairments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Revenue Recognition</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance
with ASC 606, <i>Revenue from Contracts with Customers,</i> which requires that five basic steps be followed to recognize revenue:
(1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance
obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration
given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance
obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration
given to whether that control happens&#160;over time&#160;or not. Determination of criteria (3) and (4) are based on our management's
judgments regarding the fixed nature of the selling prices of the services and products delivered and the collectability of those
amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our service and product revenues arise
from contracts with customers. Service revenues include full facility programming, engineering and design services, start-up commissioning
services, facility optimization services and IPM planning and strategy services. Product revenues include an integrated suite of
select cultivation equipment systems and crop management products. We enter into separate contracts for the service and product
revenues we provide to our customers so to clarify our obligations under the terms of the contracts. New contracts are entered
into if the services to be performed or products to be delivered need to be modified. Service revenues are satisfied when services
are rendered or completed in accordance with the terms of the contract. Product revenues are satisfied when control of the products
is transferred to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues for services and products for
the year ended December 31, 2019 were $3,167,237 and 21,022,566, respectively. Revenues for services and products for the year
ended December 31, 2018 were $928,063 and $19,122,713, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Customer Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Customer Deposits</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s policy is to collect
deposits from customers at the beginning of the contract. The customer payments received are recorded as a customer deposit liability
on the balance sheet. When the contract is complete and meets all the criteria for revenue recognition, the customer is billed
for the entire contract amount and the deposit is recorded against the customer&#8217;s receivable balance. In certain situations
when the customer has paid the deposit and services have been performed but the customer chooses not to proceed with the contract,
the Company may keep the deposit and recognize revenue.&#160;Of the outstanding customer deposit balance of $3,298,609 at December
31, 2018, $2,678,565 was recognized as revenue in the year ended December 31, 2019. At December 31, 2017, the entire customer
deposit balance of $3,151,250 was recognized as revenue in the year ended December 31, 2018.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Cost of Revenue</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s policy is to recognize
cost of revenues in the same manner as, and in conjunction with, revenue recognition. The Company&#8217;s cost of revenues includes
the costs directly attributable to revenue recognized and includes expenses related to the purchasing of products and providing
services, fees for third-party commissions and shipping costs. Total shipping costs included in the cost of goods sold for the
years ended December 31, 2019 and 2018 was $679,911 and $490,526, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Advertising Costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertisings costs
in the periods the costs are incurred. Prepayments made under contracts are included in prepaid expenses and expensed when the
advertisement is run. Total advertising expense incurred for the years ended December 31, 2019 and 2018 was $159,728 and $153,878,
respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Warrants</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The Company accounts for its
warrants issued in accordance with the GAAP accounting guidance under ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;.
The Company estimated the fair value of these warrants at the respective balance sheet dates using the Black-Scholes option pricing
based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual
term, risk-free interest rate, and expected volatility of the price of the underlying common stock. There is a moderate degree
of subjectivity involved when using option pricing models to estimate the warrants and the assumptions used in the Black-Scholes
option-pricing model are moderately judgmental.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Stock-Based Compensation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically issue shares of
its common stock to employees and consultants in non-capital raising transactions for fees and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock issued to
non-employees with the value of the stock compensation based upon the measurement date as determined at the grant date of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock grants issued
and vesting to employees with the award being measured at its fair value at the date of grant and amortized ratably over the vesting
period. The Company also estimates forfeitures at the time of grant and revises those estimates in subsequent periods if actual
forfeitures differ from its estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Income Taxes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company files
income federal tax returns in the United States and Canada and state and local tax return in applicable jurisdictions. Provisions
for current income tax liabilities, if any, would be calculated and accrued on income and expense amounts expected to be included
in the income tax returns for the current year. Income taxes reported in earnings, if any, would also include deferred income tax
provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred income
tax assets and liabilities, if any, would be computed on differences between the financial statement bases of assets and liabilities
at the enacted tax rates. Changes in deferred income tax assets and liabilities would be included as a component of income tax
expense. The effect on deferred income tax assets and liabilities attributable to changes in enacted tax rates would be charged
or credited to income tax expense in the period of enactment. Valuation allowances would be established for certain deferred tax
assets when realization is not likely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Assets and liabilities
would be established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions,
in the judgement of the Company, do not meet a more-likely-than-not threshold based on the technical merits of the positions. Valuation
allowances would be established for certain deferred tax assets when realization is not likely.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Loss Per Share</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes net loss per share
by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period.
Diluted earnings per share would be computed by dividing net loss by the weighted-average of all potentially dilutive shares of
common stock that were outstanding during the periods presented. The diluted earnings per share calculation is not presented as
it results in an anti-dilutive calculation of net loss per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treasury stock method would be used
to calculate diluted earnings per share for potentially dilutive stock options and share purchase warrants. This method assumes
that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase
common shares at the average market price for the period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Reclassifications', window );">Reclassification</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Reclassification</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified
for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronoucements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recently Issued Accounting Pronouncements</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, the Financial Accounting
Standards Board (the &#8220;FASB&#8221;) or other standards setting bodies issue new accounting pronouncements. The FASB issues
updates to new accounting pronouncements through the issuance of an Accounting Standards Update (&#34;ASU&#34;). Unless otherwise
discussed, the Company believes that the impact of recently issued guidance, whether adopted or to be adopted in the future, is
not expected to have a material impact on the Company&#8217;s financial statements upon adoption.</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Recently Adopted Accounting Pronouncements</u>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued an Accounting
Standards Update (&#8220;ASU&#8221;) amending the accounting for leases. The new guidance requires the recognition of lease assets
and liabilities for operating leases with terms of more than 12 months, in addition to those currently recorded, on the Company&#8217;s
consolidated balance sheets. Presentation of leases within the consolidated statements of operations and comprehensive loss and
consolidated cash flows will be generally consistent with the prior lease accounting guidance. The ASU was effective for reporting
periods beginning after December 15, 2018, with early adoption permitted. The Company adopted the ASU effective January 1, 2019
under the modified retrospective method with respect to lease contracts in effect as of the adoption date. The adoption of the
ASU increased our assets and liabilities by $326,095 in 2019 due to the recognition of right of use assets and lease liabilities
with respect to operating leases.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_SignificantAccountingPoliciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_SignificantAccountingPoliciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unaudited Condensed Consolidated Financial Statements [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_UnauditedCondensedConsolidatedFinancialStatementsPolicyTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Reclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Reclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=SL6953423-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5033-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5212-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5093-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256045608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock', window );">Acquisition of Impact Engineering</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for the initial acquisition
of Impact as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 77%"><font style="font-size: 10pt">Purchase Price</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Allocation of Purchase Price:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Cash</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">49,742</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accounts receivable, net</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">93,811</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Goodwill</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">902,067</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accrued expenses</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">45,620</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has initially accounted for the acquisition of Impact as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%">Purchase Price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Allocation of Purchase Price:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">49,742</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">93,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">902,067</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45,620</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672252888568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock', window );">Property, plant and equipment useful lives</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives for significant property and equipment
categories are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Computer and Technology Equipment</font></td>
    <td style="width: 23%"><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Furniture and Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Leasehold Improvements</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Lease term</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vehicles</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other Equipment</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 or 5 years</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Software</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">3 years</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of property, plant and equipment useful lives</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256121256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. Prepayments and Advances (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of prepaid balances</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">The prepaid balances are summarized
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Vendor prepayments</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,828,531</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,070,788</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Prepaid services and fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">268,655</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">187,912</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Deferred financing asset (See Note 9 - Debt)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">630,805</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Other assets</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">6,391</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">20,028</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Prepayments and other assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,734,382</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,278,728</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">The prepaid balances are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Vendor Prepayments</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,070,788</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">776,478</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Prepaid Services and Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">187,912</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">152,204</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Prepayments and Advances</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,258,700</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">928,682</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672254430088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Property Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property Plant and Equipment balances are
summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Computers &#38; Technology Equip</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">87,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">61,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture and Fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,162</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Leasehold Improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">164,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143,215</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,414</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132,875</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,783</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">R&#38;D Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,031</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,140</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(370,376</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(309,975</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property plant and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">165,035</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">441,141</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256983112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock', window );">Cost Method Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The components of investments are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>September 30,</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2020</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, <br />
2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Investment in Edyza</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Investment in TGH</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">310,000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,020,358</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The changes in the components of the Investments for the years
ended December 31, 2019 and 2018 are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="11" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31, 2019</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Edyza</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>TGH</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 58%"><font style="font-size: 10pt">Beginning Balances as of 1/1/2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">812,883</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">448,766</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,261,649</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Purchase of additional shares under SPOA</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">897,475</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">897,475</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Initial purchase of Membership interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">367,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">367,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with first option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Impairment of investment</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(505,766</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(505,766</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Ending Balances as of 12/31/2019</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,710,358</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">310,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,020,358</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="11" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31, 2018</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Edyza</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>TGH</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 58%"><font style="font-size: 10pt">Beginning Balances as of 1/1/2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-indent: -10pt; padding-left: 10pt"><font style="font-size: 10pt">Purchase of additional shares under SPOA, including $75,000 reflected in Accrued Expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Initial purchase of Membership Interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">125,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with first option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">150,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Additional Membership interest purchased with second option</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">158,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">158,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,883</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">15,766</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">28,649</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Ending Balances as of 12/31/2018</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">812,883</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">448,766</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,261,649</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A tabular disclosure of (a) the aggregate carrying amount of all cost-method investments; (b) the aggregate carrying amount of cost-method investments that the investor did not evaluate for impairment for cost-method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256012200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accrued expenses are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Accrued operating expenses</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">798,752</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">854,056</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accrued wages and related expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">402,710</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">487,327</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Accrued interest expense</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,635</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Accrued sales tax payable</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">616,999</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">345,458</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,863,096</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,686,841</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses are summarized as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Accrued operating expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">854,056</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">240,941</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued wages and related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">490,961</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,958</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accrued sales tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">345,458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">401,282</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,686,841</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,144,142</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256118600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Notes Payable and Operating Lease Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of notes payable</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 72%"><font style="font-size: 10pt">Unsecured, interest only, note payable with Chris Parkes originally due
    December 31, 2018. Initial interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018
    extending the maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the
    interest rate was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the
    interest rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making
    monthly principal payments in the amount of $10,000.</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">20,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">80,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.
    Initial interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the
    maturity date to March 31, 2019. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate
    was decreased to an annual rate of 9%. In consideration for extending the due date of the note and reducing the interest
    rate, the Company issued the holder 3,000 shares of Common Stock. Beginning in April 2020, the Company is making monthly
    principal payments in the amount of $10,000.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">40,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Note payable with Hydrofarm Holdings Group, Inc. (&#8220;Hydrofarm&#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023. The note was repaid in full on February 27, 2020.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,000,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matured on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments. The note was repaid in full on February 27, 2020.</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">632,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Paycheck Protection Program (&#8220;PPP&#8221;) loan entered into on April 16, 2020. Interest rate of 1.0% per annum. Payments of principal and interest are deferred until August 1, 2021 (the &#8220;Deferral Period&#8221;). The PPP loan may be forgiven in part or fully depending on the Company meeting certain PPP loan forgiveness guidelines. The Company has not yet determined if any of the PPP loan is subject to forgiveness and has therefore continued to present the entire PPP loan as an obligation on its financial statements. Any unforgiven portion of the PPP loan is payable over a two-year term, with payments deferred during the Deferral Period. The Company may prepay the unforgiven loan balance at any time without payment of any premium.</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,020,600</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,080,600</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,812,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Less current maturities</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(60,00</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(2,812,709</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Long Term</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,020,600</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Unsecured, interest only, note payable with Chris Parkes originally due December 31,
    2018. Interest payments due monthly at an annual rate of 20.4%. Note payable revised in December 2018 extending the maturity
    date to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was
    decreased to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate,
    the Company issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">80,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">80,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Unsecured, interest only, note payable with David Parkes originally due December 31, 2018.
    Interest payments due monthly at an annual rate of 18.0%. Note payable revised in December 2018 extending the maturity date
    to March 31, 2020. During August 2019, the maturity date was extended to March 31, 2020 and the interest rate was decreased
    to an annual rate of 9%. In consideration for extending the due date of the Note and reducing the interest rate, the Company
    issued the Holder 3,000 shares of Common Stock. Beginning of March 31, 2020, the Company has made monthly payments in the amount of $10,000</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Unsecured, interest only, note payable with Michael S. Bank originally due April 30, 2019. Interest at 19.8% per year is paid twice per month. The note contains a demand re-payment provision that can be executed by Mr. Bank at any time by providing a one-time notice. The Company may re-pay any part or the entire principal sum at any time with penalty and abatement of interest expense from date of early payment. The note includes six thousand warrants, each exercisable to purchase one share of the Company's Common Stock at a price of $1.00 per share. In March 2019, the Company repaid $35,000 of the principal and extended the maturity date to April 30, 2019. The note was repaid in full on April 30, 2019.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">298,869</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Note payable with Hydrofarm Holdings Group, Inc. (&#8220;Hydrofarm&#8221;), secured by all currently existing and future assets. Interest accrues at 8.0% per year and is paid quarterly. The note matures on the earlier of: (a) 90 days&#8217; notice from Hydrofarm; (b) acceleration of the note payable due to the Company being in default; or (c) December 2023.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Secured agreement to sell future receivables to GCF Resources, LLC, net of $30,000 in closing fees. The agreement requires 32 weekly payments of $42,190 totaling $1,350,000. The agreement matures on May 7, 2020 but is repayable prior to maturity for less than the $1,350,000 in total payments.</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">632,709</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,812,709</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,478,869</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less current maturities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,812,709</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,478,869</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's borrowings as of September 30,
2020 and December 31, 2019 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 64%"><font style="font-size: 10pt">Revolving Facility</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3,276,493</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">Term Loan, net of $315,402 unamortized debt issuance costs</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,684,598</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,961,091</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;Less current debt due within one year</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(2,196,280</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total long-term debt</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,764,811</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672252852664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Schedule of operating lease liability</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of operating
lease liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,<br /> 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,<br /> 2018</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; text-align: left">Operating lease liabilities related to right of use assets.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">222,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(123,395</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">98,841</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future minimum operating lease payments</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 44%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year ending</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Minimum</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Lease Payments</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 20%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">177,688</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">91,688</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118943654&amp;loc=d3e12069-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164451&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672414860888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Schedule of stock grant activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows stock grant activity
for the nine months ended September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; font-size: 10pt; font-weight: bold">Grants outstanding as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 11%; font-size: 10pt; text-align: right">412,501</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Grants awarded</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">794,166</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Forfeiture/Cancelled</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(200,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Grants vested</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(253,333</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of September 30, 2020</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">753,334</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following schedule shows stock grant activity for the year ended December 31, 2019</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 45%; font-weight: bold">Grants outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,802,667</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Grants awarded</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,800</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Forfeiture/Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70,000</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Grants vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,361,966</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Grants outstanding as of December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">412,501</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock', window );">Schedule of stock grant vesting periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock grant
vesting periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">Unrecognized stock compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Year Ending</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"> expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">264,167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">142,552</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 11%; text-align: center">2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">148,334</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">34,775</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">412,501</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177,327</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">The following table shows stock option
activity for the nine months ended September 30, 2020:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of <br />
Shares</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted<br />
Average<br />
Remaining <br />
Life (Years)</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted<br />
Average <br />
Exercise <br />
Price</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 52%"><font style="font-size: 10pt"><b>Stock options outstanding as of December 31, 2019</b></font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,702,167</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">9.21</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1.21</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,425,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#8211;</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">(297,501</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">9.19</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">1.21</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Stock options outstanding at September 30, 2020</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,829,666</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">9.35</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.05</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Stock options exercisable at September 30, 2020</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,437,578</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.88</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.12</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">The following schedule shows stock option activity for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <br /> Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Remaining <br /> Life (Years)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average <br /> Exercise <br /> Price</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Stock options outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,184,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">9.68</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1.15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.38</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">218,332</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">9.12</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">1.33</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options outstanding at December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,702,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">9.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.21</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Stock options exercisable at December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">703,538</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">8.89</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">1.17</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock', window );">Schedule of stock option vesting periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes stock option
vesting periods under the two stock options plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 41%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">Unrecognized stock compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Year Ending</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"> expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">540,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">359,521</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 11%; text-align: center">2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">408,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">48,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">2022</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">998,629</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">489,936</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of stock grant vesting periods [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ScheduleOfStockGrantVestingPeriodsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of stock option vesting periods [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ScheduleOfStockOptionVestingPeriodsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672257004168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrant activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">Warrants are immediately exercisable
upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt 0 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of shares</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted<br />
Average<br />
Exercise Price</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 68%"><font style="font-size: 10pt"><b>Warrants outstanding as of December 31, 2019</b></font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">692,034</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2.88</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Issued in conjunction with debt</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">124,481</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.41</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt"><font style="font-size: 10pt">Issued in conjunction with agreement with former executive (see Note 13 &#8211; Shareholders&#8217; Equity)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt"><font style="font-size: 10pt"><b>Warrants outstanding as of September 30, 2020</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,216,515</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">2.21</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Warrants exercisable as of September 30, 2020</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,216,515</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2.21</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">The following table shows warrant
activity for the years ended December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of shares</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>shares</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Warrants outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">6,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Warrants issued in connection with convertible debenture offering (see Note 10):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to convertible debenture holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,134</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Issued to 4Front as part of compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.41</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Warrants expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Warrants outstanding as of December 31, 2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">692,034</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Warrants exercisable as of December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">692,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.88</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672246197368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Acquisitions, Business Plan, and Liquidity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 07, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Allocation of Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 902,067<span></span>
</td>
<td class="nump">$ 902,067<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember', window );">Impact Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Allocation of Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">49,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable, net</a></td>
<td class="nump">93,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">902,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accrued expenses</a></td>
<td class="nump">$ 45,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245811384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 07, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,850,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,890,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,540,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,833,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,318,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,703,947)<span></span>
</td>
<td class="num">$ (6,604,564)<span></span>
</td>
<td class="num">(5,008,334)<span></span>
</td>
<td class="num">$ (5,265,472)<span></span>
</td>
<td class="num">$ (2,985,163)<span></span>
</td>
<td class="num">$ (3,826,551)<span></span>
</td>
<td class="num">$ (1,361,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,178,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember', window );">Impact Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued for acquisition, shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245851624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Details - Property and Equipment)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer and Technology Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">Lease term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Other Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">3 or 5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249111640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,920<span></span>
</td>
<td class="nump">18,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,849<span></span>
</td>
<td class="nump">$ 12,252<span></span>
</td>
<td class="nump">67,633<span></span>
</td>
<td class="nump">106,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,151<span></span>
</td>
<td class="nump">63,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,879<span></span>
</td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Shipping expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,563,594<span></span>
</td>
<td class="nump">13,892,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,728<span></span>
</td>
<td class="nump">153,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">$ 4,087,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,087,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,915,406<span></span>
</td>
<td class="nump">3,298,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Revenue recognized in current year accrued from prior year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,678,565<span></span>
</td>
<td class="nump">3,151,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">8,359,422<span></span>
</td>
<td class="nump">$ 5,583,064<span></span>
</td>
<td class="nump">16,625,688<span></span>
</td>
<td class="nump">17,056,737<span></span>
</td>
<td class="nump">24,189,803<span></span>
</td>
<td class="nump">20,050,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,910,540<span></span>
</td>
<td class="nump">4,633,974<span></span>
</td>
<td class="nump">15,135,472<span></span>
</td>
<td class="nump">14,469,616<span></span>
</td>
<td class="nump">3,167,237<span></span>
</td>
<td class="nump">21,022,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 448,882<span></span>
</td>
<td class="nump">$ 949,090<span></span>
</td>
<td class="nump">$ 1,490,216<span></span>
</td>
<td class="nump">$ 2,587,121<span></span>
</td>
<td class="nump">$ 928,063<span></span>
</td>
<td class="nump">19,122,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember', window );">First Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember', window );">Second Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">28 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Shipping expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 679,911<span></span>
</td>
<td class="nump">$ 490,526<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248968792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="nump">$ 9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,658<span></span>
</td>
<td class="nump">$ 122,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,972<span></span>
</td>
<td class="nump">18,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoMember', window );">Bravo and Enviro-Glo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,129<span></span>
</td>
<td class="nump">276,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,570<span></span>
</td>
<td class="nump">5,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member', window );">Cloud 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="nump">9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,659<span></span>
</td>
<td class="nump">79,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">13,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Related party cost of services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 24,368<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 75,617<span></span>
</td>
<td class="nump">97,329<span></span>
</td>
<td class="nump">84,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Related party sales</a></td>
<td class="nump">$ 112,405<span></span>
</td>
<td class="nump">$ 103,088<span></span>
</td>
<td class="nump">$ 359,562<span></span>
</td>
<td class="nump">$ 229,688<span></span>
</td>
<td class="nump">$ 392,963<span></span>
</td>
<td class="nump">273,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember', window );">James Lowe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt stated interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockOptionsIssuedForLoanTermRevisionsShares', window );">Stock Options Issued for loan term revisions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockOptionsIssuedForLoanTermRevisionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Options Issued for loan term revisions, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockOptionsIssuedForLoanTermRevisionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637345&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672329325144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. Prepayments and Advances (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and advances</a></td>
<td class="nump">$ 2,734,382<span></span>
</td>
<td class="nump">$ 1,258,700<span></span>
</td>
<td class="nump">$ 928,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember', window );">Vendor Prepayments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and advances</a></td>
<td class="nump">1,828,531<span></span>
</td>
<td class="nump">1,070,788<span></span>
</td>
<td class="nump">776,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember', window );">Prepaid Services and Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and advances</a></td>
<td class="nump">$ 268,655<span></span>
</td>
<td class="nump">$ 187,912<span></span>
</td>
<td class="nump">$ 152,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248329688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>5. Property Plant and Equipment, net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (370,376)<span></span>
</td>
<td class="num">$ (309,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 152,577<span></span>
</td>
<td class="nump">165,035<span></span>
</td>
<td class="nump">441,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer and Technology Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,300<span></span>
</td>
<td class="nump">61,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,518<span></span>
</td>
<td class="nump">30,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,072<span></span>
</td>
<td class="nump">143,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,414<span></span>
</td>
<td class="nump">132,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,721<span></span>
</td>
<td class="nump">233,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Research and Development Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,031<span></span>
</td>
<td class="nump">84,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Other Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,355<span></span>
</td>
<td class="nump">$ 65,140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255955352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Property Plant and Equipment, net (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 264,597<span></span>
</td>
<td class="nump">$ 153,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249701928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Beginning Balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,020,358<span></span>
</td>
<td class="nump">$ 1,261,649<span></span>
</td>
<td class="nump">$ 1,261,649<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">572,250<span></span>
</td>
<td class="nump">1,085,975<span></span>
</td>
<td class="nump">861,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 506,000<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="nump">506,000<span></span>
</td>
<td class="nump">505,766<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Ending Balances</a></td>
<td class="nump">1,710,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,020,358<span></span>
</td>
<td class="nump">1,261,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember', window );">Edyza [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Beginning Balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,358<span></span>
</td>
<td class="nump">812,883<span></span>
</td>
<td class="nump">812,883<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Ending Balances</a></td>
<td class="nump">$ 1,710,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,710,358<span></span>
</td>
<td class="nump">812,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember', window );">Edyza [Member] | Stock Purchase and Option Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">897,475<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember', window );">Total Grow Holdings Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Beginning Balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="nump">$ 448,766<span></span>
</td>
<td class="nump">448,766<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(505,766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Ending Balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="nump">448,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember', window );">Total Grow Holdings Cost [Member] | Initial Purchase of Membership Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 367,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember', window );">Total Grow Holdings Cost [Member] | Additional Membership Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember', window );">Total Grow Holdings Cost [Member] | Additional Membership Interest with Second Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_StockPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_StockPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowHoldingsCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_InitialPurchaseMembershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_InitialPurchaseMembershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_AddtlMembershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_AddtlMembershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_AddtlMembershipInterest2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_AddtlMembershipInterest2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672247999368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 572,250<span></span>
</td>
<td class="nump">$ 1,085,975<span></span>
</td>
<td class="nump">$ 861,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 1,863,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,863,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,686,841<span></span>
</td>
<td class="nump">1,144,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="nump">$ 506,000<span></span>
</td>
<td class="nump">$ 505,766<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaSensorsMember', window );">Edyza Sensors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockReceivedForAcquisitionShares', window );">Stock received for acquisition, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">827,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 897,475<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaSensorsMember', window );">Edyza Sensors [Member] | Stock Purchase and Option Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockReceivedForAcquisitionShares', window );">Stock received for acquisition, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockReceivedForAcquisitionValue', window );">Stock received for acquisition, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowControlsMember', window );">Total Grow Controls [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 505,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockReceivedForAcquisitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock received for acquisition, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockReceivedForAcquisitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockReceivedForAcquisitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock received for acquisition, value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockReceivedForAcquisitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaSensorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaSensorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_StockPurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_StockPurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowControlsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowControlsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672254356824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Other Assets (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 86,151<span></span>
</td>
<td class="nump">$ 63,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 1,879<span></span>
</td>
<td class="nump">$ 974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_PatentsIssued', window );">Number of patents | Integer</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_PatentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_PatentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672247929544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>8. Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 1,863,096<span></span>
</td>
<td class="nump">$ 1,686,841<span></span>
</td>
<td class="nump">$ 1,144,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember', window );">Accrued Operating Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">798,752<span></span>
</td>
<td class="nump">854,056<span></span>
</td>
<td class="nump">240,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember', window );">Accrued Wages and Related Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">402,710<span></span>
</td>
<td class="nump">487,327<span></span>
</td>
<td class="nump">490,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember', window );">Accrued Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">44,635<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember', window );">Accrued Sales Tax Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 616,999<span></span>
</td>
<td class="nump">$ 345,458<span></span>
</td>
<td class="nump">$ 401,282<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248084920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>9. Notes Payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">$ 1,080,600<span></span>
</td>
<td class="nump">$ 2,812,709<span></span>
</td>
<td class="nump">$ 2,478,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Notes payable, current maturities</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="num">(2,812,709)<span></span>
</td>
<td class="num">(2,478,869)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, long term</a></td>
<td class="nump">1,020,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">298,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member', window );">Note Payable 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">$ 1,020,600<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member', window );">Note Payable 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 632,709<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248224280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="nump">$ 596,075<span></span>
</td>
<td class="nump">$ 119,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares', window );">Stock issued in consideration for extending due date of note, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Periodic payment frequency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares', window );">Stock issued in consideration for extending due date of note, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Periodic payment frequency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member', window );">Note Payable 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member', window );">Note Payable 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  07,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares', window );">Stock issued in consideration for extending due date of note, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued in consideration for extending due date of note, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672246141592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Unit Offering (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted, amount converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_DebtConversionConvertedInterestAmount1', window );">Debt converted, interest converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt converted, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_DebtConversionConvertedInterestAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt converted, interest converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_DebtConversionConvertedInterestAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672252818616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 222,236<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability - current</a></td>
<td class="num">$ (80,339)<span></span>
</td>
<td class="num">(123,395)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability - noncurrent</a></td>
<td class="nump">$ 49,347<span></span>
</td>
<td class="nump">$ 98,841<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672344341448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Minimum future lease payment 2020</a></td>
<td class="nump">$ 177,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Minimum future lease payment 2021</a></td>
<td class="nump">$ 91,688<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672324999112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember', window );">First Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_LeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">Sep.  01,  2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Aug. 31,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease term</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember', window );">Second Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_LeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">Sep.  01,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease discount rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease term</a></td>
<td class="text">28 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_LeaseCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease commencement date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_LeaseCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_FirstLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=urgo_SecondLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672247928088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Risks and Uncertainties (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | One Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Second Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Bravo Lighting [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Cloud 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AutomatedFertigationMember', window );">Automated Fertigation Controls [Member] | Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember', window );">One Customer [Member] | Sales Revenue Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember', window );">One Customer [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherCustomerMember', window );">Another Customer [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_AnotherVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_AnotherVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_BravoLightingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_BravoLightingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_Cloud9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_Cloud9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AutomatedFertigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=urgo_AutomatedFertigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672251737864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock Compensation (Details - Grant activity) - Common Stock Grants [Member] - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants, beginning balance</a></td>
<td class="nump">412,501<span></span>
</td>
<td class="nump">1,802,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock grants, awards</a></td>
<td class="nump">794,166<span></span>
</td>
<td class="nump">41,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Common stock grants, forfeiture/cancelled</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Common stock grants, vested</a></td>
<td class="num">(253,333)<span></span>
</td>
<td class="num">(1,361,966)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants, ending balance</a></td>
<td class="nump">753,334<span></span>
</td>
<td class="nump">412,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249021160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock Compensation (Details - Grant vesting periods) - Common Stock Grants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants outstanding</a></td>
<td class="nump">412,501<span></span>
</td>
<td class="nump">753,334<span></span>
</td>
<td class="nump">1,802,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="nump">$ 177,327<span></span>
</td>
<td class="nump">$ 393,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember', window );">Grant 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants outstanding</a></td>
<td class="nump">264,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="nump">$ 142,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember', window );">Grant 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants outstanding</a></td>
<td class="nump">148,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="nump">$ 34,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=urgo_Grant1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=urgo_Grant1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=urgo_Grant2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=urgo_Grant2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249130008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock Compensation (Details - Option activity) - Options [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, beginning balance</a></td>
<td class="nump">1,702,167<span></span>
</td>
<td class="nump">1,184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="nump">2,425,000<span></span>
</td>
<td class="nump">736,499<span></span>
</td>
<td class="nump">1,259,000<span></span>
</td>
<td class="nump">1,995,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Stock options expired</a></td>
<td class="num">(297,501)<span></span>
</td>
<td class="num">(218,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, ending balance</a></td>
<td class="nump">3,829,666<span></span>
</td>
<td class="nump">1,702,167<span></span>
</td>
<td class="nump">1,184,000<span></span>
</td>
<td class="nump">1,702,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable</a></td>
<td class="nump">1,437,578<span></span>
</td>
<td class="nump">703,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">9 years 8 months 5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeIssued', window );">Weighted average remaining life, issued</a></td>
<td class="text">9 years 5 months 27 days<span></span>
</td>
<td class="text">9 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeExpired', window );">Weighted average remaining life, expired</a></td>
<td class="text">9 years 2 months 8 days<span></span>
</td>
<td class="text">9 years 1 month 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeOutstanding', window );">Weighted average remaining life, outstanding</a></td>
<td class="text">9 years 4 months 6 days<span></span>
</td>
<td class="text">9 years 2 months 16 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeExercisable', window );">Weighted average remaining life, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 10 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, issued</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="nump">1.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired</a></td>
<td class="nump">1.21<span></span>
</td>
<td class="nump">1.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">1.05<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable</a></td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672246210344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock Compensation (Details - Options vesting schedule) - Options [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">3,829,666<span></span>
</td>
<td class="nump">1,702,167<span></span>
</td>
<td class="nump">1,184,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 489,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Vesting period</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">9 years 8 months 5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Options 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Options 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Options 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=urgo_Option1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=urgo_Option1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=urgo_Option2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=urgo_Option2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=urgo_Option3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=urgo_Option3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249125016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Stock Compensation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">$ 399,258<span></span>
</td>
<td class="nump">$ 509,219<span></span>
</td>
<td class="nump">$ 1,391,807<span></span>
</td>
<td class="nump">$ 1,606,355<span></span>
</td>
<td class="nump">$ 1,830,426<span></span>
</td>
<td class="nump">$ 1,245,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember', window );">Common Stock Grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Stock grants vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,361,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">736,499<span></span>
</td>
<td class="nump">1,259,000<span></span>
</td>
<td class="nump">1,995,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember', window );">New Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock authorized for issuance</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=urgo_StockOptionPlanMember', window );">Stock Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=urgo_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=urgo_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255606792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Shareholder's Equity (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock returned</a></td>
<td class="nump">375,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256837880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Income Taxes (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=urgo_Year2016Member', window );">2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">NOL carryforward with expiration</a></td>
<td class="nump">$ 1,618,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforward expiration date</a></td>
<td class="text">Dec. 31,  2036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=urgo_Year2017Member', window );">2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">NOL carryforward with expiration</a></td>
<td class="nump">$ 2,182,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforward expiration date</a></td>
<td class="text">Dec. 31,  2037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=urgo_Year2018Member', window );">2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">NOL carryforward without expiration</a></td>
<td class="nump">$ 3,060,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=urgo_Year2019Member', window );">2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">NOL carryforward without expiration</a></td>
<td class="nump">$ 6,819,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=urgo_Year2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=urgo_Year2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=urgo_Year2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=urgo_Year2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=urgo_Year2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=urgo_Year2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=urgo_Year2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=urgo_Year2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248039784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Derivative Financial Instruments (Details) - Warrants [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, beginning balance</a></td>
<td class="nump">692,034<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants issued</a></td>
<td class="nump">124,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, ending balance</a></td>
<td class="nump">1,216,515<span></span>
</td>
<td class="nump">692,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber', window );">Warrants exercisable, end of period</a></td>
<td class="nump">1,216,515<span></span>
</td>
<td class="nump">692,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price, beginning</a></td>
<td class="nump">$ 2.88<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price</a></td>
<td class="nump">2.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price, ending</a></td>
<td class="nump">2.21<span></span>
</td>
<td class="nump">2.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageExercisePriceExercisable', window );">Weighted average exercise price, exercisable</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember', window );">Convertible Debenture Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember', window );">4Front Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable, end of period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageExercisePriceExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageExercisePriceExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=urgo_ConvertibleDebentureHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=urgo_ConvertibleDebentureHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=urgo_Front4CompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=urgo_Front4CompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672255975784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Derivative Financial Instruments (Details Narrative) - Warrants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WarrantsExpireDate', window );">Warrants expire date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value of warrants outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of warrants exercisable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WarrantsExpireDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WarrantsExpireDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249707224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Related Party Transactions (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="nump">$ 9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,658<span></span>
</td>
<td class="nump">$ 122,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,972<span></span>
</td>
<td class="nump">18,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoAndEnviroMember', window );">Bravo and Enviro-Glo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 7,442<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 43,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member', window );">Cloud 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Related party receivables</a></td>
<td class="nump">9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,659<span></span>
</td>
<td class="nump">79,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">13,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Related party cost of services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,368<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,617<span></span>
</td>
<td class="nump">97,329<span></span>
</td>
<td class="nump">84,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Related party sales</a></td>
<td class="nump">$ 112,405<span></span>
</td>
<td class="nump">$ 103,088<span></span>
</td>
<td class="nump">$ 359,562<span></span>
</td>
<td class="nump">$ 229,688<span></span>
</td>
<td class="nump">$ 392,963<span></span>
</td>
<td class="nump">273,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember', window );">James Lowe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt stated interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockOptionsIssuedForLoanTermRevisionsShares', window );">Stock Options Issued for loan term revisions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockOptionsIssuedForLoanTermRevisionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Options Issued for loan term revisions, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockOptionsIssuedForLoanTermRevisionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637345&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoAndEnviroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_BravoAndEnviroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_Cloud9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_JamesLoweMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249120456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. Prepayments And Other Assets (Sept 2020 Note) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments And Other Assets</a></td>
<td class="nump">$ 2,734,382<span></span>
</td>
<td class="nump">$ 1,258,700<span></span>
</td>
<td class="nump">$ 928,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember', window );">Vendor Prepayments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments And Other Assets</a></td>
<td class="nump">1,828,531<span></span>
</td>
<td class="nump">1,070,788<span></span>
</td>
<td class="nump">776,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember', window );">Prepaid Services and Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments And Other Assets</a></td>
<td class="nump">268,655<span></span>
</td>
<td class="nump">187,912<span></span>
</td>
<td class="nump">$ 152,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_DeferredFinancingAssetMember', window );">Deferred Financing Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments And Other Assets</a></td>
<td class="nump">630,805<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments And Other Assets</a></td>
<td class="nump">$ 6,391<span></span>
</td>
<td class="nump">$ 20,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_VendorPrepaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_PrepaidServicesAndFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_DeferredFinancingAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_DeferredFinancingAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256841176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>5. Investments (Sept 2020 Note) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 1,710,358<span></span>
</td>
<td class="nump">$ 2,020,358<span></span>
</td>
<td class="nump">$ 1,261,649<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember', window );">Edyza [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">1,710,358<span></span>
</td>
<td class="nump">1,710,358<span></span>
</td>
<td class="nump">$ 812,883<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowMember', window );">Total Grow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_EdyzaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TotalGrowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672247914904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Investments (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 24, 2020</div></th>
<th class="th"><div>Jan. 24, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorney's fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_MrPullarMember', window );">Mr Pullar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock issued per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fully vested warrant</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TghLTermMember', window );">TGH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorney's fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_MrPullarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=urgo_MrPullarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TghLTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=urgo_TghLTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672251232856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Goodwill (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 07, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 902,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 902,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember', window );">Impact Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 902,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=urgo_ImpactEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672247949560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>7. Accrued Expenses (Sept 2020 Note) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 1,863,096<span></span>
</td>
<td class="nump">$ 1,686,841<span></span>
</td>
<td class="nump">$ 1,144,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember', window );">Accrued Operating Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">798,752<span></span>
</td>
<td class="nump">854,056<span></span>
</td>
<td class="nump">240,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember', window );">Accrued Wages and Related Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">402,710<span></span>
</td>
<td class="nump">487,327<span></span>
</td>
<td class="nump">490,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember', window );">Accrued Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">44,635<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember', window );">Accrued Sales Tax Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 616,999<span></span>
</td>
<td class="nump">$ 345,458<span></span>
</td>
<td class="nump">$ 401,282<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedOperatingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedWagesAndRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=urgo_AccruedSalesTaxPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672249773864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>8. Notes Payable (Sept 2020 Note) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">$ 1,080,600<span></span>
</td>
<td class="nump">$ 2,812,709<span></span>
</td>
<td class="nump">$ 2,478,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Notes payable, current maturities</a></td>
<td class="num">(60,000)<span></span>
</td>
<td class="nump">2,812,709<span></span>
</td>
<td class="nump">2,478,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, long term</a></td>
<td class="nump">1,020,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">298,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member', window );">Note Payable 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">632,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member', window );">Note Payable 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="nump">$ 1,020,600<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245755496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Notes Payable (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="nump">$ 2,743,428<span></span>
</td>
<td class="nump">$ 227,749<span></span>
</td>
<td class="nump">$ 629,772<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares', window );">Stock issued in consideration for extending due date of note, shares</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Periodic payment frequency</a></td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares', window );">Stock issued in consideration for extending due date of note, shares</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Periodic payment frequency</a></td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member', window );">Note Payable 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="nump">$ 632,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member', window );">Note Payable 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued in consideration for extending due date of note, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_StockIssuedInConsiderationForExtendingDueDateOfNoteShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=urgo_NotePayable5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245985160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>9. Debt (Sept 2020 Note) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Total debt</a></td>
<td class="nump">$ 4,961,091<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Less: current debt due within one yar</a></td>
<td class="num">(2,196,280)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesAndLoans', window );">Total long-term debt</a></td>
<td class="nump">2,764,811<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember', window );">Revolving Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Total debt</a></td>
<td class="nump">3,276,493<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_TermLoanMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Total debt</a></td>
<td class="nump">$ 1,684,598<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesAndLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesAndLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=urgo_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=urgo_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245536104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Debt (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 04, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="nump">$ 596,075<span></span>
</td>
<td class="nump">$ 119,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember', window );">Revolving Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember', window );">Revolving Facility [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_TermLoanMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_TermLoanMember', window );">Term Loan [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line maximum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember', window );">Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Credit line interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bank of Nova Scotia as the prime rate, plus 11% per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,314,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">393,158<span></span>
</td>
<td class="nump">125,733<span></span>
</td>
<td class="nump">$ 1,057,501<span></span>
</td>
<td class="nump">374,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember', window );">Credit Agreement [Member] | Amortization of Debt Issuance Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember', window );">Credit Agreement [Member] | Amortization Of Convertible Debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember', window );">Credit Agreement [Member] | Common Stock and Warrant Issuances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 676,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=urgo_RevolvingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=urgo_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=urgo_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=urgo_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=urgo_AmortDebtIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=urgo_AmortDebtIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=urgo_AmortizationOfConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=urgo_AmortizationOfConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_CommonStockAndWarrantIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_CommonStockAndWarrantIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248928040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Unit Offering (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted, amount converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_DebtConversionConvertedInterestAmount1', window );">Debt converted, interest converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt converted, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=urgo_UnitOfferingMember', window );">Unit Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted, amount converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_DebtConversionConvertedInterestAmount1', window );">Debt converted, interest converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt converted, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_DebtConversionConvertedInterestAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt converted, interest converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_DebtConversionConvertedInterestAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=urgo_UnitOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=urgo_UnitOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245827432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | One Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember', window );">One Client [Member] | Sales Revenue Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember', window );">One Client [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherClientMember', window );">Another Client [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=urgo_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=urgo_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=urgo_AnotherClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248081848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Stock Compensation (Sept 2020 Note) (Details - Grant activity) - Common Stock Grants [Member] - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants, beginning balance</a></td>
<td class="nump">412,501<span></span>
</td>
<td class="nump">1,802,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock grants, awards</a></td>
<td class="nump">794,166<span></span>
</td>
<td class="nump">41,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Common stock grants, forfeiture/cancelled</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Common stock grants, vested</a></td>
<td class="num">(253,333)<span></span>
</td>
<td class="num">(1,361,966)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Common stock grants, ending balance</a></td>
<td class="nump">753,334<span></span>
</td>
<td class="nump">412,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248994584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Stock Compensation (Sept 2020 Note) (Details - Option activity) - Options [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, beginning balance</a></td>
<td class="nump">1,702,167<span></span>
</td>
<td class="nump">1,184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="nump">2,425,000<span></span>
</td>
<td class="nump">736,499<span></span>
</td>
<td class="nump">1,259,000<span></span>
</td>
<td class="nump">1,995,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Stock options expired</a></td>
<td class="num">(297,501)<span></span>
</td>
<td class="num">(218,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, ending balance</a></td>
<td class="nump">3,829,666<span></span>
</td>
<td class="nump">1,702,167<span></span>
</td>
<td class="nump">1,184,000<span></span>
</td>
<td class="nump">1,702,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable</a></td>
<td class="nump">1,437,578<span></span>
</td>
<td class="nump">703,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life, outstanding</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">9 years 8 months 5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeIssued', window );">Weighted average remaining life, issued</a></td>
<td class="text">9 years 5 months 27 days<span></span>
</td>
<td class="text">9 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeExpired', window );">Weighted average remaining life, expired</a></td>
<td class="text">9 years 2 months 8 days<span></span>
</td>
<td class="text">9 years 1 month 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageRemainingLifeOutstanding', window );">Weighted average remaining life, outstanding</a></td>
<td class="text">9 years 4 months 6 days<span></span>
</td>
<td class="text">9 years 2 months 16 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life, exercisable</a></td>
<td class="text">8 years 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, issued</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="nump">1.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired</a></td>
<td class="nump">1.21<span></span>
</td>
<td class="nump">1.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">1.05<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable</a></td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageRemainingLifeOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageRemainingLifeOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672245488312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Stock Compensation (Sept 2020 Note) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">$ 399,258<span></span>
</td>
<td class="nump">$ 509,219<span></span>
</td>
<td class="nump">$ 1,391,807<span></span>
</td>
<td class="nump">$ 1,606,355<span></span>
</td>
<td class="nump">$ 1,830,426<span></span>
</td>
<td class="nump">$ 1,245,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=urgo_StockOptionsMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="nump">1,919,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,919,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember', window );">Common Stock Grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock compensation expense</a></td>
<td class="nump">$ 393,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember', window );">New Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock authorized for issuance</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=urgo_CommonStockGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=urgo_NewEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248493320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Shareholder's Equity (Sept 2020 Note) (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock returned and retired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=urgo_ExecutiveMember', window );">Executive [Member] | Separation Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock returned and retired</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_IssuedInConjunctionWithAgreementWithFormerExecutive', window );">Issued in conjunction with agreement with former executive</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock issued per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_IssuedInConjunctionWithAgreementWithFormerExecutive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued in conjunction with agreement with former executive</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_IssuedInConjunctionWithAgreementWithFormerExecutive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=urgo_ExecutiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=urgo_ExecutiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=urgo_SeparationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=urgo_SeparationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672248955864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Warrants (Sept 2020 Note) (Details) - Warrants [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, beginning balance</a></td>
<td class="nump">692,034<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants issued</a></td>
<td class="nump">124,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_IssuedInConjunctionWithAgreementWithFormerExecutive', window );">Issued in conjunction with agreement with former executive</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding, ending balance</a></td>
<td class="nump">1,216,515<span></span>
</td>
<td class="nump">692,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber', window );">Warrants exercisable, end of period</a></td>
<td class="nump">1,216,515<span></span>
</td>
<td class="nump">692,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price, beginning</a></td>
<td class="nump">$ 2.88<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, issued</a></td>
<td class="nump">2.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive', window );">Weighted average exercise price, Issued in conjunction with agreement with former executive</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price, ending</a></td>
<td class="nump">2.21<span></span>
</td>
<td class="nump">2.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_WeightedAverageExercisePriceExercisable', window );">Weighted average exercise price, exercisable</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_IssuedInConjunctionWithAgreementWithFormerExecutive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued in conjunction with agreement with former executive</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_IssuedInConjunctionWithAgreementWithFormerExecutive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable, end of period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageExercisePriceExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageExercisePriceExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, Issued in conjunction with agreement with former executive</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_WeightedAverageExercisePriceIssuedInConjunctionWithAgreementWithFormerExecutive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140672256154872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Warrants (Sept 2020 Note) (Details Narrative) - Warrants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value of warrants outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of warrants exercisable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average life of warrants</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">urgo_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>urgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'Y)3AY')O!&PC NN7#X^CK(45@YQ&/FXG"FI @M'G1BI**,_35_4D-0/R:1
MDLF!C?*CGBI)<W?5^#B>YXH1]VG#<"+E9[@)G?Q$)X]FQ=]-\SI&9N*4$BM(
MY,*\0U$#S^^K9 MJU+\:)U]_VE7;X5D(+M"CUVD.86F6.4'#<#(EW T:@A."
M4A'(-?1,<&F4WQ_ KNBKYCFI-10L23M4)HE9)3NX.,0Q3)+Z@Z>"4(^DCV,T
M5<)=N0B.!/A9K:3L8C;M^G'=HA283R&C$'_E<O"!0S'A 1>81R8IZ$> BE5I
M&I?IGXPI7ZJZ1GEP/T? \*0W%=?A%@@N-!56J&E<J?_HU[J-)!J*R+/(F2MJ
M"(P24#57G1%<+J4,38.59QK7YT/>;"ZDFR,E7UI9+B'?<9>4#^2"Y%!'N:P0
ML<YR2* A7E:M:5RN#[PB7'QAS5(H>+BW5!"@()ET"\<% DPS(3(9*#RH%6N:
M754BUU7Q5-557[E"/?5K)9/&-?-4;$(M$"IEJ"]PE/)#YS&-$Z*$6<J5].*$
M>)2<J)P'XF0UD^:7^+0[*-'T9^C<.[R:.;J8W%W![7/I\D& $NJ4,Y$Z\D&
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M?G8</_QXXK>B?:Z:#LJ<%5B2-QFX: ^_1SA<]&8[GM _F;XWF_'M6A= <0#
M]RL#DG2\& []3[\*N?L74$L#!!0    ( 'F"15+OP,#3\P(  .<*   8
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MUT.#LCX:O7RYL@YS;V=@478JHI2IGU:E9,)-1@@.DB^C;C)"<)1+FA$W&V'
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MY$J0Q.,RQX"<$H3TY8CGU ?G1L/6[3>SL6ZD2RXH7<2%Q31U&2.>CGK5=X[
M!$M2X;+%HJ7)2$%A@T]C89_65]2.<1U.KK]$M4*'G_ENYTK$(HU=]XH!P><F
M*7%5P9&)S)A;;% D;#,Y'=GKL<%LL;#9.IP0E=T)T9-:ZT8=9#'Y#SSK,=_\
M7"6PS\\\,1 @RX@4W%T2&))+(;.,N6(@2)%2&9,1Y\D&Z\7"UNOAR/M8'#Y
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M_ZFJVH\'_=VT_;<=;_\/4$L#!!0    ( 'F"15+#W?]A<PH  &4O   8
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&ULE5I=;]LZ$OTK0K /+;"NQ6^I2 ,T
MMKL;H'<W:&[W/BLV$VNO+?E*<M+NK]^AI(@6.:+=E]A6#C_F<#AS..+U:UG]
M66^U;J(?^UU1?[K:-LWAXWQ>K[=ZG]4?RH,NX#]/9;7/&OA9/<_K0Z6S3=MH
MOYO3.);S?9875S?7[;/[ZN:Z/#:[O-#W550?]_NL^GFK=^7KIRMR]?;@6_Z\
M;<R#^<WU(7O6#[KY?KBOX-=\Z&63[W51YV415?KIT]5G\G$EJ&G0(OZ3Z]?Z
MY'MD3'DLRS_-C[O-IZO8S$CO]+HQ763P\:(7>K<S/<$\_NH[O1K&- U/O[_U
M_J4U'HQYS&J]*'=_Y)MF^^DJN8HV^BD[[IIOY>L_=6^0,/VMRUW=_HU>.ZRB
M5]'Z6#?EOF\,,]CG1?>9_>B).&D _> -:-^ N@WX1 /6-V!N SG1@/<-^*4C
MB+Y!:_J\L[TE;IDUV<UU5;Y&E4%#;^9+RW[;&OC*"^,H#TT%_\VA77.S*(NZ
MW.6;K-&;Z*&!#_""IH[*IVB1U=OH"WA2'<VB[P_+Z-W?WE_/&QC4-)VO^P%N
MNP'HQ !I]%M9--LZ6A4;O4':+\/M"0UT, =K!Y/IF\FW--CC@SY\B%C\]XC&
M-$8FM+BX.4DQ>\+-EWH-S<ED\]7ES9, &6Q8?];VQZ;6WR[R4U7NHW\?=)4U
M>?$<?39;.&]R70>&X<,PO!V&3PSS+PAY7\NZQORG:RG:EB:NO=S,6"K2)*'7
M\Y?3=4& 0I&4QWP,7"+ A(E8*#8&KK"ADU0D)\"1N6(P5P19_;SY+VQ=LY.B
MIH1XNBZ+=;[340$T[("&CNNRXQIVX,< Q7(84P8I7FK(%.L\Z^)OL8FR?5DU
M^?_:!QCO77?RQ'B2$"5BAW4$EL+Z2(=S'T:EY,J!K9#>!"=,XGRKP785M/WS
MB:DF= '?+QJ>/ +G&_T(ZW"L-#S='\K"A#>,#N7-S&7"1R0D)M)EPH<122A)
ME4-%:, 1"\G 0O)++$"^U%4%<?TI+S)P0-C4Z[+&K4^\R3"92$D<"GS8Q)S3
M8<YI<,X/3;G^<V92_:9='Y @W?SU#_-=8W--?8)92I+8(7B!X&0LF1#.@B&X
MA,6<NKZ+X"@7"9UP7A+;'!P'28 D;$*N"1?@N76^Z>-"B(2^R_%.$G'L.BV"
MFU@R<J(92'"^=_M#EE=M> ,WRV&O=<$.G2?Q/8O$R#Q]G(BEAUNB.*'<7;A"
M<%-V4VLW#=K]1U95&1@]O2S+OH= &%DA$,92/C$YF\@)"R\*+$/1E-7/Z+7*
M&STKGY[0G=YW<SJ\HE0D[GKX,,B?@KK+X<-2KJ@;Z[!!E6!DPF@K*TA85]QF
M&Q/@0TMRVW=Q.C9G"4]=@WT8 5X\@WV85)*YR@+K+99<3BVS519$!"W^!QS^
M(@@-F[P^E'6V,SLPJVN-A_6^LY&O<>FMM8^:I4)YIB,P13GQMIZ/F]IZ5MP0
M&=:IVPP"9 W!YE2BMG:W8N=KGCWFNU:NAL04L8J"G)$4ZW5Y-"<A$%4Z?\E
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MUQ$?)$>O[L!6VVT2RB23HWL%:#CX>$M4\-!SKEM03";*%KZDH@FJ].5DWWH
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MKI0$A-$ /%\8E,OA!VW0?CS^\C]02P,$%     @ >8)%4MLB.W%^'@  2F
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M,'4%RHQN$&ET*_>KH@</L<4G]:<-N$M<1:B&V4VGLZTNND-UK;L>_#S,PVB
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MAY14E LXN>I1:I>QN:#$Y)UD&Q/V>>)I5KF9%-\'2],+XROP3!UEGGUV#X0
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MXD80_NY?,4)1U9-<[/4+AA202$+42)>$$NZJJNJ'Q1ZP=;;7M[L^0G]]9]?
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M_23N@>STLEMHT5B-6@M-BF?-G'XQ*(T#G6^$T,>%27#Z:4W_!5!+ P04
M" !Y@D52W71HK!8/   *+P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6RM6FUSVS82_LY?@?$Y-\Z,JG?9<O,RX[A.ZTR<>.)<.S<W]P$B(0D-2;
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M7X2S9X;R8I4:^I]M[+NSTR,65Z94F1L,&F0RMW_Y=^>'8,!\N&? V T8/W7
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M<+++A6X+"#WE6?C)QS,_@.B)+\;H+:B.JZ;_ F'\Y>.^#6AY:,-?\#3U*6#
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M1[5M2R%5^6I+ F8 EE99@4>E2-QK1YR1T%G=CFZ$CMR)&V&IQAX\F?:!!T
MI^#%<Q!$=ZE@"JWQS!9(LXLNK9*'=U_UT +[+(8JP_U8!Z6DO>16&[OM*:H3
ML,OI,WEX;N[*B *&V/M*2&<1ZY0W[6F&38N1Z[;NG:>;&+MFT<$=VXX)B1)6
MA36_M_#A"PF9GII)F!#*?=F@M06!DRL(P58+MPE16+OA25><DM\KNLJ I,R6
M:OVN>ZB#X+IQ)O2*;F%CAH9%L#>/ZU_KB]X7=+]YT+QN;XD#H5[AXJ9B"4.'
M_;/9D6UU^"^E*NCR\D*5I<KHXUK DFA\ 9XO%;C<?<$)ZNOO;_\'4$L#!!0
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MLK::=CGYV?FX!_>V0@T+8]"::60)U&U%V1[@N@5(3@#$"7Q1TE8&;F6.^4N
MB-ATE)(#I>OD3<0;S'HPB$-(^O''-_ &78H#CS<XB5>@UIC#4AEK0EBRAELF
M^'?,0UAI;!BG 9/Y"R7@AIM,*+/1"'\M4F,U7:"_WZ S[.@,/9WA"3J_DOMM
M[]_O'V]A#._?39(XOH+[QT^W#[!8KV\?UW G,[&A,P N0?DHK$V%40XTAT()
M>H1<EF=<6B9+G@K<VUR>O7\73P97L&(6I9,I4_3RC"5K4 4(+)F@-5(0G&!@
M%4%RG=-,6X[&+:"Q+!7<5,!HV>&$L*UX5GD&V0_=82,M%U0):,O2&R<H9CW%
MUJVES)I&JR>R=F?#C=G04&DJ!?_0D\:\!W=%9Q.^@&]Y>HQ:$3T?TKA47 QW
MENZQ?G#B0HVV4@3\1'JY74J"TVLG#T'UPKCDCXB%4*)$S83804'[L$.F30\>
MR62IZH;)'52,U-BJ ^4N)8]%MQOKE&(=;KC/KF(YR-<>]I7YI'<XJ,\\H]I(
MAXIH#C+OS\S%<<O=257LJ;T!>XK^^HROR$"K?)-1J Q)IH)3\'1'IR>9JYD^
M2XV9*J67D&H_HY'?Z[T@\)/6K9@HC]61U&%2)IC,T/%[=0/I=W92GU<RP);D
M/)]<A/$H]A;G%X-P/!J%Q-<TZ&N]V/5@T7+RE &?&\_8*KHH1/,\#B?C-L#Y
MQ_'PC'J<5\FS!G3U[ 0?1^&G4/]7&J*CPERC+GW[(;$5W?^V1G>K78=;M(7]
MAWG;'K\P77)IZ"$6Y-KOC4<!Z+;EM!.K&E_F4V6I:?AA15T:M3.@_4(I>YBX
M %W?G_\'4$L#!!0    ( 'F"15+-'QGTJ ,  $$)   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$U+GAM;*U6VX[B1A!]YRM*SBI/%KX"]@20&(8H^[ ;-.PF
MD:(\-':!6VN[O=UMF,G7I]JW)0F@B927H;J[SJG+Z>GR_"SD%Y4A:G@I\E(M
MK$SKZL%Q5))AP=185%C2R4'(@FE:RJ.C*HDL;4!%[OBN.W4*QDMK.6_VMG(Y
M%[7.>8E;":HN"B9?'S$7YX7E6?W&,S]FVFPXRWG%CKA#_;G:2EHY TO*"RP5
M%R5(/"RLE?>P#HU_X_ +Q[.ZL,%4LA?BBUF\3Q>6:Q+"'!-M&!C]G'"->6Z(
M*(VO':<UA#3 2[MG_[&IG6K9,X5KD?_*4YTMK,B"% ^LSO6S./^$73T3PY>(
M7#5_X=SZ!H$%2:VT*#HP95#PLOUE+UT?+@"1>P/@=P#_K8"@ P1-H6UF35E/
M3+/E7(HS2.--;,9H>M.@J1I>&A5W6M(I)YQ>1F-8)8FL,87-"UT-A6KN:"(V
MQT[2D3RV)/X-DA@^B%)G"C9EBND5_/H^WO/O$#A4T5"6WY?UZ-]EW&$UAL"U
MP7=]]UI"]^%/F!#<,W OOI-.,'0Y:/B"&WQ;]LKV.2I@9=KVF^4*?E_ME99T
MD?^X$R(<0H1-B/!&B+>H>)_AX\^?-C"#[[^+?,_[ 5;K]?/GS1-L?MMN/NXV
MN^&>8!<!F,3NOY__2?M,P4'D]"RHAQ'U7V.Q1]F(0.WL%IX],HHT?1WUA/0D
M2:9Y>?Q&_0YF<63/)CY9T22TW<ET<#_3Z])V4F+.]&5&H>O;,\^%,)K9@3\;
M(+S4*%'IWA/"T)X&D[[6P4\Q(Y)F+U"UBL'4F]IQ'$,03NQP$HW>@6='T\!V
MXRD8>QI-[2CTX#8#5Y"(HI)<83H2!V"%J$NM(*T1M( 3=4_4"I2F4MJRUJQD
M*6<E5%*<>)F@::PT/9N SJ2HCUESK\?7+O8;-([^'XTO5?VGQ%YLTHWN2]P)
M2Y8?NG8<>F^2N)46PI@@4^^VQ'V-'OE-HCL2=]+2Y?%L/_)'E[(:VZ/+XH7^
M?Y"8+-*+2N;BFON_5;\BKQ>/X5.&L"9B5KY"1JU7--7KRO#0'-50Y:Q4-"]T
M1CCL.4<4RC2:6E@FW(06IHL<3]BXB7W.C\S,T#; W]DD?JTY:5Z8]SA_[4\5
M]7=(NK_!XD1ZL[Y.JIO>\0:GQM<>-.=B2A4HC\WP-ITCLG9@#;O#]\&J&8O.
M-_?VX^(#DT=.V>9X(*@[GDTLD.W ;A=:5,W,VPM-$[0Q,_K&06D<Z/P@A.X7
M)L#PU;3\"U!+ P04    " !Y@D5225/4,&D)  #U'P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6SM65MOV\@5?N>O&*C>K@THNE"^2+X!CIUL MA>
M(<YN411]&)$C:6J2H\P,+>O?]SLSO$F6O<FF,8JB+[9(SKE_YT:>+I6^-W,A
M+'M,D\R<M>;6+HZ[71/-1<I-1RU$AB=3I5-N<:EG7;/0@L>.*$VZ8:]WV$VY
MS%KGI^[>6)^?JMPF,A-CS4R>IEROWHI$+<]:_59YXY.<S2W=Z)Z?+OA,W G[
MVV*L<=6MN,0R%9F1*F-:3,]:%_WCRWTZ[P[\+L72-'XSLF2BU#U=?(S/6CU2
M2"0BLL2!X]^#N!1)0HR@QI>"9ZL2283-WR7W]\YVV#+A1ERJY&\RMO.SUK#%
M8C'E>6(_J>4'4=AS0/PBE1CWERW]V?"HQ:+<6)46Q- @E9G_SQ\+/S0(AKUG
M",*"(/Q:@D%!,'"&>LV<65?<\O-3K99,TVEPHQ_.-XX:ULB,HGAG-9Y*T-GS
M48?=*BL,&_,5GR3BM&O!E9YUHX+#6\\A?(X#NU&9G1OV+HM%O(7^\F7Z?O@"
M@R[,J6P*2YO>AB]RO!.+#AOTVBSLA;UM"KU,?B4BD/>)O#]Z09U!Y>*!XS=X
MEM_$LBMIHD297 OVCXN)L1KX_><+S/<KYON.^?XSS/\P>"^24XTX-@L>B;,6
MBH 1^D&TSF]__?R.#=E?_S(,^_T31I=W;'SQ]XNWU^_8Y[E@4Y4@^V4V8](P
M7E8 IJ8L<^HLO#J!>(R2/*9S6B3<BAA/M%VMGSH.$"\KTHG0+FAP?W'1;P<4
M01>'X+?,B CNB]M,9E9 6<M4EJS:CEO)#-ECY^QRKB4Y1=]#C-)R)C.>)"L6
MYR)HLB?.PP[[F$DK>5+S!3,4*FN(@*4$3A!SRSC*3I;E.*IA#=D;]CK[/_D4
MJE30XD$:V"JSVA82!'=8D3EW6#@1)2C7$MZ(B9=5[(;K:%X!K\.N\!AG+_(9
MRH"[U]Y"N.2&><80N<$%ON-93$1!99LNB6(1H>P;3_74LM%/Y!@6*13L6. N
M%5UT#;9N!7DH+DCHV@6#A")2>52<6I?NK;A4Z8)G*R#(Y,+IR.8JB2DP[5ZO
MQ\R<:XK>E$XB!NS.JNB^P]X*1#-SV,O8Q4++Q!FZR11>NL>AH(P>#F:17,#
M*KB@)QJ>JCRS)&BGWR/1';8#EDZ)'39T/[X)?5?\0<;;T<>>HB_X#O2!O/>U
MZ%N/6_"JZ&-K\0]>&7V5]."UT5=&+_@F].U[[/5['GJW3P#V815K->4Z91^@
M,^08]HM6^:(-EZ%U[5+A#GLGU3%WW3_9:[,"Q&P"0"4)Y@NMH0S@)1ZEL:0Q
M.6^:6^I3W!B!"1%,B^#Q*-(YO (L$O#8 NY:":X=D:2"#MQ_R5'BA4Y6'=<J
M7$0<9LB=WF:0)!*T:GK,=OD>&_40Q)5Q_>;HA$ADA":C55J;>L)V)WND 0;
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M"$NL7\-N=*%C<QZ8K#REBRR'F>*-N^\WHZ?CAI?H9X9B,FR,4_6HBN;R9.Z
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M63D_';Q,7ISOLWP0^%W)I5M[)O9D9LPG?GF;G0[&;) L9.H90>#?C3R71<%
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MZ]D;1M<Y:G_;WJ%@TP*%GY'L#YSWJ3?!@,/> &1RT= WHV\6OM(96C00_<P
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MU8+"6S2G>6WIE034N'A9EZWU%7OV-7X5_(U,'V*Y5I;J9-%(OHY%TY8>6[7
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M*$NSS2\+^C.!V@G0?:Z4/6P<P?'OR?@'4$L#!!0    ( 'F"15(A !K, @L
M $8>   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;+5977/;NA%]YZ_
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MC6K&XOAH)*9'TZ-="NW?_D[EV#ZA[9.7>]0Y[KU]S/*.'Y'WB*?%/\YG/CA
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MS>!9G,'%U@S^IZX<_5DLF252FD,%U,C8GEH'JA@+Z)=V(5%Y>41G+O$W">H
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MK!PMP/O2 L/I!QW0?SI^\V]02P,$%     @ >8)%4C7V7?,S"0  /!X  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C N>&ULS5EM;^/&$?[.7[%0+T4#T!)?
M)?)B&[!]3GL-SF><+@V*HA_6U$IB3'*5W:5USJ_/S"Q)BWJSG5R*?K@3N;OS
M/COSC'FZENI>+X4P[$M95/ILL#1F]78TTME2E%P/Y4I4L#.7JN0&7M5BI%=*
M\!D1E<4H\+SQJ.1Y-3@_I;5;=7XJ:U/DE;A53-=ER=7CI2CD^FS@#]J%3_EB
M:7!A='ZZX@LQ%>;'U:V"MU''99:7HM*YK)@2\[/!A?_V*L+S=.!?N5CKC6>&
MEMQ)>8\O[V=G P\5$H7(#'+@\/,@KD11("-0XY>&YZ 3B82;SRWW[\EVL.6.
M:W$EBY_RF5F>#9(!FXDYKPOS2:[_(1I[8N27R4+3_VQMST;A@&6U-K)LB$&#
M,J_L+__2^&&#(/$.$ 0-0?!2@K A",E0JQF9]8X;?GZJY)HI/ W<\(%\0]1@
M35YA%*=&P6X.=.;<#X=L:F1V?W()SIBQ*UE"@FB./CX=&9" YT99P^W2<@L.
M<$O9!UF9I6;7U4S,]M!?':?W@R,,1F!:9U_0VG<9'.4X%:LA"SV7!5[@[5/H
M./D[D0&YC^1^>D2=L'-W2/S"0^HLN1(G=^3J6_X(U\&P"Z5XM1#T_)^+.VT4
MY/9_CPB+.F$1"8L."7M%7(]RPE+R5J]X)LX&4"NT4 ]B<'[S\?,U@XC]]2])
MX/O?L>GGCU<_G%Q>3*_?L:N/'VZO;Z87G]]_O&GRRQJ=;>C!Q!=\%@R*$3-+
MX50@EI4V 00F (/P&5'>"=7%D/%J1M%@:Z[9&]\-4]]-O FMP^O8&[MA'+M0
M8O1*4)$H'EUFI8-,D,,>A#9YM6!8$V=U(9B<DWR-BK(%A,-HXB=7J*=NK@A[
MW@3XI\1K;0C3U WBQ"$+8@]>_/3WZ,\.ZW\C6<;UDLVA:C,QGP-C.*$$G#)Y
MEJ^X$3,';=AD,63O*_9/7M50WE'=B4M2,)5X]<CNQ()7]B@HX\ RF-UXRDC&
M#24R&F*@F[BDD!)KKF9,E*M"/@JQ(R+IB\CA'%T,L!UDB5_JW,!JE<$2.(:M
M"E@%698M.; 1^R2"Y,YR!29+9=^Z"*(KJQDND^V0UWD&%.NE@ :S6A5YQN\*
M04I^X*1@VE>0S\#%J!RKQ-K9JQ\87INE5/FO&#+0ER\6"EQG*&RA&WN>ZWD>
MTU@:-*[U/(F*Y5K7')BB:"5JR"HU9)^7N=[QB$,>P:P"]95\ -7N'C<UILLZ
M^4Y;<4M9 "^->47VA;;0M?G>9!())"9[Q=E$>N!%C8XP='"EP)']M&QR=]88
M3KS1"K@[/%>6'C>:TS9S[3'@^ZP.X(R,%UE=<#JNT=EX_++@4'RF&9@*WD6]
M<*>4,U'T+Q7>J9*( <[< W[J-,)=DE\\TJTC!1M#\1!5 J<47-?*EG$TTB8*
M+$#R(UD&-0$SL^8%,T*56]ZQ]L)MR?7]R1R+2 Z&0T88IH@;)BY6FPQ5?)!@
M9UZ@(YK:M:'@9OZ0AR$\X!Y.5B,SP#D+E(#>KN]^IBIC?0I\,6?H C0.:1UY
M($#KW"Q)@;ZC[?:6OR$MD1.'="X;\AHC@/G3ZE8\LI_KV0+=R(NM1$07]*4C
MI9:E $V%=B04-H7\(-!<&506JP95 HH+'8"][!X0JHN5 \H !(V"DU=UX\^F
M$#"X>GB3VJJ%5W$E%$%GR+Y=Y9R^<N9Q!06D (L4)BU66^:CT) ]"DZ\<CE#
M@8UX,>LIVU6D3:E0=N%1;-=[UM9NI_$\]HBN<?V=5'QK;YLLH E05+&X02&0
M:]UCQ9M\<-JF]I*^_-:Q0AB,"MJ ,ZC:43T#$-6<;8 4B_P ZI[?DG!T+W"=
MI)'KC\<. /2YR T$9G2%-A<%;/XM: KEMRT9FD@;<>B&8?BTL:O"GAX\(:J(
M71PXT"_T2ZX=:-0A].88[@G4 V@H<E'EOX(&>@/5[44'2MBR!+$'IEILM5D;
MI(\V;9Z-4AOA-DSL=6&ZJ6D!;/Z)9APXUCXXTU[^OB22OCOQ @C:A*7#P&=O
MF \_SGNXX< W<*,@IIBEPRBE3<]SKK\(E>7HJQ8Y;OW"B56N*++I!/.$?0L,
M_+3E?D1+LR_2H9L$J3L>CX%+&%LUXBTNPBI%OM[/Q7>C$+29)"P9)@EQ ?#[
MBNSQW13@0QR$7RU_.GBW;[#YW8@^_(J('NM<FXR[R=/ X*2%\@EX+PK&+90/
MHA@B-^Y#X=<C8:>'A-_5JNUH5(0/Z.9"O,,QA RRID%F3;E!;FO;4BG)L8D\
MP=D>T.86:#M;0)O],:"M7X6P;8/N0X)^WU*"[6F<!(D.=4[G4.?LMZ^CS?.:
M9\M&$"1,HTS3*)$.0Y[/\PS 4E63CAO<G8TN:)L6];L&C=B^VR6'[;-T43?:
MK^YS?/DDXCP_B;##D\BK9X_I-N#YG\.<SULHU0X9[50#.H=8X[>&F,QFG+89
M!Q<IC=TH33M#EOP!L0P:VW3_)XA_2_P/=!S$65 ;XI0$=C 4;V3+:3]I\O\Y
MQ^V.6LZ^,0>@M(1#Y5>>MO!0Z\/>".7\F2/49G+L3%)L8Y)RR( WWC#U7CI/
M=;@ ;KMG;_K!J0H/!<-)_,VAZ<IIF/8\?,@0DNA]\P=&+NOS_NSDD*,UW>+&
MOST[4?.]4U5>/46/]>>RDZVY[)GYR]F4I;>;1S=_[6LC7Z,P.<<*TQ-0[C#
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MFF,I[%!7J'AFK4TIB+MF$]K*H,@\J"S")(I^#DLA53";^+$;,YOHF@JI\,:
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M?LOC!K]WR+,!UE<. Z!Y80?M+ZBS_P%02P,$%     @ >8)%4L8Z/RDQ!
M7 L  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULK5;;;MM&$'WG5PS4
MH&@ E7<ILB,+D"]!7-2N8;OU0]&'%3D2MR&YRN[2M/Z^LTN*5F*)=M&^2'N9
M,SN7,\.9UD)^41FBAJ<B+]7)(--Z?>QY*LFP8,H5:RSI9BEDP31MY<I3:XDL
MM: B]T+?'WL%X^5@-K5G-W(V%97.>8DW$E15%$QN3C$7]<D@&&P/;ODJT^;
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ML;4B/F!%7X+[D=>_W5] $,.//TS"(/@(#_/;V_GU_5W'&6!D+"\*3#G3F&\
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M[83?0W(,=UKAL'^^R8UDWQ%/4C=/!8-H41!F#2!!;=5A&EKBS":: ,*_*-H
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MWNVD_?YG.+ZX.+P].3V%FP+AP)25T(\\&YFQ7&^8+[.3&C*C?]4ZM/Y:(ZD
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MU\*T74AV)E@[70[S 1A/:-03NN!2Y3%,) \*DR%#D&AK7; * @SQ;D&('HI
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M4)<8>'IH2LF3[EM+7R,X8$5#,V,'<;6[/4O9&-]TSR4^F_2AIH-Z@=,ID=,
M;B'H0<FH\T4"LA>N8ZN'5\__Z:/E<4F<FPMP2_0S]STG-Q05AB>M^W! 8U"$
M.KC#@X10?VFLU'ND$D3*QO%!%O>)B"4,[2+D0<)A]OD2EZPKOJ^*_B F=/GJ
MPU '828K'I#L*ZF^ZMS7YFI/F_L.#4ZOLW>'%AJOS-.Y88$;Z#6>]9E4,Z$I
M>#;=H?NV5V_Z(=S^F##ADROBTQU?V2UX>]\<D=)I[O71M^H1.+W@5'-;!%K@
MD5LJR>@M%50%&JD:J8/09]'7#'(].>K^&Y%-WQ>)2L/?=\ZI&(DUI>1 +TNV
MAYQ3@=%LC 9-Z^2:.:';. GJJK&>)]OK,.=4;.+=:TI38(8#MX_,P^EB$Q=2
MA95O'M,:KA^/]P2Q_\/:Y.LQ0B7C&W;[0AD-4CS%L//0<3R?[@V.NI5&7[UX
M\NQ>WQ-J;[R)BU>G\0:[TTG401IW#DF/?$02WP!2:SYGLC"#AD;]43>Y&72B
MF6H):Y)CV/B\O)A$E_A#Q)+X903\,FI@BYA<^A)["G922\Q#^\]\NF7G/5]E
MP\X'9))#EP&>O\J@,B\L:-W=N?Z->>YSO+F[51>G%ZERRY$,W(K>E$SFK:NZ
MI^IGT/+BM;LR(<:WT?6\!LLKM$K>7\77[D_4G:S@9[G+5Z"/2PQN^:AA\563
M;8!S5F"VP4)46O/C%A7F;/'THQ "%%+3'G=;SBS0C7 T;F& 7Q?S01OGO+KO
M:=&W[WY46W">*P<%#4ZK5SL_[ 2+:_TM^R<Z*HIA5PT_+=%Q53[AAXI@^R5X
MM.(P^^R\W5FJOU)ZK:FW\0U.H2WWN.,UMH8;D"U>%$6-&PCL/.R1HTD\G@_:
ME8Q0B*@WTK=3V)J*K24<WW+'MGQ1FI44I4"'CH7B'OZ)^DD_1.B@!!+";-QK
MU- 1>JY+;*L;O,/*M3FW6_FNT*@#T2^NM&]$V-3@=AGT-/<XB')W@*[%[]F7
M== 2#BXK[K*0]JE2'WA#XN N1TY^!"B-KDL?#LBNL&'=701H?$]8U/ORWJU)
MY:>8)SUAL$?:A5$'HRA.H)^ELXO+='YVR5'5+#V=S]/SBXMA&/<TJ#YX._".
MQ)5 O9Y?I:<7KJGC.IT!T,O9V=,#NGGH1)M/MX\YE81%433,X^;KF6N,ID?H
M;0-*\% W O7!)(6;P8K.BY%X0 L-NJJ2]$F?AWZ)3MWW'H6\?R_31!E /UA@
MADLDR5@:0,KA,5#$W;$\5^ U^=AX90N'8>]%8S(Z:6<JFF!5TAZGTKT8\')T
MD?1?FPG@Q-4)ET,8[R@EKERC5+RRIWC4-"5;H^C'];W!6MSF:Y.0BG/8T7M1
M=/$F@DR*W#%WZ#X.ZF?1]5$!1Z"F:C1Z('#L4I\)"L+M->U=E$/G]H/6VSW@
MWA8[^IZHGZ4=KVM](6?OI*,\#DCT_/HJO3B]'FO<ODK5%_/TXO(*9/R<4CA]
M!S1R !Y3(.#1MGN?7J:]@Q8\DW$\9^>S='Y^^EEH3#9:ST/WUWRZ?^M6FH=$
MS8WJB&>M\+B&\#M.7.=2Y">P$<PV>*FDJBBMQQ6'D?>%TC%9/!E%8 027P-)
M7&>+#1V!6=LV!AC>-24.H+@N'7^3Q+^UT&]G=HDN47+>7(3>L8'SY=+'[=HT
MQ3%>:]M%GAI/M&NSW?(3&)82FIA0''RZ=V=^I$/LTQH2K]/KV8R-UZOKT_1\
M/C274SP9>K_FTRU;-P65+8APR%WCENN9:_0C?G=B61C&3&)=$<H]:Q;X0[+/
MDLA[A_U78IOH/2#V /L>7GP0]'J)B5[FB)[I""63Q&$4GBCI*G?,$;8^H^S[
M YZ70I86[//K]')^)>[(^5EZ!0HR>?*)AOZ7^72GRN]2'!L]R*=-G6PG2**J
M,MVN/^"UXA,P\3L![A*^'!Z&>J^N3E-76/B.*SR= ?G"+IOX4@QZ-=_3724I
M.7"&QG.8SZ&-UGMM5 CWS9J^G:WGKBA^Y.! Y5YQY=[=8DMZ708!"6DP[25.
M:<^EO!(9=1X(/N&NT/ R;2KX8DNBO,;C<H@)Q@4I7=8XQA:,?D-/ZGF>TDKW
M-797E/ZNC-P@?@0_=^T#"_74J$"!'M^OQ?R0[19_:'=Y$.\\8,61Y8MIV*>8
MW/NCI(F0J]^GX)RT^"V@S@;E^G@C!:D"ARG8ES^Z8L7WOR:E*[3OS*=;;^Z0
M+,>O,WX[U-U[.9 R^;2E#G=,\\L=]+@D52ZXN2=B)R0L>-;U3FOWE&6%N<0L
MNO\G#0+ )*S<>@\14)NEFQR2# ?U@6N^(470U@D""!AX7="3!9Z3QSON-P/M
M"0%Z:U%CC0C-"GFFU[23 2,5CV*[BK47%3WNI9+1(Y]'GE:5R]3Q%?9^!G3X
MEA1C1U4M7SD G@0_9Q=*! (X<3VU/<Q+6T=/9 '^2RW-S@**ZF0]4-A2;^D2
M5^\M*3SZT$GDS2VV+;$FB1>/WZ3"+887J:8$*'02S!_K J"W*G[)/HZWOCUC
M>H]<2U/RZUCXM5R8HU[>1L.^*N_O]M]=XJN*559DDE_+)"C%AKAX/EDY;C5
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MT(]KG<&AX0#X'O_DC/L% ?@_4??M_P%02P,$%     @ >8)%4@+DDF?N @
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MBLHZT/I62G,:V W&-WGU U!+ P04    " !Y@D52;<_X)^L(   ?'@  &0
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M/+<?_7KKY>[3*;:.&6WHF9A"M-\] CZ4^QSI+HQ<V"]ZD31&YO;G7(#=*%J
MYU.)F55=D('FF_#9OP!02P,$%     @ >8)%4JQAH"'D @  I08  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL?55M;]HP$/[.KSAE4]5*B+P Y:6
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M55HU5-3M8=J#22[$JA.GM@/M?OUL)Z2TA Q-&@_$=NXY]Y[K&U\/]XP_BAA
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M/.Q"(-9@R3<%7_.$%AK<)(G8%9H7&_ H,IYPIL";.=.49PK\2:6DU29Z"_X
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ML !CQS\(S1Z<./IZ>"1\26N!2E@HHC.*E )OC]RV(UEC#J$YD^I(,\V5NJ6
M:X":7S F=QU]KO7W7OH!4$L#!!0    ( 'F"15++N<$L@0,  ,,,   9
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M^PIM/D/'EVMI_9?M&M_19<#RK45=M6!24 G5_/F^K<,1(!J= ,0M('X+&)P
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M,14 _GQ#"'NY$1,TI\/S_P!02P,$%     @ >8)%4@$F"SS_ P  _ \  !D
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MYUL&%GF,8PU_WL[W;_'OV_G!+7[8SH=6BX A(EV'VWH+]]1J55SAW1WHFY^
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M$B"^KPGA;R]R@KKA'_\-4$L#!!0    ( 'F"15+U4H?CG (  ((&   9
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M''P.MN\=[1E_%EL B5Z3.!5C:RME=F?;8KF%A(H>RR!53]:,)U2J(=_8(N-
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M731P#5#/UTS-OASHMJOJRR?_ 5!+ P04    " !Y@D52'HWP!'H$  "<%@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6RU6-]OXC@0?M[[*RQT)^U*
M>R1V(!!$D=K2]/:A*[1H[QY.]V"2 :(F,6N;4O[[<WXT(1"<%'9?(#'S?>.9
ML><S'N\8?Q9K (E>HS 6-YVUE)N180AO#1$57;:!6/VR9#RB4KWRE2$V'*B?
M@J+0(*9I&Q$-XLYDG([-^&3,MC(,8IAQ)+911/G^#D*VN^G@SMO MV"UELF
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MX3&D"NZ>A2\OA]\,%,/OSM\W?/Y9OD2BF(BT9&++ ?VZ3X3DZOK^'B /.O+
MD =#Y"FC.^ 2LH\(5VQ+CRQ]U6L80\.HF]PN\L)QZ#CJI'8]4L).2O@N*81*
MX"#^(R9\(^;6<_Q)OY1Q)V7\+BFBP$H)(D)L^U4T=.,C%:[K>*'K]^N8=#HF
M@SI6G*4 F4 Y9]5!$$E*4(TVD7TW??*F'*^GTER=MQZGI]>D=*'?<BABD[1]
MU/LJX!LS=(1*1WUIS37HK-U<NS?M_,0^=^\6;H\]5G.P&5NO],T0?<!\0ZA
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MPWQ&#R27OVPIR["0MVQG\@,C."Z3LM1$EN69&4YR8SDOQY[9<DZ/(DUR\LP
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M"D&S\G)/<$Q8$2!_WU(JSC?% YHSP.4/4$L#!!0    ( 'F"15(*NB1":P,
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MC5OE3H?E-)^0;<,,-%K48-Y9\NFYX_A&WJ\!&1>6?&/&,']T'PJ*;D>OH]5
M7T5Z=HF>D4>ML'%454/]+X ZJZ/?[.1WE5TEKJ&:D-GT(\G2Z9WUQNT5ZFP\
MA5F@SBY0AYI_+7<6C6N4WU>8^<C, S._P-RBKHZN;[$SZO_28Z51?Q/T_O&\
ME+/;>9JF!7TYWY>>W:X$<P@];$FE.X7QHL?9\9DL8W?\38]O[)&9 U>6"-@[
M:3JY=5UI8M_& '4;>F6GT75>&#;NJ8/Q"6Y]KS6> K_!^.=1_@%02P,$%
M  @ >8)%4M35UVC" @  S0@  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N
M>&ULM59=;YLP%'WN?H6%]M!*4\!\A50$J6DVK=+ZH7;='J8].' 34,%FME/2
M?S\;$I(HE'33]@*V\3WW')\K7\**\2>1 DBT*G(JQD8J97ENFB).H2!BP$J@
MZLN<\8)(->4+4Y0<2%('%;EI6Y9O%B2C1A36:W<\"ME2YAF%.X[$LB@(?YE
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M)V$0Q5-_UY^/PRP(@M;H&77<4L>745,IM\YUO8Y/AL5A'(^Q>^"D'3CY#[G
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M-'A'>76SAQK#JLJ/\DI96@S^6-#J1NT"Z'ZME-T;+D'W,YC]!E!+ P04
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MGAGNU),/N!:H^QNF3J1JHH^^^ED:_P-02P,$%     @ >8)%4A*25QD1 P
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M] 87&(^L^WT]T:*T_6DM-'8[.\SPB01I#'!_([ 9-1/CH'UTX]]02P,$%
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M@;J^8FKGJ@=ZGVQ>I*;_ 5!+ P04    " !Y@D52G<*H4O,"  "S"P  &0
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M8 H@Q]=4JBT[J@RKZO3P'5!+ P04    " !Y@D523-W <CL$  ">$P  &0
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MRSG'Y]CNYVS/Q:,L 11ZJBB34Z=4JKYT75F44&$YXC4P/;/FHL)*=\7&E;4
MO+*DBKJ!Y\5NA0ES\LR.W8D\XUM%"8,[@>2VJK!XO@+*]U/'=UX'[LFF5&;
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M<VAE970W-RYX;6RMEUUOVC 4AO^*%6E2)TTD#M\(D%J^MHMVJ%6[BVD7)CE
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M+'(916Q/I79)!,D36:5PBDEZI6COK":9NL-9BS9W<]:B+6JX?DWR^V4>^LY
MEY3)+?#S%0 'KTU1<-82S&OBX0HCYTOSCUJW#/C&=.4"F?WE?SWE;-GY7YI^
M]]W\%1Y,<,7\% ]F5?-S_09A6LA7V?SUXYKP34(%2F&MEA TNNH8Y7E'GP\D
MVYF&<L6D:D_-Y5:]!0'7#ZC[:Z:ZQ6*@!<KWJO$_4$L#!!0    ( 'F"15)W
MBS>&QP(  .4'   9    >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;)652V_B
M,!#'OXJ54RNUY$%(2@5(A>[KT%55M+N'U1Y,,A"KCLW:!MIOW[&39@.DK.!
M_)C_Y#?CR7BTD^I9%P"&O)1<Z+%7&+.^]7V=%5!2W9-K$+BSE*JD!J=JY>NU
M IH[4<G]* @2OZ1,>).16WM4DY'<&,X$/"JB-V5)U>L4N-R-O=![7WABJ\+8
M!7\R6M,5S,'\6#\JG/F-EYR5(#23@BA8CKV[\':66GMG\)/!3K?&Q$:RD/+9
M3K[E8R^P0, A,]8#Q<<69L"Y=808?VN?7O-**VR/W[U_=K%C+ NJ82;Y+Y:;
M8NS=>"2')=UP\R1W7Z&.9V#]99)K]T]VM6W@D6RCC2QK,1*43%1/^E+GH25
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M#OT"=, /F!&^T(4DFC].#RI2]R4I-$+*!X\T%0<.'M*0A(K\]70^1', #],
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M(6A27!X(#@G+ ^3O.TK%^29_0'U"N/H!4$L#!!0    ( 'F"15(.$<F13@,
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MW0@_:VM_L\N+YGW![9LS_0-02P,$%     @ >8)%4I>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !Y@D52P*KN4@H&
M  #Y-@  #P   'AL+W=O<FMB;V]K+GAM;,6;2V_;.!1&_PKAS6068UMOMV@*
MI$W;*5 T09UVE@4CT3$1/5R23IK^^B'E>D(J\H?9W'B5Z&'IF!3ON9>47]UW
MZO:ZZV[9SZ9N]>ED;<SFY6RFR[5HN)YV&]':(ZM.-=S8374STQLE>*770IBF
MGL7S>3YKN&PGKU_MKW6I9OY&9T1I9-?:G6['-RGN]>-QM\GNI);7LI;FX732
M_U^+"6MD*QOY2U2GD_F$Z75W_W>GY*^N-;Q>EJJKZ]-)M#OP32@CRR>[EP[R
MBE_K?H_AUU^X!3F=Y'-[P954VO1G]-?GEO%.V)-W6UO3O9>U$>J<&_%!==N-
M;&_<9>RWF'E?HV^'_=]=([Y4_Z<9N]5*EN*\*[>-:,VN'96H'6"KUW*C)ZSE
MC3B=[$]AO*W8N];81F(?V]VE[+GNF]I;?ZQVW]I87*\-U4MI#ZB/50].!_G6
M;G>UK.S=*_:&U[PM!>L;5WN ,0",CP;(3BZY!YD R.09(9<.PGU LV[%+C9"
M>9 I@$S)(2O1:DLXBNM!9@ R.UI++M?<;\D<0.9'@WS+]=J#+ !D00L93=F%
MNN&M_-4?ZZ/06?EC:SD&X6<!(!>TD/&4+;=-P]5#W\/RII7VD]P&S;.R[+8>
MY L ^8(6,IFR+VZ_[>Q+KFP4OU*\U;QWHQ\EHSF*XW-:R'3*+I78\(?=H]CW
M=G7GHF6 "%5#[)K,(=H+N":\K/G>C/:1W+A/^IA(.!&Q<?*IU?2=T*9O29\*
M&28B5DQAA[-9"\7.M [E'"&G1,1264S=2%5;.S;>_=PXO01HR"01L4I>3-EG
MF\)J.V@?>'_K1RXDCXC8'M%\RKZVTK"+U4HHFYWZ8$@8$;4QG#+L\+1'VAOV
M27 MV"?)^_Q>AOV*E!$1.R.RTO@B]>TNR'VU$4X96\<,$9$P(F)C1%892].5
MMW^]X;N$JW%C8YCWQT@8,;$P(FL,EU*)=5=70OVA^TAL'GP^9(N8V!91YN)P
MV36"7?&?0=_&L!XAUD-D_? /5S8%"$LD)(>86 Y1X?*H:RU^;%W!^>YN8*X8
M*2(F5H1MKP]=5]W+NF8G2[$Q+)['\SXV_^DS(E?$]*XX%]<&\B%GQ,3.@'GR
M]]C'1 :)CUESA)C((/$QJX[OB8^)+!(36P2D].SD*ICZ0"))B$4"T_J@TQ/D
MDX38)V%:[QK0WE_[(SQ!6DF(M3*22(\RPEDN8LT,,^J^HQ\S1A\3"2<A%@[,
M8\,'$CDG(78.2A)MU_N82#T)=;F2.S<J><?=/#M[+UL;@22O[6C21OE3- E2
M3W)4]?@Q/4'J2:B+%XB9^IA(/0FQ>K A?<P4J2<E5@_&S'Q,I)Z46#UP I&=
M^)A(02FQ@F"^<>[/GZ3(0BFQA7"^X8_T%*ZV$%L(8P9#"%DH);;0,"TZ%X;+
M.L@Y4J2?E%@_ =]_>.RSJ\"MD'Q,I)^46#^#Z=DAJ(^)]),2ZV<TRQSK<B2?
ME%@^3]+,,<(,>2<C]LY!PEUW^YC(.QGU%-IPICGD]#&1=S+J&368K_L!/4/>
MR:@GV2"F'] SY)WLJ-6/GQ-E<)V?NOHY/(L_2#8RI)^,NOK9%VF#\NSW./(Q
MD7XRZNH'808E;X;TDU%7/Q S&.E(0-ES+=^,8OHC/4<6RJE7<""F/])S9*&<
MVD('%II^@_J8R$(YM84&ZTV'G9XC"^74%D+3,<%(SY&%<FH+04Q_I.?(0CFQ
MA6!E'K8F?-^,V$*#ROS,3;N.OPR2(POEQ!;*!K7DX<6T'%DH)[80Q P['5DH
M)[806C>UP<E_RQ!9J""V4#%64C[B^IC(0@6QA19/2K:@27U,9*&"?AGH,&;P
M;!;(0@7]2M#H>OE3IQ?(0@6QA2!FV)K(0@5U+?2T3O>!?4QDH8*Z%HI R;;T
M2[8"OO=,70O%XVGQ[R;U,9&%BF=XC>T@9OAL(@L5U+40Q/03N06RT.(Y:J'1
M(J,']3&1A1;/4 OM7QX;B4H^)K+0@KH60IC!L[E %EKT%IKU)^O7KRJQDJVH
M/MM;:+N_Y'5YJ9C[XZX4Q6GF7MI<;>OZK=UWT7[J>+7_Y=;^5V>O_P502P,$
M%     @ >8)%4C1..WUZ @   #$  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<\W:36ZC0!"&X:M8'""XJZJKR"C.:C;9CG(!Y+1_%-M8P&B2VX_E
M+.P/S6(V$=\*-8CB7:!'"'CZ50[MN.].PVY_'A8?Q\-I6%6[<3S_J.MAO2O'
M=GCHSN5T.;+I^F,[7I;]MCZWZ_=V6VI9+KWN[V=4ST_W,Q>OG^?R/Q.[S6:_
M+C^[]>]C.8W_&%S_Z?KW85?*6"U>VWY;QE55?QQNNX?ZNDD/E\G5XN5M5?4O
M;ZFJYPX2")+Y@Q2"=/X@@R";/RA#4)X_R"'(YP\*"(KY@QH(:N8/>H2@Q_F#
MTA)E7!(D3; FT#HAUXG ZX1@)P*Q$Y*=",Q.B'8B4#LAVXG [81P)P*Y$]*=
M".Q.B'<BT%M0;R'06U!O(=!;)@_;!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ
M+01Z"^HM!'H+ZBT$>BOJK01Z*^JM!'HKZJT$>NOD90F!WHIZ*X'>BGHK@=Z*
M>BN!WHIZ*X'>BGHK@=Z*>BN!WH9Z&X'>AGH;@=Z&>AN!WH9Z&X'>-GG93:"W
MH=Y&H+>AWD:@MZ'>1J"WH=Y&H+>AWD:@=T:],X'>&?7.!'IGU#L3Z)U1[TR@
M=T:],X'>>?*QDD#OC'IG KTSZIT)],ZH=R;0.Z/>F4!O1[V=0&]'O9U ;T>]
MG4!O1[V=0&]'O9U ;T>]G4!OG_QL0J"WH]Y.H+>CWDZ@MZ/>3J!WH-Y!H'>@
MWD&@=Z#>0:!WH-Y!H'>@WD&@=Z#>0:!WH-Y!H'=,?A8DT#M0[R#0.U#O(-"[
M0;T; KT;U+LAT+M!O1L"O1O4N_E.O8?Q\U"&6\_7&J__G52/EW/+[?+7Y=?.
MR:URQ;F^KQB>_P)02P,$%     @ >8)%4B!P#MDD @  J2\  !,   !;0V]N
M=&5N=%]4>7!E<UTN>&ULS=I-;MLP$ 7@JQC:!A;-?[6(LVF[;;/H!5AI' N6
M1()D4N?VI>0D0(O42. "?1L+-LEY(P[PK7S]_3%06AW'84K;:I]S^,A8:O<T
MNE3[0%-9V?DXNER^QCL67'MP=\3$9F-8ZZ=,4U[GN49U<_V9=NY^R*LOQ_)S
MZOVTK2(-J5I].FV<L[:5"V'H6Y?+.GN8NC]2UD\)=3FY[$G[/J2KLJ%BKR;,
M*W\/>#KW[8%B[#M:W;J8O[JQ[&+'@:7\.%"JSY=XI4>_V_4M=;Z]'\N1.H5(
MKDM[HCP.]:GHU?GD7&Z83I_\XORES+G LO,V^I#*Q"*]/^YY)//I=2B%*.;^
M_"N^));2%[\?S=/NJ'MC=KG>GSX>EGDDMCPNO^/?9_Q2_YU]") ^)$@?"J0/
M#=*' >G#@O31@/3Q :0/OD%I!$54CD(J1S&5HZ#*453E**QR%%<Y"JP<15:!
M(JM D56@R"I09!4HL@H4606*K )%5H$BJT"15:+(*E%DE2BR2A19)8JL$D56
MB2*K1)%5HL@J4615*+(J%%D5BJP*15:%(JM"D56AR*I09%4HLBH4636*K!I%
M5HTBJT:15:/(JE%DU2BR:A19-8JL&D56@R*K09'5H,AJ4&0U*+(:%%D-BJP&
M15:#(JM!D=6BR&I19+4HLEH462V*K!9%5HLBJT61U:+(:E%D;5!D;5!D;5!D
M;?ZGK#^\/_SC^.59CZZ?GO/9\@_]FU]02P$"% ,4    " !Y@D52!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( 'F"15+L7(UZ[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'F"15*97)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M>8)%4AT^,KO3 @  [ @  !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( 'F"15('Z2599 <  "$B   8
M          " @1<+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " !Y@D52[\# T_,"  #G"@  &               @(&Q$@  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ >8)%4O*<]7-H!0  IA,
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M965T."YX;6Q02P$"% ,4    " !Y@D52VR([<7X>  !*8   &
M    @(%R1P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M>8)%4GTF7X)""   [AT  !D              ("!)F8  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " !Y@D52]*(8<8L#  #C"   &0
M            @(&?;@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( 'F"15)KY]R!4P,  , &   9              " @6%R  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ >8)%4MUT:*P6#P
M"B\  !D              ("!ZW4  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " !Y@D528Z\S5+,#   #"   &0              @($X
MA0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( 'F"15+-
M'QGTJ ,  $$)   9              " @2*)  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ >8)%4DE3U#!I"0  ]1\  !D
M     ("! 8T  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'F"15(5/+)]@@,  &$)   9              "
M@4:V  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ >8)%
M4EF"$,75!0  30T  !D              ("!_[D  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " !Y@D52QCH_*3$$  !<"P  &0
M        @($+P   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( 'F"15(HCTXYL0D  (X7   9              " @7/$  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ >8)%4L'Q),#) @  Z@4
M !D              ("!6\X  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " !Y@D52P'R5QK8*  "3&P  &0              @(%;T0
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( 'F"15+/(B2F
M!"   *YN   9              " @4C<  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ >8)%4@+DDF?N @  BP<  !D
M ("!@_P  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !Y
M@D52*5MO;XD"  "'!0  &0              @(&H_P  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( 'F"15)!2*)Y/ ,  *8'   9
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M970S-"YX;6Q02P$"% ,4    " !Y@D52K&&@(>0"  "E!@  &0
M    @(&H&0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M 'F"15*8V4;9M00  "8/   9              " @<,< 0!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ >8)%4HM92!_B P  4PH  !D
M             ("!KR$! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    " !Y@D52'>HI,@(#   ;"0  &0              @('()0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( 'F"15(NH;.#@@,
M !(+   9              " @0$I 0!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ >8)%4O(P:NJW @  #PD  !D              ("!
MNBP! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !Y@D52
M6?+Z(:4%  !=%P  &0              @(&H+P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( 'F"15(7'>_4G@0  #\3   9
M      " @80U 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ >8)%4HN4C;YN @   P<  !D              ("!63H! 'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !Y@D52R[G!+($#  ###
M&0              @('^/ $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    ( 'F"15*GLYH@1 (  "0%   9              " @;9  0!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ >8)%4F0YC"JK
M!   *18  !D              ("!,4,! 'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    " !Y@D52 28+//\#  #\#P  &0
M@($32 $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( 'F"
M15+U4H?CG (  ((&   9              " @4E, 0!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L! A0#%     @ >8)%4KHX:S7/ @  0PD  !D
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M=#4S+GAM;%!+ 0(4 Q0    ( 'F"15)SDN#R*0(  ,8$   9
M  " @9A? 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @
M>8)%4K;;R=O) @  K D  !D              ("!^&$! 'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"% ,4    " !Y@D52&().M=H#  "O$@  &0
M            @('X9 $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4
M Q0    ( 'F"15)2H0]RN@(  -0'   9              " @0EI 0!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ >8)%4KU^KI,! P
M$0H  !D              ("!^FL! 'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"% ,4    " !Y@D52O_2 K78$   /%   &0              @($R
M;P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( 'F"15(*
MNB1":P,  /@,   9              " @=]S 0!X;"]W;W)K<VAE971S+W-H
M965T-C N>&UL4$L! A0#%     @ >8)%4IQU&R*A P  [0T  !D
M     ("!@7<! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'F"15*@0%O8JP0  ,\3   9              "
M@>B& 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ >8)%
M4A0N;,S- @  -PD  !D              ("!RHL! 'AL+W=O<FMS:&5E=',O
M<VAE970V-RYX;6Q02P$"% ,4    " !Y@D52E70=/6$"  !7!P  &0
M        @('.C@$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0
M   ( 'F"15(2DE<9$0,  ',)   9              " @6:1 0!X;"]W;W)K
M<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ >8)%4KL98YB* @  @ <
M !D              ("!KI0! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q0
M2P$"% ,4    " !Y@D5215H1)MT"  !4"0  &0              @(%OEP$
M>&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( 'F"15*=PJA2
M\P(  +,+   9              " @8.: 0!X;"]W;W)K<VAE971S+W-H965T
M-S(N>&UL4$L! A0#%     @ >8)%4DS=P'([!   GA,  !D
M ("!K9T! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " !Y
M@D52.DK]<8@"   E!P  &0              @($?H@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( 'F"15*B%I5XC@0  .02   9
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M970W.2YX;6Q02P$"% ,4    " !Y@D52#A')D4X#  !="P  &0
M    @($3N $ >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    (
M 'F"15)C."(IMP(  %D'   9              " @9B[ 0!X;"]W;W)K<VAE
M971S+W-H965T.#$N>&UL4$L! A0#%     @ >8)%4@'*^VLW P  _ H  !D
M             ("!AKX! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"
M% ,4    " !Y@D52G']H-6\"   >!@  &0              @('TP0$ >&PO
M=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( 'F"15*QYD/P. (
M ( *   -              "  9K$ 0!X;"]S='EL97,N>&UL4$L! A0#%
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K 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !; %L ]!@  "33 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>273</ContextCount>
  <ElementCount>385</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>87</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StatementsOfOperationsAndComprehensiveIncomeLossSept2020Note</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (Sept 2020 Note)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Shareholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StatementsOfShareholdersDeficit</Role>
      <ShortName>Consolidated Statements of Shareholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity</Role>
      <ShortName>1. Organization and Acquisitions, Business Plan, and Liquidity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - 2. Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>2. Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - 3. Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RelatedPartyTransactions</Role>
      <ShortName>3. Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - 4. Prepayments and Advances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PrepaymentsAndAdvances</Role>
      <ShortName>4. Prepayments and Advances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - 5. Property Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PropertyPlantAndEquipmentNet</Role>
      <ShortName>5. Property Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - 6. Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/Investments</Role>
      <ShortName>6. Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - 7. Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OtherAssets</Role>
      <ShortName>7. Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - 8. Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/AccruedExpenses</Role>
      <ShortName>8. Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - 9. Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayable</Role>
      <ShortName>9. Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - 10. Unit Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/UnitOffering</Role>
      <ShortName>10. Unit Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies</Role>
      <ShortName>11. Operating Lease Liabilities &amp; Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - 12. Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RisksAndUncertainties</Role>
      <ShortName>12. Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - 13. Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/Stock-basedCompensation</Role>
      <ShortName>13. Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - 14. Shareholder's Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/ShareholdersEquity</Role>
      <ShortName>14. Shareholder's Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - 15. Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/IncomeTaxes</Role>
      <ShortName>15. Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - 16. Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/Warrants</Role>
      <ShortName>16. Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - 17. Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SubsequentEvents</Role>
      <ShortName>17. Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - 6. Goodwill (Sept 2020 Note)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/GoodwillSept2020Note</Role>
      <ShortName>6. Goodwill (Sept 2020 Note)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - 9. Debt (Sept 2020 Note)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DebtSept2020Note</Role>
      <ShortName>9. Debt (Sept 2020 Note)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://urbangro.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables</Role>
      <ShortName>1. Organization and Acquisitions, Business Plan, and Liquidity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - 4. Prepayments and Advances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PrepaymentsAndAdvancesTables</Role>
      <ShortName>4. Prepayments and Advances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/PrepaymentsAndAdvances</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - 5. Property Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PropertyPlantAndEquipmentNetTables</Role>
      <ShortName>5. Property Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/PropertyPlantAndEquipmentNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - 6. Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/InvestmentsTables</Role>
      <ShortName>6. Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/Investments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - 8. Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/AccruedExpensesTables</Role>
      <ShortName>8. Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/AccruedExpenses</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - 9. Notes Payable and Operating Lease Liabilities (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables</Role>
      <ShortName>9. Notes Payable and Operating Lease Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables</Role>
      <ShortName>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingencies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - 13. Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/Stock-basedCompensationTables</Role>
      <ShortName>13. Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://urbangro.com/role/Stock-basedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - 16. Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>16. Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetails</Role>
      <ShortName>1. Organization and Acquisitions, Business Plan, and Liquidity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - 1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityDetailsNarrative</Role>
      <ShortName>1. Organization and Acquisitions, Business Plan, and Liquidity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OrganizationAndAcquisitionsBusinessPlanAndLiquidityTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Property and Equipment)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Details - Property and Equipment)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - 3. Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>3. Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/RelatedPartyTransactions</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - 4. Prepayments and Advances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PrepaymentsAndAdvancesDetails</Role>
      <ShortName>4. Prepayments and Advances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/PrepaymentsAndAdvancesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - 5. Property Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PropertyPlantAndEquipmentNetDetails</Role>
      <ShortName>5. Property Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/PropertyPlantAndEquipmentNetTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - 5. Property Plant and Equipment, net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PropertyPlantAndEquipmentNetDetailsNarrative</Role>
      <ShortName>5. Property Plant and Equipment, net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/PropertyPlantAndEquipmentNetTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - 6. Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/InvestmentsDetails</Role>
      <ShortName>6. Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/InvestmentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - 6. Investment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/InvestmentDetailsNarrative</Role>
      <ShortName>6. Investment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/InvestmentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - 7. Other Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OtherAssetsDetailsNarrative</Role>
      <ShortName>7. Other Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OtherAssets</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - 8. Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/AccruedExpensesDetails</Role>
      <ShortName>8. Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/AccruedExpensesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - 9. Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayableDetails</Role>
      <ShortName>9. Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - 9. Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>9. Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/NotesPayableAndOperatingLeaseLiabilitiesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - 10. Unit Offering (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/UnitOfferingDetailsNarrative</Role>
      <ShortName>10. Unit Offering (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/UnitOffering</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-Lease</Role>
      <ShortName>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Lease)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetails-FutureMinimumOperatingLeasePayments</Role>
      <ShortName>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details - Future minimum operating lease payments)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - 11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>11. Operating Lease Liabilities &amp; Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/OperatingLeaseLiabilitiesCommitmentsAndContingenciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - 12. Risks and Uncertainties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RisksAndUncertaintiesDetailsNarrative</Role>
      <ShortName>12. Risks and Uncertainties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/RisksAndUncertainties</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - 13. Stock Compensation (Details - Grant activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationDetails-GrantActivity</Role>
      <ShortName>13. Stock Compensation (Details - Grant activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - 13. Stock Compensation (Details - Grant vesting periods)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationDetails-GrantVestingPeriods</Role>
      <ShortName>13. Stock Compensation (Details - Grant vesting periods)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - 13. Stock Compensation (Details - Option activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationDetails-OptionActivity</Role>
      <ShortName>13. Stock Compensation (Details - Option activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - 13. Stock Compensation (Details - Options vesting schedule)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationDetails-OptionsVestingSchedule</Role>
      <ShortName>13. Stock Compensation (Details - Options vesting schedule)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - 13. Stock Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationDetailsNarrative</Role>
      <ShortName>13. Stock Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - 14. Shareholder's Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>14. Shareholder's Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/ShareholdersEquity</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - 15. Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>15. Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/IncomeTaxes</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - 16. Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DerivativeFinancialInstrumentsDetails</Role>
      <ShortName>16. Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - 16. Derivative Financial Instruments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DerivativeFinancialInstrumentsDetailsNarrative</Role>
      <ShortName>16. Derivative Financial Instruments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - 3. Related Party Transactions (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RelatedPartyTransactionsSept2020NoteDetailsNarrative</Role>
      <ShortName>3. Related Party Transactions (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/RelatedPartyTransactions</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - 4. Prepayments And Other Assets (Sept 2020 Note) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/PrepaymentsAndOtherAssetsSept2020NoteDetails</Role>
      <ShortName>4. Prepayments And Other Assets (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - 5. Investments (Sept 2020 Note) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/InvestmentsSept2020NoteDetails</Role>
      <ShortName>5. Investments (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - 5. Investments (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/InvestmentsSept2020NoteDetailsNarrative</Role>
      <ShortName>5. Investments (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - 6. Goodwill (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/GoodwillSept2020NoteDetailsNarrative</Role>
      <ShortName>6. Goodwill (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/GoodwillSept2020Note</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - 7. Accrued Expenses (Sept 2020 Note) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/AccruedExpensesSept2020NoteDetails</Role>
      <ShortName>7. Accrued Expenses (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayableSept2020NoteDetails</Role>
      <ShortName>8. Notes Payable (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - 8. Notes Payable (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://urbangro.com/role/NotesPayableSept2020NoteDetailsNarrative</Role>
      <ShortName>8. Notes Payable (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - 9. Debt (Sept 2020 Note) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DebtSept2020NoteDetails</Role>
      <ShortName>9. Debt (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/DebtSept2020Note</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - 9. Debt (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/DebtSept2020NoteDetailsNarrative</Role>
      <ShortName>9. Debt (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/DebtSept2020Note</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - 10. Unit Offering (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/UnitOfferingSept2020NoteDetailsNarrative</Role>
      <ShortName>10. Unit Offering (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://urbangro.com/role/UnitOffering</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - 11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/RisksAndUncertaintiesSept2020NoteDetailsNarrative</Role>
      <ShortName>11. Risks and Uncertainties (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationSept2020NoteDetails-GrantActivity</Role>
      <ShortName>12. Stock Compensation (Sept 2020 Note) (Details - Grant activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details - Option activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationSept2020NoteDetails-OptionActivity</Role>
      <ShortName>12. Stock Compensation (Sept 2020 Note) (Details - Option activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - 12. Stock Compensation (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/StockCompensationSept2020NoteDetailsNarrative</Role>
      <ShortName>12. Stock Compensation (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - 13. Shareholder's Equity (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/ShareholdersEquitySept2020NoteDetailsNarrative</Role>
      <ShortName>13. Shareholder's Equity (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - 14. Warrants (Sept 2020 Note) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/WarrantsSept2020NoteDetails</Role>
      <ShortName>14. Warrants (Sept 2020 Note) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="urgo-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - 14. Warrants (Sept 2020 Note) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://urbangro.com/role/WarrantsSept2020NoteDetailsNarrative</Role>
      <ShortName>14. Warrants (Sept 2020 Note) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>urgo-20191231.xml</File>
    <File>urgo-20191231.xsd</File>
    <File>urgo-20191231_cal.xml</File>
    <File>urgo-20191231_def.xml</File>
    <File>urgo-20191231_lab.xml</File>
    <File>urgo-20191231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>101
<FILENAME>0001683168-21-000402-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-21-000402-xbrl.zip
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M2<YYZ8+78O+>K#?F,OS@/MHNP@N<PIC9=]L ;R8(KI;_VMJ!G4N/EFSXR'0
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M@LZ;'CA_RW!K.E^1OV[:B[J)%?S7.^'OAT!VBUV?&4626L4[<:9(+Q1IH)8
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MB[?=O'A1\;W,FJ:GB+;F71*+;IM+XJFS5QY/#'?5LL4, :LNZ? X:A\-B(,
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M+'B-7VAZ'M/U5Z\A0-/<NJ:I"UD;8.-]<.D?3W:(JE@S#U*Y)-]%%L$]:S!
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M(?2C"VV,[U=L@"9H@2PJ(-3"V]G!31(88?'S,Z'$#W9F/S'P?A+#7%($)GO
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M(*5X!$PA<@>1O.E>]@?.V=7Z^)39.E8J:-&1$5M,5G2[Y"+Y.\:HR1R/#V:
M29=5VIB2?MS:.U*U.7(O4K5(!(:IDX&3WD\T<P' V(S#]I>]ML.X?S$Q,LQG
MTW9H7=4K:'P8F01S7T#=4_D,MNM8*1C\][0%;T L%C.JW(+VQ\A^!NZC)SA1
M&+H2_?@9LS?1-(_XV$',C_%^\"_Q3S7ZTVA^0,%;\>^>?^04NCS"1"+]?^'5
M8%R^1FKJ^<?(R R""!?$5L(6AL(8'!)C<-#GKA((MBX4QY"N[&E3 S==$90
M8N;B<,3'HM5NZ8?!:Q"B=4#*S'QL#U/%3)9ZE^"EYE*8X"N\'])H&MLS_K,-
MU75D64(NNC953^F"U((HR"@#()%EM?$1:7\-YSTVQZ$C/?[C:NLX1&EC141:
M.>!U,6>88"J]4A.L!IL2.XBU?+CLHM26B5:C"Q,8XH7C91DC3^5!6051.PT7
MZ]LEL56(ZEJ: 6)_#)VZ3?SE$@LREGW_E;$*STQ_85<R+7^28U>253OH&_9
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MSVK8W[6Q]!OXA'W@K$*6ZG+&?N^JYCW5\\)\*;?&K\K:) FZZY D\:AZQOP
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M[Y E_$".GXZG::^4K5651]18>;?!HZHP+&TK-M1N!J^1'+\D<MB4I:B"[SI
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MT!J_D_X5&]MK?*Y@ZWVYQ?8W8BN))8[)B7*D[59<.1A_KOW,41=FC(;Q1]/
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M2+JH]TR1IN(D2:)LL +?%Q3-CCM%%R2M#5_<N$MOC3YA4[$/,;E0=)57^2)
MTH7:@=)45"XDG><5O4AB.X+26%XN,(M@6-1A0&DD-!>"#"GF >C35' N!'P,
MZ:(X#"B-I.="YB'MWH@^-] "#P5ACQ:BQLN9BH?<$LT!:"HR@F 8JE 7 %),
M_MESO2RN>D2((BFL&U&]8&?HFF)+E%6V1F)8Z)KK'$%6#9TM-AL>P&::2)$5
MC:U!')B\S?63+*@:?SC^:ZRU!%55)*$M@(-*+C[Q=*Q+&-@& :NQ36 HF1#9
M$$"UD%1>T10V(3046,WD4S(D01F:@LVE4E0T-K-P ':O@RL-FU5\<ZA2\P)6
MOL:0V.X6/Q/9'YX;O$,KST?T=U_-;RCX\ U[OYYOV:[IO]Z$:$UJEO&3ON<X
M9#EZ:/<BQCKTG- R5XD' WA<U+1P+[#3=0ZH::[0)$,Q=%T\#]0T4ZJJ(8NZ
M</J8::[819TWE*S[<[JH:7:Z*)I@R+P\'FKP&Z+SZQUR44\I\1U2[ZS2'I:F
MVGQ 6!JKSX%A::2OAJ114PTQ,"R-1+(Q+)]1V'.D=<<TRRS1=/GNYD_?R_\C
M>O@?3+U.<:>);X']UK6=O[P)_2UZP_W4Y^(E5TX.#\@7%)JVBZP/IN]":Y<:
M33=ZIE$!AQZ.1E6+'Y1&58"TH5&O8MR#J=YU^6[F<%<&[6AR]B@?;<RZOG'?
MB3&')DTGX!I1#BNGC8^>\.%L/T<F,?[Y[0J?V<.<Q!4+=@.M^RD]%&@]:)XA
M0>NFE0:C9W>--21H';59?=!BR8]O.[PS WMYY5KO;6<;YNJ_ZPIIV=V+"_Y2
M8IANS]+= =TKLA6 "NKA -TOP%6 RH<%M%J<*P#E#TGZO=)=A5'AL(!6RWH%
MH&)KC,;3 */A?W2ZXNV*/,G<=.NL#,HNAJB2H/-LH[AV  VVJVK-4;8K69=U
M49KLKO:HF=)+/!JO&FQ9V?1V5:&32G>%_\&'YE1WM4>!E<J5H"F\H4]Y5Q7:
MKO1*&U3'2WW3JLF=YO)@BR0(LB:(JM+F:MZ^J\5-[H+W ^+.3<9>0-0:A*Q*
MD<?+:N;.9Q^0@<)068>X#62Z+O&&IO</F=$9LOS]RYX8KCO.%,QHZ@"BT!UG
MJJ$+,MNAO!0R_]%[>^V8+S =*IH,\PN,@4$6?:3/8'L)M!)6]T0F]L'2 >;*
MZ%8+F-.>G=V!WFTW5C]:4Q:-[F>U^N'Y[)4&<I%@#P@#0=HHEI^OP1H/['HQ
MS/ZHW5H>BMO7#HFW2E [D+L9W)$>O;+^N8WZSG_U2A8G5;1]1%_U;'^(VFL/
M#'-O2;O! &O/%5-'>3<]T0 Z<G@]F &R( R+W("4!7U!_]K:@1VB>^0_VTMH
M+V-[UA>T]!Y=\I92Y=?XOB2V1V7V]L'00$\ 1XVOVT@R-D&5<\?10?71(??3
M7HW-G'&Z:O.HV;VW,IRS/RRZUQ%-DST:Y;,5WA %X]SH7EH)TUZ"1D8D46*T
MC=K[K8]9ECY%(RAQ*C"[S@$"4XJB9R/=S:$<9I]M3X6R8!;TG,I$"R>RT=ZC
M=I*@JMKT]EDIU&WV*:C\83B7"',GQFUX*O4#1X?(ZM!PM(S"*>Q=Z>; '7QW
M'0)WQ[;57JRQP>2O;=07GQF3H\(PWL7%T>UU.AS79YZ!+;N<#A'^+WMOVMPV
MDJ6-?K^_ E'CFK$C(!7WI?Q.1\BR[%*_MJ6QY*[;]\L$2"8E=($ &XM4K%]_
MSY(K"&X2*=*6.J:G90E GLP\>?*LSWG0O5T%G7-X/+:SR,MWMI./F>IVMW4=
ML^SW(,7X507T]0-=\9UZJV;C[&Q,Q"XFL:FOO-7>U!VZCRD\J6_O400^_$Q\
M9SOQ9+ZTAYS;+6S'/DYWM:PC;K^8$OS 2B_2-@1;L]MK/,3G]3C*#WJ]GCZX
M\+33>O@Y>6&60XDW[&1NFT%@UVJUQO/FA1THR_M=5<P#,]E?LJ?+AR3]E 3Q
MM4@G7\4=? >^N#@O=MMN^8[)4-N LHTGM+6<G6:]N1G!<YF!6Z?WH=9XYT"G
M\8C[J]X@+.M#G-4N_55\*$Z3^$ZD2.'%F'_.PT$$0F$(C\ZU+=_1>:[7&NWZ
MNE&9E11OX ;9UNR7B^].NUMKKHZNK4?1'F;W8,]=;?6>'OZD'W%O=]KMOEW9
M]MVNP>[ET,F0U1$4E6O4%C9!T?K?(:A!R>1_SR?38)B?Q3= H<#OKIW&4.HS
MN#:!NYO8XU,S#F!.V\Y.:+1W.B<Z,@_8II7%'^L0/3?X;FE^:!#]@&?R</G<
M[_</>6([#U8^X!@OY_EV>\\LO\6H:J-]N#-Y1$)PN]5]S,30W#F#7^<S>N1B
M?/:G2(=A)B[3<"A.LBP9AMAC^?<PO[4TC_=B(.*\6-\]L'02B(?4[4N3[5'4
M//6TMK"#/\#D'U_3^2Y-_A"IC+9D+HG(S4$\%([JNUT&;'1['8($>"0M3SNE
M;5@TW_?$MW*COA?35"")L(+8.'&2 %E_/2:SLV0T=EI=*^5XR7"/(VSCHKIV
MJ]Y\ L(V!CRL]^K.G;:S%=L4N:_>;_;;#UJQ#T&8\AVL??T78W5$M@P1OW2L
MQ]*U*9,UFS9JTR:DG8-\B/,DG?V>AKEXG]QOY33"76OW69\?Y$%4;-X_N-VL
M;YN*C<]9M]&PNQ9M:2TV/53M;K/=V("*CR#Q$;KV(GX?9M.$]=F+,=PS(L_J
M6U%'&RT;3W+Y@(^F[A$-&'9+V0. :EMVPOJ.UVWSQJ]V#\*-B#N/AZD(,E!4
M^'_/XY/A,"E 9GT50Q'>!:#$;(/Q>JU^L]VVS\+J<;=$ZL82K-FO=_=!Z>9<
MV6DC)N)>5G53'NWU^ST;9W,KI"J)NJ7HUU&KU6PV&LN(M$9\+'4;*[6=;JU5
M>QKB-E=LNXCM]T0KMWF3S%:CVUHJ?3:A[C(54S!&WXNQ2%.PT+CE"VC)A ;#
M<G8KJ1@-(+NYC.IU*-G9=#9&0NIU>JU#G<WF&F:OU:@O/8U[W9S-CTBCV>PN
MO4JV,A\EY"^#&4IX-"V'P[00HT]A, BC+28R=.N]9F^=^V89*3N;S\9]IFMM
MI^KYL*:SN>;2:'5K[?7T@;WLSZ;GIU'OM%KUI:K# ^;S1>2G079[F29WX4B,
MWLV^96)T'NO&]"?#/+S;VIG!?LW=5M.Z)]<??ZN$;]SA!+%E'8???@A_@%E9
M:_3J]>:^"=_\NNAU&OW^%LB&PZ"R@S&$EPKX!+R4SRZC(,[AC&"T9XJ/;"73
MH=_HMRT=9/W1MTKVQI[&3K_5J^V;[,UM CB6MB6]I]7>E+>;O:Y3\/EPLM-D
M*,2(VK->!9&X&.^6N1MU)T5D@^&W2_@CW'[[HODQ_5GWMLZ;,G:KMB7^0%$O
MS\((W[:R+[;!R*U^MV6W!%L\VN/H>@2?[HJFQ_#ASM9I8SY[Z/[-2=KS. _B
M&PRD;\^KTJHU;$?TRC&W0>/FH<5.=YF:L@,:'R4!GV(--[;(W 2_36E<H-&B
MGS#;@>F%WM-^J[%2HZX8?ZN$;VQZU1L=T$U76S [)GQSTZNLG>YIP3>WO/JM
MNAV+?##=]OUO)R_IS-,M)V^L'&\;]#T2GG]3&A<L_H<PAC>W+B4:_5H;N';E
MWE<,OU6Z-[[.:MV&L\S[H7MC&='HU]N=^FHWQZ[7>V,+%A>\7=\"W?06I5F7
M_9E;N?6ZS5J]U7=5Q>KA'D77QI=:J]OM-W=.UP.\YLUVTVX*NJ/UVEC5:C8Z
M73NVMS9=H(2)%.XI3.X%)MT.TE6C[@9^G"$V)V#C.'V]W^_4MT? QFS2Z=;J
MG?865V!C?NC76ZT-5@"[0E\'?XILBVS@AF9+ SR(@D>X"[9#P6-,M"VMP::<
ML!8%U+VI*F?>A,@4!\G'Z!?)EE554_N^!8)V/+>'\.+69Z5__57DZ-S9UK&M
M_OKF8V^LIIK><0M'E\S\%=N^7HQ!C2+GP<6 BS7.X[,_A[=!?",^)*D.?GW"
MBT\%>6?;R0SJU/J6L^ 1Y.QV8H^0F8<ZI\=(X4.=T^86!C)@>Q<3 ]&3I\$P
MIPH^ DT0J7[VM$C3<C#$;3Z\TIYKV?FRZPRV)?K6$D"-?@_6=1_TK<7)K5JO
MV[;ESH/HFTQ"1@2#>P<_ !PAP HMF;[+MW5%W=N&@SRL>\!F@RQ:X%6 >E;A
MU<48[NS\?9A1'M%E*B9A,=E*2*39:-MMHU<.N@TB'W$U/(X^[?4X3;+MA)3J
MS6:SW5A(H#O@(VG;VK(MI0H->(S^W@41\7=^&J3I#!Z>AP;;0/Z6@I6+!W@T
M-0\(YZY-C7N/X>IM)WNCV>Y8893Y4>9@W"0ZXK90#B5$T=^#B<@^)?=BHS;:
M-BC=FG3-S8<+/^@5*T:\9J_ 6L^:P]EH]E=P)>(L267AM/H+#719I*"59(()
M70?NNE:>XQ):MSLO9V\.9EZ702XTA.!ZX@!MRQNDI\0^#3F\\\F-QIH_[(O&
MJBT;2QX\E=]^'?S)@6%S$I,L(\$P3M+[(!UE5\7@7V*87R=G?T[#=+X6VUT+
MM57_%$$*O^VL!6&)2>Q.6?9CB-O33+OKH#74>R  6_N?Z9<D?]1D>^O >-8Z
MM5:K^:#)5M.WO_GVUX&G[]7[_0=N[EKSK880/L'B^QN!&OJ[F7E$9H*<X.<9
M2^8\SD#[)DV>:EFNP625EYB$2HTYFO&[0#M7C$[N@-P;07]\#[)$%_]OBO(A
M 0)<65[EI/LMB48BK40!N5QP+S>/'8"K0UFB'WKKX+TX;]DSV63'&L=VU.1@
M5N8[VK$JYUSUCOU(.S)?:[34,;.5T'VSUVS4EA:G+J5A^S/8.$S;ZCHMX?8]
M@<W+*^I=T)J6EFP^\19LC%O1:/>7E]MO,@$[=PNT!J$*[;:"K=-=G"=FC_4(
MDC;FWWZ_L6.:-F=)>*RSXW7:F,D>MG47Z4T02V<9<&&61.%(H6%=PE4!4MQU
MI 71%?R&KH$,W9%1DH'>=@W4OXLVB%#_[3^C_.W4R_)9)/[[IS&\]*M7KTUS
M[SJ<B,S[(NZ]K\DDB'W^A>]=P94Q?NM-@O0FC'_U\-':6P^'.@JB\ 9^-108
MUOWI/V_RM_CQ7Z;TTW_4F_+_;7U !, *QS,]X@!_^')Q?>;5_S.83-_^1[U3
M>\L_]1KU^EOOXNO'DR_G_]_)]?G%%^_DRWNBZ^3T?[Z=7YWC[ZY\[]VWJ_,O
M9U=7WN6GDR\^/N1].H<'WI]?_Y-F-=C3_,R$]K*V(?Y@,ZL7Q"//QD,ENL+G
MMSI%.@CBHYLT\3VX6(Z]UXKC&K6W]\+7_P+^L_Y29/9?B,RD2.V'D]0#[<U^
M![7!()Y9#[WQPLP+O$@$(S!JS2H(@_P.4BH#FKV,>]J@FY:^ A\/<B]$#Q;8
MNO+WD?C3$_%=".8%"I@@(L*$K@[+9AF(GLS+$P^OSEQXMZ!">F!5@QT]P2QF
M^.(H =*'192'=\PIXV"H2N#'<E8W43(((AQS@L"J\.,M!@WP+9!FN/1_B/S8
MNRCP2W@?$R%Y$$8)V/.^-\72L2.4.&DX](+I-$V"X2W2Q=.%)T#^PJ>0;)]X
M54T5*9IRABJN709K!#? -(&_>\G8"[A\7JD?P3!-,G@NBKP@FXIAGO%>C:LF
MFK![ 0X#DP[2O. _C,=@57OC(AXRRBA^FC;@5D333,X1'X%%!%6<U@@H#V$M
M[ &B<"R&LV$$;(54C$&^J]6=>?:FXX3EQL.::+KX]\'L*$^.X'_D:+A&Q][O
M@LF$-1D7,%VR-G!%F#C#0$0WF!]$@F:@D7</RA,\%<$B.40;]L'18>E'!3RA
MU@;.V_UM"'MW#YN0PGV:AM$,_EJDP$PTP?PV3.&](,4U$\/;.(F2FQE^C"B
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M'19";07_I=F#(Q<" PSPMH)+J!@R*^MO=*QO!&'JC:/D7O^9"'K=M1Z!^Z/
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MD[$(^<_;#NJ?QM6KQ/^3B9TN!N 6H?TJT/PD14O@%G>,ZO=D*: ;JQ9X7)?
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MU]\@]\WZ(FI?K1JS7GZ5"*=W&XT&+%=GY1<6C;W&R3S,B5LJUO8GOPV&_MW
M-U>O3IFDQ=+@$Z5?J;QJ],O+8&+5I!\E4M84(P]EI4V^:[;Z=;W1])O]]B93
M7D#CFV>T;.N<D/57;J=G91/AO_K8-([;ZN DZ) &Y7OM!3#O/GKCZ5/>*"E
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MFXH\3E30\4FIG9,!H)IKYB8K/<=C((;J*O$J"*2?6'Z6,O=+(V)I0<R=(XA
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M.9Z(:G*UO,:N"J+\*>"LU\?2KC<7 AUT4#U?^?YW"N>]>-IH^&QYUMOFY?5
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MB =3.PN';HOZ^TI%@?K'6P+/5*@2$3K4$6;>J]J*MNJ;1_!V&PS<:?$]_O#
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M\[[9@\*T7,'9\N<>(VAE!O?WIE-NL,P[$ B[VPZ=&'+@^N;"&W E55M2.RO
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M[<>;$QKANV'PQW52;F_02?F=ANEYQ^ DF?2 UG^I_Z)/\!/V#GZ"#L#U1W4
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M+Z)[%EM':S#0FYT^D4 KZ33@%PA76WP=6O8:8FCL%D-CUQ)([$1#M=#8CRC
M17'98\"_>>'9L<=J/@1N;3/ZMI2A= 3NL>W#KB/P]E9XW%6%4OX^M8,5SA 9
MQ!T\9+ ,WT-\W>%2I5RJ[][;@$T[]1P8,Q"=QINM/1=+55AUQ\"IM31@:LGC
MDI&IXV\_]+$8.OH:.F) UMH^0:S3T:N)% 7!FA:;%[<ZMNY,Q&H]"ZE:M64*
MH?'6#UN#4G/&"(9F;!;KN\")B#,]CF<M\*:#=,3J33C4JHF+4Q##H"8R#MTQ
M($G@2J%F(#I3P,IXLPL83FE)P=]$61<!T1 ZWE9#$*/,K"F],!0#K@E[SIC!
M=H&Z9%P>4\<<=6X8/8P4'0-/9)C7X?-SU%,?[I,8XK*X6/J(*&9YW/:SPQ(O
M\]F^>R34\78G#1]G1]3Q[&C;::".&QL'S0^@<6Z@XZHDG!O >&^ >&'94<\*
M;. .2,+TT?-&$V\VGAF<N'H::^CP/!+2:>FMHD4PSQHX?-61VU[$GA-R>(\D
M+3](W@&1PZO@>.]O[JL,L8W'*J<F"PJ\: U:>M/H8&^L,)8>BF' =<\6/GLD
MP]LZ:UM9G6#YL2_2MRR\<>8WZ>+ 72MW:C44LX+:==1+]2'1N_9_O>YWS@#+
MJR .]QZQO+*]I*VQMT^%80(?*\8NCI45^]TNB&$U?U/YNRT66;F,/5+N?+M1
M&K)9COA<Z?GM)2&;;:I'KT2J^YZ1S:J>Z;\?9+-]K+I&-DNPN:FWFYVU(;33
MJF(87+8K!M-6'-NLM,VHL<W6<KI& GN.*ZJQS8Y>HG'1'/0*-2'(KC8H=*4J
MS+8C8IJ=4 '+P3'-"F )/7-,LP)O.>>+*M32^\V!WBW0/?CDD'+*!S5KY>\U
M='+<*@U7J+%G)IT\J%FM?U!.]'8+_)U>C6M6!-?LC+E5'JY9?N3;T\<U.YT,
M T,?& C0TBHMQT 6\QVR6/@^' ;67R%\Y.9Q4QFP,8C*@.'?1O-URRBG#!@\
MD1P/TWL2B=R3#_$?K#BX%R\._O'N_N;_?MQ\_4Y$W?P#_G5/Y Z/3_C^,R8*
M\>_:M\;V0KO"HB24S/VSJ9K)-;>N]L$:^JPRU!"JYLG2Z-44M(/M8I4I4>)8
M"_B=9@J>:1>HDH0$-ANK3!5_,MZ^PJI(JAJ=>;RZB^LR'1\2P>'QO2?+U[70
M'YKN:_ KM6O3-<>F]MT:35WP+Q]L6.XG=W0I"U _P?='"^W&A85:L&KW0:</
MT(@/L"33Q4)4ICD=S'+Q6776DI5VPL*2*_C,/J42SDKAWOGV^ %ONA]LE^J@
M:")&2J"9XYGMVL'"-ZD0U7Q [HA4&S[FREQ7#PD6L3+%)!-A-Z;V:(KE=&/+
M]6 BTMJ@[HE!MNF"3^@XIL\LPL7U"R 92Q2!O;Y-58<3[<)^A=5?S=>4\J,%
MEFM3?=<HQ#T>6S-<(Y4).AX,.#%'K-K/9@6+L&DAU;!IUR^:ESUM9CL.FI(+
M^*DA?GK%*24RL"!V$E)B$8QA+S#+:&$#SY>B"!*M!S*4*C63O/F.I'P&4E3^
MO*6=N+#C:^'$^Q86$E+E(V.@6 ,OS]/".5JZZQ>=R[9"?WN5?C@Z6'JMC7WS
M"5@!-D?#.C^RD_#_NBA@Y(:3V":JG5V8F2XG@44" /0Q%K+B[<36LH)I*QCY
M]A 8-0E]E$N8&\OGDRSY)A?X@:],5YA#0RV\!XM&$!62FN2CK@XEZ.$#P<&*
MB>'STH"410>'RH$O+$(?I5X4#R,'%1Z17(.LH'!0&:_I.S9+<,+SQ011CX14
MUB$OIG _A2-I-$7*G3E9\#IC]1CH;.-,;>XM\+@ 34 T>%8HJTS:B(C8H,WV
M^D%7!.F+6.9[^.NJ_HD6K/'%FGY4',QKD4W7#4V'B*'J7O@3N.MV,"4( 1)J
M8#0I*EX-_\YT_T1.??4>3>U^Y,'J1&$NJ"DX7JSL>.Z$ ;[58\TIS3*[U*Y&
M(S]DIH@1P36($H!DU=E@ A!DPE'TU2)U1=HXM(C.N;FD^ %QT"%]9_H^)E#I
M8A;'A!F'6.5M!:""32K3M4S4$_@EMM]>=,AC['V&9VE53PF%RHU\A""!]Q/^
M.^2@J2AQN+> ;(/L@#B,0U]4A*N5[-&V@MCXWJ.-QH9.!1L4OJ,""ZS2%3O0
MCCVSN;B:S B:CZ;MF$.V!*Q_#AT380&PH)YI_B"<B<,_:+S$?]I4TPUG8#1"
M"0Q@12/+?D09TYE2Z'?X![&DAIPDI.+!-\>6\N& /@T?[[&/>Z36,T9]?*5U
MV/06;(F-\HS#H_.SY.KH\15W@H* *:QKM'P=8?J8Y_"BI1A#]KTK24'H8N(K
M@P-@QXL +.2,>-ZQ@/ROT)[S^G'R>M +BGX9+ .XUP82G8#9S8MWQ!=IJ?--
M!7L^@?4 L; C$E&$IJ7M8G,S311-R)1<II!R16+-39L\%U;,CPH0S#-("BIH
MT#NHHRV8%[YGHAE?,A<AAZ22G58MLS@=T:2L^AEG8Q,3#6)B,:WBA'0;J)8(
M<0*^X()J':$$,"4U,O%F'WUX9/D(%*.-X-C"20>W/_):0-52].$*1F+*/8H^
M7+]HQ!PGN&]%LL+7F<)5 D9A!\EA$$:3$"L$E3/Z#'6D"..$"*KQ;T*UF8.S
MB)SEK 3A'EG6F#D=S >-"0W!\4SX7<3Z:3.D)ANTW1".#9HJ';%+G) ]SVFJ
MH\[4&[D:_[L<PRDR_1F_>W"Z4'CY/4.8-?E)]FT0&K@[^'"FP6I*=U/X'7P1
M<.+< $L/T".F0,YL[JA.0=(AOE0RFP4'R ,G$A*V'$$X)$()\ /.$,%ZH#J&
M'\&TP\7HR8VX@[S1/'!3'DP.XR$\-91+N(U9/FB2)\__DZX1YMQ>P,_ST)][
M@?4<Q53E%=]2*;G"KB8N$M+#$G=+LNL3VP<G"IQEEQOVBQ2--$>A6^!FX@<#
M] Z3MZ@5@:&P HR%?B#ZRPXSZB;JSHE ?;$6*^33;8W/^S0%:[-\#:*"45,8
MRX9+M6];R2]16.')<AR&S"(<!@RYAGY *"D!V2(>>K L8=#>@75WK*7VE2"S
M AZ1N)[:U@0SS4<A10UN)Q-0W'YBUF<H=JO79"?P2'_ =@61Y>*V&CR_@(,9
M66!$ X3PX>A&3^#,HV!P;#*+8LO(X+$U,4.'Q6@FD? 2ZT$\79-L%,6K8%?\
M&8_KP,\N@HGA#R,/1L-R/!8%BI2ML-0D($2)'GV81=W)2? T5'4+B^EP@N%Q
M4#N"$L*E>/Z#Z=K_9C%[DM>IZ3Y8 J_']YR8?F54C.#N(LP(/T4NNA1,5[-I
M5"/QS*0+1Z>2P2N0JS''9=+NP,#800#>,MQ.%VR;[T-\@T4;*-SC>*CX; L/
MUT(5@N"Y%LE;9/,MIL"DZY(:Z8J_7L5CRZX24<:?<6N$#R3VQ?52 AF)?8M%
MF\<2:O)VM/#P(0U1#QGV(:KO&2MZ%!!\#9U##@ZMQ9-EN2O&XMKQPO$ Q&*.
MCIH(,[L4U<28)AD/HP'7,#!(?S.1WY_A7LLCQ!(5,6F'5F+"2!=JA]08^J5V
M!Y8F-%T9>US]O*Y]\2]I;L96<HTHBC263E1JH"O);7(Z5ZI[Q,3T31F83D3#
MQ(5$*4[E7WG#;IKF*^0\^SJ/WZ(FQAL0 Q^#,6=X(^9^(@NA*Y?YI'R]Q:O2
MQ?!5G*18*$:RGKX:/]**&HQ>.#/?)'=XN]P/A+%\_"KP=-C)>#K4#O%L6(S@
MA-+;&U79I'PQ7?.!::@I:@_P*8- ACK9;8D'GX@2UZ,@A0T.'1[60$J(<$'P
M[L*N+&/VCLYC1OZ8NP97]]=:O]/923#?@YF_\QQ[M#S.<WK54+7W,6/<K;CV
M7,J6PU@'FJ1@_[["T=T"-6X@ Y2$H[N@2[]@"#\8"_3%%Q'(+L9;P4J,(M1/
M>?%G44Y\&$-39*J#,1/%WI(1O50F(L,%8>&',W;($@>**&CWP-;CR1!@U^&<
M!>]MG_OFCRI4;)"&'4N!! YOC+"G+'&&'FBE+H@!OHJX".'5BELA_4$=( %=
MFXB@1*'#.#'\CH/Q'L0<7>H)0C+P:1D5E.OS.@:7>JE=)_C,\4ZEUG&6V@@F
MM1D.+VP"?/;?E&44I$+MXMR"2B0.;\R$[29?SUG\$8,MICU^C=%)%GR1#V+P
M!00J]V3EL<DV ;4G/?7($!G<YJS$^T]2;BZU&XJ,IL@F@=8"(4M<CWC IP"2
MN#V9H+1="Q0[OLZQ(>AY;F*Q.^.%XLV]N_X0SR088\B.H<2N;F0D#T1.#/L7
M?V\O)-BO)"VY-)U"_(QJ@E]G-U5))0G@I?9NW1)HN]G37I1-QNBPZ270AT-F
MCQCA G"<[2CMC(OW3;B'!F3B"F\NN&?A2-ZZ>-P'Y8V AM?OK':QHVCP-U#Q
M77Y*W-3/!GBM!TZPX"**!G^K,,6#/BQ?RCVR::WDX-N ;RG'";XM7CR)#)ZW
MIRLG.MIC^38ZLQ93;ZQKWJ-H=$KI"7R](N=O92V;9(+?'?"\2\QBRG(1ZE/S
M1FJ0P11Q?G)XZ$M22 CJF7.4#3-:,KT0$!9TJM.3XLPDW!U,![)]/".W_GL;
MY"DPG=O)9S 1G]&*7%$@L*+^4!5B(A'_< .1;Z\=,K^,<\\U[*'Z-Q;#8$=T
M=YFA84NV"</N1*SCT6>4> L/I(A ^CR:%V!@>V3[HW"&+LR(?C&&6X-(\,A0
M?A@TP:'I\1 .,-XD\'PAE@GV42!2OF=\=X5 /'PXB#(".A-PP;9^,E=,>>U>
M,(AZKB%1EXB.'T'L.09.<^@LXN]786!%@5A\2!_3.;75ER^BZ%*[<A7.RE<%
MU2(%:FH:N)'LZI_",+$O*0L7ZT-?-;+&J0IH&_7"-=38LM_<4*#HF_5 :8+N
MXJLYLW('"&12)$MP_.]?LT9<F?#:PG=OYY,[MG[^W5KFGK'1:!B]1K?3;*N3
M)4939GOOC<CK_KZ<YU_6_6OCURLVOOK]E45\L!W+OX8S\>#Y^9?P%3Q;N )8
M#@'\CS4:15U-;-B52>]G<"]Y)_)^\DX*EP]+G2,VRLH<-S,+==##1]][6DR%
MEMEVKM315N?\^1TO%73F[E@+@+P33DPGB,^X,M;*=""OGC_W? JDWR^ V]=X
M)OWE-5PV<L]\?:M.NW;,A%?P&3E_.V%1OVOV9!V;]@K^JDP%NLUF?_AQ__X7
M<"5'-FQA@%AROW4;^)]():2-G9C^"_PIG*$/1O& '0DP.H-NLZ]0D#Y\D@6@
MHS!S ,D5U&Y+0;/;Z[8'+84'*8.OY\%7F3JP+1']?LOH9S(A&C]!!_WUCF7\
M\3*5.]/'A[_=23(:"=G(,UG&/JE?W9Z>9J,;D]64P1/SWV*2V4>6!G'ECJ]B
M2>TWO&HHYXE=1YM"59XIRZ.R5WDJ\?+1BRX?.?:YV^NWVL<BU3@PJ<*0@FT;
M\K?9:WD5O<;+.'7S@5]?X;6;A>R#:W*U/[E7Y UBN5KJ5S[;/-G3*$/(C4XG
MI@\.1'JE&%;HO#UWAA4^^L^<5X5TS]%Y1<H.++\WIT^Z#^C#YK\!KEM;!WRR
M3D*MKLZT$SV%#G*S;?3V1TYQ"VDT._W]TE/,#!J];O[M\A^\-P1[03T4OGOW
M\)E@LKSB#VW<D6.0RCDW[P\^]1^L:1^-_H6R/!2ZV8@JZ9^^?OCEMT&WC4>I
M"%7%5O(/>@TI00H+44JS[H_07!Q/\^$KMX K^9IS9]KC3^XU>\K)L9A!M[7K
M<ABJZ0?/_XR/2]\LEO=Y,-GO\ M>+GIR$E^:N+>,7,058>P!)+Q3!9*WE^E6
M8[#5"J[8&Q]Y#.1*B+>X]]80 ^.^A<$[SZ6W@IPO5.MO7D;3&/0XI45F+Y/J
MOD)U/P?5C>/2NU58XYC\+>J(](V&T>WN0#3W8.)?9?@(X,<0 @S<Z]^+M_0R
M>-SJ]KM=(_*>\LY='LF[7#V*4HL;DW'1*#$<)R_>FZ?;B;"M.)>?)L[C.YX]
MAG/&XO-EL*K9;/3:K6:THYFSK:/*,]U2#D,S&7->F64+*G:1[V+S1^\&I>Z1
MT>@.&JJ.V#AK"526Q[4<]'$LK:0&*8-YW5:_T>XJM&7,M3U).W$J'S68*O2)
MYY?2WS^Q!Y?Q>RK/QO<7,YC>^O0>8SK\Y^]1JF4IG.QU^TU%4^Q,U $6N<O>
ME+V^CYXWQJR/"&?N\'45>8LINK%:BH^WM^]___3YLW:L:H6J9$O)A+\'OI>4
M[.2Y_PK=*,%3UI'9(&:83V6._@KM*"6(@WQ1H98_FFH]5H?$\C3EP$/3H6SR
MK+:BE'6T6LST)& 4!XVFWNCV+K6/DE26$B73,6E"WV*_CR:F1'<6&UR8/Z-B
M\5@Y_=@>R_PJ?TQP$4INTV@*K.49E@HF8VP*RHNG!(OL=GVT1N)-6OK2FO.D
M>G4_8!=N)Q-"4SM.EF1:L5(C=L!^?/WT7;O]\.'FVZ>O'_=\RE8I.E0UTOIS
M=B,S?_]FNH3>-Q EC$I](<\;Q@)- IE80?"CT]>&+85_\[B'AAK:M1 !B54Y
M?O?PSYXN /G4#'?VU7B2^Q.>D^%2#"NK$%FZ/YQEGKDG:!0[VWN+"80C)PQP
M67/''/'J;\HSME>K3TU,9W_$5,GHPQZ77<QG!CZZK":$ZP[B#ZL"8;0QG4.\
M<>575XHRQ7F(%9A*1+D77>QIA/^-,LT#TZ$L:#Q- <]S)S06_(62-1YE)KXP
M: 2U]$+>O%<(DG]1<=LPJ=1,_52,;BIF954G#$[[+@368++^[SQ5G95H)J:4
M?U3'4A&X$7%#C 2WI,MVER'0DD*.36@N-$0::A#$%WV&5)S)%1SE@3YYVM(2
MD(:2K7("K(%@*C9B!>68(ZX7%O0R#=\T>-I] L&L_U(G>$2/ 10R,#-GR3=*
M?I) PECVJ*B834[* <MX[1.AE W#!;A,',J'C:2S_%4S1-P"PE)WEB(%G];N
MQNHD1NHMEXJD64TU9R+C*F;BKU1V(.]>-"_;AL+;S 1]QP9#.\;R6$K'O=2N
MDK_29A:X9V\TK-==J-ASLG@WZQS'-AQ,IH,5-+RBQC>ISH,#?D5XQ?194  ,
MY@#QBVQ"O>)JAUM!/$&\=(@R_P*."CE\Q2!'&)"#38%8%)A8N;0XR2HV#E]"
M1"Y5&3N4/SST!+!-Q&@"Q>;?YX3P(A55%H$D91S\Z^^R3FMJ@GX;8I7Y. 1!
M0$0Q>V(+[#&?)_32Y@>XQ!G7?]'R-;9TG4KGGH0B(<T3\8#5EV)U'$R"7+?H
MH"9Y\N/R_E+]FF,^(?@='4C?"S"A.PPDW*@9]VPFMD.&126:5R\)PJ6#=W]S
MC9L>.2Y&3YHLCX_ :U;4G4Q'';B5>OX[ILFG,TTBD<*EQ3$1<2 JF)&P %U)
M!.SL@R4!O))G0>3EPW*''@<#P<^]:.J=+O6U0UH5&2#-\&( CF6K)\3$3$(9
M/EF^K"P2B B&;H [VC%:VLJ13QQNMAE"L@1$"NP'EM2;B/\F=+2E2: 41@LO
MR^,=4363=T%E.D,JDUSG6R31O^BLU^H37HP6<,0;KD^60=QAS71#M_%3CWLQ
M/*+C>A)U]?F\6$UXL!Q,(]V+13". WF/Y(NLS' $5Y)A_L2+$"O@2A)94BL=
MU95D^R7<22VG*TE:.=V7]'QK"U^2J3KR)[6=?4F+@4=LY4YR0X1(V(=W)YDI
MIA)H7OLM?4OM6'XENX+YJ\[5@?U*%OZ)^9;:P?U*Q:V.?,ND1W8 OY)=^U)\
M2^U@?B6OH,ST+;7#^97"><SP+;5#^97<_*[S+;4#^)5,.#;XE@1 )?!LT[KI
M@(Z4ZYN:8W9NQ(+&6WFD)AQ\:GT#!Q0(P7]0;U+<7/Y@93KW0H"46M%AA9Q7
MJO"6:]'D8C1U-9I<3J0Q:$W[+1(_UI-'ON<.1(8B$&>?P>82_@S]B>!D!2.E
MSR:9.1',C+1+L*)._=#A^A_T4>B8,5165(%X(N0DRIA $3YAL*NR59@.LOE2
M'*C!@>UFGE]O#GXP8M5P&X9&!'P19!D-EX3,<#U_)OH(H&XF+:E\GD%PHG(S
MG4 #;6T% 5X3V/&GBFT5\G.=:HEX$UNT>#D*II8EL#PS/JIP!2'9Y]RE$KT_
M9D#)%)LU$!P'/0E=.%X0O-*SYHX/2,IMZCEJ QJ@G+F.!,TA0(=R#*84Y2??
MCSC#^),6K],/N)Q(KR,H+BK!U N=<01'\& *3!BQ<3:U6"![AUP".L7L!';
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M9.U=;7/;.)+^?/,K>*ZZVVSMZ-6Q'6>2V?+KC'>=V&<[R>Q]F8)(2,:%(C0
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M<^SYEY3-S_$4!2ZX[(\ N61*L+-G^8C-L"^&$U\@&Y=(BX8D\CP* Q?FJ+!
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MG5?0!KA*9=-*IT*6@\)@YJ UZMYCFWJ.)IK1532M[(E'Q;L'NI!&7]6TPO_
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M>!$G6?$DSF1&[RH[Q2G;77.9H 7.%W*< *26,W\H9& CN(;>6L%5<G!! @J
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MN#P) O60[X55DY*+%3>I4$&#%%\T >G2!*8XF$[_0[=2_O,O_P=02P,$%
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MICZ2B1VY866%3+NOD,Q^ZWCBY-(5^W&%;/(:$F],QBGA?+P-+Y*S7_,QDMH
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M"8([$A!&UC/CN 1X6MT[]T*\/E<0J&9?B/_='CT['O'?LERKH)1T,OPN0GD
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MHK5+3"=4T8!((&4]KO4\"/@VD3,A\:8/G!)1=\0+K#[Y$ @?6P-!:G,J&.F
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M#<.>NG80W$P24^;&O^,%;Q2/*28GG14]#272]$]JZ]"/TK=M[@9"XV=M2U*
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MVF[V[Z<T"*]I^&\2WI$1G7IR=6KLD]C5JEG&05_=2 *$\_9,749!$(<8RF=
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M(=3G)%\.Q%/5:CY([=?TN?FF:! *2UVVCA3!!5_>#&)#NX##:[R"NDRI+EM
MXNSTT^-7_U9KGB"NB^A:$C7:)XAIH[\R_?_WK]_LOAR,E&R!NBXQ:2!^P,MG
M3#35HI7V2#X+XC;A-*)02&:&UR=6+<T9]81G+UF>YHOMCESHKT(?!K%N,5W
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M4)JX,"0D.1RWV%9RB%UV!G./),I@+&  4NBI )  QF8'U-2W2?3,$LXEV.8
MHY3T2 (#TC8C%&)0)@\]M#Y-6I+06.+F'F-2",,9!T<9O31 !@USF4F!$:J^
M/[N/MNSBR^VJLR\<X&93C5=UD=F5A$(@(SJM%\5*2$-A#EGC6.X)^A+KY/WR
MQXRZ1R&U," 6&0$JB,3D$1;WE""'H#&^%V;5<,/38*\+DQX@TKEB-?M;0!K-
M+O*,3]^_).5+G3BD[E9;,PG=5'WZGPXH2\<_U4$/"@D'8)678D(<Q7C%'D+
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M6:7 9YXZ,Z90>T;"H%-UGMD//6,Y_I3% QPTZS"KSI?[LD"/E34PY1AIS^6
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M"K-L ,VT*J)@\\P]R6<8Q](JA\7 5K6$21[<O.($5I'?CBN)_25I-Q2([L[
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M387A"V"L>%TL)'<N/X?GK>:[7RA[;:7UQ6&!H]EIM*!\,51N_] -\NZ)TWH
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M]V5; :"M;?BFO@W?'SC53M869O[X[6>2/K#HQ/6$*./_'OEA^K5T$"JWG_9
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M5%99'R!V>&Q%:@:@P&GB\3<P$TH83]X%@Z7L"$0,CVT(R H4L&V29."(R?H
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MD'D6,/]5HMZ\+--IIR$'E9#7!_>L;]#V!SPE&_)-H^*GY!E/!-MO?,VH-YZ
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MYWLY&O*9['XV0,:Q7(?8^.$ YZ5UF7"3>M961%$F&C:J\[,7WC;#.>OQG,J
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MLO$LI)0%*/0%,#P=83%F\.@."V8X>($49AVX6#[&T2IWA:F@D7:R;!?I#A.
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MCVMZ$3$K&7_\1:!GU-I8%E?[QJ!)()*[M9#)RF<DI0G)'^O7ZB\'3M'?*0?
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MYIRQ=59&(=[0=7<VGY,9,[!<DWC&N+R0V <TAQF*P;,3=U"<A-LS_^RF[&'
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MGCLB#9O/\.SIT<\C1MG\)&[R]M9#"6B6T8H"C.W=^HWXBX>4>),5_>V",&6
M!6"PD/DB4AYJ[8",A#_4N2ME0P$X-\>5?V3%2"0[47^DH00]=^61=8O5C9_\
MSE3X+_2LCU,ZS11LDGK?,$D='3A\/&YJVAH1EZFIE6BU:4G1#8'-8HBF)! 8
MH^D(E>$!K^GH) K9!9H+2VQI'3^KLX"EG8:#BI0,%(:?Q@PA^<#23BC0 2PZ
M%538\H*IBNYEL[0Q3[&E8:W:2_M9=T\J%V#3N 9@A!F+PR1+Z=2H('G.HF@7
M_-OR9UHD'6"<_P4#YQ64F&3Y-"0G64*_36(IIUO:09<V$@X+*36TEL.(O; *
M8JZ@+9#!!F/H]):PC&(4FGW+O75,PMG#THU_UY:8:CU17,Q=Q:8:+2@JJ32G
M64Y26X!J]$0!%G0U*N&K4V?$U46/SZ\D]"+E-;'="IO\(UA$M8NBC5*CUP2
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MT<+6EG5(U7*I:I(*BLVH^RPDZS)R0_GS,K5&EM4!'::VTX="!> B\"3TV/2
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M@C%/6')#5B3,R!61W"@;QUE+<VS7O0H4*3&(T)G,>/PEG>2,^"MV!*L $O>
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ME+79< 196YV:,P&N3R3&00L@#6.%OA"Y%.ZY.[1IGMP[3T:'7M/59&<A@R<
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M,#$Y,3(S,2YX;6Q02P$"% ,4    " !Y@D52$D,:H%H3   BY0  $0
M        @ &<%@$ =7)G;RTR,#$Y,3(S,2YX<V102P$"% ,4    " !Y@D52
MX+Q[V;H5  !O, $ %0              @ $E*@$ =7)G;RTR,#$Y,3(S,5]C
M86PN>&UL4$L! A0#%     @ >8)%4G*2^TXQ0   Y<T$ !4
M ( !$D ! '5R9V\M,C Q.3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( 'F"15+8
M/'QUKUT  %BD!0 5              "  7:  0!U<F=O+3(P,3DQ,C,Q7VQA
M8BYX;6Q02P$"% ,4    " !Y@D52'LFCP)%6  #5= 8 %0
M@ %8W@$ =7)G;RTR,#$Y,3(S,5]P<F4N>&UL4$L%!@     &  8 B@$  !PU
$ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
